Last updated: 2022-08-20

Checks: 6 1

Knit directory: genie_ras_hallmarks/

This reproducible R Markdown analysis was created with workflowr (version 1.7.0). The Checks tab describes the reproducibility checks that were applied when the results were created. The Past versions tab lists the development history.


The R Markdown is untracked by Git. To know which version of the R Markdown file created these results, you'll want to first commit it to the Git repo. If you're still working on the analysis, you can ignore this warning. When you're finished, you can run wflow_publish to commit the R Markdown file and build the HTML.

Great job! The global environment was empty. Objects defined in the global environment can affect the analysis in your R Markdown file in unknown ways. For reproduciblity it's best to always run the code in an empty environment.

The command set.seed(20220803) was run prior to running the code in the R Markdown file. Setting a seed ensures that any results that rely on randomness, e.g. subsampling or permutations, are reproducible.

Great job! Recording the operating system, R version, and package versions is critical for reproducibility.

Nice! There were no cached chunks for this analysis, so you can be confident that you successfully produced the results during this run.

Great job! Using relative paths to the files within your workflowr project makes it easier to run your code on other machines.

Great! You are using Git for version control. Tracking code development and connecting the code version to the results is critical for reproducibility.

The results in this page were generated with repository version 12e3255. See the Past versions tab to see a history of the changes made to the R Markdown and HTML files.

Note that you need to be careful to ensure that all relevant files for the analysis have been committed to Git prior to generating the results (you can use wflow_publish or wflow_git_commit). workflowr only checks the R Markdown file, but you know if there are other scripts or data files that it depends on. Below is the status of the Git repository when the results were generated:


Ignored files:
    Ignored:    .DS_Store

Untracked files:
    Untracked:  analysis/table_s7.Rmd

Note that any generated files, e.g. HTML, png, CSS, etc., are not included in this status report because it is ok for generated content to have uncommitted changes.


There are no past versions. Publish this analysis with wflow_publish() to start tracking its development.


Table S7

HUGO symbol Codon Cancer type Group variants (n) patients (n) Mean Median 2.5% 97.5%
KRAS G12A appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.02
KRAS G12A appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.01
KRAS G12A appendiceal cancer 50-65yrs 1 161 0.00 0.00 0.00 0.02
KRAS G12A appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.01
KRAS G12A colorectal cancer <40yrs 7 565 0.02 0.02 0.01 0.03
KRAS G12A colorectal cancer 40-50yrs 28 1280 0.02 0.02 0.02 0.03
KRAS G12A colorectal cancer 50-65yrs 70 2815 0.02 0.02 0.02 0.03
KRAS G12A colorectal cancer >65yrs 40 2055 0.02 0.02 0.02 0.02
KRAS G12A cancer of unknown primary <40yrs 0 167 0.01 0.01 0.00 0.01
KRAS G12A cancer of unknown primary 40-50yrs 1 211 0.01 0.01 0.00 0.01
KRAS G12A cancer of unknown primary 50-65yrs 5 810 0.01 0.01 0.00 0.01
KRAS G12A cancer of unknown primary >65yrs 8 797 0.01 0.01 0.00 0.01
KRAS G12A non-small cell lung cancer <40yrs 0 161 0.01 0.00 0.00 0.02
KRAS G12A non-small cell lung cancer 40-50yrs 3 585 0.01 0.01 0.00 0.02
KRAS G12A non-small cell lung cancer 50-65yrs 67 3677 0.02 0.02 0.01 0.02
KRAS G12A non-small cell lung cancer >65yrs 156 5698 0.03 0.03 0.02 0.03
KRAS G12A non-small cell lung cancer Age:NA 0 10 0.02 0.01 0.00 0.06
KRAS G12A breast cancer <40yrs 0 841 0.00 0.00 0.00 0.00
KRAS G12A breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
KRAS G12A breast cancer 50-65yrs 2 3989 0.00 0.00 0.00 0.00
KRAS G12A breast cancer >65yrs 4 2583 0.00 0.00 0.00 0.00
KRAS G12A breast cancer Age:NA 0 10 0.00 0.00 0.00 0.01
KRAS G12A soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
KRAS G12A soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
KRAS G12A soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
KRAS G12A soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
KRAS G12A pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.01
KRAS G12A pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.01
KRAS G12A pancreatic cancer 50-65yrs 4 1000 0.00 0.00 0.00 0.01
KRAS G12A pancreatic cancer >65yrs 9 1205 0.01 0.01 0.00 0.01
KRAS G12A leukemia <40yrs 1 204 0.00 0.00 0.00 0.01
KRAS G12A leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.01
KRAS G12A leukemia 50-65yrs 1 515 0.00 0.00 0.00 0.01
KRAS G12A leukemia >65yrs 3 720 0.00 0.00 0.00 0.01
KRAS G12A melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
KRAS G12A melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
KRAS G12A melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
KRAS G12A melanoma >65yrs 1 1259 0.00 0.00 0.00 0.00
KRAS G12A head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
KRAS G12A head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
KRAS G12A head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
KRAS G12A head and neck cancer >65yrs 1 582 0.00 0.00 0.00 0.00
KRAS G12A uterine cancer <40yrs 0 57 0.01 0.01 0.00 0.02
KRAS G12A uterine cancer 40-50yrs 1 162 0.01 0.01 0.00 0.02
KRAS G12A uterine cancer 50-65yrs 17 1046 0.02 0.01 0.01 0.02
KRAS G12A uterine cancer >65yrs 13 988 0.01 0.01 0.01 0.02
KRAS G12A non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12A non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
KRAS G12A non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
KRAS G12A non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
KRAS G12A myelodysplastic/myeloproliferative syndromes <40yrs 1 87 0.01 0.00 0.00 0.03
KRAS G12A myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.01
KRAS G12A myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
KRAS G12A myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
KRAS G12A adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12A adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
KRAS G12A adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS G12A adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
KRAS G12A ovarian cancer <40yrs 3 141 0.01 0.01 0.00 0.03
KRAS G12A ovarian cancer 40-50yrs 1 253 0.01 0.01 0.00 0.01
KRAS G12A ovarian cancer 50-65yrs 6 1092 0.01 0.01 0.00 0.01
KRAS G12A ovarian cancer >65yrs 4 849 0.01 0.01 0.00 0.01
KRAS G12A esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.01
KRAS G12A esophagogastric cancer 40-50yrs 1 200 0.00 0.00 0.00 0.01
KRAS G12A esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
KRAS G12A esophagogastric cancer >65yrs 5 725 0.01 0.00 0.00 0.01
KRAS G12A thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
KRAS G12A thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
KRAS G12A thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
KRAS G12A thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
KRAS G12A cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.01
KRAS G12A cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.01
KRAS G12A cervical cancer 50-65yrs 1 144 0.00 0.00 0.00 0.02
KRAS G12A cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.02
KRAS G12A hepatobiliary cancer <40yrs 0 138 0.00 0.00 0.00 0.01
KRAS G12A hepatobiliary cancer 40-50yrs 1 110 0.01 0.00 0.00 0.02
KRAS G12A hepatobiliary cancer 50-65yrs 5 525 0.01 0.01 0.00 0.02
KRAS G12A hepatobiliary cancer >65yrs 1 601 0.00 0.00 0.00 0.01
KRAS G12A kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
KRAS G12A kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
KRAS G12A kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
KRAS G12A kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
KRAS G12A mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS G12A mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
KRAS G12A mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
KRAS G12A mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
KRAS G12A cns cancer <40yrs 5 1602 0.00 0.00 0.00 0.00
KRAS G12A cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
KRAS G12A cns cancer 50-65yrs 1 1439 0.00 0.00 0.00 0.00
KRAS G12A cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
KRAS G12A prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
KRAS G12A prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
KRAS G12A prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
KRAS G12A anal cancer 40-50yrs 0 12 0.01 0.00 0.00 0.04
KRAS G12A anal cancer 50-65yrs 1 88 0.01 0.01 0.00 0.03
KRAS G12A anal cancer >65yrs 0 45 0.01 0.00 0.00 0.03
KRAS G12A neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.02
KRAS G12A neuroendocrine tumors 40-50yrs 1 55 0.01 0.00 0.00 0.05
KRAS G12A neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.01
KRAS G12A neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.01
KRAS G12A bladder cancer <40yrs 1 25 0.01 0.00 0.00 0.08
KRAS G12A bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.01
KRAS G12A bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
KRAS G12A bladder cancer >65yrs 2 962 0.00 0.00 0.00 0.00
KRAS G12A b-lymphoblastic leukemia/lymphoma <40yrs 1 142 0.00 0.00 0.00 0.02
KRAS G12A b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.02
KRAS G12A b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.02
KRAS G12A b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.02
KRAS G12A small bowel cancer 40-50yrs 0 29 0.02 0.02 0.00 0.05
KRAS G12A small bowel cancer 50-65yrs 3 96 0.02 0.02 0.01 0.06
KRAS G12A small bowel cancer >65yrs 1 78 0.02 0.02 0.00 0.05
KRAS G12A sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
KRAS G12A sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
KRAS G12A sex cord stromal tumor 50-65yrs 0 37 0.00 0.00 0.00 0.01
KRAS G12A sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
KRAS G12A bone cancer <40yrs 0 342 0.00 0.00 0.00 0.01
KRAS G12A bone cancer 40-50yrs 1 61 0.01 0.00 0.00 0.04
KRAS G12A bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.01
KRAS G12A bone cancer >65yrs 1 67 0.01 0.00 0.00 0.04
KRAS G12A vaginal cancer 50-65yrs 0 34 0.01 0.01 0.00 0.06
KRAS G12A vaginal cancer >65yrs 1 30 0.02 0.02 0.00 0.09
KRAS G12A thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
KRAS G12A thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS G12A thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS G12A thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS G12A ampullary cancer 40-50yrs 1 12 0.05 0.02 0.00 0.22
KRAS G12A ampullary cancer 50-65yrs 0 40 0.01 0.00 0.00 0.04
KRAS G12A ampullary cancer >65yrs 0 50 0.01 0.00 0.00 0.04
KRAS G12A small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.02
KRAS G12A small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.01
KRAS G12A small cell lung cancer >65yrs 1 224 0.00 0.00 0.00 0.01
KRAS G12A mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS G12A mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G12A mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS G12A mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS G12A germ cell tumor <40yrs 4 650 0.01 0.01 0.00 0.02
KRAS G12A germ cell tumor 40-50yrs 2 131 0.01 0.01 0.00 0.02
KRAS G12A germ cell tumor 50-65yrs 1 92 0.01 0.01 0.00 0.02
KRAS G12A germ cell tumor >65yrs 0 12 0.01 0.01 0.00 0.03
KRAS G12A nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.02
KRAS G12A nerve sheath tumor 40-50yrs 1 27 0.02 0.01 0.00 0.09
KRAS G12A nerve sheath tumor 50-65yrs 0 37 0.01 0.00 0.00 0.03
KRAS G12A nerve sheath tumor >65yrs 0 13 0.01 0.00 0.00 0.04
KRAS G12A penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G12A penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G12A pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
KRAS G12A b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
KRAS G12A b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.01
KRAS G12A b cell lymphoma 50-65yrs 1 357 0.00 0.00 0.00 0.01
KRAS G12A b cell lymphoma >65yrs 1 413 0.00 0.00 0.00 0.01
KRAS G12A non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
KRAS G12A t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.01
KRAS G12A retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS G12A hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
KRAS G12A lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
KRAS G12A peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
KRAS G12C appendiceal cancer <40yrs 1 28 0.03 0.03 0.01 0.07
KRAS G12C appendiceal cancer 40-50yrs 1 62 0.02 0.02 0.01 0.05
KRAS G12C appendiceal cancer 50-65yrs 2 161 0.02 0.02 0.01 0.04
KRAS G12C appendiceal cancer >65yrs 5 90 0.04 0.03 0.01 0.08
KRAS G12C colorectal cancer <40yrs 16 565 0.03 0.03 0.02 0.04
KRAS G12C colorectal cancer 40-50yrs 34 1280 0.03 0.03 0.02 0.04
KRAS G12C colorectal cancer 50-65yrs 102 2815 0.03 0.03 0.03 0.04
KRAS G12C colorectal cancer >65yrs 58 2055 0.03 0.03 0.02 0.04
KRAS G12C cancer of unknown primary <40yrs 0 167 0.01 0.01 0.00 0.03
KRAS G12C cancer of unknown primary 40-50yrs 3 211 0.02 0.02 0.00 0.04
KRAS G12C cancer of unknown primary 50-65yrs 28 810 0.03 0.03 0.02 0.05
KRAS G12C cancer of unknown primary >65yrs 30 797 0.04 0.04 0.02 0.05
KRAS G12C non-small cell lung cancer <40yrs 1 161 0.02 0.01 0.00 0.04
KRAS G12C non-small cell lung cancer 40-50yrs 41 585 0.07 0.07 0.05 0.09
KRAS G12C non-small cell lung cancer 50-65yrs 439 3677 0.12 0.12 0.11 0.13
KRAS G12C non-small cell lung cancer >65yrs 731 5698 0.13 0.13 0.12 0.14
KRAS G12C non-small cell lung cancer Age:NA 1 10 0.09 0.08 0.01 0.27
KRAS G12C breast cancer <40yrs 0 841 0.00 0.00 0.00 0.00
KRAS G12C breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
KRAS G12C breast cancer 50-65yrs 3 3989 0.00 0.00 0.00 0.00
KRAS G12C breast cancer >65yrs 5 2583 0.00 0.00 0.00 0.00
KRAS G12C breast cancer Age:NA 0 10 0.00 0.00 0.00 0.01
KRAS G12C soft tissue sarcoma <40yrs 2 672 0.00 0.00 0.00 0.00
KRAS G12C soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
KRAS G12C soft tissue sarcoma 50-65yrs 1 951 0.00 0.00 0.00 0.00
KRAS G12C soft tissue sarcoma >65yrs 2 777 0.00 0.00 0.00 0.00
KRAS G12C pancreatic cancer <40yrs 0 87 0.01 0.01 0.00 0.02
KRAS G12C pancreatic cancer 40-50yrs 1 200 0.01 0.01 0.00 0.02
KRAS G12C pancreatic cancer 50-65yrs 6 1000 0.01 0.01 0.00 0.01
KRAS G12C pancreatic cancer >65yrs 15 1205 0.01 0.01 0.01 0.02
KRAS G12C leukemia <40yrs 0 204 0.00 0.00 0.00 0.00
KRAS G12C leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.00
KRAS G12C leukemia 50-65yrs 0 515 0.00 0.00 0.00 0.00
KRAS G12C leukemia >65yrs 0 720 0.00 0.00 0.00 0.00
KRAS G12C melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
KRAS G12C melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
KRAS G12C melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
KRAS G12C melanoma >65yrs 2 1259 0.00 0.00 0.00 0.00
KRAS G12C head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
KRAS G12C head and neck cancer 40-50yrs 1 216 0.00 0.00 0.00 0.01
KRAS G12C head and neck cancer 50-65yrs 1 799 0.00 0.00 0.00 0.00
KRAS G12C head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
KRAS G12C uterine cancer <40yrs 0 57 0.01 0.01 0.00 0.02
KRAS G12C uterine cancer 40-50yrs 0 162 0.01 0.01 0.00 0.02
KRAS G12C uterine cancer 50-65yrs 13 1046 0.01 0.01 0.01 0.02
KRAS G12C uterine cancer >65yrs 13 988 0.01 0.01 0.01 0.02
KRAS G12C non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12C non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
KRAS G12C non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
KRAS G12C non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
KRAS G12C myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS G12C myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
KRAS G12C myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
KRAS G12C myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
KRAS G12C adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12C adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
KRAS G12C adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS G12C adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
KRAS G12C ovarian cancer <40yrs 4 141 0.02 0.02 0.00 0.05
KRAS G12C ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.01
KRAS G12C ovarian cancer 50-65yrs 3 1092 0.00 0.00 0.00 0.01
KRAS G12C ovarian cancer >65yrs 3 849 0.00 0.00 0.00 0.01
KRAS G12C esophagogastric cancer <40yrs 1 122 0.00 0.00 0.00 0.01
KRAS G12C esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.01
KRAS G12C esophagogastric cancer 50-65yrs 2 752 0.00 0.00 0.00 0.01
KRAS G12C esophagogastric cancer >65yrs 2 725 0.00 0.00 0.00 0.01
KRAS G12C thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.01
KRAS G12C thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.01
KRAS G12C thyroid cancer 50-65yrs 1 374 0.00 0.00 0.00 0.01
KRAS G12C thyroid cancer >65yrs 1 370 0.00 0.00 0.00 0.01
KRAS G12C cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.01
KRAS G12C cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.01
KRAS G12C cervical cancer 50-65yrs 1 144 0.00 0.00 0.00 0.02
KRAS G12C cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.01
KRAS G12C hepatobiliary cancer <40yrs 0 138 0.01 0.01 0.00 0.01
KRAS G12C hepatobiliary cancer 40-50yrs 0 110 0.01 0.01 0.00 0.01
KRAS G12C hepatobiliary cancer 50-65yrs 5 525 0.01 0.01 0.00 0.02
KRAS G12C hepatobiliary cancer >65yrs 5 601 0.01 0.01 0.00 0.01
KRAS G12C kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
KRAS G12C kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
KRAS G12C kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
KRAS G12C kidney cancer >65yrs 1 440 0.00 0.00 0.00 0.01
KRAS G12C mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS G12C mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
KRAS G12C mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
KRAS G12C mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
KRAS G12C cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
KRAS G12C cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
KRAS G12C cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
KRAS G12C cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
KRAS G12C prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
KRAS G12C prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
KRAS G12C prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
KRAS G12C anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
KRAS G12C anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
KRAS G12C anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
KRAS G12C neuroendocrine tumors <40yrs 0 22 0.01 0.00 0.00 0.02
KRAS G12C neuroendocrine tumors 40-50yrs 1 55 0.01 0.01 0.00 0.04
KRAS G12C neuroendocrine tumors 50-65yrs 1 161 0.01 0.00 0.00 0.02
KRAS G12C neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.02
KRAS G12C bladder cancer <40yrs 0 25 0.01 0.00 0.00 0.02
KRAS G12C bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.01
KRAS G12C bladder cancer 50-65yrs 3 511 0.00 0.00 0.00 0.01
KRAS G12C bladder cancer >65yrs 5 962 0.00 0.00 0.00 0.01
KRAS G12C b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
KRAS G12C b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
KRAS G12C b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
KRAS G12C b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
KRAS G12C small bowel cancer 40-50yrs 0 29 0.02 0.02 0.00 0.07
KRAS G12C small bowel cancer 50-65yrs 7 96 0.06 0.06 0.02 0.12
KRAS G12C small bowel cancer >65yrs 1 78 0.02 0.02 0.00 0.06
KRAS G12C sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
KRAS G12C sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
KRAS G12C sex cord stromal tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS G12C sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12C bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
KRAS G12C bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
KRAS G12C bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS G12C bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
KRAS G12C vaginal cancer 50-65yrs 1 34 0.02 0.02 0.00 0.08
KRAS G12C vaginal cancer >65yrs 0 30 0.01 0.01 0.00 0.06
KRAS G12C thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
KRAS G12C thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS G12C thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS G12C thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS G12C ampullary cancer 40-50yrs 0 12 0.04 0.03 0.00 0.10
KRAS G12C ampullary cancer 50-65yrs 3 40 0.05 0.04 0.01 0.13
KRAS G12C ampullary cancer >65yrs 1 50 0.03 0.03 0.00 0.08
KRAS G12C small cell lung cancer 40-50yrs 0 22 0.01 0.01 0.00 0.03
KRAS G12C small cell lung cancer 50-65yrs 1 144 0.01 0.01 0.00 0.02
KRAS G12C small cell lung cancer >65yrs 2 224 0.01 0.01 0.00 0.02
KRAS G12C mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS G12C mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G12C mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS G12C mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS G12C germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.01
KRAS G12C germ cell tumor 40-50yrs 3 131 0.02 0.02 0.00 0.05
KRAS G12C germ cell tumor 50-65yrs 1 92 0.01 0.01 0.00 0.04
KRAS G12C germ cell tumor >65yrs 0 12 0.01 0.00 0.00 0.06
KRAS G12C nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
KRAS G12C nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12C nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS G12C nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.01
KRAS G12C penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G12C penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G12C pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
KRAS G12C b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS G12C b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
KRAS G12C b cell lymphoma 50-65yrs 0 357 0.00 0.00 0.00 0.00
KRAS G12C b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
KRAS G12C non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
KRAS G12C t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
KRAS G12C retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS G12C hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
KRAS G12C lung cancer >65yrs 2 18 0.12 0.10 0.02 0.29
KRAS G12C peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.06
KRAS G12D appendiceal cancer <40yrs 12 28 0.31 0.29 0.22 0.47
KRAS G12D appendiceal cancer 40-50yrs 18 62 0.28 0.28 0.21 0.36
KRAS G12D appendiceal cancer 50-65yrs 40 161 0.26 0.26 0.21 0.32
KRAS G12D appendiceal cancer >65yrs 22 90 0.26 0.26 0.20 0.33
KRAS G12D colorectal cancer <40yrs 86 565 0.14 0.14 0.12 0.16
KRAS G12D colorectal cancer 40-50yrs 180 1280 0.14 0.14 0.12 0.15
KRAS G12D colorectal cancer 50-65yrs 365 2815 0.13 0.13 0.12 0.14
KRAS G12D colorectal cancer >65yrs 253 2055 0.13 0.13 0.11 0.14
KRAS G12D cancer of unknown primary <40yrs 5 167 0.05 0.05 0.02 0.07
KRAS G12D cancer of unknown primary 40-50yrs 8 211 0.05 0.05 0.03 0.07
KRAS G12D cancer of unknown primary 50-65yrs 43 810 0.05 0.05 0.04 0.07
KRAS G12D cancer of unknown primary >65yrs 51 797 0.06 0.06 0.04 0.08
KRAS G12D non-small cell lung cancer <40yrs 6 161 0.04 0.04 0.03 0.05
KRAS G12D non-small cell lung cancer 40-50yrs 19 585 0.04 0.04 0.03 0.05
KRAS G12D non-small cell lung cancer 50-65yrs 154 3677 0.04 0.04 0.04 0.05
KRAS G12D non-small cell lung cancer >65yrs 253 5698 0.04 0.04 0.04 0.05
KRAS G12D non-small cell lung cancer Age:NA 0 10 0.04 0.04 0.02 0.06
KRAS G12D breast cancer <40yrs 0 841 0.00 0.00 0.00 0.00
KRAS G12D breast cancer 40-50yrs 1 1910 0.00 0.00 0.00 0.00
KRAS G12D breast cancer 50-65yrs 4 3989 0.00 0.00 0.00 0.00
KRAS G12D breast cancer >65yrs 5 2583 0.00 0.00 0.00 0.00
KRAS G12D breast cancer Age:NA 1 10 0.02 0.00 0.00 0.14
KRAS G12D soft tissue sarcoma <40yrs 3 672 0.00 0.00 0.00 0.01
KRAS G12D soft tissue sarcoma 40-50yrs 1 367 0.00 0.00 0.00 0.01
KRAS G12D soft tissue sarcoma 50-65yrs 3 951 0.00 0.00 0.00 0.01
KRAS G12D soft tissue sarcoma >65yrs 4 777 0.00 0.00 0.00 0.01
KRAS G12D pancreatic cancer <40yrs 16 87 0.26 0.26 0.15 0.33
KRAS G12D pancreatic cancer 40-50yrs 56 200 0.29 0.29 0.23 0.34
KRAS G12D pancreatic cancer 50-65yrs 327 1000 0.32 0.32 0.30 0.35
KRAS G12D pancreatic cancer >65yrs 383 1205 0.32 0.32 0.29 0.34
KRAS G12D leukemia <40yrs 3 204 0.01 0.01 0.01 0.02
KRAS G12D leukemia 40-50yrs 0 128 0.01 0.01 0.00 0.02
KRAS G12D leukemia 50-65yrs 7 515 0.01 0.01 0.01 0.02
KRAS G12D leukemia >65yrs 11 720 0.01 0.01 0.01 0.02
KRAS G12D melanoma <40yrs 0 289 0.00 0.00 0.00 0.01
KRAS G12D melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.01
KRAS G12D melanoma 50-65yrs 5 1016 0.00 0.00 0.00 0.01
KRAS G12D melanoma >65yrs 9 1259 0.01 0.01 0.00 0.01
KRAS G12D head and neck cancer <40yrs 1 140 0.00 0.00 0.00 0.01
KRAS G12D head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.01
KRAS G12D head and neck cancer 50-65yrs 3 799 0.00 0.00 0.00 0.01
KRAS G12D head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
KRAS G12D uterine cancer <40yrs 1 57 0.04 0.04 0.01 0.07
KRAS G12D uterine cancer 40-50yrs 14 162 0.06 0.06 0.04 0.11
KRAS G12D uterine cancer 50-65yrs 50 1046 0.05 0.05 0.04 0.06
KRAS G12D uterine cancer >65yrs 37 988 0.04 0.04 0.03 0.05
KRAS G12D non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.02
KRAS G12D non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.02
KRAS G12D non-melanoma skin cancers 50-65yrs 1 149 0.00 0.00 0.00 0.02
KRAS G12D non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.01
KRAS G12D myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.01
KRAS G12D myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.01
KRAS G12D myelodysplastic/myeloproliferative syndromes 50-65yrs 2 373 0.00 0.00 0.00 0.01
KRAS G12D myelodysplastic/myeloproliferative syndromes >65yrs 2 664 0.00 0.00 0.00 0.01
KRAS G12D adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12D adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
KRAS G12D adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS G12D adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
KRAS G12D ovarian cancer <40yrs 12 141 0.06 0.06 0.03 0.11
KRAS G12D ovarian cancer 40-50yrs 10 253 0.04 0.04 0.02 0.06
KRAS G12D ovarian cancer 50-65yrs 40 1092 0.04 0.04 0.03 0.05
KRAS G12D ovarian cancer >65yrs 20 849 0.03 0.03 0.02 0.04
KRAS G12D esophagogastric cancer <40yrs 2 122 0.02 0.02 0.01 0.03
KRAS G12D esophagogastric cancer 40-50yrs 4 200 0.02 0.02 0.01 0.03
KRAS G12D esophagogastric cancer 50-65yrs 12 752 0.02 0.02 0.01 0.02
KRAS G12D esophagogastric cancer >65yrs 15 725 0.02 0.02 0.01 0.03
KRAS G12D thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.01
KRAS G12D thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.01
KRAS G12D thyroid cancer 50-65yrs 3 374 0.01 0.00 0.00 0.02
KRAS G12D thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.01
KRAS G12D cervical cancer <40yrs 1 85 0.02 0.02 0.01 0.05
KRAS G12D cervical cancer 40-50yrs 2 99 0.03 0.03 0.01 0.05
KRAS G12D cervical cancer 50-65yrs 5 144 0.03 0.03 0.01 0.06
KRAS G12D cervical cancer >65yrs 2 36 0.03 0.03 0.01 0.08
KRAS G12D hepatobiliary cancer <40yrs 6 138 0.04 0.04 0.02 0.06
KRAS G12D hepatobiliary cancer 40-50yrs 4 110 0.04 0.04 0.02 0.06
KRAS G12D hepatobiliary cancer 50-65yrs 16 525 0.04 0.04 0.02 0.05
KRAS G12D hepatobiliary cancer >65yrs 29 601 0.04 0.04 0.03 0.06
KRAS G12D kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.01
KRAS G12D kidney cancer 40-50yrs 2 159 0.01 0.00 0.00 0.02
KRAS G12D kidney cancer 50-65yrs 1 628 0.00 0.00 0.00 0.01
KRAS G12D kidney cancer >65yrs 2 440 0.00 0.00 0.00 0.01
KRAS G12D mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS G12D mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
KRAS G12D mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
KRAS G12D mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
KRAS G12D cns cancer <40yrs 2 1602 0.00 0.00 0.00 0.00
KRAS G12D cns cancer 40-50yrs 4 687 0.00 0.00 0.00 0.01
KRAS G12D cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
KRAS G12D cns cancer >65yrs 2 836 0.00 0.00 0.00 0.00
KRAS G12D prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.01
KRAS G12D prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
KRAS G12D prostate cancer >65yrs 2 1402 0.00 0.00 0.00 0.00
KRAS G12D anal cancer 40-50yrs 0 12 0.01 0.00 0.00 0.04
KRAS G12D anal cancer 50-65yrs 1 88 0.01 0.01 0.00 0.03
KRAS G12D anal cancer >65yrs 0 45 0.01 0.00 0.00 0.03
KRAS G12D neuroendocrine tumors <40yrs 0 22 0.03 0.03 0.00 0.08
KRAS G12D neuroendocrine tumors 40-50yrs 6 55 0.07 0.06 0.02 0.16
KRAS G12D neuroendocrine tumors 50-65yrs 5 161 0.04 0.03 0.01 0.06
KRAS G12D neuroendocrine tumors >65yrs 3 121 0.03 0.03 0.01 0.06
KRAS G12D bladder cancer <40yrs 0 25 0.02 0.02 0.00 0.04
KRAS G12D bladder cancer 40-50yrs 0 78 0.02 0.02 0.00 0.03
KRAS G12D bladder cancer 50-65yrs 12 511 0.02 0.02 0.01 0.03
KRAS G12D bladder cancer >65yrs 20 962 0.02 0.02 0.01 0.03
KRAS G12D b-lymphoblastic leukemia/lymphoma <40yrs 5 142 0.03 0.03 0.01 0.06
KRAS G12D b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.03 0.03 0.00 0.07
KRAS G12D b-lymphoblastic leukemia/lymphoma 50-65yrs 1 48 0.03 0.03 0.01 0.06
KRAS G12D b-lymphoblastic leukemia/lymphoma >65yrs 2 42 0.04 0.03 0.01 0.08
KRAS G12D small bowel cancer 40-50yrs 2 29 0.11 0.11 0.05 0.18
KRAS G12D small bowel cancer 50-65yrs 12 96 0.12 0.12 0.07 0.18
KRAS G12D small bowel cancer >65yrs 10 78 0.12 0.12 0.07 0.18
KRAS G12D sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
KRAS G12D sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
KRAS G12D sex cord stromal tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS G12D sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12D bone cancer <40yrs 1 342 0.00 0.00 0.00 0.01
KRAS G12D bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.01
KRAS G12D bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.01
KRAS G12D bone cancer >65yrs 1 67 0.01 0.00 0.00 0.03
KRAS G12D vaginal cancer 50-65yrs 0 34 0.01 0.01 0.00 0.06
KRAS G12D vaginal cancer >65yrs 1 30 0.02 0.02 0.00 0.09
KRAS G12D thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
KRAS G12D thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS G12D thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS G12D thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS G12D ampullary cancer 40-50yrs 0 12 0.12 0.08 0.00 0.33
KRAS G12D ampullary cancer 50-65yrs 11 40 0.27 0.27 0.16 0.40
KRAS G12D ampullary cancer >65yrs 17 50 0.32 0.31 0.20 0.46
KRAS G12D small cell lung cancer 40-50yrs 0 22 0.01 0.01 0.00 0.03
KRAS G12D small cell lung cancer 50-65yrs 1 144 0.01 0.01 0.00 0.02
KRAS G12D small cell lung cancer >65yrs 3 224 0.01 0.01 0.00 0.03
KRAS G12D mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS G12D mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G12D mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS G12D mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS G12D germ cell tumor <40yrs 7 650 0.01 0.01 0.00 0.02
KRAS G12D germ cell tumor 40-50yrs 2 131 0.01 0.01 0.00 0.03
KRAS G12D germ cell tumor 50-65yrs 0 92 0.01 0.01 0.00 0.02
KRAS G12D germ cell tumor >65yrs 0 12 0.01 0.01 0.00 0.03
KRAS G12D nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
KRAS G12D nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12D nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS G12D nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.01
KRAS G12D penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.02
KRAS G12D penile cancer >65yrs 0 11 0.00 0.00 0.00 0.02
KRAS G12D pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.05
KRAS G12D b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
KRAS G12D b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.01
KRAS G12D b cell lymphoma 50-65yrs 2 357 0.00 0.00 0.00 0.01
KRAS G12D b cell lymphoma >65yrs 1 413 0.00 0.00 0.00 0.01
KRAS G12D non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
KRAS G12D t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
KRAS G12D retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS G12D hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
KRAS G12D lung cancer >65yrs 0 18 0.00 0.00 0.00 0.00
KRAS G12D peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.06
KRAS G12F appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS G12F appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
KRAS G12F appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
KRAS G12F appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer 50-65yrs 1 2815 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer >65yrs 0 2055 0.00 0.00 0.00 0.00
KRAS G12F cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
KRAS G12F cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
KRAS G12F cancer of unknown primary 50-65yrs 1 810 0.00 0.00 0.00 0.00
KRAS G12F cancer of unknown primary >65yrs 2 797 0.00 0.00 0.00 0.00
KRAS G12F non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.01
KRAS G12F non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
KRAS G12F non-small cell lung cancer 50-65yrs 10 3677 0.00 0.00 0.00 0.00
KRAS G12F non-small cell lung cancer >65yrs 22 5698 0.00 0.00 0.00 0.00
KRAS G12F non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.01
KRAS G12F breast cancer <40yrs 0 841 0.00 0.00 0.00 0.00
KRAS G12F breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
KRAS G12F breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
KRAS G12F breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
KRAS G12F breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
KRAS G12F pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS G12F pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
KRAS G12F pancreatic cancer 50-65yrs 0 1000 0.00 0.00 0.00 0.00
KRAS G12F pancreatic cancer >65yrs 1 1205 0.00 0.00 0.00 0.00
KRAS G12F leukemia <40yrs 0 204 0.00 0.00 0.00 0.00
KRAS G12F leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.00
KRAS G12F leukemia 50-65yrs 0 515 0.00 0.00 0.00 0.00
KRAS G12F leukemia >65yrs 0 720 0.00 0.00 0.00 0.00
KRAS G12F melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
KRAS G12F melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
KRAS G12F melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
KRAS G12F melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
KRAS G12F head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
KRAS G12F head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
KRAS G12F head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
KRAS G12F head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
KRAS G12F uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.00
KRAS G12F uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
KRAS G12F uterine cancer 50-65yrs 0 1046 0.00 0.00 0.00 0.00
KRAS G12F uterine cancer >65yrs 0 988 0.00 0.00 0.00 0.00
KRAS G12F non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12F non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
KRAS G12F non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
KRAS G12F non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
KRAS G12F myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS G12F myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
KRAS G12F myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
KRAS G12F myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
KRAS G12F adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12F adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
KRAS G12F adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS G12F adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
KRAS G12F ovarian cancer <40yrs 1 141 0.00 0.00 0.00 0.02
KRAS G12F ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
KRAS G12F ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
KRAS G12F ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
KRAS G12F esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
KRAS G12F esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
KRAS G12F esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
KRAS G12F esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
KRAS G12F thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
KRAS G12F thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
KRAS G12F thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
KRAS G12F thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
KRAS G12F cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
KRAS G12F cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
KRAS G12F cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS G12F cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
KRAS G12F hepatobiliary cancer <40yrs 0 138 0.00 0.00 0.00 0.00
KRAS G12F hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
KRAS G12F hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
KRAS G12F hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
KRAS G12F kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
KRAS G12F kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
KRAS G12F kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
KRAS G12F kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
KRAS G12F mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS G12F mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
KRAS G12F mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
KRAS G12F mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
KRAS G12F cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
KRAS G12F cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
KRAS G12F cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
KRAS G12F cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
KRAS G12F prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
KRAS G12F prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
KRAS G12F prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
KRAS G12F anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
KRAS G12F anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
KRAS G12F anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
KRAS G12F neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
KRAS G12F neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
KRAS G12F neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
KRAS G12F neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
KRAS G12F bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
KRAS G12F bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
KRAS G12F bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
KRAS G12F bladder cancer >65yrs 0 962 0.00 0.00 0.00 0.00
KRAS G12F b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
KRAS G12F b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
KRAS G12F b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
KRAS G12F b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
KRAS G12F small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G12F small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS G12F small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
KRAS G12F sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
KRAS G12F sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
KRAS G12F sex cord stromal tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS G12F sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12F bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
KRAS G12F bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
KRAS G12F bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS G12F bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
KRAS G12F vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
KRAS G12F vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
KRAS G12F thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.01
KRAS G12F thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS G12F thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS G12F thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS G12F ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
KRAS G12F ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
KRAS G12F ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
KRAS G12F small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
KRAS G12F small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS G12F small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
KRAS G12F mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS G12F mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G12F mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS G12F mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
KRAS G12F nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
KRAS G12F nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12F nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS G12F nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
KRAS G12F penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G12F penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G12F pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
KRAS G12F b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS G12F b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
KRAS G12F b cell lymphoma 50-65yrs 0 357 0.00 0.00 0.00 0.00
KRAS G12F b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
KRAS G12F non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
KRAS G12F t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
KRAS G12F retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS G12F hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
KRAS G12F lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
KRAS G12F peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
KRAS G12R appendiceal cancer <40yrs 0 28 0.01 0.01 0.00 0.03
KRAS G12R appendiceal cancer 40-50yrs 1 62 0.01 0.01 0.00 0.04
KRAS G12R appendiceal cancer 50-65yrs 2 161 0.01 0.01 0.00 0.03
KRAS G12R appendiceal cancer >65yrs 0 90 0.01 0.01 0.00 0.02
KRAS G12R colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.01
KRAS G12R colorectal cancer 40-50yrs 7 1280 0.00 0.00 0.00 0.01
KRAS G12R colorectal cancer 50-65yrs 13 2815 0.00 0.00 0.00 0.01
KRAS G12R colorectal cancer >65yrs 14 2055 0.01 0.00 0.00 0.01
KRAS G12R cancer of unknown primary <40yrs 0 167 0.01 0.01 0.00 0.01
KRAS G12R cancer of unknown primary 40-50yrs 2 211 0.01 0.01 0.00 0.02
KRAS G12R cancer of unknown primary 50-65yrs 9 810 0.01 0.01 0.00 0.02
KRAS G12R cancer of unknown primary >65yrs 6 797 0.01 0.01 0.00 0.01
KRAS G12R non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.01
KRAS G12R non-small cell lung cancer 40-50yrs 3 585 0.00 0.00 0.00 0.01
KRAS G12R non-small cell lung cancer 50-65yrs 11 3677 0.00 0.00 0.00 0.00
KRAS G12R non-small cell lung cancer >65yrs 22 5698 0.00 0.00 0.00 0.00
KRAS G12R non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.01
KRAS G12R breast cancer <40yrs 1 841 0.00 0.00 0.00 0.00
KRAS G12R breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
KRAS G12R breast cancer 50-65yrs 2 3989 0.00 0.00 0.00 0.00
KRAS G12R breast cancer >65yrs 1 2583 0.00 0.00 0.00 0.00
KRAS G12R breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
KRAS G12R soft tissue sarcoma <40yrs 1 672 0.00 0.00 0.00 0.00
KRAS G12R soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
KRAS G12R soft tissue sarcoma 50-65yrs 1 951 0.00 0.00 0.00 0.00
KRAS G12R soft tissue sarcoma >65yrs 1 777 0.00 0.00 0.00 0.00
KRAS G12R pancreatic cancer <40yrs 4 87 0.08 0.08 0.03 0.12
KRAS G12R pancreatic cancer 40-50yrs 16 200 0.09 0.09 0.06 0.12
KRAS G12R pancreatic cancer 50-65yrs 102 1000 0.10 0.10 0.08 0.12
KRAS G12R pancreatic cancer >65yrs 154 1205 0.12 0.12 0.10 0.14
KRAS G12R leukemia <40yrs 0 204 0.00 0.00 0.00 0.00
KRAS G12R leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.00
KRAS G12R leukemia 50-65yrs 1 515 0.00 0.00 0.00 0.00
KRAS G12R leukemia >65yrs 1 720 0.00 0.00 0.00 0.00
KRAS G12R melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
KRAS G12R melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
KRAS G12R melanoma 50-65yrs 1 1016 0.00 0.00 0.00 0.00
KRAS G12R melanoma >65yrs 2 1259 0.00 0.00 0.00 0.00
KRAS G12R head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
KRAS G12R head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
KRAS G12R head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
KRAS G12R head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
KRAS G12R uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.00
KRAS G12R uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
KRAS G12R uterine cancer 50-65yrs 1 1046 0.00 0.00 0.00 0.00
KRAS G12R uterine cancer >65yrs 1 988 0.00 0.00 0.00 0.00
KRAS G12R non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12R non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
KRAS G12R non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
KRAS G12R non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
KRAS G12R myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.01
KRAS G12R myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.01
KRAS G12R myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
KRAS G12R myelodysplastic/myeloproliferative syndromes >65yrs 2 664 0.00 0.00 0.00 0.01
KRAS G12R adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12R adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
KRAS G12R adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS G12R adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
KRAS G12R ovarian cancer <40yrs 1 141 0.00 0.00 0.00 0.01
KRAS G12R ovarian cancer 40-50yrs 3 253 0.01 0.00 0.00 0.02
KRAS G12R ovarian cancer 50-65yrs 3 1092 0.00 0.00 0.00 0.01
KRAS G12R ovarian cancer >65yrs 3 849 0.00 0.00 0.00 0.01
KRAS G12R esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
KRAS G12R esophagogastric cancer 40-50yrs 1 200 0.00 0.00 0.00 0.01
KRAS G12R esophagogastric cancer 50-65yrs 1 752 0.00 0.00 0.00 0.00
KRAS G12R esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
KRAS G12R thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
KRAS G12R thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
KRAS G12R thyroid cancer 50-65yrs 1 374 0.00 0.00 0.00 0.01
KRAS G12R thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
KRAS G12R cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.01
KRAS G12R cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.01
KRAS G12R cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.01
KRAS G12R cervical cancer >65yrs 1 36 0.01 0.00 0.00 0.07
KRAS G12R hepatobiliary cancer <40yrs 0 138 0.00 0.00 0.00 0.01
KRAS G12R hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.01
KRAS G12R hepatobiliary cancer 50-65yrs 1 525 0.00 0.00 0.00 0.01
KRAS G12R hepatobiliary cancer >65yrs 2 601 0.00 0.00 0.00 0.01
KRAS G12R kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
KRAS G12R kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
KRAS G12R kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
KRAS G12R kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
KRAS G12R mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS G12R mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
KRAS G12R mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
KRAS G12R mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
KRAS G12R cns cancer <40yrs 1 1602 0.00 0.00 0.00 0.00
KRAS G12R cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
KRAS G12R cns cancer 50-65yrs 1 1439 0.00 0.00 0.00 0.00
KRAS G12R cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
KRAS G12R prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.01
KRAS G12R prostate cancer 50-65yrs 2 960 0.00 0.00 0.00 0.00
KRAS G12R prostate cancer >65yrs 1 1402 0.00 0.00 0.00 0.00
KRAS G12R anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
KRAS G12R anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
KRAS G12R anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
KRAS G12R neuroendocrine tumors <40yrs 0 22 0.01 0.00 0.00 0.02
KRAS G12R neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.02
KRAS G12R neuroendocrine tumors 50-65yrs 2 161 0.01 0.01 0.00 0.02
KRAS G12R neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.02
KRAS G12R bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.01
KRAS G12R bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.01
KRAS G12R bladder cancer 50-65yrs 2 511 0.00 0.00 0.00 0.01
KRAS G12R bladder cancer >65yrs 1 962 0.00 0.00 0.00 0.00
KRAS G12R b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
KRAS G12R b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
KRAS G12R b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
KRAS G12R b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
KRAS G12R small bowel cancer 40-50yrs 0 29 0.01 0.01 0.00 0.04
KRAS G12R small bowel cancer 50-65yrs 1 96 0.01 0.01 0.00 0.04
KRAS G12R small bowel cancer >65yrs 2 78 0.02 0.02 0.00 0.05
KRAS G12R sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
KRAS G12R sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
KRAS G12R sex cord stromal tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS G12R sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12R bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
KRAS G12R bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
KRAS G12R bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS G12R bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
KRAS G12R vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
KRAS G12R vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
KRAS G12R thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.01
KRAS G12R thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS G12R thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS G12R thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS G12R ampullary cancer 40-50yrs 0 12 0.02 0.01 0.00 0.08
KRAS G12R ampullary cancer 50-65yrs 0 40 0.02 0.01 0.00 0.06
KRAS G12R ampullary cancer >65yrs 3 50 0.05 0.04 0.01 0.12
KRAS G12R small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
KRAS G12R small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS G12R small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
KRAS G12R mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS G12R mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G12R mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS G12R mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS G12R germ cell tumor <40yrs 3 650 0.01 0.01 0.00 0.02
KRAS G12R germ cell tumor 40-50yrs 3 131 0.02 0.01 0.00 0.04
KRAS G12R germ cell tumor 50-65yrs 1 92 0.01 0.01 0.00 0.03
KRAS G12R germ cell tumor >65yrs 1 12 0.03 0.01 0.00 0.13
KRAS G12R nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
KRAS G12R nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12R nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS G12R nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
KRAS G12R penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G12R penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G12R pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
KRAS G12R b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
KRAS G12R b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.01
KRAS G12R b cell lymphoma 50-65yrs 1 357 0.00 0.00 0.00 0.01
KRAS G12R b cell lymphoma >65yrs 1 413 0.00 0.00 0.00 0.01
KRAS G12R non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
KRAS G12R t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
KRAS G12R retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS G12R hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
KRAS G12R lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
KRAS G12R peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
KRAS G12S appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.02
KRAS G12S appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.01
KRAS G12S appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.01
KRAS G12S appendiceal cancer >65yrs 1 90 0.01 0.00 0.00 0.03
KRAS G12S colorectal cancer <40yrs 15 565 0.02 0.02 0.02 0.03
KRAS G12S colorectal cancer 40-50yrs 23 1280 0.02 0.02 0.01 0.02
KRAS G12S colorectal cancer 50-65yrs 51 2815 0.02 0.02 0.02 0.02
KRAS G12S colorectal cancer >65yrs 37 2055 0.02 0.02 0.02 0.02
KRAS G12S cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.01
KRAS G12S cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.01
KRAS G12S cancer of unknown primary 50-65yrs 1 810 0.00 0.00 0.00 0.00
KRAS G12S cancer of unknown primary >65yrs 4 797 0.00 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer 40-50yrs 1 585 0.00 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer 50-65yrs 21 3677 0.00 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer >65yrs 30 5698 0.00 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.01
KRAS G12S breast cancer <40yrs 0 841 0.00 0.00 0.00 0.00
KRAS G12S breast cancer 40-50yrs 1 1910 0.00 0.00 0.00 0.00
KRAS G12S breast cancer 50-65yrs 4 3989 0.00 0.00 0.00 0.00
KRAS G12S breast cancer >65yrs 1 2583 0.00 0.00 0.00 0.00
KRAS G12S breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
KRAS G12S soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
KRAS G12S soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
KRAS G12S soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
KRAS G12S soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
KRAS G12S pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS G12S pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
KRAS G12S pancreatic cancer 50-65yrs 0 1000 0.00 0.00 0.00 0.00
KRAS G12S pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
KRAS G12S leukemia <40yrs 0 204 0.00 0.00 0.00 0.00
KRAS G12S leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.00
KRAS G12S leukemia 50-65yrs 1 515 0.00 0.00 0.00 0.00
KRAS G12S leukemia >65yrs 0 720 0.00 0.00 0.00 0.00
KRAS G12S melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
KRAS G12S melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
KRAS G12S melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
KRAS G12S melanoma >65yrs 1 1259 0.00 0.00 0.00 0.00
KRAS G12S head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
KRAS G12S head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
KRAS G12S head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
KRAS G12S head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
KRAS G12S uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.01
KRAS G12S uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.01
KRAS G12S uterine cancer 50-65yrs 2 1046 0.00 0.00 0.00 0.00
KRAS G12S uterine cancer >65yrs 4 988 0.00 0.00 0.00 0.01
KRAS G12S non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12S non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
KRAS G12S non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
KRAS G12S non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
KRAS G12S myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.01
KRAS G12S myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.01
KRAS G12S myelodysplastic/myeloproliferative syndromes 50-65yrs 1 373 0.00 0.00 0.00 0.01
KRAS G12S myelodysplastic/myeloproliferative syndromes >65yrs 1 664 0.00 0.00 0.00 0.00
KRAS G12S adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12S adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
KRAS G12S adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS G12S adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
KRAS G12S ovarian cancer <40yrs 1 141 0.00 0.00 0.00 0.02
KRAS G12S ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
KRAS G12S ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
KRAS G12S ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
KRAS G12S esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.01
KRAS G12S esophagogastric cancer 40-50yrs 1 200 0.00 0.00 0.00 0.01
KRAS G12S esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
KRAS G12S esophagogastric cancer >65yrs 3 725 0.00 0.00 0.00 0.01
KRAS G12S thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
KRAS G12S thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
KRAS G12S thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
KRAS G12S thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
KRAS G12S cervical cancer <40yrs 0 85 0.01 0.01 0.00 0.02
KRAS G12S cervical cancer 40-50yrs 1 99 0.01 0.01 0.00 0.02
KRAS G12S cervical cancer 50-65yrs 2 144 0.01 0.01 0.00 0.03
KRAS G12S cervical cancer >65yrs 0 36 0.01 0.01 0.00 0.02
KRAS G12S hepatobiliary cancer <40yrs 0 138 0.00 0.00 0.00 0.00
KRAS G12S hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.01
KRAS G12S hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
KRAS G12S hepatobiliary cancer >65yrs 2 601 0.00 0.00 0.00 0.01
KRAS G12S kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
KRAS G12S kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
KRAS G12S kidney cancer 50-65yrs 1 628 0.00 0.00 0.00 0.00
KRAS G12S kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
KRAS G12S mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS G12S mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
KRAS G12S mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
KRAS G12S mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
KRAS G12S cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
KRAS G12S cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
KRAS G12S cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
KRAS G12S cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
KRAS G12S prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
KRAS G12S prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
KRAS G12S prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
KRAS G12S anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
KRAS G12S anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
KRAS G12S anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
KRAS G12S neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
KRAS G12S neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
KRAS G12S neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
KRAS G12S neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
KRAS G12S bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.01
KRAS G12S bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.01
KRAS G12S bladder cancer 50-65yrs 1 511 0.00 0.00 0.00 0.00
KRAS G12S bladder cancer >65yrs 1 962 0.00 0.00 0.00 0.00
KRAS G12S b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
KRAS G12S b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
KRAS G12S b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
KRAS G12S b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
KRAS G12S small bowel cancer 40-50yrs 0 29 0.01 0.00 0.00 0.04
KRAS G12S small bowel cancer 50-65yrs 3 96 0.02 0.02 0.00 0.06
KRAS G12S small bowel cancer >65yrs 0 78 0.01 0.00 0.00 0.03
KRAS G12S sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
KRAS G12S sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
KRAS G12S sex cord stromal tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS G12S sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12S bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
KRAS G12S bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
KRAS G12S bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS G12S bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
KRAS G12S vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
KRAS G12S vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
KRAS G12S thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
KRAS G12S thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS G12S thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS G12S thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS G12S ampullary cancer 40-50yrs 0 12 0.01 0.01 0.00 0.05
KRAS G12S ampullary cancer 50-65yrs 1 40 0.02 0.01 0.00 0.07
KRAS G12S ampullary cancer >65yrs 0 50 0.01 0.00 0.00 0.04
KRAS G12S small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
KRAS G12S small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS G12S small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
KRAS G12S mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS G12S mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G12S mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS G12S mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS G12S germ cell tumor <40yrs 2 650 0.00 0.00 0.00 0.01
KRAS G12S germ cell tumor 40-50yrs 2 131 0.01 0.01 0.00 0.03
KRAS G12S germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.01
KRAS G12S germ cell tumor >65yrs 0 12 0.01 0.00 0.00 0.03
KRAS G12S nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
KRAS G12S nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12S nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS G12S nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.01
KRAS G12S penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.02
KRAS G12S penile cancer >65yrs 0 11 0.00 0.00 0.00 0.02
KRAS G12S pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.05
KRAS G12S b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
KRAS G12S b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.01
KRAS G12S b cell lymphoma 50-65yrs 1 357 0.00 0.00 0.00 0.01
KRAS G12S b cell lymphoma >65yrs 2 413 0.00 0.00 0.00 0.01
KRAS G12S non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
KRAS G12S t-lymphoblastic leukemia/lymphoma <40yrs 1 27 0.04 0.03 0.00 0.14
KRAS G12S retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS G12S hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
KRAS G12S lung cancer >65yrs 0 18 0.00 0.00 0.00 0.00
KRAS G12S peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.06
KRAS G12V appendiceal cancer <40yrs 6 28 0.14 0.13 0.08 0.24
KRAS G12V appendiceal cancer 40-50yrs 5 62 0.11 0.11 0.06 0.16
KRAS G12V appendiceal cancer 50-65yrs 20 161 0.12 0.12 0.08 0.17
KRAS G12V appendiceal cancer >65yrs 10 90 0.12 0.12 0.08 0.17
KRAS G12V colorectal cancer <40yrs 32 565 0.07 0.07 0.05 0.09
KRAS G12V colorectal cancer 40-50yrs 118 1280 0.09 0.09 0.08 0.11
KRAS G12V colorectal cancer 50-65yrs 279 2815 0.10 0.10 0.09 0.11
KRAS G12V colorectal cancer >65yrs 191 2055 0.09 0.09 0.08 0.10
KRAS G12V cancer of unknown primary <40yrs 0 167 0.01 0.01 0.00 0.05
KRAS G12V cancer of unknown primary 40-50yrs 12 211 0.06 0.05 0.03 0.09
KRAS G12V cancer of unknown primary 50-65yrs 48 810 0.06 0.06 0.04 0.08
KRAS G12V cancer of unknown primary >65yrs 47 797 0.06 0.06 0.04 0.08
KRAS G12V non-small cell lung cancer <40yrs 3 161 0.04 0.04 0.01 0.06
KRAS G12V non-small cell lung cancer 40-50yrs 20 585 0.04 0.04 0.02 0.06
KRAS G12V non-small cell lung cancer 50-65yrs 202 3677 0.05 0.05 0.05 0.06
KRAS G12V non-small cell lung cancer >65yrs 323 5698 0.06 0.06 0.05 0.06
KRAS G12V non-small cell lung cancer Age:NA 0 10 0.04 0.05 0.01 0.09
KRAS G12V breast cancer <40yrs 2 841 0.00 0.00 0.00 0.00
KRAS G12V breast cancer 40-50yrs 4 1910 0.00 0.00 0.00 0.00
KRAS G12V breast cancer 50-65yrs 15 3989 0.00 0.00 0.00 0.00
KRAS G12V breast cancer >65yrs 9 2583 0.00 0.00 0.00 0.00
KRAS G12V breast cancer Age:NA 0 10 0.00 0.00 0.00 0.01
KRAS G12V soft tissue sarcoma <40yrs 2 672 0.00 0.00 0.00 0.00
KRAS G12V soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
KRAS G12V soft tissue sarcoma 50-65yrs 1 951 0.00 0.00 0.00 0.00
KRAS G12V soft tissue sarcoma >65yrs 1 777 0.00 0.00 0.00 0.00
KRAS G12V pancreatic cancer <40yrs 2 87 0.04 0.04 0.01 0.10
KRAS G12V pancreatic cancer 40-50yrs 31 200 0.16 0.15 0.11 0.21
KRAS G12V pancreatic cancer 50-65yrs 229 1000 0.23 0.23 0.20 0.25
KRAS G12V pancreatic cancer >65yrs 320 1205 0.26 0.26 0.24 0.29
KRAS G12V leukemia <40yrs 3 204 0.01 0.01 0.00 0.02
KRAS G12V leukemia 40-50yrs 0 128 0.01 0.01 0.00 0.02
KRAS G12V leukemia 50-65yrs 7 515 0.01 0.01 0.01 0.02
KRAS G12V leukemia >65yrs 6 720 0.01 0.01 0.00 0.02
KRAS G12V melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
KRAS G12V melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
KRAS G12V melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
KRAS G12V melanoma >65yrs 2 1259 0.00 0.00 0.00 0.00
KRAS G12V head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
KRAS G12V head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
KRAS G12V head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
KRAS G12V head and neck cancer >65yrs 1 582 0.00 0.00 0.00 0.00
KRAS G12V uterine cancer <40yrs 0 57 0.04 0.04 0.00 0.06
KRAS G12V uterine cancer 40-50yrs 11 162 0.06 0.06 0.04 0.10
KRAS G12V uterine cancer 50-65yrs 63 1046 0.06 0.06 0.04 0.07
KRAS G12V uterine cancer >65yrs 38 988 0.04 0.04 0.03 0.06
KRAS G12V non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.01
KRAS G12V non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.01
KRAS G12V non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.01
KRAS G12V non-melanoma skin cancers >65yrs 1 317 0.00 0.00 0.00 0.01
KRAS G12V myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.01
KRAS G12V myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.01
KRAS G12V myelodysplastic/myeloproliferative syndromes 50-65yrs 1 373 0.00 0.00 0.00 0.01
KRAS G12V myelodysplastic/myeloproliferative syndromes >65yrs 1 664 0.00 0.00 0.00 0.00
KRAS G12V adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12V adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
KRAS G12V adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS G12V adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
KRAS G12V ovarian cancer <40yrs 11 141 0.06 0.06 0.03 0.11
KRAS G12V ovarian cancer 40-50yrs 15 253 0.05 0.05 0.03 0.08
KRAS G12V ovarian cancer 50-65yrs 31 1092 0.03 0.03 0.02 0.04
KRAS G12V ovarian cancer >65yrs 26 849 0.03 0.03 0.02 0.04
KRAS G12V esophagogastric cancer <40yrs 1 122 0.01 0.01 0.00 0.02
KRAS G12V esophagogastric cancer 40-50yrs 0 200 0.01 0.01 0.00 0.01
KRAS G12V esophagogastric cancer 50-65yrs 8 752 0.01 0.01 0.00 0.02
KRAS G12V esophagogastric cancer >65yrs 6 725 0.01 0.01 0.00 0.01
KRAS G12V thyroid cancer <40yrs 1 150 0.01 0.01 0.00 0.01
KRAS G12V thyroid cancer 40-50yrs 0 122 0.01 0.00 0.00 0.01
KRAS G12V thyroid cancer 50-65yrs 3 374 0.01 0.01 0.00 0.01
KRAS G12V thyroid cancer >65yrs 2 370 0.01 0.01 0.00 0.01
KRAS G12V cervical cancer <40yrs 2 85 0.03 0.03 0.01 0.06
KRAS G12V cervical cancer 40-50yrs 2 99 0.03 0.03 0.01 0.05
KRAS G12V cervical cancer 50-65yrs 6 144 0.03 0.03 0.02 0.06
KRAS G12V cervical cancer >65yrs 1 36 0.03 0.03 0.01 0.06
KRAS G12V hepatobiliary cancer <40yrs 0 138 0.02 0.02 0.00 0.04
KRAS G12V hepatobiliary cancer 40-50yrs 5 110 0.03 0.03 0.02 0.07
KRAS G12V hepatobiliary cancer 50-65yrs 16 525 0.03 0.03 0.02 0.04
KRAS G12V hepatobiliary cancer >65yrs 17 601 0.03 0.03 0.02 0.04
KRAS G12V kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.01
KRAS G12V kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.01
KRAS G12V kidney cancer 50-65yrs 2 628 0.00 0.00 0.00 0.01
KRAS G12V kidney cancer >65yrs 2 440 0.00 0.00 0.00 0.01
KRAS G12V mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.03
KRAS G12V mature t and nk neoplasms 40-50yrs 1 21 0.02 0.01 0.00 0.12
KRAS G12V mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.02
KRAS G12V mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.02
KRAS G12V cns cancer <40yrs 2 1602 0.00 0.00 0.00 0.00
KRAS G12V cns cancer 40-50yrs 3 687 0.00 0.00 0.00 0.01
KRAS G12V cns cancer 50-65yrs 3 1439 0.00 0.00 0.00 0.00
KRAS G12V cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
KRAS G12V prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
KRAS G12V prostate cancer 50-65yrs 1 960 0.00 0.00 0.00 0.00
KRAS G12V prostate cancer >65yrs 1 1402 0.00 0.00 0.00 0.00
KRAS G12V anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
KRAS G12V anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
KRAS G12V anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
KRAS G12V neuroendocrine tumors <40yrs 0 22 0.02 0.02 0.00 0.04
KRAS G12V neuroendocrine tumors 40-50yrs 3 55 0.03 0.02 0.01 0.08
KRAS G12V neuroendocrine tumors 50-65yrs 2 161 0.02 0.02 0.00 0.03
KRAS G12V neuroendocrine tumors >65yrs 1 121 0.02 0.01 0.00 0.03
KRAS G12V bladder cancer <40yrs 0 25 0.01 0.01 0.00 0.02
KRAS G12V bladder cancer 40-50yrs 0 78 0.01 0.01 0.00 0.02
KRAS G12V bladder cancer 50-65yrs 7 511 0.01 0.01 0.01 0.02
KRAS G12V bladder cancer >65yrs 12 962 0.01 0.01 0.01 0.02
KRAS G12V b-lymphoblastic leukemia/lymphoma <40yrs 1 142 0.00 0.00 0.00 0.02
KRAS G12V b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.02
KRAS G12V b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.02
KRAS G12V b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.02
KRAS G12V small bowel cancer 40-50yrs 3 29 0.12 0.12 0.06 0.19
KRAS G12V small bowel cancer 50-65yrs 12 96 0.12 0.12 0.08 0.18
KRAS G12V small bowel cancer >65yrs 10 78 0.12 0.12 0.08 0.18
KRAS G12V sex cord stromal tumor <40yrs 1 29 0.02 0.02 0.00 0.07
KRAS G12V sex cord stromal tumor 40-50yrs 0 15 0.02 0.02 0.00 0.06
KRAS G12V sex cord stromal tumor 50-65yrs 1 37 0.02 0.02 0.00 0.06
KRAS G12V sex cord stromal tumor >65yrs 0 27 0.02 0.02 0.00 0.06
KRAS G12V bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
KRAS G12V bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
KRAS G12V bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS G12V bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
KRAS G12V vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
KRAS G12V vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
KRAS G12V thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
KRAS G12V thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS G12V thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS G12V thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS G12V ampullary cancer 40-50yrs 2 12 0.13 0.12 0.05 0.27
KRAS G12V ampullary cancer 50-65yrs 6 40 0.13 0.12 0.06 0.22
KRAS G12V ampullary cancer >65yrs 4 50 0.11 0.11 0.05 0.18
KRAS G12V small cell lung cancer 40-50yrs 0 22 0.01 0.01 0.00 0.03
KRAS G12V small cell lung cancer 50-65yrs 2 144 0.01 0.01 0.00 0.03
KRAS G12V small cell lung cancer >65yrs 1 224 0.01 0.01 0.00 0.02
KRAS G12V mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS G12V mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G12V mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS G12V mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS G12V germ cell tumor <40yrs 10 650 0.02 0.02 0.01 0.03
KRAS G12V germ cell tumor 40-50yrs 6 131 0.03 0.03 0.01 0.07
KRAS G12V germ cell tumor 50-65yrs 2 92 0.02 0.02 0.01 0.05
KRAS G12V germ cell tumor >65yrs 0 12 0.02 0.02 0.00 0.06
KRAS G12V nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
KRAS G12V nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
KRAS G12V nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS G12V nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
KRAS G12V penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G12V penile cancer >65yrs 0 11 0.00 0.00 0.00 0.04
KRAS G12V pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.05
KRAS G12V b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
KRAS G12V b cell lymphoma 40-50yrs 1 105 0.00 0.00 0.00 0.02
KRAS G12V b cell lymphoma 50-65yrs 1 357 0.00 0.00 0.00 0.01
KRAS G12V b cell lymphoma >65yrs 2 413 0.00 0.00 0.00 0.01
KRAS G12V non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
KRAS G12V t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
KRAS G12V retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS G12V hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
KRAS G12V lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
KRAS G12V peritoneal cancer >65yrs 0 11 0.01 0.00 0.00 0.07
KRAS G13C appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS G13C appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
KRAS G13C appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
KRAS G13C appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
KRAS G13C colorectal cancer <40yrs 1 565 0.00 0.00 0.00 0.01
KRAS G13C colorectal cancer 40-50yrs 1 1280 0.00 0.00 0.00 0.00
KRAS G13C colorectal cancer 50-65yrs 15 2815 0.00 0.00 0.00 0.01
KRAS G13C colorectal cancer >65yrs 7 2055 0.00 0.00 0.00 0.01
KRAS G13C cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.01
KRAS G13C cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.01
KRAS G13C cancer of unknown primary 50-65yrs 4 810 0.00 0.00 0.00 0.01
KRAS G13C cancer of unknown primary >65yrs 4 797 0.00 0.00 0.00 0.01
KRAS G13C non-small cell lung cancer <40yrs 2 161 0.01 0.01 0.01 0.02
KRAS G13C non-small cell lung cancer 40-50yrs 3 585 0.01 0.01 0.00 0.01
KRAS G13C non-small cell lung cancer 50-65yrs 42 3677 0.01 0.01 0.01 0.01
KRAS G13C non-small cell lung cancer >65yrs 62 5698 0.01 0.01 0.01 0.01
KRAS G13C non-small cell lung cancer Age:NA 0 10 0.01 0.01 0.00 0.02
KRAS G13C breast cancer <40yrs 0 841 0.00 0.00 0.00 0.00
KRAS G13C breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
KRAS G13C breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
KRAS G13C breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
KRAS G13C breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma >65yrs 1 777 0.00 0.00 0.00 0.00
KRAS G13C pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS G13C pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
KRAS G13C pancreatic cancer 50-65yrs 0 1000 0.00 0.00 0.00 0.00
KRAS G13C pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
KRAS G13C leukemia <40yrs 0 204 0.00 0.00 0.00 0.00
KRAS G13C leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.00
KRAS G13C leukemia 50-65yrs 1 515 0.00 0.00 0.00 0.00
KRAS G13C leukemia >65yrs 0 720 0.00 0.00 0.00 0.00
KRAS G13C melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
KRAS G13C melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
KRAS G13C melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
KRAS G13C melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
KRAS G13C head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
KRAS G13C head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
KRAS G13C head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
KRAS G13C head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
KRAS G13C uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.01
KRAS G13C uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.01
KRAS G13C uterine cancer 50-65yrs 1 1046 0.00 0.00 0.00 0.00
KRAS G13C uterine cancer >65yrs 4 988 0.00 0.00 0.00 0.01
KRAS G13C non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G13C non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
KRAS G13C non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
KRAS G13C non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
KRAS G13C myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS G13C myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
KRAS G13C myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
KRAS G13C myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
KRAS G13C adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G13C adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.01
KRAS G13C adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS G13C adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.01
KRAS G13C ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
KRAS G13C ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
KRAS G13C ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
KRAS G13C ovarian cancer >65yrs 1 849 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
KRAS G13C thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
KRAS G13C thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
KRAS G13C thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
KRAS G13C thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
KRAS G13C cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
KRAS G13C cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
KRAS G13C cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS G13C cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
KRAS G13C hepatobiliary cancer <40yrs 0 138 0.00 0.00 0.00 0.00
KRAS G13C hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
KRAS G13C hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
KRAS G13C hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
KRAS G13C kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
KRAS G13C kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
KRAS G13C kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
KRAS G13C kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
KRAS G13C mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS G13C mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
KRAS G13C mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
KRAS G13C mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
KRAS G13C cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
KRAS G13C cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
KRAS G13C cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
KRAS G13C cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
KRAS G13C prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
KRAS G13C prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
KRAS G13C prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
KRAS G13C anal cancer 40-50yrs 0 12 0.01 0.00 0.00 0.04
KRAS G13C anal cancer 50-65yrs 1 88 0.01 0.01 0.00 0.03
KRAS G13C anal cancer >65yrs 0 45 0.01 0.00 0.00 0.03
KRAS G13C neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
KRAS G13C neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
KRAS G13C neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
KRAS G13C neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
KRAS G13C bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
KRAS G13C bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
KRAS G13C bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
KRAS G13C bladder cancer >65yrs 0 962 0.00 0.00 0.00 0.00
KRAS G13C b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
KRAS G13C b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
KRAS G13C b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
KRAS G13C b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
KRAS G13C small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G13C small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS G13C small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
KRAS G13C sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
KRAS G13C sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
KRAS G13C sex cord stromal tumor 50-65yrs 0 37 0.00 0.00 0.00 0.01
KRAS G13C sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
KRAS G13C bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
KRAS G13C bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
KRAS G13C bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS G13C bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
KRAS G13C vaginal cancer 50-65yrs 1 34 0.02 0.02 0.00 0.08
KRAS G13C vaginal cancer >65yrs 0 30 0.01 0.01 0.00 0.06
KRAS G13C thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
KRAS G13C thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS G13C thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS G13C thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS G13C ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
KRAS G13C ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
KRAS G13C ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
KRAS G13C small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
KRAS G13C small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS G13C small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
KRAS G13C mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS G13C mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G13C mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS G13C mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
KRAS G13C nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.01
KRAS G13C nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.01
KRAS G13C nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.01
KRAS G13C nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.01
KRAS G13C penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G13C penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G13C pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.03
KRAS G13C b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
KRAS G13C b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
KRAS G13C b cell lymphoma 50-65yrs 1 357 0.00 0.00 0.00 0.01
KRAS G13C b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
KRAS G13C non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
KRAS G13C t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
KRAS G13C retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS G13C hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
KRAS G13C lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
KRAS G13C peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
KRAS G13D appendiceal cancer <40yrs 0 28 0.04 0.04 0.00 0.07
KRAS G13D appendiceal cancer 40-50yrs 4 62 0.05 0.04 0.02 0.10
KRAS G13D appendiceal cancer 50-65yrs 4 161 0.04 0.03 0.01 0.06
KRAS G13D appendiceal cancer >65yrs 6 90 0.05 0.05 0.02 0.10
KRAS G13D colorectal cancer <40yrs 46 565 0.08 0.08 0.06 0.09
KRAS G13D colorectal cancer 40-50yrs 93 1280 0.07 0.07 0.06 0.08
KRAS G13D colorectal cancer 50-65yrs 197 2815 0.07 0.07 0.06 0.08
KRAS G13D colorectal cancer >65yrs 162 2055 0.08 0.08 0.07 0.09
KRAS G13D cancer of unknown primary <40yrs 3 167 0.02 0.01 0.01 0.03
KRAS G13D cancer of unknown primary 40-50yrs 7 211 0.02 0.02 0.01 0.05
KRAS G13D cancer of unknown primary 50-65yrs 9 810 0.01 0.01 0.01 0.02
KRAS G13D cancer of unknown primary >65yrs 7 797 0.01 0.01 0.00 0.02
KRAS G13D non-small cell lung cancer <40yrs 0 161 0.01 0.01 0.00 0.01
KRAS G13D non-small cell lung cancer 40-50yrs 5 585 0.01 0.01 0.00 0.01
KRAS G13D non-small cell lung cancer 50-65yrs 37 3677 0.01 0.01 0.01 0.01
KRAS G13D non-small cell lung cancer >65yrs 45 5698 0.01 0.01 0.01 0.01
KRAS G13D non-small cell lung cancer Age:NA 0 10 0.01 0.01 0.00 0.02
KRAS G13D breast cancer <40yrs 0 841 0.00 0.00 0.00 0.00
KRAS G13D breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
KRAS G13D breast cancer 50-65yrs 5 3989 0.00 0.00 0.00 0.00
KRAS G13D breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
KRAS G13D breast cancer Age:NA 0 10 0.00 0.00 0.00 0.02
KRAS G13D soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
KRAS G13D soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
KRAS G13D soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
KRAS G13D soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
KRAS G13D pancreatic cancer <40yrs 0 87 0.01 0.00 0.00 0.01
KRAS G13D pancreatic cancer 40-50yrs 1 200 0.01 0.00 0.00 0.01
KRAS G13D pancreatic cancer 50-65yrs 5 1000 0.01 0.00 0.00 0.01
KRAS G13D pancreatic cancer >65yrs 8 1205 0.01 0.01 0.00 0.01
KRAS G13D leukemia <40yrs 10 204 0.04 0.04 0.02 0.07
KRAS G13D leukemia 40-50yrs 3 128 0.02 0.02 0.01 0.05
KRAS G13D leukemia 50-65yrs 7 515 0.02 0.01 0.01 0.02
KRAS G13D leukemia >65yrs 5 720 0.01 0.01 0.00 0.02
KRAS G13D melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
KRAS G13D melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
KRAS G13D melanoma 50-65yrs 1 1016 0.00 0.00 0.00 0.00
KRAS G13D melanoma >65yrs 6 1259 0.00 0.00 0.00 0.01
KRAS G13D head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
KRAS G13D head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
KRAS G13D head and neck cancer 50-65yrs 2 799 0.00 0.00 0.00 0.00
KRAS G13D head and neck cancer >65yrs 1 582 0.00 0.00 0.00 0.00
KRAS G13D uterine cancer <40yrs 1 57 0.02 0.02 0.01 0.03
KRAS G13D uterine cancer 40-50yrs 4 162 0.02 0.02 0.01 0.03
KRAS G13D uterine cancer 50-65yrs 20 1046 0.02 0.02 0.01 0.03
KRAS G13D uterine cancer >65yrs 21 988 0.02 0.02 0.01 0.03
KRAS G13D non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G13D non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
KRAS G13D non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
KRAS G13D non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
KRAS G13D myelodysplastic/myeloproliferative syndromes <40yrs 2 87 0.01 0.01 0.00 0.03
KRAS G13D myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.01 0.00 0.00 0.02
KRAS G13D myelodysplastic/myeloproliferative syndromes 50-65yrs 1 373 0.00 0.00 0.00 0.01
KRAS G13D myelodysplastic/myeloproliferative syndromes >65yrs 4 664 0.01 0.01 0.00 0.01
KRAS G13D adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G13D adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.01
KRAS G13D adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS G13D adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.01
KRAS G13D ovarian cancer <40yrs 1 141 0.00 0.00 0.00 0.01
KRAS G13D ovarian cancer 40-50yrs 3 253 0.01 0.00 0.00 0.02
KRAS G13D ovarian cancer 50-65yrs 3 1092 0.00 0.00 0.00 0.01
KRAS G13D ovarian cancer >65yrs 3 849 0.00 0.00 0.00 0.01
KRAS G13D esophagogastric cancer <40yrs 1 122 0.01 0.01 0.00 0.02
KRAS G13D esophagogastric cancer 40-50yrs 2 200 0.01 0.01 0.00 0.02
KRAS G13D esophagogastric cancer 50-65yrs 7 752 0.01 0.01 0.01 0.02
KRAS G13D esophagogastric cancer >65yrs 12 725 0.01 0.01 0.01 0.02
KRAS G13D thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
KRAS G13D thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
KRAS G13D thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
KRAS G13D thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
KRAS G13D cervical cancer <40yrs 0 85 0.01 0.01 0.00 0.02
KRAS G13D cervical cancer 40-50yrs 3 99 0.02 0.02 0.00 0.05
KRAS G13D cervical cancer 50-65yrs 1 144 0.01 0.01 0.00 0.02
KRAS G13D cervical cancer >65yrs 0 36 0.01 0.01 0.00 0.03
KRAS G13D hepatobiliary cancer <40yrs 0 138 0.01 0.01 0.00 0.01
KRAS G13D hepatobiliary cancer 40-50yrs 2 110 0.01 0.01 0.00 0.02
KRAS G13D hepatobiliary cancer 50-65yrs 4 525 0.01 0.01 0.00 0.01
KRAS G13D hepatobiliary cancer >65yrs 3 601 0.01 0.01 0.00 0.01
KRAS G13D kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
KRAS G13D kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
KRAS G13D kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
KRAS G13D kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
KRAS G13D mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS G13D mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
KRAS G13D mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
KRAS G13D mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
KRAS G13D cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
KRAS G13D cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
KRAS G13D cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
KRAS G13D cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
KRAS G13D prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
KRAS G13D prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
KRAS G13D prostate cancer >65yrs 1 1402 0.00 0.00 0.00 0.00
KRAS G13D anal cancer 40-50yrs 0 12 0.01 0.00 0.00 0.05
KRAS G13D anal cancer 50-65yrs 0 88 0.01 0.00 0.00 0.02
KRAS G13D anal cancer >65yrs 1 45 0.01 0.01 0.00 0.06
KRAS G13D neuroendocrine tumors <40yrs 2 22 0.03 0.02 0.01 0.13
KRAS G13D neuroendocrine tumors 40-50yrs 1 55 0.02 0.02 0.00 0.05
KRAS G13D neuroendocrine tumors 50-65yrs 2 161 0.02 0.02 0.00 0.03
KRAS G13D neuroendocrine tumors >65yrs 1 121 0.02 0.01 0.00 0.03
KRAS G13D bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.02
KRAS G13D bladder cancer 40-50yrs 1 78 0.01 0.00 0.00 0.03
KRAS G13D bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.01
KRAS G13D bladder cancer >65yrs 3 962 0.00 0.00 0.00 0.01
KRAS G13D b-lymphoblastic leukemia/lymphoma <40yrs 8 142 0.05 0.05 0.02 0.10
KRAS G13D b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.01 0.00 0.00 0.06
KRAS G13D b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.01 0.00 0.00 0.04
KRAS G13D b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.01 0.00 0.00 0.04
KRAS G13D small bowel cancer 40-50yrs 6 29 0.15 0.14 0.05 0.32
KRAS G13D small bowel cancer 50-65yrs 4 96 0.05 0.05 0.02 0.10
KRAS G13D small bowel cancer >65yrs 3 78 0.05 0.05 0.01 0.10
KRAS G13D sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
KRAS G13D sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
KRAS G13D sex cord stromal tumor 50-65yrs 0 37 0.00 0.00 0.00 0.01
KRAS G13D sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
KRAS G13D bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
KRAS G13D bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
KRAS G13D bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS G13D bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
KRAS G13D vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
KRAS G13D vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
KRAS G13D thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
KRAS G13D thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS G13D thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS G13D thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS G13D ampullary cancer 40-50yrs 0 12 0.04 0.04 0.00 0.11
KRAS G13D ampullary cancer 50-65yrs 3 40 0.06 0.05 0.02 0.13
KRAS G13D ampullary cancer >65yrs 2 50 0.05 0.04 0.01 0.10
KRAS G13D small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
KRAS G13D small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS G13D small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
KRAS G13D mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS G13D mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G13D mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS G13D mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS G13D germ cell tumor <40yrs 1 650 0.00 0.00 0.00 0.00
KRAS G13D germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.01
KRAS G13D germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.01
KRAS G13D germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.01
KRAS G13D nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.01
KRAS G13D nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.01
KRAS G13D nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.01
KRAS G13D nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.01
KRAS G13D penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G13D penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G13D pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.03
KRAS G13D b cell lymphoma <40yrs 0 87 0.01 0.01 0.00 0.02
KRAS G13D b cell lymphoma 40-50yrs 1 105 0.01 0.01 0.00 0.02
KRAS G13D b cell lymphoma 50-65yrs 1 357 0.01 0.01 0.00 0.01
KRAS G13D b cell lymphoma >65yrs 5 413 0.01 0.01 0.00 0.02
KRAS G13D non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
KRAS G13D t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
KRAS G13D retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS G13D hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
KRAS G13D lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
KRAS G13D peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
KRAS G13R appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS G13R appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
KRAS G13R appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
KRAS G13R appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer 40-50yrs 1 1280 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer 50-65yrs 1 2815 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer >65yrs 0 2055 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary 50-65yrs 1 810 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary >65yrs 0 797 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer 50-65yrs 3 3677 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer >65yrs 3 5698 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
KRAS G13R breast cancer <40yrs 0 841 0.00 0.00 0.00 0.00
KRAS G13R breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
KRAS G13R breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
KRAS G13R breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
KRAS G13R breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
KRAS G13R pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS G13R pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
KRAS G13R pancreatic cancer 50-65yrs 0 1000 0.00 0.00 0.00 0.00
KRAS G13R pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
KRAS G13R leukemia <40yrs 0 204 0.00 0.00 0.00 0.00
KRAS G13R leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.00
KRAS G13R leukemia 50-65yrs 0 515 0.00 0.00 0.00 0.00
KRAS G13R leukemia >65yrs 0 720 0.00 0.00 0.00 0.00
KRAS G13R melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
KRAS G13R melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
KRAS G13R melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
KRAS G13R melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
KRAS G13R head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
KRAS G13R head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
KRAS G13R head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
KRAS G13R head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
KRAS G13R uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.00
KRAS G13R uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
KRAS G13R uterine cancer 50-65yrs 0 1046 0.00 0.00 0.00 0.00
KRAS G13R uterine cancer >65yrs 0 988 0.00 0.00 0.00 0.00
KRAS G13R non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G13R non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
KRAS G13R non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
KRAS G13R non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
KRAS G13R myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS G13R myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
KRAS G13R myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
KRAS G13R myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
KRAS G13R adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G13R adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
KRAS G13R adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS G13R adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
KRAS G13R ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
KRAS G13R ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
KRAS G13R ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
KRAS G13R ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
KRAS G13R thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
KRAS G13R thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
KRAS G13R thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
KRAS G13R thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
KRAS G13R cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
KRAS G13R cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
KRAS G13R cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS G13R cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
KRAS G13R hepatobiliary cancer <40yrs 0 138 0.00 0.00 0.00 0.00
KRAS G13R hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
KRAS G13R hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
KRAS G13R hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
KRAS G13R kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
KRAS G13R kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
KRAS G13R kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
KRAS G13R kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
KRAS G13R mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS G13R mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
KRAS G13R mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
KRAS G13R mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
KRAS G13R cns cancer <40yrs 1 1602 0.00 0.00 0.00 0.00
KRAS G13R cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
KRAS G13R cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
KRAS G13R cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
KRAS G13R prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
KRAS G13R prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
KRAS G13R prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
KRAS G13R anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
KRAS G13R anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
KRAS G13R anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
KRAS G13R neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
KRAS G13R neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
KRAS G13R neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
KRAS G13R neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
KRAS G13R bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
KRAS G13R bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
KRAS G13R bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
KRAS G13R bladder cancer >65yrs 0 962 0.00 0.00 0.00 0.00
KRAS G13R b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
KRAS G13R b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
KRAS G13R b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
KRAS G13R b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
KRAS G13R small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G13R small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS G13R small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
KRAS G13R sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
KRAS G13R sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
KRAS G13R sex cord stromal tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS G13R sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
KRAS G13R bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
KRAS G13R bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
KRAS G13R bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS G13R bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
KRAS G13R vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
KRAS G13R vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
KRAS G13R thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.01
KRAS G13R thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS G13R thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS G13R thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS G13R ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
KRAS G13R ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
KRAS G13R ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
KRAS G13R small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
KRAS G13R small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS G13R small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
KRAS G13R mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS G13R mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G13R mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS G13R mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
KRAS G13R nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
KRAS G13R nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
KRAS G13R nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS G13R nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
KRAS G13R penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.04
KRAS G13R penile cancer >65yrs 0 11 0.00 0.00 0.00 0.05
KRAS G13R pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.05
KRAS G13R b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS G13R b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
KRAS G13R b cell lymphoma 50-65yrs 0 357 0.00 0.00 0.00 0.00
KRAS G13R b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
KRAS G13R non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
KRAS G13R t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
KRAS G13R retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS G13R hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
KRAS G13R lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
KRAS G13R peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.02
KRAS G13V appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS G13V appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
KRAS G13V appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
KRAS G13V appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer 50-65yrs 0 2815 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer >65yrs 2 2055 0.00 0.00 0.00 0.00
KRAS G13V cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
KRAS G13V cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
KRAS G13V cancer of unknown primary 50-65yrs 0 810 0.00 0.00 0.00 0.00
KRAS G13V cancer of unknown primary >65yrs 0 797 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer 40-50yrs 1 585 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer 50-65yrs 3 3677 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.01
KRAS G13V breast cancer <40yrs 0 841 0.00 0.00 0.00 0.00
KRAS G13V breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
KRAS G13V breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
KRAS G13V breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
KRAS G13V breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
KRAS G13V pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS G13V pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
KRAS G13V pancreatic cancer 50-65yrs 1 1000 0.00 0.00 0.00 0.00
KRAS G13V pancreatic cancer >65yrs 1 1205 0.00 0.00 0.00 0.00
KRAS G13V leukemia <40yrs 0 204 0.00 0.00 0.00 0.00
KRAS G13V leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.00
KRAS G13V leukemia 50-65yrs 0 515 0.00 0.00 0.00 0.00
KRAS G13V leukemia >65yrs 0 720 0.00 0.00 0.00 0.00
KRAS G13V melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
KRAS G13V melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
KRAS G13V melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
KRAS G13V melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
KRAS G13V head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
KRAS G13V head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
KRAS G13V head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
KRAS G13V head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
KRAS G13V uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.00
KRAS G13V uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
KRAS G13V uterine cancer 50-65yrs 0 1046 0.00 0.00 0.00 0.00
KRAS G13V uterine cancer >65yrs 0 988 0.00 0.00 0.00 0.00
KRAS G13V non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G13V non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
KRAS G13V non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
KRAS G13V non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
KRAS G13V myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS G13V myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
KRAS G13V myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
KRAS G13V myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
KRAS G13V adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS G13V adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
KRAS G13V adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS G13V adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
KRAS G13V ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
KRAS G13V ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
KRAS G13V ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
KRAS G13V ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
KRAS G13V thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
KRAS G13V thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
KRAS G13V thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
KRAS G13V thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
KRAS G13V cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
KRAS G13V cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
KRAS G13V cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS G13V cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
KRAS G13V hepatobiliary cancer <40yrs 0 138 0.00 0.00 0.00 0.00
KRAS G13V hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
KRAS G13V hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
KRAS G13V hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
KRAS G13V kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
KRAS G13V kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
KRAS G13V kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
KRAS G13V kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
KRAS G13V mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS G13V mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
KRAS G13V mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
KRAS G13V mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
KRAS G13V cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
KRAS G13V cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
KRAS G13V cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
KRAS G13V cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
KRAS G13V prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
KRAS G13V prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
KRAS G13V prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
KRAS G13V anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
KRAS G13V anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
KRAS G13V anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
KRAS G13V neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
KRAS G13V neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
KRAS G13V neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
KRAS G13V neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
KRAS G13V bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
KRAS G13V bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
KRAS G13V bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
KRAS G13V bladder cancer >65yrs 0 962 0.00 0.00 0.00 0.00
KRAS G13V b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
KRAS G13V b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
KRAS G13V b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
KRAS G13V b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
KRAS G13V small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G13V small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS G13V small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
KRAS G13V sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
KRAS G13V sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
KRAS G13V sex cord stromal tumor 50-65yrs 0 37 0.00 0.00 0.00 0.01
KRAS G13V sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
KRAS G13V bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
KRAS G13V bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
KRAS G13V bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS G13V bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
KRAS G13V vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
KRAS G13V vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
KRAS G13V thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
KRAS G13V thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS G13V thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS G13V thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS G13V ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
KRAS G13V ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
KRAS G13V ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
KRAS G13V small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
KRAS G13V small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS G13V small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
KRAS G13V mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS G13V mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS G13V mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS G13V mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS G13V germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.00
KRAS G13V germ cell tumor 40-50yrs 1 131 0.00 0.00 0.00 0.02
KRAS G13V germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.01
KRAS G13V germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.02
KRAS G13V nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
KRAS G13V nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
KRAS G13V nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS G13V nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
KRAS G13V penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G13V penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
KRAS G13V pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
KRAS G13V b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS G13V b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
KRAS G13V b cell lymphoma 50-65yrs 0 357 0.00 0.00 0.00 0.00
KRAS G13V b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
KRAS G13V non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.06
KRAS G13V t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
KRAS G13V retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS G13V hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
KRAS G13V lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
KRAS G13V peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
KRAS Q61H appendiceal cancer <40yrs 1 28 0.02 0.01 0.00 0.07
KRAS Q61H appendiceal cancer 40-50yrs 0 62 0.01 0.01 0.00 0.02
KRAS Q61H appendiceal cancer 50-65yrs 2 161 0.01 0.01 0.00 0.03
KRAS Q61H appendiceal cancer >65yrs 0 90 0.01 0.01 0.00 0.02
KRAS Q61H colorectal cancer <40yrs 2 565 0.01 0.01 0.00 0.01
KRAS Q61H colorectal cancer 40-50yrs 15 1280 0.01 0.01 0.01 0.02
KRAS Q61H colorectal cancer 50-65yrs 30 2815 0.01 0.01 0.01 0.01
KRAS Q61H colorectal cancer >65yrs 17 2055 0.01 0.01 0.01 0.01
KRAS Q61H cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.01
KRAS Q61H cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.01
KRAS Q61H cancer of unknown primary 50-65yrs 5 810 0.01 0.01 0.00 0.01
KRAS Q61H cancer of unknown primary >65yrs 10 797 0.01 0.01 0.00 0.02
KRAS Q61H non-small cell lung cancer <40yrs 0 161 0.01 0.01 0.00 0.02
KRAS Q61H non-small cell lung cancer 40-50yrs 8 585 0.01 0.01 0.01 0.02
KRAS Q61H non-small cell lung cancer 50-65yrs 52 3677 0.01 0.01 0.01 0.02
KRAS Q61H non-small cell lung cancer >65yrs 71 5698 0.01 0.01 0.01 0.02
KRAS Q61H non-small cell lung cancer Age:NA 0 10 0.01 0.01 0.01 0.02
KRAS Q61H breast cancer <40yrs 0 841 0.00 0.00 0.00 0.00
KRAS Q61H breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
KRAS Q61H breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
KRAS Q61H breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
KRAS Q61H breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
KRAS Q61H soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
KRAS Q61H soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
KRAS Q61H soft tissue sarcoma 50-65yrs 1 951 0.00 0.00 0.00 0.00
KRAS Q61H soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
KRAS Q61H pancreatic cancer <40yrs 0 87 0.02 0.02 0.00 0.04
KRAS Q61H pancreatic cancer 40-50yrs 8 200 0.04 0.04 0.02 0.06
KRAS Q61H pancreatic cancer 50-65yrs 25 1000 0.03 0.03 0.02 0.04
KRAS Q61H pancreatic cancer >65yrs 53 1205 0.04 0.04 0.03 0.05
KRAS Q61H leukemia <40yrs 1 204 0.00 0.00 0.00 0.01
KRAS Q61H leukemia 40-50yrs 1 128 0.00 0.00 0.00 0.01
KRAS Q61H leukemia 50-65yrs 1 515 0.00 0.00 0.00 0.01
KRAS Q61H leukemia >65yrs 1 720 0.00 0.00 0.00 0.01
KRAS Q61H melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
KRAS Q61H melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
KRAS Q61H melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
KRAS Q61H melanoma >65yrs 2 1259 0.00 0.00 0.00 0.00
KRAS Q61H head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
KRAS Q61H head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
KRAS Q61H head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
KRAS Q61H head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
KRAS Q61H uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.01
KRAS Q61H uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.01
KRAS Q61H uterine cancer 50-65yrs 3 1046 0.00 0.00 0.00 0.01
KRAS Q61H uterine cancer >65yrs 3 988 0.00 0.00 0.00 0.01
KRAS Q61H non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS Q61H non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
KRAS Q61H non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
KRAS Q61H non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
KRAS Q61H myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS Q61H myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
KRAS Q61H myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
KRAS Q61H myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
KRAS Q61H adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS Q61H adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
KRAS Q61H adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS Q61H adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
KRAS Q61H ovarian cancer <40yrs 2 141 0.01 0.00 0.00 0.02
KRAS Q61H ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.01
KRAS Q61H ovarian cancer 50-65yrs 5 1092 0.00 0.00 0.00 0.01
KRAS Q61H ovarian cancer >65yrs 1 849 0.00 0.00 0.00 0.01
KRAS Q61H esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
KRAS Q61H esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
KRAS Q61H esophagogastric cancer 50-65yrs 1 752 0.00 0.00 0.00 0.00
KRAS Q61H esophagogastric cancer >65yrs 1 725 0.00 0.00 0.00 0.00
KRAS Q61H thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
KRAS Q61H thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
KRAS Q61H thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
KRAS Q61H thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
KRAS Q61H cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
KRAS Q61H cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
KRAS Q61H cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS Q61H cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
KRAS Q61H hepatobiliary cancer <40yrs 0 138 0.01 0.01 0.00 0.02
KRAS Q61H hepatobiliary cancer 40-50yrs 1 110 0.01 0.01 0.00 0.02
KRAS Q61H hepatobiliary cancer 50-65yrs 5 525 0.01 0.01 0.00 0.02
KRAS Q61H hepatobiliary cancer >65yrs 8 601 0.01 0.01 0.01 0.02
KRAS Q61H kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
KRAS Q61H kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
KRAS Q61H kidney cancer 50-65yrs 1 628 0.00 0.00 0.00 0.00
KRAS Q61H kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
KRAS Q61H mature t and nk neoplasms <40yrs 1 28 0.02 0.01 0.00 0.07
KRAS Q61H mature t and nk neoplasms 40-50yrs 0 21 0.01 0.01 0.00 0.03
KRAS Q61H mature t and nk neoplasms 50-65yrs 0 76 0.01 0.01 0.00 0.02
KRAS Q61H mature t and nk neoplasms >65yrs 1 106 0.01 0.01 0.00 0.03
KRAS Q61H cns cancer <40yrs 1 1602 0.00 0.00 0.00 0.00
KRAS Q61H cns cancer 40-50yrs 1 687 0.00 0.00 0.00 0.00
KRAS Q61H cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
KRAS Q61H cns cancer >65yrs 1 836 0.00 0.00 0.00 0.00
KRAS Q61H prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
KRAS Q61H prostate cancer 50-65yrs 1 960 0.00 0.00 0.00 0.00
KRAS Q61H prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
KRAS Q61H anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
KRAS Q61H anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
KRAS Q61H anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
KRAS Q61H neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.02
KRAS Q61H neuroendocrine tumors 40-50yrs 1 55 0.01 0.00 0.00 0.05
KRAS Q61H neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.01
KRAS Q61H neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.01
KRAS Q61H bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.02
KRAS Q61H bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.01
KRAS Q61H bladder cancer 50-65yrs 3 511 0.00 0.00 0.00 0.01
KRAS Q61H bladder cancer >65yrs 0 962 0.00 0.00 0.00 0.00
KRAS Q61H b-lymphoblastic leukemia/lymphoma <40yrs 3 142 0.02 0.02 0.00 0.04
KRAS Q61H b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.01 0.00 0.00 0.04
KRAS Q61H b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.01 0.00 0.00 0.03
KRAS Q61H b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.01 0.00 0.00 0.03
KRAS Q61H small bowel cancer 40-50yrs 2 29 0.04 0.03 0.01 0.11
KRAS Q61H small bowel cancer 50-65yrs 3 96 0.03 0.03 0.01 0.06
KRAS Q61H small bowel cancer >65yrs 1 78 0.03 0.02 0.00 0.06
KRAS Q61H sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
KRAS Q61H sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
KRAS Q61H sex cord stromal tumor 50-65yrs 0 37 0.00 0.00 0.00 0.01
KRAS Q61H sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
KRAS Q61H bone cancer <40yrs 1 342 0.00 0.00 0.00 0.01
KRAS Q61H bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.01
KRAS Q61H bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.01
KRAS Q61H bone cancer >65yrs 0 67 0.00 0.00 0.00 0.01
KRAS Q61H vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
KRAS Q61H vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
KRAS Q61H thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
KRAS Q61H thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS Q61H thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS Q61H thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS Q61H ampullary cancer 40-50yrs 0 12 0.02 0.01 0.00 0.07
KRAS Q61H ampullary cancer 50-65yrs 0 40 0.02 0.01 0.00 0.05
KRAS Q61H ampullary cancer >65yrs 2 50 0.03 0.02 0.00 0.08
KRAS Q61H small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
KRAS Q61H small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS Q61H small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
KRAS Q61H mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS Q61H mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS Q61H mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS Q61H mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
KRAS Q61H nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
KRAS Q61H nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
KRAS Q61H nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS Q61H nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
KRAS Q61H penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
KRAS Q61H penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
KRAS Q61H pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
KRAS Q61H b cell lymphoma <40yrs 0 87 0.01 0.01 0.00 0.02
KRAS Q61H b cell lymphoma 40-50yrs 2 105 0.01 0.01 0.00 0.03
KRAS Q61H b cell lymphoma 50-65yrs 2 357 0.01 0.01 0.00 0.02
KRAS Q61H b cell lymphoma >65yrs 6 413 0.01 0.01 0.00 0.02
KRAS Q61H non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.06
KRAS Q61H t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
KRAS Q61H retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS Q61H hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
KRAS Q61H lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
KRAS Q61H peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
KRAS Q61K appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS Q61K appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
KRAS Q61K appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
KRAS Q61K appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer 40-50yrs 1 1280 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer 50-65yrs 3 2815 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer >65yrs 8 2055 0.00 0.00 0.00 0.01
KRAS Q61K cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
KRAS Q61K cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
KRAS Q61K cancer of unknown primary 50-65yrs 0 810 0.00 0.00 0.00 0.00
KRAS Q61K cancer of unknown primary >65yrs 1 797 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer 50-65yrs 1 3677 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer >65yrs 1 5698 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer <40yrs 0 841 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
KRAS Q61K pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS Q61K pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
KRAS Q61K pancreatic cancer 50-65yrs 2 1000 0.00 0.00 0.00 0.00
KRAS Q61K pancreatic cancer >65yrs 1 1205 0.00 0.00 0.00 0.00
KRAS Q61K leukemia <40yrs 0 204 0.00 0.00 0.00 0.00
KRAS Q61K leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.00
KRAS Q61K leukemia 50-65yrs 0 515 0.00 0.00 0.00 0.00
KRAS Q61K leukemia >65yrs 0 720 0.00 0.00 0.00 0.00
KRAS Q61K melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
KRAS Q61K melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
KRAS Q61K melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
KRAS Q61K melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
KRAS Q61K head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
KRAS Q61K head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
KRAS Q61K head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
KRAS Q61K head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
KRAS Q61K uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.00
KRAS Q61K uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
KRAS Q61K uterine cancer 50-65yrs 0 1046 0.00 0.00 0.00 0.00
KRAS Q61K uterine cancer >65yrs 1 988 0.00 0.00 0.00 0.00
KRAS Q61K non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS Q61K non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
KRAS Q61K non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
KRAS Q61K non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
KRAS Q61K myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS Q61K myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
KRAS Q61K myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
KRAS Q61K myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
KRAS Q61K adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS Q61K adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
KRAS Q61K adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS Q61K adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
KRAS Q61K ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
KRAS Q61K ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
KRAS Q61K ovarian cancer 50-65yrs 1 1092 0.00 0.00 0.00 0.00
KRAS Q61K ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
KRAS Q61K esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
KRAS Q61K esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
KRAS Q61K esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
KRAS Q61K esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
KRAS Q61K thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
KRAS Q61K thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
KRAS Q61K thyroid cancer 50-65yrs 1 374 0.00 0.00 0.00 0.01
KRAS Q61K thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
KRAS Q61K cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
KRAS Q61K cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
KRAS Q61K cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS Q61K cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
KRAS Q61K hepatobiliary cancer <40yrs 0 138 0.00 0.00 0.00 0.00
KRAS Q61K hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
KRAS Q61K hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
KRAS Q61K hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
KRAS Q61K kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
KRAS Q61K kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
KRAS Q61K kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
KRAS Q61K kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
KRAS Q61K mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS Q61K mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
KRAS Q61K mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
KRAS Q61K mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer <40yrs 2 1602 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
KRAS Q61K prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
KRAS Q61K prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
KRAS Q61K prostate cancer >65yrs 1 1402 0.00 0.00 0.00 0.00
KRAS Q61K anal cancer 40-50yrs 0 12 0.01 0.00 0.00 0.04
KRAS Q61K anal cancer 50-65yrs 1 88 0.01 0.01 0.00 0.03
KRAS Q61K anal cancer >65yrs 0 45 0.01 0.00 0.00 0.03
KRAS Q61K neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.02
KRAS Q61K neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.01
KRAS Q61K neuroendocrine tumors 50-65yrs 1 161 0.00 0.00 0.00 0.02
KRAS Q61K neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.01
KRAS Q61K bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
KRAS Q61K bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
KRAS Q61K bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
KRAS Q61K bladder cancer >65yrs 0 962 0.00 0.00 0.00 0.00
KRAS Q61K b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
KRAS Q61K b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
KRAS Q61K b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
KRAS Q61K b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
KRAS Q61K small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS Q61K small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS Q61K small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
KRAS Q61K sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
KRAS Q61K sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
KRAS Q61K sex cord stromal tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS Q61K sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
KRAS Q61K bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
KRAS Q61K bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
KRAS Q61K bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS Q61K bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
KRAS Q61K vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
KRAS Q61K vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
KRAS Q61K thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
KRAS Q61K thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS Q61K thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS Q61K thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS Q61K ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
KRAS Q61K ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
KRAS Q61K ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
KRAS Q61K small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
KRAS Q61K small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS Q61K small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
KRAS Q61K mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS Q61K mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS Q61K mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS Q61K mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
KRAS Q61K nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
KRAS Q61K nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
KRAS Q61K nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS Q61K nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.01
KRAS Q61K penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.02
KRAS Q61K penile cancer >65yrs 0 11 0.00 0.00 0.00 0.02
KRAS Q61K pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
KRAS Q61K b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS Q61K b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
KRAS Q61K b cell lymphoma 50-65yrs 0 357 0.00 0.00 0.00 0.00
KRAS Q61K b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
KRAS Q61K non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
KRAS Q61K t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
KRAS Q61K retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS Q61K hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
KRAS Q61K lung cancer >65yrs 0 18 0.00 0.00 0.00 0.02
KRAS Q61K peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.06
KRAS Q61L appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.02
KRAS Q61L appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.01
KRAS Q61L appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.01
KRAS Q61L appendiceal cancer >65yrs 1 90 0.01 0.00 0.00 0.03
KRAS Q61L colorectal cancer <40yrs 2 565 0.00 0.00 0.00 0.01
KRAS Q61L colorectal cancer 40-50yrs 2 1280 0.00 0.00 0.00 0.00
KRAS Q61L colorectal cancer 50-65yrs 13 2815 0.00 0.00 0.00 0.01
KRAS Q61L colorectal cancer >65yrs 7 2055 0.00 0.00 0.00 0.00
KRAS Q61L cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
KRAS Q61L cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
KRAS Q61L cancer of unknown primary 50-65yrs 1 810 0.00 0.00 0.00 0.00
KRAS Q61L cancer of unknown primary >65yrs 2 797 0.00 0.00 0.00 0.00
KRAS Q61L non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.01
KRAS Q61L non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
KRAS Q61L non-small cell lung cancer 50-65yrs 11 3677 0.00 0.00 0.00 0.00
KRAS Q61L non-small cell lung cancer >65yrs 26 5698 0.00 0.00 0.00 0.01
KRAS Q61L non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.01
KRAS Q61L breast cancer <40yrs 0 841 0.00 0.00 0.00 0.00
KRAS Q61L breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
KRAS Q61L breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
KRAS Q61L breast cancer >65yrs 1 2583 0.00 0.00 0.00 0.00
KRAS Q61L breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
KRAS Q61L soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
KRAS Q61L soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
KRAS Q61L soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
KRAS Q61L soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
KRAS Q61L pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.01
KRAS Q61L pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.01
KRAS Q61L pancreatic cancer 50-65yrs 3 1000 0.00 0.00 0.00 0.01
KRAS Q61L pancreatic cancer >65yrs 3 1205 0.00 0.00 0.00 0.00
KRAS Q61L leukemia <40yrs 0 204 0.00 0.00 0.00 0.00
KRAS Q61L leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.00
KRAS Q61L leukemia 50-65yrs 0 515 0.00 0.00 0.00 0.00
KRAS Q61L leukemia >65yrs 1 720 0.00 0.00 0.00 0.00
KRAS Q61L melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
KRAS Q61L melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
KRAS Q61L melanoma 50-65yrs 2 1016 0.00 0.00 0.00 0.00
KRAS Q61L melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
KRAS Q61L head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
KRAS Q61L head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
KRAS Q61L head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
KRAS Q61L head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
KRAS Q61L uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.01
KRAS Q61L uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
KRAS Q61L uterine cancer 50-65yrs 2 1046 0.00 0.00 0.00 0.00
KRAS Q61L uterine cancer >65yrs 0 988 0.00 0.00 0.00 0.00
KRAS Q61L non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS Q61L non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
KRAS Q61L non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
KRAS Q61L non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
KRAS Q61L myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS Q61L myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
KRAS Q61L myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
KRAS Q61L myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
KRAS Q61L adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS Q61L adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
KRAS Q61L adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS Q61L adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
KRAS Q61L ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
KRAS Q61L ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
KRAS Q61L ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
KRAS Q61L ovarian cancer >65yrs 1 849 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
KRAS Q61L thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
KRAS Q61L thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
KRAS Q61L thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
KRAS Q61L thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
KRAS Q61L cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
KRAS Q61L cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
KRAS Q61L cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS Q61L cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
KRAS Q61L hepatobiliary cancer <40yrs 0 138 0.00 0.00 0.00 0.00
KRAS Q61L hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.01
KRAS Q61L hepatobiliary cancer 50-65yrs 1 525 0.00 0.00 0.00 0.00
KRAS Q61L hepatobiliary cancer >65yrs 1 601 0.00 0.00 0.00 0.00
KRAS Q61L kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
KRAS Q61L kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
KRAS Q61L kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
KRAS Q61L kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
KRAS Q61L mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS Q61L mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
KRAS Q61L mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
KRAS Q61L mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer <40yrs 1 1602 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer >65yrs 1 836 0.00 0.00 0.00 0.00
KRAS Q61L prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
KRAS Q61L prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
KRAS Q61L prostate cancer >65yrs 1 1402 0.00 0.00 0.00 0.00
KRAS Q61L anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
KRAS Q61L anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
KRAS Q61L anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
KRAS Q61L neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
KRAS Q61L neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
KRAS Q61L neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
KRAS Q61L neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
KRAS Q61L bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.01
KRAS Q61L bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
KRAS Q61L bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
KRAS Q61L bladder cancer >65yrs 1 962 0.00 0.00 0.00 0.00
KRAS Q61L b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
KRAS Q61L b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
KRAS Q61L b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
KRAS Q61L b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
KRAS Q61L small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS Q61L small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS Q61L small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
KRAS Q61L sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
KRAS Q61L sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
KRAS Q61L sex cord stromal tumor 50-65yrs 0 37 0.00 0.00 0.00 0.01
KRAS Q61L sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
KRAS Q61L bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
KRAS Q61L bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
KRAS Q61L bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS Q61L bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
KRAS Q61L vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
KRAS Q61L vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
KRAS Q61L thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
KRAS Q61L thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS Q61L thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS Q61L thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS Q61L ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
KRAS Q61L ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
KRAS Q61L ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
KRAS Q61L small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
KRAS Q61L small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS Q61L small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
KRAS Q61L mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS Q61L mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS Q61L mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS Q61L mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
KRAS Q61L nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
KRAS Q61L nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
KRAS Q61L nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS Q61L nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
KRAS Q61L penile cancer 50-65yrs 0 11 0.03 0.01 0.00 0.15
KRAS Q61L penile cancer >65yrs 1 11 0.07 0.05 0.00 0.25
KRAS Q61L pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
KRAS Q61L b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
KRAS Q61L b cell lymphoma 40-50yrs 1 105 0.00 0.00 0.00 0.03
KRAS Q61L b cell lymphoma 50-65yrs 0 357 0.00 0.00 0.00 0.00
KRAS Q61L b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
KRAS Q61L non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.06
KRAS Q61L t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
KRAS Q61L retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS Q61L hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
KRAS Q61L lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
KRAS Q61L peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
KRAS Q61R appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.02
KRAS Q61R appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.01
KRAS Q61R appendiceal cancer 50-65yrs 1 161 0.00 0.00 0.00 0.02
KRAS Q61R appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.01
KRAS Q61R colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
KRAS Q61R colorectal cancer 40-50yrs 5 1280 0.00 0.00 0.00 0.01
KRAS Q61R colorectal cancer 50-65yrs 8 2815 0.00 0.00 0.00 0.00
KRAS Q61R colorectal cancer >65yrs 7 2055 0.00 0.00 0.00 0.00
KRAS Q61R cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
KRAS Q61R cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
KRAS Q61R cancer of unknown primary 50-65yrs 3 810 0.00 0.00 0.00 0.01
KRAS Q61R cancer of unknown primary >65yrs 0 797 0.00 0.00 0.00 0.00
KRAS Q61R non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
KRAS Q61R non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
KRAS Q61R non-small cell lung cancer 50-65yrs 3 3677 0.00 0.00 0.00 0.00
KRAS Q61R non-small cell lung cancer >65yrs 4 5698 0.00 0.00 0.00 0.00
KRAS Q61R non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer <40yrs 0 841 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer >65yrs 1 2583 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
KRAS Q61R soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
KRAS Q61R soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
KRAS Q61R soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
KRAS Q61R soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
KRAS Q61R pancreatic cancer <40yrs 0 87 0.01 0.01 0.00 0.02
KRAS Q61R pancreatic cancer 40-50yrs 2 200 0.01 0.01 0.00 0.02
KRAS Q61R pancreatic cancer 50-65yrs 9 1000 0.01 0.01 0.00 0.02
KRAS Q61R pancreatic cancer >65yrs 27 1205 0.02 0.02 0.01 0.03
KRAS Q61R leukemia <40yrs 0 204 0.00 0.00 0.00 0.00
KRAS Q61R leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.00
KRAS Q61R leukemia 50-65yrs 0 515 0.00 0.00 0.00 0.00
KRAS Q61R leukemia >65yrs 1 720 0.00 0.00 0.00 0.00
KRAS Q61R melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
KRAS Q61R melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
KRAS Q61R melanoma 50-65yrs 1 1016 0.00 0.00 0.00 0.00
KRAS Q61R melanoma >65yrs 2 1259 0.00 0.00 0.00 0.00
KRAS Q61R head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
KRAS Q61R head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
KRAS Q61R head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
KRAS Q61R head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
KRAS Q61R uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.00
KRAS Q61R uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
KRAS Q61R uterine cancer 50-65yrs 0 1046 0.00 0.00 0.00 0.00
KRAS Q61R uterine cancer >65yrs 0 988 0.00 0.00 0.00 0.00
KRAS Q61R non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS Q61R non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
KRAS Q61R non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
KRAS Q61R non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
KRAS Q61R myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.00
KRAS Q61R myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
KRAS Q61R myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
KRAS Q61R myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
KRAS Q61R adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
KRAS Q61R adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
KRAS Q61R adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
KRAS Q61R adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
KRAS Q61R ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
KRAS Q61R ovarian cancer 40-50yrs 2 253 0.01 0.00 0.00 0.02
KRAS Q61R ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
KRAS Q61R ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
KRAS Q61R esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
KRAS Q61R esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
KRAS Q61R esophagogastric cancer 50-65yrs 1 752 0.00 0.00 0.00 0.00
KRAS Q61R esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
KRAS Q61R thyroid cancer <40yrs 2 150 0.02 0.01 0.01 0.03
KRAS Q61R thyroid cancer 40-50yrs 2 122 0.02 0.01 0.01 0.03
KRAS Q61R thyroid cancer 50-65yrs 6 374 0.02 0.02 0.01 0.02
KRAS Q61R thyroid cancer >65yrs 5 370 0.02 0.01 0.01 0.02
KRAS Q61R cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
KRAS Q61R cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
KRAS Q61R cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS Q61R cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
KRAS Q61R hepatobiliary cancer <40yrs 0 138 0.00 0.00 0.00 0.00
KRAS Q61R hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.01
KRAS Q61R hepatobiliary cancer 50-65yrs 1 525 0.00 0.00 0.00 0.00
KRAS Q61R hepatobiliary cancer >65yrs 1 601 0.00 0.00 0.00 0.00
KRAS Q61R kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
KRAS Q61R kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
KRAS Q61R kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
KRAS Q61R kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
KRAS Q61R mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
KRAS Q61R mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
KRAS Q61R mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
KRAS Q61R mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer <40yrs 1 1602 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer 40-50yrs 1 687 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer 50-65yrs 1 1439 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer >65yrs 1 836 0.00 0.00 0.00 0.00
KRAS Q61R prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
KRAS Q61R prostate cancer 50-65yrs 1 960 0.00 0.00 0.00 0.00
KRAS Q61R prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
KRAS Q61R anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
KRAS Q61R anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
KRAS Q61R anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
KRAS Q61R neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
KRAS Q61R neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
KRAS Q61R neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
KRAS Q61R neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
KRAS Q61R bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.01
KRAS Q61R bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
KRAS Q61R bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
KRAS Q61R bladder cancer >65yrs 1 962 0.00 0.00 0.00 0.00
KRAS Q61R b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
KRAS Q61R b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
KRAS Q61R b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
KRAS Q61R b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
KRAS Q61R small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS Q61R small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS Q61R small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
KRAS Q61R sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
KRAS Q61R sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
KRAS Q61R sex cord stromal tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS Q61R sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
KRAS Q61R bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
KRAS Q61R bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
KRAS Q61R bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
KRAS Q61R bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
KRAS Q61R vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
KRAS Q61R vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
KRAS Q61R thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.01
KRAS Q61R thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
KRAS Q61R thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
KRAS Q61R thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
KRAS Q61R ampullary cancer 40-50yrs 0 12 0.02 0.01 0.00 0.07
KRAS Q61R ampullary cancer 50-65yrs 2 40 0.04 0.03 0.00 0.11
KRAS Q61R ampullary cancer >65yrs 0 50 0.01 0.01 0.00 0.05
KRAS Q61R small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
KRAS Q61R small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
KRAS Q61R small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
KRAS Q61R mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
KRAS Q61R mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
KRAS Q61R mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
KRAS Q61R mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
KRAS Q61R nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
KRAS Q61R nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
KRAS Q61R nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
KRAS Q61R nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
KRAS Q61R penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.02
KRAS Q61R penile cancer >65yrs 0 11 0.00 0.00 0.00 0.02
KRAS Q61R pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
KRAS Q61R b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
KRAS Q61R b cell lymphoma 40-50yrs 1 105 0.00 0.00 0.00 0.02
KRAS Q61R b cell lymphoma 50-65yrs 2 357 0.00 0.00 0.00 0.01
KRAS Q61R b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.01
KRAS Q61R non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.03
KRAS Q61R t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
KRAS Q61R retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
KRAS Q61R hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
KRAS Q61R lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
KRAS Q61R peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.04
HRAS G12A appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12A appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS G12A appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12A appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary <40yrs 0 166 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary 50-65yrs 0 809 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary >65yrs 0 795 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12A breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
HRAS G12A breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
HRAS G12A breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
HRAS G12A breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
HRAS G12A breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12A pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G12A pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G12A pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
HRAS G12A pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
HRAS G12A leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS G12A leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS G12A leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G12A leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS G12A melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
HRAS G12A melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
HRAS G12A melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
HRAS G12A melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
HRAS G12A head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
HRAS G12A head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
HRAS G12A head and neck cancer 50-65yrs 1 799 0.00 0.00 0.00 0.00
HRAS G12A head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
HRAS G12A uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.00
HRAS G12A uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
HRAS G12A uterine cancer 50-65yrs 0 1043 0.00 0.00 0.00 0.00
HRAS G12A uterine cancer >65yrs 0 986 0.00 0.00 0.00 0.00
HRAS G12A non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G12A non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
HRAS G12A non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
HRAS G12A non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
HRAS G12A myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS G12A myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS G12A myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS G12A myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS G12A adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G12A adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
HRAS G12A adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS G12A adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma <40yrs 0 667 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma 50-65yrs 0 936 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma >65yrs 0 766 0.00 0.00 0.00 0.00
HRAS G12A ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS G12A ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS G12A ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
HRAS G12A ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
HRAS G12A thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
HRAS G12A thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12A thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
HRAS G12A thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
HRAS G12A cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
HRAS G12A cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
HRAS G12A cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G12A cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G12A hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS G12A hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
HRAS G12A hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS G12A hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS G12A kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS G12A kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS G12A kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS G12A kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS G12A cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
HRAS G12A cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS G12A cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS G12A cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS G12A prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
HRAS G12A prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
HRAS G12A prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
HRAS G12A anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS G12A anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS G12A anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
HRAS G12A neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
HRAS G12A neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
HRAS G12A neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12A neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
HRAS G12A bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
HRAS G12A bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
HRAS G12A bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G12A bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
HRAS G12A b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS G12A b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS G12A b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS G12A b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS G12A small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12A small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS G12A small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS G12A sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
HRAS G12A sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
HRAS G12A sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.01
HRAS G12A sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
HRAS G12A bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS G12A bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS G12A bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS G12A bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS G12A vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
HRAS G12A vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
HRAS G12A thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
HRAS G12A thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12A thymic tumor 50-65yrs 0 71 0.00 0.00 0.00 0.00
HRAS G12A thymic tumor >65yrs 0 39 0.00 0.00 0.00 0.00
HRAS G12A ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS G12A ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
HRAS G12A ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
HRAS G12A small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
HRAS G12A small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G12A small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
HRAS G12A mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12A mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS G12A mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS G12A mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS G12A mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS G12A mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12A mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12A mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor <40yrs 0 649 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12A nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS G12A nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS G12A nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS G12A nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
HRAS G12A penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
HRAS G12A penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
HRAS G12A pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
HRAS G12A b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G12A b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS G12A b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS G12A b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS G12A non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
HRAS G12A t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.01
HRAS G12A retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS G12A hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
HRAS G12A lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
HRAS G12A peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
HRAS G12C appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12C appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS G12C appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12C appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary <40yrs 0 166 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary 50-65yrs 0 809 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary >65yrs 0 795 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12C breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
HRAS G12C breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
HRAS G12C breast cancer 50-65yrs 2 3989 0.00 0.00 0.00 0.00
HRAS G12C breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
HRAS G12C breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12C pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G12C pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G12C pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
HRAS G12C pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
HRAS G12C leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS G12C leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS G12C leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G12C leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS G12C melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
HRAS G12C melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
HRAS G12C melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
HRAS G12C melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
HRAS G12C head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
HRAS G12C head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
HRAS G12C head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
HRAS G12C head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
HRAS G12C uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.00
HRAS G12C uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
HRAS G12C uterine cancer 50-65yrs 0 1043 0.00 0.00 0.00 0.00
HRAS G12C uterine cancer >65yrs 0 986 0.00 0.00 0.00 0.00
HRAS G12C non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS G12C non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.02
HRAS G12C non-melanoma skin cancers 50-65yrs 1 149 0.00 0.00 0.00 0.02
HRAS G12C non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.01
HRAS G12C myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS G12C myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS G12C myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS G12C myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS G12C adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G12C adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
HRAS G12C adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS G12C adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma <40yrs 0 667 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma 50-65yrs 0 936 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma >65yrs 0 766 0.00 0.00 0.00 0.00
HRAS G12C ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS G12C ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS G12C ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
HRAS G12C ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
HRAS G12C thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
HRAS G12C thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12C thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
HRAS G12C thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
HRAS G12C cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
HRAS G12C cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
HRAS G12C cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G12C cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G12C hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS G12C hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
HRAS G12C hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS G12C hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS G12C kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS G12C kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS G12C kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS G12C kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS G12C cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
HRAS G12C cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS G12C cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS G12C cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS G12C prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
HRAS G12C prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
HRAS G12C prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
HRAS G12C anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12C anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS G12C anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
HRAS G12C neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
HRAS G12C neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
HRAS G12C neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12C neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
HRAS G12C bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.01
HRAS G12C bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.01
HRAS G12C bladder cancer 50-65yrs 2 511 0.00 0.00 0.00 0.01
HRAS G12C bladder cancer >65yrs 1 961 0.00 0.00 0.00 0.00
HRAS G12C b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS G12C b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS G12C b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS G12C b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS G12C small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12C small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS G12C small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS G12C sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
HRAS G12C sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
HRAS G12C sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.01
HRAS G12C sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
HRAS G12C bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS G12C bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS G12C bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS G12C bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS G12C vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.00
HRAS G12C vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.00
HRAS G12C thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
HRAS G12C thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12C thymic tumor 50-65yrs 0 71 0.00 0.00 0.00 0.00
HRAS G12C thymic tumor >65yrs 0 39 0.00 0.00 0.00 0.00
HRAS G12C ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12C ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
HRAS G12C ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
HRAS G12C small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.02
HRAS G12C small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.01
HRAS G12C small cell lung cancer >65yrs 1 224 0.00 0.00 0.00 0.01
HRAS G12C mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12C mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS G12C mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS G12C mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS G12C mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS G12C mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12C mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12C mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor <40yrs 0 649 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12C nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS G12C nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS G12C nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS G12C nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.01
HRAS G12C penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
HRAS G12C penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
HRAS G12C pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
HRAS G12C b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G12C b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS G12C b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS G12C b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS G12C non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
HRAS G12C t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS G12C retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS G12C hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
HRAS G12C lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
HRAS G12C peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
HRAS G12D appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12D appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS G12D appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12D appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS G12D colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS G12D colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS G12D colorectal cancer 50-65yrs 1 2814 0.00 0.00 0.00 0.00
HRAS G12D colorectal cancer >65yrs 2 2052 0.00 0.00 0.00 0.00
HRAS G12D cancer of unknown primary <40yrs 0 166 0.00 0.00 0.00 0.00
HRAS G12D cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
HRAS G12D cancer of unknown primary 50-65yrs 0 809 0.00 0.00 0.00 0.00
HRAS G12D cancer of unknown primary >65yrs 0 795 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer >65yrs 1 5698 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12D breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
HRAS G12D breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
HRAS G12D breast cancer 50-65yrs 2 3989 0.00 0.00 0.00 0.00
HRAS G12D breast cancer >65yrs 1 2583 0.00 0.00 0.00 0.00
HRAS G12D breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12D pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G12D pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G12D pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
HRAS G12D pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
HRAS G12D leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS G12D leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS G12D leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G12D leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS G12D melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
HRAS G12D melanoma 40-50yrs 1 282 0.00 0.00 0.00 0.01
HRAS G12D melanoma 50-65yrs 1 1016 0.00 0.00 0.00 0.00
HRAS G12D melanoma >65yrs 5 1259 0.00 0.00 0.00 0.01
HRAS G12D head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
HRAS G12D head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
HRAS G12D head and neck cancer 50-65yrs 2 799 0.00 0.00 0.00 0.00
HRAS G12D head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
HRAS G12D uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.01
HRAS G12D uterine cancer 40-50yrs 1 162 0.00 0.00 0.00 0.01
HRAS G12D uterine cancer 50-65yrs 0 1043 0.00 0.00 0.00 0.00
HRAS G12D uterine cancer >65yrs 1 986 0.00 0.00 0.00 0.00
HRAS G12D non-melanoma skin cancers <40yrs 1 27 0.02 0.01 0.00 0.10
HRAS G12D non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.03
HRAS G12D non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.01
HRAS G12D non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.01
HRAS G12D myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS G12D myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS G12D myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS G12D myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS G12D adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G12D adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
HRAS G12D adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS G12D adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
HRAS G12D soft tissue sarcoma <40yrs 0 667 0.00 0.00 0.00 0.00
HRAS G12D soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS G12D soft tissue sarcoma 50-65yrs 0 936 0.00 0.00 0.00 0.00
HRAS G12D soft tissue sarcoma >65yrs 1 766 0.00 0.00 0.00 0.00
HRAS G12D ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS G12D ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS G12D ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
HRAS G12D ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
HRAS G12D thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
HRAS G12D thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12D thyroid cancer 50-65yrs 1 374 0.00 0.00 0.00 0.01
HRAS G12D thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
HRAS G12D cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
HRAS G12D cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
HRAS G12D cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G12D cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G12D hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS G12D hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
HRAS G12D hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS G12D hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS G12D kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS G12D kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS G12D kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS G12D kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS G12D cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
HRAS G12D cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS G12D cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS G12D cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS G12D prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
HRAS G12D prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
HRAS G12D prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
HRAS G12D anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12D anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS G12D anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
HRAS G12D neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
HRAS G12D neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
HRAS G12D neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12D neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
HRAS G12D bladder cancer <40yrs 1 25 0.01 0.01 0.00 0.07
HRAS G12D bladder cancer 40-50yrs 2 78 0.01 0.01 0.00 0.05
HRAS G12D bladder cancer 50-65yrs 1 511 0.00 0.00 0.00 0.01
HRAS G12D bladder cancer >65yrs 5 961 0.01 0.01 0.00 0.01
HRAS G12D b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS G12D b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS G12D b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS G12D b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS G12D small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12D small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS G12D small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS G12D sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12D sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
HRAS G12D sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G12D sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
HRAS G12D bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS G12D bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS G12D bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS G12D bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS G12D vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
HRAS G12D vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
HRAS G12D thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
HRAS G12D thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12D thymic tumor 50-65yrs 0 71 0.00 0.00 0.00 0.00
HRAS G12D thymic tumor >65yrs 0 39 0.00 0.00 0.00 0.00
HRAS G12D ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS G12D ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
HRAS G12D ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
HRAS G12D small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
HRAS G12D small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G12D small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
HRAS G12D mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12D mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS G12D mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS G12D mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS G12D mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS G12D mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12D mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12D mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor <40yrs 0 649 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12D nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS G12D nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS G12D nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS G12D nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
HRAS G12D penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
HRAS G12D penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
HRAS G12D pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
HRAS G12D b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G12D b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS G12D b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS G12D b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS G12D non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
HRAS G12D t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS G12D retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS G12D hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
HRAS G12D lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
HRAS G12D peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
HRAS G12F appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12F appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS G12F appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12F appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary <40yrs 0 166 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary 50-65yrs 0 809 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary >65yrs 0 795 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12F breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
HRAS G12F breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
HRAS G12F breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
HRAS G12F breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
HRAS G12F breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12F pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G12F pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G12F pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
HRAS G12F pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
HRAS G12F leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS G12F leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS G12F leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G12F leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS G12F melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
HRAS G12F melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
HRAS G12F melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
HRAS G12F melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
HRAS G12F head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
HRAS G12F head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
HRAS G12F head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
HRAS G12F head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
HRAS G12F uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.00
HRAS G12F uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
HRAS G12F uterine cancer 50-65yrs 0 1043 0.00 0.00 0.00 0.00
HRAS G12F uterine cancer >65yrs 0 986 0.00 0.00 0.00 0.00
HRAS G12F non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G12F non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
HRAS G12F non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
HRAS G12F non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
HRAS G12F myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS G12F myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS G12F myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS G12F myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS G12F adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G12F adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
HRAS G12F adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS G12F adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
HRAS G12F soft tissue sarcoma <40yrs 0 667 0.00 0.00 0.00 0.00
HRAS G12F soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS G12F soft tissue sarcoma 50-65yrs 0 936 0.00 0.00 0.00 0.00
HRAS G12F soft tissue sarcoma >65yrs 0 766 0.00 0.00 0.00 0.00
HRAS G12F ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS G12F ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS G12F ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
HRAS G12F ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
HRAS G12F thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
HRAS G12F thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12F thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
HRAS G12F thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
HRAS G12F cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
HRAS G12F cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
HRAS G12F cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G12F cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G12F hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS G12F hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
HRAS G12F hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS G12F hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS G12F kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS G12F kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS G12F kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS G12F kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS G12F cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
HRAS G12F cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS G12F cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS G12F cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS G12F prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
HRAS G12F prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
HRAS G12F prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
HRAS G12F anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12F anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS G12F anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
HRAS G12F neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
HRAS G12F neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
HRAS G12F neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12F neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
HRAS G12F bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.01
HRAS G12F bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
HRAS G12F bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G12F bladder cancer >65yrs 1 961 0.00 0.00 0.00 0.00
HRAS G12F b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS G12F b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS G12F b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS G12F b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS G12F small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12F small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS G12F small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS G12F sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12F sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
HRAS G12F sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G12F sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
HRAS G12F bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS G12F bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS G12F bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS G12F bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS G12F vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
HRAS G12F vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
HRAS G12F thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
HRAS G12F thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12F thymic tumor 50-65yrs 0 71 0.00 0.00 0.00 0.00
HRAS G12F thymic tumor >65yrs 0 39 0.00 0.00 0.00 0.00
HRAS G12F ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS G12F ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
HRAS G12F ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
HRAS G12F small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
HRAS G12F small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G12F small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
HRAS G12F mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12F mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS G12F mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS G12F mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS G12F mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS G12F mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12F mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12F mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor <40yrs 0 649 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12F nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS G12F nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS G12F nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS G12F nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
HRAS G12F penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
HRAS G12F penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
HRAS G12F pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
HRAS G12F b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G12F b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS G12F b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS G12F b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS G12F non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
HRAS G12F t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS G12F retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS G12F hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
HRAS G12F lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
HRAS G12F peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
HRAS G12R appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12R appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS G12R appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12R appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary <40yrs 0 166 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary 50-65yrs 0 809 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary >65yrs 0 795 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12R breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
HRAS G12R breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
HRAS G12R breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
HRAS G12R breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
HRAS G12R breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12R pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G12R pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G12R pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
HRAS G12R pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
HRAS G12R leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS G12R leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS G12R leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G12R leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS G12R melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
HRAS G12R melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
HRAS G12R melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
HRAS G12R melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
HRAS G12R head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
HRAS G12R head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
HRAS G12R head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
HRAS G12R head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
HRAS G12R uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.00
HRAS G12R uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
HRAS G12R uterine cancer 50-65yrs 0 1043 0.00 0.00 0.00 0.00
HRAS G12R uterine cancer >65yrs 0 986 0.00 0.00 0.00 0.00
HRAS G12R non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G12R non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
HRAS G12R non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
HRAS G12R non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
HRAS G12R myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS G12R myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS G12R myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS G12R myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS G12R adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G12R adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
HRAS G12R adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS G12R adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma <40yrs 0 667 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma 50-65yrs 0 936 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma >65yrs 0 766 0.00 0.00 0.00 0.00
HRAS G12R ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS G12R ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS G12R ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
HRAS G12R ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
HRAS G12R thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
HRAS G12R thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12R thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
HRAS G12R thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
HRAS G12R cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
HRAS G12R cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
HRAS G12R cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G12R cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G12R hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS G12R hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
HRAS G12R hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS G12R hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS G12R kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS G12R kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS G12R kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS G12R kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS G12R cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
HRAS G12R cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS G12R cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS G12R cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS G12R prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
HRAS G12R prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
HRAS G12R prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
HRAS G12R anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12R anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS G12R anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
HRAS G12R neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
HRAS G12R neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
HRAS G12R neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12R neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
HRAS G12R bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
HRAS G12R bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
HRAS G12R bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G12R bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
HRAS G12R b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS G12R b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS G12R b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS G12R b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS G12R small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12R small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS G12R small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS G12R sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
HRAS G12R sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
HRAS G12R sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.01
HRAS G12R sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
HRAS G12R bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS G12R bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS G12R bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS G12R bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS G12R vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
HRAS G12R vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
HRAS G12R thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
HRAS G12R thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12R thymic tumor 50-65yrs 0 71 0.00 0.00 0.00 0.00
HRAS G12R thymic tumor >65yrs 0 39 0.00 0.00 0.00 0.00
HRAS G12R ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS G12R ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
HRAS G12R ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
HRAS G12R small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
HRAS G12R small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G12R small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
HRAS G12R mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12R mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS G12R mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS G12R mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS G12R mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS G12R mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12R mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12R mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor <40yrs 0 649 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12R nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS G12R nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS G12R nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS G12R nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.01
HRAS G12R penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.02
HRAS G12R penile cancer >65yrs 0 11 0.00 0.00 0.00 0.02
HRAS G12R pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.05
HRAS G12R b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G12R b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS G12R b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS G12R b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS G12R non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
HRAS G12R t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS G12R retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS G12R hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
HRAS G12R lung cancer >65yrs 0 18 0.00 0.00 0.00 0.00
HRAS G12R peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.06
HRAS G12S appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12S appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS G12S appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12S appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer >65yrs 1 2052 0.00 0.00 0.00 0.00
HRAS G12S cancer of unknown primary <40yrs 0 166 0.00 0.00 0.00 0.00
HRAS G12S cancer of unknown primary 40-50yrs 1 211 0.00 0.00 0.00 0.01
HRAS G12S cancer of unknown primary 50-65yrs 0 809 0.00 0.00 0.00 0.00
HRAS G12S cancer of unknown primary >65yrs 0 795 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12S breast cancer <40yrs 1 840 0.00 0.00 0.00 0.00
HRAS G12S breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
HRAS G12S breast cancer 50-65yrs 1 3989 0.00 0.00 0.00 0.00
HRAS G12S breast cancer >65yrs 1 2583 0.00 0.00 0.00 0.00
HRAS G12S breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12S pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G12S pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G12S pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
HRAS G12S pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
HRAS G12S leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS G12S leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS G12S leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G12S leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS G12S melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
HRAS G12S melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
HRAS G12S melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
HRAS G12S melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
HRAS G12S head and neck cancer <40yrs 1 140 0.01 0.01 0.00 0.01
HRAS G12S head and neck cancer 40-50yrs 2 216 0.01 0.01 0.00 0.02
HRAS G12S head and neck cancer 50-65yrs 3 799 0.01 0.01 0.00 0.01
HRAS G12S head and neck cancer >65yrs 5 582 0.01 0.01 0.00 0.01
HRAS G12S uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.00
HRAS G12S uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
HRAS G12S uterine cancer 50-65yrs 1 1043 0.00 0.00 0.00 0.00
HRAS G12S uterine cancer >65yrs 1 986 0.00 0.00 0.00 0.00
HRAS G12S non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS G12S non-melanoma skin cancers 40-50yrs 1 20 0.02 0.01 0.00 0.10
HRAS G12S non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.01
HRAS G12S non-melanoma skin cancers >65yrs 1 317 0.00 0.00 0.00 0.01
HRAS G12S myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS G12S myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS G12S myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS G12S myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS G12S adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G12S adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
HRAS G12S adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS G12S adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma <40yrs 0 667 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma 50-65yrs 0 936 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma >65yrs 0 766 0.00 0.00 0.00 0.00
HRAS G12S ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS G12S ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS G12S ovarian cancer 50-65yrs 1 1092 0.00 0.00 0.00 0.00
HRAS G12S ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS G12S esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12S esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G12S esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
HRAS G12S esophagogastric cancer >65yrs 1 725 0.00 0.00 0.00 0.00
HRAS G12S thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
HRAS G12S thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12S thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
HRAS G12S thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
HRAS G12S cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
HRAS G12S cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
HRAS G12S cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G12S cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G12S hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS G12S hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
HRAS G12S hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS G12S hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS G12S kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS G12S kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS G12S kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS G12S kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS G12S cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
HRAS G12S cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS G12S cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS G12S cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS G12S prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
HRAS G12S prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
HRAS G12S prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
HRAS G12S anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12S anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS G12S anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
HRAS G12S neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
HRAS G12S neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
HRAS G12S neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12S neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
HRAS G12S bladder cancer <40yrs 1 25 0.02 0.01 0.00 0.10
HRAS G12S bladder cancer 40-50yrs 1 78 0.01 0.00 0.00 0.03
HRAS G12S bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G12S bladder cancer >65yrs 1 961 0.00 0.00 0.00 0.00
HRAS G12S b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS G12S b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS G12S b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS G12S b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS G12S small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12S small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS G12S small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS G12S sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
HRAS G12S sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
HRAS G12S sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.01
HRAS G12S sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
HRAS G12S bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS G12S bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS G12S bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS G12S bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS G12S vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
HRAS G12S vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
HRAS G12S thymic tumor <40yrs 0 14 0.01 0.00 0.00 0.04
HRAS G12S thymic tumor 40-50yrs 0 28 0.01 0.00 0.00 0.03
HRAS G12S thymic tumor 50-65yrs 0 71 0.00 0.00 0.00 0.02
HRAS G12S thymic tumor >65yrs 1 39 0.01 0.01 0.00 0.06
HRAS G12S ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS G12S ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
HRAS G12S ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
HRAS G12S small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
HRAS G12S small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G12S small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
HRAS G12S mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12S mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS G12S mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS G12S mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS G12S mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS G12S mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12S mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12S mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor <40yrs 0 649 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12S nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS G12S nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS G12S nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS G12S nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.01
HRAS G12S penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.02
HRAS G12S penile cancer >65yrs 0 11 0.00 0.00 0.00 0.02
HRAS G12S pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.05
HRAS G12S b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G12S b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS G12S b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS G12S b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS G12S non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
HRAS G12S t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS G12S retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS G12S hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
HRAS G12S lung cancer >65yrs 0 18 0.00 0.00 0.00 0.00
HRAS G12S peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.06
HRAS G12V appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12V appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS G12V appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12V appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary <40yrs 0 166 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary 50-65yrs 0 809 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary >65yrs 1 795 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12V breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
HRAS G12V breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
HRAS G12V breast cancer 50-65yrs 1 3989 0.00 0.00 0.00 0.00
HRAS G12V breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
HRAS G12V breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12V pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G12V pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G12V pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
HRAS G12V pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
HRAS G12V leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS G12V leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS G12V leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G12V leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS G12V melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
HRAS G12V melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
HRAS G12V melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
HRAS G12V melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
HRAS G12V head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
HRAS G12V head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
HRAS G12V head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
HRAS G12V head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
HRAS G12V uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.00
HRAS G12V uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
HRAS G12V uterine cancer 50-65yrs 0 1043 0.00 0.00 0.00 0.00
HRAS G12V uterine cancer >65yrs 0 986 0.00 0.00 0.00 0.00
HRAS G12V non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G12V non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
HRAS G12V non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
HRAS G12V non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
HRAS G12V myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS G12V myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS G12V myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS G12V myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS G12V adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G12V adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.01
HRAS G12V adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS G12V adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.01
HRAS G12V soft tissue sarcoma <40yrs 2 667 0.00 0.00 0.00 0.01
HRAS G12V soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS G12V soft tissue sarcoma 50-65yrs 0 936 0.00 0.00 0.00 0.00
HRAS G12V soft tissue sarcoma >65yrs 0 766 0.00 0.00 0.00 0.00
HRAS G12V ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS G12V ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS G12V ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
HRAS G12V ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
HRAS G12V thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
HRAS G12V thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12V thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
HRAS G12V thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
HRAS G12V cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.01
HRAS G12V cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.01
HRAS G12V cervical cancer 50-65yrs 1 144 0.00 0.00 0.00 0.02
HRAS G12V cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.02
HRAS G12V hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS G12V hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
HRAS G12V hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS G12V hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS G12V kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS G12V kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS G12V kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS G12V kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS G12V cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
HRAS G12V cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS G12V cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS G12V cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS G12V prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
HRAS G12V prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
HRAS G12V prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
HRAS G12V anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12V anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS G12V anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
HRAS G12V neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
HRAS G12V neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
HRAS G12V neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G12V neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
HRAS G12V bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
HRAS G12V bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
HRAS G12V bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G12V bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
HRAS G12V b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS G12V b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS G12V b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS G12V b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS G12V small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12V small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS G12V small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS G12V sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12V sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
HRAS G12V sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G12V sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
HRAS G12V bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS G12V bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS G12V bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS G12V bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS G12V vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
HRAS G12V vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
HRAS G12V thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
HRAS G12V thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12V thymic tumor 50-65yrs 0 71 0.00 0.00 0.00 0.00
HRAS G12V thymic tumor >65yrs 0 39 0.00 0.00 0.00 0.00
HRAS G12V ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12V ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
HRAS G12V ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
HRAS G12V small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
HRAS G12V small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G12V small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
HRAS G12V mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G12V mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS G12V mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS G12V mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS G12V mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS G12V mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G12V mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS G12V mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor <40yrs 0 649 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
HRAS G12V nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS G12V nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS G12V nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS G12V nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
HRAS G12V penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
HRAS G12V penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
HRAS G12V pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.03
HRAS G12V b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G12V b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS G12V b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS G12V b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS G12V non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
HRAS G12V t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS G12V retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS G12V hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
HRAS G12V lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
HRAS G12V peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
HRAS G13C appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G13C appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS G13C appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G13C appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary <40yrs 0 166 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary 50-65yrs 0 809 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary >65yrs 0 795 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G13C breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
HRAS G13C breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
HRAS G13C breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
HRAS G13C breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
HRAS G13C breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G13C pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G13C pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G13C pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
HRAS G13C pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
HRAS G13C leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS G13C leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS G13C leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G13C leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS G13C melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
HRAS G13C melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
HRAS G13C melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
HRAS G13C melanoma >65yrs 1 1259 0.00 0.00 0.00 0.00
HRAS G13C head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
HRAS G13C head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
HRAS G13C head and neck cancer 50-65yrs 1 799 0.00 0.00 0.00 0.00
HRAS G13C head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
HRAS G13C uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.00
HRAS G13C uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
HRAS G13C uterine cancer 50-65yrs 0 1043 0.00 0.00 0.00 0.00
HRAS G13C uterine cancer >65yrs 0 986 0.00 0.00 0.00 0.00
HRAS G13C non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G13C non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
HRAS G13C non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
HRAS G13C non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
HRAS G13C myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS G13C myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS G13C myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS G13C myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS G13C adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G13C adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.01
HRAS G13C adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS G13C adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.01
HRAS G13C soft tissue sarcoma <40yrs 0 667 0.00 0.00 0.00 0.00
HRAS G13C soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS G13C soft tissue sarcoma 50-65yrs 0 936 0.00 0.00 0.00 0.00
HRAS G13C soft tissue sarcoma >65yrs 0 766 0.00 0.00 0.00 0.00
HRAS G13C ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS G13C ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS G13C ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
HRAS G13C ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
HRAS G13C thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
HRAS G13C thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
HRAS G13C thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
HRAS G13C thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
HRAS G13C cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
HRAS G13C cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
HRAS G13C cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G13C cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G13C hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS G13C hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
HRAS G13C hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS G13C hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS G13C kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS G13C kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS G13C kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS G13C kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS G13C cns cancer <40yrs 1 1602 0.00 0.00 0.00 0.00
HRAS G13C cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS G13C cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS G13C cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS G13C prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
HRAS G13C prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
HRAS G13C prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
HRAS G13C anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
HRAS G13C anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS G13C anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
HRAS G13C neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
HRAS G13C neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
HRAS G13C neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G13C neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
HRAS G13C bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
HRAS G13C bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
HRAS G13C bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G13C bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
HRAS G13C b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS G13C b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS G13C b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS G13C b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS G13C small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G13C small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS G13C small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS G13C sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
HRAS G13C sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
HRAS G13C sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G13C sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
HRAS G13C bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS G13C bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS G13C bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS G13C bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS G13C vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
HRAS G13C vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
HRAS G13C thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
HRAS G13C thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
HRAS G13C thymic tumor 50-65yrs 0 71 0.00 0.00 0.00 0.00
HRAS G13C thymic tumor >65yrs 0 39 0.00 0.00 0.00 0.00
HRAS G13C ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
HRAS G13C ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
HRAS G13C ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
HRAS G13C small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
HRAS G13C small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G13C small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
HRAS G13C mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G13C mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS G13C mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS G13C mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS G13C mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS G13C mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G13C mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS G13C mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor <40yrs 0 649 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
HRAS G13C nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS G13C nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS G13C nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS G13C nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
HRAS G13C penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
HRAS G13C penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
HRAS G13C pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.03
HRAS G13C b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G13C b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS G13C b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS G13C b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS G13C non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
HRAS G13C t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS G13C retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS G13C hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
HRAS G13C lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
HRAS G13C peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
HRAS G13D appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G13D appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS G13D appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G13D appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary <40yrs 0 166 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary 50-65yrs 0 809 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary >65yrs 0 795 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G13D breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
HRAS G13D breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
HRAS G13D breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
HRAS G13D breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
HRAS G13D breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G13D pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G13D pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G13D pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
HRAS G13D pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
HRAS G13D leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS G13D leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS G13D leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G13D leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS G13D melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
HRAS G13D melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
HRAS G13D melanoma 50-65yrs 3 1016 0.00 0.00 0.00 0.00
HRAS G13D melanoma >65yrs 3 1259 0.00 0.00 0.00 0.00
HRAS G13D head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
HRAS G13D head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
HRAS G13D head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
HRAS G13D head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
HRAS G13D uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.00
HRAS G13D uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
HRAS G13D uterine cancer 50-65yrs 0 1043 0.00 0.00 0.00 0.00
HRAS G13D uterine cancer >65yrs 0 986 0.00 0.00 0.00 0.00
HRAS G13D non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G13D non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
HRAS G13D non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
HRAS G13D non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
HRAS G13D myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS G13D myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS G13D myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS G13D myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS G13D adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G13D adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
HRAS G13D adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS G13D adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma <40yrs 0 667 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma 50-65yrs 0 936 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma >65yrs 0 766 0.00 0.00 0.00 0.00
HRAS G13D ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS G13D ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS G13D ovarian cancer 50-65yrs 1 1092 0.00 0.00 0.00 0.00
HRAS G13D ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS G13D esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS G13D esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G13D esophagogastric cancer 50-65yrs 1 752 0.00 0.00 0.00 0.00
HRAS G13D esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
HRAS G13D thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
HRAS G13D thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
HRAS G13D thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
HRAS G13D thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
HRAS G13D cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
HRAS G13D cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
HRAS G13D cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G13D cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G13D hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS G13D hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
HRAS G13D hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS G13D hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS G13D kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS G13D kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS G13D kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS G13D kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS G13D cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
HRAS G13D cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS G13D cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS G13D cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS G13D prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
HRAS G13D prostate cancer 50-65yrs 1 960 0.00 0.00 0.00 0.00
HRAS G13D prostate cancer >65yrs 1 1402 0.00 0.00 0.00 0.00
HRAS G13D anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS G13D anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS G13D anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
HRAS G13D neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
HRAS G13D neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
HRAS G13D neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G13D neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
HRAS G13D bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.01
HRAS G13D bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.01
HRAS G13D bladder cancer 50-65yrs 2 511 0.00 0.00 0.00 0.01
HRAS G13D bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
HRAS G13D b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS G13D b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS G13D b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS G13D b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS G13D small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G13D small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS G13D small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS G13D sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
HRAS G13D sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
HRAS G13D sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G13D sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
HRAS G13D bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS G13D bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS G13D bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS G13D bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS G13D vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
HRAS G13D vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
HRAS G13D thymic tumor <40yrs 0 14 0.01 0.00 0.00 0.04
HRAS G13D thymic tumor 40-50yrs 0 28 0.01 0.00 0.00 0.03
HRAS G13D thymic tumor 50-65yrs 1 71 0.01 0.01 0.00 0.04
HRAS G13D thymic tumor >65yrs 0 39 0.01 0.00 0.00 0.03
HRAS G13D ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS G13D ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
HRAS G13D ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
HRAS G13D small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
HRAS G13D small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G13D small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
HRAS G13D mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G13D mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS G13D mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS G13D mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS G13D mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS G13D mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G13D mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS G13D mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor <40yrs 0 649 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
HRAS G13D nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS G13D nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS G13D nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS G13D nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
HRAS G13D penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.04
HRAS G13D penile cancer >65yrs 0 11 0.00 0.00 0.00 0.05
HRAS G13D pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.05
HRAS G13D b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G13D b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS G13D b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS G13D b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS G13D non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
HRAS G13D t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS G13D retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS G13D hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
HRAS G13D lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
HRAS G13D peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.02
HRAS G13R appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G13R appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS G13R appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G13R appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
HRAS G13R cancer of unknown primary <40yrs 0 166 0.00 0.00 0.00 0.00
HRAS G13R cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
HRAS G13R cancer of unknown primary 50-65yrs 0 809 0.00 0.00 0.00 0.00
HRAS G13R cancer of unknown primary >65yrs 3 795 0.00 0.00 0.00 0.01
HRAS G13R non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer 50-65yrs 1 3677 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer >65yrs 3 5698 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G13R breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
HRAS G13R breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
HRAS G13R breast cancer 50-65yrs 5 3989 0.00 0.00 0.00 0.00
HRAS G13R breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
HRAS G13R breast cancer Age:NA 0 10 0.00 0.00 0.00 0.02
HRAS G13R pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G13R pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G13R pancreatic cancer 50-65yrs 1 999 0.00 0.00 0.00 0.00
HRAS G13R pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
HRAS G13R leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS G13R leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS G13R leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G13R leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS G13R melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
HRAS G13R melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
HRAS G13R melanoma 50-65yrs 2 1016 0.00 0.00 0.00 0.00
HRAS G13R melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
HRAS G13R head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.01
HRAS G13R head and neck cancer 40-50yrs 2 216 0.01 0.01 0.00 0.01
HRAS G13R head and neck cancer 50-65yrs 5 799 0.01 0.01 0.00 0.01
HRAS G13R head and neck cancer >65yrs 3 582 0.01 0.00 0.00 0.01
HRAS G13R uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.00
HRAS G13R uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
HRAS G13R uterine cancer 50-65yrs 0 1043 0.00 0.00 0.00 0.00
HRAS G13R uterine cancer >65yrs 0 986 0.00 0.00 0.00 0.00
HRAS G13R non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.01
HRAS G13R non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.01
HRAS G13R non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.01
HRAS G13R non-melanoma skin cancers >65yrs 1 317 0.00 0.00 0.00 0.01
HRAS G13R myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS G13R myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS G13R myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS G13R myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS G13R adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G13R adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
HRAS G13R adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS G13R adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
HRAS G13R soft tissue sarcoma <40yrs 2 667 0.00 0.00 0.00 0.01
HRAS G13R soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS G13R soft tissue sarcoma 50-65yrs 2 936 0.00 0.00 0.00 0.00
HRAS G13R soft tissue sarcoma >65yrs 0 766 0.00 0.00 0.00 0.00
HRAS G13R ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS G13R ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS G13R ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
HRAS G13R ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
HRAS G13R thyroid cancer <40yrs 1 150 0.00 0.00 0.00 0.01
HRAS G13R thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.01
HRAS G13R thyroid cancer 50-65yrs 1 374 0.00 0.00 0.00 0.01
HRAS G13R thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.01
HRAS G13R cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
HRAS G13R cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
HRAS G13R cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G13R cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G13R hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS G13R hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
HRAS G13R hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS G13R hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS G13R kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS G13R kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS G13R kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS G13R kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS G13R cns cancer <40yrs 1 1602 0.00 0.00 0.00 0.00
HRAS G13R cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS G13R cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS G13R cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS G13R prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
HRAS G13R prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
HRAS G13R prostate cancer >65yrs 1 1402 0.00 0.00 0.00 0.00
HRAS G13R anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS G13R anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS G13R anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
HRAS G13R neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
HRAS G13R neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
HRAS G13R neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G13R neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
HRAS G13R bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.01
HRAS G13R bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.01
HRAS G13R bladder cancer 50-65yrs 2 511 0.00 0.00 0.00 0.01
HRAS G13R bladder cancer >65yrs 6 961 0.00 0.00 0.00 0.01
HRAS G13R b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS G13R b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS G13R b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS G13R b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS G13R small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G13R small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS G13R small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS G13R sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
HRAS G13R sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
HRAS G13R sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G13R sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
HRAS G13R bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS G13R bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS G13R bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS G13R bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS G13R vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
HRAS G13R vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
HRAS G13R thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
HRAS G13R thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
HRAS G13R thymic tumor 50-65yrs 0 71 0.00 0.00 0.00 0.00
HRAS G13R thymic tumor >65yrs 0 39 0.00 0.00 0.00 0.00
HRAS G13R ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS G13R ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
HRAS G13R ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
HRAS G13R small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
HRAS G13R small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G13R small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
HRAS G13R mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G13R mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS G13R mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS G13R mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS G13R mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS G13R mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G13R mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS G13R mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS G13R germ cell tumor <40yrs 1 649 0.00 0.00 0.00 0.00
HRAS G13R germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.01
HRAS G13R germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.01
HRAS G13R germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.01
HRAS G13R nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS G13R nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS G13R nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS G13R nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
HRAS G13R penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.04
HRAS G13R penile cancer >65yrs 0 11 0.00 0.00 0.00 0.05
HRAS G13R pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.05
HRAS G13R b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G13R b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS G13R b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS G13R b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS G13R non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
HRAS G13R t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS G13R retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS G13R hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
HRAS G13R lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
HRAS G13R peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.02
HRAS G13V appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G13V appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS G13V appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G13V appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
HRAS G13V cancer of unknown primary <40yrs 0 166 0.00 0.00 0.00 0.00
HRAS G13V cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
HRAS G13V cancer of unknown primary 50-65yrs 1 809 0.00 0.00 0.00 0.00
HRAS G13V cancer of unknown primary >65yrs 0 795 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer >65yrs 6 5698 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.01
HRAS G13V breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
HRAS G13V breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
HRAS G13V breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
HRAS G13V breast cancer >65yrs 1 2583 0.00 0.00 0.00 0.00
HRAS G13V breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS G13V pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G13V pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G13V pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
HRAS G13V pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
HRAS G13V leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS G13V leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS G13V leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS G13V leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS G13V melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
HRAS G13V melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
HRAS G13V melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
HRAS G13V melanoma >65yrs 3 1259 0.00 0.00 0.00 0.00
HRAS G13V head and neck cancer <40yrs 1 140 0.00 0.00 0.00 0.01
HRAS G13V head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
HRAS G13V head and neck cancer 50-65yrs 1 799 0.00 0.00 0.00 0.00
HRAS G13V head and neck cancer >65yrs 1 582 0.00 0.00 0.00 0.00
HRAS G13V uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.00
HRAS G13V uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
HRAS G13V uterine cancer 50-65yrs 1 1043 0.00 0.00 0.00 0.00
HRAS G13V uterine cancer >65yrs 0 986 0.00 0.00 0.00 0.00
HRAS G13V non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS G13V non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.02
HRAS G13V non-melanoma skin cancers 50-65yrs 1 149 0.00 0.00 0.00 0.02
HRAS G13V non-melanoma skin cancers >65yrs 1 317 0.00 0.00 0.00 0.01
HRAS G13V myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS G13V myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS G13V myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS G13V myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS G13V adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS G13V adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
HRAS G13V adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS G13V adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma <40yrs 0 667 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma 50-65yrs 0 936 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma >65yrs 0 766 0.00 0.00 0.00 0.00
HRAS G13V ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS G13V ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS G13V ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
HRAS G13V ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
HRAS G13V thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
HRAS G13V thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
HRAS G13V thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
HRAS G13V thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
HRAS G13V cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
HRAS G13V cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
HRAS G13V cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS G13V cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
HRAS G13V hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS G13V hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
HRAS G13V hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS G13V hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS G13V kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS G13V kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS G13V kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS G13V kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS G13V cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
HRAS G13V cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS G13V cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS G13V cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS G13V prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
HRAS G13V prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
HRAS G13V prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
HRAS G13V anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
HRAS G13V anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS G13V anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
HRAS G13V neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
HRAS G13V neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
HRAS G13V neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS G13V neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
HRAS G13V bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.01
HRAS G13V bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.01
HRAS G13V bladder cancer 50-65yrs 2 511 0.00 0.00 0.00 0.01
HRAS G13V bladder cancer >65yrs 1 961 0.00 0.00 0.00 0.00
HRAS G13V b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS G13V b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS G13V b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS G13V b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS G13V small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G13V small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS G13V small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS G13V sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
HRAS G13V sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
HRAS G13V sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.01
HRAS G13V sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
HRAS G13V bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS G13V bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS G13V bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS G13V bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS G13V vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
HRAS G13V vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
HRAS G13V thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
HRAS G13V thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
HRAS G13V thymic tumor 50-65yrs 0 71 0.00 0.00 0.00 0.00
HRAS G13V thymic tumor >65yrs 0 39 0.00 0.00 0.00 0.00
HRAS G13V ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS G13V ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
HRAS G13V ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
HRAS G13V small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.02
HRAS G13V small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.01
HRAS G13V small cell lung cancer >65yrs 1 224 0.00 0.00 0.00 0.01
HRAS G13V mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS G13V mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS G13V mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS G13V mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS G13V mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS G13V mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS G13V mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS G13V mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor <40yrs 0 649 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
HRAS G13V nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS G13V nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS G13V nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS G13V nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
HRAS G13V penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
HRAS G13V penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
HRAS G13V pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
HRAS G13V b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS G13V b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS G13V b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS G13V b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS G13V non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.06
HRAS G13V t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS G13V retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS G13V hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
HRAS G13V lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
HRAS G13V peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
HRAS Q61H appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS Q61H appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS Q61H appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS Q61H appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary <40yrs 0 166 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary 50-65yrs 0 809 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary >65yrs 0 795 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer >65yrs 2 5698 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.01
HRAS Q61H breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS Q61H pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS Q61H pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS Q61H pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
HRAS Q61H pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
HRAS Q61H leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS Q61H leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS Q61H leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS Q61H leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS Q61H melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
HRAS Q61H melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
HRAS Q61H melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
HRAS Q61H melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
HRAS Q61H head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
HRAS Q61H head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
HRAS Q61H head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
HRAS Q61H head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
HRAS Q61H uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.00
HRAS Q61H uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
HRAS Q61H uterine cancer 50-65yrs 1 1043 0.00 0.00 0.00 0.00
HRAS Q61H uterine cancer >65yrs 0 986 0.00 0.00 0.00 0.00
HRAS Q61H non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS Q61H non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
HRAS Q61H non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
HRAS Q61H non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
HRAS Q61H myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS Q61H myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS Q61H myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS Q61H myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS Q61H adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS Q61H adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
HRAS Q61H adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS Q61H adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma <40yrs 0 667 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma 50-65yrs 0 936 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma >65yrs 0 766 0.00 0.00 0.00 0.00
HRAS Q61H ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS Q61H ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS Q61H ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
HRAS Q61H ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
HRAS Q61H thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
HRAS Q61H thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
HRAS Q61H thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
HRAS Q61H thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
HRAS Q61H cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
HRAS Q61H cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
HRAS Q61H cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS Q61H cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
HRAS Q61H hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS Q61H hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
HRAS Q61H hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS Q61H hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS Q61H kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS Q61H kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS Q61H kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS Q61H kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS Q61H prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
HRAS Q61H prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
HRAS Q61H prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
HRAS Q61H anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS Q61H anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS Q61H anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
HRAS Q61H neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
HRAS Q61H neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
HRAS Q61H neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS Q61H neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
HRAS Q61H bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
HRAS Q61H bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
HRAS Q61H bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS Q61H bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
HRAS Q61H b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS Q61H b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS Q61H b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS Q61H b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS Q61H small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS Q61H small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS Q61H small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS Q61H sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
HRAS Q61H sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
HRAS Q61H sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
HRAS Q61H sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
HRAS Q61H bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS Q61H bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS Q61H bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS Q61H bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS Q61H vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
HRAS Q61H vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
HRAS Q61H thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
HRAS Q61H thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
HRAS Q61H thymic tumor 50-65yrs 0 71 0.00 0.00 0.00 0.00
HRAS Q61H thymic tumor >65yrs 0 39 0.00 0.00 0.00 0.00
HRAS Q61H ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS Q61H ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
HRAS Q61H ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
HRAS Q61H small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
HRAS Q61H small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS Q61H small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
HRAS Q61H mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS Q61H mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS Q61H mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS Q61H mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS Q61H mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS Q61H mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS Q61H mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS Q61H mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor <40yrs 0 649 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
HRAS Q61H nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS Q61H nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS Q61H nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS Q61H nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
HRAS Q61H penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.02
HRAS Q61H penile cancer >65yrs 0 11 0.00 0.00 0.00 0.02
HRAS Q61H pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
HRAS Q61H b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS Q61H b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS Q61H b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS Q61H b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS Q61H non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.03
HRAS Q61H t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS Q61H retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS Q61H hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
HRAS Q61H lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
HRAS Q61H peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.04
HRAS Q61K appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS Q61K appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS Q61K appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS Q61K appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
HRAS Q61K cancer of unknown primary <40yrs 1 166 0.00 0.00 0.00 0.01
HRAS Q61K cancer of unknown primary 40-50yrs 1 211 0.00 0.00 0.00 0.01
HRAS Q61K cancer of unknown primary 50-65yrs 0 809 0.00 0.00 0.00 0.00
HRAS Q61K cancer of unknown primary >65yrs 1 795 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer >65yrs 2 2583 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer Age:NA 0 10 0.00 0.00 0.00 0.01
HRAS Q61K pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS Q61K pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS Q61K pancreatic cancer 50-65yrs 1 999 0.00 0.00 0.00 0.00
HRAS Q61K pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
HRAS Q61K leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS Q61K leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS Q61K leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS Q61K leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS Q61K melanoma <40yrs 0 289 0.00 0.00 0.00 0.01
HRAS Q61K melanoma 40-50yrs 1 282 0.00 0.00 0.00 0.01
HRAS Q61K melanoma 50-65yrs 4 1016 0.00 0.00 0.00 0.01
HRAS Q61K melanoma >65yrs 3 1259 0.00 0.00 0.00 0.00
HRAS Q61K head and neck cancer <40yrs 1 140 0.00 0.00 0.00 0.01
HRAS Q61K head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.01
HRAS Q61K head and neck cancer 50-65yrs 3 799 0.00 0.00 0.00 0.01
HRAS Q61K head and neck cancer >65yrs 1 582 0.00 0.00 0.00 0.01
HRAS Q61K uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.00
HRAS Q61K uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
HRAS Q61K uterine cancer 50-65yrs 0 1043 0.00 0.00 0.00 0.00
HRAS Q61K uterine cancer >65yrs 0 986 0.00 0.00 0.00 0.00
HRAS Q61K non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS Q61K non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.02
HRAS Q61K non-melanoma skin cancers 50-65yrs 1 149 0.00 0.00 0.00 0.02
HRAS Q61K non-melanoma skin cancers >65yrs 1 317 0.00 0.00 0.00 0.01
HRAS Q61K myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS Q61K myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS Q61K myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS Q61K myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS Q61K adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS Q61K adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
HRAS Q61K adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS Q61K adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma <40yrs 1 667 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma 50-65yrs 0 936 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma >65yrs 0 766 0.00 0.00 0.00 0.00
HRAS Q61K ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS Q61K ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS Q61K ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
HRAS Q61K ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
HRAS Q61K thyroid cancer <40yrs 3 150 0.01 0.01 0.01 0.03
HRAS Q61K thyroid cancer 40-50yrs 1 122 0.01 0.01 0.00 0.02
HRAS Q61K thyroid cancer 50-65yrs 5 374 0.01 0.01 0.01 0.02
HRAS Q61K thyroid cancer >65yrs 3 370 0.01 0.01 0.00 0.02
HRAS Q61K cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
HRAS Q61K cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
HRAS Q61K cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS Q61K cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
HRAS Q61K hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS Q61K hepatobiliary cancer 40-50yrs 1 110 0.00 0.00 0.00 0.02
HRAS Q61K hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS Q61K hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS Q61K kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS Q61K kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS Q61K kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS Q61K kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS Q61K prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.01
HRAS Q61K prostate cancer 50-65yrs 4 960 0.00 0.00 0.00 0.01
HRAS Q61K prostate cancer >65yrs 2 1402 0.00 0.00 0.00 0.00
HRAS Q61K anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS Q61K anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS Q61K anal cancer >65yrs 0 45 0.00 0.00 0.00 0.01
HRAS Q61K neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
HRAS Q61K neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
HRAS Q61K neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS Q61K neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
HRAS Q61K bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.02
HRAS Q61K bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.01
HRAS Q61K bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.01
HRAS Q61K bladder cancer >65yrs 5 961 0.00 0.00 0.00 0.01
HRAS Q61K b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS Q61K b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS Q61K b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS Q61K b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS Q61K small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS Q61K small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS Q61K small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS Q61K sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
HRAS Q61K sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
HRAS Q61K sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.01
HRAS Q61K sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
HRAS Q61K bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS Q61K bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS Q61K bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS Q61K bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS Q61K vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
HRAS Q61K vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
HRAS Q61K thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
HRAS Q61K thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
HRAS Q61K thymic tumor 50-65yrs 0 71 0.00 0.00 0.00 0.00
HRAS Q61K thymic tumor >65yrs 0 39 0.00 0.00 0.00 0.00
HRAS Q61K ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS Q61K ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
HRAS Q61K ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
HRAS Q61K small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
HRAS Q61K small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS Q61K small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
HRAS Q61K mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS Q61K mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS Q61K mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS Q61K mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS Q61K mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS Q61K mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS Q61K mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS Q61K mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor <40yrs 0 649 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
HRAS Q61K nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS Q61K nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS Q61K nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS Q61K nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
HRAS Q61K penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.02
HRAS Q61K penile cancer >65yrs 0 11 0.00 0.00 0.00 0.02
HRAS Q61K pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
HRAS Q61K b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS Q61K b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS Q61K b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS Q61K b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS Q61K non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
HRAS Q61K t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS Q61K retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS Q61K hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
HRAS Q61K lung cancer >65yrs 0 18 0.00 0.00 0.00 0.02
HRAS Q61K peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.06
HRAS Q61L appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS Q61L appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS Q61L appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS Q61L appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary <40yrs 0 166 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary 50-65yrs 0 809 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary >65yrs 0 795 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS Q61L pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS Q61L pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS Q61L pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
HRAS Q61L pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
HRAS Q61L leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS Q61L leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS Q61L leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS Q61L leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS Q61L melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
HRAS Q61L melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
HRAS Q61L melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
HRAS Q61L melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
HRAS Q61L head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
HRAS Q61L head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
HRAS Q61L head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
HRAS Q61L head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
HRAS Q61L uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.00
HRAS Q61L uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
HRAS Q61L uterine cancer 50-65yrs 0 1043 0.00 0.00 0.00 0.00
HRAS Q61L uterine cancer >65yrs 0 986 0.00 0.00 0.00 0.00
HRAS Q61L non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS Q61L non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
HRAS Q61L non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
HRAS Q61L non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
HRAS Q61L myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS Q61L myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS Q61L myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS Q61L myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS Q61L adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS Q61L adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
HRAS Q61L adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS Q61L adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
HRAS Q61L soft tissue sarcoma <40yrs 1 667 0.00 0.00 0.00 0.00
HRAS Q61L soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS Q61L soft tissue sarcoma 50-65yrs 0 936 0.00 0.00 0.00 0.00
HRAS Q61L soft tissue sarcoma >65yrs 0 766 0.00 0.00 0.00 0.00
HRAS Q61L ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS Q61L ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS Q61L ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
HRAS Q61L ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
HRAS Q61L thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
HRAS Q61L thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
HRAS Q61L thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
HRAS Q61L thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
HRAS Q61L cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
HRAS Q61L cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
HRAS Q61L cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS Q61L cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
HRAS Q61L hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS Q61L hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
HRAS Q61L hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS Q61L hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS Q61L kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS Q61L kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS Q61L kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS Q61L kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS Q61L prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
HRAS Q61L prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
HRAS Q61L prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
HRAS Q61L anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
HRAS Q61L anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS Q61L anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
HRAS Q61L neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
HRAS Q61L neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
HRAS Q61L neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS Q61L neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
HRAS Q61L bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
HRAS Q61L bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
HRAS Q61L bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS Q61L bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
HRAS Q61L b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS Q61L b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS Q61L b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS Q61L b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS Q61L small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS Q61L small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS Q61L small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS Q61L sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
HRAS Q61L sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
HRAS Q61L sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.01
HRAS Q61L sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
HRAS Q61L bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS Q61L bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS Q61L bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS Q61L bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS Q61L vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
HRAS Q61L vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
HRAS Q61L thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
HRAS Q61L thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
HRAS Q61L thymic tumor 50-65yrs 0 71 0.00 0.00 0.00 0.00
HRAS Q61L thymic tumor >65yrs 0 39 0.00 0.00 0.00 0.00
HRAS Q61L ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS Q61L ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
HRAS Q61L ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
HRAS Q61L small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
HRAS Q61L small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS Q61L small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
HRAS Q61L mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS Q61L mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS Q61L mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS Q61L mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS Q61L mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS Q61L mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS Q61L mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS Q61L mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor <40yrs 0 649 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
HRAS Q61L nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS Q61L nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS Q61L nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS Q61L nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
HRAS Q61L penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
HRAS Q61L penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
HRAS Q61L pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
HRAS Q61L b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS Q61L b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS Q61L b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS Q61L b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS Q61L non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.06
HRAS Q61L t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS Q61L retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS Q61L hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
HRAS Q61L lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
HRAS Q61L peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
HRAS Q61R appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS Q61R appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
HRAS Q61R appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
HRAS Q61R appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary <40yrs 0 166 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary 50-65yrs 0 809 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary >65yrs 0 795 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer 50-65yrs 1 3677 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer >65yrs 2 5698 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer 40-50yrs 2 1910 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer >65yrs 2 2583 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer Age:NA 0 10 0.00 0.00 0.00 0.01
HRAS Q61R pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS Q61R pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS Q61R pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
HRAS Q61R pancreatic cancer >65yrs 1 1205 0.00 0.00 0.00 0.00
HRAS Q61R leukemia <40yrs 0 203 0.00 0.00 0.00 0.00
HRAS Q61R leukemia 40-50yrs 0 127 0.00 0.00 0.00 0.00
HRAS Q61R leukemia 50-65yrs 0 511 0.00 0.00 0.00 0.00
HRAS Q61R leukemia >65yrs 0 719 0.00 0.00 0.00 0.00
HRAS Q61R melanoma <40yrs 1 289 0.00 0.00 0.00 0.01
HRAS Q61R melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
HRAS Q61R melanoma 50-65yrs 3 1016 0.00 0.00 0.00 0.00
HRAS Q61R melanoma >65yrs 1 1259 0.00 0.00 0.00 0.00
HRAS Q61R head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.01
HRAS Q61R head and neck cancer 40-50yrs 1 216 0.00 0.00 0.00 0.01
HRAS Q61R head and neck cancer 50-65yrs 6 799 0.01 0.01 0.00 0.01
HRAS Q61R head and neck cancer >65yrs 2 582 0.00 0.00 0.00 0.01
HRAS Q61R uterine cancer <40yrs 0 56 0.00 0.00 0.00 0.00
HRAS Q61R uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
HRAS Q61R uterine cancer 50-65yrs 0 1043 0.00 0.00 0.00 0.00
HRAS Q61R uterine cancer >65yrs 0 986 0.00 0.00 0.00 0.00
HRAS Q61R non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS Q61R non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.02
HRAS Q61R non-melanoma skin cancers 50-65yrs 1 149 0.00 0.00 0.00 0.02
HRAS Q61R non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.01
HRAS Q61R myelodysplastic/myeloproliferative syndromes <40yrs 0 86 0.00 0.00 0.00 0.00
HRAS Q61R myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
HRAS Q61R myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
HRAS Q61R myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
HRAS Q61R adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
HRAS Q61R adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
HRAS Q61R adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
HRAS Q61R adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
HRAS Q61R soft tissue sarcoma <40yrs 0 667 0.00 0.00 0.00 0.00
HRAS Q61R soft tissue sarcoma 40-50yrs 0 363 0.00 0.00 0.00 0.00
HRAS Q61R soft tissue sarcoma 50-65yrs 0 936 0.00 0.00 0.00 0.00
HRAS Q61R soft tissue sarcoma >65yrs 1 766 0.00 0.00 0.00 0.00
HRAS Q61R ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
HRAS Q61R ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
HRAS Q61R ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
HRAS Q61R ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer 50-65yrs 1 752 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
HRAS Q61R thyroid cancer <40yrs 4 150 0.03 0.03 0.02 0.05
HRAS Q61R thyroid cancer 40-50yrs 2 122 0.03 0.03 0.01 0.04
HRAS Q61R thyroid cancer 50-65yrs 9 374 0.03 0.03 0.02 0.04
HRAS Q61R thyroid cancer >65yrs 15 370 0.03 0.03 0.02 0.05
HRAS Q61R cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
HRAS Q61R cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
HRAS Q61R cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS Q61R cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
HRAS Q61R hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
HRAS Q61R hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
HRAS Q61R hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
HRAS Q61R hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
HRAS Q61R kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
HRAS Q61R kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
HRAS Q61R kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
HRAS Q61R kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer 50-65yrs 0 1438 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
HRAS Q61R prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.01
HRAS Q61R prostate cancer 50-65yrs 4 960 0.00 0.00 0.00 0.01
HRAS Q61R prostate cancer >65yrs 2 1402 0.00 0.00 0.00 0.00
HRAS Q61R anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS Q61R anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
HRAS Q61R anal cancer >65yrs 0 45 0.00 0.00 0.00 0.01
HRAS Q61R neuroendocrine tumors <40yrs 1 22 0.02 0.01 0.00 0.12
HRAS Q61R neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.02
HRAS Q61R neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.01
HRAS Q61R neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.01
HRAS Q61R bladder cancer <40yrs 0 25 0.01 0.01 0.00 0.03
HRAS Q61R bladder cancer 40-50yrs 2 78 0.01 0.01 0.00 0.04
HRAS Q61R bladder cancer 50-65yrs 3 511 0.01 0.01 0.00 0.02
HRAS Q61R bladder cancer >65yrs 11 961 0.01 0.01 0.01 0.02
HRAS Q61R b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
HRAS Q61R b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
HRAS Q61R b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
HRAS Q61R b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
HRAS Q61R small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS Q61R small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
HRAS Q61R small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
HRAS Q61R sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
HRAS Q61R sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
HRAS Q61R sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.01
HRAS Q61R sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
HRAS Q61R bone cancer <40yrs 0 335 0.00 0.00 0.00 0.00
HRAS Q61R bone cancer 40-50yrs 0 60 0.00 0.00 0.00 0.00
HRAS Q61R bone cancer 50-65yrs 0 93 0.00 0.00 0.00 0.00
HRAS Q61R bone cancer >65yrs 0 63 0.00 0.00 0.00 0.00
HRAS Q61R vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
HRAS Q61R vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
HRAS Q61R thymic tumor <40yrs 0 14 0.01 0.00 0.00 0.04
HRAS Q61R thymic tumor 40-50yrs 0 28 0.01 0.00 0.00 0.03
HRAS Q61R thymic tumor 50-65yrs 0 71 0.01 0.00 0.00 0.02
HRAS Q61R thymic tumor >65yrs 1 39 0.01 0.01 0.00 0.05
HRAS Q61R ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
HRAS Q61R ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
HRAS Q61R ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
HRAS Q61R small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
HRAS Q61R small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
HRAS Q61R small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
HRAS Q61R mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
HRAS Q61R mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
HRAS Q61R mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
HRAS Q61R mature t and nk neoplasms >65yrs 0 105 0.00 0.00 0.00 0.00
HRAS Q61R mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
HRAS Q61R mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
HRAS Q61R mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
HRAS Q61R mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor <40yrs 0 649 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
HRAS Q61R nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
HRAS Q61R nerve sheath tumor 40-50yrs 0 26 0.00 0.00 0.00 0.00
HRAS Q61R nerve sheath tumor 50-65yrs 0 35 0.00 0.00 0.00 0.00
HRAS Q61R nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
HRAS Q61R penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.02
HRAS Q61R penile cancer >65yrs 0 11 0.00 0.00 0.00 0.02
HRAS Q61R pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
HRAS Q61R b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
HRAS Q61R b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
HRAS Q61R b cell lymphoma 50-65yrs 0 356 0.00 0.00 0.00 0.00
HRAS Q61R b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
HRAS Q61R non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
HRAS Q61R t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
HRAS Q61R retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
HRAS Q61R hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
HRAS Q61R lung cancer >65yrs 0 18 0.00 0.00 0.00 0.02
HRAS Q61R peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.06
NRAS G12A appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12A appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
NRAS G12A appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12A appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer 50-65yrs 1 2814 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer >65yrs 4 2052 0.00 0.00 0.00 0.00
NRAS G12A cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
NRAS G12A cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
NRAS G12A cancer of unknown primary 50-65yrs 0 810 0.00 0.00 0.00 0.00
NRAS G12A cancer of unknown primary >65yrs 0 796 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer >65yrs 2 5698 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12A breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS G12A breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS G12A breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
NRAS G12A breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS G12A breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
NRAS G12A pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G12A pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G12A pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
NRAS G12A pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
NRAS G12A leukemia <40yrs 1 204 0.01 0.01 0.00 0.02
NRAS G12A leukemia 40-50yrs 2 128 0.01 0.01 0.00 0.03
NRAS G12A leukemia 50-65yrs 1 515 0.01 0.01 0.00 0.01
NRAS G12A leukemia >65yrs 10 720 0.01 0.01 0.01 0.02
NRAS G12A melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
NRAS G12A melanoma 40-50yrs 2 282 0.00 0.00 0.00 0.01
NRAS G12A melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
NRAS G12A melanoma >65yrs 3 1259 0.00 0.00 0.00 0.00
NRAS G12A head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
NRAS G12A head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
NRAS G12A head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
NRAS G12A head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
NRAS G12A uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.00
NRAS G12A uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
NRAS G12A uterine cancer 50-65yrs 0 1046 0.00 0.00 0.00 0.00
NRAS G12A uterine cancer >65yrs 0 987 0.00 0.00 0.00 0.00
NRAS G12A non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12A non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
NRAS G12A non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
NRAS G12A non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
NRAS G12A myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS G12A myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.01
NRAS G12A myelodysplastic/myeloproliferative syndromes 50-65yrs 3 373 0.00 0.00 0.00 0.01
NRAS G12A myelodysplastic/myeloproliferative syndromes >65yrs 1 664 0.00 0.00 0.00 0.01
NRAS G12A adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12A adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
NRAS G12A adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
NRAS G12A adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
NRAS G12A ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
NRAS G12A ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
NRAS G12A ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
NRAS G12A ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
NRAS G12A esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12A esophagogastric cancer 40-50yrs 1 200 0.00 0.00 0.00 0.01
NRAS G12A esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
NRAS G12A esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
NRAS G12A thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
NRAS G12A thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12A thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
NRAS G12A thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
NRAS G12A cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
NRAS G12A cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
NRAS G12A cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G12A cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G12A hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
NRAS G12A hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
NRAS G12A hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
NRAS G12A hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
NRAS G12A kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS G12A kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS G12A kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS G12A kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS G12A mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12A mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
NRAS G12A mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
NRAS G12A mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
NRAS G12A cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
NRAS G12A cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
NRAS G12A cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
NRAS G12A cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
NRAS G12A prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
NRAS G12A prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS G12A prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
NRAS G12A anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS G12A anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS G12A anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
NRAS G12A neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
NRAS G12A neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
NRAS G12A neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12A neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
NRAS G12A bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
NRAS G12A bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
NRAS G12A bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
NRAS G12A bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
NRAS G12A b-lymphoblastic leukemia/lymphoma <40yrs 2 142 0.01 0.01 0.00 0.03
NRAS G12A b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.01 0.00 0.00 0.03
NRAS G12A b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.01 0.00 0.00 0.02
NRAS G12A b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.01 0.00 0.00 0.03
NRAS G12A small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12A small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G12A small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
NRAS G12A sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
NRAS G12A sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
NRAS G12A sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.01
NRAS G12A sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
NRAS G12A bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS G12A bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS G12A bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G12A bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS G12A vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS G12A vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS G12A thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
NRAS G12A thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12A thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
NRAS G12A thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G12A ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS G12A ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
NRAS G12A ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
NRAS G12A small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
NRAS G12A small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G12A small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
NRAS G12A mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
NRAS G12A mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12A mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12A mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
NRAS G12A germ cell tumor <40yrs 1 650 0.00 0.00 0.00 0.00
NRAS G12A germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.01
NRAS G12A germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.01
NRAS G12A germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.01
NRAS G12A nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
NRAS G12A nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12A nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
NRAS G12A nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
NRAS G12A penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G12A penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G12A pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
NRAS G12A b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G12A b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
NRAS G12A b cell lymphoma 50-65yrs 0 357 0.00 0.00 0.00 0.00
NRAS G12A b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
NRAS G12A non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
NRAS G12A t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.01
NRAS G12A retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
NRAS G12A hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
NRAS G12A lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
NRAS G12A peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
NRAS G12C appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.02
NRAS G12C appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.01
NRAS G12C appendiceal cancer 50-65yrs 1 161 0.00 0.00 0.00 0.02
NRAS G12C appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.01
NRAS G12C colorectal cancer <40yrs 1 565 0.00 0.00 0.00 0.00
NRAS G12C colorectal cancer 40-50yrs 3 1280 0.00 0.00 0.00 0.00
NRAS G12C colorectal cancer 50-65yrs 3 2814 0.00 0.00 0.00 0.00
NRAS G12C colorectal cancer >65yrs 9 2052 0.00 0.00 0.00 0.01
NRAS G12C cancer of unknown primary <40yrs 1 167 0.00 0.00 0.00 0.01
NRAS G12C cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
NRAS G12C cancer of unknown primary 50-65yrs 1 810 0.00 0.00 0.00 0.00
NRAS G12C cancer of unknown primary >65yrs 0 796 0.00 0.00 0.00 0.00
NRAS G12C non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12C non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
NRAS G12C non-small cell lung cancer 50-65yrs 1 3677 0.00 0.00 0.00 0.00
NRAS G12C non-small cell lung cancer >65yrs 2 5698 0.00 0.00 0.00 0.00
NRAS G12C non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12C breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS G12C breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS G12C breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
NRAS G12C breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS G12C breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
NRAS G12C pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G12C pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G12C pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
NRAS G12C pancreatic cancer >65yrs 1 1205 0.00 0.00 0.00 0.00
NRAS G12C leukemia <40yrs 3 204 0.01 0.01 0.00 0.03
NRAS G12C leukemia 40-50yrs 1 128 0.01 0.00 0.00 0.02
NRAS G12C leukemia 50-65yrs 0 515 0.00 0.00 0.00 0.01
NRAS G12C leukemia >65yrs 4 720 0.00 0.00 0.00 0.01
NRAS G12C melanoma <40yrs 0 289 0.00 0.00 0.00 0.01
NRAS G12C melanoma 40-50yrs 1 282 0.00 0.00 0.00 0.01
NRAS G12C melanoma 50-65yrs 3 1016 0.00 0.00 0.00 0.01
NRAS G12C melanoma >65yrs 8 1259 0.00 0.00 0.00 0.01
NRAS G12C head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
NRAS G12C head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
NRAS G12C head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
NRAS G12C head and neck cancer >65yrs 1 582 0.00 0.00 0.00 0.00
NRAS G12C uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.01
NRAS G12C uterine cancer 40-50yrs 1 162 0.00 0.00 0.00 0.01
NRAS G12C uterine cancer 50-65yrs 3 1046 0.00 0.00 0.00 0.01
NRAS G12C uterine cancer >65yrs 1 987 0.00 0.00 0.00 0.00
NRAS G12C non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12C non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
NRAS G12C non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
NRAS G12C non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
NRAS G12C myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G12C myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
NRAS G12C myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
NRAS G12C myelodysplastic/myeloproliferative syndromes >65yrs 1 664 0.00 0.00 0.00 0.00
NRAS G12C adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12C adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
NRAS G12C adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
NRAS G12C adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
NRAS G12C ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
NRAS G12C ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
NRAS G12C ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
NRAS G12C ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
NRAS G12C thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
NRAS G12C thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12C thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
NRAS G12C thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
NRAS G12C cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
NRAS G12C cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
NRAS G12C cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G12C cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G12C hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
NRAS G12C hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.01
NRAS G12C hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
NRAS G12C hepatobiliary cancer >65yrs 2 601 0.00 0.00 0.00 0.01
NRAS G12C kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS G12C kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS G12C kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS G12C kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS G12C mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12C mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
NRAS G12C mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
NRAS G12C mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
NRAS G12C cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
NRAS G12C cns cancer 40-50yrs 1 687 0.00 0.00 0.00 0.00
NRAS G12C cns cancer 50-65yrs 1 1439 0.00 0.00 0.00 0.00
NRAS G12C cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
NRAS G12C prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
NRAS G12C prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS G12C prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
NRAS G12C anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
NRAS G12C anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS G12C anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
NRAS G12C neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
NRAS G12C neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
NRAS G12C neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12C neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
NRAS G12C bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.01
NRAS G12C bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
NRAS G12C bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
NRAS G12C bladder cancer >65yrs 1 961 0.00 0.00 0.00 0.00
NRAS G12C b-lymphoblastic leukemia/lymphoma <40yrs 1 142 0.01 0.00 0.00 0.02
NRAS G12C b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.02
NRAS G12C b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.02
NRAS G12C b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.02
NRAS G12C small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12C small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G12C small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
NRAS G12C sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
NRAS G12C sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
NRAS G12C sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.01
NRAS G12C sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
NRAS G12C bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS G12C bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS G12C bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G12C bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS G12C vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS G12C vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS G12C thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
NRAS G12C thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12C thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
NRAS G12C thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G12C ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS G12C ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
NRAS G12C ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
NRAS G12C small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
NRAS G12C small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G12C small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
NRAS G12C mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
NRAS G12C mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12C mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12C mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
NRAS G12C germ cell tumor <40yrs 1 650 0.00 0.00 0.00 0.00
NRAS G12C germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.01
NRAS G12C germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.01
NRAS G12C germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.01
NRAS G12C nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
NRAS G12C nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12C nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
NRAS G12C nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
NRAS G12C penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.02
NRAS G12C penile cancer >65yrs 0 11 0.00 0.00 0.00 0.02
NRAS G12C pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
NRAS G12C b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G12C b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
NRAS G12C b cell lymphoma 50-65yrs 0 357 0.00 0.00 0.00 0.00
NRAS G12C b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
NRAS G12C non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
NRAS G12C t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.01
NRAS G12C retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
NRAS G12C hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
NRAS G12C lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
NRAS G12C peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.04
NRAS G12D appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12D appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
NRAS G12D appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12D appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
NRAS G12D colorectal cancer <40yrs 5 565 0.01 0.01 0.00 0.01
NRAS G12D colorectal cancer 40-50yrs 13 1280 0.01 0.01 0.01 0.01
NRAS G12D colorectal cancer 50-65yrs 16 2814 0.01 0.01 0.00 0.01
NRAS G12D colorectal cancer >65yrs 19 2052 0.01 0.01 0.01 0.01
NRAS G12D cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
NRAS G12D cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
NRAS G12D cancer of unknown primary 50-65yrs 1 810 0.00 0.00 0.00 0.00
NRAS G12D cancer of unknown primary >65yrs 2 796 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer 50-65yrs 4 3677 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer >65yrs 4 5698 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12D breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS G12D breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS G12D breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
NRAS G12D breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS G12D breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma <40yrs 1 672 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma >65yrs 1 777 0.00 0.00 0.00 0.00
NRAS G12D pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G12D pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G12D pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
NRAS G12D pancreatic cancer >65yrs 1 1205 0.00 0.00 0.00 0.00
NRAS G12D leukemia <40yrs 8 204 0.04 0.04 0.03 0.06
NRAS G12D leukemia 40-50yrs 8 128 0.05 0.05 0.03 0.07
NRAS G12D leukemia 50-65yrs 24 515 0.05 0.04 0.03 0.06
NRAS G12D leukemia >65yrs 31 720 0.04 0.04 0.03 0.06
NRAS G12D melanoma <40yrs 0 289 0.00 0.00 0.00 0.01
NRAS G12D melanoma 40-50yrs 1 282 0.00 0.00 0.00 0.01
NRAS G12D melanoma 50-65yrs 6 1016 0.01 0.01 0.00 0.01
NRAS G12D melanoma >65yrs 10 1259 0.01 0.01 0.00 0.01
NRAS G12D head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
NRAS G12D head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
NRAS G12D head and neck cancer 50-65yrs 3 799 0.00 0.00 0.00 0.01
NRAS G12D head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
NRAS G12D uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.01
NRAS G12D uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.01
NRAS G12D uterine cancer 50-65yrs 7 1046 0.00 0.00 0.00 0.01
NRAS G12D uterine cancer >65yrs 1 987 0.00 0.00 0.00 0.00
NRAS G12D non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.01
NRAS G12D non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.01
NRAS G12D non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.01
NRAS G12D non-melanoma skin cancers >65yrs 1 317 0.00 0.00 0.00 0.01
NRAS G12D myelodysplastic/myeloproliferative syndromes <40yrs 3 87 0.02 0.02 0.01 0.04
NRAS G12D myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.02 0.02 0.00 0.03
NRAS G12D myelodysplastic/myeloproliferative syndromes 50-65yrs 5 373 0.02 0.02 0.01 0.03
NRAS G12D myelodysplastic/myeloproliferative syndromes >65yrs 12 664 0.02 0.02 0.01 0.03
NRAS G12D adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12D adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
NRAS G12D adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
NRAS G12D adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
NRAS G12D ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
NRAS G12D ovarian cancer 40-50yrs 1 253 0.00 0.00 0.00 0.01
NRAS G12D ovarian cancer 50-65yrs 1 1092 0.00 0.00 0.00 0.00
NRAS G12D ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
NRAS G12D thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
NRAS G12D thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12D thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
NRAS G12D thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
NRAS G12D cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
NRAS G12D cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
NRAS G12D cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G12D cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G12D hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.01
NRAS G12D hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.01
NRAS G12D hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
NRAS G12D hepatobiliary cancer >65yrs 4 601 0.01 0.00 0.00 0.01
NRAS G12D kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS G12D kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS G12D kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS G12D kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS G12D mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12D mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
NRAS G12D mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
NRAS G12D mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
NRAS G12D cns cancer <40yrs 2 1602 0.00 0.00 0.00 0.00
NRAS G12D cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
NRAS G12D cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
NRAS G12D cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
NRAS G12D prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
NRAS G12D prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS G12D prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
NRAS G12D anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
NRAS G12D anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS G12D anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
NRAS G12D neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.02
NRAS G12D neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.01
NRAS G12D neuroendocrine tumors 50-65yrs 1 161 0.00 0.00 0.00 0.02
NRAS G12D neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.01
NRAS G12D bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.01
NRAS G12D bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
NRAS G12D bladder cancer 50-65yrs 1 511 0.00 0.00 0.00 0.00
NRAS G12D bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
NRAS G12D b-lymphoblastic leukemia/lymphoma <40yrs 10 142 0.07 0.06 0.03 0.11
NRAS G12D b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.01 0.00 0.00 0.07
NRAS G12D b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.01 0.00 0.00 0.04
NRAS G12D b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.01 0.00 0.00 0.05
NRAS G12D small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12D small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G12D small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
NRAS G12D sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12D sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
NRAS G12D sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G12D sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12D bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS G12D bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS G12D bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G12D bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS G12D vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS G12D vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS G12D thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.01
NRAS G12D thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12D thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
NRAS G12D thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G12D ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS G12D ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
NRAS G12D ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
NRAS G12D small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
NRAS G12D small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G12D small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
NRAS G12D mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
NRAS G12D mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12D mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12D mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
NRAS G12D germ cell tumor <40yrs 1 650 0.00 0.00 0.00 0.01
NRAS G12D germ cell tumor 40-50yrs 1 131 0.00 0.00 0.00 0.02
NRAS G12D germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.01
NRAS G12D germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.02
NRAS G12D nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
NRAS G12D nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12D nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
NRAS G12D nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
NRAS G12D penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G12D penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G12D pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
NRAS G12D b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS G12D b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.01
NRAS G12D b cell lymphoma 50-65yrs 1 357 0.00 0.00 0.00 0.01
NRAS G12D b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
NRAS G12D non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
NRAS G12D t-lymphoblastic leukemia/lymphoma <40yrs 1 27 0.04 0.03 0.00 0.14
NRAS G12D retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
NRAS G12D hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
NRAS G12D lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
NRAS G12D peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
NRAS G12F appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12F appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
NRAS G12F appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12F appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary 50-65yrs 0 810 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary >65yrs 0 796 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12F breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS G12F breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS G12F breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
NRAS G12F breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS G12F breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
NRAS G12F pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G12F pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G12F pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
NRAS G12F pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
NRAS G12F leukemia <40yrs 0 204 0.00 0.00 0.00 0.00
NRAS G12F leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.00
NRAS G12F leukemia 50-65yrs 0 515 0.00 0.00 0.00 0.00
NRAS G12F leukemia >65yrs 0 720 0.00 0.00 0.00 0.00
NRAS G12F melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
NRAS G12F melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
NRAS G12F melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
NRAS G12F melanoma >65yrs 0 1259 0.00 0.00 0.00 0.00
NRAS G12F head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
NRAS G12F head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
NRAS G12F head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
NRAS G12F head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
NRAS G12F uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.00
NRAS G12F uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
NRAS G12F uterine cancer 50-65yrs 0 1046 0.00 0.00 0.00 0.00
NRAS G12F uterine cancer >65yrs 0 987 0.00 0.00 0.00 0.00
NRAS G12F non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12F non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
NRAS G12F non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
NRAS G12F non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
NRAS G12F myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G12F myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
NRAS G12F myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
NRAS G12F myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
NRAS G12F adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12F adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
NRAS G12F adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
NRAS G12F adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
NRAS G12F ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
NRAS G12F ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
NRAS G12F ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
NRAS G12F ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
NRAS G12F thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
NRAS G12F thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12F thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
NRAS G12F thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
NRAS G12F cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
NRAS G12F cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
NRAS G12F cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G12F cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G12F hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
NRAS G12F hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
NRAS G12F hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
NRAS G12F hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
NRAS G12F kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS G12F kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS G12F kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS G12F kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS G12F mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12F mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
NRAS G12F mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
NRAS G12F mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
NRAS G12F cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
NRAS G12F cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
NRAS G12F cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
NRAS G12F cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
NRAS G12F prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
NRAS G12F prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS G12F prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
NRAS G12F anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
NRAS G12F anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS G12F anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
NRAS G12F neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
NRAS G12F neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
NRAS G12F neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12F neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
NRAS G12F bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
NRAS G12F bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
NRAS G12F bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
NRAS G12F bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
NRAS G12F b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
NRAS G12F b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
NRAS G12F b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
NRAS G12F b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
NRAS G12F small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12F small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G12F small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
NRAS G12F sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12F sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
NRAS G12F sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G12F sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12F bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS G12F bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS G12F bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G12F bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS G12F vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS G12F vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS G12F thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.01
NRAS G12F thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12F thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
NRAS G12F thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G12F ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS G12F ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
NRAS G12F ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
NRAS G12F small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
NRAS G12F small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G12F small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
NRAS G12F mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
NRAS G12F mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12F mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12F mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
NRAS G12F nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
NRAS G12F nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12F nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
NRAS G12F nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
NRAS G12F penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G12F penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G12F pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
NRAS G12F b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G12F b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
NRAS G12F b cell lymphoma 50-65yrs 0 357 0.00 0.00 0.00 0.00
NRAS G12F b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
NRAS G12F non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
NRAS G12F t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
NRAS G12F retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
NRAS G12F hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
NRAS G12F lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
NRAS G12F peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
NRAS G12R appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12R appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
NRAS G12R appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12R appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary 50-65yrs 0 810 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary >65yrs 0 796 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12R breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS G12R breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS G12R breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
NRAS G12R breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS G12R breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
NRAS G12R pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G12R pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G12R pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
NRAS G12R pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
NRAS G12R leukemia <40yrs 0 204 0.00 0.00 0.00 0.00
NRAS G12R leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.01
NRAS G12R leukemia 50-65yrs 1 515 0.00 0.00 0.00 0.00
NRAS G12R leukemia >65yrs 2 720 0.00 0.00 0.00 0.01
NRAS G12R melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
NRAS G12R melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
NRAS G12R melanoma 50-65yrs 1 1016 0.00 0.00 0.00 0.00
NRAS G12R melanoma >65yrs 2 1259 0.00 0.00 0.00 0.00
NRAS G12R head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
NRAS G12R head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
NRAS G12R head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
NRAS G12R head and neck cancer >65yrs 1 582 0.00 0.00 0.00 0.00
NRAS G12R uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.00
NRAS G12R uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
NRAS G12R uterine cancer 50-65yrs 1 1046 0.00 0.00 0.00 0.00
NRAS G12R uterine cancer >65yrs 0 987 0.00 0.00 0.00 0.00
NRAS G12R non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12R non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
NRAS G12R non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
NRAS G12R non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
NRAS G12R myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS G12R myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.01
NRAS G12R myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.01
NRAS G12R myelodysplastic/myeloproliferative syndromes >65yrs 5 664 0.01 0.01 0.00 0.01
NRAS G12R adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12R adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
NRAS G12R adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
NRAS G12R adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
NRAS G12R ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
NRAS G12R ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
NRAS G12R ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
NRAS G12R ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
NRAS G12R thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
NRAS G12R thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12R thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
NRAS G12R thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
NRAS G12R cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
NRAS G12R cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
NRAS G12R cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G12R cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G12R hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
NRAS G12R hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
NRAS G12R hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
NRAS G12R hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
NRAS G12R kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS G12R kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS G12R kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS G12R kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS G12R mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12R mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
NRAS G12R mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
NRAS G12R mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
NRAS G12R cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
NRAS G12R cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
NRAS G12R cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
NRAS G12R cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
NRAS G12R prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
NRAS G12R prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS G12R prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
NRAS G12R anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
NRAS G12R anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS G12R anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
NRAS G12R neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
NRAS G12R neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
NRAS G12R neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12R neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
NRAS G12R bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
NRAS G12R bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
NRAS G12R bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
NRAS G12R bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
NRAS G12R b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
NRAS G12R b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
NRAS G12R b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
NRAS G12R b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
NRAS G12R small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12R small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G12R small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
NRAS G12R sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12R sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
NRAS G12R sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G12R sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12R bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS G12R bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS G12R bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G12R bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS G12R vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS G12R vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS G12R thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.01
NRAS G12R thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12R thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
NRAS G12R thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G12R ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS G12R ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
NRAS G12R ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
NRAS G12R small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
NRAS G12R small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G12R small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
NRAS G12R mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
NRAS G12R mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12R mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12R mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
NRAS G12R nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
NRAS G12R nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12R nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
NRAS G12R nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
NRAS G12R penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G12R penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G12R pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
NRAS G12R b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS G12R b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.01
NRAS G12R b cell lymphoma 50-65yrs 0 357 0.00 0.00 0.00 0.00
NRAS G12R b cell lymphoma >65yrs 1 413 0.00 0.00 0.00 0.01
NRAS G12R non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
NRAS G12R t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
NRAS G12R retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
NRAS G12R hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
NRAS G12R lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
NRAS G12R peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
NRAS G12S appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12S appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
NRAS G12S appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12S appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer >65yrs 1 2052 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary 50-65yrs 0 810 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary >65yrs 1 796 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer 50-65yrs 1 3677 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer >65yrs 1 5698 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12S breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS G12S breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS G12S breast cancer 50-65yrs 1 3989 0.00 0.00 0.00 0.00
NRAS G12S breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS G12S breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12S soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
NRAS G12S soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
NRAS G12S soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
NRAS G12S soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
NRAS G12S pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G12S pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G12S pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
NRAS G12S pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
NRAS G12S leukemia <40yrs 1 204 0.00 0.00 0.00 0.01
NRAS G12S leukemia 40-50yrs 1 128 0.00 0.00 0.00 0.01
NRAS G12S leukemia 50-65yrs 3 515 0.00 0.00 0.00 0.01
NRAS G12S leukemia >65yrs 1 720 0.00 0.00 0.00 0.01
NRAS G12S melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
NRAS G12S melanoma 40-50yrs 1 282 0.00 0.00 0.00 0.01
NRAS G12S melanoma 50-65yrs 1 1016 0.00 0.00 0.00 0.00
NRAS G12S melanoma >65yrs 4 1259 0.00 0.00 0.00 0.00
NRAS G12S head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
NRAS G12S head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
NRAS G12S head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
NRAS G12S head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
NRAS G12S uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.00
NRAS G12S uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
NRAS G12S uterine cancer 50-65yrs 1 1046 0.00 0.00 0.00 0.00
NRAS G12S uterine cancer >65yrs 1 987 0.00 0.00 0.00 0.00
NRAS G12S non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12S non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
NRAS G12S non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
NRAS G12S non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
NRAS G12S myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS G12S myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.01
NRAS G12S myelodysplastic/myeloproliferative syndromes 50-65yrs 1 373 0.00 0.00 0.00 0.01
NRAS G12S myelodysplastic/myeloproliferative syndromes >65yrs 7 664 0.01 0.01 0.00 0.02
NRAS G12S adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12S adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
NRAS G12S adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
NRAS G12S adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
NRAS G12S ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
NRAS G12S ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
NRAS G12S ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
NRAS G12S ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer 50-65yrs 1 752 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
NRAS G12S thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
NRAS G12S thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12S thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
NRAS G12S thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
NRAS G12S cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
NRAS G12S cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
NRAS G12S cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G12S cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G12S hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
NRAS G12S hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
NRAS G12S hepatobiliary cancer 50-65yrs 1 525 0.00 0.00 0.00 0.00
NRAS G12S hepatobiliary cancer >65yrs 1 601 0.00 0.00 0.00 0.00
NRAS G12S kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS G12S kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS G12S kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS G12S kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS G12S mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12S mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
NRAS G12S mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
NRAS G12S mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
NRAS G12S cns cancer <40yrs 1 1602 0.00 0.00 0.00 0.00
NRAS G12S cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
NRAS G12S cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
NRAS G12S cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
NRAS G12S prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
NRAS G12S prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS G12S prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
NRAS G12S anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS G12S anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS G12S anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
NRAS G12S neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
NRAS G12S neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
NRAS G12S neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12S neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
NRAS G12S bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
NRAS G12S bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
NRAS G12S bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
NRAS G12S bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
NRAS G12S b-lymphoblastic leukemia/lymphoma <40yrs 4 142 0.02 0.02 0.01 0.05
NRAS G12S b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.01 0.01 0.00 0.04
NRAS G12S b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.01 0.01 0.00 0.04
NRAS G12S b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.01 0.01 0.00 0.04
NRAS G12S small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12S small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G12S small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
NRAS G12S sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12S sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
NRAS G12S sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G12S sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12S bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS G12S bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS G12S bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G12S bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS G12S vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS G12S vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS G12S thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
NRAS G12S thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12S thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
NRAS G12S thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G12S ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS G12S ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
NRAS G12S ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
NRAS G12S small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
NRAS G12S small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G12S small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
NRAS G12S mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
NRAS G12S mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12S mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12S mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
NRAS G12S germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.00
NRAS G12S germ cell tumor 40-50yrs 1 131 0.00 0.00 0.00 0.02
NRAS G12S germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.01
NRAS G12S germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.02
NRAS G12S nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
NRAS G12S nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12S nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
NRAS G12S nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
NRAS G12S penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G12S penile cancer >65yrs 0 11 0.00 0.00 0.00 0.04
NRAS G12S pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.05
NRAS G12S b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS G12S b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.01
NRAS G12S b cell lymphoma 50-65yrs 1 357 0.00 0.00 0.00 0.01
NRAS G12S b cell lymphoma >65yrs 1 413 0.00 0.00 0.00 0.01
NRAS G12S non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
NRAS G12S t-lymphoblastic leukemia/lymphoma <40yrs 1 27 0.04 0.03 0.00 0.14
NRAS G12S retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
NRAS G12S hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
NRAS G12S lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
NRAS G12S peritoneal cancer >65yrs 0 11 0.01 0.00 0.00 0.07
NRAS G12V appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12V appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
NRAS G12V appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12V appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer <40yrs 1 565 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer 40-50yrs 1 1280 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer 50-65yrs 1 2814 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer >65yrs 4 2052 0.00 0.00 0.00 0.00
NRAS G12V cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
NRAS G12V cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
NRAS G12V cancer of unknown primary 50-65yrs 2 810 0.00 0.00 0.00 0.00
NRAS G12V cancer of unknown primary >65yrs 1 796 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer 50-65yrs 1 3677 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer >65yrs 2 5698 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12V breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS G12V breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS G12V breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
NRAS G12V breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS G12V breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma >65yrs 1 777 0.00 0.00 0.00 0.00
NRAS G12V pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G12V pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G12V pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
NRAS G12V pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
NRAS G12V leukemia <40yrs 0 204 0.00 0.00 0.00 0.01
NRAS G12V leukemia 40-50yrs 1 128 0.01 0.00 0.00 0.02
NRAS G12V leukemia 50-65yrs 1 515 0.00 0.00 0.00 0.01
NRAS G12V leukemia >65yrs 6 720 0.01 0.01 0.00 0.01
NRAS G12V melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
NRAS G12V melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
NRAS G12V melanoma 50-65yrs 2 1016 0.00 0.00 0.00 0.00
NRAS G12V melanoma >65yrs 1 1259 0.00 0.00 0.00 0.00
NRAS G12V head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
NRAS G12V head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
NRAS G12V head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
NRAS G12V head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
NRAS G12V uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.01
NRAS G12V uterine cancer 40-50yrs 1 162 0.00 0.00 0.00 0.02
NRAS G12V uterine cancer 50-65yrs 0 1046 0.00 0.00 0.00 0.00
NRAS G12V uterine cancer >65yrs 0 987 0.00 0.00 0.00 0.00
NRAS G12V non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12V non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
NRAS G12V non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
NRAS G12V non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
NRAS G12V myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS G12V myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.01
NRAS G12V myelodysplastic/myeloproliferative syndromes 50-65yrs 1 373 0.00 0.00 0.00 0.01
NRAS G12V myelodysplastic/myeloproliferative syndromes >65yrs 2 664 0.00 0.00 0.00 0.01
NRAS G12V adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12V adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.01
NRAS G12V adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
NRAS G12V adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.01
NRAS G12V ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
NRAS G12V ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
NRAS G12V ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
NRAS G12V ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
NRAS G12V thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
NRAS G12V thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12V thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
NRAS G12V thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
NRAS G12V cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
NRAS G12V cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
NRAS G12V cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G12V cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G12V hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
NRAS G12V hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
NRAS G12V hepatobiliary cancer 50-65yrs 1 525 0.00 0.00 0.00 0.00
NRAS G12V hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
NRAS G12V kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS G12V kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS G12V kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS G12V kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS G12V mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12V mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
NRAS G12V mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
NRAS G12V mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
NRAS G12V cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
NRAS G12V cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
NRAS G12V cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
NRAS G12V cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
NRAS G12V prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
NRAS G12V prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS G12V prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
NRAS G12V anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
NRAS G12V anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS G12V anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
NRAS G12V neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
NRAS G12V neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
NRAS G12V neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G12V neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
NRAS G12V bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
NRAS G12V bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
NRAS G12V bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
NRAS G12V bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
NRAS G12V b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
NRAS G12V b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
NRAS G12V b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
NRAS G12V b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
NRAS G12V small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12V small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G12V small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
NRAS G12V sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12V sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
NRAS G12V sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G12V sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
NRAS G12V bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS G12V bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS G12V bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G12V bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS G12V vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS G12V vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS G12V thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
NRAS G12V thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
NRAS G12V thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
NRAS G12V thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G12V ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
NRAS G12V ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G12V ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
NRAS G12V small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
NRAS G12V small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G12V small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
NRAS G12V mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
NRAS G12V mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G12V mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
NRAS G12V mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
NRAS G12V germ cell tumor <40yrs 2 650 0.00 0.00 0.00 0.01
NRAS G12V germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.01
NRAS G12V germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.01
NRAS G12V germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.01
NRAS G12V nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.01
NRAS G12V nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.01
NRAS G12V nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.01
NRAS G12V nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.01
NRAS G12V penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G12V penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G12V pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.03
NRAS G12V b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS G12V b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
NRAS G12V b cell lymphoma 50-65yrs 1 357 0.00 0.00 0.00 0.01
NRAS G12V b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
NRAS G12V non-hodgkin lymphoma >65yrs 1 14 0.08 0.06 0.00 0.26
NRAS G12V t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
NRAS G12V retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
NRAS G12V hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
NRAS G12V lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
NRAS G12V peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
NRAS G13C appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G13C appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
NRAS G13C appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G13C appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer 40-50yrs 1 1280 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer 50-65yrs 1 2814 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer >65yrs 1 2052 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary 50-65yrs 0 810 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary >65yrs 0 796 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G13C breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS G13C breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS G13C breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
NRAS G13C breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS G13C breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
NRAS G13C pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G13C pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G13C pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
NRAS G13C pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
NRAS G13C leukemia <40yrs 1 204 0.00 0.00 0.00 0.01
NRAS G13C leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.00
NRAS G13C leukemia 50-65yrs 0 515 0.00 0.00 0.00 0.00
NRAS G13C leukemia >65yrs 0 720 0.00 0.00 0.00 0.00
NRAS G13C melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
NRAS G13C melanoma 40-50yrs 1 282 0.00 0.00 0.00 0.01
NRAS G13C melanoma 50-65yrs 0 1016 0.00 0.00 0.00 0.00
NRAS G13C melanoma >65yrs 3 1259 0.00 0.00 0.00 0.00
NRAS G13C head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
NRAS G13C head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
NRAS G13C head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
NRAS G13C head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
NRAS G13C uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.00
NRAS G13C uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
NRAS G13C uterine cancer 50-65yrs 0 1046 0.00 0.00 0.00 0.00
NRAS G13C uterine cancer >65yrs 0 987 0.00 0.00 0.00 0.00
NRAS G13C non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G13C non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
NRAS G13C non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
NRAS G13C non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
NRAS G13C myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS G13C myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.01
NRAS G13C myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.01
NRAS G13C myelodysplastic/myeloproliferative syndromes >65yrs 5 664 0.01 0.01 0.00 0.01
NRAS G13C adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G13C adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.01
NRAS G13C adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
NRAS G13C adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.01
NRAS G13C ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
NRAS G13C ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
NRAS G13C ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
NRAS G13C ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
NRAS G13C thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
NRAS G13C thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
NRAS G13C thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
NRAS G13C thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
NRAS G13C cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
NRAS G13C cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
NRAS G13C cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G13C cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G13C hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
NRAS G13C hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
NRAS G13C hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
NRAS G13C hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
NRAS G13C kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS G13C kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS G13C kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS G13C kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS G13C mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G13C mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
NRAS G13C mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
NRAS G13C mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
NRAS G13C cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
NRAS G13C cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
NRAS G13C cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
NRAS G13C cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
NRAS G13C prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
NRAS G13C prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS G13C prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
NRAS G13C anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
NRAS G13C anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS G13C anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
NRAS G13C neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
NRAS G13C neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
NRAS G13C neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G13C neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
NRAS G13C bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
NRAS G13C bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
NRAS G13C bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
NRAS G13C bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
NRAS G13C b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
NRAS G13C b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
NRAS G13C b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
NRAS G13C b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
NRAS G13C small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G13C small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G13C small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
NRAS G13C sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
NRAS G13C sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
NRAS G13C sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G13C sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
NRAS G13C bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS G13C bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS G13C bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G13C bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS G13C vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS G13C vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS G13C thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
NRAS G13C thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
NRAS G13C thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
NRAS G13C thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G13C ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
NRAS G13C ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G13C ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
NRAS G13C small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
NRAS G13C small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G13C small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
NRAS G13C mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
NRAS G13C mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G13C mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
NRAS G13C mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
NRAS G13C nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.01
NRAS G13C nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.01
NRAS G13C nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.01
NRAS G13C nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.01
NRAS G13C penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G13C penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G13C pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.03
NRAS G13C b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS G13C b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
NRAS G13C b cell lymphoma 50-65yrs 1 357 0.00 0.00 0.00 0.01
NRAS G13C b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
NRAS G13C non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
NRAS G13C t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
NRAS G13C retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
NRAS G13C hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
NRAS G13C lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
NRAS G13C peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
NRAS G13D appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G13D appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
NRAS G13D appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G13D appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer <40yrs 1 565 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer 40-50yrs 2 1280 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer 50-65yrs 3 2814 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer >65yrs 6 2052 0.00 0.00 0.00 0.00
NRAS G13D cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
NRAS G13D cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
NRAS G13D cancer of unknown primary 50-65yrs 0 810 0.00 0.00 0.00 0.00
NRAS G13D cancer of unknown primary >65yrs 0 796 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer >65yrs 0 5698 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G13D breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS G13D breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS G13D breast cancer 50-65yrs 1 3989 0.00 0.00 0.00 0.00
NRAS G13D breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS G13D breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G13D soft tissue sarcoma <40yrs 2 672 0.00 0.00 0.00 0.01
NRAS G13D soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
NRAS G13D soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
NRAS G13D soft tissue sarcoma >65yrs 1 777 0.00 0.00 0.00 0.00
NRAS G13D pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G13D pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G13D pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
NRAS G13D pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
NRAS G13D leukemia <40yrs 6 204 0.02 0.02 0.01 0.04
NRAS G13D leukemia 40-50yrs 2 128 0.02 0.02 0.01 0.03
NRAS G13D leukemia 50-65yrs 10 515 0.02 0.02 0.01 0.03
NRAS G13D leukemia >65yrs 14 720 0.02 0.02 0.01 0.03
NRAS G13D melanoma <40yrs 0 289 0.00 0.00 0.00 0.01
NRAS G13D melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.01
NRAS G13D melanoma 50-65yrs 4 1016 0.00 0.00 0.00 0.01
NRAS G13D melanoma >65yrs 4 1259 0.00 0.00 0.00 0.01
NRAS G13D head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
NRAS G13D head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
NRAS G13D head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
NRAS G13D head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
NRAS G13D uterine cancer <40yrs 1 57 0.01 0.01 0.00 0.06
NRAS G13D uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
NRAS G13D uterine cancer 50-65yrs 0 1046 0.00 0.00 0.00 0.00
NRAS G13D uterine cancer >65yrs 0 987 0.00 0.00 0.00 0.00
NRAS G13D non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G13D non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
NRAS G13D non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
NRAS G13D non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
NRAS G13D myelodysplastic/myeloproliferative syndromes <40yrs 3 87 0.02 0.01 0.00 0.06
NRAS G13D myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.01 0.01 0.00 0.02
NRAS G13D myelodysplastic/myeloproliferative syndromes 50-65yrs 3 373 0.01 0.01 0.00 0.02
NRAS G13D myelodysplastic/myeloproliferative syndromes >65yrs 3 664 0.01 0.01 0.00 0.01
NRAS G13D adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G13D adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
NRAS G13D adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
NRAS G13D adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
NRAS G13D ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
NRAS G13D ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
NRAS G13D ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
NRAS G13D ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
NRAS G13D esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
NRAS G13D esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G13D esophagogastric cancer 50-65yrs 1 752 0.00 0.00 0.00 0.00
NRAS G13D esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
NRAS G13D thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
NRAS G13D thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
NRAS G13D thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
NRAS G13D thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
NRAS G13D cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
NRAS G13D cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
NRAS G13D cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G13D cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G13D hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
NRAS G13D hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
NRAS G13D hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
NRAS G13D hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
NRAS G13D kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS G13D kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS G13D kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS G13D kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS G13D mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G13D mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
NRAS G13D mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
NRAS G13D mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
NRAS G13D cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
NRAS G13D cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
NRAS G13D cns cancer 50-65yrs 1 1439 0.00 0.00 0.00 0.00
NRAS G13D cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
NRAS G13D prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
NRAS G13D prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS G13D prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
NRAS G13D anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS G13D anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS G13D anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
NRAS G13D neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.02
NRAS G13D neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.01
NRAS G13D neuroendocrine tumors 50-65yrs 1 161 0.00 0.00 0.00 0.02
NRAS G13D neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.01
NRAS G13D bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
NRAS G13D bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
NRAS G13D bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
NRAS G13D bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
NRAS G13D b-lymphoblastic leukemia/lymphoma <40yrs 5 142 0.03 0.03 0.01 0.06
NRAS G13D b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.02 0.02 0.00 0.06
NRAS G13D b-lymphoblastic leukemia/lymphoma 50-65yrs 1 48 0.02 0.02 0.00 0.06
NRAS G13D b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.02 0.02 0.00 0.05
NRAS G13D small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G13D small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G13D small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
NRAS G13D sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
NRAS G13D sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
NRAS G13D sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G13D sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
NRAS G13D bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS G13D bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS G13D bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G13D bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS G13D vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS G13D vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS G13D thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.01
NRAS G13D thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
NRAS G13D thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
NRAS G13D thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G13D ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS G13D ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G13D ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
NRAS G13D small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
NRAS G13D small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G13D small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
NRAS G13D mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
NRAS G13D mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G13D mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
NRAS G13D mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
NRAS G13D germ cell tumor <40yrs 1 650 0.00 0.00 0.00 0.00
NRAS G13D germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.01
NRAS G13D germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.01
NRAS G13D germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.01
NRAS G13D nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
NRAS G13D nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
NRAS G13D nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
NRAS G13D nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
NRAS G13D penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.04
NRAS G13D penile cancer >65yrs 0 11 0.00 0.00 0.00 0.05
NRAS G13D pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.05
NRAS G13D b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS G13D b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.01
NRAS G13D b cell lymphoma 50-65yrs 1 357 0.00 0.00 0.00 0.01
NRAS G13D b cell lymphoma >65yrs 1 413 0.00 0.00 0.00 0.01
NRAS G13D non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.04
NRAS G13D t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
NRAS G13D retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
NRAS G13D hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
NRAS G13D lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
NRAS G13D peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.02
NRAS G13R appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.02
NRAS G13R appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.01
NRAS G13R appendiceal cancer 50-65yrs 1 161 0.00 0.00 0.00 0.02
NRAS G13R appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.01
NRAS G13R colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
NRAS G13R colorectal cancer 40-50yrs 1 1280 0.00 0.00 0.00 0.00
NRAS G13R colorectal cancer 50-65yrs 13 2814 0.00 0.00 0.00 0.01
NRAS G13R colorectal cancer >65yrs 5 2052 0.00 0.00 0.00 0.00
NRAS G13R cancer of unknown primary <40yrs 1 167 0.00 0.00 0.00 0.01
NRAS G13R cancer of unknown primary 40-50yrs 1 211 0.00 0.00 0.00 0.01
NRAS G13R cancer of unknown primary 50-65yrs 2 810 0.00 0.00 0.00 0.01
NRAS G13R cancer of unknown primary >65yrs 1 796 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer >65yrs 2 5698 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G13R breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS G13R breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS G13R breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
NRAS G13R breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS G13R breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
NRAS G13R pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G13R pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G13R pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
NRAS G13R pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
NRAS G13R leukemia <40yrs 1 204 0.00 0.00 0.00 0.01
NRAS G13R leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.01
NRAS G13R leukemia 50-65yrs 3 515 0.00 0.00 0.00 0.01
NRAS G13R leukemia >65yrs 3 720 0.00 0.00 0.00 0.01
NRAS G13R melanoma <40yrs 1 289 0.01 0.01 0.00 0.01
NRAS G13R melanoma 40-50yrs 1 282 0.01 0.01 0.00 0.01
NRAS G13R melanoma 50-65yrs 9 1016 0.01 0.01 0.00 0.01
NRAS G13R melanoma >65yrs 9 1259 0.01 0.01 0.00 0.01
NRAS G13R head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
NRAS G13R head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
NRAS G13R head and neck cancer 50-65yrs 1 799 0.00 0.00 0.00 0.00
NRAS G13R head and neck cancer >65yrs 1 582 0.00 0.00 0.00 0.00
NRAS G13R uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.00
NRAS G13R uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
NRAS G13R uterine cancer 50-65yrs 0 1046 0.00 0.00 0.00 0.00
NRAS G13R uterine cancer >65yrs 0 987 0.00 0.00 0.00 0.00
NRAS G13R non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G13R non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
NRAS G13R non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
NRAS G13R non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
NRAS G13R myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G13R myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
NRAS G13R myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
NRAS G13R myelodysplastic/myeloproliferative syndromes >65yrs 1 664 0.00 0.00 0.00 0.00
NRAS G13R adrenocortical carcinoma <40yrs 0 27 0.01 0.00 0.00 0.03
NRAS G13R adrenocortical carcinoma 40-50yrs 0 30 0.01 0.00 0.00 0.03
NRAS G13R adrenocortical carcinoma 50-65yrs 0 51 0.01 0.00 0.00 0.03
NRAS G13R adrenocortical carcinoma >65yrs 1 26 0.02 0.01 0.00 0.09
NRAS G13R ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
NRAS G13R ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
NRAS G13R ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
NRAS G13R ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
NRAS G13R thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.01
NRAS G13R thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.01
NRAS G13R thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
NRAS G13R thyroid cancer >65yrs 2 370 0.00 0.00 0.00 0.01
NRAS G13R cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
NRAS G13R cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
NRAS G13R cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G13R cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G13R hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.01
NRAS G13R hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.01
NRAS G13R hepatobiliary cancer 50-65yrs 2 525 0.00 0.00 0.00 0.01
NRAS G13R hepatobiliary cancer >65yrs 1 601 0.00 0.00 0.00 0.01
NRAS G13R kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS G13R kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS G13R kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS G13R kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS G13R mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G13R mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
NRAS G13R mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
NRAS G13R mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
NRAS G13R cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
NRAS G13R cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
NRAS G13R cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
NRAS G13R cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
NRAS G13R prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
NRAS G13R prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS G13R prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
NRAS G13R anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS G13R anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS G13R anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
NRAS G13R neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
NRAS G13R neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
NRAS G13R neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G13R neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
NRAS G13R bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.01
NRAS G13R bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.01
NRAS G13R bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
NRAS G13R bladder cancer >65yrs 2 961 0.00 0.00 0.00 0.00
NRAS G13R b-lymphoblastic leukemia/lymphoma <40yrs 1 142 0.00 0.00 0.00 0.02
NRAS G13R b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.02
NRAS G13R b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.02
NRAS G13R b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.02
NRAS G13R small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G13R small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G13R small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
NRAS G13R sex cord stromal tumor <40yrs 1 29 0.02 0.01 0.00 0.08
NRAS G13R sex cord stromal tumor 40-50yrs 0 15 0.01 0.01 0.00 0.04
NRAS G13R sex cord stromal tumor 50-65yrs 0 36 0.01 0.00 0.00 0.04
NRAS G13R sex cord stromal tumor >65yrs 0 27 0.01 0.00 0.00 0.04
NRAS G13R bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS G13R bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS G13R bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G13R bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS G13R vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS G13R vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS G13R thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.01
NRAS G13R thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
NRAS G13R thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
NRAS G13R thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G13R ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS G13R ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G13R ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
NRAS G13R small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
NRAS G13R small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G13R small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
NRAS G13R mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
NRAS G13R mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G13R mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
NRAS G13R mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
NRAS G13R germ cell tumor <40yrs 1 650 0.00 0.00 0.00 0.01
NRAS G13R germ cell tumor 40-50yrs 1 131 0.00 0.00 0.00 0.01
NRAS G13R germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.01
NRAS G13R germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.02
NRAS G13R nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
NRAS G13R nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
NRAS G13R nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
NRAS G13R nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
NRAS G13R penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.04
NRAS G13R penile cancer >65yrs 0 11 0.00 0.00 0.00 0.05
NRAS G13R pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.05
NRAS G13R b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS G13R b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.01
NRAS G13R b cell lymphoma 50-65yrs 1 357 0.00 0.00 0.00 0.01
NRAS G13R b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
NRAS G13R non-hodgkin lymphoma >65yrs 1 14 0.08 0.06 0.00 0.26
NRAS G13R t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
NRAS G13R retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
NRAS G13R hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
NRAS G13R lung cancer >65yrs 0 18 0.00 0.00 0.00 0.04
NRAS G13R peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.02
NRAS G13V appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G13V appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
NRAS G13V appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G13V appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer 40-50yrs 0 1280 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer 50-65yrs 0 2814 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer >65yrs 0 2052 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary 50-65yrs 0 810 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary >65yrs 0 796 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer >65yrs 1 5698 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G13V breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS G13V breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS G13V breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
NRAS G13V breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS G13V breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma <40yrs 0 672 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
NRAS G13V pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G13V pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G13V pancreatic cancer 50-65yrs 1 999 0.00 0.00 0.00 0.00
NRAS G13V pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
NRAS G13V leukemia <40yrs 0 204 0.00 0.00 0.00 0.01
NRAS G13V leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.01
NRAS G13V leukemia 50-65yrs 4 515 0.00 0.00 0.00 0.01
NRAS G13V leukemia >65yrs 1 720 0.00 0.00 0.00 0.01
NRAS G13V melanoma <40yrs 0 289 0.00 0.00 0.00 0.00
NRAS G13V melanoma 40-50yrs 0 282 0.00 0.00 0.00 0.00
NRAS G13V melanoma 50-65yrs 1 1016 0.00 0.00 0.00 0.00
NRAS G13V melanoma >65yrs 3 1259 0.00 0.00 0.00 0.00
NRAS G13V head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
NRAS G13V head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
NRAS G13V head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
NRAS G13V head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
NRAS G13V uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.00
NRAS G13V uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
NRAS G13V uterine cancer 50-65yrs 0 1046 0.00 0.00 0.00 0.00
NRAS G13V uterine cancer >65yrs 0 987 0.00 0.00 0.00 0.00
NRAS G13V non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G13V non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
NRAS G13V non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
NRAS G13V non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
NRAS G13V myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS G13V myelodysplastic/myeloproliferative syndromes 40-50yrs 1 83 0.01 0.00 0.00 0.02
NRAS G13V myelodysplastic/myeloproliferative syndromes 50-65yrs 2 373 0.00 0.00 0.00 0.01
NRAS G13V myelodysplastic/myeloproliferative syndromes >65yrs 2 664 0.00 0.00 0.00 0.01
NRAS G13V adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS G13V adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
NRAS G13V adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
NRAS G13V adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
NRAS G13V ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
NRAS G13V ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
NRAS G13V ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
NRAS G13V ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
NRAS G13V thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
NRAS G13V thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
NRAS G13V thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
NRAS G13V thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
NRAS G13V cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
NRAS G13V cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
NRAS G13V cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G13V cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
NRAS G13V hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
NRAS G13V hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
NRAS G13V hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
NRAS G13V hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
NRAS G13V kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS G13V kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS G13V kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS G13V kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS G13V mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS G13V mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
NRAS G13V mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
NRAS G13V mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
NRAS G13V cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
NRAS G13V cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
NRAS G13V cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
NRAS G13V cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
NRAS G13V prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
NRAS G13V prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS G13V prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
NRAS G13V anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
NRAS G13V anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS G13V anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
NRAS G13V neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
NRAS G13V neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
NRAS G13V neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS G13V neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
NRAS G13V bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
NRAS G13V bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
NRAS G13V bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
NRAS G13V bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
NRAS G13V b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.01
NRAS G13V b-lymphoblastic leukemia/lymphoma 40-50yrs 1 16 0.04 0.02 0.00 0.18
NRAS G13V b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.02
NRAS G13V b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.02
NRAS G13V small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G13V small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G13V small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
NRAS G13V sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
NRAS G13V sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
NRAS G13V sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.01
NRAS G13V sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
NRAS G13V bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS G13V bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS G13V bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS G13V bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS G13V vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS G13V vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS G13V thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
NRAS G13V thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
NRAS G13V thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
NRAS G13V thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
NRAS G13V ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS G13V ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
NRAS G13V ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
NRAS G13V small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
NRAS G13V small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS G13V small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
NRAS G13V mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
NRAS G13V mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS G13V mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
NRAS G13V mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.00
NRAS G13V nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
NRAS G13V nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
NRAS G13V nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
NRAS G13V nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
NRAS G13V penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G13V penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
NRAS G13V pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
NRAS G13V b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS G13V b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.00
NRAS G13V b cell lymphoma 50-65yrs 0 357 0.00 0.00 0.00 0.00
NRAS G13V b cell lymphoma >65yrs 0 413 0.00 0.00 0.00 0.00
NRAS G13V non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.06
NRAS G13V t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
NRAS G13V retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
NRAS G13V hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
NRAS G13V lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
NRAS G13V peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
NRAS Q61H appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS Q61H appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
NRAS Q61H appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS Q61H appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
NRAS Q61H colorectal cancer <40yrs 0 565 0.00 0.00 0.00 0.00
NRAS Q61H colorectal cancer 40-50yrs 3 1280 0.00 0.00 0.00 0.00
NRAS Q61H colorectal cancer 50-65yrs 6 2814 0.00 0.00 0.00 0.00
NRAS Q61H colorectal cancer >65yrs 8 2052 0.00 0.00 0.00 0.00
NRAS Q61H cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
NRAS Q61H cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
NRAS Q61H cancer of unknown primary 50-65yrs 2 810 0.00 0.00 0.00 0.00
NRAS Q61H cancer of unknown primary >65yrs 1 796 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer 40-50yrs 0 585 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer 50-65yrs 0 3677 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer >65yrs 4 5698 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.01
NRAS Q61H breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma <40yrs 1 672 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma 50-65yrs 1 951 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma >65yrs 1 777 0.00 0.00 0.00 0.00
NRAS Q61H pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS Q61H pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS Q61H pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
NRAS Q61H pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
NRAS Q61H leukemia <40yrs 2 204 0.01 0.00 0.00 0.02
NRAS Q61H leukemia 40-50yrs 1 128 0.00 0.00 0.00 0.01
NRAS Q61H leukemia 50-65yrs 2 515 0.00 0.00 0.00 0.01
NRAS Q61H leukemia >65yrs 2 720 0.00 0.00 0.00 0.01
NRAS Q61H melanoma <40yrs 0 289 0.00 0.00 0.00 0.01
NRAS Q61H melanoma 40-50yrs 1 282 0.01 0.01 0.00 0.01
NRAS Q61H melanoma 50-65yrs 15 1016 0.01 0.01 0.01 0.02
NRAS Q61H melanoma >65yrs 11 1259 0.01 0.01 0.00 0.01
NRAS Q61H head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
NRAS Q61H head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
NRAS Q61H head and neck cancer 50-65yrs 1 799 0.00 0.00 0.00 0.00
NRAS Q61H head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
NRAS Q61H uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.01
NRAS Q61H uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.00
NRAS Q61H uterine cancer 50-65yrs 2 1046 0.00 0.00 0.00 0.00
NRAS Q61H uterine cancer >65yrs 2 987 0.00 0.00 0.00 0.00
NRAS Q61H non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS Q61H non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
NRAS Q61H non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
NRAS Q61H non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
NRAS Q61H myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS Q61H myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.01
NRAS Q61H myelodysplastic/myeloproliferative syndromes 50-65yrs 1 373 0.00 0.00 0.00 0.01
NRAS Q61H myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
NRAS Q61H adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS Q61H adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
NRAS Q61H adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
NRAS Q61H adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
NRAS Q61H ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
NRAS Q61H ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
NRAS Q61H ovarian cancer 50-65yrs 0 1092 0.00 0.00 0.00 0.00
NRAS Q61H ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer >65yrs 0 725 0.00 0.00 0.00 0.00
NRAS Q61H thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
NRAS Q61H thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
NRAS Q61H thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
NRAS Q61H thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
NRAS Q61H cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.01
NRAS Q61H cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.01
NRAS Q61H cervical cancer 50-65yrs 1 144 0.00 0.00 0.00 0.02
NRAS Q61H cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.01
NRAS Q61H hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
NRAS Q61H hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
NRAS Q61H hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
NRAS Q61H hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
NRAS Q61H kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS Q61H kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS Q61H kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS Q61H kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS Q61H mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.02
NRAS Q61H mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.02
NRAS Q61H mature t and nk neoplasms 50-65yrs 1 76 0.01 0.00 0.00 0.04
NRAS Q61H mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.02
NRAS Q61H cns cancer <40yrs 0 1602 0.00 0.00 0.00 0.00
NRAS Q61H cns cancer 40-50yrs 0 687 0.00 0.00 0.00 0.00
NRAS Q61H cns cancer 50-65yrs 0 1439 0.00 0.00 0.00 0.00
NRAS Q61H cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
NRAS Q61H prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.01
NRAS Q61H prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS Q61H prostate cancer >65yrs 2 1402 0.00 0.00 0.00 0.00
NRAS Q61H anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS Q61H anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS Q61H anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
NRAS Q61H neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
NRAS Q61H neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
NRAS Q61H neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS Q61H neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
NRAS Q61H bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
NRAS Q61H bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
NRAS Q61H bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
NRAS Q61H bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
NRAS Q61H b-lymphoblastic leukemia/lymphoma <40yrs 2 142 0.01 0.01 0.00 0.03
NRAS Q61H b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.01 0.01 0.00 0.03
NRAS Q61H b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.01 0.00 0.00 0.02
NRAS Q61H b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.01 0.00 0.00 0.02
NRAS Q61H small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS Q61H small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS Q61H small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
NRAS Q61H sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.00
NRAS Q61H sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.00
NRAS Q61H sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.00
NRAS Q61H sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.00
NRAS Q61H bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS Q61H bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS Q61H bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS Q61H bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS Q61H vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS Q61H vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS Q61H thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
NRAS Q61H thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
NRAS Q61H thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
NRAS Q61H thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
NRAS Q61H ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS Q61H ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
NRAS Q61H ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
NRAS Q61H small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
NRAS Q61H small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS Q61H small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
NRAS Q61H mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
NRAS Q61H mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS Q61H mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
NRAS Q61H mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
NRAS Q61H germ cell tumor <40yrs 2 650 0.00 0.00 0.00 0.01
NRAS Q61H germ cell tumor 40-50yrs 1 131 0.00 0.00 0.00 0.02
NRAS Q61H germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.01
NRAS Q61H germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.02
NRAS Q61H nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
NRAS Q61H nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
NRAS Q61H nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
NRAS Q61H nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
NRAS Q61H penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
NRAS Q61H penile cancer >65yrs 0 11 0.00 0.00 0.00 0.04
NRAS Q61H pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.05
NRAS Q61H b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS Q61H b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.01
NRAS Q61H b cell lymphoma 50-65yrs 1 357 0.00 0.00 0.00 0.01
NRAS Q61H b cell lymphoma >65yrs 1 413 0.00 0.00 0.00 0.01
NRAS Q61H non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
NRAS Q61H t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.01
NRAS Q61H retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.00
NRAS Q61H hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
NRAS Q61H lung cancer >65yrs 1 18 0.06 0.05 0.00 0.20
NRAS Q61H peritoneal cancer >65yrs 0 11 0.01 0.00 0.00 0.07
NRAS Q61K appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS Q61K appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
NRAS Q61K appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS Q61K appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
NRAS Q61K colorectal cancer <40yrs 5 565 0.01 0.01 0.01 0.01
NRAS Q61K colorectal cancer 40-50yrs 12 1280 0.01 0.01 0.01 0.01
NRAS Q61K colorectal cancer 50-65yrs 30 2814 0.01 0.01 0.01 0.01
NRAS Q61K colorectal cancer >65yrs 18 2052 0.01 0.01 0.01 0.01
NRAS Q61K cancer of unknown primary <40yrs 1 167 0.00 0.00 0.00 0.01
NRAS Q61K cancer of unknown primary 40-50yrs 2 211 0.00 0.00 0.00 0.01
NRAS Q61K cancer of unknown primary 50-65yrs 2 810 0.00 0.00 0.00 0.01
NRAS Q61K cancer of unknown primary >65yrs 2 796 0.00 0.00 0.00 0.01
NRAS Q61K non-small cell lung cancer <40yrs 1 161 0.00 0.00 0.00 0.01
NRAS Q61K non-small cell lung cancer 40-50yrs 1 585 0.00 0.00 0.00 0.00
NRAS Q61K non-small cell lung cancer 50-65yrs 2 3677 0.00 0.00 0.00 0.00
NRAS Q61K non-small cell lung cancer >65yrs 4 5698 0.00 0.00 0.00 0.00
NRAS Q61K non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS Q61K soft tissue sarcoma <40yrs 9 672 0.01 0.01 0.00 0.02
NRAS Q61K soft tissue sarcoma 40-50yrs 2 367 0.01 0.00 0.00 0.01
NRAS Q61K soft tissue sarcoma 50-65yrs 1 951 0.00 0.00 0.00 0.01
NRAS Q61K soft tissue sarcoma >65yrs 3 777 0.00 0.00 0.00 0.01
NRAS Q61K pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS Q61K pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS Q61K pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
NRAS Q61K pancreatic cancer >65yrs 2 1205 0.00 0.00 0.00 0.00
NRAS Q61K leukemia <40yrs 0 204 0.01 0.01 0.00 0.02
NRAS Q61K leukemia 40-50yrs 3 128 0.01 0.01 0.00 0.04
NRAS Q61K leukemia 50-65yrs 3 515 0.01 0.01 0.00 0.01
NRAS Q61K leukemia >65yrs 8 720 0.01 0.01 0.00 0.02
NRAS Q61K melanoma <40yrs 14 289 0.06 0.06 0.04 0.08
NRAS Q61K melanoma 40-50yrs 17 282 0.07 0.07 0.05 0.08
NRAS Q61K melanoma 50-65yrs 83 1016 0.08 0.08 0.06 0.09
NRAS Q61K melanoma >65yrs 85 1259 0.07 0.07 0.06 0.08
NRAS Q61K head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.01
NRAS Q61K head and neck cancer 40-50yrs 1 216 0.00 0.00 0.00 0.01
NRAS Q61K head and neck cancer 50-65yrs 2 799 0.00 0.00 0.00 0.00
NRAS Q61K head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
NRAS Q61K uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.01
NRAS Q61K uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.01
NRAS Q61K uterine cancer 50-65yrs 3 1046 0.00 0.00 0.00 0.01
NRAS Q61K uterine cancer >65yrs 3 987 0.00 0.00 0.00 0.01
NRAS Q61K non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS Q61K non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
NRAS Q61K non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
NRAS Q61K non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
NRAS Q61K myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS Q61K myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
NRAS Q61K myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
NRAS Q61K myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
NRAS Q61K adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS Q61K adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
NRAS Q61K adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
NRAS Q61K adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
NRAS Q61K ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.01
NRAS Q61K ovarian cancer 40-50yrs 2 253 0.00 0.00 0.00 0.01
NRAS Q61K ovarian cancer 50-65yrs 2 1092 0.00 0.00 0.00 0.00
NRAS Q61K ovarian cancer >65yrs 1 849 0.00 0.00 0.00 0.00
NRAS Q61K esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
NRAS Q61K esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS Q61K esophagogastric cancer 50-65yrs 1 752 0.00 0.00 0.00 0.00
NRAS Q61K esophagogastric cancer >65yrs 1 725 0.00 0.00 0.00 0.00
NRAS Q61K thyroid cancer <40yrs 3 150 0.03 0.03 0.01 0.04
NRAS Q61K thyroid cancer 40-50yrs 2 122 0.03 0.03 0.01 0.04
NRAS Q61K thyroid cancer 50-65yrs 15 374 0.03 0.03 0.02 0.05
NRAS Q61K thyroid cancer >65yrs 9 370 0.03 0.03 0.02 0.04
NRAS Q61K cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
NRAS Q61K cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
NRAS Q61K cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS Q61K cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
NRAS Q61K hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.01
NRAS Q61K hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.01
NRAS Q61K hepatobiliary cancer 50-65yrs 3 525 0.00 0.00 0.00 0.01
NRAS Q61K hepatobiliary cancer >65yrs 4 601 0.01 0.00 0.00 0.01
NRAS Q61K kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS Q61K kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS Q61K kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS Q61K kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS Q61K mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS Q61K mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
NRAS Q61K mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
NRAS Q61K mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
NRAS Q61K cns cancer <40yrs 6 1602 0.00 0.00 0.00 0.01
NRAS Q61K cns cancer 40-50yrs 1 687 0.00 0.00 0.00 0.00
NRAS Q61K cns cancer 50-65yrs 1 1439 0.00 0.00 0.00 0.00
NRAS Q61K cns cancer >65yrs 0 836 0.00 0.00 0.00 0.00
NRAS Q61K prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
NRAS Q61K prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS Q61K prostate cancer >65yrs 1 1402 0.00 0.00 0.00 0.00
NRAS Q61K anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
NRAS Q61K anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS Q61K anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
NRAS Q61K neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
NRAS Q61K neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
NRAS Q61K neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS Q61K neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
NRAS Q61K bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.01
NRAS Q61K bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.01
NRAS Q61K bladder cancer 50-65yrs 2 511 0.00 0.00 0.00 0.01
NRAS Q61K bladder cancer >65yrs 1 961 0.00 0.00 0.00 0.00
NRAS Q61K b-lymphoblastic leukemia/lymphoma <40yrs 3 142 0.02 0.02 0.00 0.04
NRAS Q61K b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.01 0.00 0.00 0.04
NRAS Q61K b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.01 0.00 0.00 0.03
NRAS Q61K b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.01 0.00 0.00 0.03
NRAS Q61K small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS Q61K small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS Q61K small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
NRAS Q61K sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
NRAS Q61K sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
NRAS Q61K sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.01
NRAS Q61K sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
NRAS Q61K bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS Q61K bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS Q61K bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS Q61K bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS Q61K vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS Q61K vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS Q61K thymic tumor <40yrs 0 14 0.01 0.00 0.00 0.04
NRAS Q61K thymic tumor 40-50yrs 0 28 0.01 0.00 0.00 0.03
NRAS Q61K thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.02
NRAS Q61K thymic tumor >65yrs 1 40 0.01 0.01 0.00 0.06
NRAS Q61K ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS Q61K ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
NRAS Q61K ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
NRAS Q61K small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.02
NRAS Q61K small cell lung cancer 50-65yrs 1 144 0.00 0.00 0.00 0.02
NRAS Q61K small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.01
NRAS Q61K mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
NRAS Q61K mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS Q61K mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
NRAS Q61K mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
NRAS Q61K germ cell tumor <40yrs 1 650 0.00 0.00 0.00 0.01
NRAS Q61K germ cell tumor 40-50yrs 1 131 0.00 0.00 0.00 0.02
NRAS Q61K germ cell tumor 50-65yrs 1 92 0.01 0.00 0.00 0.02
NRAS Q61K germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.02
NRAS Q61K nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
NRAS Q61K nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
NRAS Q61K nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
NRAS Q61K nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
NRAS Q61K penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
NRAS Q61K penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
NRAS Q61K pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
NRAS Q61K b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS Q61K b cell lymphoma 40-50yrs 1 105 0.00 0.00 0.00 0.02
NRAS Q61K b cell lymphoma 50-65yrs 1 357 0.00 0.00 0.00 0.01
NRAS Q61K b cell lymphoma >65yrs 1 413 0.00 0.00 0.00 0.01
NRAS Q61K non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.06
NRAS Q61K t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
NRAS Q61K retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
NRAS Q61K hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
NRAS Q61K lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
NRAS Q61K peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
NRAS Q61L appendiceal cancer <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS Q61L appendiceal cancer 40-50yrs 0 62 0.00 0.00 0.00 0.00
NRAS Q61L appendiceal cancer 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS Q61L appendiceal cancer >65yrs 0 90 0.00 0.00 0.00 0.00
NRAS Q61L colorectal cancer <40yrs 2 565 0.00 0.00 0.00 0.01
NRAS Q61L colorectal cancer 40-50yrs 4 1280 0.00 0.00 0.00 0.00
NRAS Q61L colorectal cancer 50-65yrs 11 2814 0.00 0.00 0.00 0.00
NRAS Q61L colorectal cancer >65yrs 5 2052 0.00 0.00 0.00 0.00
NRAS Q61L cancer of unknown primary <40yrs 0 167 0.00 0.00 0.00 0.00
NRAS Q61L cancer of unknown primary 40-50yrs 0 211 0.00 0.00 0.00 0.00
NRAS Q61L cancer of unknown primary 50-65yrs 0 810 0.00 0.00 0.00 0.00
NRAS Q61L cancer of unknown primary >65yrs 1 796 0.00 0.00 0.00 0.00
NRAS Q61L non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.01
NRAS Q61L non-small cell lung cancer 40-50yrs 2 585 0.00 0.00 0.00 0.01
NRAS Q61L non-small cell lung cancer 50-65yrs 15 3677 0.00 0.00 0.00 0.00
NRAS Q61L non-small cell lung cancer >65yrs 15 5698 0.00 0.00 0.00 0.00
NRAS Q61L non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.01
NRAS Q61L breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS Q61L breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS Q61L breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
NRAS Q61L breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS Q61L breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS Q61L soft tissue sarcoma <40yrs 2 672 0.00 0.00 0.00 0.01
NRAS Q61L soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
NRAS Q61L soft tissue sarcoma 50-65yrs 0 951 0.00 0.00 0.00 0.00
NRAS Q61L soft tissue sarcoma >65yrs 2 777 0.00 0.00 0.00 0.00
NRAS Q61L pancreatic cancer <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS Q61L pancreatic cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS Q61L pancreatic cancer 50-65yrs 0 999 0.00 0.00 0.00 0.00
NRAS Q61L pancreatic cancer >65yrs 0 1205 0.00 0.00 0.00 0.00
NRAS Q61L leukemia <40yrs 0 204 0.00 0.00 0.00 0.01
NRAS Q61L leukemia 40-50yrs 0 128 0.00 0.00 0.00 0.01
NRAS Q61L leukemia 50-65yrs 3 515 0.00 0.00 0.00 0.01
NRAS Q61L leukemia >65yrs 3 720 0.00 0.00 0.00 0.01
NRAS Q61L melanoma <40yrs 5 289 0.02 0.02 0.01 0.04
NRAS Q61L melanoma 40-50yrs 7 282 0.03 0.02 0.01 0.04
NRAS Q61L melanoma 50-65yrs 18 1016 0.02 0.02 0.01 0.03
NRAS Q61L melanoma >65yrs 58 1259 0.04 0.04 0.03 0.06
NRAS Q61L head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
NRAS Q61L head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
NRAS Q61L head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
NRAS Q61L head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
NRAS Q61L uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.01
NRAS Q61L uterine cancer 40-50yrs 0 162 0.00 0.00 0.00 0.01
NRAS Q61L uterine cancer 50-65yrs 4 1046 0.00 0.00 0.00 0.01
NRAS Q61L uterine cancer >65yrs 2 987 0.00 0.00 0.00 0.01
NRAS Q61L non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS Q61L non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
NRAS Q61L non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
NRAS Q61L non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
NRAS Q61L myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.00
NRAS Q61L myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.00
NRAS Q61L myelodysplastic/myeloproliferative syndromes 50-65yrs 0 373 0.00 0.00 0.00 0.00
NRAS Q61L myelodysplastic/myeloproliferative syndromes >65yrs 0 664 0.00 0.00 0.00 0.00
NRAS Q61L adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS Q61L adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
NRAS Q61L adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
NRAS Q61L adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
NRAS Q61L ovarian cancer <40yrs 0 141 0.00 0.00 0.00 0.00
NRAS Q61L ovarian cancer 40-50yrs 0 253 0.00 0.00 0.00 0.00
NRAS Q61L ovarian cancer 50-65yrs 1 1092 0.00 0.00 0.00 0.00
NRAS Q61L ovarian cancer >65yrs 0 849 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer 40-50yrs 0 200 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer 50-65yrs 0 752 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer >65yrs 1 725 0.00 0.00 0.00 0.00
NRAS Q61L thyroid cancer <40yrs 0 150 0.00 0.00 0.00 0.00
NRAS Q61L thyroid cancer 40-50yrs 0 122 0.00 0.00 0.00 0.00
NRAS Q61L thyroid cancer 50-65yrs 0 374 0.00 0.00 0.00 0.00
NRAS Q61L thyroid cancer >65yrs 0 370 0.00 0.00 0.00 0.00
NRAS Q61L cervical cancer <40yrs 0 85 0.00 0.00 0.00 0.00
NRAS Q61L cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.00
NRAS Q61L cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS Q61L cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.00
NRAS Q61L hepatobiliary cancer <40yrs 0 137 0.00 0.00 0.00 0.00
NRAS Q61L hepatobiliary cancer 40-50yrs 0 110 0.00 0.00 0.00 0.00
NRAS Q61L hepatobiliary cancer 50-65yrs 0 525 0.00 0.00 0.00 0.00
NRAS Q61L hepatobiliary cancer >65yrs 0 601 0.00 0.00 0.00 0.00
NRAS Q61L kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS Q61L kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS Q61L kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS Q61L kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS Q61L mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.00
NRAS Q61L mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.00
NRAS Q61L mature t and nk neoplasms 50-65yrs 0 76 0.00 0.00 0.00 0.00
NRAS Q61L mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.00
NRAS Q61L cns cancer <40yrs 1 1602 0.00 0.00 0.00 0.00
NRAS Q61L cns cancer 40-50yrs 1 687 0.00 0.00 0.00 0.00
NRAS Q61L cns cancer 50-65yrs 1 1439 0.00 0.00 0.00 0.00
NRAS Q61L cns cancer >65yrs 2 836 0.00 0.00 0.00 0.00
NRAS Q61L prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
NRAS Q61L prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS Q61L prostate cancer >65yrs 0 1402 0.00 0.00 0.00 0.00
NRAS Q61L anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.00
NRAS Q61L anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS Q61L anal cancer >65yrs 0 45 0.00 0.00 0.00 0.00
NRAS Q61L neuroendocrine tumors <40yrs 0 22 0.00 0.00 0.00 0.00
NRAS Q61L neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.00
NRAS Q61L neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.00
NRAS Q61L neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.00
NRAS Q61L bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.00
NRAS Q61L bladder cancer 40-50yrs 0 78 0.00 0.00 0.00 0.00
NRAS Q61L bladder cancer 50-65yrs 0 511 0.00 0.00 0.00 0.00
NRAS Q61L bladder cancer >65yrs 0 961 0.00 0.00 0.00 0.00
NRAS Q61L b-lymphoblastic leukemia/lymphoma <40yrs 0 142 0.00 0.00 0.00 0.00
NRAS Q61L b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.00 0.00 0.00 0.00
NRAS Q61L b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.00 0.00 0.00 0.00
NRAS Q61L b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.00 0.00 0.00 0.00
NRAS Q61L small bowel cancer 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS Q61L small bowel cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS Q61L small bowel cancer >65yrs 0 78 0.00 0.00 0.00 0.00
NRAS Q61L sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
NRAS Q61L sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
NRAS Q61L sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.01
NRAS Q61L sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
NRAS Q61L bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS Q61L bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS Q61L bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS Q61L bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS Q61L vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS Q61L vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS Q61L thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
NRAS Q61L thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
NRAS Q61L thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
NRAS Q61L thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
NRAS Q61L ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS Q61L ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.01
NRAS Q61L ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.01
NRAS Q61L small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.02
NRAS Q61L small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.01
NRAS Q61L small cell lung cancer >65yrs 1 224 0.00 0.00 0.00 0.01
NRAS Q61L mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.00
NRAS Q61L mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.00
NRAS Q61L mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.00
NRAS Q61L mesothelioma >65yrs 0 316 0.00 0.00 0.00 0.00
NRAS Q61L germ cell tumor <40yrs 1 650 0.00 0.00 0.00 0.00
NRAS Q61L germ cell tumor 40-50yrs 0 131 0.00 0.00 0.00 0.01
NRAS Q61L germ cell tumor 50-65yrs 0 92 0.00 0.00 0.00 0.01
NRAS Q61L germ cell tumor >65yrs 0 12 0.00 0.00 0.00 0.01
NRAS Q61L nerve sheath tumor <40yrs 0 77 0.00 0.00 0.00 0.00
NRAS Q61L nerve sheath tumor 40-50yrs 0 27 0.00 0.00 0.00 0.00
NRAS Q61L nerve sheath tumor 50-65yrs 0 37 0.00 0.00 0.00 0.00
NRAS Q61L nerve sheath tumor >65yrs 0 13 0.00 0.00 0.00 0.00
NRAS Q61L penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.03
NRAS Q61L penile cancer >65yrs 0 11 0.00 0.00 0.00 0.03
NRAS Q61L pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
NRAS Q61L b cell lymphoma <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS Q61L b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.01
NRAS Q61L b cell lymphoma 50-65yrs 0 357 0.00 0.00 0.00 0.00
NRAS Q61L b cell lymphoma >65yrs 1 413 0.00 0.00 0.00 0.01
NRAS Q61L non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.06
NRAS Q61L t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
NRAS Q61L retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
NRAS Q61L hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.03
NRAS Q61L lung cancer >65yrs 0 18 0.00 0.00 0.00 0.03
NRAS Q61L peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.05
NRAS Q61R appendiceal cancer <40yrs 0 28 0.02 0.01 0.00 0.04
NRAS Q61R appendiceal cancer 40-50yrs 2 62 0.02 0.02 0.00 0.05
NRAS Q61R appendiceal cancer 50-65yrs 2 161 0.02 0.01 0.00 0.03
NRAS Q61R appendiceal cancer >65yrs 1 90 0.02 0.01 0.00 0.03
NRAS Q61R colorectal cancer <40yrs 3 565 0.01 0.01 0.00 0.01
NRAS Q61R colorectal cancer 40-50yrs 13 1280 0.01 0.01 0.00 0.01
NRAS Q61R colorectal cancer 50-65yrs 19 2814 0.01 0.01 0.00 0.01
NRAS Q61R colorectal cancer >65yrs 11 2052 0.01 0.01 0.00 0.01
NRAS Q61R cancer of unknown primary <40yrs 2 167 0.01 0.00 0.00 0.02
NRAS Q61R cancer of unknown primary 40-50yrs 1 211 0.00 0.00 0.00 0.01
NRAS Q61R cancer of unknown primary 50-65yrs 4 810 0.00 0.00 0.00 0.01
NRAS Q61R cancer of unknown primary >65yrs 1 796 0.00 0.00 0.00 0.01
NRAS Q61R non-small cell lung cancer <40yrs 0 161 0.00 0.00 0.00 0.00
NRAS Q61R non-small cell lung cancer 40-50yrs 2 585 0.00 0.00 0.00 0.00
NRAS Q61R non-small cell lung cancer 50-65yrs 6 3677 0.00 0.00 0.00 0.00
NRAS Q61R non-small cell lung cancer >65yrs 7 5698 0.00 0.00 0.00 0.00
NRAS Q61R non-small cell lung cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer <40yrs 0 840 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer 40-50yrs 0 1910 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer 50-65yrs 0 3989 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer >65yrs 0 2583 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer Age:NA 0 10 0.00 0.00 0.00 0.00
NRAS Q61R soft tissue sarcoma <40yrs 3 672 0.00 0.00 0.00 0.01
NRAS Q61R soft tissue sarcoma 40-50yrs 0 367 0.00 0.00 0.00 0.00
NRAS Q61R soft tissue sarcoma 50-65yrs 3 951 0.00 0.00 0.00 0.01
NRAS Q61R soft tissue sarcoma >65yrs 0 777 0.00 0.00 0.00 0.00
NRAS Q61R pancreatic cancer <40yrs 1 87 0.00 0.00 0.00 0.02
NRAS Q61R pancreatic cancer 40-50yrs 2 200 0.00 0.00 0.00 0.02
NRAS Q61R pancreatic cancer 50-65yrs 3 999 0.00 0.00 0.00 0.01
NRAS Q61R pancreatic cancer >65yrs 1 1205 0.00 0.00 0.00 0.00
NRAS Q61R leukemia <40yrs 5 204 0.01 0.01 0.01 0.03
NRAS Q61R leukemia 40-50yrs 1 128 0.01 0.01 0.00 0.02
NRAS Q61R leukemia 50-65yrs 5 515 0.01 0.01 0.00 0.02
NRAS Q61R leukemia >65yrs 6 720 0.01 0.01 0.00 0.02
NRAS Q61R melanoma <40yrs 18 289 0.08 0.08 0.06 0.10
NRAS Q61R melanoma 40-50yrs 28 282 0.09 0.09 0.07 0.12
NRAS Q61R melanoma 50-65yrs 92 1016 0.09 0.09 0.08 0.10
NRAS Q61R melanoma >65yrs 108 1259 0.09 0.09 0.07 0.10
NRAS Q61R head and neck cancer <40yrs 0 140 0.00 0.00 0.00 0.00
NRAS Q61R head and neck cancer 40-50yrs 0 216 0.00 0.00 0.00 0.00
NRAS Q61R head and neck cancer 50-65yrs 0 799 0.00 0.00 0.00 0.00
NRAS Q61R head and neck cancer >65yrs 0 582 0.00 0.00 0.00 0.00
NRAS Q61R uterine cancer <40yrs 0 57 0.00 0.00 0.00 0.02
NRAS Q61R uterine cancer 40-50yrs 3 162 0.01 0.01 0.00 0.03
NRAS Q61R uterine cancer 50-65yrs 5 1046 0.00 0.00 0.00 0.01
NRAS Q61R uterine cancer >65yrs 1 987 0.00 0.00 0.00 0.01
NRAS Q61R non-melanoma skin cancers <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS Q61R non-melanoma skin cancers 40-50yrs 0 20 0.00 0.00 0.00 0.00
NRAS Q61R non-melanoma skin cancers 50-65yrs 0 149 0.00 0.00 0.00 0.00
NRAS Q61R non-melanoma skin cancers >65yrs 0 317 0.00 0.00 0.00 0.00
NRAS Q61R myelodysplastic/myeloproliferative syndromes <40yrs 0 87 0.00 0.00 0.00 0.01
NRAS Q61R myelodysplastic/myeloproliferative syndromes 40-50yrs 0 83 0.00 0.00 0.00 0.01
NRAS Q61R myelodysplastic/myeloproliferative syndromes 50-65yrs 1 373 0.00 0.00 0.00 0.01
NRAS Q61R myelodysplastic/myeloproliferative syndromes >65yrs 1 664 0.00 0.00 0.00 0.00
NRAS Q61R adrenocortical carcinoma <40yrs 0 27 0.00 0.00 0.00 0.00
NRAS Q61R adrenocortical carcinoma 40-50yrs 0 30 0.00 0.00 0.00 0.00
NRAS Q61R adrenocortical carcinoma 50-65yrs 0 51 0.00 0.00 0.00 0.00
NRAS Q61R adrenocortical carcinoma >65yrs 0 26 0.00 0.00 0.00 0.00
NRAS Q61R ovarian cancer <40yrs 2 141 0.01 0.01 0.00 0.02
NRAS Q61R ovarian cancer 40-50yrs 1 253 0.01 0.01 0.00 0.02
NRAS Q61R ovarian cancer 50-65yrs 14 1092 0.01 0.01 0.01 0.02
NRAS Q61R ovarian cancer >65yrs 8 849 0.01 0.01 0.01 0.02
NRAS Q61R esophagogastric cancer <40yrs 0 122 0.00 0.00 0.00 0.01
NRAS Q61R esophagogastric cancer 40-50yrs 1 200 0.00 0.00 0.00 0.01
NRAS Q61R esophagogastric cancer 50-65yrs 1 752 0.00 0.00 0.00 0.00
NRAS Q61R esophagogastric cancer >65yrs 1 725 0.00 0.00 0.00 0.00
NRAS Q61R thyroid cancer <40yrs 8 150 0.08 0.08 0.04 0.11
NRAS Q61R thyroid cancer 40-50yrs 15 122 0.10 0.10 0.07 0.15
NRAS Q61R thyroid cancer 50-65yrs 31 374 0.09 0.09 0.06 0.11
NRAS Q61R thyroid cancer >65yrs 41 370 0.10 0.10 0.08 0.13
NRAS Q61R cervical cancer <40yrs 1 85 0.01 0.00 0.00 0.03
NRAS Q61R cervical cancer 40-50yrs 0 99 0.00 0.00 0.00 0.01
NRAS Q61R cervical cancer 50-65yrs 0 144 0.00 0.00 0.00 0.01
NRAS Q61R cervical cancer >65yrs 0 36 0.00 0.00 0.00 0.02
NRAS Q61R hepatobiliary cancer <40yrs 0 137 0.01 0.01 0.00 0.01
NRAS Q61R hepatobiliary cancer 40-50yrs 1 110 0.01 0.01 0.00 0.02
NRAS Q61R hepatobiliary cancer 50-65yrs 4 525 0.01 0.01 0.00 0.01
NRAS Q61R hepatobiliary cancer >65yrs 4 601 0.01 0.01 0.00 0.01
NRAS Q61R kidney cancer <40yrs 0 191 0.00 0.00 0.00 0.00
NRAS Q61R kidney cancer 40-50yrs 0 159 0.00 0.00 0.00 0.00
NRAS Q61R kidney cancer 50-65yrs 0 628 0.00 0.00 0.00 0.00
NRAS Q61R kidney cancer >65yrs 0 440 0.00 0.00 0.00 0.00
NRAS Q61R mature t and nk neoplasms <40yrs 0 28 0.00 0.00 0.00 0.02
NRAS Q61R mature t and nk neoplasms 40-50yrs 0 21 0.00 0.00 0.00 0.03
NRAS Q61R mature t and nk neoplasms 50-65yrs 1 76 0.01 0.00 0.00 0.03
NRAS Q61R mature t and nk neoplasms >65yrs 0 106 0.00 0.00 0.00 0.02
NRAS Q61R cns cancer <40yrs 4 1602 0.00 0.00 0.00 0.00
NRAS Q61R cns cancer 40-50yrs 1 687 0.00 0.00 0.00 0.00
NRAS Q61R cns cancer 50-65yrs 1 1439 0.00 0.00 0.00 0.00
NRAS Q61R cns cancer >65yrs 1 836 0.00 0.00 0.00 0.00
NRAS Q61R prostate cancer 40-50yrs 0 70 0.00 0.00 0.00 0.00
NRAS Q61R prostate cancer 50-65yrs 0 960 0.00 0.00 0.00 0.00
NRAS Q61R prostate cancer >65yrs 1 1402 0.00 0.00 0.00 0.00
NRAS Q61R anal cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS Q61R anal cancer 50-65yrs 0 88 0.00 0.00 0.00 0.00
NRAS Q61R anal cancer >65yrs 0 45 0.00 0.00 0.00 0.01
NRAS Q61R neuroendocrine tumors <40yrs 1 22 0.02 0.01 0.00 0.12
NRAS Q61R neuroendocrine tumors 40-50yrs 0 55 0.00 0.00 0.00 0.02
NRAS Q61R neuroendocrine tumors 50-65yrs 0 161 0.00 0.00 0.00 0.01
NRAS Q61R neuroendocrine tumors >65yrs 0 121 0.00 0.00 0.00 0.01
NRAS Q61R bladder cancer <40yrs 0 25 0.00 0.00 0.00 0.01
NRAS Q61R bladder cancer 40-50yrs 1 78 0.00 0.00 0.00 0.02
NRAS Q61R bladder cancer 50-65yrs 1 511 0.00 0.00 0.00 0.01
NRAS Q61R bladder cancer >65yrs 1 961 0.00 0.00 0.00 0.00
NRAS Q61R b-lymphoblastic leukemia/lymphoma <40yrs 2 142 0.01 0.01 0.00 0.03
NRAS Q61R b-lymphoblastic leukemia/lymphoma 40-50yrs 0 16 0.01 0.01 0.00 0.03
NRAS Q61R b-lymphoblastic leukemia/lymphoma 50-65yrs 0 48 0.01 0.00 0.00 0.02
NRAS Q61R b-lymphoblastic leukemia/lymphoma >65yrs 0 42 0.01 0.00 0.00 0.02
NRAS Q61R small bowel cancer 40-50yrs 0 29 0.01 0.01 0.00 0.04
NRAS Q61R small bowel cancer 50-65yrs 1 96 0.01 0.01 0.00 0.03
NRAS Q61R small bowel cancer >65yrs 1 78 0.01 0.01 0.00 0.03
NRAS Q61R sex cord stromal tumor <40yrs 0 29 0.00 0.00 0.00 0.01
NRAS Q61R sex cord stromal tumor 40-50yrs 0 15 0.00 0.00 0.00 0.01
NRAS Q61R sex cord stromal tumor 50-65yrs 0 36 0.00 0.00 0.00 0.01
NRAS Q61R sex cord stromal tumor >65yrs 0 27 0.00 0.00 0.00 0.01
NRAS Q61R bone cancer <40yrs 0 342 0.00 0.00 0.00 0.00
NRAS Q61R bone cancer 40-50yrs 0 61 0.00 0.00 0.00 0.00
NRAS Q61R bone cancer 50-65yrs 0 96 0.00 0.00 0.00 0.00
NRAS Q61R bone cancer >65yrs 0 67 0.00 0.00 0.00 0.00
NRAS Q61R vaginal cancer 50-65yrs 0 34 0.00 0.00 0.00 0.01
NRAS Q61R vaginal cancer >65yrs 0 30 0.00 0.00 0.00 0.01
NRAS Q61R thymic tumor <40yrs 0 14 0.00 0.00 0.00 0.00
NRAS Q61R thymic tumor 40-50yrs 0 28 0.00 0.00 0.00 0.00
NRAS Q61R thymic tumor 50-65yrs 0 72 0.00 0.00 0.00 0.00
NRAS Q61R thymic tumor >65yrs 0 40 0.00 0.00 0.00 0.00
NRAS Q61R ampullary cancer 40-50yrs 0 12 0.00 0.00 0.00 0.01
NRAS Q61R ampullary cancer 50-65yrs 0 40 0.00 0.00 0.00 0.00
NRAS Q61R ampullary cancer >65yrs 0 50 0.00 0.00 0.00 0.00
NRAS Q61R small cell lung cancer 40-50yrs 0 22 0.00 0.00 0.00 0.00
NRAS Q61R small cell lung cancer 50-65yrs 0 144 0.00 0.00 0.00 0.00
NRAS Q61R small cell lung cancer >65yrs 0 224 0.00 0.00 0.00 0.00
NRAS Q61R mesothelioma <40yrs 0 30 0.00 0.00 0.00 0.01
NRAS Q61R mesothelioma 40-50yrs 0 29 0.00 0.00 0.00 0.01
NRAS Q61R mesothelioma 50-65yrs 0 122 0.00 0.00 0.00 0.01
NRAS Q61R mesothelioma >65yrs 1 316 0.00 0.00 0.00 0.01
NRAS Q61R germ cell tumor <40yrs 0 650 0.00 0.00 0.00 0.01
NRAS Q61R germ cell tumor 40-50yrs 2 131 0.01 0.01 0.00 0.04
NRAS Q61R germ cell tumor 50-65yrs 1 92 0.01 0.00 0.00 0.03
NRAS Q61R germ cell tumor >65yrs 0 12 0.01 0.00 0.00 0.05
NRAS Q61R nerve sheath tumor <40yrs 0 77 0.01 0.01 0.00 0.03
NRAS Q61R nerve sheath tumor 40-50yrs 0 27 0.01 0.01 0.00 0.04
NRAS Q61R nerve sheath tumor 50-65yrs 1 37 0.02 0.01 0.00 0.07
NRAS Q61R nerve sheath tumor >65yrs 1 13 0.03 0.02 0.00 0.16
NRAS Q61R penile cancer 50-65yrs 0 11 0.00 0.00 0.00 0.02
NRAS Q61R penile cancer >65yrs 0 11 0.00 0.00 0.00 0.02
NRAS Q61R pineal tumor <40yrs 0 14 0.00 0.00 0.00 0.04
NRAS Q61R b cell lymphoma <40yrs 0 87 0.01 0.00 0.00 0.01
NRAS Q61R b cell lymphoma 40-50yrs 0 105 0.00 0.00 0.00 0.01
NRAS Q61R b cell lymphoma 50-65yrs 4 357 0.01 0.01 0.00 0.02
NRAS Q61R b cell lymphoma >65yrs 2 413 0.01 0.00 0.00 0.01
NRAS Q61R non-hodgkin lymphoma >65yrs 0 14 0.00 0.00 0.00 0.05
NRAS Q61R t-lymphoblastic leukemia/lymphoma <40yrs 0 27 0.00 0.00 0.00 0.02
NRAS Q61R retinoblastoma <40yrs 0 51 0.00 0.00 0.00 0.01
NRAS Q61R hodgkin lymphoma <40yrs 0 23 0.00 0.00 0.00 0.02
NRAS Q61R lung cancer >65yrs 0 18 0.00 0.00 0.00 0.02
NRAS Q61R peritoneal cancer >65yrs 0 11 0.00 0.00 0.00 0.06
KRAS G12A appendiceal cancer Black 0 17 0.00 0.00 0.00 0.04
KRAS G12A appendiceal cancer Race:NA 1 33 0.02 0.01 0.00 0.09
KRAS G12A appendiceal cancer White 0 280 0.00 0.00 0.00 0.01
KRAS G12A colorectal cancer Asian 5 313 0.02 0.02 0.01 0.03
KRAS G12A colorectal cancer Black 16 515 0.03 0.02 0.02 0.04
KRAS G12A colorectal cancer Race:NA 19 804 0.02 0.02 0.02 0.03
KRAS G12A colorectal cancer Native American 0 17 0.02 0.02 0.01 0.04
KRAS G12A colorectal cancer Race:Other 7 139 0.03 0.02 0.02 0.05
KRAS G12A colorectal cancer White 98 4925 0.02 0.02 0.02 0.02
KRAS G12A cancer of unknown primary Asian 0 73 0.01 0.01 0.00 0.01
KRAS G12A cancer of unknown primary Black 1 123 0.01 0.01 0.00 0.02
KRAS G12A cancer of unknown primary Race:NA 1 286 0.01 0.01 0.00 0.01
KRAS G12A cancer of unknown primary Race:Other 0 36 0.01 0.01 0.00 0.02
KRAS G12A cancer of unknown primary White 12 1465 0.01 0.01 0.00 0.01
KRAS G12A non-small cell lung cancer Asian 2 624 0.01 0.01 0.00 0.02
KRAS G12A non-small cell lung cancer Black 13 717 0.02 0.02 0.01 0.03
KRAS G12A non-small cell lung cancer Race:NA 12 849 0.01 0.01 0.01 0.02
KRAS G12A non-small cell lung cancer Native American 0 17 0.02 0.01 0.00 0.04
KRAS G12A non-small cell lung cancer Race:Other 3 165 0.02 0.02 0.01 0.04
KRAS G12A non-small cell lung cancer Race:Undefined 0 10 0.02 0.01 0.00 0.05
KRAS G12A non-small cell lung cancer White 196 7745 0.02 0.02 0.02 0.03
KRAS G12A breast cancer Asian 0 334 0.00 0.00 0.00 0.00
KRAS G12A breast cancer Black 0 526 0.00 0.00 0.00 0.00
KRAS G12A breast cancer Race:NA 3 3112 0.00 0.00 0.00 0.00
KRAS G12A breast cancer Native American 0 11 0.00 0.00 0.00 0.00
KRAS G12A breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
KRAS G12A breast cancer White 3 5174 0.00 0.00 0.00 0.00
KRAS G12A soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
KRAS G12A soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
KRAS G12A soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
KRAS G12A soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
KRAS G12A soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
KRAS G12A pancreatic cancer Asian 1 100 0.01 0.00 0.00 0.02
KRAS G12A pancreatic cancer Black 0 88 0.00 0.00 0.00 0.01
KRAS G12A pancreatic cancer Race:NA 2 231 0.01 0.00 0.00 0.01
KRAS G12A pancreatic cancer Race:Other 0 34 0.01 0.00 0.00 0.01
KRAS G12A pancreatic cancer White 10 2038 0.00 0.00 0.00 0.01
KRAS G12A leukemia Asian 0 37 0.00 0.00 0.00 0.01
KRAS G12A leukemia Black 0 69 0.00 0.00 0.00 0.01
KRAS G12A leukemia Race:NA 2 777 0.00 0.00 0.00 0.01
KRAS G12A leukemia Race:Other 0 13 0.00 0.00 0.00 0.01
KRAS G12A leukemia White 3 662 0.00 0.00 0.00 0.01
KRAS G12A melanoma Asian 0 33 0.00 0.00 0.00 0.00
KRAS G12A melanoma Black 0 34 0.00 0.00 0.00 0.00
KRAS G12A melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
KRAS G12A melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G12A melanoma White 1 2348 0.00 0.00 0.00 0.00
KRAS G12A head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
KRAS G12A head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
KRAS G12A head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
KRAS G12A head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
KRAS G12A head and neck cancer White 1 1264 0.00 0.00 0.00 0.00
KRAS G12A uterine cancer Asian 1 108 0.01 0.01 0.00 0.03
KRAS G12A uterine cancer Black 0 163 0.00 0.00 0.00 0.02
KRAS G12A uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.02
KRAS G12A uterine cancer Race:Other 0 37 0.01 0.00 0.00 0.03
KRAS G12A uterine cancer White 30 1754 0.02 0.02 0.01 0.02
KRAS G12A non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
KRAS G12A non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
KRAS G12A non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
KRAS G12A non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
KRAS G12A myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.01
KRAS G12A myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.01
KRAS G12A myelodysplastic/myeloproliferative syndromes Race:NA 1 571 0.00 0.00 0.00 0.00
KRAS G12A myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
KRAS G12A adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
KRAS G12A adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS G12A ovarian cancer Asian 2 134 0.01 0.01 0.00 0.03
KRAS G12A ovarian cancer Black 0 74 0.00 0.00 0.00 0.01
KRAS G12A ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.01
KRAS G12A ovarian cancer Race:Other 0 36 0.01 0.00 0.00 0.02
KRAS G12A ovarian cancer White 12 1852 0.01 0.01 0.00 0.01
KRAS G12A esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.01
KRAS G12A esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.01
KRAS G12A esophagogastric cancer Race:NA 2 191 0.00 0.00 0.00 0.02
KRAS G12A esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.01
KRAS G12A esophagogastric cancer White 4 1379 0.00 0.00 0.00 0.01
KRAS G12A thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
KRAS G12A thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
KRAS G12A thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
KRAS G12A thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G12A thyroid cancer White 0 803 0.00 0.00 0.00 0.00
KRAS G12A cervical cancer Asian 1 27 0.02 0.01 0.00 0.09
KRAS G12A cervical cancer Black 0 19 0.00 0.00 0.00 0.02
KRAS G12A cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.01
KRAS G12A cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.03
KRAS G12A cervical cancer White 0 228 0.00 0.00 0.00 0.01
KRAS G12A hepatobiliary cancer Asian 1 98 0.01 0.00 0.00 0.02
KRAS G12A hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.01
KRAS G12A hepatobiliary cancer Race:NA 2 235 0.01 0.00 0.00 0.01
KRAS G12A hepatobiliary cancer Race:Other 0 25 0.01 0.00 0.00 0.02
KRAS G12A hepatobiliary cancer White 4 948 0.00 0.00 0.00 0.01
KRAS G12A kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
KRAS G12A kidney cancer Black 0 77 0.00 0.00 0.00 0.00
KRAS G12A kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS G12A kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G12A kidney cancer White 0 1113 0.00 0.00 0.00 0.00
KRAS G12A mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
KRAS G12A mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
KRAS G12A mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
KRAS G12A mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
KRAS G12A cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS G12A cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS G12A cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
KRAS G12A cns cancer Race:Other 1 108 0.00 0.00 0.00 0.02
KRAS G12A cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.01
KRAS G12A cns cancer White 5 3331 0.00 0.00 0.00 0.00
KRAS G12A prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
KRAS G12A prostate cancer Black 0 175 0.00 0.00 0.00 0.00
KRAS G12A prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS G12A prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
KRAS G12A prostate cancer White 0 1882 0.00 0.00 0.00 0.00
KRAS G12A anal cancer Race:NA 0 13 0.01 0.00 0.00 0.05
KRAS G12A anal cancer White 1 126 0.01 0.01 0.00 0.03
KRAS G12A neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.02
KRAS G12A neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.02
KRAS G12A neuroendocrine tumors White 1 283 0.00 0.00 0.00 0.01
KRAS G12A bladder cancer Asian 0 40 0.00 0.00 0.00 0.01
KRAS G12A bladder cancer Black 0 43 0.00 0.00 0.00 0.01
KRAS G12A bladder cancer Race:NA 1 169 0.00 0.00 0.00 0.01
KRAS G12A bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.01
KRAS G12A bladder cancer White 2 1311 0.00 0.00 0.00 0.00
KRAS G12A b-lymphoblastic leukemia/lymphoma Asian 1 17 0.04 0.02 0.00 0.17
KRAS G12A b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.02
KRAS G12A b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.01
KRAS G12A small bowel cancer Black 0 25 0.02 0.01 0.00 0.05
KRAS G12A small bowel cancer Race:NA 0 22 0.02 0.01 0.00 0.05
KRAS G12A small bowel cancer White 4 150 0.02 0.02 0.01 0.05
KRAS G12A sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS G12A sex cord stromal tumor White 0 69 0.00 0.00 0.00 0.00
KRAS G12A bone cancer Asian 0 30 0.00 0.00 0.00 0.02
KRAS G12A bone cancer Black 0 32 0.00 0.00 0.00 0.01
KRAS G12A bone cancer Race:NA 0 86 0.00 0.00 0.00 0.01
KRAS G12A bone cancer Race:Other 0 29 0.00 0.00 0.00 0.02
KRAS G12A bone cancer White 2 391 0.00 0.00 0.00 0.01
KRAS G12A vaginal cancer White 1 68 0.02 0.01 0.00 0.06
KRAS G12A thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
KRAS G12A thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
KRAS G12A thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS G12A ampullary cancer White 1 86 0.01 0.01 0.00 0.04
KRAS G12A small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.04
KRAS G12A small cell lung cancer Race:NA 1 30 0.02 0.01 0.00 0.10
KRAS G12A small cell lung cancer White 0 337 0.00 0.00 0.00 0.01
KRAS G12A mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS G12A mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS G12A mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS G12A mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS G12A germ cell tumor Asian 0 36 0.01 0.01 0.00 0.02
KRAS G12A germ cell tumor Black 0 23 0.01 0.01 0.00 0.02
KRAS G12A germ cell tumor Race:NA 1 179 0.01 0.01 0.00 0.02
KRAS G12A germ cell tumor Race:Other 0 37 0.01 0.01 0.00 0.02
KRAS G12A germ cell tumor White 6 603 0.01 0.01 0.00 0.02
KRAS G12A nerve sheath tumor Black 0 12 0.01 0.00 0.00 0.04
KRAS G12A nerve sheath tumor Race:NA 0 26 0.01 0.00 0.00 0.03
KRAS G12A nerve sheath tumor White 1 105 0.01 0.01 0.00 0.03
KRAS G12A penile cancer White 0 20 0.00 0.00 0.00 0.03
KRAS G12A pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
KRAS G12A pineal tumor White 0 14 0.00 0.00 0.00 0.03
KRAS G12A b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.01
KRAS G12A b cell lymphoma Black 0 25 0.00 0.00 0.00 0.01
KRAS G12A b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.01
KRAS G12A b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.02
KRAS G12A b cell lymphoma White 2 859 0.00 0.00 0.00 0.01
KRAS G12A non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
KRAS G12A t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS G12A t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
KRAS G12A retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS G12A retinoblastoma White 0 25 0.00 0.00 0.00 0.02
KRAS G12A hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
KRAS G12A lung cancer White 0 17 0.00 0.00 0.00 0.02
KRAS G12A peritoneal cancer White 0 11 0.00 0.00 0.00 0.04
KRAS G12A parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
KRAS G12C appendiceal cancer Black 0 17 0.02 0.02 0.00 0.05
KRAS G12C appendiceal cancer Race:NA 0 33 0.02 0.01 0.00 0.04
KRAS G12C appendiceal cancer White 7 280 0.02 0.02 0.01 0.04
KRAS G12C colorectal cancer Asian 8 313 0.03 0.03 0.02 0.04
KRAS G12C colorectal cancer Black 15 515 0.03 0.03 0.02 0.04
KRAS G12C colorectal cancer Race:NA 30 804 0.03 0.03 0.03 0.04
KRAS G12C colorectal cancer Native American 2 17 0.03 0.03 0.02 0.05
KRAS G12C colorectal cancer Race:Other 4 139 0.03 0.03 0.02 0.04
KRAS G12C colorectal cancer White 152 4925 0.03 0.03 0.03 0.04
KRAS G12C cancer of unknown primary Asian 1 73 0.03 0.03 0.01 0.04
KRAS G12C cancer of unknown primary Black 5 123 0.03 0.03 0.02 0.05
KRAS G12C cancer of unknown primary Race:NA 7 286 0.03 0.03 0.02 0.04
KRAS G12C cancer of unknown primary Race:Other 0 36 0.03 0.03 0.01 0.04
KRAS G12C cancer of unknown primary White 48 1465 0.03 0.03 0.02 0.04
KRAS G12C non-small cell lung cancer Asian 21 624 0.04 0.04 0.02 0.06
KRAS G12C non-small cell lung cancer Black 78 717 0.11 0.11 0.09 0.13
KRAS G12C non-small cell lung cancer Race:NA 76 849 0.09 0.09 0.07 0.11
KRAS G12C non-small cell lung cancer Native American 1 17 0.08 0.07 0.02 0.17
KRAS G12C non-small cell lung cancer Race:Other 10 165 0.06 0.06 0.04 0.10
KRAS G12C non-small cell lung cancer Race:Undefined 0 10 0.07 0.06 0.01 0.16
KRAS G12C non-small cell lung cancer White 1026 7745 0.13 0.13 0.12 0.14
KRAS G12C breast cancer Asian 0 334 0.00 0.00 0.00 0.00
KRAS G12C breast cancer Black 0 526 0.00 0.00 0.00 0.00
KRAS G12C breast cancer Race:NA 2 3112 0.00 0.00 0.00 0.00
KRAS G12C breast cancer Native American 0 11 0.00 0.00 0.00 0.00
KRAS G12C breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
KRAS G12C breast cancer White 6 5174 0.00 0.00 0.00 0.00
KRAS G12C soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
KRAS G12C soft tissue sarcoma Black 1 193 0.00 0.00 0.00 0.01
KRAS G12C soft tissue sarcoma Race:NA 1 350 0.00 0.00 0.00 0.01
KRAS G12C soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.01
KRAS G12C soft tissue sarcoma White 3 2005 0.00 0.00 0.00 0.00
KRAS G12C pancreatic cancer Asian 0 100 0.01 0.01 0.00 0.02
KRAS G12C pancreatic cancer Black 1 88 0.01 0.01 0.00 0.02
KRAS G12C pancreatic cancer Race:NA 3 231 0.01 0.01 0.00 0.02
KRAS G12C pancreatic cancer Race:Other 0 34 0.01 0.01 0.00 0.02
KRAS G12C pancreatic cancer White 18 2038 0.01 0.01 0.01 0.01
KRAS G12C leukemia Asian 0 37 0.00 0.00 0.00 0.00
KRAS G12C leukemia Black 0 69 0.00 0.00 0.00 0.00
KRAS G12C leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
KRAS G12C leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
KRAS G12C leukemia White 0 662 0.00 0.00 0.00 0.00
KRAS G12C melanoma Asian 0 33 0.00 0.00 0.00 0.00
KRAS G12C melanoma Black 0 34 0.00 0.00 0.00 0.00
KRAS G12C melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
KRAS G12C melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G12C melanoma White 2 2348 0.00 0.00 0.00 0.00
KRAS G12C head and neck cancer Asian 0 94 0.00 0.00 0.00 0.01
KRAS G12C head and neck cancer Black 1 62 0.01 0.00 0.00 0.04
KRAS G12C head and neck cancer Race:NA 1 292 0.00 0.00 0.00 0.01
KRAS G12C head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.02
KRAS G12C head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
KRAS G12C uterine cancer Asian 2 108 0.01 0.01 0.01 0.03
KRAS G12C uterine cancer Black 1 163 0.01 0.01 0.00 0.02
KRAS G12C uterine cancer Race:NA 1 190 0.01 0.01 0.00 0.02
KRAS G12C uterine cancer Race:Other 1 37 0.01 0.01 0.00 0.03
KRAS G12C uterine cancer White 21 1754 0.01 0.01 0.01 0.02
KRAS G12C non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
KRAS G12C non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
KRAS G12C non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
KRAS G12C non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
KRAS G12C myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
KRAS G12C myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.00
KRAS G12C myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
KRAS G12C myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
KRAS G12C adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
KRAS G12C adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS G12C ovarian cancer Asian 1 134 0.00 0.00 0.00 0.01
KRAS G12C ovarian cancer Black 0 74 0.00 0.00 0.00 0.01
KRAS G12C ovarian cancer Race:NA 2 239 0.00 0.00 0.00 0.01
KRAS G12C ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.01
KRAS G12C ovarian cancer White 7 1852 0.00 0.00 0.00 0.01
KRAS G12C esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.01
KRAS G12C esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.01
KRAS G12C esophagogastric cancer Race:NA 1 191 0.00 0.00 0.00 0.01
KRAS G12C esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.01
KRAS G12C esophagogastric cancer White 4 1379 0.00 0.00 0.00 0.01
KRAS G12C thyroid cancer Asian 0 66 0.00 0.00 0.00 0.01
KRAS G12C thyroid cancer Black 0 40 0.00 0.00 0.00 0.01
KRAS G12C thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.01
KRAS G12C thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.01
KRAS G12C thyroid cancer White 2 803 0.00 0.00 0.00 0.01
KRAS G12C cervical cancer Asian 0 27 0.00 0.00 0.00 0.02
KRAS G12C cervical cancer Black 0 19 0.00 0.00 0.00 0.02
KRAS G12C cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.01
KRAS G12C cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.02
KRAS G12C cervical cancer White 1 228 0.00 0.00 0.00 0.01
KRAS G12C hepatobiliary cancer Asian 0 98 0.01 0.01 0.00 0.01
KRAS G12C hepatobiliary cancer Black 0 64 0.01 0.01 0.00 0.02
KRAS G12C hepatobiliary cancer Race:NA 1 235 0.01 0.01 0.00 0.01
KRAS G12C hepatobiliary cancer Race:Other 0 25 0.01 0.01 0.00 0.02
KRAS G12C hepatobiliary cancer White 9 948 0.01 0.01 0.00 0.01
KRAS G12C kidney cancer Asian 0 33 0.00 0.00 0.00 0.01
KRAS G12C kidney cancer Black 0 77 0.00 0.00 0.00 0.00
KRAS G12C kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS G12C kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.01
KRAS G12C kidney cancer White 1 1113 0.00 0.00 0.00 0.00
KRAS G12C mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
KRAS G12C mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
KRAS G12C mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
KRAS G12C mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
KRAS G12C cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS G12C cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS G12C cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
KRAS G12C cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
KRAS G12C cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
KRAS G12C cns cancer White 0 3331 0.00 0.00 0.00 0.00
KRAS G12C prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
KRAS G12C prostate cancer Black 0 175 0.00 0.00 0.00 0.00
KRAS G12C prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS G12C prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
KRAS G12C prostate cancer White 0 1882 0.00 0.00 0.00 0.00
KRAS G12C anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
KRAS G12C anal cancer White 0 126 0.00 0.00 0.00 0.00
KRAS G12C neuroendocrine tumors Black 0 23 0.01 0.00 0.00 0.03
KRAS G12C neuroendocrine tumors Race:NA 1 45 0.01 0.01 0.00 0.05
KRAS G12C neuroendocrine tumors White 1 283 0.01 0.00 0.00 0.02
KRAS G12C bladder cancer Asian 0 40 0.00 0.00 0.00 0.01
KRAS G12C bladder cancer Black 0 43 0.00 0.00 0.00 0.01
KRAS G12C bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.01
KRAS G12C bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.02
KRAS G12C bladder cancer White 7 1311 0.00 0.00 0.00 0.01
KRAS G12C b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
KRAS G12C b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
KRAS G12C b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
KRAS G12C small bowel cancer Black 3 25 0.07 0.06 0.02 0.22
KRAS G12C small bowel cancer Race:NA 1 22 0.04 0.03 0.00 0.13
KRAS G12C small bowel cancer White 2 150 0.02 0.02 0.00 0.05
KRAS G12C sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS G12C sex cord stromal tumor White 0 69 0.00 0.00 0.00 0.01
KRAS G12C bone cancer Asian 0 30 0.00 0.00 0.00 0.00
KRAS G12C bone cancer Black 0 32 0.00 0.00 0.00 0.00
KRAS G12C bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
KRAS G12C bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G12C bone cancer White 0 391 0.00 0.00 0.00 0.00
KRAS G12C vaginal cancer White 0 68 0.00 0.00 0.00 0.01
KRAS G12C thymic tumor Asian 0 13 0.00 0.00 0.00 0.01
KRAS G12C thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS G12C thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS G12C ampullary cancer White 2 86 0.02 0.02 0.00 0.07
KRAS G12C small cell lung cancer Asian 0 15 0.01 0.01 0.00 0.04
KRAS G12C small cell lung cancer Race:NA 0 30 0.01 0.01 0.00 0.03
KRAS G12C small cell lung cancer White 3 337 0.01 0.01 0.00 0.02
KRAS G12C mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS G12C mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS G12C mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS G12C mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS G12C germ cell tumor Asian 0 36 0.00 0.00 0.00 0.01
KRAS G12C germ cell tumor Black 0 23 0.00 0.00 0.00 0.02
KRAS G12C germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.01
KRAS G12C germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.01
KRAS G12C germ cell tumor White 4 603 0.01 0.00 0.00 0.01
KRAS G12C nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.01
KRAS G12C nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.01
KRAS G12C nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
KRAS G12C penile cancer White 0 20 0.00 0.00 0.00 0.03
KRAS G12C pheochromocytoma White 0 15 0.00 0.00 0.00 0.06
KRAS G12C pineal tumor White 0 14 0.00 0.00 0.00 0.04
KRAS G12C b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
KRAS G12C b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
KRAS G12C b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
KRAS G12C b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
KRAS G12C b cell lymphoma White 0 859 0.00 0.00 0.00 0.00
KRAS G12C non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
KRAS G12C t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS G12C t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
KRAS G12C retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS G12C retinoblastoma White 0 25 0.00 0.00 0.00 0.01
KRAS G12C hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
KRAS G12C lung cancer White 1 17 0.07 0.05 0.00 0.22
KRAS G12C peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
KRAS G12C parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
KRAS G12D appendiceal cancer Black 5 17 0.28 0.27 0.18 0.42
KRAS G12D appendiceal cancer Race:NA 12 33 0.30 0.29 0.21 0.44
KRAS G12D appendiceal cancer White 71 280 0.26 0.26 0.21 0.31
KRAS G12D colorectal cancer Asian 45 313 0.14 0.14 0.12 0.16
KRAS G12D colorectal cancer Black 79 515 0.14 0.14 0.12 0.17
KRAS G12D colorectal cancer Race:NA 104 804 0.13 0.13 0.12 0.15
KRAS G12D colorectal cancer Native American 4 17 0.14 0.13 0.11 0.18
KRAS G12D colorectal cancer Race:Other 15 139 0.13 0.13 0.10 0.16
KRAS G12D colorectal cancer White 634 4925 0.13 0.13 0.12 0.14
KRAS G12D cancer of unknown primary Asian 5 73 0.06 0.06 0.04 0.08
KRAS G12D cancer of unknown primary Black 7 123 0.06 0.05 0.04 0.08
KRAS G12D cancer of unknown primary Race:NA 14 286 0.05 0.05 0.04 0.07
KRAS G12D cancer of unknown primary Race:Other 3 36 0.06 0.06 0.04 0.09
KRAS G12D cancer of unknown primary White 78 1465 0.05 0.05 0.04 0.06
KRAS G12D non-small cell lung cancer Asian 15 624 0.04 0.04 0.02 0.05
KRAS G12D non-small cell lung cancer Black 27 717 0.04 0.04 0.03 0.05
KRAS G12D non-small cell lung cancer Race:NA 40 849 0.04 0.04 0.04 0.06
KRAS G12D non-small cell lung cancer Native American 1 17 0.04 0.04 0.02 0.07
KRAS G12D non-small cell lung cancer Race:Other 7 165 0.04 0.04 0.03 0.06
KRAS G12D non-small cell lung cancer Race:Undefined 1 10 0.04 0.04 0.02 0.07
KRAS G12D non-small cell lung cancer White 340 7745 0.04 0.04 0.04 0.05
KRAS G12D breast cancer Asian 1 334 0.00 0.00 0.00 0.01
KRAS G12D breast cancer Black 0 526 0.00 0.00 0.00 0.00
KRAS G12D breast cancer Race:NA 3 3112 0.00 0.00 0.00 0.00
KRAS G12D breast cancer Native American 0 11 0.00 0.00 0.00 0.01
KRAS G12D breast cancer Race:Other 2 176 0.00 0.00 0.00 0.02
KRAS G12D breast cancer White 5 5174 0.00 0.00 0.00 0.00
KRAS G12D soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.01
KRAS G12D soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.01
KRAS G12D soft tissue sarcoma Race:NA 2 350 0.00 0.00 0.00 0.01
KRAS G12D soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.01
KRAS G12D soft tissue sarcoma White 9 2005 0.00 0.00 0.00 0.01
KRAS G12D pancreatic cancer Asian 24 100 0.29 0.30 0.22 0.34
KRAS G12D pancreatic cancer Black 24 88 0.30 0.30 0.24 0.35
KRAS G12D pancreatic cancer Race:NA 78 231 0.32 0.32 0.28 0.37
KRAS G12D pancreatic cancer Race:Other 12 34 0.32 0.31 0.25 0.39
KRAS G12D pancreatic cancer White 642 2038 0.31 0.31 0.30 0.33
KRAS G12D leukemia Asian 1 37 0.02 0.01 0.00 0.04
KRAS G12D leukemia Black 0 69 0.01 0.01 0.00 0.02
KRAS G12D leukemia Race:NA 14 777 0.02 0.02 0.01 0.02
KRAS G12D leukemia Race:Other 0 13 0.01 0.01 0.00 0.03
KRAS G12D leukemia White 6 662 0.01 0.01 0.00 0.02
KRAS G12D melanoma Asian 0 33 0.00 0.00 0.00 0.02
KRAS G12D melanoma Black 1 34 0.01 0.01 0.00 0.06
KRAS G12D melanoma Race:NA 0 398 0.00 0.00 0.00 0.01
KRAS G12D melanoma Race:Other 0 26 0.00 0.00 0.00 0.02
KRAS G12D melanoma White 13 2348 0.00 0.00 0.00 0.01
KRAS G12D head and neck cancer Asian 0 94 0.00 0.00 0.00 0.01
KRAS G12D head and neck cancer Black 0 62 0.00 0.00 0.00 0.01
KRAS G12D head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
KRAS G12D head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.01
KRAS G12D head and neck cancer White 4 1264 0.00 0.00 0.00 0.01
KRAS G12D uterine cancer Asian 4 108 0.04 0.04 0.03 0.06
KRAS G12D uterine cancer Black 4 163 0.04 0.04 0.02 0.06
KRAS G12D uterine cancer Race:NA 10 190 0.05 0.04 0.03 0.07
KRAS G12D uterine cancer Race:Other 2 37 0.05 0.04 0.03 0.07
KRAS G12D uterine cancer White 82 1754 0.05 0.05 0.04 0.06
KRAS G12D non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.04
KRAS G12D non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.04
KRAS G12D non-melanoma skin cancers Race:NA 1 53 0.01 0.00 0.00 0.05
KRAS G12D non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.01
KRAS G12D myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.01
KRAS G12D myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.01
KRAS G12D myelodysplastic/myeloproliferative syndromes Race:NA 2 571 0.00 0.00 0.00 0.01
KRAS G12D myelodysplastic/myeloproliferative syndromes White 2 584 0.00 0.00 0.00 0.01
KRAS G12D adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
KRAS G12D adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS G12D ovarian cancer Asian 5 134 0.04 0.04 0.02 0.06
KRAS G12D ovarian cancer Black 5 74 0.04 0.04 0.03 0.09
KRAS G12D ovarian cancer Race:NA 8 239 0.04 0.04 0.02 0.05
KRAS G12D ovarian cancer Race:Other 4 36 0.05 0.04 0.03 0.12
KRAS G12D ovarian cancer White 60 1852 0.03 0.03 0.03 0.04
KRAS G12D esophagogastric cancer Asian 1 115 0.02 0.02 0.01 0.03
KRAS G12D esophagogastric cancer Black 1 68 0.02 0.02 0.01 0.03
KRAS G12D esophagogastric cancer Race:NA 3 191 0.02 0.02 0.01 0.03
KRAS G12D esophagogastric cancer Race:Other 1 46 0.02 0.02 0.01 0.03
KRAS G12D esophagogastric cancer White 27 1379 0.02 0.02 0.01 0.03
KRAS G12D thyroid cancer Asian 0 66 0.00 0.00 0.00 0.01
KRAS G12D thyroid cancer Black 0 40 0.00 0.00 0.00 0.01
KRAS G12D thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.01
KRAS G12D thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.01
KRAS G12D thyroid cancer White 3 803 0.00 0.00 0.00 0.01
KRAS G12D cervical cancer Asian 0 27 0.03 0.02 0.00 0.05
KRAS G12D cervical cancer Black 1 19 0.03 0.03 0.01 0.08
KRAS G12D cervical cancer Race:NA 3 77 0.03 0.03 0.01 0.06
KRAS G12D cervical cancer Race:Other 0 15 0.03 0.03 0.00 0.06
KRAS G12D cervical cancer White 6 228 0.03 0.03 0.01 0.05
KRAS G12D hepatobiliary cancer Asian 7 98 0.05 0.04 0.03 0.09
KRAS G12D hepatobiliary cancer Black 0 64 0.03 0.04 0.00 0.06
KRAS G12D hepatobiliary cancer Race:NA 11 235 0.04 0.04 0.03 0.06
KRAS G12D hepatobiliary cancer Race:Other 1 25 0.04 0.04 0.02 0.08
KRAS G12D hepatobiliary cancer White 36 948 0.04 0.04 0.03 0.05
KRAS G12D kidney cancer Asian 0 33 0.00 0.00 0.00 0.02
KRAS G12D kidney cancer Black 1 77 0.01 0.00 0.00 0.02
KRAS G12D kidney cancer Race:NA 2 169 0.01 0.00 0.00 0.02
KRAS G12D kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.02
KRAS G12D kidney cancer White 2 1113 0.00 0.00 0.00 0.01
KRAS G12D mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
KRAS G12D mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
KRAS G12D mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
KRAS G12D mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
KRAS G12D cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS G12D cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS G12D cns cancer Race:NA 1 817 0.00 0.00 0.00 0.00
KRAS G12D cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
KRAS G12D cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.01
KRAS G12D cns cancer White 7 3331 0.00 0.00 0.00 0.00
KRAS G12D prostate cancer Asian 0 62 0.00 0.00 0.00 0.01
KRAS G12D prostate cancer Black 1 175 0.00 0.00 0.00 0.01
KRAS G12D prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS G12D prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.01
KRAS G12D prostate cancer White 1 1882 0.00 0.00 0.00 0.00
KRAS G12D anal cancer Race:NA 0 13 0.01 0.00 0.00 0.05
KRAS G12D anal cancer White 1 126 0.01 0.01 0.00 0.03
KRAS G12D neuroendocrine tumors Black 0 23 0.03 0.03 0.00 0.08
KRAS G12D neuroendocrine tumors Race:NA 5 45 0.08 0.07 0.02 0.18
KRAS G12D neuroendocrine tumors White 9 283 0.04 0.03 0.02 0.06
KRAS G12D bladder cancer Asian 0 40 0.02 0.02 0.00 0.03
KRAS G12D bladder cancer Black 1 43 0.02 0.02 0.00 0.04
KRAS G12D bladder cancer Race:NA 2 169 0.02 0.02 0.00 0.03
KRAS G12D bladder cancer Race:Other 0 14 0.02 0.02 0.00 0.04
KRAS G12D bladder cancer White 28 1311 0.02 0.02 0.01 0.03
KRAS G12D b-lymphoblastic leukemia/lymphoma Asian 0 17 0.03 0.03 0.00 0.08
KRAS G12D b-lymphoblastic leukemia/lymphoma Race:NA 5 92 0.04 0.04 0.02 0.09
KRAS G12D b-lymphoblastic leukemia/lymphoma White 3 125 0.03 0.03 0.01 0.06
KRAS G12D small bowel cancer Black 3 25 0.12 0.12 0.06 0.21
KRAS G12D small bowel cancer Race:NA 3 22 0.13 0.12 0.06 0.22
KRAS G12D small bowel cancer White 18 150 0.12 0.12 0.08 0.17
KRAS G12D sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS G12D sex cord stromal tumor White 0 69 0.00 0.00 0.00 0.01
KRAS G12D bone cancer Asian 0 30 0.00 0.00 0.00 0.02
KRAS G12D bone cancer Black 0 32 0.00 0.00 0.00 0.02
KRAS G12D bone cancer Race:NA 0 86 0.00 0.00 0.00 0.01
KRAS G12D bone cancer Race:Other 1 29 0.01 0.00 0.00 0.06
KRAS G12D bone cancer White 1 391 0.00 0.00 0.00 0.01
KRAS G12D vaginal cancer White 0 68 0.00 0.00 0.00 0.00
KRAS G12D thymic tumor Asian 0 13 0.00 0.00 0.00 0.01
KRAS G12D thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
KRAS G12D thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS G12D ampullary cancer White 22 86 0.26 0.26 0.17 0.35
KRAS G12D small cell lung cancer Asian 0 15 0.01 0.01 0.00 0.03
KRAS G12D small cell lung cancer Race:NA 0 30 0.01 0.00 0.00 0.03
KRAS G12D small cell lung cancer White 3 337 0.01 0.01 0.00 0.02
KRAS G12D mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS G12D mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS G12D mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS G12D mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS G12D germ cell tumor Asian 0 36 0.01 0.01 0.00 0.02
KRAS G12D germ cell tumor Black 0 23 0.01 0.01 0.00 0.02
KRAS G12D germ cell tumor Race:NA 1 179 0.01 0.01 0.00 0.02
KRAS G12D germ cell tumor Race:Other 1 37 0.01 0.01 0.00 0.04
KRAS G12D germ cell tumor White 7 603 0.01 0.01 0.00 0.02
KRAS G12D nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
KRAS G12D nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS G12D nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
KRAS G12D penile cancer White 0 20 0.00 0.00 0.00 0.03
KRAS G12D pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
KRAS G12D pineal tumor White 0 14 0.00 0.00 0.00 0.04
KRAS G12D b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.02
KRAS G12D b cell lymphoma Black 0 25 0.00 0.00 0.00 0.01
KRAS G12D b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.01
KRAS G12D b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.02
KRAS G12D b cell lymphoma White 3 859 0.00 0.00 0.00 0.01
KRAS G12D non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
KRAS G12D t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
KRAS G12D t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
KRAS G12D retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.01
KRAS G12D retinoblastoma White 0 25 0.00 0.00 0.00 0.01
KRAS G12D hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
KRAS G12D lung cancer White 0 17 0.00 0.00 0.00 0.04
KRAS G12D peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
KRAS G12D parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
KRAS G12F appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
KRAS G12F appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
KRAS G12F appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer Black 0 515 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer Race:NA 1 804 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer White 0 4925 0.00 0.00 0.00 0.00
KRAS G12F cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.01
KRAS G12F cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
KRAS G12F cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
KRAS G12F cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.01
KRAS G12F cancer of unknown primary White 3 1465 0.00 0.00 0.00 0.00
KRAS G12F non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
KRAS G12F non-small cell lung cancer Black 5 717 0.00 0.00 0.00 0.01
KRAS G12F non-small cell lung cancer Race:NA 1 849 0.00 0.00 0.00 0.00
KRAS G12F non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.01
KRAS G12F non-small cell lung cancer Race:Other 1 165 0.00 0.00 0.00 0.01
KRAS G12F non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.01
KRAS G12F non-small cell lung cancer White 25 7745 0.00 0.00 0.00 0.00
KRAS G12F breast cancer Asian 0 334 0.00 0.00 0.00 0.00
KRAS G12F breast cancer Black 0 526 0.00 0.00 0.00 0.00
KRAS G12F breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
KRAS G12F breast cancer Native American 0 11 0.00 0.00 0.00 0.00
KRAS G12F breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
KRAS G12F breast cancer White 0 5174 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
KRAS G12F pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
KRAS G12F pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
KRAS G12F pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
KRAS G12F pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
KRAS G12F pancreatic cancer White 1 2038 0.00 0.00 0.00 0.00
KRAS G12F leukemia Asian 0 37 0.00 0.00 0.00 0.00
KRAS G12F leukemia Black 0 69 0.00 0.00 0.00 0.00
KRAS G12F leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
KRAS G12F leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
KRAS G12F leukemia White 0 662 0.00 0.00 0.00 0.00
KRAS G12F melanoma Asian 0 33 0.00 0.00 0.00 0.00
KRAS G12F melanoma Black 0 34 0.00 0.00 0.00 0.00
KRAS G12F melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
KRAS G12F melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G12F melanoma White 0 2348 0.00 0.00 0.00 0.00
KRAS G12F head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
KRAS G12F head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
KRAS G12F head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
KRAS G12F head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
KRAS G12F head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
KRAS G12F uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
KRAS G12F uterine cancer Black 0 163 0.00 0.00 0.00 0.00
KRAS G12F uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
KRAS G12F uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
KRAS G12F uterine cancer White 0 1754 0.00 0.00 0.00 0.00
KRAS G12F non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
KRAS G12F non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
KRAS G12F non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
KRAS G12F non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
KRAS G12F myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
KRAS G12F myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.00
KRAS G12F myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
KRAS G12F myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
KRAS G12F adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS G12F adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS G12F ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
KRAS G12F ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
KRAS G12F ovarian cancer Race:NA 1 239 0.00 0.00 0.00 0.01
KRAS G12F ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.01
KRAS G12F ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
KRAS G12F esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
KRAS G12F esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
KRAS G12F esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
KRAS G12F esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
KRAS G12F esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
KRAS G12F thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
KRAS G12F thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
KRAS G12F thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
KRAS G12F thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G12F thyroid cancer White 0 803 0.00 0.00 0.00 0.00
KRAS G12F cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
KRAS G12F cervical cancer Black 0 19 0.00 0.00 0.00 0.00
KRAS G12F cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
KRAS G12F cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
KRAS G12F cervical cancer White 0 228 0.00 0.00 0.00 0.00
KRAS G12F hepatobiliary cancer Asian 0 98 0.00 0.00 0.00 0.00
KRAS G12F hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
KRAS G12F hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
KRAS G12F hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
KRAS G12F hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
KRAS G12F kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
KRAS G12F kidney cancer Black 0 77 0.00 0.00 0.00 0.00
KRAS G12F kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS G12F kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G12F kidney cancer White 0 1113 0.00 0.00 0.00 0.00
KRAS G12F mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
KRAS G12F mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
KRAS G12F mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
KRAS G12F mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
KRAS G12F cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS G12F cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS G12F cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
KRAS G12F cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
KRAS G12F cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
KRAS G12F cns cancer White 0 3331 0.00 0.00 0.00 0.00
KRAS G12F prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
KRAS G12F prostate cancer Black 0 175 0.00 0.00 0.00 0.00
KRAS G12F prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS G12F prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
KRAS G12F prostate cancer White 0 1882 0.00 0.00 0.00 0.00
KRAS G12F anal cancer Race:NA 0 13 0.00 0.00 0.00 0.00
KRAS G12F anal cancer White 0 126 0.00 0.00 0.00 0.00
KRAS G12F neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
KRAS G12F neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
KRAS G12F neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
KRAS G12F bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
KRAS G12F bladder cancer Black 0 43 0.00 0.00 0.00 0.00
KRAS G12F bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS G12F bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
KRAS G12F bladder cancer White 0 1311 0.00 0.00 0.00 0.00
KRAS G12F b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
KRAS G12F b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
KRAS G12F b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
KRAS G12F small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
KRAS G12F small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
KRAS G12F small bowel cancer White 0 150 0.00 0.00 0.00 0.00
KRAS G12F sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS G12F sex cord stromal tumor White 0 69 0.00 0.00 0.00 0.01
KRAS G12F bone cancer Asian 0 30 0.00 0.00 0.00 0.00
KRAS G12F bone cancer Black 0 32 0.00 0.00 0.00 0.00
KRAS G12F bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
KRAS G12F bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G12F bone cancer White 0 391 0.00 0.00 0.00 0.00
KRAS G12F vaginal cancer White 0 68 0.00 0.00 0.00 0.01
KRAS G12F thymic tumor Asian 0 13 0.00 0.00 0.00 0.01
KRAS G12F thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
KRAS G12F thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS G12F ampullary cancer White 0 86 0.00 0.00 0.00 0.01
KRAS G12F small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
KRAS G12F small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
KRAS G12F small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
KRAS G12F mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS G12F mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS G12F mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS G12F mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor White 0 603 0.00 0.00 0.00 0.00
KRAS G12F nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
KRAS G12F nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS G12F nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
KRAS G12F penile cancer White 0 20 0.00 0.00 0.00 0.04
KRAS G12F pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
KRAS G12F pineal tumor White 0 14 0.00 0.00 0.00 0.05
KRAS G12F b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
KRAS G12F b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
KRAS G12F b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
KRAS G12F b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
KRAS G12F b cell lymphoma White 0 859 0.00 0.00 0.00 0.00
KRAS G12F non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.02
KRAS G12F t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS G12F t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
KRAS G12F retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.03
KRAS G12F retinoblastoma White 0 25 0.00 0.00 0.00 0.02
KRAS G12F hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
KRAS G12F lung cancer White 0 17 0.00 0.00 0.00 0.04
KRAS G12F peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
KRAS G12F parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
KRAS G12R appendiceal cancer Black 0 17 0.01 0.01 0.00 0.04
KRAS G12R appendiceal cancer Race:NA 0 33 0.01 0.01 0.00 0.03
KRAS G12R appendiceal cancer White 3 280 0.01 0.01 0.00 0.02
KRAS G12R colorectal cancer Asian 1 313 0.00 0.00 0.00 0.01
KRAS G12R colorectal cancer Black 1 515 0.00 0.00 0.00 0.01
KRAS G12R colorectal cancer Race:NA 10 804 0.01 0.01 0.00 0.02
KRAS G12R colorectal cancer Native American 0 17 0.01 0.00 0.00 0.02
KRAS G12R colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.01
KRAS G12R colorectal cancer White 22 4925 0.00 0.00 0.00 0.01
KRAS G12R cancer of unknown primary Asian 0 73 0.01 0.01 0.00 0.02
KRAS G12R cancer of unknown primary Black 3 123 0.01 0.01 0.00 0.03
KRAS G12R cancer of unknown primary Race:NA 4 286 0.01 0.01 0.00 0.02
KRAS G12R cancer of unknown primary Race:Other 0 36 0.01 0.01 0.00 0.02
KRAS G12R cancer of unknown primary White 10 1465 0.01 0.01 0.00 0.01
KRAS G12R non-small cell lung cancer Asian 1 624 0.00 0.00 0.00 0.01
KRAS G12R non-small cell lung cancer Black 1 717 0.00 0.00 0.00 0.01
KRAS G12R non-small cell lung cancer Race:NA 4 849 0.00 0.00 0.00 0.01
KRAS G12R non-small cell lung cancer Native American 1 17 0.00 0.00 0.00 0.02
KRAS G12R non-small cell lung cancer Race:Other 2 165 0.00 0.00 0.00 0.01
KRAS G12R non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.01
KRAS G12R non-small cell lung cancer White 27 7745 0.00 0.00 0.00 0.00
KRAS G12R breast cancer Asian 0 334 0.00 0.00 0.00 0.00
KRAS G12R breast cancer Black 1 526 0.00 0.00 0.00 0.00
KRAS G12R breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
KRAS G12R breast cancer Native American 0 11 0.00 0.00 0.00 0.00
KRAS G12R breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
KRAS G12R breast cancer White 3 5174 0.00 0.00 0.00 0.00
KRAS G12R soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
KRAS G12R soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
KRAS G12R soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
KRAS G12R soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
KRAS G12R soft tissue sarcoma White 3 2005 0.00 0.00 0.00 0.00
KRAS G12R pancreatic cancer Asian 8 100 0.10 0.10 0.07 0.13
KRAS G12R pancreatic cancer Black 10 88 0.11 0.11 0.08 0.14
KRAS G12R pancreatic cancer Race:NA 22 231 0.10 0.10 0.08 0.13
KRAS G12R pancreatic cancer Race:Other 3 34 0.11 0.11 0.07 0.14
KRAS G12R pancreatic cancer White 233 2038 0.11 0.11 0.10 0.13
KRAS G12R leukemia Asian 0 37 0.00 0.00 0.00 0.01
KRAS G12R leukemia Black 0 69 0.00 0.00 0.00 0.00
KRAS G12R leukemia Race:NA 1 777 0.00 0.00 0.00 0.00
KRAS G12R leukemia Race:Other 0 13 0.00 0.00 0.00 0.01
KRAS G12R leukemia White 1 662 0.00 0.00 0.00 0.00
KRAS G12R melanoma Asian 0 33 0.00 0.00 0.00 0.01
KRAS G12R melanoma Black 0 34 0.00 0.00 0.00 0.01
KRAS G12R melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
KRAS G12R melanoma Race:Other 0 26 0.00 0.00 0.00 0.01
KRAS G12R melanoma White 3 2348 0.00 0.00 0.00 0.00
KRAS G12R head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
KRAS G12R head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
KRAS G12R head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
KRAS G12R head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
KRAS G12R head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
KRAS G12R uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
KRAS G12R uterine cancer Black 0 163 0.00 0.00 0.00 0.00
KRAS G12R uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
KRAS G12R uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
KRAS G12R uterine cancer White 2 1754 0.00 0.00 0.00 0.00
KRAS G12R non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
KRAS G12R non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
KRAS G12R non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
KRAS G12R non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
KRAS G12R myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.01
KRAS G12R myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.01
KRAS G12R myelodysplastic/myeloproliferative syndromes Race:NA 1 571 0.00 0.00 0.00 0.00
KRAS G12R myelodysplastic/myeloproliferative syndromes White 1 584 0.00 0.00 0.00 0.00
KRAS G12R adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS G12R adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS G12R ovarian cancer Asian 0 134 0.00 0.00 0.00 0.01
KRAS G12R ovarian cancer Black 1 74 0.01 0.00 0.00 0.02
KRAS G12R ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.01
KRAS G12R ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.01
KRAS G12R ovarian cancer White 9 1852 0.00 0.00 0.00 0.01
KRAS G12R esophagogastric cancer Asian 1 115 0.00 0.00 0.00 0.02
KRAS G12R esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.01
KRAS G12R esophagogastric cancer Race:NA 1 191 0.00 0.00 0.00 0.01
KRAS G12R esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.01
KRAS G12R esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
KRAS G12R thyroid cancer Asian 0 66 0.00 0.00 0.00 0.01
KRAS G12R thyroid cancer Black 0 40 0.00 0.00 0.00 0.01
KRAS G12R thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.01
KRAS G12R thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.01
KRAS G12R thyroid cancer White 1 803 0.00 0.00 0.00 0.00
KRAS G12R cervical cancer Asian 0 27 0.00 0.00 0.00 0.02
KRAS G12R cervical cancer Black 0 19 0.00 0.00 0.00 0.02
KRAS G12R cervical cancer Race:NA 1 77 0.01 0.00 0.00 0.03
KRAS G12R cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.02
KRAS G12R cervical cancer White 0 228 0.00 0.00 0.00 0.01
KRAS G12R hepatobiliary cancer Asian 0 98 0.00 0.00 0.00 0.01
KRAS G12R hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.01
KRAS G12R hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.01
KRAS G12R hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.01
KRAS G12R hepatobiliary cancer White 3 948 0.00 0.00 0.00 0.01
KRAS G12R kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
KRAS G12R kidney cancer Black 0 77 0.00 0.00 0.00 0.00
KRAS G12R kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS G12R kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G12R kidney cancer White 0 1113 0.00 0.00 0.00 0.00
KRAS G12R mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
KRAS G12R mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
KRAS G12R mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
KRAS G12R mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
KRAS G12R cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS G12R cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS G12R cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
KRAS G12R cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
KRAS G12R cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
KRAS G12R cns cancer White 2 3331 0.00 0.00 0.00 0.00
KRAS G12R prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
KRAS G12R prostate cancer Black 0 175 0.00 0.00 0.00 0.00
KRAS G12R prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS G12R prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.01
KRAS G12R prostate cancer White 3 1882 0.00 0.00 0.00 0.00
KRAS G12R anal cancer Race:NA 0 13 0.00 0.00 0.00 0.00
KRAS G12R anal cancer White 0 126 0.00 0.00 0.00 0.00
KRAS G12R neuroendocrine tumors Black 1 23 0.02 0.01 0.00 0.09
KRAS G12R neuroendocrine tumors Race:NA 0 45 0.01 0.00 0.00 0.02
KRAS G12R neuroendocrine tumors White 1 283 0.00 0.00 0.00 0.02
KRAS G12R bladder cancer Asian 0 40 0.00 0.00 0.00 0.01
KRAS G12R bladder cancer Black 0 43 0.00 0.00 0.00 0.01
KRAS G12R bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.01
KRAS G12R bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.01
KRAS G12R bladder cancer White 3 1311 0.00 0.00 0.00 0.00
KRAS G12R b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
KRAS G12R b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
KRAS G12R b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
KRAS G12R small bowel cancer Black 1 25 0.02 0.01 0.00 0.08
KRAS G12R small bowel cancer Race:NA 0 22 0.01 0.01 0.00 0.04
KRAS G12R small bowel cancer White 1 150 0.01 0.01 0.00 0.03
KRAS G12R sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS G12R sex cord stromal tumor White 0 69 0.00 0.00 0.00 0.01
KRAS G12R bone cancer Asian 0 30 0.00 0.00 0.00 0.00
KRAS G12R bone cancer Black 0 32 0.00 0.00 0.00 0.00
KRAS G12R bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
KRAS G12R bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G12R bone cancer White 0 391 0.00 0.00 0.00 0.00
KRAS G12R vaginal cancer White 0 68 0.00 0.00 0.00 0.01
KRAS G12R thymic tumor Asian 0 13 0.00 0.00 0.00 0.01
KRAS G12R thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
KRAS G12R thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS G12R ampullary cancer White 3 86 0.04 0.03 0.01 0.08
KRAS G12R small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
KRAS G12R small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
KRAS G12R small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
KRAS G12R mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS G12R mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS G12R mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS G12R mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS G12R germ cell tumor Asian 0 36 0.01 0.00 0.00 0.02
KRAS G12R germ cell tumor Black 0 23 0.01 0.00 0.00 0.02
KRAS G12R germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.01
KRAS G12R germ cell tumor Race:Other 0 37 0.01 0.00 0.00 0.02
KRAS G12R germ cell tumor White 8 603 0.01 0.01 0.00 0.02
KRAS G12R nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
KRAS G12R nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS G12R nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
KRAS G12R penile cancer White 0 20 0.00 0.00 0.00 0.04
KRAS G12R pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
KRAS G12R pineal tumor White 0 14 0.00 0.00 0.00 0.05
KRAS G12R b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.02
KRAS G12R b cell lymphoma Black 0 25 0.00 0.00 0.00 0.02
KRAS G12R b cell lymphoma Race:NA 1 42 0.01 0.00 0.00 0.04
KRAS G12R b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.03
KRAS G12R b cell lymphoma White 1 859 0.00 0.00 0.00 0.01
KRAS G12R non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.02
KRAS G12R t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS G12R t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
KRAS G12R retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.03
KRAS G12R retinoblastoma White 0 25 0.00 0.00 0.00 0.02
KRAS G12R hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
KRAS G12R lung cancer White 0 17 0.00 0.00 0.00 0.04
KRAS G12R peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
KRAS G12R parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
KRAS G12S appendiceal cancer Black 0 17 0.00 0.00 0.00 0.02
KRAS G12S appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.02
KRAS G12S appendiceal cancer White 1 280 0.00 0.00 0.00 0.01
KRAS G12S colorectal cancer Asian 8 313 0.02 0.02 0.01 0.03
KRAS G12S colorectal cancer Black 14 515 0.02 0.02 0.02 0.03
KRAS G12S colorectal cancer Race:NA 14 804 0.02 0.02 0.01 0.03
KRAS G12S colorectal cancer Native American 0 17 0.02 0.02 0.01 0.03
KRAS G12S colorectal cancer Race:Other 4 139 0.02 0.02 0.01 0.03
KRAS G12S colorectal cancer White 85 4925 0.02 0.02 0.02 0.02
KRAS G12S cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.01
KRAS G12S cancer of unknown primary Black 2 123 0.01 0.00 0.00 0.03
KRAS G12S cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.01
KRAS G12S cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.01
KRAS G12S cancer of unknown primary White 3 1465 0.00 0.00 0.00 0.00
KRAS G12S non-small cell lung cancer Asian 5 624 0.01 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer Black 5 717 0.01 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer Race:NA 5 849 0.00 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer Native American 0 17 0.01 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer Race:Other 1 165 0.01 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer Race:Undefined 0 10 0.01 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer White 36 7745 0.00 0.00 0.00 0.01
KRAS G12S breast cancer Asian 0 334 0.00 0.00 0.00 0.00
KRAS G12S breast cancer Black 1 526 0.00 0.00 0.00 0.00
KRAS G12S breast cancer Race:NA 1 3112 0.00 0.00 0.00 0.00
KRAS G12S breast cancer Native American 0 11 0.00 0.00 0.00 0.00
KRAS G12S breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
KRAS G12S breast cancer White 4 5174 0.00 0.00 0.00 0.00
KRAS G12S soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
KRAS G12S soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
KRAS G12S soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
KRAS G12S soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
KRAS G12S soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
KRAS G12S pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
KRAS G12S pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
KRAS G12S pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
KRAS G12S pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
KRAS G12S pancreatic cancer White 0 2038 0.00 0.00 0.00 0.00
KRAS G12S leukemia Asian 0 37 0.00 0.00 0.00 0.00
KRAS G12S leukemia Black 0 69 0.00 0.00 0.00 0.00
KRAS G12S leukemia Race:NA 1 777 0.00 0.00 0.00 0.00
KRAS G12S leukemia Race:Other 0 13 0.00 0.00 0.00 0.01
KRAS G12S leukemia White 0 662 0.00 0.00 0.00 0.00
KRAS G12S melanoma Asian 0 33 0.00 0.00 0.00 0.00
KRAS G12S melanoma Black 0 34 0.00 0.00 0.00 0.00
KRAS G12S melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
KRAS G12S melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G12S melanoma White 1 2348 0.00 0.00 0.00 0.00
KRAS G12S head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
KRAS G12S head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
KRAS G12S head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
KRAS G12S head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
KRAS G12S head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
KRAS G12S uterine cancer Asian 1 108 0.00 0.00 0.00 0.02
KRAS G12S uterine cancer Black 0 163 0.00 0.00 0.00 0.01
KRAS G12S uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.01
KRAS G12S uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.01
KRAS G12S uterine cancer White 5 1754 0.00 0.00 0.00 0.00
KRAS G12S non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
KRAS G12S non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
KRAS G12S non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
KRAS G12S non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
KRAS G12S myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.02
KRAS G12S myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.01
KRAS G12S myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
KRAS G12S myelodysplastic/myeloproliferative syndromes White 2 584 0.00 0.00 0.00 0.01
KRAS G12S adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
KRAS G12S adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS G12S ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
KRAS G12S ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
KRAS G12S ovarian cancer Race:NA 1 239 0.00 0.00 0.00 0.01
KRAS G12S ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.01
KRAS G12S ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
KRAS G12S esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.01
KRAS G12S esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.01
KRAS G12S esophagogastric cancer Race:NA 1 191 0.00 0.00 0.00 0.01
KRAS G12S esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.01
KRAS G12S esophagogastric cancer White 3 1379 0.00 0.00 0.00 0.00
KRAS G12S thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
KRAS G12S thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
KRAS G12S thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
KRAS G12S thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G12S thyroid cancer White 0 803 0.00 0.00 0.00 0.00
KRAS G12S cervical cancer Asian 1 27 0.01 0.01 0.00 0.06
KRAS G12S cervical cancer Black 0 19 0.01 0.01 0.00 0.03
KRAS G12S cervical cancer Race:NA 0 77 0.01 0.01 0.00 0.02
KRAS G12S cervical cancer Race:Other 0 15 0.01 0.01 0.00 0.03
KRAS G12S cervical cancer White 2 228 0.01 0.01 0.00 0.02
KRAS G12S hepatobiliary cancer Asian 0 98 0.00 0.00 0.00 0.01
KRAS G12S hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.01
KRAS G12S hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
KRAS G12S hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.01
KRAS G12S hepatobiliary cancer White 2 948 0.00 0.00 0.00 0.00
KRAS G12S kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
KRAS G12S kidney cancer Black 0 77 0.00 0.00 0.00 0.00
KRAS G12S kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS G12S kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G12S kidney cancer White 1 1113 0.00 0.00 0.00 0.00
KRAS G12S mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
KRAS G12S mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
KRAS G12S mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
KRAS G12S mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
KRAS G12S cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS G12S cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS G12S cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
KRAS G12S cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
KRAS G12S cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
KRAS G12S cns cancer White 0 3331 0.00 0.00 0.00 0.00
KRAS G12S prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
KRAS G12S prostate cancer Black 0 175 0.00 0.00 0.00 0.00
KRAS G12S prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS G12S prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
KRAS G12S prostate cancer White 0 1882 0.00 0.00 0.00 0.00
KRAS G12S anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
KRAS G12S anal cancer White 0 126 0.00 0.00 0.00 0.00
KRAS G12S neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
KRAS G12S neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
KRAS G12S neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
KRAS G12S bladder cancer Asian 0 40 0.00 0.00 0.00 0.01
KRAS G12S bladder cancer Black 1 43 0.01 0.00 0.00 0.04
KRAS G12S bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.01
KRAS G12S bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.02
KRAS G12S bladder cancer White 1 1311 0.00 0.00 0.00 0.00
KRAS G12S b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
KRAS G12S b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
KRAS G12S b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
KRAS G12S small bowel cancer Black 1 25 0.02 0.01 0.00 0.08
KRAS G12S small bowel cancer Race:NA 0 22 0.01 0.01 0.00 0.04
KRAS G12S small bowel cancer White 1 150 0.01 0.01 0.00 0.03
KRAS G12S sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS G12S sex cord stromal tumor White 0 69 0.00 0.00 0.00 0.01
KRAS G12S bone cancer Asian 0 30 0.00 0.00 0.00 0.00
KRAS G12S bone cancer Black 0 32 0.00 0.00 0.00 0.00
KRAS G12S bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
KRAS G12S bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G12S bone cancer White 0 391 0.00 0.00 0.00 0.00
KRAS G12S vaginal cancer White 0 68 0.00 0.00 0.00 0.00
KRAS G12S thymic tumor Asian 0 13 0.00 0.00 0.00 0.01
KRAS G12S thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
KRAS G12S thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS G12S ampullary cancer White 0 86 0.00 0.00 0.00 0.01
KRAS G12S small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
KRAS G12S small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
KRAS G12S small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
KRAS G12S mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS G12S mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS G12S mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS G12S mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS G12S germ cell tumor Asian 1 36 0.01 0.00 0.00 0.04
KRAS G12S germ cell tumor Black 0 23 0.01 0.00 0.00 0.02
KRAS G12S germ cell tumor Race:NA 1 179 0.00 0.00 0.00 0.01
KRAS G12S germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.02
KRAS G12S germ cell tumor White 2 603 0.00 0.00 0.00 0.01
KRAS G12S nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
KRAS G12S nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS G12S nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
KRAS G12S penile cancer White 0 20 0.00 0.00 0.00 0.03
KRAS G12S pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
KRAS G12S pineal tumor White 0 14 0.00 0.00 0.00 0.04
KRAS G12S b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.02
KRAS G12S b cell lymphoma Black 0 25 0.00 0.00 0.00 0.01
KRAS G12S b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.01
KRAS G12S b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.02
KRAS G12S b cell lymphoma White 3 859 0.00 0.00 0.00 0.01
KRAS G12S non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
KRAS G12S t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.03 0.02 0.00 0.12
KRAS G12S t-lymphoblastic leukemia/lymphoma White 1 23 0.04 0.03 0.00 0.13
KRAS G12S retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.01
KRAS G12S retinoblastoma White 0 25 0.00 0.00 0.00 0.01
KRAS G12S hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
KRAS G12S lung cancer White 0 17 0.00 0.00 0.00 0.04
KRAS G12S peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
KRAS G12S parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
KRAS G12V appendiceal cancer Black 1 17 0.10 0.10 0.02 0.18
KRAS G12V appendiceal cancer Race:NA 2 33 0.10 0.10 0.02 0.17
KRAS G12V appendiceal cancer White 38 280 0.13 0.13 0.09 0.17
KRAS G12V colorectal cancer Asian 31 313 0.10 0.10 0.08 0.12
KRAS G12V colorectal cancer Black 64 515 0.11 0.11 0.09 0.14
KRAS G12V colorectal cancer Race:NA 72 804 0.09 0.09 0.08 0.11
KRAS G12V colorectal cancer Native American 3 17 0.10 0.10 0.07 0.16
KRAS G12V colorectal cancer Race:Other 13 139 0.10 0.10 0.07 0.13
KRAS G12V colorectal cancer White 435 4925 0.09 0.09 0.08 0.10
KRAS G12V cancer of unknown primary Asian 3 73 0.05 0.05 0.03 0.08
KRAS G12V cancer of unknown primary Black 5 123 0.05 0.05 0.03 0.07
KRAS G12V cancer of unknown primary Race:NA 11 286 0.05 0.05 0.03 0.06
KRAS G12V cancer of unknown primary Race:Other 4 36 0.06 0.06 0.04 0.11
KRAS G12V cancer of unknown primary White 84 1465 0.06 0.06 0.04 0.07
KRAS G12V non-small cell lung cancer Asian 10 624 0.02 0.02 0.01 0.04
KRAS G12V non-small cell lung cancer Black 43 717 0.06 0.06 0.04 0.08
KRAS G12V non-small cell lung cancer Race:NA 45 849 0.05 0.05 0.04 0.07
KRAS G12V non-small cell lung cancer Native American 1 17 0.05 0.04 0.02 0.12
KRAS G12V non-small cell lung cancer Race:Other 6 165 0.04 0.04 0.02 0.07
KRAS G12V non-small cell lung cancer Race:Undefined 0 10 0.04 0.04 0.01 0.10
KRAS G12V non-small cell lung cancer White 443 7745 0.06 0.06 0.05 0.06
KRAS G12V breast cancer Asian 0 334 0.00 0.00 0.00 0.00
KRAS G12V breast cancer Black 1 526 0.00 0.00 0.00 0.00
KRAS G12V breast cancer Race:NA 12 3112 0.00 0.00 0.00 0.00
KRAS G12V breast cancer Native American 0 11 0.00 0.00 0.00 0.01
KRAS G12V breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
KRAS G12V breast cancer White 17 5174 0.00 0.00 0.00 0.00
KRAS G12V soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
KRAS G12V soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
KRAS G12V soft tissue sarcoma Race:NA 1 350 0.00 0.00 0.00 0.01
KRAS G12V soft tissue sarcoma Race:Other 1 73 0.00 0.00 0.00 0.02
KRAS G12V soft tissue sarcoma White 2 2005 0.00 0.00 0.00 0.00
KRAS G12V pancreatic cancer Asian 28 100 0.24 0.24 0.20 0.31
KRAS G12V pancreatic cancer Black 23 88 0.24 0.24 0.20 0.30
KRAS G12V pancreatic cancer Race:NA 49 231 0.23 0.23 0.18 0.26
KRAS G12V pancreatic cancer Race:Other 4 34 0.22 0.23 0.14 0.27
KRAS G12V pancreatic cancer White 479 2038 0.23 0.23 0.22 0.25
KRAS G12V leukemia Asian 1 37 0.01 0.01 0.00 0.03
KRAS G12V leukemia Black 0 69 0.01 0.01 0.00 0.02
KRAS G12V leukemia Race:NA 10 777 0.01 0.01 0.01 0.02
KRAS G12V leukemia Race:Other 0 13 0.01 0.01 0.00 0.02
KRAS G12V leukemia White 5 662 0.01 0.01 0.00 0.02
KRAS G12V melanoma Asian 0 33 0.00 0.00 0.00 0.00
KRAS G12V melanoma Black 0 34 0.00 0.00 0.00 0.00
KRAS G12V melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
KRAS G12V melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G12V melanoma White 2 2348 0.00 0.00 0.00 0.00
KRAS G12V head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
KRAS G12V head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
KRAS G12V head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
KRAS G12V head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
KRAS G12V head and neck cancer White 1 1264 0.00 0.00 0.00 0.00
KRAS G12V uterine cancer Asian 7 108 0.05 0.05 0.04 0.08
KRAS G12V uterine cancer Black 5 163 0.05 0.05 0.03 0.06
KRAS G12V uterine cancer Race:NA 11 190 0.05 0.05 0.04 0.07
KRAS G12V uterine cancer Race:Other 1 37 0.05 0.05 0.03 0.07
KRAS G12V uterine cancer White 88 1754 0.05 0.05 0.04 0.06
KRAS G12V non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.02
KRAS G12V non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.02
KRAS G12V non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.01
KRAS G12V non-melanoma skin cancers White 1 436 0.00 0.00 0.00 0.01
KRAS G12V myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.01
KRAS G12V myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.01
KRAS G12V myelodysplastic/myeloproliferative syndromes Race:NA 1 571 0.00 0.00 0.00 0.00
KRAS G12V myelodysplastic/myeloproliferative syndromes White 1 584 0.00 0.00 0.00 0.00
KRAS G12V adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
KRAS G12V adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS G12V ovarian cancer Asian 4 134 0.04 0.03 0.02 0.06
KRAS G12V ovarian cancer Black 5 74 0.04 0.04 0.02 0.09
KRAS G12V ovarian cancer Race:NA 4 239 0.03 0.03 0.01 0.04
KRAS G12V ovarian cancer Race:Other 3 36 0.04 0.04 0.02 0.10
KRAS G12V ovarian cancer White 67 1852 0.04 0.04 0.03 0.04
KRAS G12V esophagogastric cancer Asian 1 115 0.01 0.01 0.00 0.02
KRAS G12V esophagogastric cancer Black 0 68 0.01 0.01 0.00 0.02
KRAS G12V esophagogastric cancer Race:NA 0 191 0.01 0.01 0.00 0.01
KRAS G12V esophagogastric cancer Race:Other 1 46 0.01 0.01 0.00 0.03
KRAS G12V esophagogastric cancer White 13 1379 0.01 0.01 0.00 0.01
KRAS G12V thyroid cancer Asian 0 66 0.00 0.00 0.00 0.01
KRAS G12V thyroid cancer Black 0 40 0.00 0.00 0.00 0.02
KRAS G12V thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.01
KRAS G12V thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.02
KRAS G12V thyroid cancer White 6 803 0.01 0.01 0.00 0.01
KRAS G12V cervical cancer Asian 1 27 0.03 0.03 0.01 0.07
KRAS G12V cervical cancer Black 0 19 0.03 0.03 0.00 0.06
KRAS G12V cervical cancer Race:NA 1 77 0.03 0.03 0.01 0.05
KRAS G12V cervical cancer Race:Other 0 15 0.03 0.03 0.00 0.06
KRAS G12V cervical cancer White 9 228 0.03 0.03 0.02 0.06
KRAS G12V hepatobiliary cancer Asian 1 98 0.02 0.02 0.00 0.04
KRAS G12V hepatobiliary cancer Black 0 64 0.02 0.02 0.00 0.04
KRAS G12V hepatobiliary cancer Race:NA 5 235 0.02 0.02 0.01 0.04
KRAS G12V hepatobiliary cancer Race:Other 0 25 0.02 0.02 0.00 0.04
KRAS G12V hepatobiliary cancer White 32 948 0.03 0.03 0.02 0.04
KRAS G12V kidney cancer Asian 0 33 0.00 0.00 0.00 0.01
KRAS G12V kidney cancer Black 1 77 0.00 0.00 0.00 0.02
KRAS G12V kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.01
KRAS G12V kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.01
KRAS G12V kidney cancer White 3 1113 0.00 0.00 0.00 0.01
KRAS G12V mature t and nk neoplasms Asian 0 12 0.01 0.00 0.00 0.05
KRAS G12V mature t and nk neoplasms Black 1 18 0.03 0.01 0.00 0.15
KRAS G12V mature t and nk neoplasms Race:NA 0 10 0.01 0.00 0.00 0.05
KRAS G12V mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.01
KRAS G12V cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS G12V cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS G12V cns cancer Race:NA 1 817 0.00 0.00 0.00 0.00
KRAS G12V cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
KRAS G12V cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.01
KRAS G12V cns cancer White 7 3331 0.00 0.00 0.00 0.00
KRAS G12V prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
KRAS G12V prostate cancer Black 0 175 0.00 0.00 0.00 0.00
KRAS G12V prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS G12V prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
KRAS G12V prostate cancer White 2 1882 0.00 0.00 0.00 0.00
KRAS G12V anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
KRAS G12V anal cancer White 0 126 0.00 0.00 0.00 0.00
KRAS G12V neuroendocrine tumors Black 0 23 0.01 0.01 0.00 0.07
KRAS G12V neuroendocrine tumors Race:NA 4 45 0.07 0.06 0.01 0.17
KRAS G12V neuroendocrine tumors White 2 283 0.01 0.01 0.00 0.02
KRAS G12V bladder cancer Asian 0 40 0.01 0.01 0.00 0.03
KRAS G12V bladder cancer Black 0 43 0.01 0.01 0.00 0.02
KRAS G12V bladder cancer Race:NA 0 169 0.01 0.01 0.00 0.02
KRAS G12V bladder cancer Race:Other 1 14 0.03 0.01 0.00 0.15
KRAS G12V bladder cancer White 18 1311 0.01 0.01 0.01 0.02
KRAS G12V b-lymphoblastic leukemia/lymphoma Asian 0 17 0.01 0.00 0.00 0.03
KRAS G12V b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.02
KRAS G12V b-lymphoblastic leukemia/lymphoma White 1 125 0.01 0.00 0.00 0.02
KRAS G12V small bowel cancer Black 4 25 0.13 0.12 0.07 0.23
KRAS G12V small bowel cancer Race:NA 2 22 0.12 0.12 0.05 0.20
KRAS G12V small bowel cancer White 18 150 0.12 0.12 0.08 0.17
KRAS G12V sex cord stromal tumor Race:NA 1 23 0.03 0.02 0.00 0.11
KRAS G12V sex cord stromal tumor White 1 69 0.02 0.02 0.00 0.06
KRAS G12V bone cancer Asian 0 30 0.00 0.00 0.00 0.00
KRAS G12V bone cancer Black 0 32 0.00 0.00 0.00 0.00
KRAS G12V bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
KRAS G12V bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G12V bone cancer White 0 391 0.00 0.00 0.00 0.00
KRAS G12V vaginal cancer White 0 68 0.00 0.00 0.00 0.00
KRAS G12V thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
KRAS G12V thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
KRAS G12V thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS G12V ampullary cancer White 11 86 0.13 0.13 0.07 0.21
KRAS G12V small cell lung cancer Asian 0 15 0.01 0.01 0.00 0.03
KRAS G12V small cell lung cancer Race:NA 0 30 0.01 0.00 0.00 0.03
KRAS G12V small cell lung cancer White 3 337 0.01 0.01 0.00 0.02
KRAS G12V mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS G12V mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS G12V mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS G12V mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS G12V germ cell tumor Asian 1 36 0.02 0.02 0.00 0.05
KRAS G12V germ cell tumor Black 0 23 0.02 0.02 0.00 0.04
KRAS G12V germ cell tumor Race:NA 2 179 0.02 0.02 0.00 0.03
KRAS G12V germ cell tumor Race:Other 0 37 0.02 0.02 0.00 0.04
KRAS G12V germ cell tumor White 15 603 0.02 0.02 0.01 0.03
KRAS G12V nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
KRAS G12V nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS G12V nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
KRAS G12V penile cancer White 0 20 0.00 0.00 0.00 0.01
KRAS G12V pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
KRAS G12V pineal tumor White 0 14 0.00 0.00 0.00 0.04
KRAS G12V b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.02
KRAS G12V b cell lymphoma Black 0 25 0.00 0.00 0.00 0.02
KRAS G12V b cell lymphoma Race:NA 1 42 0.01 0.00 0.00 0.04
KRAS G12V b cell lymphoma Race:Other 0 12 0.01 0.00 0.00 0.02
KRAS G12V b cell lymphoma White 3 859 0.00 0.00 0.00 0.01
KRAS G12V non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
KRAS G12V t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
KRAS G12V t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.03
KRAS G12V retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS G12V retinoblastoma White 0 25 0.00 0.00 0.00 0.02
KRAS G12V hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.01
KRAS G12V lung cancer White 2 17 0.12 0.11 0.02 0.31
KRAS G12V peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
KRAS G12V parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
KRAS G13C appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
KRAS G13C appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
KRAS G13C appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
KRAS G13C colorectal cancer Asian 1 313 0.00 0.00 0.00 0.01
KRAS G13C colorectal cancer Black 3 515 0.00 0.00 0.00 0.01
KRAS G13C colorectal cancer Race:NA 3 804 0.00 0.00 0.00 0.01
KRAS G13C colorectal cancer Native American 0 17 0.00 0.00 0.00 0.01
KRAS G13C colorectal cancer Race:Other 1 139 0.00 0.00 0.00 0.01
KRAS G13C colorectal cancer White 16 4925 0.00 0.00 0.00 0.00
KRAS G13C cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.01
KRAS G13C cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.01
KRAS G13C cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.01
KRAS G13C cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.01
KRAS G13C cancer of unknown primary White 8 1465 0.00 0.00 0.00 0.01
KRAS G13C non-small cell lung cancer Asian 3 624 0.01 0.01 0.00 0.01
KRAS G13C non-small cell lung cancer Black 11 717 0.01 0.01 0.01 0.02
KRAS G13C non-small cell lung cancer Race:NA 5 849 0.01 0.01 0.00 0.01
KRAS G13C non-small cell lung cancer Native American 0 17 0.01 0.01 0.00 0.02
KRAS G13C non-small cell lung cancer Race:Other 1 165 0.01 0.01 0.00 0.02
KRAS G13C non-small cell lung cancer Race:Undefined 0 10 0.01 0.01 0.00 0.02
KRAS G13C non-small cell lung cancer White 89 7745 0.01 0.01 0.01 0.01
KRAS G13C breast cancer Asian 0 334 0.00 0.00 0.00 0.00
KRAS G13C breast cancer Black 0 526 0.00 0.00 0.00 0.00
KRAS G13C breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
KRAS G13C breast cancer Native American 0 11 0.00 0.00 0.00 0.00
KRAS G13C breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
KRAS G13C breast cancer White 0 5174 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma White 1 2005 0.00 0.00 0.00 0.00
KRAS G13C pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
KRAS G13C pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
KRAS G13C pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
KRAS G13C pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
KRAS G13C pancreatic cancer White 0 2038 0.00 0.00 0.00 0.00
KRAS G13C leukemia Asian 0 37 0.00 0.00 0.00 0.01
KRAS G13C leukemia Black 0 69 0.00 0.00 0.00 0.00
KRAS G13C leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
KRAS G13C leukemia Race:Other 0 13 0.00 0.00 0.00 0.01
KRAS G13C leukemia White 1 662 0.00 0.00 0.00 0.00
KRAS G13C melanoma Asian 0 33 0.00 0.00 0.00 0.00
KRAS G13C melanoma Black 0 34 0.00 0.00 0.00 0.00
KRAS G13C melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
KRAS G13C melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G13C melanoma White 0 2348 0.00 0.00 0.00 0.00
KRAS G13C head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
KRAS G13C head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
KRAS G13C head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
KRAS G13C head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
KRAS G13C head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
KRAS G13C uterine cancer Asian 0 108 0.00 0.00 0.00 0.01
KRAS G13C uterine cancer Black 0 163 0.00 0.00 0.00 0.01
KRAS G13C uterine cancer Race:NA 1 190 0.00 0.00 0.00 0.01
KRAS G13C uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.01
KRAS G13C uterine cancer White 4 1754 0.00 0.00 0.00 0.00
KRAS G13C non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
KRAS G13C non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
KRAS G13C non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
KRAS G13C non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
KRAS G13C myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
KRAS G13C myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.00
KRAS G13C myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
KRAS G13C myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
KRAS G13C adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
KRAS G13C adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS G13C ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
KRAS G13C ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
KRAS G13C ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
KRAS G13C ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
KRAS G13C ovarian cancer White 1 1852 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
KRAS G13C thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
KRAS G13C thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
KRAS G13C thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
KRAS G13C thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G13C thyroid cancer White 0 803 0.00 0.00 0.00 0.00
KRAS G13C cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
KRAS G13C cervical cancer Black 0 19 0.00 0.00 0.00 0.00
KRAS G13C cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
KRAS G13C cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
KRAS G13C cervical cancer White 0 228 0.00 0.00 0.00 0.00
KRAS G13C hepatobiliary cancer Asian 0 98 0.00 0.00 0.00 0.00
KRAS G13C hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
KRAS G13C hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
KRAS G13C hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
KRAS G13C hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
KRAS G13C kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
KRAS G13C kidney cancer Black 0 77 0.00 0.00 0.00 0.00
KRAS G13C kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS G13C kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G13C kidney cancer White 0 1113 0.00 0.00 0.00 0.00
KRAS G13C mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
KRAS G13C mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
KRAS G13C mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
KRAS G13C mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
KRAS G13C cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS G13C cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS G13C cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
KRAS G13C cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
KRAS G13C cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
KRAS G13C cns cancer White 0 3331 0.00 0.00 0.00 0.00
KRAS G13C prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
KRAS G13C prostate cancer Black 0 175 0.00 0.00 0.00 0.00
KRAS G13C prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS G13C prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
KRAS G13C prostate cancer White 0 1882 0.00 0.00 0.00 0.00
KRAS G13C anal cancer Race:NA 0 13 0.01 0.00 0.00 0.05
KRAS G13C anal cancer White 1 126 0.01 0.01 0.00 0.03
KRAS G13C neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
KRAS G13C neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
KRAS G13C neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
KRAS G13C bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
KRAS G13C bladder cancer Black 0 43 0.00 0.00 0.00 0.00
KRAS G13C bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS G13C bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
KRAS G13C bladder cancer White 0 1311 0.00 0.00 0.00 0.00
KRAS G13C b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
KRAS G13C b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
KRAS G13C b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
KRAS G13C small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
KRAS G13C small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
KRAS G13C small bowel cancer White 0 150 0.00 0.00 0.00 0.00
KRAS G13C sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS G13C sex cord stromal tumor White 0 69 0.00 0.00 0.00 0.00
KRAS G13C bone cancer Asian 0 30 0.00 0.00 0.00 0.00
KRAS G13C bone cancer Black 0 32 0.00 0.00 0.00 0.00
KRAS G13C bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
KRAS G13C bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G13C bone cancer White 0 391 0.00 0.00 0.00 0.00
KRAS G13C vaginal cancer White 1 68 0.02 0.01 0.00 0.06
KRAS G13C thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
KRAS G13C thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
KRAS G13C thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS G13C ampullary cancer White 0 86 0.00 0.00 0.00 0.01
KRAS G13C small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
KRAS G13C small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
KRAS G13C small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
KRAS G13C mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS G13C mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS G13C mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS G13C mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor White 0 603 0.00 0.00 0.00 0.00
KRAS G13C nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
KRAS G13C nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS G13C nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
KRAS G13C penile cancer White 0 20 0.00 0.00 0.00 0.02
KRAS G13C pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
KRAS G13C pineal tumor White 0 14 0.00 0.00 0.00 0.04
KRAS G13C b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.01
KRAS G13C b cell lymphoma Black 0 25 0.00 0.00 0.00 0.01
KRAS G13C b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.01
KRAS G13C b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.01
KRAS G13C b cell lymphoma White 1 859 0.00 0.00 0.00 0.00
KRAS G13C non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
KRAS G13C t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
KRAS G13C t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
KRAS G13C retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS G13C retinoblastoma White 0 25 0.00 0.00 0.00 0.02
KRAS G13C hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
KRAS G13C lung cancer White 0 17 0.00 0.00 0.00 0.03
KRAS G13C peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
KRAS G13C parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
KRAS G13D appendiceal cancer Black 1 17 0.05 0.04 0.02 0.12
KRAS G13D appendiceal cancer Race:NA 2 33 0.05 0.04 0.02 0.11
KRAS G13D appendiceal cancer White 11 280 0.04 0.04 0.02 0.07
KRAS G13D colorectal cancer Asian 21 313 0.07 0.07 0.05 0.10
KRAS G13D colorectal cancer Black 60 515 0.10 0.10 0.08 0.13
KRAS G13D colorectal cancer Race:NA 69 804 0.08 0.08 0.07 0.10
KRAS G13D colorectal cancer Native American 0 17 0.08 0.08 0.04 0.12
KRAS G13D colorectal cancer Race:Other 12 139 0.08 0.08 0.06 0.12
KRAS G13D colorectal cancer White 338 4925 0.07 0.07 0.06 0.08
KRAS G13D cancer of unknown primary Asian 2 73 0.02 0.02 0.01 0.04
KRAS G13D cancer of unknown primary Black 2 123 0.02 0.01 0.01 0.03
KRAS G13D cancer of unknown primary Race:NA 6 286 0.02 0.02 0.01 0.03
KRAS G13D cancer of unknown primary Race:Other 1 36 0.02 0.01 0.01 0.04
KRAS G13D cancer of unknown primary White 15 1465 0.01 0.01 0.01 0.02
KRAS G13D non-small cell lung cancer Asian 1 624 0.00 0.00 0.00 0.01
KRAS G13D non-small cell lung cancer Black 1 717 0.00 0.00 0.00 0.01
KRAS G13D non-small cell lung cancer Race:NA 7 849 0.01 0.01 0.00 0.01
KRAS G13D non-small cell lung cancer Native American 0 17 0.01 0.01 0.00 0.03
KRAS G13D non-small cell lung cancer Race:Other 1 165 0.01 0.01 0.00 0.02
KRAS G13D non-small cell lung cancer Race:Undefined 1 10 0.02 0.01 0.00 0.12
KRAS G13D non-small cell lung cancer White 76 7745 0.01 0.01 0.01 0.01
KRAS G13D breast cancer Asian 0 334 0.00 0.00 0.00 0.00
KRAS G13D breast cancer Black 1 526 0.00 0.00 0.00 0.00
KRAS G13D breast cancer Race:NA 1 3112 0.00 0.00 0.00 0.00
KRAS G13D breast cancer Native American 0 11 0.00 0.00 0.00 0.00
KRAS G13D breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
KRAS G13D breast cancer White 3 5174 0.00 0.00 0.00 0.00
KRAS G13D soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
KRAS G13D soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
KRAS G13D soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
KRAS G13D soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
KRAS G13D soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
KRAS G13D pancreatic cancer Asian 1 100 0.01 0.01 0.00 0.02
KRAS G13D pancreatic cancer Black 0 88 0.01 0.00 0.00 0.01
KRAS G13D pancreatic cancer Race:NA 1 231 0.01 0.00 0.00 0.01
KRAS G13D pancreatic cancer Race:Other 0 34 0.01 0.00 0.00 0.01
KRAS G13D pancreatic cancer White 12 2038 0.01 0.01 0.00 0.01
KRAS G13D leukemia Asian 1 37 0.02 0.02 0.01 0.04
KRAS G13D leukemia Black 2 69 0.02 0.02 0.01 0.04
KRAS G13D leukemia Race:NA 10 777 0.02 0.02 0.01 0.02
KRAS G13D leukemia Race:Other 0 13 0.02 0.02 0.01 0.04
KRAS G13D leukemia White 12 662 0.02 0.02 0.01 0.03
KRAS G13D melanoma Asian 0 33 0.00 0.00 0.00 0.01
KRAS G13D melanoma Black 0 34 0.00 0.00 0.00 0.01
KRAS G13D melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
KRAS G13D melanoma Race:Other 0 26 0.00 0.00 0.00 0.01
KRAS G13D melanoma White 6 2348 0.00 0.00 0.00 0.00
KRAS G13D head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
KRAS G13D head and neck cancer Black 0 62 0.00 0.00 0.00 0.01
KRAS G13D head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
KRAS G13D head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.01
KRAS G13D head and neck cancer White 3 1264 0.00 0.00 0.00 0.00
KRAS G13D uterine cancer Asian 3 108 0.02 0.02 0.01 0.04
KRAS G13D uterine cancer Black 0 163 0.02 0.02 0.00 0.03
KRAS G13D uterine cancer Race:NA 4 190 0.02 0.02 0.01 0.04
KRAS G13D uterine cancer Race:Other 1 37 0.02 0.02 0.01 0.05
KRAS G13D uterine cancer White 38 1754 0.02 0.02 0.02 0.03
KRAS G13D non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
KRAS G13D non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
KRAS G13D non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
KRAS G13D non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
KRAS G13D myelodysplastic/myeloproliferative syndromes Asian 0 12 0.01 0.00 0.00 0.03
KRAS G13D myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.02
KRAS G13D myelodysplastic/myeloproliferative syndromes Race:NA 6 571 0.01 0.01 0.00 0.02
KRAS G13D myelodysplastic/myeloproliferative syndromes White 1 584 0.00 0.00 0.00 0.01
KRAS G13D adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
KRAS G13D adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS G13D ovarian cancer Asian 2 134 0.01 0.00 0.00 0.02
KRAS G13D ovarian cancer Black 0 74 0.00 0.00 0.00 0.01
KRAS G13D ovarian cancer Race:NA 2 239 0.01 0.00 0.00 0.01
KRAS G13D ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.02
KRAS G13D ovarian cancer White 6 1852 0.00 0.00 0.00 0.01
KRAS G13D esophagogastric cancer Asian 1 115 0.01 0.01 0.00 0.02
KRAS G13D esophagogastric cancer Black 1 68 0.01 0.01 0.00 0.02
KRAS G13D esophagogastric cancer Race:NA 1 191 0.01 0.01 0.00 0.02
KRAS G13D esophagogastric cancer Race:Other 1 46 0.01 0.01 0.00 0.03
KRAS G13D esophagogastric cancer White 18 1379 0.01 0.01 0.01 0.02
KRAS G13D thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
KRAS G13D thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
KRAS G13D thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
KRAS G13D thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G13D thyroid cancer White 0 803 0.00 0.00 0.00 0.00
KRAS G13D cervical cancer Asian 2 27 0.03 0.02 0.00 0.12
KRAS G13D cervical cancer Black 0 19 0.01 0.01 0.00 0.05
KRAS G13D cervical cancer Race:NA 1 77 0.01 0.01 0.00 0.04
KRAS G13D cervical cancer Race:Other 0 15 0.01 0.01 0.00 0.05
KRAS G13D cervical cancer White 1 228 0.01 0.01 0.00 0.02
KRAS G13D hepatobiliary cancer Asian 0 98 0.01 0.01 0.00 0.01
KRAS G13D hepatobiliary cancer Black 1 64 0.01 0.01 0.00 0.02
KRAS G13D hepatobiliary cancer Race:NA 1 235 0.01 0.01 0.00 0.01
KRAS G13D hepatobiliary cancer Race:Other 0 25 0.01 0.01 0.00 0.02
KRAS G13D hepatobiliary cancer White 7 948 0.01 0.01 0.00 0.01
KRAS G13D kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
KRAS G13D kidney cancer Black 0 77 0.00 0.00 0.00 0.00
KRAS G13D kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS G13D kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G13D kidney cancer White 0 1113 0.00 0.00 0.00 0.00
KRAS G13D mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
KRAS G13D mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
KRAS G13D mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
KRAS G13D mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
KRAS G13D cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS G13D cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS G13D cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
KRAS G13D cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
KRAS G13D cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
KRAS G13D cns cancer White 0 3331 0.00 0.00 0.00 0.00
KRAS G13D prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
KRAS G13D prostate cancer Black 0 175 0.00 0.00 0.00 0.00
KRAS G13D prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS G13D prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
KRAS G13D prostate cancer White 1 1882 0.00 0.00 0.00 0.00
KRAS G13D anal cancer Race:NA 0 13 0.01 0.00 0.00 0.05
KRAS G13D anal cancer White 1 126 0.01 0.01 0.00 0.03
KRAS G13D neuroendocrine tumors Black 0 23 0.01 0.01 0.00 0.04
KRAS G13D neuroendocrine tumors Race:NA 0 45 0.01 0.01 0.00 0.04
KRAS G13D neuroendocrine tumors White 6 283 0.02 0.02 0.01 0.04
KRAS G13D bladder cancer Asian 0 40 0.00 0.00 0.00 0.02
KRAS G13D bladder cancer Black 0 43 0.00 0.00 0.00 0.02
KRAS G13D bladder cancer Race:NA 1 169 0.00 0.00 0.00 0.02
KRAS G13D bladder cancer Race:Other 1 14 0.02 0.00 0.00 0.12
KRAS G13D bladder cancer White 2 1311 0.00 0.00 0.00 0.00
KRAS G13D b-lymphoblastic leukemia/lymphoma Asian 0 17 0.03 0.03 0.00 0.07
KRAS G13D b-lymphoblastic leukemia/lymphoma Race:NA 2 92 0.03 0.03 0.01 0.06
KRAS G13D b-lymphoblastic leukemia/lymphoma White 6 125 0.04 0.04 0.02 0.08
KRAS G13D small bowel cancer Black 1 25 0.06 0.06 0.01 0.12
KRAS G13D small bowel cancer Race:NA 3 22 0.08 0.07 0.03 0.20
KRAS G13D small bowel cancer White 8 150 0.06 0.06 0.03 0.10
KRAS G13D sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS G13D sex cord stromal tumor White 0 69 0.00 0.00 0.00 0.00
KRAS G13D bone cancer Asian 0 30 0.00 0.00 0.00 0.00
KRAS G13D bone cancer Black 0 32 0.00 0.00 0.00 0.00
KRAS G13D bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
KRAS G13D bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G13D bone cancer White 0 391 0.00 0.00 0.00 0.00
KRAS G13D vaginal cancer White 0 68 0.00 0.00 0.00 0.01
KRAS G13D thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
KRAS G13D thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
KRAS G13D thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS G13D ampullary cancer White 4 86 0.05 0.04 0.01 0.10
KRAS G13D small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
KRAS G13D small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
KRAS G13D small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
KRAS G13D mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS G13D mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS G13D mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS G13D mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS G13D germ cell tumor Asian 0 36 0.00 0.00 0.00 0.01
KRAS G13D germ cell tumor Black 0 23 0.00 0.00 0.00 0.01
KRAS G13D germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
KRAS G13D germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.01
KRAS G13D germ cell tumor White 1 603 0.00 0.00 0.00 0.00
KRAS G13D nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
KRAS G13D nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS G13D nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
KRAS G13D penile cancer White 0 20 0.00 0.00 0.00 0.02
KRAS G13D pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
KRAS G13D pineal tumor White 1 14 0.08 0.06 0.00 0.26
KRAS G13D b cell lymphoma Asian 0 21 0.01 0.01 0.00 0.02
KRAS G13D b cell lymphoma Black 0 25 0.01 0.01 0.00 0.02
KRAS G13D b cell lymphoma Race:NA 0 42 0.01 0.01 0.00 0.02
KRAS G13D b cell lymphoma Race:Other 0 12 0.01 0.01 0.00 0.03
KRAS G13D b cell lymphoma White 7 859 0.01 0.01 0.00 0.01
KRAS G13D non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
KRAS G13D t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
KRAS G13D t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
KRAS G13D retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS G13D retinoblastoma White 0 25 0.00 0.00 0.00 0.02
KRAS G13D hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
KRAS G13D lung cancer White 0 17 0.00 0.00 0.00 0.03
KRAS G13D peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
KRAS G13D parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
KRAS G13R appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
KRAS G13R appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
KRAS G13R appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer Black 0 515 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer Race:NA 1 804 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer White 1 4925 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary White 1 1465 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer White 6 7745 0.00 0.00 0.00 0.00
KRAS G13R breast cancer Asian 0 334 0.00 0.00 0.00 0.00
KRAS G13R breast cancer Black 0 526 0.00 0.00 0.00 0.00
KRAS G13R breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
KRAS G13R breast cancer Native American 0 11 0.00 0.00 0.00 0.00
KRAS G13R breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
KRAS G13R breast cancer White 0 5174 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
KRAS G13R pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
KRAS G13R pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
KRAS G13R pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
KRAS G13R pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
KRAS G13R pancreatic cancer White 0 2038 0.00 0.00 0.00 0.00
KRAS G13R leukemia Asian 0 37 0.00 0.00 0.00 0.00
KRAS G13R leukemia Black 0 69 0.00 0.00 0.00 0.00
KRAS G13R leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
KRAS G13R leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
KRAS G13R leukemia White 0 662 0.00 0.00 0.00 0.00
KRAS G13R melanoma Asian 0 33 0.00 0.00 0.00 0.00
KRAS G13R melanoma Black 0 34 0.00 0.00 0.00 0.00
KRAS G13R melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
KRAS G13R melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G13R melanoma White 0 2348 0.00 0.00 0.00 0.00
KRAS G13R head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
KRAS G13R head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
KRAS G13R head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
KRAS G13R head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
KRAS G13R head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
KRAS G13R uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
KRAS G13R uterine cancer Black 0 163 0.00 0.00 0.00 0.00
KRAS G13R uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
KRAS G13R uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
KRAS G13R uterine cancer White 0 1754 0.00 0.00 0.00 0.00
KRAS G13R non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
KRAS G13R non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
KRAS G13R non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
KRAS G13R non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
KRAS G13R myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
KRAS G13R myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.00
KRAS G13R myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
KRAS G13R myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
KRAS G13R adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS G13R adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS G13R ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
KRAS G13R ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
KRAS G13R ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
KRAS G13R ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
KRAS G13R ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
KRAS G13R thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
KRAS G13R thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
KRAS G13R thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
KRAS G13R thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G13R thyroid cancer White 0 803 0.00 0.00 0.00 0.00
KRAS G13R cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
KRAS G13R cervical cancer Black 0 19 0.00 0.00 0.00 0.00
KRAS G13R cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
KRAS G13R cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
KRAS G13R cervical cancer White 0 228 0.00 0.00 0.00 0.00
KRAS G13R hepatobiliary cancer Asian 0 98 0.00 0.00 0.00 0.00
KRAS G13R hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
KRAS G13R hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
KRAS G13R hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
KRAS G13R hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
KRAS G13R kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
KRAS G13R kidney cancer Black 0 77 0.00 0.00 0.00 0.00
KRAS G13R kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS G13R kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G13R kidney cancer White 0 1113 0.00 0.00 0.00 0.00
KRAS G13R mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
KRAS G13R mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
KRAS G13R mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
KRAS G13R mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
KRAS G13R cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS G13R cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS G13R cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
KRAS G13R cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
KRAS G13R cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
KRAS G13R cns cancer White 1 3331 0.00 0.00 0.00 0.00
KRAS G13R prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
KRAS G13R prostate cancer Black 0 175 0.00 0.00 0.00 0.00
KRAS G13R prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS G13R prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
KRAS G13R prostate cancer White 0 1882 0.00 0.00 0.00 0.00
KRAS G13R anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
KRAS G13R anal cancer White 0 126 0.00 0.00 0.00 0.00
KRAS G13R neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
KRAS G13R neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
KRAS G13R neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
KRAS G13R bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
KRAS G13R bladder cancer Black 0 43 0.00 0.00 0.00 0.00
KRAS G13R bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS G13R bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
KRAS G13R bladder cancer White 0 1311 0.00 0.00 0.00 0.00
KRAS G13R b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
KRAS G13R b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
KRAS G13R b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
KRAS G13R small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
KRAS G13R small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
KRAS G13R small bowel cancer White 0 150 0.00 0.00 0.00 0.00
KRAS G13R sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS G13R sex cord stromal tumor White 0 69 0.00 0.00 0.00 0.01
KRAS G13R bone cancer Asian 0 30 0.00 0.00 0.00 0.00
KRAS G13R bone cancer Black 0 32 0.00 0.00 0.00 0.00
KRAS G13R bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
KRAS G13R bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G13R bone cancer White 0 391 0.00 0.00 0.00 0.00
KRAS G13R vaginal cancer White 0 68 0.00 0.00 0.00 0.00
KRAS G13R thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
KRAS G13R thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
KRAS G13R thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS G13R ampullary cancer White 0 86 0.00 0.00 0.00 0.00
KRAS G13R small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
KRAS G13R small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
KRAS G13R small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
KRAS G13R mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS G13R mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS G13R mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS G13R mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor White 0 603 0.00 0.00 0.00 0.00
KRAS G13R nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
KRAS G13R nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS G13R nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
KRAS G13R penile cancer White 0 20 0.00 0.00 0.00 0.03
KRAS G13R pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
KRAS G13R pineal tumor White 0 14 0.00 0.00 0.00 0.04
KRAS G13R b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
KRAS G13R b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
KRAS G13R b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
KRAS G13R b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
KRAS G13R b cell lymphoma White 0 859 0.00 0.00 0.00 0.00
KRAS G13R non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
KRAS G13R t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS G13R t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.01
KRAS G13R retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS G13R retinoblastoma White 0 25 0.00 0.00 0.00 0.02
KRAS G13R hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.01
KRAS G13R lung cancer White 0 17 0.00 0.00 0.00 0.03
KRAS G13R peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
KRAS G13R parathyroid cancer White 0 14 0.00 0.00 0.00 0.05
KRAS G13V appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
KRAS G13V appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
KRAS G13V appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer Black 0 515 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer White 2 4925 0.00 0.00 0.00 0.00
KRAS G13V cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
KRAS G13V cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
KRAS G13V cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
KRAS G13V cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
KRAS G13V cancer of unknown primary White 0 1465 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer White 4 7745 0.00 0.00 0.00 0.00
KRAS G13V breast cancer Asian 0 334 0.00 0.00 0.00 0.00
KRAS G13V breast cancer Black 0 526 0.00 0.00 0.00 0.00
KRAS G13V breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
KRAS G13V breast cancer Native American 0 11 0.00 0.00 0.00 0.00
KRAS G13V breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
KRAS G13V breast cancer White 0 5174 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
KRAS G13V pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
KRAS G13V pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
KRAS G13V pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
KRAS G13V pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
KRAS G13V pancreatic cancer White 2 2038 0.00 0.00 0.00 0.00
KRAS G13V leukemia Asian 0 37 0.00 0.00 0.00 0.00
KRAS G13V leukemia Black 0 69 0.00 0.00 0.00 0.00
KRAS G13V leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
KRAS G13V leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
KRAS G13V leukemia White 0 662 0.00 0.00 0.00 0.00
KRAS G13V melanoma Asian 0 33 0.00 0.00 0.00 0.00
KRAS G13V melanoma Black 0 34 0.00 0.00 0.00 0.00
KRAS G13V melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
KRAS G13V melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G13V melanoma White 0 2348 0.00 0.00 0.00 0.00
KRAS G13V head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
KRAS G13V head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
KRAS G13V head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
KRAS G13V head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
KRAS G13V head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
KRAS G13V uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
KRAS G13V uterine cancer Black 0 163 0.00 0.00 0.00 0.00
KRAS G13V uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
KRAS G13V uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
KRAS G13V uterine cancer White 0 1754 0.00 0.00 0.00 0.00
KRAS G13V non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
KRAS G13V non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
KRAS G13V non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
KRAS G13V non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
KRAS G13V myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
KRAS G13V myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.00
KRAS G13V myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
KRAS G13V myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
KRAS G13V adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
KRAS G13V adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS G13V ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
KRAS G13V ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
KRAS G13V ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
KRAS G13V ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
KRAS G13V ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
KRAS G13V thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
KRAS G13V thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
KRAS G13V thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
KRAS G13V thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS G13V thyroid cancer White 0 803 0.00 0.00 0.00 0.00
KRAS G13V cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
KRAS G13V cervical cancer Black 0 19 0.00 0.00 0.00 0.00
KRAS G13V cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
KRAS G13V cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
KRAS G13V cervical cancer White 0 228 0.00 0.00 0.00 0.00
KRAS G13V hepatobiliary cancer Asian 0 98 0.00 0.00 0.00 0.00
KRAS G13V hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
KRAS G13V hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
KRAS G13V hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
KRAS G13V hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
KRAS G13V kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
KRAS G13V kidney cancer Black 0 77 0.00 0.00 0.00 0.00
KRAS G13V kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS G13V kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G13V kidney cancer White 0 1113 0.00 0.00 0.00 0.00
KRAS G13V mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
KRAS G13V mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
KRAS G13V mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
KRAS G13V mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
KRAS G13V cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS G13V cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS G13V cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
KRAS G13V cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
KRAS G13V cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
KRAS G13V cns cancer White 0 3331 0.00 0.00 0.00 0.00
KRAS G13V prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
KRAS G13V prostate cancer Black 0 175 0.00 0.00 0.00 0.00
KRAS G13V prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS G13V prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
KRAS G13V prostate cancer White 0 1882 0.00 0.00 0.00 0.00
KRAS G13V anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
KRAS G13V anal cancer White 0 126 0.00 0.00 0.00 0.00
KRAS G13V neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
KRAS G13V neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
KRAS G13V neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
KRAS G13V bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
KRAS G13V bladder cancer Black 0 43 0.00 0.00 0.00 0.00
KRAS G13V bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS G13V bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
KRAS G13V bladder cancer White 0 1311 0.00 0.00 0.00 0.00
KRAS G13V b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
KRAS G13V b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
KRAS G13V b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
KRAS G13V small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
KRAS G13V small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
KRAS G13V small bowel cancer White 0 150 0.00 0.00 0.00 0.00
KRAS G13V sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS G13V sex cord stromal tumor White 0 69 0.00 0.00 0.00 0.00
KRAS G13V bone cancer Asian 0 30 0.00 0.00 0.00 0.00
KRAS G13V bone cancer Black 0 32 0.00 0.00 0.00 0.00
KRAS G13V bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
KRAS G13V bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS G13V bone cancer White 0 391 0.00 0.00 0.00 0.00
KRAS G13V vaginal cancer White 0 68 0.00 0.00 0.00 0.01
KRAS G13V thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
KRAS G13V thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
KRAS G13V thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS G13V ampullary cancer White 0 86 0.00 0.00 0.00 0.01
KRAS G13V small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
KRAS G13V small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
KRAS G13V small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
KRAS G13V mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS G13V mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS G13V mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS G13V mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS G13V germ cell tumor Asian 0 36 0.00 0.00 0.00 0.01
KRAS G13V germ cell tumor Black 0 23 0.00 0.00 0.00 0.01
KRAS G13V germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
KRAS G13V germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.01
KRAS G13V germ cell tumor White 1 603 0.00 0.00 0.00 0.00
KRAS G13V nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.01
KRAS G13V nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS G13V nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
KRAS G13V penile cancer White 0 20 0.00 0.00 0.00 0.03
KRAS G13V pheochromocytoma White 0 15 0.00 0.00 0.00 0.05
KRAS G13V pineal tumor White 0 14 0.00 0.00 0.00 0.02
KRAS G13V b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
KRAS G13V b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
KRAS G13V b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
KRAS G13V b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
KRAS G13V b cell lymphoma White 0 859 0.00 0.00 0.00 0.00
KRAS G13V non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
KRAS G13V t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.01
KRAS G13V t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.01
KRAS G13V retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS G13V retinoblastoma White 0 25 0.00 0.00 0.00 0.02
KRAS G13V hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
KRAS G13V lung cancer White 0 17 0.00 0.00 0.00 0.04
KRAS G13V peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
KRAS G13V parathyroid cancer White 1 14 0.08 0.06 0.00 0.26
KRAS Q61H appendiceal cancer Black 0 17 0.01 0.01 0.00 0.06
KRAS Q61H appendiceal cancer Race:NA 2 33 0.04 0.02 0.00 0.13
KRAS Q61H appendiceal cancer White 1 280 0.01 0.00 0.00 0.02
KRAS Q61H colorectal cancer Asian 1 313 0.01 0.01 0.00 0.01
KRAS Q61H colorectal cancer Black 4 515 0.01 0.01 0.00 0.01
KRAS Q61H colorectal cancer Race:NA 11 804 0.01 0.01 0.01 0.02
KRAS Q61H colorectal cancer Native American 0 17 0.01 0.01 0.00 0.02
KRAS Q61H colorectal cancer Race:Other 1 139 0.01 0.01 0.00 0.02
KRAS Q61H colorectal cancer White 47 4925 0.01 0.01 0.01 0.01
KRAS Q61H cancer of unknown primary Asian 0 73 0.01 0.01 0.00 0.01
KRAS Q61H cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.01
KRAS Q61H cancer of unknown primary Race:NA 1 286 0.01 0.01 0.00 0.01
KRAS Q61H cancer of unknown primary Race:Other 0 36 0.01 0.01 0.00 0.02
KRAS Q61H cancer of unknown primary White 14 1465 0.01 0.01 0.00 0.01
KRAS Q61H non-small cell lung cancer Asian 4 624 0.01 0.01 0.00 0.02
KRAS Q61H non-small cell lung cancer Black 12 717 0.01 0.01 0.01 0.02
KRAS Q61H non-small cell lung cancer Race:NA 6 849 0.01 0.01 0.00 0.02
KRAS Q61H non-small cell lung cancer Native American 0 17 0.01 0.01 0.00 0.02
KRAS Q61H non-small cell lung cancer Race:Other 1 165 0.01 0.01 0.00 0.02
KRAS Q61H non-small cell lung cancer Race:Undefined 1 10 0.02 0.01 0.01 0.04
KRAS Q61H non-small cell lung cancer White 107 7745 0.01 0.01 0.01 0.02
KRAS Q61H breast cancer Asian 0 334 0.00 0.00 0.00 0.00
KRAS Q61H breast cancer Black 0 526 0.00 0.00 0.00 0.00
KRAS Q61H breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
KRAS Q61H breast cancer Native American 0 11 0.00 0.00 0.00 0.00
KRAS Q61H breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
KRAS Q61H breast cancer White 0 5174 0.00 0.00 0.00 0.00
KRAS Q61H soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
KRAS Q61H soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
KRAS Q61H soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
KRAS Q61H soft tissue sarcoma Race:Other 1 73 0.01 0.00 0.00 0.04
KRAS Q61H soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
KRAS Q61H pancreatic cancer Asian 3 100 0.04 0.04 0.02 0.06
KRAS Q61H pancreatic cancer Black 4 88 0.04 0.04 0.02 0.07
KRAS Q61H pancreatic cancer Race:NA 7 231 0.04 0.03 0.02 0.05
KRAS Q61H pancreatic cancer Race:Other 4 34 0.04 0.04 0.03 0.11
KRAS Q61H pancreatic cancer White 68 2038 0.03 0.03 0.03 0.04
KRAS Q61H leukemia Asian 0 37 0.00 0.00 0.00 0.01
KRAS Q61H leukemia Black 0 69 0.00 0.00 0.00 0.01
KRAS Q61H leukemia Race:NA 2 777 0.00 0.00 0.00 0.01
KRAS Q61H leukemia Race:Other 0 13 0.00 0.00 0.00 0.01
KRAS Q61H leukemia White 2 662 0.00 0.00 0.00 0.01
KRAS Q61H melanoma Asian 0 33 0.00 0.00 0.00 0.01
KRAS Q61H melanoma Black 1 34 0.01 0.00 0.00 0.06
KRAS Q61H melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
KRAS Q61H melanoma Race:Other 0 26 0.00 0.00 0.00 0.02
KRAS Q61H melanoma White 1 2348 0.00 0.00 0.00 0.00
KRAS Q61H head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
KRAS Q61H head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
KRAS Q61H head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
KRAS Q61H head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
KRAS Q61H head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
KRAS Q61H uterine cancer Asian 1 108 0.00 0.00 0.00 0.01
KRAS Q61H uterine cancer Black 0 163 0.00 0.00 0.00 0.01
KRAS Q61H uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.01
KRAS Q61H uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.01
KRAS Q61H uterine cancer White 5 1754 0.00 0.00 0.00 0.00
KRAS Q61H non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
KRAS Q61H non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
KRAS Q61H non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
KRAS Q61H non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
KRAS Q61H myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
KRAS Q61H myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.00
KRAS Q61H myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
KRAS Q61H myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
KRAS Q61H adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
KRAS Q61H adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS Q61H ovarian cancer Asian 0 134 0.00 0.00 0.00 0.01
KRAS Q61H ovarian cancer Black 0 74 0.00 0.00 0.00 0.01
KRAS Q61H ovarian cancer Race:NA 3 239 0.01 0.00 0.00 0.02
KRAS Q61H ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.01
KRAS Q61H ovarian cancer White 6 1852 0.00 0.00 0.00 0.01
KRAS Q61H esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
KRAS Q61H esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
KRAS Q61H esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
KRAS Q61H esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
KRAS Q61H esophagogastric cancer White 2 1379 0.00 0.00 0.00 0.00
KRAS Q61H thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
KRAS Q61H thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
KRAS Q61H thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
KRAS Q61H thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS Q61H thyroid cancer White 0 803 0.00 0.00 0.00 0.00
KRAS Q61H cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
KRAS Q61H cervical cancer Black 0 19 0.00 0.00 0.00 0.00
KRAS Q61H cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
KRAS Q61H cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
KRAS Q61H cervical cancer White 0 228 0.00 0.00 0.00 0.00
KRAS Q61H hepatobiliary cancer Asian 0 98 0.01 0.01 0.00 0.02
KRAS Q61H hepatobiliary cancer Black 1 64 0.01 0.01 0.00 0.03
KRAS Q61H hepatobiliary cancer Race:NA 1 235 0.01 0.01 0.00 0.02
KRAS Q61H hepatobiliary cancer Race:Other 0 25 0.01 0.01 0.00 0.02
KRAS Q61H hepatobiliary cancer White 12 948 0.01 0.01 0.01 0.02
KRAS Q61H kidney cancer Asian 0 33 0.00 0.00 0.00 0.01
KRAS Q61H kidney cancer Black 0 77 0.00 0.00 0.00 0.00
KRAS Q61H kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS Q61H kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.01
KRAS Q61H kidney cancer White 1 1113 0.00 0.00 0.00 0.00
KRAS Q61H mature t and nk neoplasms Asian 0 12 0.01 0.01 0.00 0.04
KRAS Q61H mature t and nk neoplasms Black 0 18 0.01 0.01 0.00 0.04
KRAS Q61H mature t and nk neoplasms Race:NA 0 10 0.01 0.01 0.00 0.04
KRAS Q61H mature t and nk neoplasms White 2 188 0.01 0.01 0.00 0.03
KRAS Q61H cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS Q61H cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS Q61H cns cancer Race:NA 2 817 0.00 0.00 0.00 0.00
KRAS Q61H cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
KRAS Q61H cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.01
KRAS Q61H cns cancer White 1 3331 0.00 0.00 0.00 0.00
KRAS Q61H prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
KRAS Q61H prostate cancer Black 0 175 0.00 0.00 0.00 0.00
KRAS Q61H prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS Q61H prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
KRAS Q61H prostate cancer White 1 1882 0.00 0.00 0.00 0.00
KRAS Q61H anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
KRAS Q61H anal cancer White 0 126 0.00 0.00 0.00 0.00
KRAS Q61H neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.02
KRAS Q61H neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.02
KRAS Q61H neuroendocrine tumors White 1 283 0.00 0.00 0.00 0.01
KRAS Q61H bladder cancer Asian 0 40 0.00 0.00 0.00 0.01
KRAS Q61H bladder cancer Black 0 43 0.00 0.00 0.00 0.01
KRAS Q61H bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.01
KRAS Q61H bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.01
KRAS Q61H bladder cancer White 3 1311 0.00 0.00 0.00 0.00
KRAS Q61H b-lymphoblastic leukemia/lymphoma Asian 0 17 0.01 0.01 0.00 0.04
KRAS Q61H b-lymphoblastic leukemia/lymphoma Race:NA 2 92 0.02 0.01 0.00 0.04
KRAS Q61H b-lymphoblastic leukemia/lymphoma White 1 125 0.01 0.01 0.00 0.03
KRAS Q61H small bowel cancer Black 2 25 0.04 0.03 0.01 0.15
KRAS Q61H small bowel cancer Race:NA 0 22 0.02 0.02 0.00 0.07
KRAS Q61H small bowel cancer White 3 150 0.02 0.02 0.01 0.05
KRAS Q61H sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS Q61H sex cord stromal tumor White 0 69 0.00 0.00 0.00 0.00
KRAS Q61H bone cancer Asian 1 30 0.02 0.00 0.00 0.08
KRAS Q61H bone cancer Black 0 32 0.00 0.00 0.00 0.02
KRAS Q61H bone cancer Race:NA 0 86 0.00 0.00 0.00 0.01
KRAS Q61H bone cancer Race:Other 0 29 0.00 0.00 0.00 0.02
KRAS Q61H bone cancer White 0 391 0.00 0.00 0.00 0.01
KRAS Q61H vaginal cancer White 0 68 0.00 0.00 0.00 0.01
KRAS Q61H thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
KRAS Q61H thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
KRAS Q61H thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS Q61H ampullary cancer White 2 86 0.02 0.02 0.00 0.07
KRAS Q61H small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
KRAS Q61H small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
KRAS Q61H small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
KRAS Q61H mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS Q61H mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS Q61H mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS Q61H mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor White 0 603 0.00 0.00 0.00 0.00
KRAS Q61H nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.01
KRAS Q61H nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS Q61H nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
KRAS Q61H penile cancer White 0 20 0.00 0.00 0.00 0.03
KRAS Q61H pheochromocytoma White 0 15 0.00 0.00 0.00 0.05
KRAS Q61H pineal tumor White 0 14 0.00 0.00 0.00 0.02
KRAS Q61H b cell lymphoma Asian 0 21 0.01 0.01 0.00 0.03
KRAS Q61H b cell lymphoma Black 0 25 0.01 0.01 0.00 0.03
KRAS Q61H b cell lymphoma Race:NA 1 42 0.01 0.01 0.00 0.04
KRAS Q61H b cell lymphoma Race:Other 0 12 0.01 0.01 0.00 0.03
KRAS Q61H b cell lymphoma White 9 859 0.01 0.01 0.00 0.02
KRAS Q61H non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
KRAS Q61H t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.01
KRAS Q61H t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.01
KRAS Q61H retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS Q61H retinoblastoma White 0 25 0.00 0.00 0.00 0.02
KRAS Q61H hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
KRAS Q61H lung cancer White 0 17 0.00 0.00 0.00 0.04
KRAS Q61H peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
KRAS Q61H parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
KRAS Q61K appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
KRAS Q61K appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
KRAS Q61K appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer Black 0 515 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer Native American 0 17 0.00 0.00 0.00 0.01
KRAS Q61K colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer White 12 4925 0.00 0.00 0.00 0.00
KRAS Q61K cancer of unknown primary Asian 1 73 0.01 0.00 0.00 0.04
KRAS Q61K cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
KRAS Q61K cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
KRAS Q61K cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.01
KRAS Q61K cancer of unknown primary White 0 1465 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer Race:NA 1 849 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer White 1 7745 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer Asian 0 334 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer Black 0 526 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer Native American 0 11 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer White 0 5174 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
KRAS Q61K pancreatic cancer Asian 1 100 0.00 0.00 0.00 0.02
KRAS Q61K pancreatic cancer Black 0 88 0.00 0.00 0.00 0.01
KRAS Q61K pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
KRAS Q61K pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.01
KRAS Q61K pancreatic cancer White 2 2038 0.00 0.00 0.00 0.00
KRAS Q61K leukemia Asian 0 37 0.00 0.00 0.00 0.00
KRAS Q61K leukemia Black 0 69 0.00 0.00 0.00 0.00
KRAS Q61K leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
KRAS Q61K leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
KRAS Q61K leukemia White 0 662 0.00 0.00 0.00 0.00
KRAS Q61K melanoma Asian 0 33 0.00 0.00 0.00 0.00
KRAS Q61K melanoma Black 0 34 0.00 0.00 0.00 0.00
KRAS Q61K melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
KRAS Q61K melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS Q61K melanoma White 0 2348 0.00 0.00 0.00 0.00
KRAS Q61K head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
KRAS Q61K head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
KRAS Q61K head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
KRAS Q61K head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
KRAS Q61K head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
KRAS Q61K uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
KRAS Q61K uterine cancer Black 0 163 0.00 0.00 0.00 0.00
KRAS Q61K uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
KRAS Q61K uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
KRAS Q61K uterine cancer White 1 1754 0.00 0.00 0.00 0.00
KRAS Q61K non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
KRAS Q61K non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
KRAS Q61K non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
KRAS Q61K non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
KRAS Q61K myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
KRAS Q61K myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.00
KRAS Q61K myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
KRAS Q61K myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
KRAS Q61K adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS Q61K adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS Q61K ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
KRAS Q61K ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
KRAS Q61K ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
KRAS Q61K ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
KRAS Q61K ovarian cancer White 1 1852 0.00 0.00 0.00 0.00
KRAS Q61K esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
KRAS Q61K esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
KRAS Q61K esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
KRAS Q61K esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
KRAS Q61K esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
KRAS Q61K thyroid cancer Asian 0 66 0.00 0.00 0.00 0.01
KRAS Q61K thyroid cancer Black 0 40 0.00 0.00 0.00 0.01
KRAS Q61K thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.01
KRAS Q61K thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.01
KRAS Q61K thyroid cancer White 1 803 0.00 0.00 0.00 0.00
KRAS Q61K cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
KRAS Q61K cervical cancer Black 0 19 0.00 0.00 0.00 0.00
KRAS Q61K cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
KRAS Q61K cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
KRAS Q61K cervical cancer White 0 228 0.00 0.00 0.00 0.00
KRAS Q61K hepatobiliary cancer Asian 0 98 0.00 0.00 0.00 0.00
KRAS Q61K hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
KRAS Q61K hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
KRAS Q61K hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
KRAS Q61K hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
KRAS Q61K kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
KRAS Q61K kidney cancer Black 0 77 0.00 0.00 0.00 0.00
KRAS Q61K kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS Q61K kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS Q61K kidney cancer White 0 1113 0.00 0.00 0.00 0.00
KRAS Q61K mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
KRAS Q61K mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
KRAS Q61K mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
KRAS Q61K mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer Race:NA 1 817 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer White 1 3331 0.00 0.00 0.00 0.00
KRAS Q61K prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
KRAS Q61K prostate cancer Black 0 175 0.00 0.00 0.00 0.00
KRAS Q61K prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS Q61K prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
KRAS Q61K prostate cancer White 1 1882 0.00 0.00 0.00 0.00
KRAS Q61K anal cancer Race:NA 0 13 0.01 0.00 0.00 0.05
KRAS Q61K anal cancer White 1 126 0.01 0.01 0.00 0.03
KRAS Q61K neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.02
KRAS Q61K neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.02
KRAS Q61K neuroendocrine tumors White 1 283 0.00 0.00 0.00 0.01
KRAS Q61K bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
KRAS Q61K bladder cancer Black 0 43 0.00 0.00 0.00 0.00
KRAS Q61K bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS Q61K bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
KRAS Q61K bladder cancer White 0 1311 0.00 0.00 0.00 0.00
KRAS Q61K b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
KRAS Q61K b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
KRAS Q61K b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
KRAS Q61K small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
KRAS Q61K small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
KRAS Q61K small bowel cancer White 0 150 0.00 0.00 0.00 0.00
KRAS Q61K sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS Q61K sex cord stromal tumor White 0 69 0.00 0.00 0.00 0.00
KRAS Q61K bone cancer Asian 0 30 0.00 0.00 0.00 0.00
KRAS Q61K bone cancer Black 0 32 0.00 0.00 0.00 0.00
KRAS Q61K bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
KRAS Q61K bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS Q61K bone cancer White 0 391 0.00 0.00 0.00 0.00
KRAS Q61K vaginal cancer White 0 68 0.00 0.00 0.00 0.01
KRAS Q61K thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
KRAS Q61K thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
KRAS Q61K thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS Q61K ampullary cancer White 0 86 0.00 0.00 0.00 0.00
KRAS Q61K small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
KRAS Q61K small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
KRAS Q61K small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
KRAS Q61K mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS Q61K mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS Q61K mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS Q61K mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor White 0 603 0.00 0.00 0.00 0.00
KRAS Q61K nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
KRAS Q61K nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS Q61K nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
KRAS Q61K penile cancer White 0 20 0.00 0.00 0.00 0.03
KRAS Q61K pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
KRAS Q61K pineal tumor White 0 14 0.00 0.00 0.00 0.04
KRAS Q61K b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
KRAS Q61K b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
KRAS Q61K b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
KRAS Q61K b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
KRAS Q61K b cell lymphoma White 0 859 0.00 0.00 0.00 0.00
KRAS Q61K non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.02
KRAS Q61K t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
KRAS Q61K t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
KRAS Q61K retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS Q61K retinoblastoma White 0 25 0.00 0.00 0.00 0.02
KRAS Q61K hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
KRAS Q61K lung cancer White 0 17 0.00 0.00 0.00 0.04
KRAS Q61K peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
KRAS Q61K parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
KRAS Q61L appendiceal cancer Black 0 17 0.00 0.00 0.00 0.02
KRAS Q61L appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.02
KRAS Q61L appendiceal cancer White 1 280 0.00 0.00 0.00 0.01
KRAS Q61L colorectal cancer Asian 2 313 0.00 0.00 0.00 0.01
KRAS Q61L colorectal cancer Black 0 515 0.00 0.00 0.00 0.01
KRAS Q61L colorectal cancer Race:NA 7 804 0.01 0.00 0.00 0.01
KRAS Q61L colorectal cancer Native American 0 17 0.00 0.00 0.00 0.02
KRAS Q61L colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.01
KRAS Q61L colorectal cancer White 15 4925 0.00 0.00 0.00 0.00
KRAS Q61L cancer of unknown primary Asian 1 73 0.00 0.00 0.00 0.02
KRAS Q61L cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.01
KRAS Q61L cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
KRAS Q61L cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.01
KRAS Q61L cancer of unknown primary White 2 1465 0.00 0.00 0.00 0.00
KRAS Q61L non-small cell lung cancer Asian 3 624 0.00 0.00 0.00 0.01
KRAS Q61L non-small cell lung cancer Black 1 717 0.00 0.00 0.00 0.01
KRAS Q61L non-small cell lung cancer Race:NA 4 849 0.00 0.00 0.00 0.01
KRAS Q61L non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.01
KRAS Q61L non-small cell lung cancer Race:Other 1 165 0.00 0.00 0.00 0.01
KRAS Q61L non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.01
KRAS Q61L non-small cell lung cancer White 28 7745 0.00 0.00 0.00 0.00
KRAS Q61L breast cancer Asian 0 334 0.00 0.00 0.00 0.00
KRAS Q61L breast cancer Black 0 526 0.00 0.00 0.00 0.00
KRAS Q61L breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
KRAS Q61L breast cancer Native American 0 11 0.00 0.00 0.00 0.00
KRAS Q61L breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
KRAS Q61L breast cancer White 1 5174 0.00 0.00 0.00 0.00
KRAS Q61L soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
KRAS Q61L soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
KRAS Q61L soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
KRAS Q61L soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
KRAS Q61L soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
KRAS Q61L pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.01
KRAS Q61L pancreatic cancer Black 0 88 0.00 0.00 0.00 0.01
KRAS Q61L pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
KRAS Q61L pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.01
KRAS Q61L pancreatic cancer White 6 2038 0.00 0.00 0.00 0.00
KRAS Q61L leukemia Asian 0 37 0.00 0.00 0.00 0.01
KRAS Q61L leukemia Black 0 69 0.00 0.00 0.00 0.01
KRAS Q61L leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
KRAS Q61L leukemia Race:Other 1 13 0.06 0.03 0.00 0.24
KRAS Q61L leukemia White 0 662 0.00 0.00 0.00 0.00
KRAS Q61L melanoma Asian 0 33 0.00 0.00 0.00 0.00
KRAS Q61L melanoma Black 0 34 0.00 0.00 0.00 0.00
KRAS Q61L melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
KRAS Q61L melanoma Race:Other 0 26 0.00 0.00 0.00 0.01
KRAS Q61L melanoma White 2 2348 0.00 0.00 0.00 0.00
KRAS Q61L head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
KRAS Q61L head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
KRAS Q61L head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
KRAS Q61L head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
KRAS Q61L head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
KRAS Q61L uterine cancer Asian 0 108 0.00 0.00 0.00 0.01
KRAS Q61L uterine cancer Black 1 163 0.00 0.00 0.00 0.02
KRAS Q61L uterine cancer Race:NA 1 190 0.00 0.00 0.00 0.01
KRAS Q61L uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.01
KRAS Q61L uterine cancer White 0 1754 0.00 0.00 0.00 0.00
KRAS Q61L non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
KRAS Q61L non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
KRAS Q61L non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
KRAS Q61L non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
KRAS Q61L myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
KRAS Q61L myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.00
KRAS Q61L myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
KRAS Q61L myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
KRAS Q61L adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
KRAS Q61L adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS Q61L ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
KRAS Q61L ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
KRAS Q61L ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
KRAS Q61L ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
KRAS Q61L ovarian cancer White 1 1852 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
KRAS Q61L thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
KRAS Q61L thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
KRAS Q61L thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
KRAS Q61L thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
KRAS Q61L thyroid cancer White 0 803 0.00 0.00 0.00 0.00
KRAS Q61L cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
KRAS Q61L cervical cancer Black 0 19 0.00 0.00 0.00 0.00
KRAS Q61L cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
KRAS Q61L cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
KRAS Q61L cervical cancer White 0 228 0.00 0.00 0.00 0.00
KRAS Q61L hepatobiliary cancer Asian 0 98 0.00 0.00 0.00 0.01
KRAS Q61L hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.01
KRAS Q61L hepatobiliary cancer Race:NA 1 235 0.00 0.00 0.00 0.01
KRAS Q61L hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.01
KRAS Q61L hepatobiliary cancer White 1 948 0.00 0.00 0.00 0.00
KRAS Q61L kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
KRAS Q61L kidney cancer Black 0 77 0.00 0.00 0.00 0.00
KRAS Q61L kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS Q61L kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS Q61L kidney cancer White 0 1113 0.00 0.00 0.00 0.00
KRAS Q61L mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
KRAS Q61L mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
KRAS Q61L mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
KRAS Q61L mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer Race:NA 1 817 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer White 1 3331 0.00 0.00 0.00 0.00
KRAS Q61L prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
KRAS Q61L prostate cancer Black 0 175 0.00 0.00 0.00 0.00
KRAS Q61L prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS Q61L prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
KRAS Q61L prostate cancer White 1 1882 0.00 0.00 0.00 0.00
KRAS Q61L anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
KRAS Q61L anal cancer White 0 126 0.00 0.00 0.00 0.00
KRAS Q61L neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
KRAS Q61L neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
KRAS Q61L neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
KRAS Q61L bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
KRAS Q61L bladder cancer Black 0 43 0.00 0.00 0.00 0.01
KRAS Q61L bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS Q61L bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.01
KRAS Q61L bladder cancer White 1 1311 0.00 0.00 0.00 0.00
KRAS Q61L b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
KRAS Q61L b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
KRAS Q61L b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
KRAS Q61L small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
KRAS Q61L small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
KRAS Q61L small bowel cancer White 0 150 0.00 0.00 0.00 0.00
KRAS Q61L sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS Q61L sex cord stromal tumor White 0 69 0.00 0.00 0.00 0.00
KRAS Q61L bone cancer Asian 0 30 0.00 0.00 0.00 0.00
KRAS Q61L bone cancer Black 0 32 0.00 0.00 0.00 0.00
KRAS Q61L bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
KRAS Q61L bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS Q61L bone cancer White 0 391 0.00 0.00 0.00 0.00
KRAS Q61L vaginal cancer White 0 68 0.00 0.00 0.00 0.01
KRAS Q61L thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
KRAS Q61L thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
KRAS Q61L thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS Q61L ampullary cancer White 0 86 0.00 0.00 0.00 0.01
KRAS Q61L small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
KRAS Q61L small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
KRAS Q61L small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
KRAS Q61L mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS Q61L mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS Q61L mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS Q61L mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor White 0 603 0.00 0.00 0.00 0.00
KRAS Q61L nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.01
KRAS Q61L nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS Q61L nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
KRAS Q61L penile cancer White 1 20 0.06 0.04 0.00 0.18
KRAS Q61L pheochromocytoma White 0 15 0.00 0.00 0.00 0.05
KRAS Q61L pineal tumor White 0 14 0.00 0.00 0.00 0.02
KRAS Q61L b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.01
KRAS Q61L b cell lymphoma Black 0 25 0.00 0.00 0.00 0.01
KRAS Q61L b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.01
KRAS Q61L b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.01
KRAS Q61L b cell lymphoma White 1 859 0.00 0.00 0.00 0.00
KRAS Q61L non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
KRAS Q61L t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.01
KRAS Q61L t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.01
KRAS Q61L retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS Q61L retinoblastoma White 0 25 0.00 0.00 0.00 0.02
KRAS Q61L hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
KRAS Q61L lung cancer White 0 17 0.00 0.00 0.00 0.04
KRAS Q61L peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
KRAS Q61L parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
KRAS Q61R appendiceal cancer Black 0 17 0.00 0.00 0.00 0.03
KRAS Q61R appendiceal cancer Race:NA 1 33 0.02 0.01 0.00 0.09
KRAS Q61R appendiceal cancer White 0 280 0.00 0.00 0.00 0.01
KRAS Q61R colorectal cancer Asian 2 313 0.00 0.00 0.00 0.01
KRAS Q61R colorectal cancer Black 0 515 0.00 0.00 0.00 0.00
KRAS Q61R colorectal cancer Race:NA 3 804 0.00 0.00 0.00 0.01
KRAS Q61R colorectal cancer Native American 0 17 0.00 0.00 0.00 0.01
KRAS Q61R colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.01
KRAS Q61R colorectal cancer White 15 4925 0.00 0.00 0.00 0.00
KRAS Q61R cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
KRAS Q61R cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
KRAS Q61R cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
KRAS Q61R cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.01
KRAS Q61R cancer of unknown primary White 3 1465 0.00 0.00 0.00 0.00
KRAS Q61R non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
KRAS Q61R non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
KRAS Q61R non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
KRAS Q61R non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.01
KRAS Q61R non-small cell lung cancer Race:Other 1 165 0.00 0.00 0.00 0.01
KRAS Q61R non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.01
KRAS Q61R non-small cell lung cancer White 6 7745 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer Asian 0 334 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer Black 0 526 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer Race:NA 1 3112 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer Native American 0 11 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer White 0 5174 0.00 0.00 0.00 0.00
KRAS Q61R soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
KRAS Q61R soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
KRAS Q61R soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
KRAS Q61R soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
KRAS Q61R soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
KRAS Q61R pancreatic cancer Asian 0 100 0.01 0.01 0.00 0.02
KRAS Q61R pancreatic cancer Black 1 88 0.01 0.01 0.00 0.03
KRAS Q61R pancreatic cancer Race:NA 1 231 0.01 0.01 0.00 0.02
KRAS Q61R pancreatic cancer Race:Other 1 34 0.02 0.01 0.00 0.05
KRAS Q61R pancreatic cancer White 35 2038 0.02 0.02 0.01 0.02
KRAS Q61R leukemia Asian 0 37 0.00 0.00 0.00 0.00
KRAS Q61R leukemia Black 0 69 0.00 0.00 0.00 0.00
KRAS Q61R leukemia Race:NA 1 777 0.00 0.00 0.00 0.00
KRAS Q61R leukemia Race:Other 0 13 0.00 0.00 0.00 0.01
KRAS Q61R leukemia White 0 662 0.00 0.00 0.00 0.00
KRAS Q61R melanoma Asian 0 33 0.00 0.00 0.00 0.01
KRAS Q61R melanoma Black 0 34 0.00 0.00 0.00 0.01
KRAS Q61R melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
KRAS Q61R melanoma Race:Other 0 26 0.00 0.00 0.00 0.01
KRAS Q61R melanoma White 3 2348 0.00 0.00 0.00 0.00
KRAS Q61R head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
KRAS Q61R head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
KRAS Q61R head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
KRAS Q61R head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
KRAS Q61R head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
KRAS Q61R uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
KRAS Q61R uterine cancer Black 0 163 0.00 0.00 0.00 0.00
KRAS Q61R uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
KRAS Q61R uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
KRAS Q61R uterine cancer White 0 1754 0.00 0.00 0.00 0.00
KRAS Q61R non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
KRAS Q61R non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
KRAS Q61R non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
KRAS Q61R non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
KRAS Q61R myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
KRAS Q61R myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.00
KRAS Q61R myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
KRAS Q61R myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
KRAS Q61R adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
KRAS Q61R adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
KRAS Q61R ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
KRAS Q61R ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
KRAS Q61R ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
KRAS Q61R ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
KRAS Q61R ovarian cancer White 2 1852 0.00 0.00 0.00 0.00
KRAS Q61R esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
KRAS Q61R esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
KRAS Q61R esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
KRAS Q61R esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
KRAS Q61R esophagogastric cancer White 1 1379 0.00 0.00 0.00 0.00
KRAS Q61R thyroid cancer Asian 0 66 0.01 0.01 0.00 0.03
KRAS Q61R thyroid cancer Black 1 40 0.02 0.02 0.00 0.05
KRAS Q61R thyroid cancer Race:NA 4 79 0.03 0.02 0.01 0.08
KRAS Q61R thyroid cancer Race:Other 0 26 0.02 0.01 0.00 0.04
KRAS Q61R thyroid cancer White 10 803 0.01 0.01 0.01 0.02
KRAS Q61R cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
KRAS Q61R cervical cancer Black 0 19 0.00 0.00 0.00 0.00
KRAS Q61R cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
KRAS Q61R cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
KRAS Q61R cervical cancer White 0 228 0.00 0.00 0.00 0.00
KRAS Q61R hepatobiliary cancer Asian 0 98 0.00 0.00 0.00 0.00
KRAS Q61R hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.01
KRAS Q61R hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
KRAS Q61R hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.01
KRAS Q61R hepatobiliary cancer White 2 948 0.00 0.00 0.00 0.00
KRAS Q61R kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
KRAS Q61R kidney cancer Black 0 77 0.00 0.00 0.00 0.00
KRAS Q61R kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS Q61R kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS Q61R kidney cancer White 0 1113 0.00 0.00 0.00 0.00
KRAS Q61R mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
KRAS Q61R mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
KRAS Q61R mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
KRAS Q61R mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer Asian 0 154 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer Black 0 131 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer Race:NA 1 817 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer White 3 3331 0.00 0.00 0.00 0.00
KRAS Q61R prostate cancer Asian 0 62 0.00 0.00 0.00 0.01
KRAS Q61R prostate cancer Black 1 175 0.00 0.00 0.00 0.02
KRAS Q61R prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
KRAS Q61R prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.01
KRAS Q61R prostate cancer White 0 1882 0.00 0.00 0.00 0.00
KRAS Q61R anal cancer Race:NA 0 13 0.00 0.00 0.00 0.00
KRAS Q61R anal cancer White 0 126 0.00 0.00 0.00 0.00
KRAS Q61R neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
KRAS Q61R neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
KRAS Q61R neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
KRAS Q61R bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
KRAS Q61R bladder cancer Black 0 43 0.00 0.00 0.00 0.00
KRAS Q61R bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
KRAS Q61R bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.01
KRAS Q61R bladder cancer White 1 1311 0.00 0.00 0.00 0.00
KRAS Q61R b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
KRAS Q61R b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
KRAS Q61R b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
KRAS Q61R small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
KRAS Q61R small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
KRAS Q61R small bowel cancer White 0 150 0.00 0.00 0.00 0.00
KRAS Q61R sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
KRAS Q61R sex cord stromal tumor White 0 69 0.00 0.00 0.00 0.00
KRAS Q61R bone cancer Asian 0 30 0.00 0.00 0.00 0.00
KRAS Q61R bone cancer Black 0 32 0.00 0.00 0.00 0.00
KRAS Q61R bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
KRAS Q61R bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
KRAS Q61R bone cancer White 0 391 0.00 0.00 0.00 0.00
KRAS Q61R vaginal cancer White 0 68 0.00 0.00 0.00 0.01
KRAS Q61R thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
KRAS Q61R thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
KRAS Q61R thymic tumor White 0 108 0.00 0.00 0.00 0.00
KRAS Q61R ampullary cancer White 2 86 0.02 0.02 0.00 0.07
KRAS Q61R small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
KRAS Q61R small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
KRAS Q61R small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
KRAS Q61R mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
KRAS Q61R mesothelioma Black 0 10 0.00 0.00 0.00 0.00
KRAS Q61R mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
KRAS Q61R mesothelioma White 0 434 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor White 0 603 0.00 0.00 0.00 0.00
KRAS Q61R nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.01
KRAS Q61R nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.01
KRAS Q61R nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
KRAS Q61R penile cancer White 0 20 0.00 0.00 0.00 0.03
KRAS Q61R pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
KRAS Q61R pineal tumor White 0 14 0.00 0.00 0.00 0.02
KRAS Q61R b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.01
KRAS Q61R b cell lymphoma Black 0 25 0.00 0.00 0.00 0.01
KRAS Q61R b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.01
KRAS Q61R b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.02
KRAS Q61R b cell lymphoma White 3 859 0.00 0.00 0.00 0.01
KRAS Q61R non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.02
KRAS Q61R t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
KRAS Q61R t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
KRAS Q61R retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
KRAS Q61R retinoblastoma White 0 25 0.00 0.00 0.00 0.02
KRAS Q61R hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
KRAS Q61R lung cancer White 0 17 0.00 0.00 0.00 0.03
KRAS Q61R peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
KRAS Q61R parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
HRAS G12A appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS G12A appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS G12A appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary White 0 1461 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
HRAS G12A breast cancer Asian 0 334 0.00 0.00 0.00 0.00
HRAS G12A breast cancer Black 0 525 0.00 0.00 0.00 0.00
HRAS G12A breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
HRAS G12A breast cancer Native American 0 11 0.00 0.00 0.00 0.00
HRAS G12A breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS G12A breast cancer White 0 5174 0.00 0.00 0.00 0.00
HRAS G12A pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS G12A pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS G12A pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS G12A pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS G12A pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
HRAS G12A leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS G12A leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS G12A leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS G12A leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS G12A leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS G12A melanoma Asian 0 33 0.00 0.00 0.00 0.00
HRAS G12A melanoma Black 0 34 0.00 0.00 0.00 0.00
HRAS G12A melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
HRAS G12A melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G12A melanoma White 0 2348 0.00 0.00 0.00 0.00
HRAS G12A head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
HRAS G12A head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
HRAS G12A head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
HRAS G12A head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
HRAS G12A head and neck cancer White 1 1264 0.00 0.00 0.00 0.00
HRAS G12A uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS G12A uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS G12A uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS G12A uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS G12A uterine cancer White 0 1750 0.00 0.00 0.00 0.00
HRAS G12A non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
HRAS G12A non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
HRAS G12A non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
HRAS G12A non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
HRAS G12A myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS G12A myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS G12A myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS G12A myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS G12A adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
HRAS G12A adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma Black 0 190 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma Race:NA 0 347 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma White 0 1976 0.00 0.00 0.00 0.00
HRAS G12A ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS G12A ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS G12A ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS G12A ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12A ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
HRAS G12A thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
HRAS G12A thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
HRAS G12A thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
HRAS G12A thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G12A thyroid cancer White 0 803 0.00 0.00 0.00 0.00
HRAS G12A cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
HRAS G12A cervical cancer Black 0 19 0.00 0.00 0.00 0.00
HRAS G12A cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
HRAS G12A cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
HRAS G12A cervical cancer White 0 228 0.00 0.00 0.00 0.00
HRAS G12A hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS G12A hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS G12A hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS G12A hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
HRAS G12A hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
HRAS G12A kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS G12A kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS G12A kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G12A kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G12A kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS G12A cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS G12A cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS G12A cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
HRAS G12A cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS G12A cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS G12A cns cancer White 0 3330 0.00 0.00 0.00 0.00
HRAS G12A prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
HRAS G12A prostate cancer Black 0 175 0.00 0.00 0.00 0.00
HRAS G12A prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
HRAS G12A prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
HRAS G12A prostate cancer White 0 1882 0.00 0.00 0.00 0.00
HRAS G12A anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
HRAS G12A anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS G12A neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
HRAS G12A neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
HRAS G12A neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
HRAS G12A bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
HRAS G12A bladder cancer Black 0 43 0.00 0.00 0.00 0.00
HRAS G12A bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G12A bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
HRAS G12A bladder cancer White 0 1310 0.00 0.00 0.00 0.00
HRAS G12A b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS G12A b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS G12A b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS G12A small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS G12A small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS G12A small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS G12A sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
HRAS G12A sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
HRAS G12A bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS G12A bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS G12A bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS G12A bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G12A bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS G12A vaginal cancer White 0 68 0.00 0.00 0.00 0.01
HRAS G12A thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
HRAS G12A thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
HRAS G12A thymic tumor White 0 106 0.00 0.00 0.00 0.00
HRAS G12A ampullary cancer White 0 86 0.00 0.00 0.00 0.00
HRAS G12A small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
HRAS G12A small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
HRAS G12A small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
HRAS G12A mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS G12A mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS G12A mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12A mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS G12A mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS G12A mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS G12A mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS G12A mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS G12A nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.00
HRAS G12A nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS G12A nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS G12A penile cancer White 0 20 0.00 0.00 0.00 0.03
HRAS G12A pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
HRAS G12A pineal tumor White 0 14 0.00 0.00 0.00 0.03
HRAS G12A b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS G12A b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS G12A b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS G12A b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS G12A b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS G12A non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
HRAS G12A t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS G12A t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
HRAS G12A retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS G12A retinoblastoma White 0 25 0.00 0.00 0.00 0.02
HRAS G12A hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
HRAS G12A lung cancer White 0 17 0.00 0.00 0.00 0.02
HRAS G12A peritoneal cancer White 0 11 0.00 0.00 0.00 0.04
HRAS G12A parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
HRAS G12C appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS G12C appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS G12C appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary White 0 1461 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
HRAS G12C breast cancer Asian 0 334 0.00 0.00 0.00 0.00
HRAS G12C breast cancer Black 0 525 0.00 0.00 0.00 0.00
HRAS G12C breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
HRAS G12C breast cancer Native American 0 11 0.00 0.00 0.00 0.00
HRAS G12C breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS G12C breast cancer White 2 5174 0.00 0.00 0.00 0.00
HRAS G12C pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS G12C pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS G12C pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS G12C pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS G12C pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
HRAS G12C leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS G12C leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS G12C leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS G12C leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS G12C leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS G12C melanoma Asian 0 33 0.00 0.00 0.00 0.00
HRAS G12C melanoma Black 0 34 0.00 0.00 0.00 0.00
HRAS G12C melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
HRAS G12C melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G12C melanoma White 0 2348 0.00 0.00 0.00 0.00
HRAS G12C head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
HRAS G12C head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
HRAS G12C head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
HRAS G12C head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
HRAS G12C head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
HRAS G12C uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS G12C uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS G12C uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS G12C uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS G12C uterine cancer White 0 1750 0.00 0.00 0.00 0.00
HRAS G12C non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.02
HRAS G12C non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.02
HRAS G12C non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.01
HRAS G12C non-melanoma skin cancers White 1 436 0.00 0.00 0.00 0.01
HRAS G12C myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS G12C myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS G12C myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS G12C myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS G12C adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
HRAS G12C adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma Black 0 190 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma Race:NA 0 347 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma White 0 1976 0.00 0.00 0.00 0.00
HRAS G12C ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS G12C ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS G12C ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS G12C ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12C ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
HRAS G12C thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
HRAS G12C thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
HRAS G12C thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
HRAS G12C thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G12C thyroid cancer White 0 803 0.00 0.00 0.00 0.00
HRAS G12C cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
HRAS G12C cervical cancer Black 0 19 0.00 0.00 0.00 0.00
HRAS G12C cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
HRAS G12C cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
HRAS G12C cervical cancer White 0 228 0.00 0.00 0.00 0.00
HRAS G12C hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS G12C hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS G12C hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS G12C hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
HRAS G12C hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
HRAS G12C kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS G12C kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS G12C kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G12C kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G12C kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS G12C cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS G12C cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS G12C cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
HRAS G12C cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS G12C cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS G12C cns cancer White 0 3330 0.00 0.00 0.00 0.00
HRAS G12C prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
HRAS G12C prostate cancer Black 0 175 0.00 0.00 0.00 0.00
HRAS G12C prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
HRAS G12C prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
HRAS G12C prostate cancer White 0 1882 0.00 0.00 0.00 0.00
HRAS G12C anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
HRAS G12C anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS G12C neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
HRAS G12C neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
HRAS G12C neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
HRAS G12C bladder cancer Asian 0 40 0.00 0.00 0.00 0.02
HRAS G12C bladder cancer Black 0 43 0.00 0.00 0.00 0.02
HRAS G12C bladder cancer Race:NA 1 169 0.00 0.00 0.00 0.02
HRAS G12C bladder cancer Race:Other 1 14 0.02 0.00 0.00 0.14
HRAS G12C bladder cancer White 1 1310 0.00 0.00 0.00 0.00
HRAS G12C b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS G12C b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS G12C b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS G12C small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS G12C small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS G12C small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS G12C sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
HRAS G12C sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
HRAS G12C bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS G12C bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS G12C bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS G12C bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G12C bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS G12C vaginal cancer White 0 68 0.00 0.00 0.00 0.00
HRAS G12C thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
HRAS G12C thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
HRAS G12C thymic tumor White 0 106 0.00 0.00 0.00 0.00
HRAS G12C ampullary cancer White 0 86 0.00 0.00 0.00 0.00
HRAS G12C small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.02
HRAS G12C small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.02
HRAS G12C small cell lung cancer White 1 337 0.00 0.00 0.00 0.01
HRAS G12C mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS G12C mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS G12C mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12C mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS G12C mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS G12C mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS G12C mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS G12C mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS G12C nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.00
HRAS G12C nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS G12C nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS G12C penile cancer White 0 20 0.00 0.00 0.00 0.04
HRAS G12C pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
HRAS G12C pineal tumor White 0 14 0.00 0.00 0.00 0.05
HRAS G12C b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS G12C b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS G12C b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS G12C b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS G12C b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS G12C non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
HRAS G12C t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.00
HRAS G12C t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.00
HRAS G12C retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS G12C retinoblastoma White 0 25 0.00 0.00 0.00 0.02
HRAS G12C hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
HRAS G12C lung cancer White 0 17 0.00 0.00 0.00 0.05
HRAS G12C peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
HRAS G12C parathyroid cancer White 0 14 0.00 0.00 0.00 0.05
HRAS G12D appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS G12D appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS G12D appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS G12D colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS G12D colorectal cancer Black 2 514 0.00 0.00 0.00 0.01
HRAS G12D colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS G12D colorectal cancer Native American 0 17 0.00 0.00 0.00 0.01
HRAS G12D colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS G12D colorectal cancer White 1 4922 0.00 0.00 0.00 0.00
HRAS G12D cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
HRAS G12D cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
HRAS G12D cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS G12D cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12D cancer of unknown primary White 0 1461 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer White 1 7745 0.00 0.00 0.00 0.00
HRAS G12D breast cancer Asian 0 334 0.00 0.00 0.00 0.00
HRAS G12D breast cancer Black 0 525 0.00 0.00 0.00 0.00
HRAS G12D breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
HRAS G12D breast cancer Native American 0 11 0.00 0.00 0.00 0.01
HRAS G12D breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS G12D breast cancer White 3 5174 0.00 0.00 0.00 0.00
HRAS G12D pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS G12D pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS G12D pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS G12D pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS G12D pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
HRAS G12D leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS G12D leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS G12D leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS G12D leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS G12D leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS G12D melanoma Asian 0 33 0.00 0.00 0.00 0.01
HRAS G12D melanoma Black 1 34 0.01 0.00 0.00 0.05
HRAS G12D melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
HRAS G12D melanoma Race:Other 0 26 0.00 0.00 0.00 0.01
HRAS G12D melanoma White 6 2348 0.00 0.00 0.00 0.00
HRAS G12D head and neck cancer Asian 0 94 0.00 0.00 0.00 0.01
HRAS G12D head and neck cancer Black 0 62 0.00 0.00 0.00 0.01
HRAS G12D head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
HRAS G12D head and neck cancer Race:Other 1 28 0.01 0.00 0.00 0.07
HRAS G12D head and neck cancer White 1 1264 0.00 0.00 0.00 0.00
HRAS G12D uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS G12D uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS G12D uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS G12D uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS G12D uterine cancer White 2 1750 0.00 0.00 0.00 0.00
HRAS G12D non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.04
HRAS G12D non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.03
HRAS G12D non-melanoma skin cancers Race:NA 1 53 0.01 0.01 0.00 0.05
HRAS G12D non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.01
HRAS G12D myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS G12D myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS G12D myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS G12D myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS G12D adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
HRAS G12D adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS G12D soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
HRAS G12D soft tissue sarcoma Black 0 190 0.00 0.00 0.00 0.00
HRAS G12D soft tissue sarcoma Race:NA 0 347 0.00 0.00 0.00 0.00
HRAS G12D soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
HRAS G12D soft tissue sarcoma White 1 1976 0.00 0.00 0.00 0.00
HRAS G12D ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS G12D ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS G12D ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS G12D ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12D ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
HRAS G12D thyroid cancer Asian 0 66 0.00 0.00 0.00 0.01
HRAS G12D thyroid cancer Black 0 40 0.00 0.00 0.00 0.01
HRAS G12D thyroid cancer Race:NA 1 79 0.01 0.00 0.00 0.03
HRAS G12D thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.02
HRAS G12D thyroid cancer White 0 803 0.00 0.00 0.00 0.00
HRAS G12D cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
HRAS G12D cervical cancer Black 0 19 0.00 0.00 0.00 0.00
HRAS G12D cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
HRAS G12D cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
HRAS G12D cervical cancer White 0 228 0.00 0.00 0.00 0.00
HRAS G12D hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS G12D hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS G12D hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS G12D hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
HRAS G12D hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
HRAS G12D kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS G12D kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS G12D kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G12D kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G12D kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS G12D cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS G12D cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS G12D cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
HRAS G12D cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS G12D cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS G12D cns cancer White 0 3330 0.00 0.00 0.00 0.00
HRAS G12D prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
HRAS G12D prostate cancer Black 0 175 0.00 0.00 0.00 0.00
HRAS G12D prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
HRAS G12D prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
HRAS G12D prostate cancer White 0 1882 0.00 0.00 0.00 0.00
HRAS G12D anal cancer Race:NA 0 13 0.00 0.00 0.00 0.00
HRAS G12D anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS G12D neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
HRAS G12D neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
HRAS G12D neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
HRAS G12D bladder cancer Asian 2 40 0.02 0.01 0.00 0.10
HRAS G12D bladder cancer Black 0 43 0.01 0.00 0.00 0.02
HRAS G12D bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.01
HRAS G12D bladder cancer Race:Other 0 14 0.01 0.00 0.00 0.04
HRAS G12D bladder cancer White 7 1310 0.01 0.00 0.00 0.01
HRAS G12D b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS G12D b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS G12D b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS G12D small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS G12D small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS G12D small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS G12D sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
HRAS G12D sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
HRAS G12D bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS G12D bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS G12D bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS G12D bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G12D bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS G12D vaginal cancer White 0 68 0.00 0.00 0.00 0.01
HRAS G12D thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
HRAS G12D thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
HRAS G12D thymic tumor White 0 106 0.00 0.00 0.00 0.00
HRAS G12D ampullary cancer White 0 86 0.00 0.00 0.00 0.01
HRAS G12D small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
HRAS G12D small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
HRAS G12D small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
HRAS G12D mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS G12D mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS G12D mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12D mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS G12D mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS G12D mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS G12D mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS G12D mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS G12D nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.01
HRAS G12D nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS G12D nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS G12D penile cancer White 0 20 0.00 0.00 0.00 0.04
HRAS G12D pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
HRAS G12D pineal tumor White 0 14 0.00 0.00 0.00 0.05
HRAS G12D b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS G12D b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS G12D b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS G12D b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS G12D b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS G12D non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.02
HRAS G12D t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS G12D t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
HRAS G12D retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.03
HRAS G12D retinoblastoma White 0 25 0.00 0.00 0.00 0.02
HRAS G12D hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
HRAS G12D lung cancer White 0 17 0.00 0.00 0.00 0.04
HRAS G12D peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
HRAS G12D parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
HRAS G12F appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS G12F appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS G12F appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary White 0 1461 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
HRAS G12F breast cancer Asian 0 334 0.00 0.00 0.00 0.00
HRAS G12F breast cancer Black 0 525 0.00 0.00 0.00 0.00
HRAS G12F breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
HRAS G12F breast cancer Native American 0 11 0.00 0.00 0.00 0.00
HRAS G12F breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS G12F breast cancer White 0 5174 0.00 0.00 0.00 0.00
HRAS G12F pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS G12F pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS G12F pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS G12F pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS G12F pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
HRAS G12F leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS G12F leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS G12F leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS G12F leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS G12F leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS G12F melanoma Asian 0 33 0.00 0.00 0.00 0.00
HRAS G12F melanoma Black 0 34 0.00 0.00 0.00 0.00
HRAS G12F melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
HRAS G12F melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G12F melanoma White 0 2348 0.00 0.00 0.00 0.00
HRAS G12F head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
HRAS G12F head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
HRAS G12F head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
HRAS G12F head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
HRAS G12F head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
HRAS G12F uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS G12F uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS G12F uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS G12F uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS G12F uterine cancer White 0 1750 0.00 0.00 0.00 0.00
HRAS G12F non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
HRAS G12F non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
HRAS G12F non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
HRAS G12F non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
HRAS G12F myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS G12F myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS G12F myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS G12F myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS G12F adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
HRAS G12F adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS G12F soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
HRAS G12F soft tissue sarcoma Black 0 190 0.00 0.00 0.00 0.00
HRAS G12F soft tissue sarcoma Race:NA 0 347 0.00 0.00 0.00 0.00
HRAS G12F soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
HRAS G12F soft tissue sarcoma White 0 1976 0.00 0.00 0.00 0.00
HRAS G12F ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS G12F ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS G12F ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS G12F ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12F ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
HRAS G12F thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
HRAS G12F thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
HRAS G12F thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
HRAS G12F thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G12F thyroid cancer White 0 803 0.00 0.00 0.00 0.00
HRAS G12F cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
HRAS G12F cervical cancer Black 0 19 0.00 0.00 0.00 0.00
HRAS G12F cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
HRAS G12F cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
HRAS G12F cervical cancer White 0 228 0.00 0.00 0.00 0.00
HRAS G12F hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS G12F hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS G12F hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS G12F hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
HRAS G12F hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
HRAS G12F kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS G12F kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS G12F kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G12F kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G12F kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS G12F cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS G12F cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS G12F cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
HRAS G12F cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS G12F cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS G12F cns cancer White 0 3330 0.00 0.00 0.00 0.00
HRAS G12F prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
HRAS G12F prostate cancer Black 0 175 0.00 0.00 0.00 0.00
HRAS G12F prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
HRAS G12F prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
HRAS G12F prostate cancer White 0 1882 0.00 0.00 0.00 0.00
HRAS G12F anal cancer Race:NA 0 13 0.00 0.00 0.00 0.00
HRAS G12F anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS G12F neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
HRAS G12F neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
HRAS G12F neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
HRAS G12F bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
HRAS G12F bladder cancer Black 0 43 0.00 0.00 0.00 0.00
HRAS G12F bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G12F bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.01
HRAS G12F bladder cancer White 1 1310 0.00 0.00 0.00 0.00
HRAS G12F b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS G12F b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS G12F b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS G12F small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS G12F small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS G12F small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS G12F sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
HRAS G12F sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
HRAS G12F bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS G12F bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS G12F bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS G12F bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G12F bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS G12F vaginal cancer White 0 68 0.00 0.00 0.00 0.01
HRAS G12F thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
HRAS G12F thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
HRAS G12F thymic tumor White 0 106 0.00 0.00 0.00 0.00
HRAS G12F ampullary cancer White 0 86 0.00 0.00 0.00 0.01
HRAS G12F small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
HRAS G12F small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
HRAS G12F small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
HRAS G12F mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS G12F mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS G12F mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12F mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS G12F mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS G12F mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS G12F mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS G12F mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS G12F nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.01
HRAS G12F nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS G12F nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS G12F penile cancer White 0 20 0.00 0.00 0.00 0.04
HRAS G12F pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
HRAS G12F pineal tumor White 0 14 0.00 0.00 0.00 0.05
HRAS G12F b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS G12F b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS G12F b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS G12F b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS G12F b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS G12F non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.02
HRAS G12F t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS G12F t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
HRAS G12F retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.03
HRAS G12F retinoblastoma White 0 25 0.00 0.00 0.00 0.02
HRAS G12F hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
HRAS G12F lung cancer White 0 17 0.00 0.00 0.00 0.04
HRAS G12F peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
HRAS G12F parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
HRAS G12R appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS G12R appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS G12R appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary White 0 1461 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
HRAS G12R breast cancer Asian 0 334 0.00 0.00 0.00 0.00
HRAS G12R breast cancer Black 0 525 0.00 0.00 0.00 0.00
HRAS G12R breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
HRAS G12R breast cancer Native American 0 11 0.00 0.00 0.00 0.00
HRAS G12R breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS G12R breast cancer White 0 5174 0.00 0.00 0.00 0.00
HRAS G12R pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS G12R pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS G12R pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS G12R pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS G12R pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
HRAS G12R leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS G12R leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS G12R leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS G12R leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS G12R leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS G12R melanoma Asian 0 33 0.00 0.00 0.00 0.00
HRAS G12R melanoma Black 0 34 0.00 0.00 0.00 0.00
HRAS G12R melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
HRAS G12R melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G12R melanoma White 0 2348 0.00 0.00 0.00 0.00
HRAS G12R head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
HRAS G12R head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
HRAS G12R head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
HRAS G12R head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
HRAS G12R head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
HRAS G12R uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS G12R uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS G12R uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS G12R uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS G12R uterine cancer White 0 1750 0.00 0.00 0.00 0.00
HRAS G12R non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
HRAS G12R non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
HRAS G12R non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
HRAS G12R non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
HRAS G12R myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS G12R myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS G12R myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS G12R myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS G12R adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS G12R adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma Black 0 190 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma Race:NA 0 347 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma White 0 1976 0.00 0.00 0.00 0.00
HRAS G12R ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS G12R ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS G12R ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS G12R ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12R ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
HRAS G12R thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
HRAS G12R thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
HRAS G12R thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
HRAS G12R thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G12R thyroid cancer White 0 803 0.00 0.00 0.00 0.00
HRAS G12R cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
HRAS G12R cervical cancer Black 0 19 0.00 0.00 0.00 0.00
HRAS G12R cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
HRAS G12R cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
HRAS G12R cervical cancer White 0 228 0.00 0.00 0.00 0.00
HRAS G12R hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS G12R hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS G12R hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS G12R hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
HRAS G12R hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
HRAS G12R kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS G12R kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS G12R kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G12R kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G12R kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS G12R cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS G12R cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS G12R cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
HRAS G12R cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS G12R cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS G12R cns cancer White 0 3330 0.00 0.00 0.00 0.00
HRAS G12R prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
HRAS G12R prostate cancer Black 0 175 0.00 0.00 0.00 0.00
HRAS G12R prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
HRAS G12R prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
HRAS G12R prostate cancer White 0 1882 0.00 0.00 0.00 0.00
HRAS G12R anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
HRAS G12R anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS G12R neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
HRAS G12R neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
HRAS G12R neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
HRAS G12R bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
HRAS G12R bladder cancer Black 0 43 0.00 0.00 0.00 0.00
HRAS G12R bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G12R bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
HRAS G12R bladder cancer White 0 1310 0.00 0.00 0.00 0.00
HRAS G12R b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS G12R b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS G12R b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS G12R small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS G12R small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS G12R small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS G12R sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
HRAS G12R sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
HRAS G12R bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS G12R bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS G12R bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS G12R bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G12R bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS G12R vaginal cancer White 0 68 0.00 0.00 0.00 0.00
HRAS G12R thymic tumor Asian 0 13 0.00 0.00 0.00 0.01
HRAS G12R thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.01
HRAS G12R thymic tumor White 0 106 0.00 0.00 0.00 0.00
HRAS G12R ampullary cancer White 0 86 0.00 0.00 0.00 0.01
HRAS G12R small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
HRAS G12R small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
HRAS G12R small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
HRAS G12R mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS G12R mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS G12R mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12R mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS G12R mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS G12R mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS G12R mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS G12R mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS G12R nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.01
HRAS G12R nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.01
HRAS G12R nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS G12R penile cancer White 0 20 0.00 0.00 0.00 0.03
HRAS G12R pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
HRAS G12R pineal tumor White 0 14 0.00 0.00 0.00 0.04
HRAS G12R b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS G12R b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS G12R b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS G12R b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS G12R b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS G12R non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
HRAS G12R t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
HRAS G12R t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
HRAS G12R retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.01
HRAS G12R retinoblastoma White 0 25 0.00 0.00 0.00 0.01
HRAS G12R hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
HRAS G12R lung cancer White 0 17 0.00 0.00 0.00 0.04
HRAS G12R peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
HRAS G12R parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
HRAS G12S appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS G12S appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS G12S appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer White 1 4922 0.00 0.00 0.00 0.00
HRAS G12S cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
HRAS G12S cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
HRAS G12S cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS G12S cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12S cancer of unknown primary White 1 1461 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
HRAS G12S breast cancer Asian 1 334 0.00 0.00 0.00 0.00
HRAS G12S breast cancer Black 0 525 0.00 0.00 0.00 0.00
HRAS G12S breast cancer Race:NA 1 3112 0.00 0.00 0.00 0.00
HRAS G12S breast cancer Native American 0 11 0.00 0.00 0.00 0.00
HRAS G12S breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS G12S breast cancer White 1 5174 0.00 0.00 0.00 0.00
HRAS G12S pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS G12S pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS G12S pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS G12S pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS G12S pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
HRAS G12S leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS G12S leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS G12S leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS G12S leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS G12S leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS G12S melanoma Asian 0 33 0.00 0.00 0.00 0.00
HRAS G12S melanoma Black 0 34 0.00 0.00 0.00 0.00
HRAS G12S melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
HRAS G12S melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G12S melanoma White 0 2348 0.00 0.00 0.00 0.00
HRAS G12S head and neck cancer Asian 0 94 0.00 0.00 0.00 0.01
HRAS G12S head and neck cancer Black 0 62 0.00 0.00 0.00 0.01
HRAS G12S head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.01
HRAS G12S head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.02
HRAS G12S head and neck cancer White 11 1264 0.01 0.01 0.00 0.01
HRAS G12S uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS G12S uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS G12S uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS G12S uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS G12S uterine cancer White 2 1750 0.00 0.00 0.00 0.00
HRAS G12S non-melanoma skin cancers Asian 0 11 0.01 0.00 0.00 0.05
HRAS G12S non-melanoma skin cancers Black 1 13 0.03 0.01 0.00 0.16
HRAS G12S non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.02
HRAS G12S non-melanoma skin cancers White 1 436 0.00 0.00 0.00 0.01
HRAS G12S myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS G12S myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS G12S myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS G12S myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS G12S adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS G12S adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma Black 0 190 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma Race:NA 0 347 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma White 0 1976 0.00 0.00 0.00 0.00
HRAS G12S ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS G12S ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS G12S ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS G12S ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12S ovarian cancer White 1 1852 0.00 0.00 0.00 0.00
HRAS G12S esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
HRAS G12S esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS G12S esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS G12S esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
HRAS G12S esophagogastric cancer White 1 1379 0.00 0.00 0.00 0.00
HRAS G12S thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
HRAS G12S thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
HRAS G12S thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
HRAS G12S thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G12S thyroid cancer White 0 803 0.00 0.00 0.00 0.00
HRAS G12S cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
HRAS G12S cervical cancer Black 0 19 0.00 0.00 0.00 0.00
HRAS G12S cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
HRAS G12S cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
HRAS G12S cervical cancer White 0 228 0.00 0.00 0.00 0.00
HRAS G12S hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS G12S hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS G12S hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS G12S hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
HRAS G12S hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
HRAS G12S kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS G12S kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS G12S kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G12S kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G12S kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS G12S cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS G12S cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS G12S cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
HRAS G12S cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS G12S cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS G12S cns cancer White 0 3330 0.00 0.00 0.00 0.00
HRAS G12S prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
HRAS G12S prostate cancer Black 0 175 0.00 0.00 0.00 0.00
HRAS G12S prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
HRAS G12S prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
HRAS G12S prostate cancer White 0 1882 0.00 0.00 0.00 0.00
HRAS G12S anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
HRAS G12S anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS G12S neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
HRAS G12S neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
HRAS G12S neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
HRAS G12S bladder cancer Asian 0 40 0.00 0.00 0.00 0.01
HRAS G12S bladder cancer Black 0 43 0.00 0.00 0.00 0.01
HRAS G12S bladder cancer Race:NA 1 169 0.00 0.00 0.00 0.01
HRAS G12S bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.01
HRAS G12S bladder cancer White 2 1310 0.00 0.00 0.00 0.00
HRAS G12S b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS G12S b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS G12S b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS G12S small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS G12S small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS G12S small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS G12S sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
HRAS G12S sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
HRAS G12S bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS G12S bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS G12S bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS G12S bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G12S bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS G12S vaginal cancer White 1 68 0.02 0.01 0.00 0.06
HRAS G12S thymic tumor Asian 0 13 0.01 0.00 0.00 0.04
HRAS G12S thymic tumor Race:NA 0 23 0.01 0.00 0.00 0.04
HRAS G12S thymic tumor White 1 106 0.01 0.01 0.00 0.03
HRAS G12S ampullary cancer White 0 86 0.00 0.00 0.00 0.01
HRAS G12S small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
HRAS G12S small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
HRAS G12S small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
HRAS G12S mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS G12S mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS G12S mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12S mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS G12S mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS G12S mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS G12S mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS G12S mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS G12S nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.01
HRAS G12S nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.01
HRAS G12S nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS G12S penile cancer White 0 20 0.00 0.00 0.00 0.03
HRAS G12S pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
HRAS G12S pineal tumor White 0 14 0.00 0.00 0.00 0.04
HRAS G12S b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS G12S b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS G12S b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS G12S b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS G12S b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS G12S non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
HRAS G12S t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
HRAS G12S t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
HRAS G12S retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.01
HRAS G12S retinoblastoma White 0 25 0.00 0.00 0.00 0.01
HRAS G12S hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
HRAS G12S lung cancer White 0 17 0.00 0.00 0.00 0.04
HRAS G12S peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
HRAS G12S parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
HRAS G12V appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS G12V appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS G12V appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary White 1 1461 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
HRAS G12V breast cancer Asian 0 334 0.00 0.00 0.00 0.00
HRAS G12V breast cancer Black 0 525 0.00 0.00 0.00 0.00
HRAS G12V breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
HRAS G12V breast cancer Native American 0 11 0.00 0.00 0.00 0.00
HRAS G12V breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS G12V breast cancer White 1 5174 0.00 0.00 0.00 0.00
HRAS G12V pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS G12V pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS G12V pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS G12V pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS G12V pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
HRAS G12V leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS G12V leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS G12V leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS G12V leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS G12V leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS G12V melanoma Asian 0 33 0.00 0.00 0.00 0.00
HRAS G12V melanoma Black 0 34 0.00 0.00 0.00 0.00
HRAS G12V melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
HRAS G12V melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G12V melanoma White 0 2348 0.00 0.00 0.00 0.00
HRAS G12V head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
HRAS G12V head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
HRAS G12V head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
HRAS G12V head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
HRAS G12V head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
HRAS G12V uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS G12V uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS G12V uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS G12V uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS G12V uterine cancer White 0 1750 0.00 0.00 0.00 0.00
HRAS G12V non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
HRAS G12V non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
HRAS G12V non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
HRAS G12V non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
HRAS G12V myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS G12V myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS G12V myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS G12V myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS G12V adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS G12V adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS G12V soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
HRAS G12V soft tissue sarcoma Black 1 190 0.00 0.00 0.00 0.01
HRAS G12V soft tissue sarcoma Race:NA 0 347 0.00 0.00 0.00 0.00
HRAS G12V soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
HRAS G12V soft tissue sarcoma White 1 1976 0.00 0.00 0.00 0.00
HRAS G12V ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS G12V ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS G12V ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS G12V ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12V ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
HRAS G12V thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
HRAS G12V thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
HRAS G12V thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
HRAS G12V thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G12V thyroid cancer White 0 803 0.00 0.00 0.00 0.00
HRAS G12V cervical cancer Asian 0 27 0.00 0.00 0.00 0.02
HRAS G12V cervical cancer Black 0 19 0.00 0.00 0.00 0.02
HRAS G12V cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.01
HRAS G12V cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.02
HRAS G12V cervical cancer White 1 228 0.00 0.00 0.00 0.01
HRAS G12V hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS G12V hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS G12V hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS G12V hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
HRAS G12V hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
HRAS G12V kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS G12V kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS G12V kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G12V kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G12V kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS G12V cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS G12V cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS G12V cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
HRAS G12V cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS G12V cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS G12V cns cancer White 0 3330 0.00 0.00 0.00 0.00
HRAS G12V prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
HRAS G12V prostate cancer Black 0 175 0.00 0.00 0.00 0.00
HRAS G12V prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
HRAS G12V prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
HRAS G12V prostate cancer White 0 1882 0.00 0.00 0.00 0.00
HRAS G12V anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
HRAS G12V anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS G12V neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
HRAS G12V neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
HRAS G12V neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
HRAS G12V bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
HRAS G12V bladder cancer Black 0 43 0.00 0.00 0.00 0.00
HRAS G12V bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G12V bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
HRAS G12V bladder cancer White 0 1310 0.00 0.00 0.00 0.00
HRAS G12V b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS G12V b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS G12V b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS G12V small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS G12V small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS G12V small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS G12V sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
HRAS G12V sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.00
HRAS G12V bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS G12V bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS G12V bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS G12V bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G12V bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS G12V vaginal cancer White 0 68 0.00 0.00 0.00 0.01
HRAS G12V thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
HRAS G12V thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
HRAS G12V thymic tumor White 0 106 0.00 0.00 0.00 0.00
HRAS G12V ampullary cancer White 0 86 0.00 0.00 0.00 0.01
HRAS G12V small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
HRAS G12V small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
HRAS G12V small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
HRAS G12V mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS G12V mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS G12V mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS G12V mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS G12V mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS G12V mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS G12V mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS G12V mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS G12V nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.01
HRAS G12V nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS G12V nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS G12V penile cancer White 0 20 0.00 0.00 0.00 0.02
HRAS G12V pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
HRAS G12V pineal tumor White 0 14 0.00 0.00 0.00 0.04
HRAS G12V b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS G12V b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS G12V b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS G12V b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS G12V b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS G12V non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
HRAS G12V t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
HRAS G12V t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
HRAS G12V retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS G12V retinoblastoma White 0 25 0.00 0.00 0.00 0.02
HRAS G12V hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
HRAS G12V lung cancer White 0 17 0.00 0.00 0.00 0.03
HRAS G12V peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
HRAS G12V parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
HRAS G13C appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS G13C appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS G13C appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary White 0 1461 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
HRAS G13C breast cancer Asian 0 334 0.00 0.00 0.00 0.00
HRAS G13C breast cancer Black 0 525 0.00 0.00 0.00 0.00
HRAS G13C breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
HRAS G13C breast cancer Native American 0 11 0.00 0.00 0.00 0.00
HRAS G13C breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS G13C breast cancer White 0 5174 0.00 0.00 0.00 0.00
HRAS G13C pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS G13C pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS G13C pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS G13C pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS G13C pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
HRAS G13C leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS G13C leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS G13C leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS G13C leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS G13C leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS G13C melanoma Asian 0 33 0.00 0.00 0.00 0.00
HRAS G13C melanoma Black 0 34 0.00 0.00 0.00 0.00
HRAS G13C melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
HRAS G13C melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G13C melanoma White 1 2348 0.00 0.00 0.00 0.00
HRAS G13C head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
HRAS G13C head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
HRAS G13C head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
HRAS G13C head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
HRAS G13C head and neck cancer White 1 1264 0.00 0.00 0.00 0.00
HRAS G13C uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS G13C uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS G13C uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS G13C uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS G13C uterine cancer White 0 1750 0.00 0.00 0.00 0.00
HRAS G13C non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
HRAS G13C non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
HRAS G13C non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
HRAS G13C non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
HRAS G13C myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS G13C myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS G13C myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS G13C myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS G13C adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS G13C adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS G13C soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
HRAS G13C soft tissue sarcoma Black 0 190 0.00 0.00 0.00 0.00
HRAS G13C soft tissue sarcoma Race:NA 0 347 0.00 0.00 0.00 0.00
HRAS G13C soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
HRAS G13C soft tissue sarcoma White 0 1976 0.00 0.00 0.00 0.00
HRAS G13C ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS G13C ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS G13C ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS G13C ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G13C ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
HRAS G13C thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
HRAS G13C thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
HRAS G13C thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
HRAS G13C thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G13C thyroid cancer White 0 803 0.00 0.00 0.00 0.00
HRAS G13C cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
HRAS G13C cervical cancer Black 0 19 0.00 0.00 0.00 0.00
HRAS G13C cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
HRAS G13C cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
HRAS G13C cervical cancer White 0 228 0.00 0.00 0.00 0.00
HRAS G13C hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS G13C hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS G13C hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS G13C hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
HRAS G13C hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
HRAS G13C kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS G13C kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS G13C kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G13C kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G13C kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS G13C cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS G13C cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS G13C cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
HRAS G13C cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS G13C cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS G13C cns cancer White 1 3330 0.00 0.00 0.00 0.00
HRAS G13C prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
HRAS G13C prostate cancer Black 0 175 0.00 0.00 0.00 0.00
HRAS G13C prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
HRAS G13C prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
HRAS G13C prostate cancer White 0 1882 0.00 0.00 0.00 0.00
HRAS G13C anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
HRAS G13C anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS G13C neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
HRAS G13C neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
HRAS G13C neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
HRAS G13C bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
HRAS G13C bladder cancer Black 0 43 0.00 0.00 0.00 0.00
HRAS G13C bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G13C bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
HRAS G13C bladder cancer White 0 1310 0.00 0.00 0.00 0.00
HRAS G13C b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS G13C b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS G13C b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS G13C small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS G13C small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS G13C small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS G13C sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
HRAS G13C sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.00
HRAS G13C bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS G13C bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS G13C bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS G13C bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G13C bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS G13C vaginal cancer White 0 68 0.00 0.00 0.00 0.01
HRAS G13C thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
HRAS G13C thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
HRAS G13C thymic tumor White 0 106 0.00 0.00 0.00 0.00
HRAS G13C ampullary cancer White 0 86 0.00 0.00 0.00 0.01
HRAS G13C small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
HRAS G13C small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
HRAS G13C small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
HRAS G13C mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS G13C mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS G13C mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS G13C mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS G13C mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS G13C mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS G13C mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS G13C mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS G13C nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.01
HRAS G13C nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS G13C nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS G13C penile cancer White 0 20 0.00 0.00 0.00 0.02
HRAS G13C pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
HRAS G13C pineal tumor White 0 14 0.00 0.00 0.00 0.04
HRAS G13C b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS G13C b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS G13C b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS G13C b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS G13C b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS G13C non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
HRAS G13C t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
HRAS G13C t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
HRAS G13C retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS G13C retinoblastoma White 0 25 0.00 0.00 0.00 0.02
HRAS G13C hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
HRAS G13C lung cancer White 0 17 0.00 0.00 0.00 0.03
HRAS G13C peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
HRAS G13C parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
HRAS G13D appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS G13D appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS G13D appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary White 0 1461 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
HRAS G13D breast cancer Asian 0 334 0.00 0.00 0.00 0.00
HRAS G13D breast cancer Black 0 525 0.00 0.00 0.00 0.00
HRAS G13D breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
HRAS G13D breast cancer Native American 0 11 0.00 0.00 0.00 0.00
HRAS G13D breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS G13D breast cancer White 0 5174 0.00 0.00 0.00 0.00
HRAS G13D pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS G13D pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS G13D pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS G13D pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS G13D pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
HRAS G13D leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS G13D leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS G13D leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS G13D leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS G13D leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS G13D melanoma Asian 0 33 0.00 0.00 0.00 0.01
HRAS G13D melanoma Black 0 34 0.00 0.00 0.00 0.01
HRAS G13D melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
HRAS G13D melanoma Race:Other 0 26 0.00 0.00 0.00 0.01
HRAS G13D melanoma White 6 2348 0.00 0.00 0.00 0.00
HRAS G13D head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
HRAS G13D head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
HRAS G13D head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
HRAS G13D head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
HRAS G13D head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
HRAS G13D uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS G13D uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS G13D uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS G13D uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS G13D uterine cancer White 0 1750 0.00 0.00 0.00 0.00
HRAS G13D non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
HRAS G13D non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
HRAS G13D non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
HRAS G13D non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
HRAS G13D myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS G13D myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS G13D myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS G13D myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS G13D adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
HRAS G13D adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma Black 0 190 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma Race:NA 0 347 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma White 0 1976 0.00 0.00 0.00 0.00
HRAS G13D ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS G13D ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS G13D ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS G13D ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G13D ovarian cancer White 1 1852 0.00 0.00 0.00 0.00
HRAS G13D esophagogastric cancer Asian 1 115 0.00 0.00 0.00 0.02
HRAS G13D esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS G13D esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS G13D esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.01
HRAS G13D esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
HRAS G13D thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
HRAS G13D thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
HRAS G13D thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
HRAS G13D thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G13D thyroid cancer White 0 803 0.00 0.00 0.00 0.00
HRAS G13D cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
HRAS G13D cervical cancer Black 0 19 0.00 0.00 0.00 0.00
HRAS G13D cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
HRAS G13D cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
HRAS G13D cervical cancer White 0 228 0.00 0.00 0.00 0.00
HRAS G13D hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS G13D hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS G13D hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS G13D hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
HRAS G13D hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
HRAS G13D kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS G13D kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS G13D kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G13D kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G13D kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS G13D cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS G13D cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS G13D cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
HRAS G13D cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS G13D cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS G13D cns cancer White 0 3330 0.00 0.00 0.00 0.00
HRAS G13D prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
HRAS G13D prostate cancer Black 0 175 0.00 0.00 0.00 0.00
HRAS G13D prostate cancer Race:NA 1 289 0.00 0.00 0.00 0.01
HRAS G13D prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.01
HRAS G13D prostate cancer White 1 1882 0.00 0.00 0.00 0.00
HRAS G13D anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
HRAS G13D anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS G13D neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
HRAS G13D neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
HRAS G13D neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
HRAS G13D bladder cancer Asian 0 40 0.00 0.00 0.00 0.01
HRAS G13D bladder cancer Black 0 43 0.00 0.00 0.00 0.01
HRAS G13D bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G13D bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.01
HRAS G13D bladder cancer White 2 1310 0.00 0.00 0.00 0.00
HRAS G13D b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS G13D b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS G13D b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS G13D small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS G13D small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS G13D small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS G13D sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
HRAS G13D sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
HRAS G13D bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS G13D bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS G13D bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS G13D bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G13D bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS G13D vaginal cancer White 0 68 0.00 0.00 0.00 0.00
HRAS G13D thymic tumor Asian 0 13 0.01 0.00 0.00 0.04
HRAS G13D thymic tumor Race:NA 0 23 0.01 0.00 0.00 0.04
HRAS G13D thymic tumor White 1 106 0.01 0.01 0.00 0.03
HRAS G13D ampullary cancer White 0 86 0.00 0.00 0.00 0.00
HRAS G13D small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
HRAS G13D small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
HRAS G13D small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
HRAS G13D mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS G13D mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS G13D mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS G13D mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS G13D mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS G13D mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS G13D mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS G13D mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS G13D nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.00
HRAS G13D nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS G13D nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS G13D penile cancer White 0 20 0.00 0.00 0.00 0.03
HRAS G13D pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
HRAS G13D pineal tumor White 0 14 0.00 0.00 0.00 0.04
HRAS G13D b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS G13D b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS G13D b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS G13D b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS G13D b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS G13D non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
HRAS G13D t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS G13D t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.01
HRAS G13D retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS G13D retinoblastoma White 0 25 0.00 0.00 0.00 0.02
HRAS G13D hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.01
HRAS G13D lung cancer White 0 17 0.00 0.00 0.00 0.03
HRAS G13D peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
HRAS G13D parathyroid cancer White 0 14 0.00 0.00 0.00 0.05
HRAS G13R appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS G13R appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS G13R appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
HRAS G13R cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.01
HRAS G13R cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
HRAS G13R cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS G13R cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.01
HRAS G13R cancer of unknown primary White 3 1461 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer White 4 7745 0.00 0.00 0.00 0.00
HRAS G13R breast cancer Asian 0 334 0.00 0.00 0.00 0.00
HRAS G13R breast cancer Black 1 525 0.00 0.00 0.00 0.00
HRAS G13R breast cancer Race:NA 1 3112 0.00 0.00 0.00 0.00
HRAS G13R breast cancer Native American 0 11 0.00 0.00 0.00 0.00
HRAS G13R breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS G13R breast cancer White 3 5174 0.00 0.00 0.00 0.00
HRAS G13R pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS G13R pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS G13R pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS G13R pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS G13R pancreatic cancer White 1 2037 0.00 0.00 0.00 0.00
HRAS G13R leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS G13R leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS G13R leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS G13R leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS G13R leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS G13R melanoma Asian 1 33 0.01 0.00 0.00 0.07
HRAS G13R melanoma Black 0 34 0.00 0.00 0.00 0.01
HRAS G13R melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
HRAS G13R melanoma Race:Other 0 26 0.00 0.00 0.00 0.02
HRAS G13R melanoma White 1 2348 0.00 0.00 0.00 0.00
HRAS G13R head and neck cancer Asian 1 94 0.01 0.01 0.00 0.03
HRAS G13R head and neck cancer Black 3 62 0.02 0.02 0.00 0.08
HRAS G13R head and neck cancer Race:NA 1 292 0.00 0.00 0.00 0.01
HRAS G13R head and neck cancer Race:Other 0 28 0.01 0.01 0.00 0.03
HRAS G13R head and neck cancer White 5 1264 0.00 0.00 0.00 0.01
HRAS G13R uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS G13R uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS G13R uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS G13R uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS G13R uterine cancer White 0 1750 0.00 0.00 0.00 0.00
HRAS G13R non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.02
HRAS G13R non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.02
HRAS G13R non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.01
HRAS G13R non-melanoma skin cancers White 1 436 0.00 0.00 0.00 0.01
HRAS G13R myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS G13R myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS G13R myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS G13R myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS G13R adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
HRAS G13R adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS G13R soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.01
HRAS G13R soft tissue sarcoma Black 0 190 0.00 0.00 0.00 0.01
HRAS G13R soft tissue sarcoma Race:NA 3 347 0.00 0.00 0.00 0.02
HRAS G13R soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.01
HRAS G13R soft tissue sarcoma White 1 1976 0.00 0.00 0.00 0.00
HRAS G13R ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS G13R ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS G13R ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS G13R ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G13R ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
HRAS G13R thyroid cancer Asian 0 66 0.00 0.00 0.00 0.01
HRAS G13R thyroid cancer Black 0 40 0.00 0.00 0.00 0.01
HRAS G13R thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.01
HRAS G13R thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.01
HRAS G13R thyroid cancer White 2 803 0.00 0.00 0.00 0.01
HRAS G13R cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
HRAS G13R cervical cancer Black 0 19 0.00 0.00 0.00 0.00
HRAS G13R cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
HRAS G13R cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
HRAS G13R cervical cancer White 0 228 0.00 0.00 0.00 0.00
HRAS G13R hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS G13R hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS G13R hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS G13R hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
HRAS G13R hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
HRAS G13R kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS G13R kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS G13R kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G13R kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G13R kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS G13R cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS G13R cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS G13R cns cancer Race:NA 1 817 0.00 0.00 0.00 0.00
HRAS G13R cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS G13R cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS G13R cns cancer White 0 3330 0.00 0.00 0.00 0.00
HRAS G13R prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
HRAS G13R prostate cancer Black 0 175 0.00 0.00 0.00 0.00
HRAS G13R prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
HRAS G13R prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
HRAS G13R prostate cancer White 1 1882 0.00 0.00 0.00 0.00
HRAS G13R anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
HRAS G13R anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS G13R neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
HRAS G13R neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
HRAS G13R neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
HRAS G13R bladder cancer Asian 0 40 0.00 0.00 0.00 0.02
HRAS G13R bladder cancer Black 0 43 0.00 0.00 0.00 0.02
HRAS G13R bladder cancer Race:NA 2 169 0.01 0.01 0.00 0.02
HRAS G13R bladder cancer Race:Other 0 14 0.01 0.00 0.00 0.02
HRAS G13R bladder cancer White 6 1310 0.00 0.00 0.00 0.01
HRAS G13R b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS G13R b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS G13R b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS G13R small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS G13R small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS G13R small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS G13R sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
HRAS G13R sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
HRAS G13R bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS G13R bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS G13R bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS G13R bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G13R bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS G13R vaginal cancer White 0 68 0.00 0.00 0.00 0.00
HRAS G13R thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
HRAS G13R thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
HRAS G13R thymic tumor White 0 106 0.00 0.00 0.00 0.00
HRAS G13R ampullary cancer White 0 86 0.00 0.00 0.00 0.00
HRAS G13R small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
HRAS G13R small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
HRAS G13R small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
HRAS G13R mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS G13R mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS G13R mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS G13R mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS G13R mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS G13R mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS G13R mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS G13R mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS G13R germ cell tumor Asian 0 36 0.00 0.00 0.00 0.01
HRAS G13R germ cell tumor Black 0 23 0.00 0.00 0.00 0.01
HRAS G13R germ cell tumor Race:NA 1 179 0.00 0.00 0.00 0.01
HRAS G13R germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.01
HRAS G13R germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS G13R nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.00
HRAS G13R nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS G13R nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS G13R penile cancer White 0 20 0.00 0.00 0.00 0.03
HRAS G13R pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
HRAS G13R pineal tumor White 0 14 0.00 0.00 0.00 0.04
HRAS G13R b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS G13R b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS G13R b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS G13R b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS G13R b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS G13R non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
HRAS G13R t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS G13R t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.01
HRAS G13R retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS G13R retinoblastoma White 0 25 0.00 0.00 0.00 0.02
HRAS G13R hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.01
HRAS G13R lung cancer White 0 17 0.00 0.00 0.00 0.03
HRAS G13R peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
HRAS G13R parathyroid cancer White 0 14 0.00 0.00 0.00 0.05
HRAS G13V appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS G13V appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS G13V appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
HRAS G13V cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.01
HRAS G13V cancer of unknown primary Black 1 123 0.00 0.00 0.00 0.02
HRAS G13V cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS G13V cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.01
HRAS G13V cancer of unknown primary White 0 1461 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer White 6 7745 0.00 0.00 0.00 0.00
HRAS G13V breast cancer Asian 0 334 0.00 0.00 0.00 0.00
HRAS G13V breast cancer Black 0 525 0.00 0.00 0.00 0.00
HRAS G13V breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
HRAS G13V breast cancer Native American 0 11 0.00 0.00 0.00 0.00
HRAS G13V breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS G13V breast cancer White 1 5174 0.00 0.00 0.00 0.00
HRAS G13V pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS G13V pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS G13V pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS G13V pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS G13V pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
HRAS G13V leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS G13V leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS G13V leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS G13V leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS G13V leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS G13V melanoma Asian 0 33 0.00 0.00 0.00 0.01
HRAS G13V melanoma Black 0 34 0.00 0.00 0.00 0.01
HRAS G13V melanoma Race:NA 1 398 0.00 0.00 0.00 0.00
HRAS G13V melanoma Race:Other 0 26 0.00 0.00 0.00 0.01
HRAS G13V melanoma White 2 2348 0.00 0.00 0.00 0.00
HRAS G13V head and neck cancer Asian 1 94 0.00 0.00 0.00 0.02
HRAS G13V head and neck cancer Black 0 62 0.00 0.00 0.00 0.01
HRAS G13V head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
HRAS G13V head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.01
HRAS G13V head and neck cancer White 2 1264 0.00 0.00 0.00 0.00
HRAS G13V uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS G13V uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS G13V uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS G13V uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS G13V uterine cancer White 1 1750 0.00 0.00 0.00 0.00
HRAS G13V non-melanoma skin cancers Asian 0 11 0.01 0.00 0.00 0.03
HRAS G13V non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.03
HRAS G13V non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.02
HRAS G13V non-melanoma skin cancers White 2 436 0.00 0.00 0.00 0.01
HRAS G13V myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS G13V myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS G13V myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS G13V myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS G13V adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS G13V adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma Black 0 190 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma Race:NA 0 347 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma White 0 1976 0.00 0.00 0.00 0.00
HRAS G13V ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS G13V ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS G13V ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS G13V ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G13V ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
HRAS G13V thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
HRAS G13V thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
HRAS G13V thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
HRAS G13V thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS G13V thyroid cancer White 0 803 0.00 0.00 0.00 0.00
HRAS G13V cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
HRAS G13V cervical cancer Black 0 19 0.00 0.00 0.00 0.00
HRAS G13V cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
HRAS G13V cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
HRAS G13V cervical cancer White 0 228 0.00 0.00 0.00 0.00
HRAS G13V hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS G13V hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS G13V hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS G13V hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
HRAS G13V hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
HRAS G13V kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS G13V kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS G13V kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS G13V kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G13V kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS G13V cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS G13V cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS G13V cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
HRAS G13V cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS G13V cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS G13V cns cancer White 0 3330 0.00 0.00 0.00 0.00
HRAS G13V prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
HRAS G13V prostate cancer Black 0 175 0.00 0.00 0.00 0.00
HRAS G13V prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
HRAS G13V prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
HRAS G13V prostate cancer White 0 1882 0.00 0.00 0.00 0.00
HRAS G13V anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
HRAS G13V anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS G13V neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
HRAS G13V neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
HRAS G13V neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
HRAS G13V bladder cancer Asian 0 40 0.00 0.00 0.00 0.01
HRAS G13V bladder cancer Black 0 43 0.00 0.00 0.00 0.01
HRAS G13V bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.01
HRAS G13V bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.01
HRAS G13V bladder cancer White 3 1310 0.00 0.00 0.00 0.00
HRAS G13V b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS G13V b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS G13V b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS G13V small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS G13V small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS G13V small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS G13V sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
HRAS G13V sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
HRAS G13V bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS G13V bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS G13V bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS G13V bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS G13V bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS G13V vaginal cancer White 0 68 0.00 0.00 0.00 0.01
HRAS G13V thymic tumor Asian 0 13 0.00 0.00 0.00 0.01
HRAS G13V thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
HRAS G13V thymic tumor White 0 106 0.00 0.00 0.00 0.00
HRAS G13V ampullary cancer White 0 86 0.00 0.00 0.00 0.01
HRAS G13V small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.02
HRAS G13V small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.02
HRAS G13V small cell lung cancer White 1 337 0.00 0.00 0.00 0.01
HRAS G13V mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS G13V mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS G13V mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS G13V mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS G13V mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS G13V mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS G13V mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS G13V mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS G13V nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.00
HRAS G13V nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS G13V nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS G13V penile cancer White 0 20 0.00 0.00 0.00 0.03
HRAS G13V pheochromocytoma White 0 15 0.00 0.00 0.00 0.05
HRAS G13V pineal tumor White 0 14 0.00 0.00 0.00 0.02
HRAS G13V b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS G13V b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS G13V b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS G13V b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS G13V b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS G13V non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
HRAS G13V t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.01
HRAS G13V t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.01
HRAS G13V retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS G13V retinoblastoma White 0 25 0.00 0.00 0.00 0.02
HRAS G13V hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
HRAS G13V lung cancer White 0 17 0.00 0.00 0.00 0.04
HRAS G13V peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
HRAS G13V parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
HRAS Q61H appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS Q61H appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS Q61H appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary White 0 1461 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer Race:NA 1 849 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer White 1 7745 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer Asian 0 334 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer Black 0 525 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer Native American 0 11 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer White 0 5174 0.00 0.00 0.00 0.00
HRAS Q61H pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS Q61H pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS Q61H pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS Q61H pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS Q61H pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
HRAS Q61H leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS Q61H leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS Q61H leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS Q61H leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS Q61H leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS Q61H melanoma Asian 0 33 0.00 0.00 0.00 0.00
HRAS Q61H melanoma Black 0 34 0.00 0.00 0.00 0.00
HRAS Q61H melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
HRAS Q61H melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS Q61H melanoma White 0 2348 0.00 0.00 0.00 0.00
HRAS Q61H head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
HRAS Q61H head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
HRAS Q61H head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
HRAS Q61H head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
HRAS Q61H head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
HRAS Q61H uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS Q61H uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS Q61H uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS Q61H uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS Q61H uterine cancer White 1 1750 0.00 0.00 0.00 0.00
HRAS Q61H non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
HRAS Q61H non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
HRAS Q61H non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
HRAS Q61H non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
HRAS Q61H myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS Q61H myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS Q61H myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS Q61H myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS Q61H adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS Q61H adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma Black 0 190 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma Race:NA 0 347 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma White 0 1976 0.00 0.00 0.00 0.00
HRAS Q61H ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS Q61H ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS Q61H ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS Q61H ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS Q61H ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
HRAS Q61H thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
HRAS Q61H thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
HRAS Q61H thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
HRAS Q61H thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS Q61H thyroid cancer White 0 803 0.00 0.00 0.00 0.00
HRAS Q61H cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
HRAS Q61H cervical cancer Black 0 19 0.00 0.00 0.00 0.00
HRAS Q61H cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
HRAS Q61H cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
HRAS Q61H cervical cancer White 0 228 0.00 0.00 0.00 0.00
HRAS Q61H hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS Q61H hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS Q61H hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS Q61H hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
HRAS Q61H hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
HRAS Q61H kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS Q61H kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS Q61H kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS Q61H kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS Q61H kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer White 0 3330 0.00 0.00 0.00 0.00
HRAS Q61H prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
HRAS Q61H prostate cancer Black 0 175 0.00 0.00 0.00 0.00
HRAS Q61H prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
HRAS Q61H prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
HRAS Q61H prostate cancer White 0 1882 0.00 0.00 0.00 0.00
HRAS Q61H anal cancer Race:NA 0 13 0.00 0.00 0.00 0.00
HRAS Q61H anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS Q61H neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
HRAS Q61H neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
HRAS Q61H neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
HRAS Q61H bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
HRAS Q61H bladder cancer Black 0 43 0.00 0.00 0.00 0.00
HRAS Q61H bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS Q61H bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
HRAS Q61H bladder cancer White 0 1310 0.00 0.00 0.00 0.00
HRAS Q61H b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS Q61H b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS Q61H b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS Q61H small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS Q61H small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS Q61H small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS Q61H sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
HRAS Q61H sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.00
HRAS Q61H bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS Q61H bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS Q61H bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS Q61H bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS Q61H bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS Q61H vaginal cancer White 0 68 0.00 0.00 0.00 0.01
HRAS Q61H thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
HRAS Q61H thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
HRAS Q61H thymic tumor White 0 106 0.00 0.00 0.00 0.00
HRAS Q61H ampullary cancer White 0 86 0.00 0.00 0.00 0.00
HRAS Q61H small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
HRAS Q61H small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
HRAS Q61H small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
HRAS Q61H mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS Q61H mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS Q61H mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS Q61H mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS Q61H mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS Q61H mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS Q61H mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS Q61H mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS Q61H nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.01
HRAS Q61H nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS Q61H nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS Q61H penile cancer White 0 20 0.00 0.00 0.00 0.03
HRAS Q61H pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
HRAS Q61H pineal tumor White 0 14 0.00 0.00 0.00 0.02
HRAS Q61H b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS Q61H b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS Q61H b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS Q61H b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS Q61H b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS Q61H non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.02
HRAS Q61H t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
HRAS Q61H t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
HRAS Q61H retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS Q61H retinoblastoma White 0 25 0.00 0.00 0.00 0.02
HRAS Q61H hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
HRAS Q61H lung cancer White 0 17 0.00 0.00 0.00 0.03
HRAS Q61H peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
HRAS Q61H parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
HRAS Q61K appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS Q61K appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS Q61K appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
HRAS Q61K cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.01
HRAS Q61K cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
HRAS Q61K cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS Q61K cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.01
HRAS Q61K cancer of unknown primary White 3 1461 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer Asian 0 334 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer Black 0 525 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer Race:NA 1 3112 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer Native American 0 11 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer White 1 5174 0.00 0.00 0.00 0.00
HRAS Q61K pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS Q61K pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS Q61K pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS Q61K pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS Q61K pancreatic cancer White 1 2037 0.00 0.00 0.00 0.00
HRAS Q61K leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS Q61K leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS Q61K leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS Q61K leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS Q61K leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS Q61K melanoma Asian 0 33 0.00 0.00 0.00 0.01
HRAS Q61K melanoma Black 0 34 0.00 0.00 0.00 0.01
HRAS Q61K melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
HRAS Q61K melanoma Race:Other 0 26 0.00 0.00 0.00 0.01
HRAS Q61K melanoma White 8 2348 0.00 0.00 0.00 0.01
HRAS Q61K head and neck cancer Asian 0 94 0.00 0.00 0.00 0.01
HRAS Q61K head and neck cancer Black 0 62 0.00 0.00 0.00 0.01
HRAS Q61K head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.01
HRAS Q61K head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.01
HRAS Q61K head and neck cancer White 5 1264 0.00 0.00 0.00 0.01
HRAS Q61K uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS Q61K uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS Q61K uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS Q61K uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS Q61K uterine cancer White 0 1750 0.00 0.00 0.00 0.00
HRAS Q61K non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.02
HRAS Q61K non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.02
HRAS Q61K non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.02
HRAS Q61K non-melanoma skin cancers White 2 436 0.00 0.00 0.00 0.01
HRAS Q61K myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS Q61K myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS Q61K myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS Q61K myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS Q61K adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS Q61K adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma Black 0 190 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma Race:NA 0 347 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma White 1 1976 0.00 0.00 0.00 0.00
HRAS Q61K ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS Q61K ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS Q61K ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS Q61K ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS Q61K ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
HRAS Q61K thyroid cancer Asian 2 66 0.02 0.01 0.01 0.05
HRAS Q61K thyroid cancer Black 1 40 0.02 0.01 0.00 0.04
HRAS Q61K thyroid cancer Race:NA 1 79 0.01 0.01 0.00 0.03
HRAS Q61K thyroid cancer Race:Other 1 26 0.02 0.01 0.00 0.06
HRAS Q61K thyroid cancer White 7 803 0.01 0.01 0.00 0.02
HRAS Q61K cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
HRAS Q61K cervical cancer Black 0 19 0.00 0.00 0.00 0.00
HRAS Q61K cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
HRAS Q61K cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
HRAS Q61K cervical cancer White 0 228 0.00 0.00 0.00 0.00
HRAS Q61K hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS Q61K hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS Q61K hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS Q61K hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.01
HRAS Q61K hepatobiliary cancer White 1 948 0.00 0.00 0.00 0.00
HRAS Q61K kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS Q61K kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS Q61K kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS Q61K kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS Q61K kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer White 0 3330 0.00 0.00 0.00 0.00
HRAS Q61K prostate cancer Asian 1 62 0.00 0.00 0.00 0.02
HRAS Q61K prostate cancer Black 1 175 0.00 0.00 0.00 0.01
HRAS Q61K prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.01
HRAS Q61K prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.01
HRAS Q61K prostate cancer White 4 1882 0.00 0.00 0.00 0.00
HRAS Q61K anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
HRAS Q61K anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS Q61K neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
HRAS Q61K neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
HRAS Q61K neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
HRAS Q61K bladder cancer Asian 0 40 0.00 0.00 0.00 0.01
HRAS Q61K bladder cancer Black 0 43 0.00 0.00 0.00 0.01
HRAS Q61K bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.01
HRAS Q61K bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.02
HRAS Q61K bladder cancer White 5 1310 0.00 0.00 0.00 0.01
HRAS Q61K b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS Q61K b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS Q61K b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS Q61K small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS Q61K small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS Q61K small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS Q61K sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.00
HRAS Q61K sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.00
HRAS Q61K bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS Q61K bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS Q61K bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS Q61K bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS Q61K bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS Q61K vaginal cancer White 0 68 0.00 0.00 0.00 0.01
HRAS Q61K thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
HRAS Q61K thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
HRAS Q61K thymic tumor White 0 106 0.00 0.00 0.00 0.00
HRAS Q61K ampullary cancer White 0 86 0.00 0.00 0.00 0.00
HRAS Q61K small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
HRAS Q61K small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
HRAS Q61K small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
HRAS Q61K mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS Q61K mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS Q61K mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS Q61K mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS Q61K mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS Q61K mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS Q61K mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS Q61K mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS Q61K nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.00
HRAS Q61K nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS Q61K nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS Q61K penile cancer White 0 20 0.00 0.00 0.00 0.03
HRAS Q61K pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
HRAS Q61K pineal tumor White 0 14 0.00 0.00 0.00 0.04
HRAS Q61K b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS Q61K b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS Q61K b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS Q61K b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS Q61K b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS Q61K non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.02
HRAS Q61K t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
HRAS Q61K t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
HRAS Q61K retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS Q61K retinoblastoma White 0 25 0.00 0.00 0.00 0.02
HRAS Q61K hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
HRAS Q61K lung cancer White 0 17 0.00 0.00 0.00 0.04
HRAS Q61K peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
HRAS Q61K parathyroid cancer White 1 14 0.08 0.06 0.00 0.26
HRAS Q61L appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS Q61L appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS Q61L appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary White 0 1461 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer Asian 0 334 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer Black 0 525 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer Native American 0 11 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer White 0 5174 0.00 0.00 0.00 0.00
HRAS Q61L pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS Q61L pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS Q61L pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS Q61L pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS Q61L pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
HRAS Q61L leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS Q61L leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS Q61L leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS Q61L leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS Q61L leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS Q61L melanoma Asian 0 33 0.00 0.00 0.00 0.00
HRAS Q61L melanoma Black 0 34 0.00 0.00 0.00 0.00
HRAS Q61L melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
HRAS Q61L melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS Q61L melanoma White 0 2348 0.00 0.00 0.00 0.00
HRAS Q61L head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
HRAS Q61L head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
HRAS Q61L head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
HRAS Q61L head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
HRAS Q61L head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
HRAS Q61L uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS Q61L uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS Q61L uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS Q61L uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS Q61L uterine cancer White 0 1750 0.00 0.00 0.00 0.00
HRAS Q61L non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
HRAS Q61L non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
HRAS Q61L non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
HRAS Q61L non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
HRAS Q61L myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS Q61L myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS Q61L myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS Q61L myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS Q61L adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS Q61L adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS Q61L soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
HRAS Q61L soft tissue sarcoma Black 0 190 0.00 0.00 0.00 0.00
HRAS Q61L soft tissue sarcoma Race:NA 1 347 0.00 0.00 0.00 0.01
HRAS Q61L soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
HRAS Q61L soft tissue sarcoma White 0 1976 0.00 0.00 0.00 0.00
HRAS Q61L ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS Q61L ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS Q61L ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS Q61L ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS Q61L ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
HRAS Q61L thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
HRAS Q61L thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
HRAS Q61L thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
HRAS Q61L thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
HRAS Q61L thyroid cancer White 0 803 0.00 0.00 0.00 0.00
HRAS Q61L cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
HRAS Q61L cervical cancer Black 0 19 0.00 0.00 0.00 0.00
HRAS Q61L cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
HRAS Q61L cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
HRAS Q61L cervical cancer White 0 228 0.00 0.00 0.00 0.00
HRAS Q61L hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS Q61L hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS Q61L hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS Q61L hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
HRAS Q61L hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
HRAS Q61L kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS Q61L kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS Q61L kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS Q61L kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS Q61L kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer White 0 3330 0.00 0.00 0.00 0.00
HRAS Q61L prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
HRAS Q61L prostate cancer Black 0 175 0.00 0.00 0.00 0.00
HRAS Q61L prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
HRAS Q61L prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
HRAS Q61L prostate cancer White 0 1882 0.00 0.00 0.00 0.00
HRAS Q61L anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
HRAS Q61L anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS Q61L neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
HRAS Q61L neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
HRAS Q61L neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
HRAS Q61L bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
HRAS Q61L bladder cancer Black 0 43 0.00 0.00 0.00 0.00
HRAS Q61L bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS Q61L bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
HRAS Q61L bladder cancer White 0 1310 0.00 0.00 0.00 0.00
HRAS Q61L b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS Q61L b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS Q61L b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS Q61L small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS Q61L small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS Q61L small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS Q61L sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
HRAS Q61L sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
HRAS Q61L bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS Q61L bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS Q61L bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS Q61L bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS Q61L bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS Q61L vaginal cancer White 0 68 0.00 0.00 0.00 0.01
HRAS Q61L thymic tumor Asian 0 13 0.00 0.00 0.00 0.01
HRAS Q61L thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
HRAS Q61L thymic tumor White 0 106 0.00 0.00 0.00 0.00
HRAS Q61L ampullary cancer White 0 86 0.00 0.00 0.00 0.01
HRAS Q61L small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
HRAS Q61L small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
HRAS Q61L small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
HRAS Q61L mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS Q61L mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS Q61L mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS Q61L mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS Q61L mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS Q61L mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS Q61L mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS Q61L mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS Q61L nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.00
HRAS Q61L nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS Q61L nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS Q61L penile cancer White 0 20 0.00 0.00 0.00 0.03
HRAS Q61L pheochromocytoma White 0 15 0.00 0.00 0.00 0.05
HRAS Q61L pineal tumor White 0 14 0.00 0.00 0.00 0.02
HRAS Q61L b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS Q61L b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS Q61L b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS Q61L b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS Q61L b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS Q61L non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
HRAS Q61L t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.01
HRAS Q61L t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.01
HRAS Q61L retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS Q61L retinoblastoma White 0 25 0.00 0.00 0.00 0.02
HRAS Q61L hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
HRAS Q61L lung cancer White 0 17 0.00 0.00 0.00 0.04
HRAS Q61L peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
HRAS Q61L parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
HRAS Q61R appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
HRAS Q61R appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
HRAS Q61R appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary White 0 1461 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer Race:NA 1 849 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer White 2 7745 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer Asian 1 334 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer Black 0 525 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer Race:NA 1 3112 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer Native American 0 11 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer White 2 5174 0.00 0.00 0.00 0.00
HRAS Q61R pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
HRAS Q61R pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
HRAS Q61R pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
HRAS Q61R pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
HRAS Q61R pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
HRAS Q61R leukemia Asian 0 37 0.00 0.00 0.00 0.00
HRAS Q61R leukemia Black 0 69 0.00 0.00 0.00 0.00
HRAS Q61R leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
HRAS Q61R leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
HRAS Q61R leukemia White 0 655 0.00 0.00 0.00 0.00
HRAS Q61R melanoma Asian 0 33 0.00 0.00 0.00 0.01
HRAS Q61R melanoma Black 0 34 0.00 0.00 0.00 0.01
HRAS Q61R melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
HRAS Q61R melanoma Race:Other 0 26 0.00 0.00 0.00 0.01
HRAS Q61R melanoma White 5 2348 0.00 0.00 0.00 0.00
HRAS Q61R head and neck cancer Asian 0 94 0.00 0.00 0.00 0.01
HRAS Q61R head and neck cancer Black 1 62 0.01 0.00 0.00 0.02
HRAS Q61R head and neck cancer Race:NA 1 292 0.00 0.00 0.00 0.01
HRAS Q61R head and neck cancer Race:Other 0 28 0.01 0.00 0.00 0.01
HRAS Q61R head and neck cancer White 7 1264 0.00 0.00 0.00 0.01
HRAS Q61R uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
HRAS Q61R uterine cancer Black 0 162 0.00 0.00 0.00 0.00
HRAS Q61R uterine cancer Race:NA 0 189 0.00 0.00 0.00 0.00
HRAS Q61R uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
HRAS Q61R uterine cancer White 0 1750 0.00 0.00 0.00 0.00
HRAS Q61R non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.03
HRAS Q61R non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.03
HRAS Q61R non-melanoma skin cancers Race:NA 1 53 0.01 0.00 0.00 0.05
HRAS Q61R non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.01
HRAS Q61R myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
HRAS Q61R myelodysplastic/myeloproliferative syndromes Black 0 36 0.00 0.00 0.00 0.00
HRAS Q61R myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
HRAS Q61R myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
HRAS Q61R adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS Q61R adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
HRAS Q61R soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
HRAS Q61R soft tissue sarcoma Black 0 190 0.00 0.00 0.00 0.00
HRAS Q61R soft tissue sarcoma Race:NA 1 347 0.00 0.00 0.00 0.01
HRAS Q61R soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
HRAS Q61R soft tissue sarcoma White 0 1976 0.00 0.00 0.00 0.00
HRAS Q61R ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
HRAS Q61R ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
HRAS Q61R ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
HRAS Q61R ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS Q61R ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer White 1 1379 0.00 0.00 0.00 0.00
HRAS Q61R thyroid cancer Asian 2 66 0.03 0.03 0.01 0.05
HRAS Q61R thyroid cancer Black 0 40 0.03 0.03 0.00 0.05
HRAS Q61R thyroid cancer Race:NA 1 79 0.03 0.03 0.01 0.04
HRAS Q61R thyroid cancer Race:Other 1 26 0.03 0.03 0.01 0.06
HRAS Q61R thyroid cancer White 26 803 0.03 0.03 0.02 0.04
HRAS Q61R cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
HRAS Q61R cervical cancer Black 0 19 0.00 0.00 0.00 0.00
HRAS Q61R cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
HRAS Q61R cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
HRAS Q61R cervical cancer White 0 228 0.00 0.00 0.00 0.00
HRAS Q61R hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
HRAS Q61R hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
HRAS Q61R hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
HRAS Q61R hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
HRAS Q61R hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
HRAS Q61R kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
HRAS Q61R kidney cancer Black 0 77 0.00 0.00 0.00 0.00
HRAS Q61R kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
HRAS Q61R kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS Q61R kidney cancer White 0 1113 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer Asian 0 154 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer Black 0 131 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer White 0 3330 0.00 0.00 0.00 0.00
HRAS Q61R prostate cancer Asian 0 62 0.00 0.00 0.00 0.01
HRAS Q61R prostate cancer Black 1 175 0.00 0.00 0.00 0.01
HRAS Q61R prostate cancer Race:NA 1 289 0.00 0.00 0.00 0.01
HRAS Q61R prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.01
HRAS Q61R prostate cancer White 4 1882 0.00 0.00 0.00 0.00
HRAS Q61R anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
HRAS Q61R anal cancer White 0 126 0.00 0.00 0.00 0.00
HRAS Q61R neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.02
HRAS Q61R neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.02
HRAS Q61R neuroendocrine tumors White 1 283 0.00 0.00 0.00 0.01
HRAS Q61R bladder cancer Asian 0 40 0.01 0.01 0.00 0.02
HRAS Q61R bladder cancer Black 0 43 0.01 0.01 0.00 0.02
HRAS Q61R bladder cancer Race:NA 1 169 0.01 0.01 0.00 0.02
HRAS Q61R bladder cancer Race:Other 1 14 0.02 0.01 0.00 0.08
HRAS Q61R bladder cancer White 14 1310 0.01 0.01 0.01 0.02
HRAS Q61R b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
HRAS Q61R b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
HRAS Q61R b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
HRAS Q61R small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
HRAS Q61R small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
HRAS Q61R small bowel cancer White 0 150 0.00 0.00 0.00 0.00
HRAS Q61R sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.00
HRAS Q61R sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.00
HRAS Q61R bone cancer Asian 0 30 0.00 0.00 0.00 0.00
HRAS Q61R bone cancer Black 0 29 0.00 0.00 0.00 0.00
HRAS Q61R bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
HRAS Q61R bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
HRAS Q61R bone cancer White 0 379 0.00 0.00 0.00 0.00
HRAS Q61R vaginal cancer White 0 68 0.00 0.00 0.00 0.01
HRAS Q61R thymic tumor Asian 0 13 0.01 0.00 0.00 0.04
HRAS Q61R thymic tumor Race:NA 0 23 0.01 0.00 0.00 0.03
HRAS Q61R thymic tumor White 1 106 0.01 0.01 0.00 0.03
HRAS Q61R ampullary cancer White 0 86 0.00 0.00 0.00 0.00
HRAS Q61R small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
HRAS Q61R small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
HRAS Q61R small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
HRAS Q61R mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
HRAS Q61R mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
HRAS Q61R mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
HRAS Q61R mature t and nk neoplasms White 0 187 0.00 0.00 0.00 0.00
HRAS Q61R mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
HRAS Q61R mesothelioma Black 0 10 0.00 0.00 0.00 0.00
HRAS Q61R mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
HRAS Q61R mesothelioma White 0 434 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor Race:Other 0 36 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor White 0 603 0.00 0.00 0.00 0.00
HRAS Q61R nerve sheath tumor Black 0 11 0.00 0.00 0.00 0.00
HRAS Q61R nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
HRAS Q61R nerve sheath tumor White 0 103 0.00 0.00 0.00 0.00
HRAS Q61R penile cancer White 0 20 0.00 0.00 0.00 0.03
HRAS Q61R pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
HRAS Q61R pineal tumor White 0 14 0.00 0.00 0.00 0.04
HRAS Q61R b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
HRAS Q61R b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
HRAS Q61R b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
HRAS Q61R b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
HRAS Q61R b cell lymphoma White 0 858 0.00 0.00 0.00 0.00
HRAS Q61R non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.02
HRAS Q61R t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
HRAS Q61R t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
HRAS Q61R retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
HRAS Q61R retinoblastoma White 0 25 0.00 0.00 0.00 0.02
HRAS Q61R hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
HRAS Q61R lung cancer White 0 17 0.00 0.00 0.00 0.04
HRAS Q61R peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
HRAS Q61R parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
NRAS G12A appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
NRAS G12A appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
NRAS G12A appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer White 5 4922 0.00 0.00 0.00 0.00
NRAS G12A cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
NRAS G12A cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
NRAS G12A cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
NRAS G12A cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G12A cancer of unknown primary White 0 1464 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer White 2 7745 0.00 0.00 0.00 0.00
NRAS G12A breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS G12A breast cancer Black 0 525 0.00 0.00 0.00 0.00
NRAS G12A breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
NRAS G12A breast cancer Native American 0 11 0.00 0.00 0.00 0.00
NRAS G12A breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS G12A breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
NRAS G12A pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
NRAS G12A pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
NRAS G12A pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
NRAS G12A pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
NRAS G12A pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
NRAS G12A leukemia Asian 0 37 0.01 0.01 0.00 0.02
NRAS G12A leukemia Black 0 69 0.01 0.01 0.00 0.02
NRAS G12A leukemia Race:NA 7 777 0.01 0.01 0.00 0.02
NRAS G12A leukemia Race:Other 1 13 0.01 0.01 0.00 0.06
NRAS G12A leukemia White 6 662 0.01 0.01 0.00 0.02
NRAS G12A melanoma Asian 0 33 0.00 0.00 0.00 0.01
NRAS G12A melanoma Black 0 34 0.00 0.00 0.00 0.01
NRAS G12A melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
NRAS G12A melanoma Race:Other 1 26 0.01 0.00 0.00 0.08
NRAS G12A melanoma White 4 2348 0.00 0.00 0.00 0.00
NRAS G12A head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
NRAS G12A head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
NRAS G12A head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS G12A head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
NRAS G12A head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
NRAS G12A uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
NRAS G12A uterine cancer Black 0 163 0.00 0.00 0.00 0.00
NRAS G12A uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
NRAS G12A uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
NRAS G12A uterine cancer White 0 1753 0.00 0.00 0.00 0.00
NRAS G12A non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
NRAS G12A non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
NRAS G12A non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
NRAS G12A non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
NRAS G12A myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.02
NRAS G12A myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.01
NRAS G12A myelodysplastic/myeloproliferative syndromes Race:NA 3 571 0.00 0.00 0.00 0.01
NRAS G12A myelodysplastic/myeloproliferative syndromes White 1 584 0.00 0.00 0.00 0.01
NRAS G12A adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
NRAS G12A adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
NRAS G12A ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
NRAS G12A ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
NRAS G12A ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
NRAS G12A ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G12A ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
NRAS G12A esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
NRAS G12A esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
NRAS G12A esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
NRAS G12A esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
NRAS G12A esophagogastric cancer White 1 1379 0.00 0.00 0.00 0.00
NRAS G12A thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
NRAS G12A thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
NRAS G12A thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
NRAS G12A thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
NRAS G12A thyroid cancer White 0 803 0.00 0.00 0.00 0.00
NRAS G12A cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
NRAS G12A cervical cancer Black 0 19 0.00 0.00 0.00 0.00
NRAS G12A cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
NRAS G12A cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
NRAS G12A cervical cancer White 0 228 0.00 0.00 0.00 0.00
NRAS G12A hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
NRAS G12A hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
NRAS G12A hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
NRAS G12A hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
NRAS G12A hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
NRAS G12A kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS G12A kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS G12A kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G12A kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G12A kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS G12A mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
NRAS G12A mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
NRAS G12A mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12A mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
NRAS G12A cns cancer Asian 0 154 0.00 0.00 0.00 0.00
NRAS G12A cns cancer Black 0 131 0.00 0.00 0.00 0.00
NRAS G12A cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
NRAS G12A cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
NRAS G12A cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
NRAS G12A cns cancer White 0 3331 0.00 0.00 0.00 0.00
NRAS G12A prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS G12A prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS G12A prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS G12A prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS G12A prostate cancer White 0 1882 0.00 0.00 0.00 0.00
NRAS G12A anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
NRAS G12A anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS G12A neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
NRAS G12A neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
NRAS G12A neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
NRAS G12A bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
NRAS G12A bladder cancer Black 0 43 0.00 0.00 0.00 0.00
NRAS G12A bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G12A bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
NRAS G12A bladder cancer White 0 1310 0.00 0.00 0.00 0.00
NRAS G12A b-lymphoblastic leukemia/lymphoma Asian 0 17 0.01 0.01 0.00 0.04
NRAS G12A b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.01 0.00 0.00 0.02
NRAS G12A b-lymphoblastic leukemia/lymphoma White 2 125 0.01 0.01 0.00 0.04
NRAS G12A small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
NRAS G12A small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
NRAS G12A small bowel cancer White 0 150 0.00 0.00 0.00 0.00
NRAS G12A sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
NRAS G12A sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
NRAS G12A bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS G12A bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS G12A bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS G12A bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G12A bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS G12A vaginal cancer White 0 68 0.00 0.00 0.00 0.01
NRAS G12A thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
NRAS G12A thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS G12A thymic tumor White 0 108 0.00 0.00 0.00 0.00
NRAS G12A ampullary cancer White 0 86 0.00 0.00 0.00 0.00
NRAS G12A small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
NRAS G12A small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
NRAS G12A small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
NRAS G12A mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
NRAS G12A mesothelioma Black 0 10 0.00 0.00 0.00 0.00
NRAS G12A mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
NRAS G12A mesothelioma White 0 434 0.00 0.00 0.00 0.00
NRAS G12A germ cell tumor Asian 1 36 0.01 0.00 0.00 0.07
NRAS G12A germ cell tumor Black 0 23 0.00 0.00 0.00 0.02
NRAS G12A germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.01
NRAS G12A germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS G12A germ cell tumor White 0 603 0.00 0.00 0.00 0.00
NRAS G12A nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.01
NRAS G12A nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS G12A nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
NRAS G12A penile cancer White 0 20 0.00 0.00 0.00 0.03
NRAS G12A pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
NRAS G12A pineal tumor White 0 14 0.00 0.00 0.00 0.03
NRAS G12A b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
NRAS G12A b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
NRAS G12A b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
NRAS G12A b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
NRAS G12A b cell lymphoma White 0 859 0.00 0.00 0.00 0.00
NRAS G12A non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
NRAS G12A t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS G12A t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
NRAS G12A retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS G12A retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS G12A hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
NRAS G12A lung cancer White 0 17 0.00 0.00 0.00 0.02
NRAS G12A peritoneal cancer White 0 11 0.00 0.00 0.00 0.04
NRAS G12A parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
NRAS G12C appendiceal cancer Black 0 17 0.00 0.00 0.00 0.02
NRAS G12C appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.02
NRAS G12C appendiceal cancer White 1 280 0.00 0.00 0.00 0.01
NRAS G12C colorectal cancer Asian 2 313 0.00 0.00 0.00 0.01
NRAS G12C colorectal cancer Black 1 514 0.00 0.00 0.00 0.00
NRAS G12C colorectal cancer Race:NA 2 804 0.00 0.00 0.00 0.00
NRAS G12C colorectal cancer Native American 0 17 0.00 0.00 0.00 0.01
NRAS G12C colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
NRAS G12C colorectal cancer White 11 4922 0.00 0.00 0.00 0.00
NRAS G12C cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
NRAS G12C cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
NRAS G12C cancer of unknown primary Race:NA 1 286 0.00 0.00 0.00 0.01
NRAS G12C cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.01
NRAS G12C cancer of unknown primary White 1 1464 0.00 0.00 0.00 0.00
NRAS G12C non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
NRAS G12C non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
NRAS G12C non-small cell lung cancer Race:NA 2 849 0.00 0.00 0.00 0.00
NRAS G12C non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.01
NRAS G12C non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
NRAS G12C non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.01
NRAS G12C non-small cell lung cancer White 1 7745 0.00 0.00 0.00 0.00
NRAS G12C breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS G12C breast cancer Black 0 525 0.00 0.00 0.00 0.00
NRAS G12C breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
NRAS G12C breast cancer Native American 0 11 0.00 0.00 0.00 0.00
NRAS G12C breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS G12C breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
NRAS G12C pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
NRAS G12C pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
NRAS G12C pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
NRAS G12C pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
NRAS G12C pancreatic cancer White 1 2037 0.00 0.00 0.00 0.00
NRAS G12C leukemia Asian 0 37 0.00 0.00 0.00 0.01
NRAS G12C leukemia Black 0 69 0.00 0.00 0.00 0.01
NRAS G12C leukemia Race:NA 3 777 0.00 0.00 0.00 0.01
NRAS G12C leukemia Race:Other 0 13 0.01 0.00 0.00 0.02
NRAS G12C leukemia White 5 662 0.01 0.00 0.00 0.01
NRAS G12C melanoma Asian 0 33 0.00 0.00 0.00 0.02
NRAS G12C melanoma Black 1 34 0.01 0.00 0.00 0.06
NRAS G12C melanoma Race:NA 0 398 0.00 0.00 0.00 0.01
NRAS G12C melanoma Race:Other 0 26 0.00 0.00 0.00 0.02
NRAS G12C melanoma White 11 2348 0.00 0.00 0.00 0.01
NRAS G12C head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
NRAS G12C head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
NRAS G12C head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS G12C head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
NRAS G12C head and neck cancer White 1 1264 0.00 0.00 0.00 0.00
NRAS G12C uterine cancer Asian 0 108 0.00 0.00 0.00 0.01
NRAS G12C uterine cancer Black 0 163 0.00 0.00 0.00 0.01
NRAS G12C uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
NRAS G12C uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS G12C uterine cancer White 5 1753 0.00 0.00 0.00 0.00
NRAS G12C non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
NRAS G12C non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
NRAS G12C non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
NRAS G12C non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
NRAS G12C myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.01
NRAS G12C myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.01
NRAS G12C myelodysplastic/myeloproliferative syndromes Race:NA 1 571 0.00 0.00 0.00 0.00
NRAS G12C myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
NRAS G12C adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
NRAS G12C adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
NRAS G12C ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
NRAS G12C ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
NRAS G12C ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
NRAS G12C ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G12C ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
NRAS G12C thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
NRAS G12C thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
NRAS G12C thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
NRAS G12C thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
NRAS G12C thyroid cancer White 0 803 0.00 0.00 0.00 0.00
NRAS G12C cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
NRAS G12C cervical cancer Black 0 19 0.00 0.00 0.00 0.00
NRAS G12C cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
NRAS G12C cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
NRAS G12C cervical cancer White 0 228 0.00 0.00 0.00 0.00
NRAS G12C hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.01
NRAS G12C hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.01
NRAS G12C hepatobiliary cancer Race:NA 1 235 0.00 0.00 0.00 0.01
NRAS G12C hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.01
NRAS G12C hepatobiliary cancer White 1 948 0.00 0.00 0.00 0.00
NRAS G12C kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS G12C kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS G12C kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G12C kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G12C kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS G12C mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
NRAS G12C mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
NRAS G12C mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12C mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
NRAS G12C cns cancer Asian 0 154 0.00 0.00 0.00 0.00
NRAS G12C cns cancer Black 0 131 0.00 0.00 0.00 0.00
NRAS G12C cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
NRAS G12C cns cancer Race:Other 1 108 0.00 0.00 0.00 0.02
NRAS G12C cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.01
NRAS G12C cns cancer White 1 3331 0.00 0.00 0.00 0.00
NRAS G12C prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS G12C prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS G12C prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS G12C prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS G12C prostate cancer White 0 1882 0.00 0.00 0.00 0.00
NRAS G12C anal cancer Race:NA 0 13 0.00 0.00 0.00 0.00
NRAS G12C anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS G12C neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
NRAS G12C neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
NRAS G12C neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
NRAS G12C bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
NRAS G12C bladder cancer Black 0 43 0.00 0.00 0.00 0.01
NRAS G12C bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G12C bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.01
NRAS G12C bladder cancer White 1 1310 0.00 0.00 0.00 0.00
NRAS G12C b-lymphoblastic leukemia/lymphoma Asian 0 17 0.01 0.00 0.00 0.03
NRAS G12C b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.02
NRAS G12C b-lymphoblastic leukemia/lymphoma White 1 125 0.01 0.00 0.00 0.02
NRAS G12C small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
NRAS G12C small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
NRAS G12C small bowel cancer White 0 150 0.00 0.00 0.00 0.00
NRAS G12C sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
NRAS G12C sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
NRAS G12C bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS G12C bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS G12C bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS G12C bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G12C bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS G12C vaginal cancer White 0 68 0.00 0.00 0.00 0.01
NRAS G12C thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
NRAS G12C thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS G12C thymic tumor White 0 108 0.00 0.00 0.00 0.00
NRAS G12C ampullary cancer White 0 86 0.00 0.00 0.00 0.00
NRAS G12C small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
NRAS G12C small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
NRAS G12C small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
NRAS G12C mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
NRAS G12C mesothelioma Black 0 10 0.00 0.00 0.00 0.00
NRAS G12C mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
NRAS G12C mesothelioma White 0 434 0.00 0.00 0.00 0.00
NRAS G12C germ cell tumor Asian 0 36 0.00 0.00 0.00 0.01
NRAS G12C germ cell tumor Black 0 23 0.00 0.00 0.00 0.01
NRAS G12C germ cell tumor Race:NA 1 179 0.00 0.00 0.00 0.01
NRAS G12C germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS G12C germ cell tumor White 0 603 0.00 0.00 0.00 0.00
NRAS G12C nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.01
NRAS G12C nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.01
NRAS G12C nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
NRAS G12C penile cancer White 0 20 0.00 0.00 0.00 0.03
NRAS G12C pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
NRAS G12C pineal tumor White 0 14 0.00 0.00 0.00 0.04
NRAS G12C b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
NRAS G12C b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
NRAS G12C b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
NRAS G12C b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
NRAS G12C b cell lymphoma White 0 859 0.00 0.00 0.00 0.00
NRAS G12C non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
NRAS G12C t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.01
NRAS G12C t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.01
NRAS G12C retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS G12C retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS G12C hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
NRAS G12C lung cancer White 0 17 0.00 0.00 0.00 0.04
NRAS G12C peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
NRAS G12C parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
NRAS G12D appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
NRAS G12D appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
NRAS G12D appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
NRAS G12D colorectal cancer Asian 1 313 0.01 0.01 0.00 0.01
NRAS G12D colorectal cancer Black 3 514 0.01 0.01 0.00 0.01
NRAS G12D colorectal cancer Race:NA 5 804 0.01 0.01 0.00 0.01
NRAS G12D colorectal cancer Native American 0 17 0.01 0.01 0.00 0.02
NRAS G12D colorectal cancer Race:Other 3 139 0.01 0.01 0.00 0.02
NRAS G12D colorectal cancer White 41 4922 0.01 0.01 0.01 0.01
NRAS G12D cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.01
NRAS G12D cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
NRAS G12D cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
NRAS G12D cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.01
NRAS G12D cancer of unknown primary White 3 1464 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer Asian 2 624 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer Race:NA 1 849 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer White 5 7745 0.00 0.00 0.00 0.00
NRAS G12D breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS G12D breast cancer Black 0 525 0.00 0.00 0.00 0.00
NRAS G12D breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
NRAS G12D breast cancer Native American 0 11 0.00 0.00 0.00 0.00
NRAS G12D breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS G12D breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma Race:NA 1 350 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma White 1 2005 0.00 0.00 0.00 0.00
NRAS G12D pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
NRAS G12D pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
NRAS G12D pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
NRAS G12D pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
NRAS G12D pancreatic cancer White 1 2037 0.00 0.00 0.00 0.00
NRAS G12D leukemia Asian 0 37 0.04 0.04 0.00 0.06
NRAS G12D leukemia Black 4 69 0.05 0.05 0.02 0.08
NRAS G12D leukemia Race:NA 30 777 0.04 0.04 0.03 0.06
NRAS G12D leukemia Race:Other 0 13 0.04 0.04 0.01 0.08
NRAS G12D leukemia White 37 662 0.05 0.05 0.04 0.07
NRAS G12D melanoma Asian 0 33 0.01 0.01 0.00 0.02
NRAS G12D melanoma Black 1 34 0.01 0.01 0.00 0.03
NRAS G12D melanoma Race:NA 3 398 0.01 0.01 0.00 0.01
NRAS G12D melanoma Race:Other 0 26 0.01 0.01 0.00 0.02
NRAS G12D melanoma White 13 2348 0.01 0.01 0.00 0.01
NRAS G12D head and neck cancer Asian 1 94 0.00 0.00 0.00 0.02
NRAS G12D head and neck cancer Black 0 62 0.00 0.00 0.00 0.01
NRAS G12D head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS G12D head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.01
NRAS G12D head and neck cancer White 2 1264 0.00 0.00 0.00 0.00
NRAS G12D uterine cancer Asian 1 108 0.00 0.00 0.00 0.01
NRAS G12D uterine cancer Black 0 163 0.00 0.00 0.00 0.01
NRAS G12D uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.01
NRAS G12D uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS G12D uterine cancer White 7 1753 0.00 0.00 0.00 0.01
NRAS G12D non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.02
NRAS G12D non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.02
NRAS G12D non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.01
NRAS G12D non-melanoma skin cancers White 1 436 0.00 0.00 0.00 0.01
NRAS G12D myelodysplastic/myeloproliferative syndromes Asian 0 12 0.02 0.02 0.00 0.04
NRAS G12D myelodysplastic/myeloproliferative syndromes Black 0 37 0.02 0.02 0.00 0.03
NRAS G12D myelodysplastic/myeloproliferative syndromes Race:NA 10 571 0.02 0.02 0.01 0.03
NRAS G12D myelodysplastic/myeloproliferative syndromes White 10 584 0.02 0.02 0.01 0.03
NRAS G12D adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS G12D adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
NRAS G12D ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
NRAS G12D ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
NRAS G12D ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
NRAS G12D ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G12D ovarian cancer White 2 1852 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
NRAS G12D thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
NRAS G12D thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
NRAS G12D thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
NRAS G12D thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
NRAS G12D thyroid cancer White 0 803 0.00 0.00 0.00 0.00
NRAS G12D cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
NRAS G12D cervical cancer Black 0 19 0.00 0.00 0.00 0.00
NRAS G12D cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
NRAS G12D cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
NRAS G12D cervical cancer White 0 228 0.00 0.00 0.00 0.00
NRAS G12D hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.01
NRAS G12D hepatobiliary cancer Black 1 64 0.00 0.00 0.00 0.02
NRAS G12D hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.01
NRAS G12D hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.01
NRAS G12D hepatobiliary cancer White 2 948 0.00 0.00 0.00 0.01
NRAS G12D kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS G12D kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS G12D kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G12D kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G12D kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS G12D mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
NRAS G12D mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
NRAS G12D mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12D mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
NRAS G12D cns cancer Asian 0 154 0.00 0.00 0.00 0.00
NRAS G12D cns cancer Black 0 131 0.00 0.00 0.00 0.00
NRAS G12D cns cancer Race:NA 1 817 0.00 0.00 0.00 0.00
NRAS G12D cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
NRAS G12D cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
NRAS G12D cns cancer White 1 3331 0.00 0.00 0.00 0.00
NRAS G12D prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS G12D prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS G12D prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS G12D prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS G12D prostate cancer White 0 1882 0.00 0.00 0.00 0.00
NRAS G12D anal cancer Race:NA 0 13 0.00 0.00 0.00 0.00
NRAS G12D anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS G12D neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.02
NRAS G12D neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.02
NRAS G12D neuroendocrine tumors White 1 283 0.00 0.00 0.00 0.01
NRAS G12D bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
NRAS G12D bladder cancer Black 0 43 0.00 0.00 0.00 0.00
NRAS G12D bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G12D bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.01
NRAS G12D bladder cancer White 1 1310 0.00 0.00 0.00 0.00
NRAS G12D b-lymphoblastic leukemia/lymphoma Asian 0 17 0.04 0.03 0.00 0.08
NRAS G12D b-lymphoblastic leukemia/lymphoma Race:NA 5 92 0.04 0.04 0.02 0.08
NRAS G12D b-lymphoblastic leukemia/lymphoma White 4 125 0.04 0.04 0.01 0.07
NRAS G12D small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
NRAS G12D small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
NRAS G12D small bowel cancer White 0 150 0.00 0.00 0.00 0.00
NRAS G12D sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
NRAS G12D sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
NRAS G12D bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS G12D bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS G12D bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS G12D bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G12D bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS G12D vaginal cancer White 0 68 0.00 0.00 0.00 0.01
NRAS G12D thymic tumor Asian 0 13 0.00 0.00 0.00 0.01
NRAS G12D thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS G12D thymic tumor White 0 108 0.00 0.00 0.00 0.00
NRAS G12D ampullary cancer White 0 86 0.00 0.00 0.00 0.01
NRAS G12D small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
NRAS G12D small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
NRAS G12D small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
NRAS G12D mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
NRAS G12D mesothelioma Black 0 10 0.00 0.00 0.00 0.00
NRAS G12D mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
NRAS G12D mesothelioma White 0 434 0.00 0.00 0.00 0.00
NRAS G12D germ cell tumor Asian 0 36 0.00 0.00 0.00 0.01
NRAS G12D germ cell tumor Black 0 23 0.00 0.00 0.00 0.01
NRAS G12D germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.01
NRAS G12D germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS G12D germ cell tumor White 2 603 0.00 0.00 0.00 0.01
NRAS G12D nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
NRAS G12D nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS G12D nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
NRAS G12D penile cancer White 0 20 0.00 0.00 0.00 0.04
NRAS G12D pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
NRAS G12D pineal tumor White 0 14 0.00 0.00 0.00 0.05
NRAS G12D b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.01
NRAS G12D b cell lymphoma Black 0 25 0.00 0.00 0.00 0.01
NRAS G12D b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.01
NRAS G12D b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.01
NRAS G12D b cell lymphoma White 1 859 0.00 0.00 0.00 0.00
NRAS G12D non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.02
NRAS G12D t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.03 0.02 0.00 0.12
NRAS G12D t-lymphoblastic leukemia/lymphoma White 1 23 0.04 0.03 0.00 0.13
NRAS G12D retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.03
NRAS G12D retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS G12D hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
NRAS G12D lung cancer White 0 17 0.00 0.00 0.00 0.04
NRAS G12D peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
NRAS G12D parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
NRAS G12F appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
NRAS G12F appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
NRAS G12F appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary White 0 1464 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
NRAS G12F breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS G12F breast cancer Black 0 525 0.00 0.00 0.00 0.00
NRAS G12F breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
NRAS G12F breast cancer Native American 0 11 0.00 0.00 0.00 0.00
NRAS G12F breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS G12F breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
NRAS G12F pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
NRAS G12F pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
NRAS G12F pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
NRAS G12F pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
NRAS G12F pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
NRAS G12F leukemia Asian 0 37 0.00 0.00 0.00 0.00
NRAS G12F leukemia Black 0 69 0.00 0.00 0.00 0.00
NRAS G12F leukemia Race:NA 0 777 0.00 0.00 0.00 0.00
NRAS G12F leukemia Race:Other 0 13 0.00 0.00 0.00 0.00
NRAS G12F leukemia White 0 662 0.00 0.00 0.00 0.00
NRAS G12F melanoma Asian 0 33 0.00 0.00 0.00 0.00
NRAS G12F melanoma Black 0 34 0.00 0.00 0.00 0.00
NRAS G12F melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
NRAS G12F melanoma Race:Other 0 26 0.00 0.00 0.00 0.00
NRAS G12F melanoma White 0 2348 0.00 0.00 0.00 0.00
NRAS G12F head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
NRAS G12F head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
NRAS G12F head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS G12F head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
NRAS G12F head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
NRAS G12F uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
NRAS G12F uterine cancer Black 0 163 0.00 0.00 0.00 0.00
NRAS G12F uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
NRAS G12F uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
NRAS G12F uterine cancer White 0 1753 0.00 0.00 0.00 0.00
NRAS G12F non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
NRAS G12F non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
NRAS G12F non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
NRAS G12F non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
NRAS G12F myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
NRAS G12F myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.00
NRAS G12F myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
NRAS G12F myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
NRAS G12F adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS G12F adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
NRAS G12F ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
NRAS G12F ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
NRAS G12F ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
NRAS G12F ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G12F ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
NRAS G12F thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
NRAS G12F thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
NRAS G12F thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
NRAS G12F thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
NRAS G12F thyroid cancer White 0 803 0.00 0.00 0.00 0.00
NRAS G12F cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
NRAS G12F cervical cancer Black 0 19 0.00 0.00 0.00 0.00
NRAS G12F cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
NRAS G12F cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
NRAS G12F cervical cancer White 0 228 0.00 0.00 0.00 0.00
NRAS G12F hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
NRAS G12F hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
NRAS G12F hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
NRAS G12F hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
NRAS G12F hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
NRAS G12F kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS G12F kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS G12F kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G12F kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G12F kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS G12F mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
NRAS G12F mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
NRAS G12F mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12F mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
NRAS G12F cns cancer Asian 0 154 0.00 0.00 0.00 0.00
NRAS G12F cns cancer Black 0 131 0.00 0.00 0.00 0.00
NRAS G12F cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
NRAS G12F cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
NRAS G12F cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
NRAS G12F cns cancer White 0 3331 0.00 0.00 0.00 0.00
NRAS G12F prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS G12F prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS G12F prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS G12F prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS G12F prostate cancer White 0 1882 0.00 0.00 0.00 0.00
NRAS G12F anal cancer Race:NA 0 13 0.00 0.00 0.00 0.00
NRAS G12F anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS G12F neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
NRAS G12F neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
NRAS G12F neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
NRAS G12F bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
NRAS G12F bladder cancer Black 0 43 0.00 0.00 0.00 0.00
NRAS G12F bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G12F bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
NRAS G12F bladder cancer White 0 1310 0.00 0.00 0.00 0.00
NRAS G12F b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
NRAS G12F b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
NRAS G12F b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
NRAS G12F small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
NRAS G12F small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
NRAS G12F small bowel cancer White 0 150 0.00 0.00 0.00 0.00
NRAS G12F sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
NRAS G12F sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
NRAS G12F bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS G12F bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS G12F bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS G12F bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G12F bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS G12F vaginal cancer White 0 68 0.00 0.00 0.00 0.01
NRAS G12F thymic tumor Asian 0 13 0.00 0.00 0.00 0.01
NRAS G12F thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS G12F thymic tumor White 0 108 0.00 0.00 0.00 0.00
NRAS G12F ampullary cancer White 0 86 0.00 0.00 0.00 0.01
NRAS G12F small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
NRAS G12F small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
NRAS G12F small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
NRAS G12F mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
NRAS G12F mesothelioma Black 0 10 0.00 0.00 0.00 0.00
NRAS G12F mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
NRAS G12F mesothelioma White 0 434 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor White 0 603 0.00 0.00 0.00 0.00
NRAS G12F nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
NRAS G12F nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS G12F nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
NRAS G12F penile cancer White 0 20 0.00 0.00 0.00 0.04
NRAS G12F pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
NRAS G12F pineal tumor White 0 14 0.00 0.00 0.00 0.05
NRAS G12F b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
NRAS G12F b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
NRAS G12F b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
NRAS G12F b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
NRAS G12F b cell lymphoma White 0 859 0.00 0.00 0.00 0.00
NRAS G12F non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.02
NRAS G12F t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS G12F t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
NRAS G12F retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.03
NRAS G12F retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS G12F hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
NRAS G12F lung cancer White 0 17 0.00 0.00 0.00 0.04
NRAS G12F peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
NRAS G12F parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
NRAS G12R appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
NRAS G12R appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
NRAS G12R appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary White 0 1464 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
NRAS G12R breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS G12R breast cancer Black 0 525 0.00 0.00 0.00 0.00
NRAS G12R breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
NRAS G12R breast cancer Native American 0 11 0.00 0.00 0.00 0.00
NRAS G12R breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS G12R breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
NRAS G12R pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
NRAS G12R pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
NRAS G12R pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
NRAS G12R pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
NRAS G12R pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
NRAS G12R leukemia Asian 0 37 0.00 0.00 0.00 0.01
NRAS G12R leukemia Black 0 69 0.00 0.00 0.00 0.01
NRAS G12R leukemia Race:NA 3 777 0.00 0.00 0.00 0.01
NRAS G12R leukemia Race:Other 0 13 0.00 0.00 0.00 0.02
NRAS G12R leukemia White 0 662 0.00 0.00 0.00 0.00
NRAS G12R melanoma Asian 0 33 0.00 0.00 0.00 0.01
NRAS G12R melanoma Black 1 34 0.01 0.00 0.00 0.06
NRAS G12R melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
NRAS G12R melanoma Race:Other 0 26 0.00 0.00 0.00 0.01
NRAS G12R melanoma White 2 2348 0.00 0.00 0.00 0.00
NRAS G12R head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
NRAS G12R head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
NRAS G12R head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS G12R head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
NRAS G12R head and neck cancer White 1 1264 0.00 0.00 0.00 0.00
NRAS G12R uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
NRAS G12R uterine cancer Black 0 163 0.00 0.00 0.00 0.00
NRAS G12R uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
NRAS G12R uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
NRAS G12R uterine cancer White 1 1753 0.00 0.00 0.00 0.00
NRAS G12R non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
NRAS G12R non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
NRAS G12R non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
NRAS G12R non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
NRAS G12R myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.02
NRAS G12R myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.01
NRAS G12R myelodysplastic/myeloproliferative syndromes Race:NA 3 571 0.00 0.00 0.00 0.01
NRAS G12R myelodysplastic/myeloproliferative syndromes White 2 584 0.00 0.00 0.00 0.01
NRAS G12R adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS G12R adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
NRAS G12R ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
NRAS G12R ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
NRAS G12R ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
NRAS G12R ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G12R ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
NRAS G12R thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
NRAS G12R thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
NRAS G12R thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
NRAS G12R thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
NRAS G12R thyroid cancer White 0 803 0.00 0.00 0.00 0.00
NRAS G12R cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
NRAS G12R cervical cancer Black 0 19 0.00 0.00 0.00 0.00
NRAS G12R cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
NRAS G12R cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
NRAS G12R cervical cancer White 0 228 0.00 0.00 0.00 0.00
NRAS G12R hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
NRAS G12R hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
NRAS G12R hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
NRAS G12R hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
NRAS G12R hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
NRAS G12R kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS G12R kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS G12R kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G12R kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G12R kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS G12R mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
NRAS G12R mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
NRAS G12R mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12R mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
NRAS G12R cns cancer Asian 0 154 0.00 0.00 0.00 0.00
NRAS G12R cns cancer Black 0 131 0.00 0.00 0.00 0.00
NRAS G12R cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
NRAS G12R cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
NRAS G12R cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
NRAS G12R cns cancer White 0 3331 0.00 0.00 0.00 0.00
NRAS G12R prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS G12R prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS G12R prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS G12R prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS G12R prostate cancer White 0 1882 0.00 0.00 0.00 0.00
NRAS G12R anal cancer Race:NA 0 13 0.00 0.00 0.00 0.00
NRAS G12R anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS G12R neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
NRAS G12R neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
NRAS G12R neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
NRAS G12R bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
NRAS G12R bladder cancer Black 0 43 0.00 0.00 0.00 0.00
NRAS G12R bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G12R bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
NRAS G12R bladder cancer White 0 1310 0.00 0.00 0.00 0.00
NRAS G12R b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
NRAS G12R b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
NRAS G12R b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
NRAS G12R small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
NRAS G12R small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
NRAS G12R small bowel cancer White 0 150 0.00 0.00 0.00 0.00
NRAS G12R sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
NRAS G12R sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
NRAS G12R bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS G12R bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS G12R bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS G12R bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G12R bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS G12R vaginal cancer White 0 68 0.00 0.00 0.00 0.01
NRAS G12R thymic tumor Asian 0 13 0.00 0.00 0.00 0.01
NRAS G12R thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS G12R thymic tumor White 0 108 0.00 0.00 0.00 0.00
NRAS G12R ampullary cancer White 0 86 0.00 0.00 0.00 0.01
NRAS G12R small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
NRAS G12R small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
NRAS G12R small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
NRAS G12R mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
NRAS G12R mesothelioma Black 0 10 0.00 0.00 0.00 0.00
NRAS G12R mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
NRAS G12R mesothelioma White 0 434 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor White 0 603 0.00 0.00 0.00 0.00
NRAS G12R nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
NRAS G12R nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS G12R nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
NRAS G12R penile cancer White 0 20 0.00 0.00 0.00 0.04
NRAS G12R pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
NRAS G12R pineal tumor White 0 14 0.00 0.00 0.00 0.05
NRAS G12R b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.02
NRAS G12R b cell lymphoma Black 0 25 0.00 0.00 0.00 0.02
NRAS G12R b cell lymphoma Race:NA 1 42 0.01 0.00 0.00 0.06
NRAS G12R b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.03
NRAS G12R b cell lymphoma White 0 859 0.00 0.00 0.00 0.00
NRAS G12R non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.02
NRAS G12R t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS G12R t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
NRAS G12R retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.03
NRAS G12R retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS G12R hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
NRAS G12R lung cancer White 0 17 0.00 0.00 0.00 0.04
NRAS G12R peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
NRAS G12R parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
NRAS G12S appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
NRAS G12S appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
NRAS G12S appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer Race:NA 1 804 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary White 1 1464 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer Black 1 717 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer White 1 7745 0.00 0.00 0.00 0.00
NRAS G12S breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS G12S breast cancer Black 0 525 0.00 0.00 0.00 0.00
NRAS G12S breast cancer Race:NA 1 3112 0.00 0.00 0.00 0.00
NRAS G12S breast cancer Native American 0 11 0.00 0.00 0.00 0.00
NRAS G12S breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS G12S breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS G12S soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
NRAS G12S soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
NRAS G12S soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
NRAS G12S soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
NRAS G12S soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
NRAS G12S pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
NRAS G12S pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
NRAS G12S pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
NRAS G12S pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
NRAS G12S pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
NRAS G12S leukemia Asian 0 37 0.00 0.00 0.00 0.01
NRAS G12S leukemia Black 0 69 0.00 0.00 0.00 0.01
NRAS G12S leukemia Race:NA 4 777 0.00 0.00 0.00 0.01
NRAS G12S leukemia Race:Other 0 13 0.00 0.00 0.00 0.01
NRAS G12S leukemia White 2 662 0.00 0.00 0.00 0.01
NRAS G12S melanoma Asian 0 33 0.00 0.00 0.00 0.01
NRAS G12S melanoma Black 0 34 0.00 0.00 0.00 0.01
NRAS G12S melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
NRAS G12S melanoma Race:Other 0 26 0.00 0.00 0.00 0.01
NRAS G12S melanoma White 6 2348 0.00 0.00 0.00 0.00
NRAS G12S head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
NRAS G12S head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
NRAS G12S head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS G12S head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
NRAS G12S head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
NRAS G12S uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
NRAS G12S uterine cancer Black 0 163 0.00 0.00 0.00 0.00
NRAS G12S uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
NRAS G12S uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
NRAS G12S uterine cancer White 2 1753 0.00 0.00 0.00 0.00
NRAS G12S non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
NRAS G12S non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
NRAS G12S non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
NRAS G12S non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
NRAS G12S myelodysplastic/myeloproliferative syndromes Asian 0 12 0.01 0.01 0.00 0.03
NRAS G12S myelodysplastic/myeloproliferative syndromes Black 0 37 0.01 0.01 0.00 0.02
NRAS G12S myelodysplastic/myeloproliferative syndromes Race:NA 2 571 0.01 0.00 0.00 0.01
NRAS G12S myelodysplastic/myeloproliferative syndromes White 6 584 0.01 0.01 0.00 0.02
NRAS G12S adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
NRAS G12S adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
NRAS G12S ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
NRAS G12S ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
NRAS G12S ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
NRAS G12S ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G12S ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer White 1 1379 0.00 0.00 0.00 0.00
NRAS G12S thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
NRAS G12S thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
NRAS G12S thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
NRAS G12S thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
NRAS G12S thyroid cancer White 0 803 0.00 0.00 0.00 0.00
NRAS G12S cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
NRAS G12S cervical cancer Black 0 19 0.00 0.00 0.00 0.00
NRAS G12S cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
NRAS G12S cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
NRAS G12S cervical cancer White 0 228 0.00 0.00 0.00 0.00
NRAS G12S hepatobiliary cancer Asian 1 97 0.00 0.00 0.00 0.02
NRAS G12S hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.01
NRAS G12S hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
NRAS G12S hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.01
NRAS G12S hepatobiliary cancer White 1 948 0.00 0.00 0.00 0.00
NRAS G12S kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS G12S kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS G12S kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G12S kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G12S kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS G12S mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
NRAS G12S mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
NRAS G12S mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12S mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
NRAS G12S cns cancer Asian 0 154 0.00 0.00 0.00 0.00
NRAS G12S cns cancer Black 0 131 0.00 0.00 0.00 0.00
NRAS G12S cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
NRAS G12S cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
NRAS G12S cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
NRAS G12S cns cancer White 1 3331 0.00 0.00 0.00 0.00
NRAS G12S prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS G12S prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS G12S prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS G12S prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS G12S prostate cancer White 0 1882 0.00 0.00 0.00 0.00
NRAS G12S anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
NRAS G12S anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS G12S neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
NRAS G12S neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
NRAS G12S neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
NRAS G12S bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
NRAS G12S bladder cancer Black 0 43 0.00 0.00 0.00 0.00
NRAS G12S bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G12S bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
NRAS G12S bladder cancer White 0 1310 0.00 0.00 0.00 0.00
NRAS G12S b-lymphoblastic leukemia/lymphoma Asian 0 17 0.01 0.00 0.00 0.05
NRAS G12S b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.01 0.00 0.00 0.03
NRAS G12S b-lymphoblastic leukemia/lymphoma White 4 125 0.03 0.02 0.01 0.06
NRAS G12S small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
NRAS G12S small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
NRAS G12S small bowel cancer White 0 150 0.00 0.00 0.00 0.00
NRAS G12S sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
NRAS G12S sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.00
NRAS G12S bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS G12S bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS G12S bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS G12S bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G12S bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS G12S vaginal cancer White 0 68 0.00 0.00 0.00 0.00
NRAS G12S thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
NRAS G12S thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS G12S thymic tumor White 0 108 0.00 0.00 0.00 0.00
NRAS G12S ampullary cancer White 0 86 0.00 0.00 0.00 0.00
NRAS G12S small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
NRAS G12S small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
NRAS G12S small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
NRAS G12S mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
NRAS G12S mesothelioma Black 0 10 0.00 0.00 0.00 0.00
NRAS G12S mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
NRAS G12S mesothelioma White 0 434 0.00 0.00 0.00 0.00
NRAS G12S germ cell tumor Asian 1 36 0.02 0.01 0.00 0.08
NRAS G12S germ cell tumor Black 0 23 0.00 0.00 0.00 0.02
NRAS G12S germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.01
NRAS G12S germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS G12S germ cell tumor White 0 603 0.00 0.00 0.00 0.00
NRAS G12S nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
NRAS G12S nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS G12S nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
NRAS G12S penile cancer White 0 20 0.00 0.00 0.00 0.01
NRAS G12S pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
NRAS G12S pineal tumor White 0 14 0.00 0.00 0.00 0.04
NRAS G12S b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.01
NRAS G12S b cell lymphoma Black 0 25 0.00 0.00 0.00 0.01
NRAS G12S b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.01
NRAS G12S b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.01
NRAS G12S b cell lymphoma White 2 859 0.00 0.00 0.00 0.01
NRAS G12S non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
NRAS G12S t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.03 0.02 0.00 0.12
NRAS G12S t-lymphoblastic leukemia/lymphoma White 1 23 0.04 0.03 0.00 0.13
NRAS G12S retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS G12S retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS G12S hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.01
NRAS G12S lung cancer White 0 17 0.00 0.00 0.00 0.04
NRAS G12S peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
NRAS G12S parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
NRAS G12V appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
NRAS G12V appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
NRAS G12V appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer Race:NA 1 804 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer White 6 4922 0.00 0.00 0.00 0.00
NRAS G12V cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
NRAS G12V cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
NRAS G12V cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
NRAS G12V cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.01
NRAS G12V cancer of unknown primary White 3 1464 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer White 3 7745 0.00 0.00 0.00 0.00
NRAS G12V breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS G12V breast cancer Black 0 525 0.00 0.00 0.00 0.00
NRAS G12V breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
NRAS G12V breast cancer Native American 0 11 0.00 0.00 0.00 0.00
NRAS G12V breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS G12V breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma White 1 2005 0.00 0.00 0.00 0.00
NRAS G12V pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
NRAS G12V pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
NRAS G12V pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
NRAS G12V pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
NRAS G12V pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
NRAS G12V leukemia Asian 1 37 0.01 0.00 0.00 0.04
NRAS G12V leukemia Black 1 69 0.01 0.00 0.00 0.03
NRAS G12V leukemia Race:NA 4 777 0.00 0.00 0.00 0.01
NRAS G12V leukemia Race:Other 0 13 0.01 0.00 0.00 0.03
NRAS G12V leukemia White 1 662 0.00 0.00 0.00 0.01
NRAS G12V melanoma Asian 0 33 0.00 0.00 0.00 0.01
NRAS G12V melanoma Black 0 34 0.00 0.00 0.00 0.01
NRAS G12V melanoma Race:NA 1 398 0.00 0.00 0.00 0.00
NRAS G12V melanoma Race:Other 0 26 0.00 0.00 0.00 0.01
NRAS G12V melanoma White 2 2348 0.00 0.00 0.00 0.00
NRAS G12V head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
NRAS G12V head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
NRAS G12V head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS G12V head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
NRAS G12V head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
NRAS G12V uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
NRAS G12V uterine cancer Black 0 163 0.00 0.00 0.00 0.00
NRAS G12V uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
NRAS G12V uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
NRAS G12V uterine cancer White 1 1753 0.00 0.00 0.00 0.00
NRAS G12V non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
NRAS G12V non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
NRAS G12V non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
NRAS G12V non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
NRAS G12V myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.02
NRAS G12V myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.01
NRAS G12V myelodysplastic/myeloproliferative syndromes Race:NA 3 571 0.00 0.00 0.00 0.01
NRAS G12V myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
NRAS G12V adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
NRAS G12V adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
NRAS G12V ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
NRAS G12V ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
NRAS G12V ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
NRAS G12V ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G12V ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
NRAS G12V thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
NRAS G12V thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
NRAS G12V thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
NRAS G12V thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
NRAS G12V thyroid cancer White 0 803 0.00 0.00 0.00 0.00
NRAS G12V cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
NRAS G12V cervical cancer Black 0 19 0.00 0.00 0.00 0.00
NRAS G12V cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
NRAS G12V cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
NRAS G12V cervical cancer White 0 228 0.00 0.00 0.00 0.00
NRAS G12V hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
NRAS G12V hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
NRAS G12V hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
NRAS G12V hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.01
NRAS G12V hepatobiliary cancer White 1 948 0.00 0.00 0.00 0.00
NRAS G12V kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS G12V kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS G12V kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G12V kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G12V kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS G12V mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
NRAS G12V mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
NRAS G12V mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
NRAS G12V mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
NRAS G12V cns cancer Asian 0 154 0.00 0.00 0.00 0.00
NRAS G12V cns cancer Black 0 131 0.00 0.00 0.00 0.00
NRAS G12V cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
NRAS G12V cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
NRAS G12V cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
NRAS G12V cns cancer White 0 3331 0.00 0.00 0.00 0.00
NRAS G12V prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS G12V prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS G12V prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS G12V prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS G12V prostate cancer White 0 1882 0.00 0.00 0.00 0.00
NRAS G12V anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
NRAS G12V anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS G12V neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
NRAS G12V neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
NRAS G12V neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
NRAS G12V bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
NRAS G12V bladder cancer Black 0 43 0.00 0.00 0.00 0.00
NRAS G12V bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G12V bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
NRAS G12V bladder cancer White 0 1310 0.00 0.00 0.00 0.00
NRAS G12V b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
NRAS G12V b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
NRAS G12V b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
NRAS G12V small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
NRAS G12V small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
NRAS G12V small bowel cancer White 0 150 0.00 0.00 0.00 0.00
NRAS G12V sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
NRAS G12V sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.00
NRAS G12V bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS G12V bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS G12V bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS G12V bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G12V bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS G12V vaginal cancer White 0 68 0.00 0.00 0.00 0.01
NRAS G12V thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
NRAS G12V thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS G12V thymic tumor White 0 108 0.00 0.00 0.00 0.00
NRAS G12V ampullary cancer White 0 86 0.00 0.00 0.00 0.01
NRAS G12V small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
NRAS G12V small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
NRAS G12V small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
NRAS G12V mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
NRAS G12V mesothelioma Black 0 10 0.00 0.00 0.00 0.00
NRAS G12V mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
NRAS G12V mesothelioma White 0 434 0.00 0.00 0.00 0.00
NRAS G12V germ cell tumor Asian 0 36 0.00 0.00 0.00 0.01
NRAS G12V germ cell tumor Black 0 23 0.00 0.00 0.00 0.01
NRAS G12V germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.01
NRAS G12V germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS G12V germ cell tumor White 2 603 0.00 0.00 0.00 0.01
NRAS G12V nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
NRAS G12V nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS G12V nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
NRAS G12V penile cancer White 0 20 0.00 0.00 0.00 0.02
NRAS G12V pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
NRAS G12V pineal tumor White 0 14 0.00 0.00 0.00 0.04
NRAS G12V b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.02
NRAS G12V b cell lymphoma Black 0 25 0.00 0.00 0.00 0.02
NRAS G12V b cell lymphoma Race:NA 1 42 0.01 0.00 0.00 0.07
NRAS G12V b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.03
NRAS G12V b cell lymphoma White 0 859 0.00 0.00 0.00 0.00
NRAS G12V non-hodgkin lymphoma White 1 19 0.06 0.04 0.00 0.19
NRAS G12V t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
NRAS G12V t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
NRAS G12V retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS G12V retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS G12V hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
NRAS G12V lung cancer White 0 17 0.00 0.00 0.00 0.03
NRAS G12V peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
NRAS G12V parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
NRAS G13C appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
NRAS G13C appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
NRAS G13C appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer White 3 4922 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary White 0 1464 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
NRAS G13C breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS G13C breast cancer Black 0 525 0.00 0.00 0.00 0.00
NRAS G13C breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
NRAS G13C breast cancer Native American 0 11 0.00 0.00 0.00 0.00
NRAS G13C breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS G13C breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
NRAS G13C pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
NRAS G13C pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
NRAS G13C pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
NRAS G13C pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
NRAS G13C pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
NRAS G13C leukemia Asian 0 37 0.00 0.00 0.00 0.00
NRAS G13C leukemia Black 0 69 0.00 0.00 0.00 0.00
NRAS G13C leukemia Race:NA 1 777 0.00 0.00 0.00 0.00
NRAS G13C leukemia Race:Other 0 13 0.00 0.00 0.00 0.01
NRAS G13C leukemia White 0 662 0.00 0.00 0.00 0.00
NRAS G13C melanoma Asian 0 33 0.00 0.00 0.00 0.01
NRAS G13C melanoma Black 0 34 0.00 0.00 0.00 0.01
NRAS G13C melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
NRAS G13C melanoma Race:Other 0 26 0.00 0.00 0.00 0.01
NRAS G13C melanoma White 4 2348 0.00 0.00 0.00 0.00
NRAS G13C head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
NRAS G13C head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
NRAS G13C head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS G13C head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
NRAS G13C head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
NRAS G13C uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
NRAS G13C uterine cancer Black 0 163 0.00 0.00 0.00 0.00
NRAS G13C uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
NRAS G13C uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
NRAS G13C uterine cancer White 0 1753 0.00 0.00 0.00 0.00
NRAS G13C non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
NRAS G13C non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
NRAS G13C non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
NRAS G13C non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
NRAS G13C myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.02
NRAS G13C myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.01
NRAS G13C myelodysplastic/myeloproliferative syndromes Race:NA 3 571 0.00 0.00 0.00 0.01
NRAS G13C myelodysplastic/myeloproliferative syndromes White 2 584 0.00 0.00 0.00 0.01
NRAS G13C adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
NRAS G13C adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
NRAS G13C ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
NRAS G13C ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
NRAS G13C ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
NRAS G13C ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G13C ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
NRAS G13C thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
NRAS G13C thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
NRAS G13C thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
NRAS G13C thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
NRAS G13C thyroid cancer White 0 803 0.00 0.00 0.00 0.00
NRAS G13C cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
NRAS G13C cervical cancer Black 0 19 0.00 0.00 0.00 0.00
NRAS G13C cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
NRAS G13C cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
NRAS G13C cervical cancer White 0 228 0.00 0.00 0.00 0.00
NRAS G13C hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
NRAS G13C hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
NRAS G13C hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
NRAS G13C hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
NRAS G13C hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
NRAS G13C kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS G13C kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS G13C kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G13C kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G13C kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS G13C mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
NRAS G13C mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
NRAS G13C mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
NRAS G13C mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
NRAS G13C cns cancer Asian 0 154 0.00 0.00 0.00 0.00
NRAS G13C cns cancer Black 0 131 0.00 0.00 0.00 0.00
NRAS G13C cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
NRAS G13C cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
NRAS G13C cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
NRAS G13C cns cancer White 0 3331 0.00 0.00 0.00 0.00
NRAS G13C prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS G13C prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS G13C prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS G13C prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS G13C prostate cancer White 0 1882 0.00 0.00 0.00 0.00
NRAS G13C anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
NRAS G13C anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS G13C neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
NRAS G13C neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
NRAS G13C neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
NRAS G13C bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
NRAS G13C bladder cancer Black 0 43 0.00 0.00 0.00 0.00
NRAS G13C bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G13C bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
NRAS G13C bladder cancer White 0 1310 0.00 0.00 0.00 0.00
NRAS G13C b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
NRAS G13C b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
NRAS G13C b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
NRAS G13C small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
NRAS G13C small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
NRAS G13C small bowel cancer White 0 150 0.00 0.00 0.00 0.00
NRAS G13C sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
NRAS G13C sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.00
NRAS G13C bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS G13C bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS G13C bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS G13C bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G13C bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS G13C vaginal cancer White 0 68 0.00 0.00 0.00 0.01
NRAS G13C thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
NRAS G13C thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS G13C thymic tumor White 0 108 0.00 0.00 0.00 0.00
NRAS G13C ampullary cancer White 0 86 0.00 0.00 0.00 0.01
NRAS G13C small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
NRAS G13C small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
NRAS G13C small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
NRAS G13C mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
NRAS G13C mesothelioma Black 0 10 0.00 0.00 0.00 0.00
NRAS G13C mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
NRAS G13C mesothelioma White 0 434 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor White 0 603 0.00 0.00 0.00 0.00
NRAS G13C nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
NRAS G13C nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS G13C nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
NRAS G13C penile cancer White 0 20 0.00 0.00 0.00 0.02
NRAS G13C pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
NRAS G13C pineal tumor White 0 14 0.00 0.00 0.00 0.04
NRAS G13C b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
NRAS G13C b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
NRAS G13C b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
NRAS G13C b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
NRAS G13C b cell lymphoma White 0 859 0.00 0.00 0.00 0.00
NRAS G13C non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
NRAS G13C t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
NRAS G13C t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
NRAS G13C retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS G13C retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS G13C hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
NRAS G13C lung cancer White 0 17 0.00 0.00 0.00 0.03
NRAS G13C peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
NRAS G13C parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
NRAS G13D appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
NRAS G13D appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
NRAS G13D appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer Black 1 514 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer Race:NA 3 804 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer Native American 0 17 0.00 0.00 0.00 0.01
NRAS G13D colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer White 8 4922 0.00 0.00 0.00 0.00
NRAS G13D cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
NRAS G13D cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
NRAS G13D cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
NRAS G13D cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G13D cancer of unknown primary White 0 1464 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
NRAS G13D breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS G13D breast cancer Black 1 525 0.00 0.00 0.00 0.00
NRAS G13D breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
NRAS G13D breast cancer Native American 0 11 0.00 0.00 0.00 0.01
NRAS G13D breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS G13D breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS G13D soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
NRAS G13D soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
NRAS G13D soft tissue sarcoma Race:NA 3 350 0.01 0.01 0.00 0.02
NRAS G13D soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.01
NRAS G13D soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
NRAS G13D pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
NRAS G13D pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
NRAS G13D pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
NRAS G13D pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
NRAS G13D pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
NRAS G13D leukemia Asian 0 37 0.02 0.02 0.00 0.03
NRAS G13D leukemia Black 1 69 0.02 0.02 0.01 0.03
NRAS G13D leukemia Race:NA 16 777 0.02 0.02 0.01 0.03
NRAS G13D leukemia Race:Other 0 13 0.02 0.02 0.01 0.04
NRAS G13D leukemia White 15 662 0.02 0.02 0.01 0.03
NRAS G13D melanoma Asian 0 33 0.00 0.00 0.00 0.02
NRAS G13D melanoma Black 1 34 0.01 0.00 0.00 0.04
NRAS G13D melanoma Race:NA 2 398 0.00 0.00 0.00 0.01
NRAS G13D melanoma Race:Other 0 26 0.00 0.00 0.00 0.02
NRAS G13D melanoma White 5 2348 0.00 0.00 0.00 0.00
NRAS G13D head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
NRAS G13D head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
NRAS G13D head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS G13D head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
NRAS G13D head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
NRAS G13D uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
NRAS G13D uterine cancer Black 1 163 0.00 0.00 0.00 0.02
NRAS G13D uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
NRAS G13D uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS G13D uterine cancer White 0 1753 0.00 0.00 0.00 0.00
NRAS G13D non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
NRAS G13D non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
NRAS G13D non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
NRAS G13D non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
NRAS G13D myelodysplastic/myeloproliferative syndromes Asian 0 12 0.01 0.01 0.00 0.02
NRAS G13D myelodysplastic/myeloproliferative syndromes Black 0 37 0.01 0.01 0.00 0.02
NRAS G13D myelodysplastic/myeloproliferative syndromes Race:NA 6 571 0.01 0.01 0.00 0.02
NRAS G13D myelodysplastic/myeloproliferative syndromes White 3 584 0.01 0.01 0.00 0.01
NRAS G13D adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS G13D adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
NRAS G13D ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
NRAS G13D ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
NRAS G13D ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
NRAS G13D ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G13D ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
NRAS G13D esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
NRAS G13D esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.01
NRAS G13D esophagogastric cancer Race:NA 1 191 0.00 0.00 0.00 0.01
NRAS G13D esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.01
NRAS G13D esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
NRAS G13D thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
NRAS G13D thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
NRAS G13D thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
NRAS G13D thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
NRAS G13D thyroid cancer White 0 803 0.00 0.00 0.00 0.00
NRAS G13D cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
NRAS G13D cervical cancer Black 0 19 0.00 0.00 0.00 0.00
NRAS G13D cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
NRAS G13D cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
NRAS G13D cervical cancer White 0 228 0.00 0.00 0.00 0.00
NRAS G13D hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
NRAS G13D hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
NRAS G13D hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
NRAS G13D hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
NRAS G13D hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
NRAS G13D kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS G13D kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS G13D kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G13D kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G13D kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS G13D mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
NRAS G13D mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
NRAS G13D mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
NRAS G13D mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
NRAS G13D cns cancer Asian 0 154 0.00 0.00 0.00 0.00
NRAS G13D cns cancer Black 0 131 0.00 0.00 0.00 0.00
NRAS G13D cns cancer Race:NA 1 817 0.00 0.00 0.00 0.00
NRAS G13D cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
NRAS G13D cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
NRAS G13D cns cancer White 0 3331 0.00 0.00 0.00 0.00
NRAS G13D prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS G13D prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS G13D prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS G13D prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS G13D prostate cancer White 0 1882 0.00 0.00 0.00 0.00
NRAS G13D anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
NRAS G13D anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS G13D neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.02
NRAS G13D neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.02
NRAS G13D neuroendocrine tumors White 1 283 0.00 0.00 0.00 0.01
NRAS G13D bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
NRAS G13D bladder cancer Black 0 43 0.00 0.00 0.00 0.00
NRAS G13D bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G13D bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
NRAS G13D bladder cancer White 0 1310 0.00 0.00 0.00 0.00
NRAS G13D b-lymphoblastic leukemia/lymphoma Asian 1 17 0.03 0.02 0.01 0.10
NRAS G13D b-lymphoblastic leukemia/lymphoma Race:NA 1 92 0.02 0.02 0.00 0.04
NRAS G13D b-lymphoblastic leukemia/lymphoma White 3 125 0.02 0.02 0.01 0.05
NRAS G13D small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
NRAS G13D small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
NRAS G13D small bowel cancer White 0 150 0.00 0.00 0.00 0.00
NRAS G13D sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
NRAS G13D sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
NRAS G13D bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS G13D bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS G13D bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS G13D bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G13D bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS G13D vaginal cancer White 0 68 0.00 0.00 0.00 0.00
NRAS G13D thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
NRAS G13D thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS G13D thymic tumor White 0 108 0.00 0.00 0.00 0.00
NRAS G13D ampullary cancer White 0 86 0.00 0.00 0.00 0.00
NRAS G13D small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
NRAS G13D small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
NRAS G13D small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
NRAS G13D mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
NRAS G13D mesothelioma Black 0 10 0.00 0.00 0.00 0.00
NRAS G13D mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
NRAS G13D mesothelioma White 0 434 0.00 0.00 0.00 0.00
NRAS G13D germ cell tumor Asian 0 36 0.00 0.00 0.00 0.01
NRAS G13D germ cell tumor Black 0 23 0.00 0.00 0.00 0.01
NRAS G13D germ cell tumor Race:NA 1 179 0.00 0.00 0.00 0.01
NRAS G13D germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS G13D germ cell tumor White 0 603 0.00 0.00 0.00 0.00
NRAS G13D nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
NRAS G13D nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS G13D nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
NRAS G13D penile cancer White 0 20 0.00 0.00 0.00 0.03
NRAS G13D pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
NRAS G13D pineal tumor White 0 14 0.00 0.00 0.00 0.04
NRAS G13D b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.02
NRAS G13D b cell lymphoma Black 0 25 0.00 0.00 0.00 0.02
NRAS G13D b cell lymphoma Race:NA 1 42 0.01 0.00 0.00 0.04
NRAS G13D b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.03
NRAS G13D b cell lymphoma White 1 859 0.00 0.00 0.00 0.01
NRAS G13D non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
NRAS G13D t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS G13D t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.01
NRAS G13D retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS G13D retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS G13D hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.01
NRAS G13D lung cancer White 0 17 0.00 0.00 0.00 0.03
NRAS G13D peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
NRAS G13D parathyroid cancer White 0 14 0.00 0.00 0.00 0.05
NRAS G13R appendiceal cancer Black 0 17 0.00 0.00 0.00 0.02
NRAS G13R appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.02
NRAS G13R appendiceal cancer White 1 280 0.00 0.00 0.00 0.01
NRAS G13R colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
NRAS G13R colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
NRAS G13R colorectal cancer Race:NA 2 804 0.00 0.00 0.00 0.00
NRAS G13R colorectal cancer Native American 0 17 0.00 0.00 0.00 0.01
NRAS G13R colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.01
NRAS G13R colorectal cancer White 17 4922 0.00 0.00 0.00 0.00
NRAS G13R cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.01
NRAS G13R cancer of unknown primary Black 1 123 0.00 0.00 0.00 0.01
NRAS G13R cancer of unknown primary Race:NA 1 286 0.00 0.00 0.00 0.01
NRAS G13R cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.01
NRAS G13R cancer of unknown primary White 3 1464 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer White 2 7745 0.00 0.00 0.00 0.00
NRAS G13R breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS G13R breast cancer Black 0 525 0.00 0.00 0.00 0.00
NRAS G13R breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
NRAS G13R breast cancer Native American 0 11 0.00 0.00 0.00 0.00
NRAS G13R breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS G13R breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
NRAS G13R pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
NRAS G13R pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
NRAS G13R pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
NRAS G13R pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
NRAS G13R pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
NRAS G13R leukemia Asian 1 37 0.01 0.00 0.00 0.03
NRAS G13R leukemia Black 0 69 0.00 0.00 0.00 0.01
NRAS G13R leukemia Race:NA 2 777 0.00 0.00 0.00 0.01
NRAS G13R leukemia Race:Other 0 13 0.01 0.00 0.00 0.02
NRAS G13R leukemia White 4 662 0.00 0.00 0.00 0.01
NRAS G13R melanoma Asian 0 33 0.01 0.01 0.00 0.02
NRAS G13R melanoma Black 0 34 0.01 0.01 0.00 0.02
NRAS G13R melanoma Race:NA 2 398 0.01 0.01 0.00 0.01
NRAS G13R melanoma Race:Other 0 26 0.01 0.01 0.00 0.02
NRAS G13R melanoma White 18 2348 0.01 0.01 0.00 0.01
NRAS G13R head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
NRAS G13R head and neck cancer Black 0 62 0.00 0.00 0.00 0.01
NRAS G13R head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS G13R head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.01
NRAS G13R head and neck cancer White 2 1264 0.00 0.00 0.00 0.00
NRAS G13R uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
NRAS G13R uterine cancer Black 0 163 0.00 0.00 0.00 0.00
NRAS G13R uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
NRAS G13R uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
NRAS G13R uterine cancer White 0 1753 0.00 0.00 0.00 0.00
NRAS G13R non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
NRAS G13R non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
NRAS G13R non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
NRAS G13R non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
NRAS G13R myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.01
NRAS G13R myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.01
NRAS G13R myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
NRAS G13R myelodysplastic/myeloproliferative syndromes White 1 584 0.00 0.00 0.00 0.00
NRAS G13R adrenocortical carcinoma Race:NA 0 26 0.01 0.00 0.00 0.04
NRAS G13R adrenocortical carcinoma White 1 103 0.01 0.01 0.00 0.03
NRAS G13R ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
NRAS G13R ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
NRAS G13R ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
NRAS G13R ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G13R ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
NRAS G13R thyroid cancer Asian 0 66 0.00 0.00 0.00 0.01
NRAS G13R thyroid cancer Black 0 40 0.00 0.00 0.00 0.01
NRAS G13R thyroid cancer Race:NA 1 79 0.00 0.00 0.00 0.02
NRAS G13R thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.01
NRAS G13R thyroid cancer White 1 803 0.00 0.00 0.00 0.01
NRAS G13R cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
NRAS G13R cervical cancer Black 0 19 0.00 0.00 0.00 0.00
NRAS G13R cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
NRAS G13R cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
NRAS G13R cervical cancer White 0 228 0.00 0.00 0.00 0.00
NRAS G13R hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.01
NRAS G13R hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.01
NRAS G13R hepatobiliary cancer Race:NA 1 235 0.00 0.00 0.00 0.01
NRAS G13R hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.01
NRAS G13R hepatobiliary cancer White 2 948 0.00 0.00 0.00 0.01
NRAS G13R kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS G13R kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS G13R kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G13R kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G13R kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS G13R mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
NRAS G13R mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
NRAS G13R mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
NRAS G13R mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
NRAS G13R cns cancer Asian 0 154 0.00 0.00 0.00 0.00
NRAS G13R cns cancer Black 0 131 0.00 0.00 0.00 0.00
NRAS G13R cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
NRAS G13R cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
NRAS G13R cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
NRAS G13R cns cancer White 0 3331 0.00 0.00 0.00 0.00
NRAS G13R prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS G13R prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS G13R prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS G13R prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS G13R prostate cancer White 0 1882 0.00 0.00 0.00 0.00
NRAS G13R anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
NRAS G13R anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS G13R neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
NRAS G13R neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
NRAS G13R neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
NRAS G13R bladder cancer Asian 0 40 0.00 0.00 0.00 0.01
NRAS G13R bladder cancer Black 0 43 0.00 0.00 0.00 0.01
NRAS G13R bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G13R bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.01
NRAS G13R bladder cancer White 2 1310 0.00 0.00 0.00 0.00
NRAS G13R b-lymphoblastic leukemia/lymphoma Asian 0 17 0.01 0.00 0.00 0.03
NRAS G13R b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.02
NRAS G13R b-lymphoblastic leukemia/lymphoma White 1 125 0.01 0.00 0.00 0.02
NRAS G13R small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
NRAS G13R small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
NRAS G13R small bowel cancer White 0 150 0.00 0.00 0.00 0.00
NRAS G13R sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
NRAS G13R sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
NRAS G13R bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS G13R bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS G13R bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS G13R bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G13R bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS G13R vaginal cancer White 0 68 0.00 0.00 0.00 0.00
NRAS G13R thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
NRAS G13R thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS G13R thymic tumor White 0 108 0.00 0.00 0.00 0.00
NRAS G13R ampullary cancer White 0 86 0.00 0.00 0.00 0.00
NRAS G13R small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
NRAS G13R small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
NRAS G13R small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
NRAS G13R mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
NRAS G13R mesothelioma Black 0 10 0.00 0.00 0.00 0.00
NRAS G13R mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
NRAS G13R mesothelioma White 0 434 0.00 0.00 0.00 0.00
NRAS G13R germ cell tumor Asian 0 36 0.00 0.00 0.00 0.01
NRAS G13R germ cell tumor Black 0 23 0.00 0.00 0.00 0.01
NRAS G13R germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.01
NRAS G13R germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS G13R germ cell tumor White 2 603 0.00 0.00 0.00 0.01
NRAS G13R nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.00
NRAS G13R nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS G13R nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
NRAS G13R penile cancer White 0 20 0.00 0.00 0.00 0.03
NRAS G13R pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
NRAS G13R pineal tumor White 0 14 0.00 0.00 0.00 0.04
NRAS G13R b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.01
NRAS G13R b cell lymphoma Black 0 25 0.00 0.00 0.00 0.01
NRAS G13R b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.01
NRAS G13R b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.01
NRAS G13R b cell lymphoma White 1 859 0.00 0.00 0.00 0.00
NRAS G13R non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
NRAS G13R t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.03 0.02 0.00 0.12
NRAS G13R t-lymphoblastic leukemia/lymphoma White 1 23 0.04 0.03 0.00 0.13
NRAS G13R retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS G13R retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS G13R hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.01
NRAS G13R lung cancer White 0 17 0.00 0.00 0.00 0.03
NRAS G13R peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
NRAS G13R parathyroid cancer White 0 14 0.00 0.00 0.00 0.05
NRAS G13V appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
NRAS G13V appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
NRAS G13V appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer Black 0 514 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer Race:NA 0 804 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer White 0 4922 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary White 0 1464 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer Asian 1 624 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.01
NRAS G13V non-small cell lung cancer White 0 7745 0.00 0.00 0.00 0.00
NRAS G13V breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS G13V breast cancer Black 0 525 0.00 0.00 0.00 0.00
NRAS G13V breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
NRAS G13V breast cancer Native American 0 11 0.00 0.00 0.00 0.00
NRAS G13V breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS G13V breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma White 0 2005 0.00 0.00 0.00 0.00
NRAS G13V pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
NRAS G13V pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
NRAS G13V pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
NRAS G13V pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
NRAS G13V pancreatic cancer White 1 2037 0.00 0.00 0.00 0.00
NRAS G13V leukemia Asian 0 37 0.00 0.00 0.00 0.01
NRAS G13V leukemia Black 1 69 0.00 0.00 0.00 0.02
NRAS G13V leukemia Race:NA 2 777 0.00 0.00 0.00 0.01
NRAS G13V leukemia Race:Other 0 13 0.00 0.00 0.00 0.01
NRAS G13V leukemia White 2 662 0.00 0.00 0.00 0.01
NRAS G13V melanoma Asian 0 33 0.00 0.00 0.00 0.01
NRAS G13V melanoma Black 0 34 0.00 0.00 0.00 0.01
NRAS G13V melanoma Race:NA 0 398 0.00 0.00 0.00 0.00
NRAS G13V melanoma Race:Other 0 26 0.00 0.00 0.00 0.01
NRAS G13V melanoma White 4 2348 0.00 0.00 0.00 0.00
NRAS G13V head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
NRAS G13V head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
NRAS G13V head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS G13V head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
NRAS G13V head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
NRAS G13V uterine cancer Asian 0 108 0.00 0.00 0.00 0.00
NRAS G13V uterine cancer Black 0 163 0.00 0.00 0.00 0.00
NRAS G13V uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
NRAS G13V uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.00
NRAS G13V uterine cancer White 0 1753 0.00 0.00 0.00 0.00
NRAS G13V non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
NRAS G13V non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
NRAS G13V non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
NRAS G13V non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
NRAS G13V myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.02
NRAS G13V myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.02
NRAS G13V myelodysplastic/myeloproliferative syndromes Race:NA 4 571 0.00 0.00 0.00 0.01
NRAS G13V myelodysplastic/myeloproliferative syndromes White 1 584 0.00 0.00 0.00 0.01
NRAS G13V adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
NRAS G13V adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
NRAS G13V ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
NRAS G13V ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
NRAS G13V ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
NRAS G13V ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS G13V ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
NRAS G13V thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
NRAS G13V thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
NRAS G13V thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
NRAS G13V thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
NRAS G13V thyroid cancer White 0 803 0.00 0.00 0.00 0.00
NRAS G13V cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
NRAS G13V cervical cancer Black 0 19 0.00 0.00 0.00 0.00
NRAS G13V cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
NRAS G13V cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
NRAS G13V cervical cancer White 0 228 0.00 0.00 0.00 0.00
NRAS G13V hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
NRAS G13V hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
NRAS G13V hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
NRAS G13V hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
NRAS G13V hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
NRAS G13V kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS G13V kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS G13V kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G13V kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G13V kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS G13V mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
NRAS G13V mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
NRAS G13V mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
NRAS G13V mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
NRAS G13V cns cancer Asian 0 154 0.00 0.00 0.00 0.00
NRAS G13V cns cancer Black 0 131 0.00 0.00 0.00 0.00
NRAS G13V cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
NRAS G13V cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
NRAS G13V cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
NRAS G13V cns cancer White 0 3331 0.00 0.00 0.00 0.00
NRAS G13V prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS G13V prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS G13V prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS G13V prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS G13V prostate cancer White 0 1882 0.00 0.00 0.00 0.00
NRAS G13V anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
NRAS G13V anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS G13V neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
NRAS G13V neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
NRAS G13V neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
NRAS G13V bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
NRAS G13V bladder cancer Black 0 43 0.00 0.00 0.00 0.00
NRAS G13V bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS G13V bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
NRAS G13V bladder cancer White 0 1310 0.00 0.00 0.00 0.00
NRAS G13V b-lymphoblastic leukemia/lymphoma Asian 0 17 0.01 0.00 0.00 0.03
NRAS G13V b-lymphoblastic leukemia/lymphoma Race:NA 1 92 0.01 0.00 0.00 0.03
NRAS G13V b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.02
NRAS G13V small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
NRAS G13V small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
NRAS G13V small bowel cancer White 0 150 0.00 0.00 0.00 0.00
NRAS G13V sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
NRAS G13V sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
NRAS G13V bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS G13V bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS G13V bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS G13V bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS G13V bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS G13V vaginal cancer White 0 68 0.00 0.00 0.00 0.01
NRAS G13V thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
NRAS G13V thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS G13V thymic tumor White 0 108 0.00 0.00 0.00 0.00
NRAS G13V ampullary cancer White 0 86 0.00 0.00 0.00 0.01
NRAS G13V small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
NRAS G13V small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
NRAS G13V small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
NRAS G13V mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
NRAS G13V mesothelioma Black 0 10 0.00 0.00 0.00 0.00
NRAS G13V mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
NRAS G13V mesothelioma White 0 434 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor White 0 603 0.00 0.00 0.00 0.00
NRAS G13V nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.01
NRAS G13V nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS G13V nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
NRAS G13V penile cancer White 0 20 0.00 0.00 0.00 0.03
NRAS G13V pheochromocytoma White 0 15 0.00 0.00 0.00 0.05
NRAS G13V pineal tumor White 0 14 0.00 0.00 0.00 0.02
NRAS G13V b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.00
NRAS G13V b cell lymphoma Black 0 25 0.00 0.00 0.00 0.00
NRAS G13V b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.00
NRAS G13V b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.00
NRAS G13V b cell lymphoma White 0 859 0.00 0.00 0.00 0.00
NRAS G13V non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
NRAS G13V t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.01
NRAS G13V t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.01
NRAS G13V retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS G13V retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS G13V hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
NRAS G13V lung cancer White 0 17 0.00 0.00 0.00 0.04
NRAS G13V peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
NRAS G13V parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
NRAS Q61H appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
NRAS Q61H appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
NRAS Q61H appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
NRAS Q61H colorectal cancer Asian 0 313 0.00 0.00 0.00 0.00
NRAS Q61H colorectal cancer Black 2 514 0.00 0.00 0.00 0.01
NRAS Q61H colorectal cancer Race:NA 3 804 0.00 0.00 0.00 0.00
NRAS Q61H colorectal cancer Native American 0 17 0.00 0.00 0.00 0.01
NRAS Q61H colorectal cancer Race:Other 0 139 0.00 0.00 0.00 0.00
NRAS Q61H colorectal cancer White 12 4922 0.00 0.00 0.00 0.00
NRAS Q61H cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.01
NRAS Q61H cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.01
NRAS Q61H cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
NRAS Q61H cancer of unknown primary Race:Other 1 36 0.01 0.00 0.00 0.05
NRAS Q61H cancer of unknown primary White 2 1464 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer White 4 7745 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer Black 0 525 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer Native American 0 11 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma White 3 2005 0.00 0.00 0.00 0.00
NRAS Q61H pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
NRAS Q61H pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
NRAS Q61H pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
NRAS Q61H pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
NRAS Q61H pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
NRAS Q61H leukemia Asian 1 37 0.01 0.00 0.00 0.03
NRAS Q61H leukemia Black 0 69 0.00 0.00 0.00 0.01
NRAS Q61H leukemia Race:NA 2 777 0.00 0.00 0.00 0.01
NRAS Q61H leukemia Race:Other 0 13 0.01 0.00 0.00 0.02
NRAS Q61H leukemia White 4 662 0.00 0.00 0.00 0.01
NRAS Q61H melanoma Asian 0 33 0.01 0.01 0.00 0.02
NRAS Q61H melanoma Black 0 34 0.01 0.01 0.00 0.02
NRAS Q61H melanoma Race:NA 2 398 0.01 0.01 0.00 0.01
NRAS Q61H melanoma Race:Other 0 26 0.01 0.01 0.00 0.02
NRAS Q61H melanoma White 25 2348 0.01 0.01 0.01 0.01
NRAS Q61H head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
NRAS Q61H head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
NRAS Q61H head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS Q61H head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
NRAS Q61H head and neck cancer White 1 1264 0.00 0.00 0.00 0.00
NRAS Q61H uterine cancer Asian 0 108 0.00 0.00 0.00 0.01
NRAS Q61H uterine cancer Black 0 163 0.00 0.00 0.00 0.00
NRAS Q61H uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.00
NRAS Q61H uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS Q61H uterine cancer White 4 1753 0.00 0.00 0.00 0.00
NRAS Q61H non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
NRAS Q61H non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
NRAS Q61H non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
NRAS Q61H non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
NRAS Q61H myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.01
NRAS Q61H myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.01
NRAS Q61H myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
NRAS Q61H myelodysplastic/myeloproliferative syndromes White 1 584 0.00 0.00 0.00 0.00
NRAS Q61H adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS Q61H adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
NRAS Q61H ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
NRAS Q61H ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
NRAS Q61H ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
NRAS Q61H ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS Q61H ovarian cancer White 0 1852 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer White 0 1379 0.00 0.00 0.00 0.00
NRAS Q61H thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
NRAS Q61H thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
NRAS Q61H thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
NRAS Q61H thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
NRAS Q61H thyroid cancer White 0 803 0.00 0.00 0.00 0.00
NRAS Q61H cervical cancer Asian 0 27 0.00 0.00 0.00 0.02
NRAS Q61H cervical cancer Black 0 19 0.00 0.00 0.00 0.02
NRAS Q61H cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.01
NRAS Q61H cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.02
NRAS Q61H cervical cancer White 1 228 0.00 0.00 0.00 0.01
NRAS Q61H hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
NRAS Q61H hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
NRAS Q61H hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
NRAS Q61H hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
NRAS Q61H hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
NRAS Q61H kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS Q61H kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS Q61H kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS Q61H kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS Q61H kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS Q61H mature t and nk neoplasms Asian 0 12 0.01 0.00 0.00 0.03
NRAS Q61H mature t and nk neoplasms Black 0 18 0.01 0.00 0.00 0.03
NRAS Q61H mature t and nk neoplasms Race:NA 0 10 0.01 0.00 0.00 0.03
NRAS Q61H mature t and nk neoplasms White 1 188 0.00 0.00 0.00 0.02
NRAS Q61H cns cancer Asian 0 154 0.00 0.00 0.00 0.00
NRAS Q61H cns cancer Black 0 131 0.00 0.00 0.00 0.00
NRAS Q61H cns cancer Race:NA 0 817 0.00 0.00 0.00 0.00
NRAS Q61H cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
NRAS Q61H cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
NRAS Q61H cns cancer White 0 3331 0.00 0.00 0.00 0.00
NRAS Q61H prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS Q61H prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS Q61H prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS Q61H prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS Q61H prostate cancer White 2 1882 0.00 0.00 0.00 0.00
NRAS Q61H anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
NRAS Q61H anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS Q61H neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
NRAS Q61H neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
NRAS Q61H neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
NRAS Q61H bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
NRAS Q61H bladder cancer Black 0 43 0.00 0.00 0.00 0.00
NRAS Q61H bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS Q61H bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
NRAS Q61H bladder cancer White 0 1310 0.00 0.00 0.00 0.00
NRAS Q61H b-lymphoblastic leukemia/lymphoma Asian 0 17 0.01 0.01 0.00 0.03
NRAS Q61H b-lymphoblastic leukemia/lymphoma Race:NA 1 92 0.01 0.01 0.00 0.03
NRAS Q61H b-lymphoblastic leukemia/lymphoma White 1 125 0.01 0.01 0.00 0.03
NRAS Q61H small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
NRAS Q61H small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
NRAS Q61H small bowel cancer White 0 150 0.00 0.00 0.00 0.00
NRAS Q61H sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
NRAS Q61H sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
NRAS Q61H bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS Q61H bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS Q61H bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS Q61H bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS Q61H bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS Q61H vaginal cancer White 0 68 0.00 0.00 0.00 0.01
NRAS Q61H thymic tumor Asian 0 13 0.00 0.00 0.00 0.01
NRAS Q61H thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS Q61H thymic tumor White 0 108 0.00 0.00 0.00 0.00
NRAS Q61H ampullary cancer White 0 86 0.00 0.00 0.00 0.00
NRAS Q61H small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
NRAS Q61H small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
NRAS Q61H small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
NRAS Q61H mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
NRAS Q61H mesothelioma Black 0 10 0.00 0.00 0.00 0.00
NRAS Q61H mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
NRAS Q61H mesothelioma White 0 434 0.00 0.00 0.00 0.00
NRAS Q61H germ cell tumor Asian 0 36 0.00 0.00 0.00 0.01
NRAS Q61H germ cell tumor Black 0 23 0.00 0.00 0.00 0.01
NRAS Q61H germ cell tumor Race:NA 1 179 0.00 0.00 0.00 0.01
NRAS Q61H germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS Q61H germ cell tumor White 2 603 0.00 0.00 0.00 0.01
NRAS Q61H nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.01
NRAS Q61H nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.01
NRAS Q61H nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
NRAS Q61H penile cancer White 0 20 0.00 0.00 0.00 0.02
NRAS Q61H pheochromocytoma White 0 15 0.00 0.00 0.00 0.04
NRAS Q61H pineal tumor White 0 14 0.00 0.00 0.00 0.03
NRAS Q61H b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.02
NRAS Q61H b cell lymphoma Black 0 25 0.00 0.00 0.00 0.02
NRAS Q61H b cell lymphoma Race:NA 1 42 0.01 0.00 0.00 0.04
NRAS Q61H b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.03
NRAS Q61H b cell lymphoma White 1 859 0.00 0.00 0.00 0.01
NRAS Q61H non-hodgkin lymphoma White 1 19 0.06 0.04 0.00 0.20
NRAS Q61H t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
NRAS Q61H t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
NRAS Q61H retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS Q61H retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS Q61H hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
NRAS Q61H lung cancer White 0 17 0.00 0.00 0.00 0.04
NRAS Q61H peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
NRAS Q61H parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
NRAS Q61K appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
NRAS Q61K appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
NRAS Q61K appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
NRAS Q61K colorectal cancer Asian 1 313 0.01 0.01 0.00 0.01
NRAS Q61K colorectal cancer Black 7 514 0.01 0.01 0.01 0.02
NRAS Q61K colorectal cancer Race:NA 8 804 0.01 0.01 0.01 0.01
NRAS Q61K colorectal cancer Native American 1 17 0.01 0.01 0.00 0.03
NRAS Q61K colorectal cancer Race:Other 0 139 0.01 0.01 0.00 0.01
NRAS Q61K colorectal cancer White 48 4922 0.01 0.01 0.01 0.01
NRAS Q61K cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.01
NRAS Q61K cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.01
NRAS Q61K cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.01
NRAS Q61K cancer of unknown primary Race:Other 1 36 0.01 0.00 0.00 0.05
NRAS Q61K cancer of unknown primary White 5 1464 0.00 0.00 0.00 0.01
NRAS Q61K non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
NRAS Q61K non-small cell lung cancer Black 1 717 0.00 0.00 0.00 0.00
NRAS Q61K non-small cell lung cancer Race:NA 0 849 0.00 0.00 0.00 0.00
NRAS Q61K non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS Q61K non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
NRAS Q61K non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
NRAS Q61K non-small cell lung cancer White 7 7745 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer Black 0 525 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer Native American 0 11 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS Q61K soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.01
NRAS Q61K soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.01
NRAS Q61K soft tissue sarcoma Race:NA 5 350 0.01 0.01 0.00 0.02
NRAS Q61K soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.01
NRAS Q61K soft tissue sarcoma White 10 2005 0.00 0.00 0.00 0.01
NRAS Q61K pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.01
NRAS Q61K pancreatic cancer Black 1 88 0.00 0.00 0.00 0.02
NRAS Q61K pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
NRAS Q61K pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.01
NRAS Q61K pancreatic cancer White 1 2037 0.00 0.00 0.00 0.00
NRAS Q61K leukemia Asian 0 37 0.01 0.01 0.00 0.02
NRAS Q61K leukemia Black 0 69 0.01 0.01 0.00 0.02
NRAS Q61K leukemia Race:NA 7 777 0.01 0.01 0.00 0.02
NRAS Q61K leukemia Race:Other 1 13 0.01 0.01 0.00 0.06
NRAS Q61K leukemia White 6 662 0.01 0.01 0.00 0.02
NRAS Q61K melanoma Asian 1 33 0.06 0.07 0.02 0.09
NRAS Q61K melanoma Black 2 34 0.07 0.07 0.03 0.10
NRAS Q61K melanoma Race:NA 31 398 0.07 0.07 0.06 0.09
NRAS Q61K melanoma Race:Other 0 26 0.06 0.07 0.01 0.09
NRAS Q61K melanoma White 165 2348 0.07 0.07 0.06 0.08
NRAS Q61K head and neck cancer Asian 0 94 0.00 0.00 0.00 0.01
NRAS Q61K head and neck cancer Black 0 62 0.00 0.00 0.00 0.01
NRAS Q61K head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS Q61K head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.01
NRAS Q61K head and neck cancer White 3 1264 0.00 0.00 0.00 0.00
NRAS Q61K uterine cancer Asian 1 108 0.00 0.00 0.00 0.01
NRAS Q61K uterine cancer Black 0 163 0.00 0.00 0.00 0.01
NRAS Q61K uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.01
NRAS Q61K uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS Q61K uterine cancer White 5 1753 0.00 0.00 0.00 0.00
NRAS Q61K non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
NRAS Q61K non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
NRAS Q61K non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
NRAS Q61K non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
NRAS Q61K myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
NRAS Q61K myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.00
NRAS Q61K myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
NRAS Q61K myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
NRAS Q61K adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
NRAS Q61K adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
NRAS Q61K ovarian cancer Asian 0 134 0.00 0.00 0.00 0.01
NRAS Q61K ovarian cancer Black 0 74 0.00 0.00 0.00 0.01
NRAS Q61K ovarian cancer Race:NA 1 239 0.00 0.00 0.00 0.01
NRAS Q61K ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.01
NRAS Q61K ovarian cancer White 4 1852 0.00 0.00 0.00 0.00
NRAS Q61K esophagogastric cancer Asian 1 115 0.00 0.00 0.00 0.02
NRAS Q61K esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.01
NRAS Q61K esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
NRAS Q61K esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.01
NRAS Q61K esophagogastric cancer White 1 1379 0.00 0.00 0.00 0.00
NRAS Q61K thyroid cancer Asian 3 66 0.04 0.03 0.02 0.08
NRAS Q61K thyroid cancer Black 4 40 0.05 0.04 0.02 0.14
NRAS Q61K thyroid cancer Race:NA 1 79 0.03 0.03 0.01 0.05
NRAS Q61K thyroid cancer Race:Other 2 26 0.04 0.04 0.02 0.12
NRAS Q61K thyroid cancer White 19 803 0.03 0.03 0.02 0.04
NRAS Q61K cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
NRAS Q61K cervical cancer Black 0 19 0.00 0.00 0.00 0.00
NRAS Q61K cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
NRAS Q61K cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
NRAS Q61K cervical cancer White 0 228 0.00 0.00 0.00 0.00
NRAS Q61K hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.01
NRAS Q61K hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.01
NRAS Q61K hepatobiliary cancer Race:NA 3 235 0.01 0.01 0.00 0.02
NRAS Q61K hepatobiliary cancer Race:Other 0 25 0.01 0.00 0.00 0.02
NRAS Q61K hepatobiliary cancer White 4 948 0.00 0.00 0.00 0.01
NRAS Q61K kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS Q61K kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS Q61K kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS Q61K kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS Q61K kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS Q61K mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
NRAS Q61K mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
NRAS Q61K mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
NRAS Q61K mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
NRAS Q61K cns cancer Asian 0 154 0.00 0.00 0.00 0.01
NRAS Q61K cns cancer Black 1 131 0.00 0.00 0.00 0.01
NRAS Q61K cns cancer Race:NA 4 817 0.00 0.00 0.00 0.01
NRAS Q61K cns cancer Race:Other 0 108 0.00 0.00 0.00 0.01
NRAS Q61K cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.01
NRAS Q61K cns cancer White 3 3331 0.00 0.00 0.00 0.00
NRAS Q61K prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS Q61K prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS Q61K prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS Q61K prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS Q61K prostate cancer White 1 1882 0.00 0.00 0.00 0.00
NRAS Q61K anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
NRAS Q61K anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS Q61K neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
NRAS Q61K neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
NRAS Q61K neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
NRAS Q61K bladder cancer Asian 0 40 0.00 0.00 0.00 0.01
NRAS Q61K bladder cancer Black 0 43 0.00 0.00 0.00 0.01
NRAS Q61K bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.01
NRAS Q61K bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.01
NRAS Q61K bladder cancer White 3 1310 0.00 0.00 0.00 0.00
NRAS Q61K b-lymphoblastic leukemia/lymphoma Asian 0 17 0.01 0.01 0.00 0.04
NRAS Q61K b-lymphoblastic leukemia/lymphoma Race:NA 1 92 0.01 0.01 0.00 0.04
NRAS Q61K b-lymphoblastic leukemia/lymphoma White 2 125 0.01 0.01 0.00 0.04
NRAS Q61K small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
NRAS Q61K small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
NRAS Q61K small bowel cancer White 0 150 0.00 0.00 0.00 0.00
NRAS Q61K sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
NRAS Q61K sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
NRAS Q61K bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS Q61K bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS Q61K bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS Q61K bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS Q61K bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS Q61K vaginal cancer White 0 68 0.00 0.00 0.00 0.01
NRAS Q61K thymic tumor Asian 0 13 0.01 0.00 0.00 0.04
NRAS Q61K thymic tumor Race:NA 0 23 0.01 0.00 0.00 0.04
NRAS Q61K thymic tumor White 1 108 0.01 0.01 0.00 0.03
NRAS Q61K ampullary cancer White 0 86 0.00 0.00 0.00 0.01
NRAS Q61K small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.02
NRAS Q61K small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.02
NRAS Q61K small cell lung cancer White 1 337 0.00 0.00 0.00 0.01
NRAS Q61K mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
NRAS Q61K mesothelioma Black 0 10 0.00 0.00 0.00 0.00
NRAS Q61K mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
NRAS Q61K mesothelioma White 0 434 0.00 0.00 0.00 0.00
NRAS Q61K germ cell tumor Asian 0 36 0.00 0.00 0.00 0.01
NRAS Q61K germ cell tumor Black 0 23 0.00 0.00 0.00 0.01
NRAS Q61K germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.01
NRAS Q61K germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS Q61K germ cell tumor White 3 603 0.00 0.00 0.00 0.01
NRAS Q61K nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.01
NRAS Q61K nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS Q61K nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
NRAS Q61K penile cancer White 0 20 0.00 0.00 0.00 0.03
NRAS Q61K pheochromocytoma White 0 15 0.00 0.00 0.00 0.05
NRAS Q61K pineal tumor White 0 14 0.00 0.00 0.00 0.02
NRAS Q61K b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.01
NRAS Q61K b cell lymphoma Black 0 25 0.00 0.00 0.00 0.02
NRAS Q61K b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.01
NRAS Q61K b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.02
NRAS Q61K b cell lymphoma White 3 859 0.00 0.00 0.00 0.01
NRAS Q61K non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
NRAS Q61K t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.01
NRAS Q61K t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.01
NRAS Q61K retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS Q61K retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS Q61K hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
NRAS Q61K lung cancer White 0 17 0.00 0.00 0.00 0.04
NRAS Q61K peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
NRAS Q61K parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
NRAS Q61L appendiceal cancer Black 0 17 0.00 0.00 0.00 0.00
NRAS Q61L appendiceal cancer Race:NA 0 33 0.00 0.00 0.00 0.00
NRAS Q61L appendiceal cancer White 0 280 0.00 0.00 0.00 0.00
NRAS Q61L colorectal cancer Asian 0 313 0.00 0.00 0.00 0.01
NRAS Q61L colorectal cancer Black 4 514 0.00 0.00 0.00 0.01
NRAS Q61L colorectal cancer Race:NA 2 804 0.00 0.00 0.00 0.01
NRAS Q61L colorectal cancer Native American 0 17 0.00 0.00 0.00 0.01
NRAS Q61L colorectal cancer Race:Other 2 139 0.00 0.00 0.00 0.02
NRAS Q61L colorectal cancer White 14 4922 0.00 0.00 0.00 0.00
NRAS Q61L cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.00
NRAS Q61L cancer of unknown primary Black 0 123 0.00 0.00 0.00 0.00
NRAS Q61L cancer of unknown primary Race:NA 0 286 0.00 0.00 0.00 0.00
NRAS Q61L cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS Q61L cancer of unknown primary White 1 1464 0.00 0.00 0.00 0.00
NRAS Q61L non-small cell lung cancer Asian 2 624 0.00 0.00 0.00 0.01
NRAS Q61L non-small cell lung cancer Black 0 717 0.00 0.00 0.00 0.00
NRAS Q61L non-small cell lung cancer Race:NA 3 849 0.00 0.00 0.00 0.01
NRAS Q61L non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.01
NRAS Q61L non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.01
NRAS Q61L non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.01
NRAS Q61L non-small cell lung cancer White 27 7745 0.00 0.00 0.00 0.00
NRAS Q61L breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS Q61L breast cancer Black 0 525 0.00 0.00 0.00 0.00
NRAS Q61L breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
NRAS Q61L breast cancer Native American 0 11 0.00 0.00 0.00 0.00
NRAS Q61L breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS Q61L breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS Q61L soft tissue sarcoma Asian 0 143 0.00 0.00 0.00 0.00
NRAS Q61L soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
NRAS Q61L soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
NRAS Q61L soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.00
NRAS Q61L soft tissue sarcoma White 4 2005 0.00 0.00 0.00 0.00
NRAS Q61L pancreatic cancer Asian 0 100 0.00 0.00 0.00 0.00
NRAS Q61L pancreatic cancer Black 0 88 0.00 0.00 0.00 0.00
NRAS Q61L pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.00
NRAS Q61L pancreatic cancer Race:Other 0 34 0.00 0.00 0.00 0.00
NRAS Q61L pancreatic cancer White 0 2037 0.00 0.00 0.00 0.00
NRAS Q61L leukemia Asian 0 37 0.00 0.00 0.00 0.01
NRAS Q61L leukemia Black 0 69 0.00 0.00 0.00 0.01
NRAS Q61L leukemia Race:NA 2 777 0.00 0.00 0.00 0.01
NRAS Q61L leukemia Race:Other 0 13 0.00 0.00 0.00 0.02
NRAS Q61L leukemia White 4 662 0.00 0.00 0.00 0.01
NRAS Q61L melanoma Asian 0 33 0.02 0.02 0.00 0.04
NRAS Q61L melanoma Black 0 34 0.02 0.02 0.00 0.04
NRAS Q61L melanoma Race:NA 7 398 0.02 0.02 0.01 0.04
NRAS Q61L melanoma Race:Other 0 26 0.02 0.02 0.00 0.05
NRAS Q61L melanoma White 81 2348 0.03 0.03 0.03 0.04
NRAS Q61L head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
NRAS Q61L head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
NRAS Q61L head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS Q61L head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
NRAS Q61L head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
NRAS Q61L uterine cancer Asian 0 108 0.00 0.00 0.00 0.01
NRAS Q61L uterine cancer Black 0 163 0.00 0.00 0.00 0.01
NRAS Q61L uterine cancer Race:NA 0 190 0.00 0.00 0.00 0.01
NRAS Q61L uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS Q61L uterine cancer White 6 1753 0.00 0.00 0.00 0.01
NRAS Q61L non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
NRAS Q61L non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
NRAS Q61L non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
NRAS Q61L non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
NRAS Q61L myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.00
NRAS Q61L myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.00
NRAS Q61L myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
NRAS Q61L myelodysplastic/myeloproliferative syndromes White 0 584 0.00 0.00 0.00 0.00
NRAS Q61L adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.01
NRAS Q61L adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
NRAS Q61L ovarian cancer Asian 0 134 0.00 0.00 0.00 0.00
NRAS Q61L ovarian cancer Black 0 74 0.00 0.00 0.00 0.00
NRAS Q61L ovarian cancer Race:NA 0 239 0.00 0.00 0.00 0.00
NRAS Q61L ovarian cancer Race:Other 0 36 0.00 0.00 0.00 0.00
NRAS Q61L ovarian cancer White 1 1852 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer White 1 1379 0.00 0.00 0.00 0.00
NRAS Q61L thyroid cancer Asian 0 66 0.00 0.00 0.00 0.00
NRAS Q61L thyroid cancer Black 0 40 0.00 0.00 0.00 0.00
NRAS Q61L thyroid cancer Race:NA 0 79 0.00 0.00 0.00 0.00
NRAS Q61L thyroid cancer Race:Other 0 26 0.00 0.00 0.00 0.00
NRAS Q61L thyroid cancer White 0 803 0.00 0.00 0.00 0.00
NRAS Q61L cervical cancer Asian 0 27 0.00 0.00 0.00 0.00
NRAS Q61L cervical cancer Black 0 19 0.00 0.00 0.00 0.00
NRAS Q61L cervical cancer Race:NA 0 77 0.00 0.00 0.00 0.00
NRAS Q61L cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.00
NRAS Q61L cervical cancer White 0 228 0.00 0.00 0.00 0.00
NRAS Q61L hepatobiliary cancer Asian 0 97 0.00 0.00 0.00 0.00
NRAS Q61L hepatobiliary cancer Black 0 64 0.00 0.00 0.00 0.00
NRAS Q61L hepatobiliary cancer Race:NA 0 235 0.00 0.00 0.00 0.00
NRAS Q61L hepatobiliary cancer Race:Other 0 25 0.00 0.00 0.00 0.00
NRAS Q61L hepatobiliary cancer White 0 948 0.00 0.00 0.00 0.00
NRAS Q61L kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS Q61L kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS Q61L kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS Q61L kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS Q61L kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS Q61L mature t and nk neoplasms Asian 0 12 0.00 0.00 0.00 0.00
NRAS Q61L mature t and nk neoplasms Black 0 18 0.00 0.00 0.00 0.00
NRAS Q61L mature t and nk neoplasms Race:NA 0 10 0.00 0.00 0.00 0.00
NRAS Q61L mature t and nk neoplasms White 0 188 0.00 0.00 0.00 0.00
NRAS Q61L cns cancer Asian 1 154 0.00 0.00 0.00 0.01
NRAS Q61L cns cancer Black 0 131 0.00 0.00 0.00 0.00
NRAS Q61L cns cancer Race:NA 1 817 0.00 0.00 0.00 0.00
NRAS Q61L cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
NRAS Q61L cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.00
NRAS Q61L cns cancer White 3 3331 0.00 0.00 0.00 0.00
NRAS Q61L prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS Q61L prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS Q61L prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS Q61L prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS Q61L prostate cancer White 0 1882 0.00 0.00 0.00 0.00
NRAS Q61L anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
NRAS Q61L anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS Q61L neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.00
NRAS Q61L neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.00
NRAS Q61L neuroendocrine tumors White 0 283 0.00 0.00 0.00 0.00
NRAS Q61L bladder cancer Asian 0 40 0.00 0.00 0.00 0.00
NRAS Q61L bladder cancer Black 0 43 0.00 0.00 0.00 0.00
NRAS Q61L bladder cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS Q61L bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.00
NRAS Q61L bladder cancer White 0 1310 0.00 0.00 0.00 0.00
NRAS Q61L b-lymphoblastic leukemia/lymphoma Asian 0 17 0.00 0.00 0.00 0.00
NRAS Q61L b-lymphoblastic leukemia/lymphoma Race:NA 0 92 0.00 0.00 0.00 0.00
NRAS Q61L b-lymphoblastic leukemia/lymphoma White 0 125 0.00 0.00 0.00 0.00
NRAS Q61L small bowel cancer Black 0 25 0.00 0.00 0.00 0.00
NRAS Q61L small bowel cancer Race:NA 0 22 0.00 0.00 0.00 0.00
NRAS Q61L small bowel cancer White 0 150 0.00 0.00 0.00 0.00
NRAS Q61L sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.01
NRAS Q61L sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.01
NRAS Q61L bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS Q61L bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS Q61L bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS Q61L bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS Q61L bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS Q61L vaginal cancer White 0 68 0.00 0.00 0.00 0.01
NRAS Q61L thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
NRAS Q61L thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS Q61L thymic tumor White 0 108 0.00 0.00 0.00 0.00
NRAS Q61L ampullary cancer White 0 86 0.00 0.00 0.00 0.01
NRAS Q61L small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.02
NRAS Q61L small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.02
NRAS Q61L small cell lung cancer White 1 337 0.00 0.00 0.00 0.01
NRAS Q61L mesothelioma Asian 0 11 0.00 0.00 0.00 0.00
NRAS Q61L mesothelioma Black 0 10 0.00 0.00 0.00 0.00
NRAS Q61L mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.00
NRAS Q61L mesothelioma White 0 434 0.00 0.00 0.00 0.00
NRAS Q61L germ cell tumor Asian 0 36 0.00 0.00 0.00 0.00
NRAS Q61L germ cell tumor Black 0 23 0.00 0.00 0.00 0.00
NRAS Q61L germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.00
NRAS Q61L germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.00
NRAS Q61L germ cell tumor White 0 603 0.00 0.00 0.00 0.00
NRAS Q61L nerve sheath tumor Black 0 12 0.00 0.00 0.00 0.01
NRAS Q61L nerve sheath tumor Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS Q61L nerve sheath tumor White 0 105 0.00 0.00 0.00 0.00
NRAS Q61L penile cancer White 0 20 0.00 0.00 0.00 0.03
NRAS Q61L pheochromocytoma White 0 15 0.00 0.00 0.00 0.05
NRAS Q61L pineal tumor White 0 14 0.00 0.00 0.00 0.02
NRAS Q61L b cell lymphoma Asian 0 21 0.00 0.00 0.00 0.01
NRAS Q61L b cell lymphoma Black 0 25 0.00 0.00 0.00 0.01
NRAS Q61L b cell lymphoma Race:NA 0 42 0.00 0.00 0.00 0.01
NRAS Q61L b cell lymphoma Race:Other 0 12 0.00 0.00 0.00 0.01
NRAS Q61L b cell lymphoma White 1 859 0.00 0.00 0.00 0.00
NRAS Q61L non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.03
NRAS Q61L t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.01
NRAS Q61L t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.01
NRAS Q61L retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS Q61L retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS Q61L hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
NRAS Q61L lung cancer White 0 17 0.00 0.00 0.00 0.04
NRAS Q61L peritoneal cancer White 0 11 0.00 0.00 0.00 0.06
NRAS Q61L parathyroid cancer White 0 14 0.00 0.00 0.00 0.04
NRAS Q61R appendiceal cancer Black 0 17 0.02 0.01 0.00 0.05
NRAS Q61R appendiceal cancer Race:NA 1 33 0.02 0.02 0.00 0.06
NRAS Q61R appendiceal cancer White 4 280 0.02 0.01 0.00 0.03
NRAS Q61R colorectal cancer Asian 5 313 0.01 0.01 0.00 0.02
NRAS Q61R colorectal cancer Black 7 514 0.01 0.01 0.00 0.02
NRAS Q61R colorectal cancer Race:NA 2 804 0.01 0.01 0.00 0.01
NRAS Q61R colorectal cancer Native American 0 17 0.01 0.01 0.00 0.02
NRAS Q61R colorectal cancer Race:Other 1 139 0.01 0.01 0.00 0.02
NRAS Q61R colorectal cancer White 31 4922 0.01 0.01 0.00 0.01
NRAS Q61R cancer of unknown primary Asian 0 73 0.00 0.00 0.00 0.01
NRAS Q61R cancer of unknown primary Black 1 123 0.00 0.00 0.00 0.01
NRAS Q61R cancer of unknown primary Race:NA 2 286 0.00 0.00 0.00 0.01
NRAS Q61R cancer of unknown primary Race:Other 0 36 0.00 0.00 0.00 0.01
NRAS Q61R cancer of unknown primary White 5 1464 0.00 0.00 0.00 0.01
NRAS Q61R non-small cell lung cancer Asian 0 624 0.00 0.00 0.00 0.00
NRAS Q61R non-small cell lung cancer Black 2 717 0.00 0.00 0.00 0.00
NRAS Q61R non-small cell lung cancer Race:NA 3 849 0.00 0.00 0.00 0.00
NRAS Q61R non-small cell lung cancer Native American 0 17 0.00 0.00 0.00 0.00
NRAS Q61R non-small cell lung cancer Race:Other 0 165 0.00 0.00 0.00 0.00
NRAS Q61R non-small cell lung cancer Race:Undefined 0 10 0.00 0.00 0.00 0.00
NRAS Q61R non-small cell lung cancer White 10 7745 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer Asian 0 334 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer Black 0 525 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer Race:NA 0 3112 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer Native American 0 11 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer Race:Other 0 176 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer White 0 5174 0.00 0.00 0.00 0.00
NRAS Q61R soft tissue sarcoma Asian 1 143 0.00 0.00 0.00 0.01
NRAS Q61R soft tissue sarcoma Black 0 193 0.00 0.00 0.00 0.00
NRAS Q61R soft tissue sarcoma Race:NA 0 350 0.00 0.00 0.00 0.00
NRAS Q61R soft tissue sarcoma Race:Other 0 73 0.00 0.00 0.00 0.01
NRAS Q61R soft tissue sarcoma White 5 2005 0.00 0.00 0.00 0.00
NRAS Q61R pancreatic cancer Asian 1 100 0.00 0.00 0.00 0.02
NRAS Q61R pancreatic cancer Black 1 88 0.01 0.00 0.00 0.02
NRAS Q61R pancreatic cancer Race:NA 0 231 0.00 0.00 0.00 0.01
NRAS Q61R pancreatic cancer Race:Other 1 34 0.01 0.00 0.00 0.05
NRAS Q61R pancreatic cancer White 4 2037 0.00 0.00 0.00 0.00
NRAS Q61R leukemia Asian 0 37 0.01 0.01 0.00 0.02
NRAS Q61R leukemia Black 1 69 0.01 0.01 0.00 0.03
NRAS Q61R leukemia Race:NA 6 777 0.01 0.01 0.00 0.02
NRAS Q61R leukemia Race:Other 1 13 0.02 0.01 0.00 0.06
NRAS Q61R leukemia White 9 662 0.01 0.01 0.01 0.02
NRAS Q61R melanoma Asian 3 33 0.08 0.08 0.05 0.12
NRAS Q61R melanoma Black 1 34 0.08 0.08 0.04 0.11
NRAS Q61R melanoma Race:NA 33 398 0.08 0.08 0.06 0.10
NRAS Q61R melanoma Race:Other 1 26 0.08 0.08 0.04 0.11
NRAS Q61R melanoma White 206 2348 0.09 0.09 0.08 0.10
NRAS Q61R head and neck cancer Asian 0 94 0.00 0.00 0.00 0.00
NRAS Q61R head and neck cancer Black 0 62 0.00 0.00 0.00 0.00
NRAS Q61R head and neck cancer Race:NA 0 292 0.00 0.00 0.00 0.00
NRAS Q61R head and neck cancer Race:Other 0 28 0.00 0.00 0.00 0.00
NRAS Q61R head and neck cancer White 0 1264 0.00 0.00 0.00 0.00
NRAS Q61R uterine cancer Asian 0 108 0.00 0.00 0.00 0.01
NRAS Q61R uterine cancer Black 0 163 0.00 0.00 0.00 0.01
NRAS Q61R uterine cancer Race:NA 1 190 0.00 0.00 0.00 0.01
NRAS Q61R uterine cancer Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS Q61R uterine cancer White 8 1753 0.00 0.00 0.00 0.01
NRAS Q61R non-melanoma skin cancers Asian 0 11 0.00 0.00 0.00 0.00
NRAS Q61R non-melanoma skin cancers Black 0 13 0.00 0.00 0.00 0.00
NRAS Q61R non-melanoma skin cancers Race:NA 0 53 0.00 0.00 0.00 0.00
NRAS Q61R non-melanoma skin cancers White 0 436 0.00 0.00 0.00 0.00
NRAS Q61R myelodysplastic/myeloproliferative syndromes Asian 0 12 0.00 0.00 0.00 0.02
NRAS Q61R myelodysplastic/myeloproliferative syndromes Black 0 37 0.00 0.00 0.00 0.01
NRAS Q61R myelodysplastic/myeloproliferative syndromes Race:NA 0 571 0.00 0.00 0.00 0.00
NRAS Q61R myelodysplastic/myeloproliferative syndromes White 2 584 0.00 0.00 0.00 0.01
NRAS Q61R adrenocortical carcinoma Race:NA 0 26 0.00 0.00 0.00 0.00
NRAS Q61R adrenocortical carcinoma White 0 103 0.00 0.00 0.00 0.00
NRAS Q61R ovarian cancer Asian 1 134 0.01 0.01 0.00 0.02
NRAS Q61R ovarian cancer Black 0 74 0.01 0.01 0.00 0.02
NRAS Q61R ovarian cancer Race:NA 2 239 0.01 0.01 0.00 0.02
NRAS Q61R ovarian cancer Race:Other 0 36 0.01 0.01 0.00 0.02
NRAS Q61R ovarian cancer White 22 1852 0.01 0.01 0.01 0.02
NRAS Q61R esophagogastric cancer Asian 0 115 0.00 0.00 0.00 0.01
NRAS Q61R esophagogastric cancer Black 0 68 0.00 0.00 0.00 0.01
NRAS Q61R esophagogastric cancer Race:NA 0 191 0.00 0.00 0.00 0.00
NRAS Q61R esophagogastric cancer Race:Other 0 46 0.00 0.00 0.00 0.01
NRAS Q61R esophagogastric cancer White 3 1379 0.00 0.00 0.00 0.00
NRAS Q61R thyroid cancer Asian 7 66 0.10 0.10 0.07 0.16
NRAS Q61R thyroid cancer Black 8 40 0.12 0.11 0.08 0.24
NRAS Q61R thyroid cancer Race:NA 7 79 0.10 0.10 0.06 0.15
NRAS Q61R thyroid cancer Race:Other 4 26 0.11 0.10 0.07 0.20
NRAS Q61R thyroid cancer White 69 803 0.09 0.09 0.07 0.11
NRAS Q61R cervical cancer Asian 0 27 0.00 0.00 0.00 0.02
NRAS Q61R cervical cancer Black 0 19 0.00 0.00 0.00 0.02
NRAS Q61R cervical cancer Race:NA 1 77 0.01 0.00 0.00 0.03
NRAS Q61R cervical cancer Race:Other 0 15 0.00 0.00 0.00 0.02
NRAS Q61R cervical cancer White 0 228 0.00 0.00 0.00 0.01
NRAS Q61R hepatobiliary cancer Asian 2 97 0.01 0.01 0.00 0.03
NRAS Q61R hepatobiliary cancer Black 0 64 0.01 0.01 0.00 0.02
NRAS Q61R hepatobiliary cancer Race:NA 1 235 0.01 0.01 0.00 0.01
NRAS Q61R hepatobiliary cancer Race:Other 0 25 0.01 0.01 0.00 0.02
NRAS Q61R hepatobiliary cancer White 6 948 0.01 0.01 0.00 0.01
NRAS Q61R kidney cancer Asian 0 33 0.00 0.00 0.00 0.00
NRAS Q61R kidney cancer Black 0 77 0.00 0.00 0.00 0.00
NRAS Q61R kidney cancer Race:NA 0 169 0.00 0.00 0.00 0.00
NRAS Q61R kidney cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS Q61R kidney cancer White 0 1113 0.00 0.00 0.00 0.00
NRAS Q61R mature t and nk neoplasms Asian 0 12 0.01 0.00 0.00 0.03
NRAS Q61R mature t and nk neoplasms Black 0 18 0.01 0.00 0.00 0.03
NRAS Q61R mature t and nk neoplasms Race:NA 0 10 0.01 0.00 0.00 0.03
NRAS Q61R mature t and nk neoplasms White 1 188 0.00 0.00 0.00 0.02
NRAS Q61R cns cancer Asian 1 154 0.00 0.00 0.00 0.01
NRAS Q61R cns cancer Black 0 131 0.00 0.00 0.00 0.00
NRAS Q61R cns cancer Race:NA 2 817 0.00 0.00 0.00 0.00
NRAS Q61R cns cancer Race:Other 0 108 0.00 0.00 0.00 0.00
NRAS Q61R cns cancer Race:Undefined 0 17 0.00 0.00 0.00 0.01
NRAS Q61R cns cancer White 4 3331 0.00 0.00 0.00 0.00
NRAS Q61R prostate cancer Asian 0 62 0.00 0.00 0.00 0.00
NRAS Q61R prostate cancer Black 0 175 0.00 0.00 0.00 0.00
NRAS Q61R prostate cancer Race:NA 0 289 0.00 0.00 0.00 0.00
NRAS Q61R prostate cancer Race:Other 0 31 0.00 0.00 0.00 0.00
NRAS Q61R prostate cancer White 1 1882 0.00 0.00 0.00 0.00
NRAS Q61R anal cancer Race:NA 0 13 0.00 0.00 0.00 0.01
NRAS Q61R anal cancer White 0 126 0.00 0.00 0.00 0.00
NRAS Q61R neuroendocrine tumors Black 0 23 0.00 0.00 0.00 0.02
NRAS Q61R neuroendocrine tumors Race:NA 0 45 0.00 0.00 0.00 0.02
NRAS Q61R neuroendocrine tumors White 1 283 0.00 0.00 0.00 0.01
NRAS Q61R bladder cancer Asian 0 40 0.00 0.00 0.00 0.02
NRAS Q61R bladder cancer Black 0 43 0.00 0.00 0.00 0.02
NRAS Q61R bladder cancer Race:NA 2 169 0.01 0.00 0.00 0.02
NRAS Q61R bladder cancer Race:Other 0 14 0.00 0.00 0.00 0.02
NRAS Q61R bladder cancer White 1 1310 0.00 0.00 0.00 0.00
NRAS Q61R b-lymphoblastic leukemia/lymphoma Asian 0 17 0.01 0.01 0.00 0.04
NRAS Q61R b-lymphoblastic leukemia/lymphoma Race:NA 1 92 0.01 0.01 0.00 0.03
NRAS Q61R b-lymphoblastic leukemia/lymphoma White 1 125 0.01 0.01 0.00 0.03
NRAS Q61R small bowel cancer Black 2 25 0.07 0.06 0.00 0.20
NRAS Q61R small bowel cancer Race:NA 0 22 0.01 0.00 0.00 0.04
NRAS Q61R small bowel cancer White 0 150 0.00 0.00 0.00 0.02
NRAS Q61R sex cord stromal tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS Q61R sex cord stromal tumor White 0 68 0.00 0.00 0.00 0.00
NRAS Q61R bone cancer Asian 0 30 0.00 0.00 0.00 0.00
NRAS Q61R bone cancer Black 0 32 0.00 0.00 0.00 0.00
NRAS Q61R bone cancer Race:NA 0 86 0.00 0.00 0.00 0.00
NRAS Q61R bone cancer Race:Other 0 29 0.00 0.00 0.00 0.00
NRAS Q61R bone cancer White 0 391 0.00 0.00 0.00 0.00
NRAS Q61R vaginal cancer White 0 68 0.00 0.00 0.00 0.01
NRAS Q61R thymic tumor Asian 0 13 0.00 0.00 0.00 0.00
NRAS Q61R thymic tumor Race:NA 0 23 0.00 0.00 0.00 0.00
NRAS Q61R thymic tumor White 0 108 0.00 0.00 0.00 0.00
NRAS Q61R ampullary cancer White 0 86 0.00 0.00 0.00 0.00
NRAS Q61R small cell lung cancer Asian 0 15 0.00 0.00 0.00 0.00
NRAS Q61R small cell lung cancer Race:NA 0 30 0.00 0.00 0.00 0.00
NRAS Q61R small cell lung cancer White 0 337 0.00 0.00 0.00 0.00
NRAS Q61R mesothelioma Asian 0 11 0.00 0.00 0.00 0.02
NRAS Q61R mesothelioma Black 0 10 0.00 0.00 0.00 0.02
NRAS Q61R mesothelioma Race:NA 0 32 0.00 0.00 0.00 0.01
NRAS Q61R mesothelioma White 1 434 0.00 0.00 0.00 0.01
NRAS Q61R germ cell tumor Asian 0 36 0.00 0.00 0.00 0.01
NRAS Q61R germ cell tumor Black 0 23 0.00 0.00 0.00 0.01
NRAS Q61R germ cell tumor Race:NA 0 179 0.00 0.00 0.00 0.01
NRAS Q61R germ cell tumor Race:Other 0 37 0.00 0.00 0.00 0.01
NRAS Q61R germ cell tumor White 3 603 0.00 0.00 0.00 0.01
NRAS Q61R nerve sheath tumor Black 0 12 0.01 0.00 0.00 0.06
NRAS Q61R nerve sheath tumor Race:NA 1 26 0.02 0.01 0.00 0.10
NRAS Q61R nerve sheath tumor White 0 105 0.00 0.00 0.00 0.02
NRAS Q61R penile cancer White 0 20 0.00 0.00 0.00 0.03
NRAS Q61R pheochromocytoma White 0 15 0.00 0.00 0.00 0.03
NRAS Q61R pineal tumor White 0 14 0.00 0.00 0.00 0.04
NRAS Q61R b cell lymphoma Asian 0 21 0.01 0.01 0.00 0.03
NRAS Q61R b cell lymphoma Black 0 25 0.01 0.01 0.00 0.03
NRAS Q61R b cell lymphoma Race:NA 1 42 0.01 0.01 0.00 0.05
NRAS Q61R b cell lymphoma Race:Other 1 12 0.02 0.01 0.00 0.11
NRAS Q61R b cell lymphoma White 4 859 0.01 0.01 0.00 0.01
NRAS Q61R non-hodgkin lymphoma White 0 19 0.00 0.00 0.00 0.02
NRAS Q61R t-lymphoblastic leukemia/lymphoma Race:NA 0 11 0.00 0.00 0.00 0.03
NRAS Q61R t-lymphoblastic leukemia/lymphoma White 0 23 0.00 0.00 0.00 0.02
NRAS Q61R retinoblastoma Race:NA 0 11 0.00 0.00 0.00 0.02
NRAS Q61R retinoblastoma White 0 25 0.00 0.00 0.00 0.02
NRAS Q61R hodgkin lymphoma White 0 30 0.00 0.00 0.00 0.02
NRAS Q61R lung cancer White 0 17 0.00 0.00 0.00 0.04
NRAS Q61R peritoneal cancer White 0 11 0.00 0.00 0.00 0.05
NRAS Q61R parathyroid cancer White 2 14 0.15 0.13 0.02 0.36
KRAS G12A appendiceal cancer Female 0 174 0.00 0.00 0.00 0.01
KRAS G12A appendiceal cancer Male 1 167 0.00 0.00 0.00 0.02
KRAS G12A colorectal cancer Female 71 3028 0.02 0.02 0.02 0.03
KRAS G12A colorectal cancer Male 74 3696 0.02 0.02 0.02 0.02
KRAS G12A cancer of unknown primary Female 8 1000 0.01 0.01 0.00 0.01
KRAS G12A cancer of unknown primary Male 6 989 0.01 0.01 0.00 0.01
KRAS G12A non-small cell lung cancer Female 147 5722 0.02 0.02 0.02 0.03
KRAS G12A non-small cell lung cancer Male 79 4406 0.02 0.02 0.02 0.02
KRAS G12A breast cancer Female 6 9284 0.00 0.00 0.00 0.00
KRAS G12A breast cancer Male 0 48 0.00 0.00 0.00 0.01
KRAS G12A soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
KRAS G12A soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
KRAS G12A pancreatic cancer Female 7 1153 0.01 0.00 0.00 0.01
KRAS G12A pancreatic cancer Male 6 1341 0.00 0.00 0.00 0.01
KRAS G12A leukemia Female 2 637 0.00 0.00 0.00 0.01
KRAS G12A leukemia Male 3 930 0.00 0.00 0.00 0.01
KRAS G12A melanoma Female 1 1104 0.00 0.00 0.00 0.00
KRAS G12A melanoma Male 0 1742 0.00 0.00 0.00 0.00
KRAS G12A head and neck cancer Female 1 564 0.00 0.00 0.00 0.01
KRAS G12A head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
KRAS G12A uterine cancer Female 31 2254 0.01 0.01 0.01 0.02
KRAS G12A non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
KRAS G12A non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
KRAS G12A myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
KRAS G12A myelodysplastic/myeloproliferative syndromes Male 1 724 0.00 0.00 0.00 0.00
KRAS G12A adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS G12A adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
KRAS G12A ovarian cancer Female 14 2336 0.01 0.01 0.00 0.01
KRAS G12A esophagogastric cancer Female 2 504 0.00 0.00 0.00 0.01
KRAS G12A esophagogastric cancer Male 4 1297 0.00 0.00 0.00 0.01
KRAS G12A thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
KRAS G12A thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
KRAS G12A cervical cancer Female 1 365 0.00 0.00 0.00 0.01
KRAS G12A hepatobiliary cancer Female 1 636 0.00 0.00 0.00 0.01
KRAS G12A hepatobiliary cancer Male 6 739 0.01 0.01 0.00 0.01
KRAS G12A kidney cancer Female 0 420 0.00 0.00 0.00 0.00
KRAS G12A kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
KRAS G12A mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
KRAS G12A mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
KRAS G12A cns cancer Female 4 1994 0.00 0.00 0.00 0.00
KRAS G12A cns cancer Male 2 2569 0.00 0.00 0.00 0.00
KRAS G12A prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
KRAS G12A anal cancer Female 0 102 0.00 0.00 0.00 0.02
KRAS G12A anal cancer Male 1 47 0.02 0.01 0.00 0.06
KRAS G12A neuroendocrine tumors Female 1 166 0.00 0.00 0.00 0.02
KRAS G12A neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.01
KRAS G12A bladder cancer Female 1 393 0.00 0.00 0.00 0.01
KRAS G12A bladder cancer Male 2 1188 0.00 0.00 0.00 0.00
KRAS G12A b-lymphoblastic leukemia/lymphoma Female 1 106 0.01 0.00 0.00 0.03
KRAS G12A b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.02
KRAS G12A small bowel cancer Female 1 78 0.02 0.02 0.00 0.04
KRAS G12A small bowel cancer Male 3 132 0.02 0.02 0.01 0.05
KRAS G12A sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
KRAS G12A sex cord stromal tumor Male 0 11 0.00 0.00 0.00 0.01
KRAS G12A bone cancer Female 2 242 0.01 0.00 0.00 0.02
KRAS G12A bone cancer Male 0 328 0.00 0.00 0.00 0.01
KRAS G12A vaginal cancer Female 1 78 0.02 0.01 0.00 0.05
KRAS G12A thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS G12A thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS G12A ampullary cancer Female 1 41 0.02 0.01 0.00 0.07
KRAS G12A ampullary cancer Male 0 65 0.01 0.00 0.00 0.03
KRAS G12A small cell lung cancer Female 1 193 0.00 0.00 0.00 0.02
KRAS G12A small cell lung cancer Male 0 205 0.00 0.00 0.00 0.01
KRAS G12A mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS G12A mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS G12A germ cell tumor Female 0 175 0.00 0.00 0.00 0.01
KRAS G12A germ cell tumor Male 7 711 0.01 0.01 0.00 0.02
KRAS G12A nerve sheath tumor Female 1 80 0.01 0.01 0.00 0.04
KRAS G12A nerve sheath tumor Male 0 74 0.01 0.00 0.00 0.02
KRAS G12A penile cancer Male 0 25 0.00 0.00 0.00 0.03
KRAS G12A pheochromocytoma Male 0 17 0.00 0.00 0.00 0.04
KRAS G12A pineal tumor Male 0 12 0.00 0.00 0.00 0.06
KRAS G12A b cell lymphoma Female 1 395 0.00 0.00 0.00 0.01
KRAS G12A b cell lymphoma Male 1 567 0.00 0.00 0.00 0.01
KRAS G12A non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.02
KRAS G12A non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.02
KRAS G12A t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
KRAS G12A t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
KRAS G12A retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
KRAS G12A retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
KRAS G12A hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
KRAS G12A hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.01
KRAS G12A lung cancer Male 0 16 0.00 0.00 0.00 0.02
KRAS G12A blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.06
KRAS G12A peritoneal cancer Female 0 17 0.00 0.00 0.00 0.04
KRAS G12C appendiceal cancer Female 6 174 0.03 0.03 0.01 0.06
KRAS G12C appendiceal cancer Male 3 167 0.02 0.02 0.01 0.05
KRAS G12C colorectal cancer Female 110 3028 0.04 0.04 0.03 0.04
KRAS G12C colorectal cancer Male 102 3696 0.03 0.03 0.02 0.03
KRAS G12C cancer of unknown primary Female 39 1000 0.04 0.04 0.03 0.05
KRAS G12C cancer of unknown primary Male 22 989 0.02 0.02 0.02 0.04
KRAS G12C non-small cell lung cancer Female 755 5722 0.13 0.13 0.12 0.14
KRAS G12C non-small cell lung cancer Male 458 4406 0.10 0.10 0.10 0.11
KRAS G12C breast cancer Female 8 9284 0.00 0.00 0.00 0.00
KRAS G12C breast cancer Male 0 48 0.00 0.00 0.00 0.01
KRAS G12C soft tissue sarcoma Female 4 1413 0.00 0.00 0.00 0.00
KRAS G12C soft tissue sarcoma Male 1 1360 0.00 0.00 0.00 0.00
KRAS G12C pancreatic cancer Female 8 1153 0.01 0.01 0.00 0.01
KRAS G12C pancreatic cancer Male 14 1341 0.01 0.01 0.01 0.02
KRAS G12C leukemia Female 0 637 0.00 0.00 0.00 0.00
KRAS G12C leukemia Male 0 930 0.00 0.00 0.00 0.00
KRAS G12C melanoma Female 1 1104 0.00 0.00 0.00 0.00
KRAS G12C melanoma Male 1 1742 0.00 0.00 0.00 0.00
KRAS G12C head and neck cancer Female 1 564 0.00 0.00 0.00 0.00
KRAS G12C head and neck cancer Male 1 1179 0.00 0.00 0.00 0.00
KRAS G12C uterine cancer Female 26 2254 0.01 0.01 0.01 0.02
KRAS G12C non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
KRAS G12C non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
KRAS G12C myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
KRAS G12C myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
KRAS G12C adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS G12C adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
KRAS G12C ovarian cancer Female 10 2336 0.00 0.00 0.00 0.01
KRAS G12C esophagogastric cancer Female 2 504 0.00 0.00 0.00 0.01
KRAS G12C esophagogastric cancer Male 3 1297 0.00 0.00 0.00 0.01
KRAS G12C thyroid cancer Female 1 537 0.00 0.00 0.00 0.01
KRAS G12C thyroid cancer Male 1 480 0.00 0.00 0.00 0.01
KRAS G12C cervical cancer Female 1 365 0.00 0.00 0.00 0.01
KRAS G12C hepatobiliary cancer Female 4 636 0.01 0.01 0.00 0.01
KRAS G12C hepatobiliary cancer Male 6 739 0.01 0.01 0.00 0.01
KRAS G12C kidney cancer Female 0 420 0.00 0.00 0.00 0.00
KRAS G12C kidney cancer Male 1 1002 0.00 0.00 0.00 0.00
KRAS G12C mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
KRAS G12C mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
KRAS G12C cns cancer Female 0 1994 0.00 0.00 0.00 0.00
KRAS G12C cns cancer Male 0 2569 0.00 0.00 0.00 0.00
KRAS G12C prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
KRAS G12C anal cancer Female 0 102 0.00 0.00 0.00 0.00
KRAS G12C anal cancer Male 0 47 0.00 0.00 0.00 0.00
KRAS G12C neuroendocrine tumors Female 1 166 0.01 0.00 0.00 0.02
KRAS G12C neuroendocrine tumors Male 1 193 0.01 0.00 0.00 0.02
KRAS G12C bladder cancer Female 1 393 0.00 0.00 0.00 0.01
KRAS G12C bladder cancer Male 7 1188 0.00 0.00 0.00 0.01
KRAS G12C b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
KRAS G12C b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
KRAS G12C small bowel cancer Female 2 78 0.04 0.03 0.01 0.07
KRAS G12C small bowel cancer Male 6 132 0.04 0.04 0.02 0.08
KRAS G12C sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
KRAS G12C sex cord stromal tumor Male 0 11 0.00 0.00 0.00 0.01
KRAS G12C bone cancer Female 0 242 0.00 0.00 0.00 0.00
KRAS G12C bone cancer Male 0 328 0.00 0.00 0.00 0.00
KRAS G12C vaginal cancer Female 1 78 0.02 0.01 0.00 0.05
KRAS G12C thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS G12C thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS G12C ampullary cancer Female 1 41 0.04 0.03 0.00 0.09
KRAS G12C ampullary cancer Male 3 65 0.04 0.04 0.01 0.09
KRAS G12C small cell lung cancer Female 2 193 0.01 0.01 0.00 0.02
KRAS G12C small cell lung cancer Male 1 205 0.01 0.01 0.00 0.02
KRAS G12C mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS G12C mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS G12C germ cell tumor Female 0 175 0.00 0.00 0.00 0.01
KRAS G12C germ cell tumor Male 4 711 0.00 0.00 0.00 0.01
KRAS G12C nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
KRAS G12C nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
KRAS G12C penile cancer Male 0 25 0.00 0.00 0.00 0.02
KRAS G12C pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
KRAS G12C pineal tumor Male 0 12 0.00 0.00 0.00 0.05
KRAS G12C b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
KRAS G12C b cell lymphoma Male 0 567 0.00 0.00 0.00 0.00
KRAS G12C non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
KRAS G12C non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
KRAS G12C t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
KRAS G12C t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
KRAS G12C retinoblastoma Female 0 23 0.00 0.00 0.00 0.02
KRAS G12C retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
KRAS G12C hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.01
KRAS G12C hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.01
KRAS G12C lung cancer Male 1 16 0.07 0.05 0.00 0.23
KRAS G12C blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.05
KRAS G12C peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
KRAS G12D appendiceal cancer Female 45 174 0.26 0.26 0.21 0.32
KRAS G12D appendiceal cancer Male 47 167 0.28 0.27 0.22 0.34
KRAS G12D colorectal cancer Female 417 3028 0.14 0.14 0.12 0.15
KRAS G12D colorectal cancer Male 468 3696 0.13 0.13 0.12 0.14
KRAS G12D cancer of unknown primary Female 58 1000 0.06 0.06 0.04 0.07
KRAS G12D cancer of unknown primary Male 49 989 0.05 0.05 0.04 0.06
KRAS G12D non-small cell lung cancer Female 263 5722 0.04 0.04 0.04 0.05
KRAS G12D non-small cell lung cancer Male 169 4406 0.04 0.04 0.03 0.04
KRAS G12D breast cancer Female 11 9284 0.00 0.00 0.00 0.00
KRAS G12D breast cancer Male 0 48 0.00 0.00 0.00 0.01
KRAS G12D soft tissue sarcoma Female 7 1413 0.00 0.00 0.00 0.01
KRAS G12D soft tissue sarcoma Male 4 1360 0.00 0.00 0.00 0.01
KRAS G12D pancreatic cancer Female 374 1153 0.32 0.32 0.30 0.35
KRAS G12D pancreatic cancer Male 408 1341 0.31 0.31 0.28 0.33
KRAS G12D leukemia Female 8 637 0.01 0.01 0.01 0.02
KRAS G12D leukemia Male 13 930 0.01 0.01 0.01 0.02
KRAS G12D melanoma Female 6 1104 0.00 0.00 0.00 0.01
KRAS G12D melanoma Male 8 1742 0.00 0.00 0.00 0.01
KRAS G12D head and neck cancer Female 1 564 0.00 0.00 0.00 0.01
KRAS G12D head and neck cancer Male 3 1179 0.00 0.00 0.00 0.01
KRAS G12D uterine cancer Female 102 2254 0.04 0.04 0.04 0.05
KRAS G12D non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.01
KRAS G12D non-melanoma skin cancers Male 1 330 0.00 0.00 0.00 0.01
KRAS G12D myelodysplastic/myeloproliferative syndromes Female 3 483 0.00 0.00 0.00 0.01
KRAS G12D myelodysplastic/myeloproliferative syndromes Male 1 724 0.00 0.00 0.00 0.01
KRAS G12D adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS G12D adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
KRAS G12D ovarian cancer Female 82 2336 0.04 0.04 0.03 0.04
KRAS G12D esophagogastric cancer Female 13 504 0.02 0.02 0.01 0.04
KRAS G12D esophagogastric cancer Male 20 1297 0.02 0.02 0.01 0.02
KRAS G12D thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
KRAS G12D thyroid cancer Male 3 480 0.00 0.00 0.00 0.01
KRAS G12D cervical cancer Female 10 365 0.03 0.03 0.01 0.05
KRAS G12D hepatobiliary cancer Female 28 636 0.04 0.04 0.03 0.06
KRAS G12D hepatobiliary cancer Male 27 739 0.04 0.04 0.03 0.05
KRAS G12D kidney cancer Female 1 420 0.00 0.00 0.00 0.01
KRAS G12D kidney cancer Male 4 1002 0.00 0.00 0.00 0.01
KRAS G12D mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
KRAS G12D mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
KRAS G12D cns cancer Female 4 1994 0.00 0.00 0.00 0.00
KRAS G12D cns cancer Male 4 2569 0.00 0.00 0.00 0.00
KRAS G12D prostate cancer Male 1 2436 0.00 0.00 0.00 0.00
KRAS G12D anal cancer Female 0 102 0.00 0.00 0.00 0.02
KRAS G12D anal cancer Male 1 47 0.02 0.01 0.00 0.06
KRAS G12D neuroendocrine tumors Female 5 166 0.04 0.04 0.02 0.06
KRAS G12D neuroendocrine tumors Male 9 193 0.04 0.04 0.02 0.07
KRAS G12D bladder cancer Female 9 393 0.02 0.02 0.01 0.04
KRAS G12D bladder cancer Male 23 1188 0.02 0.02 0.01 0.03
KRAS G12D b-lymphoblastic leukemia/lymphoma Female 6 106 0.05 0.04 0.02 0.09
KRAS G12D b-lymphoblastic leukemia/lymphoma Male 2 142 0.02 0.02 0.00 0.05
KRAS G12D small bowel cancer Female 8 78 0.11 0.11 0.06 0.17
KRAS G12D small bowel cancer Male 17 132 0.12 0.12 0.08 0.18
KRAS G12D sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
KRAS G12D sex cord stromal tumor Male 0 11 0.00 0.00 0.00 0.00
KRAS G12D bone cancer Female 1 242 0.00 0.00 0.00 0.01
KRAS G12D bone cancer Male 1 328 0.00 0.00 0.00 0.01
KRAS G12D vaginal cancer Female 1 78 0.02 0.01 0.00 0.05
KRAS G12D thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS G12D thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS G12D ampullary cancer Female 12 41 0.27 0.27 0.18 0.40
KRAS G12D ampullary cancer Male 16 65 0.26 0.26 0.17 0.35
KRAS G12D small cell lung cancer Female 1 193 0.01 0.01 0.00 0.02
KRAS G12D small cell lung cancer Male 3 205 0.01 0.01 0.00 0.03
KRAS G12D mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS G12D mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS G12D germ cell tumor Female 0 175 0.00 0.00 0.00 0.02
KRAS G12D germ cell tumor Male 9 711 0.01 0.01 0.00 0.02
KRAS G12D nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
KRAS G12D nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
KRAS G12D penile cancer Male 0 25 0.00 0.00 0.00 0.03
KRAS G12D pheochromocytoma Male 0 17 0.00 0.00 0.00 0.01
KRAS G12D pineal tumor Male 0 12 0.00 0.00 0.00 0.03
KRAS G12D b cell lymphoma Female 2 395 0.00 0.00 0.00 0.01
KRAS G12D b cell lymphoma Male 1 567 0.00 0.00 0.00 0.01
KRAS G12D non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.04
KRAS G12D non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
KRAS G12D t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
KRAS G12D t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
KRAS G12D retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
KRAS G12D retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
KRAS G12D hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
KRAS G12D hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
KRAS G12D lung cancer Male 0 16 0.00 0.00 0.00 0.06
KRAS G12D blastic plasmacytoid dendritic cell neoplasm Male 1 11 0.10 0.08 0.00 0.32
KRAS G12D peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
KRAS G12F appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
KRAS G12F appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer Female 1 3028 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer Male 0 3696 0.00 0.00 0.00 0.00
KRAS G12F cancer of unknown primary Female 2 1000 0.00 0.00 0.00 0.00
KRAS G12F cancer of unknown primary Male 1 989 0.00 0.00 0.00 0.00
KRAS G12F non-small cell lung cancer Female 18 5722 0.00 0.00 0.00 0.00
KRAS G12F non-small cell lung cancer Male 14 4406 0.00 0.00 0.00 0.00
KRAS G12F breast cancer Female 0 9284 0.00 0.00 0.00 0.00
KRAS G12F breast cancer Male 0 48 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
KRAS G12F pancreatic cancer Female 1 1153 0.00 0.00 0.00 0.00
KRAS G12F pancreatic cancer Male 0 1341 0.00 0.00 0.00 0.00
KRAS G12F leukemia Female 0 637 0.00 0.00 0.00 0.00
KRAS G12F leukemia Male 0 930 0.00 0.00 0.00 0.00
KRAS G12F melanoma Female 0 1104 0.00 0.00 0.00 0.00
KRAS G12F melanoma Male 0 1742 0.00 0.00 0.00 0.00
KRAS G12F head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
KRAS G12F head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
KRAS G12F uterine cancer Female 0 2254 0.00 0.00 0.00 0.00
KRAS G12F non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
KRAS G12F non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
KRAS G12F myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
KRAS G12F myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
KRAS G12F adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS G12F adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.01
KRAS G12F ovarian cancer Female 1 2336 0.00 0.00 0.00 0.00
KRAS G12F esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
KRAS G12F esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
KRAS G12F thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
KRAS G12F thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
KRAS G12F cervical cancer Female 0 365 0.00 0.00 0.00 0.00
KRAS G12F hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
KRAS G12F hepatobiliary cancer Male 0 739 0.00 0.00 0.00 0.00
KRAS G12F kidney cancer Female 0 420 0.00 0.00 0.00 0.00
KRAS G12F kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
KRAS G12F mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
KRAS G12F mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
KRAS G12F cns cancer Female 0 1994 0.00 0.00 0.00 0.00
KRAS G12F cns cancer Male 0 2569 0.00 0.00 0.00 0.00
KRAS G12F prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
KRAS G12F anal cancer Female 0 102 0.00 0.00 0.00 0.00
KRAS G12F anal cancer Male 0 47 0.00 0.00 0.00 0.00
KRAS G12F neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
KRAS G12F neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
KRAS G12F bladder cancer Female 0 393 0.00 0.00 0.00 0.00
KRAS G12F bladder cancer Male 0 1188 0.00 0.00 0.00 0.00
KRAS G12F b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
KRAS G12F b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
KRAS G12F small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
KRAS G12F small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
KRAS G12F sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
KRAS G12F sex cord stromal tumor Male 0 11 0.00 0.00 0.00 0.01
KRAS G12F bone cancer Female 0 242 0.00 0.00 0.00 0.00
KRAS G12F bone cancer Male 0 328 0.00 0.00 0.00 0.00
KRAS G12F vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
KRAS G12F thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS G12F thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS G12F ampullary cancer Female 0 41 0.00 0.00 0.00 0.00
KRAS G12F ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
KRAS G12F small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
KRAS G12F small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
KRAS G12F mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS G12F mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor Male 0 711 0.00 0.00 0.00 0.00
KRAS G12F nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
KRAS G12F nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
KRAS G12F penile cancer Male 0 25 0.00 0.00 0.00 0.01
KRAS G12F pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
KRAS G12F pineal tumor Male 0 12 0.00 0.00 0.00 0.05
KRAS G12F b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
KRAS G12F b cell lymphoma Male 0 567 0.00 0.00 0.00 0.00
KRAS G12F non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
KRAS G12F non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
KRAS G12F t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.03
KRAS G12F t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
KRAS G12F retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
KRAS G12F retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
KRAS G12F hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
KRAS G12F hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
KRAS G12F lung cancer Male 0 16 0.00 0.00 0.00 0.04
KRAS G12F blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.05
KRAS G12F peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
KRAS G12R appendiceal cancer Female 2 174 0.01 0.01 0.00 0.03
KRAS G12R appendiceal cancer Male 1 167 0.01 0.01 0.00 0.02
KRAS G12R colorectal cancer Female 19 3028 0.01 0.01 0.00 0.01
KRAS G12R colorectal cancer Male 15 3696 0.00 0.00 0.00 0.01
KRAS G12R cancer of unknown primary Female 7 1000 0.01 0.01 0.00 0.01
KRAS G12R cancer of unknown primary Male 10 989 0.01 0.01 0.00 0.02
KRAS G12R non-small cell lung cancer Female 24 5722 0.00 0.00 0.00 0.01
KRAS G12R non-small cell lung cancer Male 12 4406 0.00 0.00 0.00 0.00
KRAS G12R breast cancer Female 4 9284 0.00 0.00 0.00 0.00
KRAS G12R breast cancer Male 0 48 0.00 0.00 0.00 0.01
KRAS G12R soft tissue sarcoma Female 2 1413 0.00 0.00 0.00 0.00
KRAS G12R soft tissue sarcoma Male 1 1360 0.00 0.00 0.00 0.00
KRAS G12R pancreatic cancer Female 131 1153 0.11 0.11 0.10 0.13
KRAS G12R pancreatic cancer Male 145 1341 0.11 0.11 0.10 0.12
KRAS G12R leukemia Female 0 637 0.00 0.00 0.00 0.00
KRAS G12R leukemia Male 2 930 0.00 0.00 0.00 0.00
KRAS G12R melanoma Female 0 1104 0.00 0.00 0.00 0.00
KRAS G12R melanoma Male 3 1742 0.00 0.00 0.00 0.00
KRAS G12R head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
KRAS G12R head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
KRAS G12R uterine cancer Female 2 2254 0.00 0.00 0.00 0.00
KRAS G12R non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
KRAS G12R non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
KRAS G12R myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
KRAS G12R myelodysplastic/myeloproliferative syndromes Male 2 724 0.00 0.00 0.00 0.01
KRAS G12R adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS G12R adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.01
KRAS G12R ovarian cancer Female 10 2336 0.00 0.00 0.00 0.01
KRAS G12R esophagogastric cancer Female 2 504 0.00 0.00 0.00 0.01
KRAS G12R esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
KRAS G12R thyroid cancer Female 1 537 0.00 0.00 0.00 0.01
KRAS G12R thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
KRAS G12R cervical cancer Female 1 365 0.00 0.00 0.00 0.01
KRAS G12R hepatobiliary cancer Female 2 636 0.00 0.00 0.00 0.01
KRAS G12R hepatobiliary cancer Male 1 739 0.00 0.00 0.00 0.01
KRAS G12R kidney cancer Female 0 420 0.00 0.00 0.00 0.00
KRAS G12R kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
KRAS G12R mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
KRAS G12R mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
KRAS G12R cns cancer Female 1 1994 0.00 0.00 0.00 0.00
KRAS G12R cns cancer Male 1 2569 0.00 0.00 0.00 0.00
KRAS G12R prostate cancer Male 3 2436 0.00 0.00 0.00 0.00
KRAS G12R anal cancer Female 0 102 0.00 0.00 0.00 0.00
KRAS G12R anal cancer Male 0 47 0.00 0.00 0.00 0.00
KRAS G12R neuroendocrine tumors Female 1 166 0.01 0.00 0.00 0.02
KRAS G12R neuroendocrine tumors Male 1 193 0.01 0.00 0.00 0.02
KRAS G12R bladder cancer Female 1 393 0.00 0.00 0.00 0.01
KRAS G12R bladder cancer Male 2 1188 0.00 0.00 0.00 0.00
KRAS G12R b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
KRAS G12R b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
KRAS G12R small bowel cancer Female 0 78 0.01 0.00 0.00 0.03
KRAS G12R small bowel cancer Male 3 132 0.02 0.02 0.00 0.05
KRAS G12R sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
KRAS G12R sex cord stromal tumor Male 0 11 0.00 0.00 0.00 0.01
KRAS G12R bone cancer Female 0 242 0.00 0.00 0.00 0.00
KRAS G12R bone cancer Male 0 328 0.00 0.00 0.00 0.00
KRAS G12R vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
KRAS G12R thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS G12R thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS G12R ampullary cancer Female 1 41 0.03 0.03 0.00 0.08
KRAS G12R ampullary cancer Male 2 65 0.03 0.03 0.01 0.08
KRAS G12R small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
KRAS G12R small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
KRAS G12R mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS G12R mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS G12R germ cell tumor Female 1 175 0.01 0.01 0.00 0.02
KRAS G12R germ cell tumor Male 7 711 0.01 0.01 0.00 0.02
KRAS G12R nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
KRAS G12R nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
KRAS G12R penile cancer Male 1 25 0.04 0.03 0.00 0.15
KRAS G12R pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
KRAS G12R pineal tumor Male 0 12 0.00 0.00 0.00 0.05
KRAS G12R b cell lymphoma Female 1 395 0.00 0.00 0.00 0.01
KRAS G12R b cell lymphoma Male 1 567 0.00 0.00 0.00 0.01
KRAS G12R non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
KRAS G12R non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
KRAS G12R t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.03
KRAS G12R t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
KRAS G12R retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
KRAS G12R retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
KRAS G12R hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
KRAS G12R hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
KRAS G12R lung cancer Male 0 16 0.00 0.00 0.00 0.04
KRAS G12R blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.05
KRAS G12R peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
KRAS G12S appendiceal cancer Female 0 174 0.00 0.00 0.00 0.01
KRAS G12S appendiceal cancer Male 1 167 0.00 0.00 0.00 0.02
KRAS G12S colorectal cancer Female 66 3028 0.02 0.02 0.02 0.03
KRAS G12S colorectal cancer Male 60 3696 0.02 0.02 0.01 0.02
KRAS G12S cancer of unknown primary Female 1 1000 0.00 0.00 0.00 0.00
KRAS G12S cancer of unknown primary Male 4 989 0.00 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer Female 30 5722 0.00 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer Male 22 4406 0.00 0.00 0.00 0.01
KRAS G12S breast cancer Female 6 9284 0.00 0.00 0.00 0.00
KRAS G12S breast cancer Male 0 48 0.00 0.00 0.00 0.01
KRAS G12S soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
KRAS G12S soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
KRAS G12S pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
KRAS G12S pancreatic cancer Male 0 1341 0.00 0.00 0.00 0.00
KRAS G12S leukemia Female 1 637 0.00 0.00 0.00 0.00
KRAS G12S leukemia Male 0 930 0.00 0.00 0.00 0.00
KRAS G12S melanoma Female 0 1104 0.00 0.00 0.00 0.00
KRAS G12S melanoma Male 1 1742 0.00 0.00 0.00 0.00
KRAS G12S head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
KRAS G12S head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
KRAS G12S uterine cancer Female 6 2254 0.00 0.00 0.00 0.00
KRAS G12S non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
KRAS G12S non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
KRAS G12S myelodysplastic/myeloproliferative syndromes Female 1 483 0.00 0.00 0.00 0.01
KRAS G12S myelodysplastic/myeloproliferative syndromes Male 1 724 0.00 0.00 0.00 0.00
KRAS G12S adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS G12S adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
KRAS G12S ovarian cancer Female 1 2336 0.00 0.00 0.00 0.00
KRAS G12S esophagogastric cancer Female 1 504 0.00 0.00 0.00 0.01
KRAS G12S esophagogastric cancer Male 3 1297 0.00 0.00 0.00 0.00
KRAS G12S thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
KRAS G12S thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
KRAS G12S cervical cancer Female 3 365 0.01 0.01 0.00 0.02
KRAS G12S hepatobiliary cancer Female 2 636 0.00 0.00 0.00 0.01
KRAS G12S hepatobiliary cancer Male 0 739 0.00 0.00 0.00 0.00
KRAS G12S kidney cancer Female 0 420 0.00 0.00 0.00 0.00
KRAS G12S kidney cancer Male 1 1002 0.00 0.00 0.00 0.00
KRAS G12S mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
KRAS G12S mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
KRAS G12S cns cancer Female 0 1994 0.00 0.00 0.00 0.00
KRAS G12S cns cancer Male 0 2569 0.00 0.00 0.00 0.00
KRAS G12S prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
KRAS G12S anal cancer Female 0 102 0.00 0.00 0.00 0.00
KRAS G12S anal cancer Male 0 47 0.00 0.00 0.00 0.00
KRAS G12S neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
KRAS G12S neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
KRAS G12S bladder cancer Female 1 393 0.00 0.00 0.00 0.01
KRAS G12S bladder cancer Male 1 1188 0.00 0.00 0.00 0.00
KRAS G12S b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
KRAS G12S b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
KRAS G12S small bowel cancer Female 1 78 0.02 0.01 0.00 0.04
KRAS G12S small bowel cancer Male 2 132 0.02 0.01 0.00 0.04
KRAS G12S sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
KRAS G12S sex cord stromal tumor Male 0 11 0.00 0.00 0.00 0.00
KRAS G12S bone cancer Female 0 242 0.00 0.00 0.00 0.00
KRAS G12S bone cancer Male 0 328 0.00 0.00 0.00 0.00
KRAS G12S vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
KRAS G12S thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS G12S thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS G12S ampullary cancer Female 1 41 0.02 0.01 0.00 0.07
KRAS G12S ampullary cancer Male 0 65 0.01 0.00 0.00 0.03
KRAS G12S small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
KRAS G12S small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
KRAS G12S mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS G12S mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS G12S germ cell tumor Female 0 175 0.00 0.00 0.00 0.01
KRAS G12S germ cell tumor Male 4 711 0.00 0.00 0.00 0.01
KRAS G12S nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
KRAS G12S nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
KRAS G12S penile cancer Male 0 25 0.00 0.00 0.00 0.03
KRAS G12S pheochromocytoma Male 0 17 0.00 0.00 0.00 0.01
KRAS G12S pineal tumor Male 0 12 0.00 0.00 0.00 0.03
KRAS G12S b cell lymphoma Female 1 395 0.00 0.00 0.00 0.01
KRAS G12S b cell lymphoma Male 2 567 0.00 0.00 0.00 0.01
KRAS G12S non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.04
KRAS G12S non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
KRAS G12S t-lymphoblastic leukemia/lymphoma Female 0 12 0.02 0.01 0.00 0.10
KRAS G12S t-lymphoblastic leukemia/lymphoma Male 1 28 0.03 0.02 0.00 0.11
KRAS G12S retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
KRAS G12S retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
KRAS G12S hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
KRAS G12S hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
KRAS G12S lung cancer Male 0 16 0.00 0.00 0.00 0.06
KRAS G12S blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.04
KRAS G12S peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
KRAS G12V appendiceal cancer Female 18 174 0.11 0.11 0.07 0.16
KRAS G12V appendiceal cancer Male 23 167 0.13 0.13 0.09 0.18
KRAS G12V colorectal cancer Female 299 3028 0.10 0.10 0.09 0.11
KRAS G12V colorectal cancer Male 321 3696 0.09 0.09 0.08 0.10
KRAS G12V cancer of unknown primary Female 58 1000 0.06 0.06 0.04 0.07
KRAS G12V cancer of unknown primary Male 49 989 0.05 0.05 0.04 0.06
KRAS G12V non-small cell lung cancer Female 327 5722 0.06 0.06 0.05 0.06
KRAS G12V non-small cell lung cancer Male 221 4406 0.05 0.05 0.04 0.06
KRAS G12V breast cancer Female 30 9284 0.00 0.00 0.00 0.00
KRAS G12V breast cancer Male 0 48 0.00 0.00 0.00 0.02
KRAS G12V soft tissue sarcoma Female 2 1413 0.00 0.00 0.00 0.00
KRAS G12V soft tissue sarcoma Male 2 1360 0.00 0.00 0.00 0.00
KRAS G12V pancreatic cancer Female 257 1153 0.23 0.23 0.20 0.25
KRAS G12V pancreatic cancer Male 326 1341 0.24 0.24 0.22 0.26
KRAS G12V leukemia Female 9 637 0.01 0.01 0.01 0.02
KRAS G12V leukemia Male 7 930 0.01 0.01 0.00 0.02
KRAS G12V melanoma Female 0 1104 0.00 0.00 0.00 0.00
KRAS G12V melanoma Male 2 1742 0.00 0.00 0.00 0.00
KRAS G12V head and neck cancer Female 1 564 0.00 0.00 0.00 0.01
KRAS G12V head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
KRAS G12V uterine cancer Female 112 2254 0.05 0.05 0.04 0.06
KRAS G12V non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.01
KRAS G12V non-melanoma skin cancers Male 1 330 0.00 0.00 0.00 0.01
KRAS G12V myelodysplastic/myeloproliferative syndromes Female 1 483 0.00 0.00 0.00 0.01
KRAS G12V myelodysplastic/myeloproliferative syndromes Male 1 724 0.00 0.00 0.00 0.00
KRAS G12V adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS G12V adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
KRAS G12V ovarian cancer Female 83 2336 0.04 0.04 0.03 0.04
KRAS G12V esophagogastric cancer Female 4 504 0.01 0.01 0.00 0.02
KRAS G12V esophagogastric cancer Male 11 1297 0.01 0.01 0.00 0.01
KRAS G12V thyroid cancer Female 1 537 0.00 0.00 0.00 0.01
KRAS G12V thyroid cancer Male 5 480 0.01 0.01 0.00 0.02
KRAS G12V cervical cancer Female 11 365 0.03 0.03 0.02 0.05
KRAS G12V hepatobiliary cancer Female 17 636 0.03 0.03 0.02 0.04
KRAS G12V hepatobiliary cancer Male 21 739 0.03 0.03 0.02 0.04
KRAS G12V kidney cancer Female 1 420 0.00 0.00 0.00 0.01
KRAS G12V kidney cancer Male 3 1002 0.00 0.00 0.00 0.01
KRAS G12V mature t and nk neoplasms Female 1 107 0.01 0.00 0.00 0.03
KRAS G12V mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.02
KRAS G12V cns cancer Female 4 1994 0.00 0.00 0.00 0.00
KRAS G12V cns cancer Male 4 2569 0.00 0.00 0.00 0.00
KRAS G12V prostate cancer Male 2 2436 0.00 0.00 0.00 0.00
KRAS G12V anal cancer Female 0 102 0.00 0.00 0.00 0.00
KRAS G12V anal cancer Male 0 47 0.00 0.00 0.00 0.00
KRAS G12V neuroendocrine tumors Female 2 166 0.02 0.02 0.00 0.03
KRAS G12V neuroendocrine tumors Male 4 193 0.02 0.02 0.01 0.04
KRAS G12V bladder cancer Female 5 393 0.01 0.01 0.01 0.02
KRAS G12V bladder cancer Male 14 1188 0.01 0.01 0.01 0.02
KRAS G12V b-lymphoblastic leukemia/lymphoma Female 1 106 0.01 0.00 0.00 0.03
KRAS G12V b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.02
KRAS G12V small bowel cancer Female 13 78 0.14 0.14 0.08 0.23
KRAS G12V small bowel cancer Male 12 132 0.11 0.10 0.06 0.16
KRAS G12V sex cord stromal tumor Female 2 97 0.02 0.02 0.00 0.05
KRAS G12V sex cord stromal tumor Male 0 11 0.02 0.01 0.00 0.08
KRAS G12V bone cancer Female 0 242 0.00 0.00 0.00 0.00
KRAS G12V bone cancer Male 0 328 0.00 0.00 0.00 0.00
KRAS G12V vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
KRAS G12V thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS G12V thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS G12V ampullary cancer Female 3 41 0.10 0.10 0.03 0.18
KRAS G12V ampullary cancer Male 9 65 0.12 0.12 0.06 0.21
KRAS G12V small cell lung cancer Female 2 193 0.01 0.01 0.00 0.02
KRAS G12V small cell lung cancer Male 1 205 0.01 0.01 0.00 0.02
KRAS G12V mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS G12V mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS G12V germ cell tumor Female 2 175 0.02 0.02 0.00 0.03
KRAS G12V germ cell tumor Male 16 711 0.02 0.02 0.01 0.03
KRAS G12V nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
KRAS G12V nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
KRAS G12V penile cancer Male 0 25 0.00 0.00 0.00 0.02
KRAS G12V pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
KRAS G12V pineal tumor Male 0 12 0.00 0.00 0.00 0.03
KRAS G12V b cell lymphoma Female 1 395 0.00 0.00 0.00 0.01
KRAS G12V b cell lymphoma Male 3 567 0.00 0.00 0.00 0.01
KRAS G12V non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
KRAS G12V non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
KRAS G12V t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
KRAS G12V t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
KRAS G12V retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
KRAS G12V retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
KRAS G12V hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
KRAS G12V hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
KRAS G12V lung cancer Male 1 16 0.07 0.05 0.00 0.23
KRAS G12V blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.04
KRAS G12V peritoneal cancer Female 0 17 0.00 0.00 0.00 0.04
KRAS G13C appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
KRAS G13C appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
KRAS G13C colorectal cancer Female 15 3028 0.00 0.00 0.00 0.01
KRAS G13C colorectal cancer Male 9 3696 0.00 0.00 0.00 0.00
KRAS G13C cancer of unknown primary Female 3 1000 0.00 0.00 0.00 0.01
KRAS G13C cancer of unknown primary Male 5 989 0.00 0.00 0.00 0.01
KRAS G13C non-small cell lung cancer Female 70 5722 0.01 0.01 0.01 0.02
KRAS G13C non-small cell lung cancer Male 39 4406 0.01 0.01 0.01 0.01
KRAS G13C breast cancer Female 0 9284 0.00 0.00 0.00 0.00
KRAS G13C breast cancer Male 0 48 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma Male 1 1360 0.00 0.00 0.00 0.00
KRAS G13C pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
KRAS G13C pancreatic cancer Male 0 1341 0.00 0.00 0.00 0.00
KRAS G13C leukemia Female 0 637 0.00 0.00 0.00 0.00
KRAS G13C leukemia Male 1 930 0.00 0.00 0.00 0.00
KRAS G13C melanoma Female 0 1104 0.00 0.00 0.00 0.00
KRAS G13C melanoma Male 0 1742 0.00 0.00 0.00 0.00
KRAS G13C head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
KRAS G13C head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
KRAS G13C uterine cancer Female 5 2254 0.00 0.00 0.00 0.00
KRAS G13C non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
KRAS G13C non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
KRAS G13C myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
KRAS G13C myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
KRAS G13C adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS G13C adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
KRAS G13C ovarian cancer Female 1 2336 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
KRAS G13C thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
KRAS G13C thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
KRAS G13C cervical cancer Female 0 365 0.00 0.00 0.00 0.00
KRAS G13C hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
KRAS G13C hepatobiliary cancer Male 0 739 0.00 0.00 0.00 0.00
KRAS G13C kidney cancer Female 0 420 0.00 0.00 0.00 0.00
KRAS G13C kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
KRAS G13C mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
KRAS G13C mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
KRAS G13C cns cancer Female 0 1994 0.00 0.00 0.00 0.00
KRAS G13C cns cancer Male 0 2569 0.00 0.00 0.00 0.00
KRAS G13C prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
KRAS G13C anal cancer Female 1 102 0.01 0.01 0.00 0.03
KRAS G13C anal cancer Male 0 47 0.01 0.00 0.00 0.03
KRAS G13C neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
KRAS G13C neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
KRAS G13C bladder cancer Female 0 393 0.00 0.00 0.00 0.00
KRAS G13C bladder cancer Male 0 1188 0.00 0.00 0.00 0.00
KRAS G13C b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
KRAS G13C b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
KRAS G13C small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
KRAS G13C small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
KRAS G13C sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.01
KRAS G13C sex cord stromal tumor Male 0 11 0.00 0.00 0.00 0.01
KRAS G13C bone cancer Female 0 242 0.00 0.00 0.00 0.00
KRAS G13C bone cancer Male 0 328 0.00 0.00 0.00 0.00
KRAS G13C vaginal cancer Female 1 78 0.02 0.01 0.00 0.05
KRAS G13C thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS G13C thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS G13C ampullary cancer Female 0 41 0.00 0.00 0.00 0.00
KRAS G13C ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
KRAS G13C small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
KRAS G13C small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
KRAS G13C mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS G13C mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor Male 0 711 0.00 0.00 0.00 0.00
KRAS G13C nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
KRAS G13C nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
KRAS G13C penile cancer Male 0 25 0.00 0.00 0.00 0.01
KRAS G13C pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
KRAS G13C pineal tumor Male 0 12 0.00 0.00 0.00 0.04
KRAS G13C b cell lymphoma Female 1 395 0.00 0.00 0.00 0.01
KRAS G13C b cell lymphoma Male 0 567 0.00 0.00 0.00 0.00
KRAS G13C non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
KRAS G13C non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.02
KRAS G13C t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
KRAS G13C t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
KRAS G13C retinoblastoma Female 0 23 0.00 0.00 0.00 0.02
KRAS G13C retinoblastoma Male 0 28 0.00 0.00 0.00 0.02
KRAS G13C hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
KRAS G13C hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
KRAS G13C lung cancer Male 0 16 0.00 0.00 0.00 0.04
KRAS G13C blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.04
KRAS G13C peritoneal cancer Female 0 17 0.00 0.00 0.00 0.02
KRAS G13D appendiceal cancer Female 6 174 0.04 0.04 0.02 0.07
KRAS G13D appendiceal cancer Male 8 167 0.04 0.04 0.02 0.07
KRAS G13D colorectal cancer Female 236 3028 0.08 0.08 0.07 0.09
KRAS G13D colorectal cancer Male 265 3696 0.07 0.07 0.06 0.08
KRAS G13D cancer of unknown primary Female 11 1000 0.01 0.01 0.01 0.02
KRAS G13D cancer of unknown primary Male 15 989 0.01 0.01 0.01 0.02
KRAS G13D non-small cell lung cancer Female 48 5722 0.01 0.01 0.01 0.01
KRAS G13D non-small cell lung cancer Male 39 4406 0.01 0.01 0.01 0.01
KRAS G13D breast cancer Female 4 9284 0.00 0.00 0.00 0.00
KRAS G13D breast cancer Male 1 48 0.01 0.01 0.00 0.06
KRAS G13D soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
KRAS G13D soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
KRAS G13D pancreatic cancer Female 6 1153 0.01 0.00 0.00 0.01
KRAS G13D pancreatic cancer Male 8 1341 0.01 0.01 0.00 0.01
KRAS G13D leukemia Female 11 637 0.02 0.02 0.01 0.03
KRAS G13D leukemia Male 14 930 0.02 0.02 0.01 0.02
KRAS G13D melanoma Female 2 1104 0.00 0.00 0.00 0.00
KRAS G13D melanoma Male 5 1742 0.00 0.00 0.00 0.00
KRAS G13D head and neck cancer Female 1 564 0.00 0.00 0.00 0.00
KRAS G13D head and neck cancer Male 2 1179 0.00 0.00 0.00 0.00
KRAS G13D uterine cancer Female 46 2254 0.02 0.02 0.02 0.03
KRAS G13D non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
KRAS G13D non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
KRAS G13D myelodysplastic/myeloproliferative syndromes Female 4 483 0.01 0.01 0.00 0.02
KRAS G13D myelodysplastic/myeloproliferative syndromes Male 3 724 0.00 0.00 0.00 0.01
KRAS G13D adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS G13D adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
KRAS G13D ovarian cancer Female 10 2336 0.00 0.00 0.00 0.01
KRAS G13D esophagogastric cancer Female 8 504 0.01 0.01 0.01 0.02
KRAS G13D esophagogastric cancer Male 14 1297 0.01 0.01 0.01 0.02
KRAS G13D thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
KRAS G13D thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
KRAS G13D cervical cancer Female 4 365 0.01 0.01 0.00 0.02
KRAS G13D hepatobiliary cancer Female 3 636 0.01 0.01 0.00 0.01
KRAS G13D hepatobiliary cancer Male 6 739 0.01 0.01 0.00 0.01
KRAS G13D kidney cancer Female 0 420 0.00 0.00 0.00 0.00
KRAS G13D kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
KRAS G13D mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
KRAS G13D mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
KRAS G13D cns cancer Female 0 1994 0.00 0.00 0.00 0.00
KRAS G13D cns cancer Male 0 2569 0.00 0.00 0.00 0.00
KRAS G13D prostate cancer Male 1 2436 0.00 0.00 0.00 0.00
KRAS G13D anal cancer Female 1 102 0.01 0.01 0.00 0.03
KRAS G13D anal cancer Male 0 47 0.01 0.00 0.00 0.03
KRAS G13D neuroendocrine tumors Female 2 166 0.02 0.02 0.00 0.03
KRAS G13D neuroendocrine tumors Male 4 193 0.02 0.02 0.01 0.04
KRAS G13D bladder cancer Female 2 393 0.00 0.00 0.00 0.01
KRAS G13D bladder cancer Male 2 1188 0.00 0.00 0.00 0.00
KRAS G13D b-lymphoblastic leukemia/lymphoma Female 2 106 0.03 0.03 0.01 0.06
KRAS G13D b-lymphoblastic leukemia/lymphoma Male 6 142 0.04 0.04 0.02 0.07
KRAS G13D small bowel cancer Female 3 78 0.05 0.05 0.02 0.10
KRAS G13D small bowel cancer Male 10 132 0.07 0.07 0.04 0.11
KRAS G13D sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.01
KRAS G13D sex cord stromal tumor Male 0 11 0.00 0.00 0.00 0.01
KRAS G13D bone cancer Female 0 242 0.00 0.00 0.00 0.00
KRAS G13D bone cancer Male 0 328 0.00 0.00 0.00 0.00
KRAS G13D vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
KRAS G13D thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS G13D thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS G13D ampullary cancer Female 3 41 0.06 0.05 0.02 0.13
KRAS G13D ampullary cancer Male 2 65 0.04 0.04 0.01 0.09
KRAS G13D small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
KRAS G13D small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
KRAS G13D mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS G13D mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS G13D germ cell tumor Female 0 175 0.00 0.00 0.00 0.01
KRAS G13D germ cell tumor Male 1 711 0.00 0.00 0.00 0.00
KRAS G13D nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
KRAS G13D nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
KRAS G13D penile cancer Male 0 25 0.00 0.00 0.00 0.01
KRAS G13D pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
KRAS G13D pineal tumor Male 1 12 0.09 0.07 0.00 0.30
KRAS G13D b cell lymphoma Female 5 395 0.01 0.01 0.00 0.02
KRAS G13D b cell lymphoma Male 2 567 0.01 0.00 0.00 0.01
KRAS G13D non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
KRAS G13D non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.02
KRAS G13D t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
KRAS G13D t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
KRAS G13D retinoblastoma Female 0 23 0.00 0.00 0.00 0.02
KRAS G13D retinoblastoma Male 0 28 0.00 0.00 0.00 0.02
KRAS G13D hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
KRAS G13D hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
KRAS G13D lung cancer Male 0 16 0.00 0.00 0.00 0.04
KRAS G13D blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.04
KRAS G13D peritoneal cancer Female 0 17 0.00 0.00 0.00 0.02
KRAS G13R appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
KRAS G13R appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer Female 1 3028 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer Male 1 3696 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary Female 1 1000 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary Male 0 989 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer Female 4 5722 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer Male 2 4406 0.00 0.00 0.00 0.00
KRAS G13R breast cancer Female 0 9284 0.00 0.00 0.00 0.00
KRAS G13R breast cancer Male 0 48 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
KRAS G13R pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
KRAS G13R pancreatic cancer Male 0 1341 0.00 0.00 0.00 0.00
KRAS G13R leukemia Female 0 637 0.00 0.00 0.00 0.00
KRAS G13R leukemia Male 0 930 0.00 0.00 0.00 0.00
KRAS G13R melanoma Female 0 1104 0.00 0.00 0.00 0.00
KRAS G13R melanoma Male 0 1742 0.00 0.00 0.00 0.00
KRAS G13R head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
KRAS G13R head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
KRAS G13R uterine cancer Female 0 2254 0.00 0.00 0.00 0.00
KRAS G13R non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
KRAS G13R non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
KRAS G13R myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
KRAS G13R myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
KRAS G13R adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS G13R adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
KRAS G13R ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
KRAS G13R thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
KRAS G13R thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
KRAS G13R cervical cancer Female 0 365 0.00 0.00 0.00 0.00
KRAS G13R hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
KRAS G13R hepatobiliary cancer Male 0 739 0.00 0.00 0.00 0.00
KRAS G13R kidney cancer Female 0 420 0.00 0.00 0.00 0.00
KRAS G13R kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
KRAS G13R mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
KRAS G13R mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
KRAS G13R cns cancer Female 0 1994 0.00 0.00 0.00 0.00
KRAS G13R cns cancer Male 1 2569 0.00 0.00 0.00 0.00
KRAS G13R prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
KRAS G13R anal cancer Female 0 102 0.00 0.00 0.00 0.00
KRAS G13R anal cancer Male 0 47 0.00 0.00 0.00 0.00
KRAS G13R neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
KRAS G13R neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
KRAS G13R bladder cancer Female 0 393 0.00 0.00 0.00 0.00
KRAS G13R bladder cancer Male 0 1188 0.00 0.00 0.00 0.00
KRAS G13R b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
KRAS G13R b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
KRAS G13R small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
KRAS G13R small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
KRAS G13R sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
KRAS G13R sex cord stromal tumor Male 0 11 0.00 0.00 0.00 0.01
KRAS G13R bone cancer Female 0 242 0.00 0.00 0.00 0.00
KRAS G13R bone cancer Male 0 328 0.00 0.00 0.00 0.00
KRAS G13R vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
KRAS G13R thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS G13R thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS G13R ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
KRAS G13R ampullary cancer Male 0 65 0.00 0.00 0.00 0.01
KRAS G13R small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
KRAS G13R small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
KRAS G13R mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS G13R mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor Male 0 711 0.00 0.00 0.00 0.00
KRAS G13R nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
KRAS G13R nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
KRAS G13R penile cancer Male 0 25 0.00 0.00 0.00 0.02
KRAS G13R pheochromocytoma Male 0 17 0.00 0.00 0.00 0.04
KRAS G13R pineal tumor Male 0 12 0.00 0.00 0.00 0.06
KRAS G13R b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
KRAS G13R b cell lymphoma Male 0 567 0.00 0.00 0.00 0.00
KRAS G13R non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.02
KRAS G13R non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.02
KRAS G13R t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.01
KRAS G13R t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
KRAS G13R retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
KRAS G13R retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
KRAS G13R hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
KRAS G13R hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
KRAS G13R lung cancer Male 0 16 0.00 0.00 0.00 0.04
KRAS G13R blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
KRAS G13R peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
KRAS G13V appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
KRAS G13V appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer Female 0 3028 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer Male 2 3696 0.00 0.00 0.00 0.00
KRAS G13V cancer of unknown primary Female 0 1000 0.00 0.00 0.00 0.00
KRAS G13V cancer of unknown primary Male 0 989 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer Female 2 5722 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer Male 2 4406 0.00 0.00 0.00 0.00
KRAS G13V breast cancer Female 0 9284 0.00 0.00 0.00 0.00
KRAS G13V breast cancer Male 0 48 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
KRAS G13V pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
KRAS G13V pancreatic cancer Male 2 1341 0.00 0.00 0.00 0.00
KRAS G13V leukemia Female 0 637 0.00 0.00 0.00 0.00
KRAS G13V leukemia Male 0 930 0.00 0.00 0.00 0.00
KRAS G13V melanoma Female 0 1104 0.00 0.00 0.00 0.00
KRAS G13V melanoma Male 0 1742 0.00 0.00 0.00 0.00
KRAS G13V head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
KRAS G13V head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
KRAS G13V uterine cancer Female 0 2254 0.00 0.00 0.00 0.00
KRAS G13V non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
KRAS G13V non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
KRAS G13V myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
KRAS G13V myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
KRAS G13V adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS G13V adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
KRAS G13V ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
KRAS G13V thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
KRAS G13V thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
KRAS G13V cervical cancer Female 0 365 0.00 0.00 0.00 0.00
KRAS G13V hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
KRAS G13V hepatobiliary cancer Male 0 739 0.00 0.00 0.00 0.00
KRAS G13V kidney cancer Female 0 420 0.00 0.00 0.00 0.00
KRAS G13V kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
KRAS G13V mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
KRAS G13V mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
KRAS G13V cns cancer Female 0 1994 0.00 0.00 0.00 0.00
KRAS G13V cns cancer Male 0 2569 0.00 0.00 0.00 0.00
KRAS G13V prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
KRAS G13V anal cancer Female 0 102 0.00 0.00 0.00 0.00
KRAS G13V anal cancer Male 0 47 0.00 0.00 0.00 0.00
KRAS G13V neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
KRAS G13V neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
KRAS G13V bladder cancer Female 0 393 0.00 0.00 0.00 0.00
KRAS G13V bladder cancer Male 0 1188 0.00 0.00 0.00 0.00
KRAS G13V b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
KRAS G13V b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
KRAS G13V small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
KRAS G13V small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
KRAS G13V sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
KRAS G13V sex cord stromal tumor Male 0 11 0.00 0.00 0.00 0.00
KRAS G13V bone cancer Female 0 242 0.00 0.00 0.00 0.00
KRAS G13V bone cancer Male 0 328 0.00 0.00 0.00 0.00
KRAS G13V vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
KRAS G13V thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS G13V thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS G13V ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
KRAS G13V ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
KRAS G13V small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
KRAS G13V small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
KRAS G13V mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS G13V mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS G13V germ cell tumor Female 0 175 0.00 0.00 0.00 0.01
KRAS G13V germ cell tumor Male 1 711 0.00 0.00 0.00 0.00
KRAS G13V nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
KRAS G13V nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
KRAS G13V penile cancer Male 0 25 0.00 0.00 0.00 0.03
KRAS G13V pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
KRAS G13V pineal tumor Male 0 12 0.00 0.00 0.00 0.05
KRAS G13V b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
KRAS G13V b cell lymphoma Male 0 567 0.00 0.00 0.00 0.00
KRAS G13V non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
KRAS G13V non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
KRAS G13V t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.01
KRAS G13V t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
KRAS G13V retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
KRAS G13V retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
KRAS G13V hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.01
KRAS G13V hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.01
KRAS G13V lung cancer Male 0 16 0.00 0.00 0.00 0.04
KRAS G13V blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
KRAS G13V peritoneal cancer Female 0 17 0.00 0.00 0.00 0.04
KRAS Q61H appendiceal cancer Female 0 174 0.00 0.00 0.00 0.02
KRAS Q61H appendiceal cancer Male 3 167 0.02 0.01 0.00 0.04
KRAS Q61H colorectal cancer Female 29 3028 0.01 0.01 0.01 0.01
KRAS Q61H colorectal cancer Male 35 3696 0.01 0.01 0.01 0.01
KRAS Q61H cancer of unknown primary Female 8 1000 0.01 0.01 0.00 0.01
KRAS Q61H cancer of unknown primary Male 7 989 0.01 0.01 0.00 0.01
KRAS Q61H non-small cell lung cancer Female 84 5722 0.01 0.01 0.01 0.02
KRAS Q61H non-small cell lung cancer Male 47 4406 0.01 0.01 0.01 0.02
KRAS Q61H breast cancer Female 0 9284 0.00 0.00 0.00 0.00
KRAS Q61H breast cancer Male 0 48 0.00 0.00 0.00 0.00
KRAS Q61H soft tissue sarcoma Female 1 1413 0.00 0.00 0.00 0.00
KRAS Q61H soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
KRAS Q61H pancreatic cancer Female 38 1153 0.03 0.03 0.02 0.04
KRAS Q61H pancreatic cancer Male 48 1341 0.04 0.04 0.03 0.04
KRAS Q61H leukemia Female 2 637 0.00 0.00 0.00 0.01
KRAS Q61H leukemia Male 2 930 0.00 0.00 0.00 0.01
KRAS Q61H melanoma Female 1 1104 0.00 0.00 0.00 0.00
KRAS Q61H melanoma Male 1 1742 0.00 0.00 0.00 0.00
KRAS Q61H head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
KRAS Q61H head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
KRAS Q61H uterine cancer Female 6 2254 0.00 0.00 0.00 0.00
KRAS Q61H non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
KRAS Q61H non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
KRAS Q61H myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
KRAS Q61H myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
KRAS Q61H adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS Q61H adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
KRAS Q61H ovarian cancer Female 9 2336 0.00 0.00 0.00 0.01
KRAS Q61H esophagogastric cancer Female 1 504 0.00 0.00 0.00 0.00
KRAS Q61H esophagogastric cancer Male 1 1297 0.00 0.00 0.00 0.00
KRAS Q61H thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
KRAS Q61H thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
KRAS Q61H cervical cancer Female 0 365 0.00 0.00 0.00 0.00
KRAS Q61H hepatobiliary cancer Female 7 636 0.01 0.01 0.00 0.02
KRAS Q61H hepatobiliary cancer Male 7 739 0.01 0.01 0.00 0.02
KRAS Q61H kidney cancer Female 1 420 0.00 0.00 0.00 0.01
KRAS Q61H kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
KRAS Q61H mature t and nk neoplasms Female 1 107 0.01 0.01 0.00 0.03
KRAS Q61H mature t and nk neoplasms Male 1 124 0.01 0.01 0.00 0.03
KRAS Q61H cns cancer Female 1 1994 0.00 0.00 0.00 0.00
KRAS Q61H cns cancer Male 2 2569 0.00 0.00 0.00 0.00
KRAS Q61H prostate cancer Male 1 2436 0.00 0.00 0.00 0.00
KRAS Q61H anal cancer Female 0 102 0.00 0.00 0.00 0.00
KRAS Q61H anal cancer Male 0 47 0.00 0.00 0.00 0.00
KRAS Q61H neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.01
KRAS Q61H neuroendocrine tumors Male 1 193 0.00 0.00 0.00 0.02
KRAS Q61H bladder cancer Female 2 393 0.00 0.00 0.00 0.01
KRAS Q61H bladder cancer Male 1 1188 0.00 0.00 0.00 0.00
KRAS Q61H b-lymphoblastic leukemia/lymphoma Female 1 106 0.01 0.01 0.00 0.03
KRAS Q61H b-lymphoblastic leukemia/lymphoma Male 2 142 0.01 0.01 0.00 0.03
KRAS Q61H small bowel cancer Female 4 78 0.04 0.04 0.01 0.09
KRAS Q61H small bowel cancer Male 2 132 0.02 0.02 0.00 0.05
KRAS Q61H sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
KRAS Q61H sex cord stromal tumor Male 0 11 0.00 0.00 0.00 0.00
KRAS Q61H bone cancer Female 1 242 0.00 0.00 0.00 0.01
KRAS Q61H bone cancer Male 0 328 0.00 0.00 0.00 0.01
KRAS Q61H vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
KRAS Q61H thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS Q61H thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS Q61H ampullary cancer Female 0 41 0.01 0.01 0.00 0.05
KRAS Q61H ampullary cancer Male 2 65 0.02 0.02 0.00 0.07
KRAS Q61H small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
KRAS Q61H small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
KRAS Q61H mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS Q61H mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor Male 0 711 0.00 0.00 0.00 0.00
KRAS Q61H nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
KRAS Q61H nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
KRAS Q61H penile cancer Male 0 25 0.00 0.00 0.00 0.03
KRAS Q61H pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
KRAS Q61H pineal tumor Male 0 12 0.00 0.00 0.00 0.05
KRAS Q61H b cell lymphoma Female 4 395 0.01 0.01 0.00 0.02
KRAS Q61H b cell lymphoma Male 6 567 0.01 0.01 0.00 0.02
KRAS Q61H non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
KRAS Q61H non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
KRAS Q61H t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.01
KRAS Q61H t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
KRAS Q61H retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
KRAS Q61H retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
KRAS Q61H hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.01
KRAS Q61H hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.01
KRAS Q61H lung cancer Male 0 16 0.00 0.00 0.00 0.04
KRAS Q61H blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
KRAS Q61H peritoneal cancer Female 0 17 0.00 0.00 0.00 0.04
KRAS Q61K appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
KRAS Q61K appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer Female 9 3028 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer Male 3 3696 0.00 0.00 0.00 0.00
KRAS Q61K cancer of unknown primary Female 1 1000 0.00 0.00 0.00 0.00
KRAS Q61K cancer of unknown primary Male 0 989 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer Female 1 5722 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer Male 1 4406 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer Female 0 9284 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer Male 0 48 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
KRAS Q61K pancreatic cancer Female 2 1153 0.00 0.00 0.00 0.00
KRAS Q61K pancreatic cancer Male 1 1341 0.00 0.00 0.00 0.00
KRAS Q61K leukemia Female 0 637 0.00 0.00 0.00 0.00
KRAS Q61K leukemia Male 0 930 0.00 0.00 0.00 0.00
KRAS Q61K melanoma Female 0 1104 0.00 0.00 0.00 0.00
KRAS Q61K melanoma Male 0 1742 0.00 0.00 0.00 0.00
KRAS Q61K head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
KRAS Q61K head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
KRAS Q61K uterine cancer Female 1 2254 0.00 0.00 0.00 0.00
KRAS Q61K non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
KRAS Q61K non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
KRAS Q61K myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
KRAS Q61K myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
KRAS Q61K adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS Q61K adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
KRAS Q61K ovarian cancer Female 1 2336 0.00 0.00 0.00 0.00
KRAS Q61K esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
KRAS Q61K esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
KRAS Q61K thyroid cancer Female 1 537 0.00 0.00 0.00 0.01
KRAS Q61K thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
KRAS Q61K cervical cancer Female 0 365 0.00 0.00 0.00 0.00
KRAS Q61K hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
KRAS Q61K hepatobiliary cancer Male 0 739 0.00 0.00 0.00 0.00
KRAS Q61K kidney cancer Female 0 420 0.00 0.00 0.00 0.00
KRAS Q61K kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
KRAS Q61K mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
KRAS Q61K mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer Female 1 1994 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer Male 1 2569 0.00 0.00 0.00 0.00
KRAS Q61K prostate cancer Male 1 2436 0.00 0.00 0.00 0.00
KRAS Q61K anal cancer Female 1 102 0.01 0.01 0.00 0.03
KRAS Q61K anal cancer Male 0 47 0.01 0.00 0.00 0.03
KRAS Q61K neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.01
KRAS Q61K neuroendocrine tumors Male 1 193 0.00 0.00 0.00 0.02
KRAS Q61K bladder cancer Female 0 393 0.00 0.00 0.00 0.00
KRAS Q61K bladder cancer Male 0 1188 0.00 0.00 0.00 0.00
KRAS Q61K b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
KRAS Q61K b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
KRAS Q61K small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
KRAS Q61K small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
KRAS Q61K sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
KRAS Q61K sex cord stromal tumor Male 0 11 0.00 0.00 0.00 0.01
KRAS Q61K bone cancer Female 0 242 0.00 0.00 0.00 0.00
KRAS Q61K bone cancer Male 0 328 0.00 0.00 0.00 0.00
KRAS Q61K vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
KRAS Q61K thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS Q61K thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS Q61K ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
KRAS Q61K ampullary cancer Male 0 65 0.00 0.00 0.00 0.01
KRAS Q61K small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
KRAS Q61K small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
KRAS Q61K mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS Q61K mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor Male 0 711 0.00 0.00 0.00 0.00
KRAS Q61K nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
KRAS Q61K nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
KRAS Q61K penile cancer Male 0 25 0.00 0.00 0.00 0.02
KRAS Q61K pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
KRAS Q61K pineal tumor Male 0 12 0.00 0.00 0.00 0.03
KRAS Q61K b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
KRAS Q61K b cell lymphoma Male 0 567 0.00 0.00 0.00 0.00
KRAS Q61K non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.04
KRAS Q61K non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.04
KRAS Q61K t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
KRAS Q61K t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
KRAS Q61K retinoblastoma Female 0 23 0.00 0.00 0.00 0.02
KRAS Q61K retinoblastoma Male 0 28 0.00 0.00 0.00 0.02
KRAS Q61K hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.03
KRAS Q61K hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
KRAS Q61K lung cancer Male 0 16 0.00 0.00 0.00 0.04
KRAS Q61K blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
KRAS Q61K peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
KRAS Q61L appendiceal cancer Female 0 174 0.00 0.00 0.00 0.01
KRAS Q61L appendiceal cancer Male 1 167 0.00 0.00 0.00 0.02
KRAS Q61L colorectal cancer Female 15 3028 0.00 0.00 0.00 0.01
KRAS Q61L colorectal cancer Male 9 3696 0.00 0.00 0.00 0.00
KRAS Q61L cancer of unknown primary Female 2 1000 0.00 0.00 0.00 0.00
KRAS Q61L cancer of unknown primary Male 1 989 0.00 0.00 0.00 0.00
KRAS Q61L non-small cell lung cancer Female 23 5722 0.00 0.00 0.00 0.00
KRAS Q61L non-small cell lung cancer Male 14 4406 0.00 0.00 0.00 0.00
KRAS Q61L breast cancer Female 1 9284 0.00 0.00 0.00 0.00
KRAS Q61L breast cancer Male 0 48 0.00 0.00 0.00 0.01
KRAS Q61L soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
KRAS Q61L soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
KRAS Q61L pancreatic cancer Female 5 1153 0.00 0.00 0.00 0.01
KRAS Q61L pancreatic cancer Male 1 1341 0.00 0.00 0.00 0.00
KRAS Q61L leukemia Female 0 637 0.00 0.00 0.00 0.00
KRAS Q61L leukemia Male 1 930 0.00 0.00 0.00 0.00
KRAS Q61L melanoma Female 1 1104 0.00 0.00 0.00 0.00
KRAS Q61L melanoma Male 1 1742 0.00 0.00 0.00 0.00
KRAS Q61L head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
KRAS Q61L head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
KRAS Q61L uterine cancer Female 2 2254 0.00 0.00 0.00 0.00
KRAS Q61L non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
KRAS Q61L non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
KRAS Q61L myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
KRAS Q61L myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
KRAS Q61L adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS Q61L adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
KRAS Q61L ovarian cancer Female 1 2336 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
KRAS Q61L thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
KRAS Q61L thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
KRAS Q61L cervical cancer Female 0 365 0.00 0.00 0.00 0.00
KRAS Q61L hepatobiliary cancer Female 1 636 0.00 0.00 0.00 0.00
KRAS Q61L hepatobiliary cancer Male 1 739 0.00 0.00 0.00 0.00
KRAS Q61L kidney cancer Female 0 420 0.00 0.00 0.00 0.00
KRAS Q61L kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
KRAS Q61L mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
KRAS Q61L mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer Female 0 1994 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer Male 2 2569 0.00 0.00 0.00 0.00
KRAS Q61L prostate cancer Male 1 2436 0.00 0.00 0.00 0.00
KRAS Q61L anal cancer Female 0 102 0.00 0.00 0.00 0.00
KRAS Q61L anal cancer Male 0 47 0.00 0.00 0.00 0.00
KRAS Q61L neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
KRAS Q61L neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
KRAS Q61L bladder cancer Female 1 393 0.00 0.00 0.00 0.01
KRAS Q61L bladder cancer Male 0 1188 0.00 0.00 0.00 0.00
KRAS Q61L b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
KRAS Q61L b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
KRAS Q61L small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
KRAS Q61L small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
KRAS Q61L sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
KRAS Q61L sex cord stromal tumor Male 0 11 0.00 0.00 0.00 0.00
KRAS Q61L bone cancer Female 0 242 0.00 0.00 0.00 0.00
KRAS Q61L bone cancer Male 0 328 0.00 0.00 0.00 0.00
KRAS Q61L vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
KRAS Q61L thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS Q61L thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS Q61L ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
KRAS Q61L ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
KRAS Q61L small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
KRAS Q61L small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
KRAS Q61L mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS Q61L mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor Male 0 711 0.00 0.00 0.00 0.00
KRAS Q61L nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
KRAS Q61L nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
KRAS Q61L penile cancer Male 1 25 0.04 0.03 0.00 0.15
KRAS Q61L pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
KRAS Q61L pineal tumor Male 0 12 0.00 0.00 0.00 0.05
KRAS Q61L b cell lymphoma Female 1 395 0.00 0.00 0.00 0.01
KRAS Q61L b cell lymphoma Male 0 567 0.00 0.00 0.00 0.00
KRAS Q61L non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
KRAS Q61L non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
KRAS Q61L t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.01
KRAS Q61L t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
KRAS Q61L retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
KRAS Q61L retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
KRAS Q61L hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.01
KRAS Q61L hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.01
KRAS Q61L lung cancer Male 0 16 0.00 0.00 0.00 0.04
KRAS Q61L blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
KRAS Q61L peritoneal cancer Female 0 17 0.00 0.00 0.00 0.04
KRAS Q61R appendiceal cancer Female 0 174 0.00 0.00 0.00 0.01
KRAS Q61R appendiceal cancer Male 1 167 0.00 0.00 0.00 0.02
KRAS Q61R colorectal cancer Female 8 3028 0.00 0.00 0.00 0.00
KRAS Q61R colorectal cancer Male 12 3696 0.00 0.00 0.00 0.00
KRAS Q61R cancer of unknown primary Female 1 1000 0.00 0.00 0.00 0.00
KRAS Q61R cancer of unknown primary Male 2 989 0.00 0.00 0.00 0.00
KRAS Q61R non-small cell lung cancer Female 5 5722 0.00 0.00 0.00 0.00
KRAS Q61R non-small cell lung cancer Male 2 4406 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer Female 1 9284 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer Male 0 48 0.00 0.00 0.00 0.01
KRAS Q61R soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
KRAS Q61R soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
KRAS Q61R pancreatic cancer Female 16 1153 0.02 0.02 0.01 0.02
KRAS Q61R pancreatic cancer Male 22 1341 0.02 0.02 0.01 0.02
KRAS Q61R leukemia Female 0 637 0.00 0.00 0.00 0.00
KRAS Q61R leukemia Male 1 930 0.00 0.00 0.00 0.00
KRAS Q61R melanoma Female 2 1104 0.00 0.00 0.00 0.00
KRAS Q61R melanoma Male 1 1742 0.00 0.00 0.00 0.00
KRAS Q61R head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
KRAS Q61R head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
KRAS Q61R uterine cancer Female 0 2254 0.00 0.00 0.00 0.00
KRAS Q61R non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
KRAS Q61R non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
KRAS Q61R myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
KRAS Q61R myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
KRAS Q61R adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
KRAS Q61R adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
KRAS Q61R ovarian cancer Female 2 2336 0.00 0.00 0.00 0.00
KRAS Q61R esophagogastric cancer Female 1 504 0.00 0.00 0.00 0.01
KRAS Q61R esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
KRAS Q61R thyroid cancer Female 9 537 0.02 0.02 0.01 0.03
KRAS Q61R thyroid cancer Male 6 480 0.01 0.01 0.01 0.02
KRAS Q61R cervical cancer Female 0 365 0.00 0.00 0.00 0.00
KRAS Q61R hepatobiliary cancer Female 2 636 0.00 0.00 0.00 0.01
KRAS Q61R hepatobiliary cancer Male 0 739 0.00 0.00 0.00 0.00
KRAS Q61R kidney cancer Female 0 420 0.00 0.00 0.00 0.00
KRAS Q61R kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
KRAS Q61R mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
KRAS Q61R mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer Female 1 1994 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer Male 3 2569 0.00 0.00 0.00 0.00
KRAS Q61R prostate cancer Male 1 2436 0.00 0.00 0.00 0.00
KRAS Q61R anal cancer Female 0 102 0.00 0.00 0.00 0.00
KRAS Q61R anal cancer Male 0 47 0.00 0.00 0.00 0.00
KRAS Q61R neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
KRAS Q61R neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
KRAS Q61R bladder cancer Female 0 393 0.00 0.00 0.00 0.00
KRAS Q61R bladder cancer Male 1 1188 0.00 0.00 0.00 0.00
KRAS Q61R b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
KRAS Q61R b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
KRAS Q61R small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
KRAS Q61R small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
KRAS Q61R sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
KRAS Q61R sex cord stromal tumor Male 0 11 0.00 0.00 0.00 0.01
KRAS Q61R bone cancer Female 0 242 0.00 0.00 0.00 0.00
KRAS Q61R bone cancer Male 0 328 0.00 0.00 0.00 0.00
KRAS Q61R vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
KRAS Q61R thymic tumor Female 0 70 0.00 0.00 0.00 0.00
KRAS Q61R thymic tumor Male 0 86 0.00 0.00 0.00 0.00
KRAS Q61R ampullary cancer Female 2 41 0.04 0.03 0.00 0.12
KRAS Q61R ampullary cancer Male 0 65 0.01 0.00 0.00 0.04
KRAS Q61R small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
KRAS Q61R small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
KRAS Q61R mesothelioma Female 0 145 0.00 0.00 0.00 0.00
KRAS Q61R mesothelioma Male 0 352 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor Male 0 711 0.00 0.00 0.00 0.00
KRAS Q61R nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
KRAS Q61R nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
KRAS Q61R penile cancer Male 0 25 0.00 0.00 0.00 0.02
KRAS Q61R pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
KRAS Q61R pineal tumor Male 0 12 0.00 0.00 0.00 0.04
KRAS Q61R b cell lymphoma Female 0 395 0.00 0.00 0.00 0.01
KRAS Q61R b cell lymphoma Male 3 567 0.00 0.00 0.00 0.01
KRAS Q61R non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.04
KRAS Q61R non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.04
KRAS Q61R t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
KRAS Q61R t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
KRAS Q61R retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
KRAS Q61R retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
KRAS Q61R hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
KRAS Q61R hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
KRAS Q61R lung cancer Male 0 16 0.00 0.00 0.00 0.03
KRAS Q61R blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.05
KRAS Q61R peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
HRAS G12A appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS G12A appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary Female 0 999 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary Male 0 986 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
HRAS G12A breast cancer Female 0 9283 0.00 0.00 0.00 0.00
HRAS G12A breast cancer Male 0 48 0.00 0.00 0.00 0.00
HRAS G12A pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
HRAS G12A pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
HRAS G12A leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS G12A leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS G12A melanoma Female 0 1104 0.00 0.00 0.00 0.00
HRAS G12A melanoma Male 0 1742 0.00 0.00 0.00 0.00
HRAS G12A head and neck cancer Female 1 564 0.00 0.00 0.00 0.01
HRAS G12A head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
HRAS G12A uterine cancer Female 0 2248 0.00 0.00 0.00 0.00
HRAS G12A non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
HRAS G12A non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
HRAS G12A myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS G12A myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS G12A adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS G12A adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma Female 0 1400 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma Male 0 1338 0.00 0.00 0.00 0.00
HRAS G12A ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
HRAS G12A thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
HRAS G12A thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
HRAS G12A cervical cancer Female 0 365 0.00 0.00 0.00 0.00
HRAS G12A hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS G12A hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
HRAS G12A kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS G12A kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS G12A cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS G12A cns cancer Male 0 2569 0.00 0.00 0.00 0.00
HRAS G12A prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
HRAS G12A anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS G12A anal cancer Male 0 47 0.00 0.00 0.00 0.01
HRAS G12A neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
HRAS G12A neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
HRAS G12A bladder cancer Female 0 393 0.00 0.00 0.00 0.00
HRAS G12A bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
HRAS G12A b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS G12A b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS G12A small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G12A small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS G12A sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.01
HRAS G12A sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
HRAS G12A bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS G12A bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS G12A vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G12A thymic tumor Female 0 68 0.00 0.00 0.00 0.00
HRAS G12A thymic tumor Male 0 86 0.00 0.00 0.00 0.00
HRAS G12A ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
HRAS G12A ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
HRAS G12A small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
HRAS G12A small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
HRAS G12A mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS G12A mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS G12A mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS G12A mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor Male 0 710 0.00 0.00 0.00 0.00
HRAS G12A nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS G12A nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS G12A penile cancer Male 0 25 0.00 0.00 0.00 0.03
HRAS G12A pheochromocytoma Male 0 17 0.00 0.00 0.00 0.04
HRAS G12A pineal tumor Male 0 12 0.00 0.00 0.00 0.06
HRAS G12A b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS G12A b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS G12A non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.02
HRAS G12A non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.02
HRAS G12A t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
HRAS G12A t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
HRAS G12A retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
HRAS G12A retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
HRAS G12A hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
HRAS G12A hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.01
HRAS G12A lung cancer Male 0 16 0.00 0.00 0.00 0.02
HRAS G12A blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.06
HRAS G12A peritoneal cancer Female 0 17 0.00 0.00 0.00 0.04
HRAS G12C appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS G12C appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary Female 0 999 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary Male 0 986 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
HRAS G12C breast cancer Female 2 9283 0.00 0.00 0.00 0.00
HRAS G12C breast cancer Male 0 48 0.00 0.00 0.00 0.01
HRAS G12C pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
HRAS G12C pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
HRAS G12C leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS G12C leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS G12C melanoma Female 0 1104 0.00 0.00 0.00 0.00
HRAS G12C melanoma Male 0 1742 0.00 0.00 0.00 0.00
HRAS G12C head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
HRAS G12C head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
HRAS G12C uterine cancer Female 0 2248 0.00 0.00 0.00 0.00
HRAS G12C non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.01
HRAS G12C non-melanoma skin cancers Male 1 330 0.00 0.00 0.00 0.01
HRAS G12C myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS G12C myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS G12C adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS G12C adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma Female 0 1400 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma Male 0 1338 0.00 0.00 0.00 0.00
HRAS G12C ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
HRAS G12C thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
HRAS G12C thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
HRAS G12C cervical cancer Female 0 365 0.00 0.00 0.00 0.00
HRAS G12C hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS G12C hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
HRAS G12C kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS G12C kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS G12C cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS G12C cns cancer Male 0 2569 0.00 0.00 0.00 0.00
HRAS G12C prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
HRAS G12C anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS G12C anal cancer Male 0 47 0.00 0.00 0.00 0.00
HRAS G12C neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
HRAS G12C neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
HRAS G12C bladder cancer Female 1 393 0.00 0.00 0.00 0.01
HRAS G12C bladder cancer Male 2 1187 0.00 0.00 0.00 0.00
HRAS G12C b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS G12C b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS G12C small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G12C small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS G12C sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.01
HRAS G12C sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.02
HRAS G12C bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS G12C bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS G12C vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G12C thymic tumor Female 0 68 0.00 0.00 0.00 0.00
HRAS G12C thymic tumor Male 0 86 0.00 0.00 0.00 0.00
HRAS G12C ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
HRAS G12C ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
HRAS G12C small cell lung cancer Female 1 193 0.00 0.00 0.00 0.02
HRAS G12C small cell lung cancer Male 0 205 0.00 0.00 0.00 0.01
HRAS G12C mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS G12C mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS G12C mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS G12C mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor Male 0 710 0.00 0.00 0.00 0.00
HRAS G12C nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS G12C nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS G12C penile cancer Male 0 25 0.00 0.00 0.00 0.02
HRAS G12C pheochromocytoma Male 0 17 0.00 0.00 0.00 0.04
HRAS G12C pineal tumor Male 0 12 0.00 0.00 0.00 0.04
HRAS G12C b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS G12C b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS G12C non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
HRAS G12C non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.04
HRAS G12C t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
HRAS G12C t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
HRAS G12C retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
HRAS G12C retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
HRAS G12C hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
HRAS G12C hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
HRAS G12C lung cancer Male 0 16 0.00 0.00 0.00 0.04
HRAS G12C blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.05
HRAS G12C peritoneal cancer Female 0 17 0.00 0.00 0.00 0.01
HRAS G12D appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS G12D appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS G12D colorectal cancer Female 2 3026 0.00 0.00 0.00 0.00
HRAS G12D colorectal cancer Male 1 3694 0.00 0.00 0.00 0.00
HRAS G12D cancer of unknown primary Female 0 999 0.00 0.00 0.00 0.00
HRAS G12D cancer of unknown primary Male 0 986 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer Female 1 5722 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
HRAS G12D breast cancer Female 3 9283 0.00 0.00 0.00 0.00
HRAS G12D breast cancer Male 0 48 0.00 0.00 0.00 0.01
HRAS G12D pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
HRAS G12D pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
HRAS G12D leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS G12D leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS G12D melanoma Female 3 1104 0.00 0.00 0.00 0.01
HRAS G12D melanoma Male 4 1742 0.00 0.00 0.00 0.00
HRAS G12D head and neck cancer Female 1 564 0.00 0.00 0.00 0.00
HRAS G12D head and neck cancer Male 1 1179 0.00 0.00 0.00 0.00
HRAS G12D uterine cancer Female 2 2248 0.00 0.00 0.00 0.00
HRAS G12D non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.01
HRAS G12D non-melanoma skin cancers Male 1 330 0.00 0.00 0.00 0.01
HRAS G12D myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS G12D myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS G12D adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS G12D adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.01
HRAS G12D soft tissue sarcoma Female 1 1400 0.00 0.00 0.00 0.00
HRAS G12D soft tissue sarcoma Male 0 1338 0.00 0.00 0.00 0.00
HRAS G12D ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
HRAS G12D thyroid cancer Female 1 537 0.00 0.00 0.00 0.01
HRAS G12D thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
HRAS G12D cervical cancer Female 0 365 0.00 0.00 0.00 0.00
HRAS G12D hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS G12D hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
HRAS G12D kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS G12D kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS G12D cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS G12D cns cancer Male 0 2569 0.00 0.00 0.00 0.00
HRAS G12D prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
HRAS G12D anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS G12D anal cancer Male 0 47 0.00 0.00 0.00 0.00
HRAS G12D neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
HRAS G12D neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
HRAS G12D bladder cancer Female 2 393 0.01 0.00 0.00 0.01
HRAS G12D bladder cancer Male 7 1187 0.01 0.01 0.00 0.01
HRAS G12D b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS G12D b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS G12D small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G12D small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS G12D sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
HRAS G12D sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
HRAS G12D bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS G12D bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS G12D vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G12D thymic tumor Female 0 68 0.00 0.00 0.00 0.00
HRAS G12D thymic tumor Male 0 86 0.00 0.00 0.00 0.00
HRAS G12D ampullary cancer Female 0 41 0.00 0.00 0.00 0.00
HRAS G12D ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
HRAS G12D small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
HRAS G12D small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
HRAS G12D mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS G12D mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS G12D mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS G12D mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor Male 0 710 0.00 0.00 0.00 0.00
HRAS G12D nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS G12D nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS G12D penile cancer Male 0 25 0.00 0.00 0.00 0.01
HRAS G12D pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
HRAS G12D pineal tumor Male 0 12 0.00 0.00 0.00 0.05
HRAS G12D b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS G12D b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS G12D non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
HRAS G12D non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
HRAS G12D t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.03
HRAS G12D t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
HRAS G12D retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
HRAS G12D retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
HRAS G12D hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
HRAS G12D hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
HRAS G12D lung cancer Male 0 16 0.00 0.00 0.00 0.04
HRAS G12D blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.05
HRAS G12D peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
HRAS G12F appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS G12F appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary Female 0 999 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary Male 0 986 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
HRAS G12F breast cancer Female 0 9283 0.00 0.00 0.00 0.00
HRAS G12F breast cancer Male 0 48 0.00 0.00 0.00 0.00
HRAS G12F pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
HRAS G12F pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
HRAS G12F leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS G12F leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS G12F melanoma Female 0 1104 0.00 0.00 0.00 0.00
HRAS G12F melanoma Male 0 1742 0.00 0.00 0.00 0.00
HRAS G12F head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
HRAS G12F head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
HRAS G12F uterine cancer Female 0 2248 0.00 0.00 0.00 0.00
HRAS G12F non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
HRAS G12F non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
HRAS G12F myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS G12F myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS G12F adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS G12F adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.01
HRAS G12F soft tissue sarcoma Female 0 1400 0.00 0.00 0.00 0.00
HRAS G12F soft tissue sarcoma Male 0 1338 0.00 0.00 0.00 0.00
HRAS G12F ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
HRAS G12F thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
HRAS G12F thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
HRAS G12F cervical cancer Female 0 365 0.00 0.00 0.00 0.00
HRAS G12F hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS G12F hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
HRAS G12F kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS G12F kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS G12F cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS G12F cns cancer Male 0 2569 0.00 0.00 0.00 0.00
HRAS G12F prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
HRAS G12F anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS G12F anal cancer Male 0 47 0.00 0.00 0.00 0.00
HRAS G12F neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
HRAS G12F neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
HRAS G12F bladder cancer Female 0 393 0.00 0.00 0.00 0.00
HRAS G12F bladder cancer Male 1 1187 0.00 0.00 0.00 0.00
HRAS G12F b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS G12F b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS G12F small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G12F small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS G12F sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
HRAS G12F sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
HRAS G12F bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS G12F bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS G12F vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G12F thymic tumor Female 0 68 0.00 0.00 0.00 0.00
HRAS G12F thymic tumor Male 0 86 0.00 0.00 0.00 0.00
HRAS G12F ampullary cancer Female 0 41 0.00 0.00 0.00 0.00
HRAS G12F ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
HRAS G12F small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
HRAS G12F small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
HRAS G12F mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS G12F mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS G12F mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS G12F mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor Male 0 710 0.00 0.00 0.00 0.00
HRAS G12F nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS G12F nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS G12F penile cancer Male 0 25 0.00 0.00 0.00 0.01
HRAS G12F pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
HRAS G12F pineal tumor Male 0 12 0.00 0.00 0.00 0.05
HRAS G12F b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS G12F b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS G12F non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
HRAS G12F non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
HRAS G12F t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.03
HRAS G12F t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
HRAS G12F retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
HRAS G12F retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
HRAS G12F hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
HRAS G12F hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
HRAS G12F lung cancer Male 0 16 0.00 0.00 0.00 0.04
HRAS G12F blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.05
HRAS G12F peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
HRAS G12R appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS G12R appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary Female 0 999 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary Male 0 986 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
HRAS G12R breast cancer Female 0 9283 0.00 0.00 0.00 0.00
HRAS G12R breast cancer Male 0 48 0.00 0.00 0.00 0.00
HRAS G12R pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
HRAS G12R pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
HRAS G12R leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS G12R leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS G12R melanoma Female 0 1104 0.00 0.00 0.00 0.00
HRAS G12R melanoma Male 0 1742 0.00 0.00 0.00 0.00
HRAS G12R head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
HRAS G12R head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
HRAS G12R uterine cancer Female 0 2248 0.00 0.00 0.00 0.00
HRAS G12R non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
HRAS G12R non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
HRAS G12R myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS G12R myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS G12R adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS G12R adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma Female 0 1400 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma Male 0 1338 0.00 0.00 0.00 0.00
HRAS G12R ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
HRAS G12R thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
HRAS G12R thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
HRAS G12R cervical cancer Female 0 365 0.00 0.00 0.00 0.00
HRAS G12R hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS G12R hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
HRAS G12R kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS G12R kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS G12R cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS G12R cns cancer Male 0 2569 0.00 0.00 0.00 0.00
HRAS G12R prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
HRAS G12R anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS G12R anal cancer Male 0 47 0.00 0.00 0.00 0.00
HRAS G12R neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
HRAS G12R neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
HRAS G12R bladder cancer Female 0 393 0.00 0.00 0.00 0.00
HRAS G12R bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
HRAS G12R b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS G12R b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS G12R small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G12R small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS G12R sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
HRAS G12R sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
HRAS G12R bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS G12R bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS G12R vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
HRAS G12R thymic tumor Female 0 68 0.00 0.00 0.00 0.00
HRAS G12R thymic tumor Male 0 86 0.00 0.00 0.00 0.00
HRAS G12R ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
HRAS G12R ampullary cancer Male 0 65 0.00 0.00 0.00 0.01
HRAS G12R small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
HRAS G12R small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
HRAS G12R mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS G12R mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS G12R mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS G12R mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor Male 0 710 0.00 0.00 0.00 0.00
HRAS G12R nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS G12R nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS G12R penile cancer Male 0 25 0.00 0.00 0.00 0.03
HRAS G12R pheochromocytoma Male 0 17 0.00 0.00 0.00 0.01
HRAS G12R pineal tumor Male 0 12 0.00 0.00 0.00 0.03
HRAS G12R b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS G12R b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS G12R non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.04
HRAS G12R non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
HRAS G12R t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
HRAS G12R t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
HRAS G12R retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
HRAS G12R retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
HRAS G12R hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
HRAS G12R hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
HRAS G12R lung cancer Male 0 16 0.00 0.00 0.00 0.06
HRAS G12R blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.04
HRAS G12R peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
HRAS G12S appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS G12S appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer Male 1 3694 0.00 0.00 0.00 0.00
HRAS G12S cancer of unknown primary Female 1 999 0.00 0.00 0.00 0.00
HRAS G12S cancer of unknown primary Male 0 986 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
HRAS G12S breast cancer Female 3 9283 0.00 0.00 0.00 0.00
HRAS G12S breast cancer Male 0 48 0.00 0.00 0.00 0.01
HRAS G12S pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
HRAS G12S pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
HRAS G12S leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS G12S leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS G12S melanoma Female 0 1104 0.00 0.00 0.00 0.00
HRAS G12S melanoma Male 0 1742 0.00 0.00 0.00 0.00
HRAS G12S head and neck cancer Female 4 564 0.01 0.01 0.00 0.01
HRAS G12S head and neck cancer Male 7 1179 0.01 0.01 0.00 0.01
HRAS G12S uterine cancer Female 2 2248 0.00 0.00 0.00 0.00
HRAS G12S non-melanoma skin cancers Female 1 183 0.00 0.00 0.00 0.02
HRAS G12S non-melanoma skin cancers Male 1 330 0.00 0.00 0.00 0.01
HRAS G12S myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS G12S myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS G12S adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS G12S adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma Female 0 1400 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma Male 0 1338 0.00 0.00 0.00 0.00
HRAS G12S ovarian cancer Female 1 2336 0.00 0.00 0.00 0.00
HRAS G12S esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
HRAS G12S esophagogastric cancer Male 1 1297 0.00 0.00 0.00 0.00
HRAS G12S thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
HRAS G12S thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
HRAS G12S cervical cancer Female 0 365 0.00 0.00 0.00 0.00
HRAS G12S hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS G12S hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
HRAS G12S kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS G12S kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS G12S cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS G12S cns cancer Male 0 2569 0.00 0.00 0.00 0.00
HRAS G12S prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
HRAS G12S anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS G12S anal cancer Male 0 47 0.00 0.00 0.00 0.00
HRAS G12S neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
HRAS G12S neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
HRAS G12S bladder cancer Female 0 393 0.00 0.00 0.00 0.00
HRAS G12S bladder cancer Male 3 1187 0.00 0.00 0.00 0.01
HRAS G12S b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS G12S b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS G12S small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G12S small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS G12S sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
HRAS G12S sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
HRAS G12S bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS G12S bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS G12S vaginal cancer Female 1 78 0.02 0.01 0.00 0.05
HRAS G12S thymic tumor Female 0 68 0.01 0.00 0.00 0.02
HRAS G12S thymic tumor Male 1 86 0.01 0.01 0.00 0.04
HRAS G12S ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
HRAS G12S ampullary cancer Male 0 65 0.00 0.00 0.00 0.01
HRAS G12S small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
HRAS G12S small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
HRAS G12S mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS G12S mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS G12S mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS G12S mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor Male 0 710 0.00 0.00 0.00 0.00
HRAS G12S nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS G12S nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS G12S penile cancer Male 0 25 0.00 0.00 0.00 0.03
HRAS G12S pheochromocytoma Male 0 17 0.00 0.00 0.00 0.01
HRAS G12S pineal tumor Male 0 12 0.00 0.00 0.00 0.03
HRAS G12S b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS G12S b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS G12S non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.04
HRAS G12S non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
HRAS G12S t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
HRAS G12S t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
HRAS G12S retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
HRAS G12S retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
HRAS G12S hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
HRAS G12S hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
HRAS G12S lung cancer Male 0 16 0.00 0.00 0.00 0.06
HRAS G12S blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.04
HRAS G12S peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
HRAS G12V appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS G12V appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary Female 0 999 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary Male 1 986 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
HRAS G12V breast cancer Female 1 9283 0.00 0.00 0.00 0.00
HRAS G12V breast cancer Male 0 48 0.00 0.00 0.00 0.01
HRAS G12V pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
HRAS G12V pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
HRAS G12V leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS G12V leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS G12V melanoma Female 0 1104 0.00 0.00 0.00 0.00
HRAS G12V melanoma Male 0 1742 0.00 0.00 0.00 0.00
HRAS G12V head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
HRAS G12V head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
HRAS G12V uterine cancer Female 0 2248 0.00 0.00 0.00 0.00
HRAS G12V non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
HRAS G12V non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
HRAS G12V myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS G12V myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS G12V adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS G12V adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
HRAS G12V soft tissue sarcoma Female 0 1400 0.00 0.00 0.00 0.00
HRAS G12V soft tissue sarcoma Male 2 1338 0.00 0.00 0.00 0.00
HRAS G12V ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
HRAS G12V thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
HRAS G12V thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
HRAS G12V cervical cancer Female 1 365 0.00 0.00 0.00 0.01
HRAS G12V hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS G12V hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
HRAS G12V kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS G12V kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS G12V cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS G12V cns cancer Male 0 2569 0.00 0.00 0.00 0.00
HRAS G12V prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
HRAS G12V anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS G12V anal cancer Male 0 47 0.00 0.00 0.00 0.00
HRAS G12V neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
HRAS G12V neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
HRAS G12V bladder cancer Female 0 393 0.00 0.00 0.00 0.00
HRAS G12V bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
HRAS G12V b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS G12V b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS G12V small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G12V small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS G12V sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
HRAS G12V sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.00
HRAS G12V bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS G12V bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS G12V vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
HRAS G12V thymic tumor Female 0 68 0.00 0.00 0.00 0.00
HRAS G12V thymic tumor Male 0 86 0.00 0.00 0.00 0.00
HRAS G12V ampullary cancer Female 0 41 0.00 0.00 0.00 0.00
HRAS G12V ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
HRAS G12V small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
HRAS G12V small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
HRAS G12V mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS G12V mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS G12V mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS G12V mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor Male 0 710 0.00 0.00 0.00 0.00
HRAS G12V nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS G12V nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS G12V penile cancer Male 0 25 0.00 0.00 0.00 0.01
HRAS G12V pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
HRAS G12V pineal tumor Male 0 12 0.00 0.00 0.00 0.04
HRAS G12V b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS G12V b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS G12V non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
HRAS G12V non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.02
HRAS G12V t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
HRAS G12V t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
HRAS G12V retinoblastoma Female 0 23 0.00 0.00 0.00 0.02
HRAS G12V retinoblastoma Male 0 28 0.00 0.00 0.00 0.02
HRAS G12V hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
HRAS G12V hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
HRAS G12V lung cancer Male 0 16 0.00 0.00 0.00 0.04
HRAS G12V blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.04
HRAS G12V peritoneal cancer Female 0 17 0.00 0.00 0.00 0.02
HRAS G13C appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS G13C appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary Female 0 999 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary Male 0 986 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
HRAS G13C breast cancer Female 0 9283 0.00 0.00 0.00 0.00
HRAS G13C breast cancer Male 0 48 0.00 0.00 0.00 0.00
HRAS G13C pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
HRAS G13C pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
HRAS G13C leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS G13C leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS G13C melanoma Female 0 1104 0.00 0.00 0.00 0.00
HRAS G13C melanoma Male 1 1742 0.00 0.00 0.00 0.00
HRAS G13C head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
HRAS G13C head and neck cancer Male 1 1179 0.00 0.00 0.00 0.00
HRAS G13C uterine cancer Female 0 2248 0.00 0.00 0.00 0.00
HRAS G13C non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
HRAS G13C non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
HRAS G13C myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS G13C myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS G13C adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS G13C adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
HRAS G13C soft tissue sarcoma Female 0 1400 0.00 0.00 0.00 0.00
HRAS G13C soft tissue sarcoma Male 0 1338 0.00 0.00 0.00 0.00
HRAS G13C ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
HRAS G13C thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
HRAS G13C thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
HRAS G13C cervical cancer Female 0 365 0.00 0.00 0.00 0.00
HRAS G13C hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS G13C hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
HRAS G13C kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS G13C kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS G13C cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS G13C cns cancer Male 1 2569 0.00 0.00 0.00 0.00
HRAS G13C prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
HRAS G13C anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS G13C anal cancer Male 0 47 0.00 0.00 0.00 0.00
HRAS G13C neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
HRAS G13C neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
HRAS G13C bladder cancer Female 0 393 0.00 0.00 0.00 0.00
HRAS G13C bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
HRAS G13C b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS G13C b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS G13C small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G13C small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS G13C sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
HRAS G13C sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.00
HRAS G13C bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS G13C bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS G13C vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
HRAS G13C thymic tumor Female 0 68 0.00 0.00 0.00 0.00
HRAS G13C thymic tumor Male 0 86 0.00 0.00 0.00 0.00
HRAS G13C ampullary cancer Female 0 41 0.00 0.00 0.00 0.00
HRAS G13C ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
HRAS G13C small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
HRAS G13C small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
HRAS G13C mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS G13C mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS G13C mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS G13C mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor Male 0 710 0.00 0.00 0.00 0.00
HRAS G13C nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS G13C nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS G13C penile cancer Male 0 25 0.00 0.00 0.00 0.01
HRAS G13C pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
HRAS G13C pineal tumor Male 0 12 0.00 0.00 0.00 0.04
HRAS G13C b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS G13C b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS G13C non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
HRAS G13C non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.02
HRAS G13C t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
HRAS G13C t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
HRAS G13C retinoblastoma Female 0 23 0.00 0.00 0.00 0.02
HRAS G13C retinoblastoma Male 0 28 0.00 0.00 0.00 0.02
HRAS G13C hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
HRAS G13C hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
HRAS G13C lung cancer Male 0 16 0.00 0.00 0.00 0.04
HRAS G13C blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.04
HRAS G13C peritoneal cancer Female 0 17 0.00 0.00 0.00 0.02
HRAS G13D appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS G13D appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary Female 0 999 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary Male 0 986 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
HRAS G13D breast cancer Female 0 9283 0.00 0.00 0.00 0.00
HRAS G13D breast cancer Male 0 48 0.00 0.00 0.00 0.00
HRAS G13D pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
HRAS G13D pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
HRAS G13D leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS G13D leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS G13D melanoma Female 3 1104 0.00 0.00 0.00 0.00
HRAS G13D melanoma Male 3 1742 0.00 0.00 0.00 0.00
HRAS G13D head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
HRAS G13D head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
HRAS G13D uterine cancer Female 0 2248 0.00 0.00 0.00 0.00
HRAS G13D non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
HRAS G13D non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
HRAS G13D myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS G13D myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS G13D adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS G13D adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma Female 0 1400 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma Male 0 1338 0.00 0.00 0.00 0.00
HRAS G13D ovarian cancer Female 1 2336 0.00 0.00 0.00 0.00
HRAS G13D esophagogastric cancer Female 1 504 0.00 0.00 0.00 0.01
HRAS G13D esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
HRAS G13D thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
HRAS G13D thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
HRAS G13D cervical cancer Female 0 365 0.00 0.00 0.00 0.00
HRAS G13D hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS G13D hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
HRAS G13D kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS G13D kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS G13D cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS G13D cns cancer Male 0 2569 0.00 0.00 0.00 0.00
HRAS G13D prostate cancer Male 2 2436 0.00 0.00 0.00 0.00
HRAS G13D anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS G13D anal cancer Male 0 47 0.00 0.00 0.00 0.00
HRAS G13D neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
HRAS G13D neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
HRAS G13D bladder cancer Female 0 393 0.00 0.00 0.00 0.00
HRAS G13D bladder cancer Male 2 1187 0.00 0.00 0.00 0.00
HRAS G13D b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS G13D b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS G13D small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G13D small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS G13D sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
HRAS G13D sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.00
HRAS G13D bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS G13D bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS G13D vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
HRAS G13D thymic tumor Female 1 68 0.01 0.01 0.00 0.04
HRAS G13D thymic tumor Male 0 86 0.00 0.00 0.00 0.02
HRAS G13D ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
HRAS G13D ampullary cancer Male 0 65 0.00 0.00 0.00 0.01
HRAS G13D small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
HRAS G13D small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
HRAS G13D mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS G13D mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS G13D mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS G13D mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor Male 0 710 0.00 0.00 0.00 0.00
HRAS G13D nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS G13D nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS G13D penile cancer Male 0 25 0.00 0.00 0.00 0.02
HRAS G13D pheochromocytoma Male 0 17 0.00 0.00 0.00 0.04
HRAS G13D pineal tumor Male 0 12 0.00 0.00 0.00 0.06
HRAS G13D b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS G13D b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS G13D non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.02
HRAS G13D non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.02
HRAS G13D t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.01
HRAS G13D t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
HRAS G13D retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
HRAS G13D retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
HRAS G13D hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
HRAS G13D hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
HRAS G13D lung cancer Male 0 16 0.00 0.00 0.00 0.04
HRAS G13D blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
HRAS G13D peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
HRAS G13R appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS G13R appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
HRAS G13R cancer of unknown primary Female 3 999 0.00 0.00 0.00 0.01
HRAS G13R cancer of unknown primary Male 0 986 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer Female 3 5722 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer Male 1 4406 0.00 0.00 0.00 0.00
HRAS G13R breast cancer Female 5 9283 0.00 0.00 0.00 0.00
HRAS G13R breast cancer Male 0 48 0.00 0.00 0.00 0.01
HRAS G13R pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
HRAS G13R pancreatic cancer Male 1 1340 0.00 0.00 0.00 0.00
HRAS G13R leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS G13R leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS G13R melanoma Female 1 1104 0.00 0.00 0.00 0.00
HRAS G13R melanoma Male 1 1742 0.00 0.00 0.00 0.00
HRAS G13R head and neck cancer Female 2 564 0.00 0.00 0.00 0.01
HRAS G13R head and neck cancer Male 8 1179 0.01 0.01 0.00 0.01
HRAS G13R uterine cancer Female 0 2248 0.00 0.00 0.00 0.00
HRAS G13R non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.01
HRAS G13R non-melanoma skin cancers Male 1 330 0.00 0.00 0.00 0.01
HRAS G13R myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS G13R myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS G13R adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS G13R adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
HRAS G13R soft tissue sarcoma Female 1 1400 0.00 0.00 0.00 0.00
HRAS G13R soft tissue sarcoma Male 3 1338 0.00 0.00 0.00 0.00
HRAS G13R ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
HRAS G13R thyroid cancer Female 1 537 0.00 0.00 0.00 0.01
HRAS G13R thyroid cancer Male 1 480 0.00 0.00 0.00 0.01
HRAS G13R cervical cancer Female 0 365 0.00 0.00 0.00 0.00
HRAS G13R hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS G13R hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
HRAS G13R kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS G13R kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS G13R cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS G13R cns cancer Male 1 2569 0.00 0.00 0.00 0.00
HRAS G13R prostate cancer Male 1 2436 0.00 0.00 0.00 0.00
HRAS G13R anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS G13R anal cancer Male 0 47 0.00 0.00 0.00 0.00
HRAS G13R neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
HRAS G13R neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
HRAS G13R bladder cancer Female 0 393 0.00 0.00 0.00 0.01
HRAS G13R bladder cancer Male 8 1187 0.01 0.01 0.00 0.01
HRAS G13R b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS G13R b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS G13R small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G13R small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS G13R sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
HRAS G13R sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.00
HRAS G13R bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS G13R bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS G13R vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
HRAS G13R thymic tumor Female 0 68 0.00 0.00 0.00 0.00
HRAS G13R thymic tumor Male 0 86 0.00 0.00 0.00 0.00
HRAS G13R ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
HRAS G13R ampullary cancer Male 0 65 0.00 0.00 0.00 0.01
HRAS G13R small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
HRAS G13R small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
HRAS G13R mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS G13R mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS G13R mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS G13R mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS G13R germ cell tumor Female 0 175 0.00 0.00 0.00 0.01
HRAS G13R germ cell tumor Male 1 710 0.00 0.00 0.00 0.00
HRAS G13R nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS G13R nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS G13R penile cancer Male 0 25 0.00 0.00 0.00 0.02
HRAS G13R pheochromocytoma Male 0 17 0.00 0.00 0.00 0.04
HRAS G13R pineal tumor Male 0 12 0.00 0.00 0.00 0.06
HRAS G13R b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS G13R b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS G13R non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.02
HRAS G13R non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.02
HRAS G13R t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.01
HRAS G13R t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
HRAS G13R retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
HRAS G13R retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
HRAS G13R hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
HRAS G13R hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
HRAS G13R lung cancer Male 0 16 0.00 0.00 0.00 0.04
HRAS G13R blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
HRAS G13R peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
HRAS G13V appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS G13V appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
HRAS G13V cancer of unknown primary Female 1 999 0.00 0.00 0.00 0.00
HRAS G13V cancer of unknown primary Male 0 986 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer Female 4 5722 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer Male 2 4406 0.00 0.00 0.00 0.00
HRAS G13V breast cancer Female 1 9283 0.00 0.00 0.00 0.00
HRAS G13V breast cancer Male 0 48 0.00 0.00 0.00 0.01
HRAS G13V pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
HRAS G13V pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
HRAS G13V leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS G13V leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS G13V melanoma Female 1 1104 0.00 0.00 0.00 0.00
HRAS G13V melanoma Male 2 1742 0.00 0.00 0.00 0.00
HRAS G13V head and neck cancer Female 2 564 0.00 0.00 0.00 0.01
HRAS G13V head and neck cancer Male 1 1179 0.00 0.00 0.00 0.00
HRAS G13V uterine cancer Female 1 2248 0.00 0.00 0.00 0.00
HRAS G13V non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.01
HRAS G13V non-melanoma skin cancers Male 2 330 0.00 0.00 0.00 0.02
HRAS G13V myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS G13V myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS G13V adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS G13V adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma Female 0 1400 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma Male 0 1338 0.00 0.00 0.00 0.00
HRAS G13V ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
HRAS G13V thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
HRAS G13V thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
HRAS G13V cervical cancer Female 0 365 0.00 0.00 0.00 0.00
HRAS G13V hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS G13V hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
HRAS G13V kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS G13V kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS G13V cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS G13V cns cancer Male 0 2569 0.00 0.00 0.00 0.00
HRAS G13V prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
HRAS G13V anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS G13V anal cancer Male 0 47 0.00 0.00 0.00 0.00
HRAS G13V neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
HRAS G13V neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
HRAS G13V bladder cancer Female 2 393 0.00 0.00 0.00 0.01
HRAS G13V bladder cancer Male 1 1187 0.00 0.00 0.00 0.00
HRAS G13V b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS G13V b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS G13V small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS G13V small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS G13V sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
HRAS G13V sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
HRAS G13V bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS G13V bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS G13V vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
HRAS G13V thymic tumor Female 0 68 0.00 0.00 0.00 0.00
HRAS G13V thymic tumor Male 0 86 0.00 0.00 0.00 0.00
HRAS G13V ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
HRAS G13V ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
HRAS G13V small cell lung cancer Female 1 193 0.00 0.00 0.00 0.02
HRAS G13V small cell lung cancer Male 0 205 0.00 0.00 0.00 0.01
HRAS G13V mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS G13V mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS G13V mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS G13V mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor Male 0 710 0.00 0.00 0.00 0.00
HRAS G13V nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS G13V nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS G13V penile cancer Male 0 25 0.00 0.00 0.00 0.03
HRAS G13V pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
HRAS G13V pineal tumor Male 0 12 0.00 0.00 0.00 0.05
HRAS G13V b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS G13V b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS G13V non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
HRAS G13V non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
HRAS G13V t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.01
HRAS G13V t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
HRAS G13V retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
HRAS G13V retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
HRAS G13V hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.01
HRAS G13V hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.01
HRAS G13V lung cancer Male 0 16 0.00 0.00 0.00 0.04
HRAS G13V blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
HRAS G13V peritoneal cancer Female 0 17 0.00 0.00 0.00 0.04
HRAS Q61H appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS Q61H appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary Female 0 999 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary Male 0 986 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer Male 2 4406 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer Female 0 9283 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer Male 0 48 0.00 0.00 0.00 0.00
HRAS Q61H pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
HRAS Q61H pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
HRAS Q61H leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS Q61H leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS Q61H melanoma Female 0 1104 0.00 0.00 0.00 0.00
HRAS Q61H melanoma Male 0 1742 0.00 0.00 0.00 0.00
HRAS Q61H head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
HRAS Q61H head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
HRAS Q61H uterine cancer Female 1 2248 0.00 0.00 0.00 0.00
HRAS Q61H non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
HRAS Q61H non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
HRAS Q61H myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS Q61H myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS Q61H adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS Q61H adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma Female 0 1400 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma Male 0 1338 0.00 0.00 0.00 0.00
HRAS Q61H ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
HRAS Q61H thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
HRAS Q61H thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
HRAS Q61H cervical cancer Female 0 365 0.00 0.00 0.00 0.00
HRAS Q61H hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS Q61H hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
HRAS Q61H kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS Q61H kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer Male 0 2569 0.00 0.00 0.00 0.00
HRAS Q61H prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
HRAS Q61H anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS Q61H anal cancer Male 0 47 0.00 0.00 0.00 0.00
HRAS Q61H neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
HRAS Q61H neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
HRAS Q61H bladder cancer Female 0 393 0.00 0.00 0.00 0.00
HRAS Q61H bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
HRAS Q61H b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS Q61H b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS Q61H small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS Q61H small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS Q61H sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
HRAS Q61H sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
HRAS Q61H bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS Q61H bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS Q61H vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS Q61H thymic tumor Female 0 68 0.00 0.00 0.00 0.00
HRAS Q61H thymic tumor Male 0 86 0.00 0.00 0.00 0.00
HRAS Q61H ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
HRAS Q61H ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
HRAS Q61H small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
HRAS Q61H small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
HRAS Q61H mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS Q61H mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS Q61H mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS Q61H mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor Male 0 710 0.00 0.00 0.00 0.00
HRAS Q61H nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS Q61H nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS Q61H penile cancer Male 0 25 0.00 0.00 0.00 0.02
HRAS Q61H pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
HRAS Q61H pineal tumor Male 0 12 0.00 0.00 0.00 0.04
HRAS Q61H b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS Q61H b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS Q61H non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.04
HRAS Q61H non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.04
HRAS Q61H t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
HRAS Q61H t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
HRAS Q61H retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
HRAS Q61H retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
HRAS Q61H hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
HRAS Q61H hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
HRAS Q61H lung cancer Male 0 16 0.00 0.00 0.00 0.03
HRAS Q61H blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.05
HRAS Q61H peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
HRAS Q61K appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS Q61K appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
HRAS Q61K cancer of unknown primary Female 1 999 0.00 0.00 0.00 0.00
HRAS Q61K cancer of unknown primary Male 2 986 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer Female 2 9283 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer Male 0 48 0.00 0.00 0.00 0.01
HRAS Q61K pancreatic cancer Female 1 1153 0.00 0.00 0.00 0.00
HRAS Q61K pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
HRAS Q61K leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS Q61K leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS Q61K melanoma Female 2 1104 0.00 0.00 0.00 0.00
HRAS Q61K melanoma Male 6 1742 0.00 0.00 0.00 0.01
HRAS Q61K head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
HRAS Q61K head and neck cancer Male 5 1179 0.00 0.00 0.00 0.01
HRAS Q61K uterine cancer Female 0 2248 0.00 0.00 0.00 0.00
HRAS Q61K non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.01
HRAS Q61K non-melanoma skin cancers Male 2 330 0.00 0.00 0.00 0.02
HRAS Q61K myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS Q61K myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS Q61K adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS Q61K adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma Female 1 1400 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma Male 0 1338 0.00 0.00 0.00 0.00
HRAS Q61K ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
HRAS Q61K thyroid cancer Female 8 537 0.01 0.01 0.01 0.02
HRAS Q61K thyroid cancer Male 4 480 0.01 0.01 0.00 0.02
HRAS Q61K cervical cancer Female 0 365 0.00 0.00 0.00 0.00
HRAS Q61K hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS Q61K hepatobiliary cancer Male 1 738 0.00 0.00 0.00 0.00
HRAS Q61K kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS Q61K kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer Male 0 2569 0.00 0.00 0.00 0.00
HRAS Q61K prostate cancer Male 6 2436 0.00 0.00 0.00 0.00
HRAS Q61K anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS Q61K anal cancer Male 0 47 0.00 0.00 0.00 0.00
HRAS Q61K neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
HRAS Q61K neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
HRAS Q61K bladder cancer Female 1 393 0.00 0.00 0.00 0.01
HRAS Q61K bladder cancer Male 4 1187 0.00 0.00 0.00 0.01
HRAS Q61K b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS Q61K b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS Q61K small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS Q61K small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS Q61K sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
HRAS Q61K sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
HRAS Q61K bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS Q61K bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS Q61K vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
HRAS Q61K thymic tumor Female 0 68 0.00 0.00 0.00 0.00
HRAS Q61K thymic tumor Male 0 86 0.00 0.00 0.00 0.00
HRAS Q61K ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
HRAS Q61K ampullary cancer Male 0 65 0.00 0.00 0.00 0.01
HRAS Q61K small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
HRAS Q61K small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
HRAS Q61K mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS Q61K mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS Q61K mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS Q61K mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor Male 0 710 0.00 0.00 0.00 0.00
HRAS Q61K nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS Q61K nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS Q61K penile cancer Male 0 25 0.00 0.00 0.00 0.02
HRAS Q61K pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
HRAS Q61K pineal tumor Male 0 12 0.00 0.00 0.00 0.03
HRAS Q61K b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS Q61K b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS Q61K non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.04
HRAS Q61K non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.04
HRAS Q61K t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
HRAS Q61K t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
HRAS Q61K retinoblastoma Female 0 23 0.00 0.00 0.00 0.02
HRAS Q61K retinoblastoma Male 0 28 0.00 0.00 0.00 0.02
HRAS Q61K hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.03
HRAS Q61K hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
HRAS Q61K lung cancer Male 0 16 0.00 0.00 0.00 0.04
HRAS Q61K blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
HRAS Q61K peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
HRAS Q61L appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS Q61L appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary Female 0 999 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary Male 0 986 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer Female 0 9283 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer Male 0 48 0.00 0.00 0.00 0.00
HRAS Q61L pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
HRAS Q61L pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
HRAS Q61L leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS Q61L leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS Q61L melanoma Female 0 1104 0.00 0.00 0.00 0.00
HRAS Q61L melanoma Male 0 1742 0.00 0.00 0.00 0.00
HRAS Q61L head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
HRAS Q61L head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
HRAS Q61L uterine cancer Female 0 2248 0.00 0.00 0.00 0.00
HRAS Q61L non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
HRAS Q61L non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
HRAS Q61L myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS Q61L myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS Q61L adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS Q61L adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
HRAS Q61L soft tissue sarcoma Female 0 1400 0.00 0.00 0.00 0.00
HRAS Q61L soft tissue sarcoma Male 1 1338 0.00 0.00 0.00 0.00
HRAS Q61L ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
HRAS Q61L thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
HRAS Q61L thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
HRAS Q61L cervical cancer Female 0 365 0.00 0.00 0.00 0.00
HRAS Q61L hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS Q61L hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
HRAS Q61L kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS Q61L kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer Male 0 2569 0.00 0.00 0.00 0.00
HRAS Q61L prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
HRAS Q61L anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS Q61L anal cancer Male 0 47 0.00 0.00 0.00 0.00
HRAS Q61L neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
HRAS Q61L neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
HRAS Q61L bladder cancer Female 0 393 0.00 0.00 0.00 0.00
HRAS Q61L bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
HRAS Q61L b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS Q61L b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS Q61L small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS Q61L small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS Q61L sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
HRAS Q61L sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
HRAS Q61L bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS Q61L bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS Q61L vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
HRAS Q61L thymic tumor Female 0 68 0.00 0.00 0.00 0.00
HRAS Q61L thymic tumor Male 0 86 0.00 0.00 0.00 0.00
HRAS Q61L ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
HRAS Q61L ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
HRAS Q61L small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
HRAS Q61L small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
HRAS Q61L mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS Q61L mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS Q61L mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS Q61L mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor Male 0 710 0.00 0.00 0.00 0.00
HRAS Q61L nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS Q61L nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS Q61L penile cancer Male 0 25 0.00 0.00 0.00 0.03
HRAS Q61L pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
HRAS Q61L pineal tumor Male 0 12 0.00 0.00 0.00 0.05
HRAS Q61L b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS Q61L b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS Q61L non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
HRAS Q61L non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
HRAS Q61L t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.01
HRAS Q61L t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
HRAS Q61L retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
HRAS Q61L retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
HRAS Q61L hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.01
HRAS Q61L hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.01
HRAS Q61L lung cancer Male 0 16 0.00 0.00 0.00 0.04
HRAS Q61L blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
HRAS Q61L peritoneal cancer Female 0 17 0.00 0.00 0.00 0.04
HRAS Q61R appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
HRAS Q61R appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary Female 0 999 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary Male 0 986 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer Female 2 5722 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer Male 1 4406 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer Female 4 9283 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer Male 0 48 0.00 0.00 0.00 0.01
HRAS Q61R pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
HRAS Q61R pancreatic cancer Male 1 1340 0.00 0.00 0.00 0.00
HRAS Q61R leukemia Female 0 635 0.00 0.00 0.00 0.00
HRAS Q61R leukemia Male 0 925 0.00 0.00 0.00 0.00
HRAS Q61R melanoma Female 2 1104 0.00 0.00 0.00 0.00
HRAS Q61R melanoma Male 3 1742 0.00 0.00 0.00 0.00
HRAS Q61R head and neck cancer Female 3 564 0.00 0.00 0.00 0.01
HRAS Q61R head and neck cancer Male 6 1179 0.00 0.00 0.00 0.01
HRAS Q61R uterine cancer Female 0 2248 0.00 0.00 0.00 0.00
HRAS Q61R non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.01
HRAS Q61R non-melanoma skin cancers Male 1 330 0.00 0.00 0.00 0.01
HRAS Q61R myelodysplastic/myeloproliferative syndromes Female 0 482 0.00 0.00 0.00 0.00
HRAS Q61R myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
HRAS Q61R adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
HRAS Q61R adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
HRAS Q61R soft tissue sarcoma Female 1 1400 0.00 0.00 0.00 0.00
HRAS Q61R soft tissue sarcoma Male 0 1338 0.00 0.00 0.00 0.00
HRAS Q61R ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer Male 1 1297 0.00 0.00 0.00 0.00
HRAS Q61R thyroid cancer Female 17 537 0.03 0.03 0.02 0.04
HRAS Q61R thyroid cancer Male 13 480 0.03 0.03 0.02 0.04
HRAS Q61R cervical cancer Female 0 365 0.00 0.00 0.00 0.00
HRAS Q61R hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
HRAS Q61R hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
HRAS Q61R kidney cancer Female 0 420 0.00 0.00 0.00 0.00
HRAS Q61R kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer Female 0 1993 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer Male 0 2569 0.00 0.00 0.00 0.00
HRAS Q61R prostate cancer Male 6 2436 0.00 0.00 0.00 0.00
HRAS Q61R anal cancer Female 0 102 0.00 0.00 0.00 0.00
HRAS Q61R anal cancer Male 0 47 0.00 0.00 0.00 0.00
HRAS Q61R neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.01
HRAS Q61R neuroendocrine tumors Male 1 193 0.00 0.00 0.00 0.02
HRAS Q61R bladder cancer Female 3 393 0.01 0.01 0.00 0.02
HRAS Q61R bladder cancer Male 13 1187 0.01 0.01 0.01 0.02
HRAS Q61R b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
HRAS Q61R b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
HRAS Q61R small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
HRAS Q61R small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
HRAS Q61R sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
HRAS Q61R sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
HRAS Q61R bone cancer Female 0 237 0.00 0.00 0.00 0.00
HRAS Q61R bone cancer Male 0 318 0.00 0.00 0.00 0.00
HRAS Q61R vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
HRAS Q61R thymic tumor Female 0 68 0.00 0.00 0.00 0.02
HRAS Q61R thymic tumor Male 1 86 0.01 0.01 0.00 0.04
HRAS Q61R ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
HRAS Q61R ampullary cancer Male 0 65 0.00 0.00 0.00 0.01
HRAS Q61R small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
HRAS Q61R small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
HRAS Q61R mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
HRAS Q61R mature t and nk neoplasms Male 0 123 0.00 0.00 0.00 0.00
HRAS Q61R mesothelioma Female 0 145 0.00 0.00 0.00 0.00
HRAS Q61R mesothelioma Male 0 352 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor Male 0 710 0.00 0.00 0.00 0.00
HRAS Q61R nerve sheath tumor Female 0 79 0.00 0.00 0.00 0.00
HRAS Q61R nerve sheath tumor Male 0 72 0.00 0.00 0.00 0.00
HRAS Q61R penile cancer Male 0 25 0.00 0.00 0.00 0.02
HRAS Q61R pheochromocytoma Male 1 17 0.07 0.05 0.00 0.22
HRAS Q61R pineal tumor Male 0 12 0.00 0.00 0.00 0.03
HRAS Q61R b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
HRAS Q61R b cell lymphoma Male 0 566 0.00 0.00 0.00 0.00
HRAS Q61R non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.04
HRAS Q61R non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.04
HRAS Q61R t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
HRAS Q61R t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
HRAS Q61R retinoblastoma Female 0 23 0.00 0.00 0.00 0.02
HRAS Q61R retinoblastoma Male 0 28 0.00 0.00 0.00 0.02
HRAS Q61R hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.03
HRAS Q61R hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
HRAS Q61R lung cancer Male 0 16 0.00 0.00 0.00 0.04
HRAS Q61R blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
HRAS Q61R peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
NRAS G12A appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
NRAS G12A appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer Male 5 3694 0.00 0.00 0.00 0.00
NRAS G12A cancer of unknown primary Female 0 1000 0.00 0.00 0.00 0.00
NRAS G12A cancer of unknown primary Male 0 988 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer Female 1 5722 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer Male 1 4406 0.00 0.00 0.00 0.00
NRAS G12A breast cancer Female 0 9283 0.00 0.00 0.00 0.00
NRAS G12A breast cancer Male 0 48 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
NRAS G12A pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
NRAS G12A pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
NRAS G12A leukemia Female 6 637 0.01 0.01 0.00 0.02
NRAS G12A leukemia Male 8 930 0.01 0.01 0.00 0.02
NRAS G12A melanoma Female 2 1104 0.00 0.00 0.00 0.00
NRAS G12A melanoma Male 3 1742 0.00 0.00 0.00 0.00
NRAS G12A head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
NRAS G12A head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
NRAS G12A uterine cancer Female 0 2253 0.00 0.00 0.00 0.00
NRAS G12A non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
NRAS G12A non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
NRAS G12A myelodysplastic/myeloproliferative syndromes Female 1 483 0.00 0.00 0.00 0.01
NRAS G12A myelodysplastic/myeloproliferative syndromes Male 3 724 0.00 0.00 0.00 0.01
NRAS G12A adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
NRAS G12A adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
NRAS G12A ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
NRAS G12A esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
NRAS G12A esophagogastric cancer Male 1 1297 0.00 0.00 0.00 0.00
NRAS G12A thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
NRAS G12A thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
NRAS G12A cervical cancer Female 0 365 0.00 0.00 0.00 0.00
NRAS G12A hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
NRAS G12A hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
NRAS G12A kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS G12A kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS G12A mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
NRAS G12A mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
NRAS G12A cns cancer Female 0 1994 0.00 0.00 0.00 0.00
NRAS G12A cns cancer Male 0 2569 0.00 0.00 0.00 0.00
NRAS G12A prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
NRAS G12A anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS G12A anal cancer Male 0 47 0.00 0.00 0.00 0.01
NRAS G12A neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
NRAS G12A neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
NRAS G12A bladder cancer Female 0 393 0.00 0.00 0.00 0.00
NRAS G12A bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
NRAS G12A b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.02
NRAS G12A b-lymphoblastic leukemia/lymphoma Male 2 142 0.01 0.01 0.00 0.03
NRAS G12A small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G12A small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
NRAS G12A sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.01
NRAS G12A sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
NRAS G12A bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS G12A bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS G12A vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G12A thymic tumor Female 0 70 0.00 0.00 0.00 0.00
NRAS G12A thymic tumor Male 0 86 0.00 0.00 0.00 0.00
NRAS G12A ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
NRAS G12A ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
NRAS G12A small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
NRAS G12A small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
NRAS G12A mesothelioma Female 0 145 0.00 0.00 0.00 0.00
NRAS G12A mesothelioma Male 0 352 0.00 0.00 0.00 0.00
NRAS G12A germ cell tumor Female 0 175 0.00 0.00 0.00 0.01
NRAS G12A germ cell tumor Male 1 711 0.00 0.00 0.00 0.00
NRAS G12A nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
NRAS G12A nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
NRAS G12A penile cancer Male 0 25 0.00 0.00 0.00 0.03
NRAS G12A pheochromocytoma Male 0 17 0.00 0.00 0.00 0.04
NRAS G12A pineal tumor Male 0 12 0.00 0.00 0.00 0.06
NRAS G12A b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
NRAS G12A b cell lymphoma Male 0 567 0.00 0.00 0.00 0.00
NRAS G12A non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.02
NRAS G12A non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.02
NRAS G12A t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
NRAS G12A t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
NRAS G12A retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
NRAS G12A retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
NRAS G12A hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
NRAS G12A hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.01
NRAS G12A lung cancer Male 0 16 0.00 0.00 0.00 0.02
NRAS G12A blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.06
NRAS G12A peritoneal cancer Female 0 17 0.00 0.00 0.00 0.04
NRAS G12C appendiceal cancer Female 1 174 0.00 0.00 0.00 0.02
NRAS G12C appendiceal cancer Male 0 167 0.00 0.00 0.00 0.01
NRAS G12C colorectal cancer Female 7 3026 0.00 0.00 0.00 0.00
NRAS G12C colorectal cancer Male 9 3694 0.00 0.00 0.00 0.00
NRAS G12C cancer of unknown primary Female 1 1000 0.00 0.00 0.00 0.00
NRAS G12C cancer of unknown primary Male 1 988 0.00 0.00 0.00 0.00
NRAS G12C non-small cell lung cancer Female 1 5722 0.00 0.00 0.00 0.00
NRAS G12C non-small cell lung cancer Male 2 4406 0.00 0.00 0.00 0.00
NRAS G12C breast cancer Female 0 9283 0.00 0.00 0.00 0.00
NRAS G12C breast cancer Male 0 48 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
NRAS G12C pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
NRAS G12C pancreatic cancer Male 1 1340 0.00 0.00 0.00 0.00
NRAS G12C leukemia Female 4 637 0.01 0.00 0.00 0.01
NRAS G12C leukemia Male 4 930 0.00 0.00 0.00 0.01
NRAS G12C melanoma Female 7 1104 0.00 0.00 0.00 0.01
NRAS G12C melanoma Male 5 1742 0.00 0.00 0.00 0.01
NRAS G12C head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
NRAS G12C head and neck cancer Male 1 1179 0.00 0.00 0.00 0.00
NRAS G12C uterine cancer Female 5 2253 0.00 0.00 0.00 0.00
NRAS G12C non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
NRAS G12C non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
NRAS G12C myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
NRAS G12C myelodysplastic/myeloproliferative syndromes Male 1 724 0.00 0.00 0.00 0.00
NRAS G12C adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
NRAS G12C adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
NRAS G12C ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
NRAS G12C thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
NRAS G12C thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
NRAS G12C cervical cancer Female 0 365 0.00 0.00 0.00 0.00
NRAS G12C hepatobiliary cancer Female 1 636 0.00 0.00 0.00 0.00
NRAS G12C hepatobiliary cancer Male 1 738 0.00 0.00 0.00 0.00
NRAS G12C kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS G12C kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS G12C mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
NRAS G12C mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
NRAS G12C cns cancer Female 1 1994 0.00 0.00 0.00 0.00
NRAS G12C cns cancer Male 1 2569 0.00 0.00 0.00 0.00
NRAS G12C prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
NRAS G12C anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS G12C anal cancer Male 0 47 0.00 0.00 0.00 0.00
NRAS G12C neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
NRAS G12C neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
NRAS G12C bladder cancer Female 1 393 0.00 0.00 0.00 0.01
NRAS G12C bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
NRAS G12C b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.02
NRAS G12C b-lymphoblastic leukemia/lymphoma Male 1 142 0.01 0.00 0.00 0.02
NRAS G12C small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G12C small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
NRAS G12C sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
NRAS G12C sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.00
NRAS G12C bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS G12C bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS G12C vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G12C thymic tumor Female 0 70 0.00 0.00 0.00 0.00
NRAS G12C thymic tumor Male 0 86 0.00 0.00 0.00 0.00
NRAS G12C ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
NRAS G12C ampullary cancer Male 0 65 0.00 0.00 0.00 0.01
NRAS G12C small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
NRAS G12C small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
NRAS G12C mesothelioma Female 0 145 0.00 0.00 0.00 0.00
NRAS G12C mesothelioma Male 0 352 0.00 0.00 0.00 0.00
NRAS G12C germ cell tumor Female 1 175 0.00 0.00 0.00 0.02
NRAS G12C germ cell tumor Male 0 711 0.00 0.00 0.00 0.00
NRAS G12C nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
NRAS G12C nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
NRAS G12C penile cancer Male 0 25 0.00 0.00 0.00 0.01
NRAS G12C pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
NRAS G12C pineal tumor Male 0 12 0.00 0.00 0.00 0.05
NRAS G12C b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
NRAS G12C b cell lymphoma Male 0 567 0.00 0.00 0.00 0.00
NRAS G12C non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
NRAS G12C non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
NRAS G12C t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
NRAS G12C t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
NRAS G12C retinoblastoma Female 0 23 0.00 0.00 0.00 0.00
NRAS G12C retinoblastoma Male 0 28 0.00 0.00 0.00 0.00
NRAS G12C hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
NRAS G12C hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
NRAS G12C lung cancer Male 0 16 0.00 0.00 0.00 0.03
NRAS G12C blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.06
NRAS G12C peritoneal cancer Female 0 17 0.00 0.00 0.00 0.04
NRAS G12D appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
NRAS G12D appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
NRAS G12D colorectal cancer Female 27 3026 0.01 0.01 0.01 0.01
NRAS G12D colorectal cancer Male 26 3694 0.01 0.01 0.00 0.01
NRAS G12D cancer of unknown primary Female 2 1000 0.00 0.00 0.00 0.00
NRAS G12D cancer of unknown primary Male 1 988 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer Female 5 5722 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer Male 3 4406 0.00 0.00 0.00 0.00
NRAS G12D breast cancer Female 0 9283 0.00 0.00 0.00 0.00
NRAS G12D breast cancer Male 0 48 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma Female 1 1413 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma Male 1 1360 0.00 0.00 0.00 0.00
NRAS G12D pancreatic cancer Female 1 1153 0.00 0.00 0.00 0.00
NRAS G12D pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
NRAS G12D leukemia Female 32 637 0.05 0.05 0.04 0.06
NRAS G12D leukemia Male 39 930 0.04 0.04 0.03 0.06
NRAS G12D melanoma Female 6 1104 0.01 0.01 0.00 0.01
NRAS G12D melanoma Male 11 1742 0.01 0.01 0.00 0.01
NRAS G12D head and neck cancer Female 1 564 0.00 0.00 0.00 0.00
NRAS G12D head and neck cancer Male 2 1179 0.00 0.00 0.00 0.00
NRAS G12D uterine cancer Female 8 2253 0.00 0.00 0.00 0.01
NRAS G12D non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.01
NRAS G12D non-melanoma skin cancers Male 1 330 0.00 0.00 0.00 0.01
NRAS G12D myelodysplastic/myeloproliferative syndromes Female 8 483 0.02 0.02 0.01 0.03
NRAS G12D myelodysplastic/myeloproliferative syndromes Male 12 724 0.02 0.02 0.01 0.03
NRAS G12D adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
NRAS G12D adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.01
NRAS G12D ovarian cancer Female 2 2336 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
NRAS G12D thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
NRAS G12D thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
NRAS G12D cervical cancer Female 0 365 0.00 0.00 0.00 0.00
NRAS G12D hepatobiliary cancer Female 1 636 0.00 0.00 0.00 0.01
NRAS G12D hepatobiliary cancer Male 3 738 0.00 0.00 0.00 0.01
NRAS G12D kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS G12D kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS G12D mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
NRAS G12D mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
NRAS G12D cns cancer Female 0 1994 0.00 0.00 0.00 0.00
NRAS G12D cns cancer Male 1 2569 0.00 0.00 0.00 0.00
NRAS G12D prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
NRAS G12D anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS G12D anal cancer Male 0 47 0.00 0.00 0.00 0.00
NRAS G12D neuroendocrine tumors Female 1 166 0.00 0.00 0.00 0.02
NRAS G12D neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.01
NRAS G12D bladder cancer Female 0 393 0.00 0.00 0.00 0.00
NRAS G12D bladder cancer Male 1 1187 0.00 0.00 0.00 0.00
NRAS G12D b-lymphoblastic leukemia/lymphoma Female 3 106 0.04 0.04 0.01 0.07
NRAS G12D b-lymphoblastic leukemia/lymphoma Male 7 142 0.04 0.04 0.02 0.08
NRAS G12D small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G12D small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
NRAS G12D sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
NRAS G12D sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
NRAS G12D bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS G12D bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS G12D vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G12D thymic tumor Female 0 70 0.00 0.00 0.00 0.00
NRAS G12D thymic tumor Male 0 86 0.00 0.00 0.00 0.00
NRAS G12D ampullary cancer Female 0 41 0.00 0.00 0.00 0.00
NRAS G12D ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
NRAS G12D small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
NRAS G12D small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
NRAS G12D mesothelioma Female 0 145 0.00 0.00 0.00 0.00
NRAS G12D mesothelioma Male 0 352 0.00 0.00 0.00 0.00
NRAS G12D germ cell tumor Female 0 175 0.00 0.00 0.00 0.01
NRAS G12D germ cell tumor Male 2 711 0.00 0.00 0.00 0.01
NRAS G12D nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
NRAS G12D nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
NRAS G12D penile cancer Male 0 25 0.00 0.00 0.00 0.01
NRAS G12D pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
NRAS G12D pineal tumor Male 0 12 0.00 0.00 0.00 0.05
NRAS G12D b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
NRAS G12D b cell lymphoma Male 1 567 0.00 0.00 0.00 0.01
NRAS G12D non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
NRAS G12D non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
NRAS G12D t-lymphoblastic leukemia/lymphoma Female 1 12 0.06 0.04 0.00 0.24
NRAS G12D t-lymphoblastic leukemia/lymphoma Male 0 28 0.02 0.01 0.00 0.08
NRAS G12D retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
NRAS G12D retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
NRAS G12D hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
NRAS G12D hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
NRAS G12D lung cancer Male 0 16 0.00 0.00 0.00 0.04
NRAS G12D blastic plasmacytoid dendritic cell neoplasm Male 2 11 0.19 0.17 0.03 0.45
NRAS G12D peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
NRAS G12F appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
NRAS G12F appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary Female 0 1000 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary Male 0 988 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
NRAS G12F breast cancer Female 0 9283 0.00 0.00 0.00 0.00
NRAS G12F breast cancer Male 0 48 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
NRAS G12F pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
NRAS G12F pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
NRAS G12F leukemia Female 0 637 0.00 0.00 0.00 0.00
NRAS G12F leukemia Male 0 930 0.00 0.00 0.00 0.00
NRAS G12F melanoma Female 0 1104 0.00 0.00 0.00 0.00
NRAS G12F melanoma Male 0 1742 0.00 0.00 0.00 0.00
NRAS G12F head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
NRAS G12F head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
NRAS G12F uterine cancer Female 0 2253 0.00 0.00 0.00 0.00
NRAS G12F non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
NRAS G12F non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
NRAS G12F myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
NRAS G12F myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
NRAS G12F adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
NRAS G12F adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.01
NRAS G12F ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
NRAS G12F thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
NRAS G12F thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
NRAS G12F cervical cancer Female 0 365 0.00 0.00 0.00 0.00
NRAS G12F hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
NRAS G12F hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
NRAS G12F kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS G12F kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS G12F mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
NRAS G12F mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
NRAS G12F cns cancer Female 0 1994 0.00 0.00 0.00 0.00
NRAS G12F cns cancer Male 0 2569 0.00 0.00 0.00 0.00
NRAS G12F prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
NRAS G12F anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS G12F anal cancer Male 0 47 0.00 0.00 0.00 0.00
NRAS G12F neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
NRAS G12F neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
NRAS G12F bladder cancer Female 0 393 0.00 0.00 0.00 0.00
NRAS G12F bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
NRAS G12F b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
NRAS G12F b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
NRAS G12F small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G12F small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
NRAS G12F sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
NRAS G12F sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
NRAS G12F bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS G12F bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS G12F vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G12F thymic tumor Female 0 70 0.00 0.00 0.00 0.00
NRAS G12F thymic tumor Male 0 86 0.00 0.00 0.00 0.00
NRAS G12F ampullary cancer Female 0 41 0.00 0.00 0.00 0.00
NRAS G12F ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
NRAS G12F small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
NRAS G12F small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
NRAS G12F mesothelioma Female 0 145 0.00 0.00 0.00 0.00
NRAS G12F mesothelioma Male 0 352 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor Male 0 711 0.00 0.00 0.00 0.00
NRAS G12F nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
NRAS G12F nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
NRAS G12F penile cancer Male 0 25 0.00 0.00 0.00 0.01
NRAS G12F pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
NRAS G12F pineal tumor Male 0 12 0.00 0.00 0.00 0.05
NRAS G12F b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
NRAS G12F b cell lymphoma Male 0 567 0.00 0.00 0.00 0.00
NRAS G12F non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
NRAS G12F non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
NRAS G12F t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.03
NRAS G12F t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
NRAS G12F retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
NRAS G12F retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
NRAS G12F hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
NRAS G12F hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
NRAS G12F lung cancer Male 0 16 0.00 0.00 0.00 0.04
NRAS G12F blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.05
NRAS G12F peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
NRAS G12R appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
NRAS G12R appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary Female 0 1000 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary Male 0 988 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
NRAS G12R breast cancer Female 0 9283 0.00 0.00 0.00 0.00
NRAS G12R breast cancer Male 0 48 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
NRAS G12R pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
NRAS G12R pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
NRAS G12R leukemia Female 1 637 0.00 0.00 0.00 0.00
NRAS G12R leukemia Male 2 930 0.00 0.00 0.00 0.00
NRAS G12R melanoma Female 1 1104 0.00 0.00 0.00 0.00
NRAS G12R melanoma Male 2 1742 0.00 0.00 0.00 0.00
NRAS G12R head and neck cancer Female 1 564 0.00 0.00 0.00 0.01
NRAS G12R head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
NRAS G12R uterine cancer Female 1 2253 0.00 0.00 0.00 0.00
NRAS G12R non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
NRAS G12R non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
NRAS G12R myelodysplastic/myeloproliferative syndromes Female 2 483 0.00 0.00 0.00 0.01
NRAS G12R myelodysplastic/myeloproliferative syndromes Male 3 724 0.00 0.00 0.00 0.01
NRAS G12R adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
NRAS G12R adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.01
NRAS G12R ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
NRAS G12R thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
NRAS G12R thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
NRAS G12R cervical cancer Female 0 365 0.00 0.00 0.00 0.00
NRAS G12R hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
NRAS G12R hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
NRAS G12R kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS G12R kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS G12R mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
NRAS G12R mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
NRAS G12R cns cancer Female 0 1994 0.00 0.00 0.00 0.00
NRAS G12R cns cancer Male 0 2569 0.00 0.00 0.00 0.00
NRAS G12R prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
NRAS G12R anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS G12R anal cancer Male 0 47 0.00 0.00 0.00 0.00
NRAS G12R neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
NRAS G12R neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
NRAS G12R bladder cancer Female 0 393 0.00 0.00 0.00 0.00
NRAS G12R bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
NRAS G12R b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
NRAS G12R b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
NRAS G12R small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G12R small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
NRAS G12R sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
NRAS G12R sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
NRAS G12R bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS G12R bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS G12R vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G12R thymic tumor Female 0 70 0.00 0.00 0.00 0.00
NRAS G12R thymic tumor Male 0 86 0.00 0.00 0.00 0.00
NRAS G12R ampullary cancer Female 0 41 0.00 0.00 0.00 0.00
NRAS G12R ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
NRAS G12R small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
NRAS G12R small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
NRAS G12R mesothelioma Female 0 145 0.00 0.00 0.00 0.00
NRAS G12R mesothelioma Male 0 352 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor Male 0 711 0.00 0.00 0.00 0.00
NRAS G12R nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
NRAS G12R nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
NRAS G12R penile cancer Male 0 25 0.00 0.00 0.00 0.01
NRAS G12R pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
NRAS G12R pineal tumor Male 0 12 0.00 0.00 0.00 0.05
NRAS G12R b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
NRAS G12R b cell lymphoma Male 1 567 0.00 0.00 0.00 0.01
NRAS G12R non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
NRAS G12R non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
NRAS G12R t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.03
NRAS G12R t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
NRAS G12R retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
NRAS G12R retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
NRAS G12R hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
NRAS G12R hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
NRAS G12R lung cancer Male 0 16 0.00 0.00 0.00 0.04
NRAS G12R blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.05
NRAS G12R peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
NRAS G12S appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
NRAS G12S appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer Male 1 3694 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary Female 0 1000 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary Male 1 988 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer Female 2 5722 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
NRAS G12S breast cancer Female 1 9283 0.00 0.00 0.00 0.00
NRAS G12S breast cancer Male 0 48 0.00 0.00 0.00 0.01
NRAS G12S soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
NRAS G12S soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
NRAS G12S pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
NRAS G12S pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
NRAS G12S leukemia Female 2 637 0.00 0.00 0.00 0.01
NRAS G12S leukemia Male 4 930 0.00 0.00 0.00 0.01
NRAS G12S melanoma Female 2 1104 0.00 0.00 0.00 0.00
NRAS G12S melanoma Male 4 1742 0.00 0.00 0.00 0.00
NRAS G12S head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
NRAS G12S head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
NRAS G12S uterine cancer Female 2 2253 0.00 0.00 0.00 0.00
NRAS G12S non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
NRAS G12S non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
NRAS G12S myelodysplastic/myeloproliferative syndromes Female 2 483 0.01 0.01 0.00 0.01
NRAS G12S myelodysplastic/myeloproliferative syndromes Male 6 724 0.01 0.01 0.00 0.01
NRAS G12S adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
NRAS G12S adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
NRAS G12S ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer Male 1 1297 0.00 0.00 0.00 0.00
NRAS G12S thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
NRAS G12S thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
NRAS G12S cervical cancer Female 0 365 0.00 0.00 0.00 0.00
NRAS G12S hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
NRAS G12S hepatobiliary cancer Male 2 738 0.00 0.00 0.00 0.01
NRAS G12S kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS G12S kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS G12S mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
NRAS G12S mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
NRAS G12S cns cancer Female 0 1994 0.00 0.00 0.00 0.00
NRAS G12S cns cancer Male 1 2569 0.00 0.00 0.00 0.00
NRAS G12S prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
NRAS G12S anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS G12S anal cancer Male 0 47 0.00 0.00 0.00 0.00
NRAS G12S neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
NRAS G12S neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
NRAS G12S bladder cancer Female 0 393 0.00 0.00 0.00 0.00
NRAS G12S bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
NRAS G12S b-lymphoblastic leukemia/lymphoma Female 1 106 0.02 0.01 0.00 0.04
NRAS G12S b-lymphoblastic leukemia/lymphoma Male 3 142 0.02 0.02 0.00 0.04
NRAS G12S small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G12S small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
NRAS G12S sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
NRAS G12S sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
NRAS G12S bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS G12S bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS G12S vaginal cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G12S thymic tumor Female 0 70 0.00 0.00 0.00 0.00
NRAS G12S thymic tumor Male 0 86 0.00 0.00 0.00 0.00
NRAS G12S ampullary cancer Female 0 41 0.00 0.00 0.00 0.00
NRAS G12S ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
NRAS G12S small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
NRAS G12S small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
NRAS G12S mesothelioma Female 0 145 0.00 0.00 0.00 0.00
NRAS G12S mesothelioma Male 0 352 0.00 0.00 0.00 0.00
NRAS G12S germ cell tumor Female 0 175 0.00 0.00 0.00 0.01
NRAS G12S germ cell tumor Male 1 711 0.00 0.00 0.00 0.00
NRAS G12S nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
NRAS G12S nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
NRAS G12S penile cancer Male 0 25 0.00 0.00 0.00 0.02
NRAS G12S pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
NRAS G12S pineal tumor Male 0 12 0.00 0.00 0.00 0.03
NRAS G12S b cell lymphoma Female 1 395 0.00 0.00 0.00 0.01
NRAS G12S b cell lymphoma Male 1 567 0.00 0.00 0.00 0.01
NRAS G12S non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
NRAS G12S non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
NRAS G12S t-lymphoblastic leukemia/lymphoma Female 0 12 0.02 0.01 0.00 0.10
NRAS G12S t-lymphoblastic leukemia/lymphoma Male 1 28 0.03 0.02 0.00 0.11
NRAS G12S retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
NRAS G12S retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
NRAS G12S hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
NRAS G12S hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
NRAS G12S lung cancer Male 0 16 0.00 0.00 0.00 0.04
NRAS G12S blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.04
NRAS G12S peritoneal cancer Female 0 17 0.00 0.00 0.00 0.04
NRAS G12V appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
NRAS G12V appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer Female 3 3026 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer Male 4 3694 0.00 0.00 0.00 0.00
NRAS G12V cancer of unknown primary Female 1 1000 0.00 0.00 0.00 0.00
NRAS G12V cancer of unknown primary Male 2 988 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer Male 3 4406 0.00 0.00 0.00 0.00
NRAS G12V breast cancer Female 0 9283 0.00 0.00 0.00 0.00
NRAS G12V breast cancer Male 0 48 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma Female 1 1413 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
NRAS G12V pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
NRAS G12V pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
NRAS G12V leukemia Female 5 637 0.01 0.01 0.00 0.01
NRAS G12V leukemia Male 3 930 0.00 0.00 0.00 0.01
NRAS G12V melanoma Female 1 1104 0.00 0.00 0.00 0.00
NRAS G12V melanoma Male 2 1742 0.00 0.00 0.00 0.00
NRAS G12V head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
NRAS G12V head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
NRAS G12V uterine cancer Female 1 2253 0.00 0.00 0.00 0.00
NRAS G12V non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
NRAS G12V non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
NRAS G12V myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
NRAS G12V myelodysplastic/myeloproliferative syndromes Male 3 724 0.00 0.00 0.00 0.01
NRAS G12V adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
NRAS G12V adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
NRAS G12V ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
NRAS G12V thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
NRAS G12V thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
NRAS G12V cervical cancer Female 0 365 0.00 0.00 0.00 0.00
NRAS G12V hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
NRAS G12V hepatobiliary cancer Male 1 738 0.00 0.00 0.00 0.00
NRAS G12V kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS G12V kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS G12V mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
NRAS G12V mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
NRAS G12V cns cancer Female 0 1994 0.00 0.00 0.00 0.00
NRAS G12V cns cancer Male 0 2569 0.00 0.00 0.00 0.00
NRAS G12V prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
NRAS G12V anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS G12V anal cancer Male 0 47 0.00 0.00 0.00 0.00
NRAS G12V neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
NRAS G12V neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
NRAS G12V bladder cancer Female 0 393 0.00 0.00 0.00 0.00
NRAS G12V bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
NRAS G12V b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
NRAS G12V b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
NRAS G12V small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G12V small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
NRAS G12V sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
NRAS G12V sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.00
NRAS G12V bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS G12V bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS G12V vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
NRAS G12V thymic tumor Female 0 70 0.00 0.00 0.00 0.00
NRAS G12V thymic tumor Male 0 86 0.00 0.00 0.00 0.00
NRAS G12V ampullary cancer Female 0 41 0.00 0.00 0.00 0.00
NRAS G12V ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
NRAS G12V small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
NRAS G12V small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
NRAS G12V mesothelioma Female 0 145 0.00 0.00 0.00 0.00
NRAS G12V mesothelioma Male 0 352 0.00 0.00 0.00 0.00
NRAS G12V germ cell tumor Female 0 175 0.00 0.00 0.00 0.01
NRAS G12V germ cell tumor Male 2 711 0.00 0.00 0.00 0.01
NRAS G12V nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
NRAS G12V nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
NRAS G12V penile cancer Male 0 25 0.00 0.00 0.00 0.01
NRAS G12V pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
NRAS G12V pineal tumor Male 0 12 0.00 0.00 0.00 0.04
NRAS G12V b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
NRAS G12V b cell lymphoma Male 1 567 0.00 0.00 0.00 0.01
NRAS G12V non-hodgkin lymphoma Female 0 12 0.03 0.02 0.00 0.15
NRAS G12V non-hodgkin lymphoma Male 1 11 0.07 0.05 0.00 0.25
NRAS G12V t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
NRAS G12V t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
NRAS G12V retinoblastoma Female 0 23 0.00 0.00 0.00 0.02
NRAS G12V retinoblastoma Male 0 28 0.00 0.00 0.00 0.02
NRAS G12V hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
NRAS G12V hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
NRAS G12V lung cancer Male 0 16 0.00 0.00 0.00 0.04
NRAS G12V blastic plasmacytoid dendritic cell neoplasm Male 1 11 0.10 0.08 0.00 0.32
NRAS G12V peritoneal cancer Female 0 17 0.00 0.00 0.00 0.02
NRAS G13C appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
NRAS G13C appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer Female 2 3026 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer Male 1 3694 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary Female 0 1000 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary Male 0 988 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
NRAS G13C breast cancer Female 0 9283 0.00 0.00 0.00 0.00
NRAS G13C breast cancer Male 0 48 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
NRAS G13C pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
NRAS G13C pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
NRAS G13C leukemia Female 0 637 0.00 0.00 0.00 0.00
NRAS G13C leukemia Male 1 930 0.00 0.00 0.00 0.00
NRAS G13C melanoma Female 0 1104 0.00 0.00 0.00 0.00
NRAS G13C melanoma Male 4 1742 0.00 0.00 0.00 0.00
NRAS G13C head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
NRAS G13C head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
NRAS G13C uterine cancer Female 0 2253 0.00 0.00 0.00 0.00
NRAS G13C non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
NRAS G13C non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
NRAS G13C myelodysplastic/myeloproliferative syndromes Female 2 483 0.00 0.00 0.00 0.01
NRAS G13C myelodysplastic/myeloproliferative syndromes Male 3 724 0.00 0.00 0.00 0.01
NRAS G13C adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
NRAS G13C adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
NRAS G13C ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
NRAS G13C thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
NRAS G13C thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
NRAS G13C cervical cancer Female 0 365 0.00 0.00 0.00 0.00
NRAS G13C hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
NRAS G13C hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
NRAS G13C kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS G13C kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS G13C mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
NRAS G13C mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
NRAS G13C cns cancer Female 0 1994 0.00 0.00 0.00 0.00
NRAS G13C cns cancer Male 0 2569 0.00 0.00 0.00 0.00
NRAS G13C prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
NRAS G13C anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS G13C anal cancer Male 0 47 0.00 0.00 0.00 0.00
NRAS G13C neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
NRAS G13C neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
NRAS G13C bladder cancer Female 0 393 0.00 0.00 0.00 0.00
NRAS G13C bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
NRAS G13C b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
NRAS G13C b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
NRAS G13C small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G13C small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
NRAS G13C sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
NRAS G13C sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.00
NRAS G13C bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS G13C bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS G13C vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
NRAS G13C thymic tumor Female 0 70 0.00 0.00 0.00 0.00
NRAS G13C thymic tumor Male 0 86 0.00 0.00 0.00 0.00
NRAS G13C ampullary cancer Female 0 41 0.00 0.00 0.00 0.00
NRAS G13C ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
NRAS G13C small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
NRAS G13C small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
NRAS G13C mesothelioma Female 0 145 0.00 0.00 0.00 0.00
NRAS G13C mesothelioma Male 0 352 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor Male 0 711 0.00 0.00 0.00 0.00
NRAS G13C nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
NRAS G13C nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
NRAS G13C penile cancer Male 0 25 0.00 0.00 0.00 0.01
NRAS G13C pheochromocytoma Male 0 17 0.00 0.00 0.00 0.03
NRAS G13C pineal tumor Male 0 12 0.00 0.00 0.00 0.04
NRAS G13C b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
NRAS G13C b cell lymphoma Male 1 567 0.00 0.00 0.00 0.01
NRAS G13C non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
NRAS G13C non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.02
NRAS G13C t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
NRAS G13C t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
NRAS G13C retinoblastoma Female 0 23 0.00 0.00 0.00 0.02
NRAS G13C retinoblastoma Male 0 28 0.00 0.00 0.00 0.02
NRAS G13C hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
NRAS G13C hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
NRAS G13C lung cancer Male 0 16 0.00 0.00 0.00 0.04
NRAS G13C blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.04
NRAS G13C peritoneal cancer Female 0 17 0.00 0.00 0.00 0.02
NRAS G13D appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
NRAS G13D appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer Female 6 3026 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer Male 6 3694 0.00 0.00 0.00 0.00
NRAS G13D cancer of unknown primary Female 0 1000 0.00 0.00 0.00 0.00
NRAS G13D cancer of unknown primary Male 0 988 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
NRAS G13D breast cancer Female 1 9283 0.00 0.00 0.00 0.00
NRAS G13D breast cancer Male 0 48 0.00 0.00 0.00 0.01
NRAS G13D soft tissue sarcoma Female 1 1413 0.00 0.00 0.00 0.00
NRAS G13D soft tissue sarcoma Male 2 1360 0.00 0.00 0.00 0.00
NRAS G13D pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
NRAS G13D pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
NRAS G13D leukemia Female 14 637 0.02 0.02 0.01 0.03
NRAS G13D leukemia Male 18 930 0.02 0.02 0.01 0.03
NRAS G13D melanoma Female 0 1104 0.00 0.00 0.00 0.00
NRAS G13D melanoma Male 8 1742 0.00 0.00 0.00 0.01
NRAS G13D head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
NRAS G13D head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
NRAS G13D uterine cancer Female 1 2253 0.00 0.00 0.00 0.00
NRAS G13D non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
NRAS G13D non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
NRAS G13D myelodysplastic/myeloproliferative syndromes Female 5 483 0.01 0.01 0.00 0.02
NRAS G13D myelodysplastic/myeloproliferative syndromes Male 4 724 0.01 0.01 0.00 0.01
NRAS G13D adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
NRAS G13D adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
NRAS G13D ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
NRAS G13D esophagogastric cancer Female 1 504 0.00 0.00 0.00 0.01
NRAS G13D esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
NRAS G13D thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
NRAS G13D thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
NRAS G13D cervical cancer Female 0 365 0.00 0.00 0.00 0.00
NRAS G13D hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
NRAS G13D hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
NRAS G13D kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS G13D kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS G13D mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
NRAS G13D mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
NRAS G13D cns cancer Female 0 1994 0.00 0.00 0.00 0.00
NRAS G13D cns cancer Male 1 2569 0.00 0.00 0.00 0.00
NRAS G13D prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
NRAS G13D anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS G13D anal cancer Male 0 47 0.00 0.00 0.00 0.00
NRAS G13D neuroendocrine tumors Female 1 166 0.00 0.00 0.00 0.02
NRAS G13D neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.01
NRAS G13D bladder cancer Female 0 393 0.00 0.00 0.00 0.00
NRAS G13D bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
NRAS G13D b-lymphoblastic leukemia/lymphoma Female 3 106 0.03 0.02 0.01 0.06
NRAS G13D b-lymphoblastic leukemia/lymphoma Male 3 142 0.02 0.02 0.01 0.05
NRAS G13D small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G13D small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
NRAS G13D sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
NRAS G13D sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.00
NRAS G13D bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS G13D bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS G13D vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
NRAS G13D thymic tumor Female 0 70 0.00 0.00 0.00 0.00
NRAS G13D thymic tumor Male 0 86 0.00 0.00 0.00 0.00
NRAS G13D ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
NRAS G13D ampullary cancer Male 0 65 0.00 0.00 0.00 0.01
NRAS G13D small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
NRAS G13D small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
NRAS G13D mesothelioma Female 0 145 0.00 0.00 0.00 0.00
NRAS G13D mesothelioma Male 0 352 0.00 0.00 0.00 0.00
NRAS G13D germ cell tumor Female 1 175 0.00 0.00 0.00 0.02
NRAS G13D germ cell tumor Male 0 711 0.00 0.00 0.00 0.00
NRAS G13D nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
NRAS G13D nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
NRAS G13D penile cancer Male 0 25 0.00 0.00 0.00 0.02
NRAS G13D pheochromocytoma Male 0 17 0.00 0.00 0.00 0.04
NRAS G13D pineal tumor Male 0 12 0.00 0.00 0.00 0.06
NRAS G13D b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
NRAS G13D b cell lymphoma Male 2 567 0.00 0.00 0.00 0.01
NRAS G13D non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.02
NRAS G13D non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.02
NRAS G13D t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.01
NRAS G13D t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
NRAS G13D retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
NRAS G13D retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
NRAS G13D hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
NRAS G13D hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
NRAS G13D lung cancer Male 0 16 0.00 0.00 0.00 0.04
NRAS G13D blastic plasmacytoid dendritic cell neoplasm Male 1 11 0.10 0.08 0.00 0.32
NRAS G13D peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
NRAS G13R appendiceal cancer Female 1 174 0.00 0.00 0.00 0.02
NRAS G13R appendiceal cancer Male 0 167 0.00 0.00 0.00 0.01
NRAS G13R colorectal cancer Female 12 3026 0.00 0.00 0.00 0.01
NRAS G13R colorectal cancer Male 7 3694 0.00 0.00 0.00 0.00
NRAS G13R cancer of unknown primary Female 2 1000 0.00 0.00 0.00 0.01
NRAS G13R cancer of unknown primary Male 3 988 0.00 0.00 0.00 0.01
NRAS G13R non-small cell lung cancer Female 0 5722 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer Male 2 4406 0.00 0.00 0.00 0.00
NRAS G13R breast cancer Female 0 9283 0.00 0.00 0.00 0.00
NRAS G13R breast cancer Male 0 48 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
NRAS G13R pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
NRAS G13R pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
NRAS G13R leukemia Female 1 637 0.00 0.00 0.00 0.01
NRAS G13R leukemia Male 6 930 0.01 0.00 0.00 0.01
NRAS G13R melanoma Female 6 1104 0.01 0.01 0.00 0.01
NRAS G13R melanoma Male 14 1742 0.01 0.01 0.00 0.01
NRAS G13R head and neck cancer Female 2 564 0.00 0.00 0.00 0.01
NRAS G13R head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
NRAS G13R uterine cancer Female 0 2253 0.00 0.00 0.00 0.00
NRAS G13R non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
NRAS G13R non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
NRAS G13R myelodysplastic/myeloproliferative syndromes Female 1 483 0.00 0.00 0.00 0.01
NRAS G13R myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
NRAS G13R adrenocortical carcinoma Female 1 80 0.01 0.01 0.00 0.04
NRAS G13R adrenocortical carcinoma Male 0 54 0.01 0.00 0.00 0.03
NRAS G13R ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
NRAS G13R thyroid cancer Female 1 537 0.00 0.00 0.00 0.01
NRAS G13R thyroid cancer Male 1 480 0.00 0.00 0.00 0.01
NRAS G13R cervical cancer Female 0 365 0.00 0.00 0.00 0.00
NRAS G13R hepatobiliary cancer Female 1 636 0.00 0.00 0.00 0.01
NRAS G13R hepatobiliary cancer Male 2 738 0.00 0.00 0.00 0.01
NRAS G13R kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS G13R kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS G13R mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
NRAS G13R mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
NRAS G13R cns cancer Female 0 1994 0.00 0.00 0.00 0.00
NRAS G13R cns cancer Male 0 2569 0.00 0.00 0.00 0.00
NRAS G13R prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
NRAS G13R anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS G13R anal cancer Male 0 47 0.00 0.00 0.00 0.00
NRAS G13R neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
NRAS G13R neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
NRAS G13R bladder cancer Female 0 393 0.00 0.00 0.00 0.00
NRAS G13R bladder cancer Male 2 1187 0.00 0.00 0.00 0.00
NRAS G13R b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.02
NRAS G13R b-lymphoblastic leukemia/lymphoma Male 1 142 0.01 0.00 0.00 0.02
NRAS G13R small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G13R small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
NRAS G13R sex cord stromal tumor Female 1 97 0.01 0.01 0.00 0.04
NRAS G13R sex cord stromal tumor Male 0 10 0.01 0.01 0.00 0.07
NRAS G13R bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS G13R bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS G13R vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
NRAS G13R thymic tumor Female 0 70 0.00 0.00 0.00 0.00
NRAS G13R thymic tumor Male 0 86 0.00 0.00 0.00 0.00
NRAS G13R ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
NRAS G13R ampullary cancer Male 0 65 0.00 0.00 0.00 0.01
NRAS G13R small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
NRAS G13R small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
NRAS G13R mesothelioma Female 0 145 0.00 0.00 0.00 0.00
NRAS G13R mesothelioma Male 0 352 0.00 0.00 0.00 0.00
NRAS G13R germ cell tumor Female 0 175 0.00 0.00 0.00 0.01
NRAS G13R germ cell tumor Male 2 711 0.00 0.00 0.00 0.01
NRAS G13R nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
NRAS G13R nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
NRAS G13R penile cancer Male 0 25 0.00 0.00 0.00 0.02
NRAS G13R pheochromocytoma Male 0 17 0.00 0.00 0.00 0.04
NRAS G13R pineal tumor Male 0 12 0.00 0.00 0.00 0.06
NRAS G13R b cell lymphoma Female 1 395 0.00 0.00 0.00 0.01
NRAS G13R b cell lymphoma Male 0 567 0.00 0.00 0.00 0.00
NRAS G13R non-hodgkin lymphoma Female 0 12 0.03 0.02 0.00 0.14
NRAS G13R non-hodgkin lymphoma Male 1 11 0.07 0.05 0.00 0.25
NRAS G13R t-lymphoblastic leukemia/lymphoma Female 0 12 0.02 0.02 0.00 0.10
NRAS G13R t-lymphoblastic leukemia/lymphoma Male 1 28 0.03 0.02 0.00 0.11
NRAS G13R retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
NRAS G13R retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
NRAS G13R hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
NRAS G13R hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
NRAS G13R lung cancer Male 0 16 0.00 0.00 0.00 0.04
NRAS G13R blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
NRAS G13R peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
NRAS G13V appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
NRAS G13V appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer Female 0 3026 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer Male 0 3694 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary Female 0 1000 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary Male 0 988 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer Female 1 5722 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer Male 0 4406 0.00 0.00 0.00 0.00
NRAS G13V breast cancer Female 0 9283 0.00 0.00 0.00 0.00
NRAS G13V breast cancer Male 0 48 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma Female 0 1413 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma Male 0 1360 0.00 0.00 0.00 0.00
NRAS G13V pancreatic cancer Female 1 1153 0.00 0.00 0.00 0.00
NRAS G13V pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
NRAS G13V leukemia Female 3 637 0.00 0.00 0.00 0.01
NRAS G13V leukemia Male 2 930 0.00 0.00 0.00 0.01
NRAS G13V melanoma Female 1 1104 0.00 0.00 0.00 0.00
NRAS G13V melanoma Male 3 1742 0.00 0.00 0.00 0.00
NRAS G13V head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
NRAS G13V head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
NRAS G13V uterine cancer Female 0 2253 0.00 0.00 0.00 0.00
NRAS G13V non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
NRAS G13V non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
NRAS G13V myelodysplastic/myeloproliferative syndromes Female 1 483 0.00 0.00 0.00 0.01
NRAS G13V myelodysplastic/myeloproliferative syndromes Male 4 724 0.00 0.00 0.00 0.01
NRAS G13V adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
NRAS G13V adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
NRAS G13V ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
NRAS G13V thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
NRAS G13V thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
NRAS G13V cervical cancer Female 0 365 0.00 0.00 0.00 0.00
NRAS G13V hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
NRAS G13V hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
NRAS G13V kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS G13V kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS G13V mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
NRAS G13V mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
NRAS G13V cns cancer Female 0 1994 0.00 0.00 0.00 0.00
NRAS G13V cns cancer Male 0 2569 0.00 0.00 0.00 0.00
NRAS G13V prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
NRAS G13V anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS G13V anal cancer Male 0 47 0.00 0.00 0.00 0.00
NRAS G13V neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
NRAS G13V neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
NRAS G13V bladder cancer Female 0 393 0.00 0.00 0.00 0.00
NRAS G13V bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
NRAS G13V b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.02
NRAS G13V b-lymphoblastic leukemia/lymphoma Male 1 142 0.01 0.00 0.00 0.02
NRAS G13V small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS G13V small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
NRAS G13V sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
NRAS G13V sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
NRAS G13V bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS G13V bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS G13V vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
NRAS G13V thymic tumor Female 0 70 0.00 0.00 0.00 0.00
NRAS G13V thymic tumor Male 0 86 0.00 0.00 0.00 0.00
NRAS G13V ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
NRAS G13V ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
NRAS G13V small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
NRAS G13V small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
NRAS G13V mesothelioma Female 0 145 0.00 0.00 0.00 0.00
NRAS G13V mesothelioma Male 0 352 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor Female 0 175 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor Male 0 711 0.00 0.00 0.00 0.00
NRAS G13V nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
NRAS G13V nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
NRAS G13V penile cancer Male 0 25 0.00 0.00 0.00 0.03
NRAS G13V pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
NRAS G13V pineal tumor Male 0 12 0.00 0.00 0.00 0.05
NRAS G13V b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
NRAS G13V b cell lymphoma Male 0 567 0.00 0.00 0.00 0.00
NRAS G13V non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
NRAS G13V non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
NRAS G13V t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.01
NRAS G13V t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
NRAS G13V retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
NRAS G13V retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
NRAS G13V hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.01
NRAS G13V hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.01
NRAS G13V lung cancer Male 0 16 0.00 0.00 0.00 0.04
NRAS G13V blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
NRAS G13V peritoneal cancer Female 0 17 0.00 0.00 0.00 0.04
NRAS Q61H appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
NRAS Q61H appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
NRAS Q61H colorectal cancer Female 6 3026 0.00 0.00 0.00 0.00
NRAS Q61H colorectal cancer Male 11 3694 0.00 0.00 0.00 0.00
NRAS Q61H cancer of unknown primary Female 1 1000 0.00 0.00 0.00 0.00
NRAS Q61H cancer of unknown primary Male 2 988 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer Female 1 5722 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer Male 3 4406 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer Female 0 9283 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer Male 0 48 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma Female 1 1413 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma Male 2 1360 0.00 0.00 0.00 0.00
NRAS Q61H pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
NRAS Q61H pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
NRAS Q61H leukemia Female 4 637 0.00 0.00 0.00 0.01
NRAS Q61H leukemia Male 3 930 0.00 0.00 0.00 0.01
NRAS Q61H melanoma Female 10 1104 0.01 0.01 0.00 0.01
NRAS Q61H melanoma Male 17 1742 0.01 0.01 0.01 0.01
NRAS Q61H head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
NRAS Q61H head and neck cancer Male 1 1179 0.00 0.00 0.00 0.00
NRAS Q61H uterine cancer Female 4 2253 0.00 0.00 0.00 0.00
NRAS Q61H non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
NRAS Q61H non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
NRAS Q61H myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
NRAS Q61H myelodysplastic/myeloproliferative syndromes Male 1 724 0.00 0.00 0.00 0.00
NRAS Q61H adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
NRAS Q61H adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
NRAS Q61H ovarian cancer Female 0 2336 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer Male 0 1297 0.00 0.00 0.00 0.00
NRAS Q61H thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
NRAS Q61H thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
NRAS Q61H cervical cancer Female 1 365 0.00 0.00 0.00 0.01
NRAS Q61H hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
NRAS Q61H hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
NRAS Q61H kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS Q61H kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS Q61H mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.02
NRAS Q61H mature t and nk neoplasms Male 1 124 0.01 0.00 0.00 0.02
NRAS Q61H cns cancer Female 0 1994 0.00 0.00 0.00 0.00
NRAS Q61H cns cancer Male 0 2569 0.00 0.00 0.00 0.00
NRAS Q61H prostate cancer Male 2 2436 0.00 0.00 0.00 0.00
NRAS Q61H anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS Q61H anal cancer Male 0 47 0.00 0.00 0.00 0.00
NRAS Q61H neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
NRAS Q61H neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
NRAS Q61H bladder cancer Female 0 393 0.00 0.00 0.00 0.00
NRAS Q61H bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
NRAS Q61H b-lymphoblastic leukemia/lymphoma Female 1 106 0.01 0.01 0.00 0.03
NRAS Q61H b-lymphoblastic leukemia/lymphoma Male 1 142 0.01 0.01 0.00 0.02
NRAS Q61H small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS Q61H small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
NRAS Q61H sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
NRAS Q61H sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
NRAS Q61H bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS Q61H bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS Q61H vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
NRAS Q61H thymic tumor Female 0 70 0.00 0.00 0.00 0.00
NRAS Q61H thymic tumor Male 0 86 0.00 0.00 0.00 0.00
NRAS Q61H ampullary cancer Female 0 41 0.00 0.00 0.00 0.00
NRAS Q61H ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
NRAS Q61H small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
NRAS Q61H small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
NRAS Q61H mesothelioma Female 0 145 0.00 0.00 0.00 0.00
NRAS Q61H mesothelioma Male 0 352 0.00 0.00 0.00 0.00
NRAS Q61H germ cell tumor Female 1 175 0.00 0.00 0.00 0.02
NRAS Q61H germ cell tumor Male 2 711 0.00 0.00 0.00 0.01
NRAS Q61H nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
NRAS Q61H nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
NRAS Q61H penile cancer Male 0 25 0.00 0.00 0.00 0.02
NRAS Q61H pheochromocytoma Male 0 17 0.00 0.00 0.00 0.04
NRAS Q61H pineal tumor Male 0 12 0.00 0.00 0.00 0.06
NRAS Q61H b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
NRAS Q61H b cell lymphoma Male 2 567 0.00 0.00 0.00 0.01
NRAS Q61H non-hodgkin lymphoma Female 1 12 0.06 0.04 0.00 0.22
NRAS Q61H non-hodgkin lymphoma Male 0 11 0.04 0.02 0.00 0.16
NRAS Q61H t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
NRAS Q61H t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.02
NRAS Q61H retinoblastoma Female 0 23 0.00 0.00 0.00 0.02
NRAS Q61H retinoblastoma Male 0 28 0.00 0.00 0.00 0.02
NRAS Q61H hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.02
NRAS Q61H hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.01
NRAS Q61H lung cancer Male 1 16 0.07 0.05 0.00 0.23
NRAS Q61H blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.00 0.00 0.00 0.06
NRAS Q61H peritoneal cancer Female 0 17 0.00 0.00 0.00 0.02
NRAS Q61K appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
NRAS Q61K appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
NRAS Q61K colorectal cancer Female 32 3026 0.01 0.01 0.01 0.01
NRAS Q61K colorectal cancer Male 33 3694 0.01 0.01 0.01 0.01
NRAS Q61K cancer of unknown primary Female 4 1000 0.00 0.00 0.00 0.01
NRAS Q61K cancer of unknown primary Male 3 988 0.00 0.00 0.00 0.01
NRAS Q61K non-small cell lung cancer Female 6 5722 0.00 0.00 0.00 0.00
NRAS Q61K non-small cell lung cancer Male 2 4406 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer Female 0 9283 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer Male 0 48 0.00 0.00 0.00 0.00
NRAS Q61K soft tissue sarcoma Female 6 1413 0.00 0.00 0.00 0.01
NRAS Q61K soft tissue sarcoma Male 9 1360 0.01 0.01 0.00 0.01
NRAS Q61K pancreatic cancer Female 2 1153 0.00 0.00 0.00 0.00
NRAS Q61K pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
NRAS Q61K leukemia Female 5 637 0.01 0.01 0.00 0.02
NRAS Q61K leukemia Male 9 930 0.01 0.01 0.00 0.02
NRAS Q61K melanoma Female 74 1104 0.07 0.07 0.06 0.08
NRAS Q61K melanoma Male 125 1742 0.07 0.07 0.06 0.08
NRAS Q61K head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
NRAS Q61K head and neck cancer Male 3 1179 0.00 0.00 0.00 0.01
NRAS Q61K uterine cancer Female 6 2253 0.00 0.00 0.00 0.00
NRAS Q61K non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
NRAS Q61K non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
NRAS Q61K myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
NRAS Q61K myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
NRAS Q61K adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
NRAS Q61K adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
NRAS Q61K ovarian cancer Female 5 2336 0.00 0.00 0.00 0.00
NRAS Q61K esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
NRAS Q61K esophagogastric cancer Male 2 1297 0.00 0.00 0.00 0.00
NRAS Q61K thyroid cancer Female 16 537 0.03 0.03 0.02 0.04
NRAS Q61K thyroid cancer Male 13 480 0.03 0.03 0.02 0.04
NRAS Q61K cervical cancer Female 0 365 0.00 0.00 0.00 0.00
NRAS Q61K hepatobiliary cancer Female 4 636 0.01 0.00 0.00 0.01
NRAS Q61K hepatobiliary cancer Male 3 738 0.00 0.00 0.00 0.01
NRAS Q61K kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS Q61K kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS Q61K mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
NRAS Q61K mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
NRAS Q61K cns cancer Female 3 1994 0.00 0.00 0.00 0.00
NRAS Q61K cns cancer Male 5 2569 0.00 0.00 0.00 0.00
NRAS Q61K prostate cancer Male 1 2436 0.00 0.00 0.00 0.00
NRAS Q61K anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS Q61K anal cancer Male 0 47 0.00 0.00 0.00 0.00
NRAS Q61K neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
NRAS Q61K neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
NRAS Q61K bladder cancer Female 0 393 0.00 0.00 0.00 0.00
NRAS Q61K bladder cancer Male 3 1187 0.00 0.00 0.00 0.01
NRAS Q61K b-lymphoblastic leukemia/lymphoma Female 2 106 0.02 0.01 0.00 0.04
NRAS Q61K b-lymphoblastic leukemia/lymphoma Male 1 142 0.01 0.01 0.00 0.03
NRAS Q61K small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS Q61K small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
NRAS Q61K sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
NRAS Q61K sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
NRAS Q61K bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS Q61K bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS Q61K vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
NRAS Q61K thymic tumor Female 1 70 0.01 0.01 0.00 0.04
NRAS Q61K thymic tumor Male 0 86 0.00 0.00 0.00 0.02
NRAS Q61K ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
NRAS Q61K ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
NRAS Q61K small cell lung cancer Female 0 193 0.00 0.00 0.00 0.01
NRAS Q61K small cell lung cancer Male 1 205 0.00 0.00 0.00 0.02
NRAS Q61K mesothelioma Female 0 145 0.00 0.00 0.00 0.00
NRAS Q61K mesothelioma Male 0 352 0.00 0.00 0.00 0.00
NRAS Q61K germ cell tumor Female 0 175 0.00 0.00 0.00 0.01
NRAS Q61K germ cell tumor Male 3 711 0.00 0.00 0.00 0.01
NRAS Q61K nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
NRAS Q61K nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
NRAS Q61K penile cancer Male 0 25 0.00 0.00 0.00 0.03
NRAS Q61K pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
NRAS Q61K pineal tumor Male 0 12 0.00 0.00 0.00 0.05
NRAS Q61K b cell lymphoma Female 2 395 0.00 0.00 0.00 0.01
NRAS Q61K b cell lymphoma Male 1 567 0.00 0.00 0.00 0.01
NRAS Q61K non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
NRAS Q61K non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
NRAS Q61K t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.01
NRAS Q61K t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
NRAS Q61K retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
NRAS Q61K retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
NRAS Q61K hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.01
NRAS Q61K hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.01
NRAS Q61K lung cancer Male 0 16 0.00 0.00 0.00 0.04
NRAS Q61K blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
NRAS Q61K peritoneal cancer Female 0 17 0.00 0.00 0.00 0.04
NRAS Q61L appendiceal cancer Female 0 174 0.00 0.00 0.00 0.00
NRAS Q61L appendiceal cancer Male 0 167 0.00 0.00 0.00 0.00
NRAS Q61L colorectal cancer Female 12 3026 0.00 0.00 0.00 0.01
NRAS Q61L colorectal cancer Male 10 3694 0.00 0.00 0.00 0.00
NRAS Q61L cancer of unknown primary Female 0 1000 0.00 0.00 0.00 0.00
NRAS Q61L cancer of unknown primary Male 1 988 0.00 0.00 0.00 0.00
NRAS Q61L non-small cell lung cancer Female 18 5722 0.00 0.00 0.00 0.00
NRAS Q61L non-small cell lung cancer Male 14 4406 0.00 0.00 0.00 0.00
NRAS Q61L breast cancer Female 0 9283 0.00 0.00 0.00 0.00
NRAS Q61L breast cancer Male 0 48 0.00 0.00 0.00 0.00
NRAS Q61L soft tissue sarcoma Female 1 1413 0.00 0.00 0.00 0.00
NRAS Q61L soft tissue sarcoma Male 3 1360 0.00 0.00 0.00 0.00
NRAS Q61L pancreatic cancer Female 0 1153 0.00 0.00 0.00 0.00
NRAS Q61L pancreatic cancer Male 0 1340 0.00 0.00 0.00 0.00
NRAS Q61L leukemia Female 2 637 0.00 0.00 0.00 0.01
NRAS Q61L leukemia Male 4 930 0.00 0.00 0.00 0.01
NRAS Q61L melanoma Female 24 1104 0.02 0.02 0.02 0.03
NRAS Q61L melanoma Male 64 1742 0.04 0.04 0.03 0.04
NRAS Q61L head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
NRAS Q61L head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
NRAS Q61L uterine cancer Female 6 2253 0.00 0.00 0.00 0.00
NRAS Q61L non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
NRAS Q61L non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
NRAS Q61L myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
NRAS Q61L myelodysplastic/myeloproliferative syndromes Male 0 724 0.00 0.00 0.00 0.00
NRAS Q61L adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
NRAS Q61L adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
NRAS Q61L ovarian cancer Female 1 2336 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer Male 1 1297 0.00 0.00 0.00 0.00
NRAS Q61L thyroid cancer Female 0 537 0.00 0.00 0.00 0.00
NRAS Q61L thyroid cancer Male 0 480 0.00 0.00 0.00 0.00
NRAS Q61L cervical cancer Female 0 365 0.00 0.00 0.00 0.00
NRAS Q61L hepatobiliary cancer Female 0 636 0.00 0.00 0.00 0.00
NRAS Q61L hepatobiliary cancer Male 0 738 0.00 0.00 0.00 0.00
NRAS Q61L kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS Q61L kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS Q61L mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.00
NRAS Q61L mature t and nk neoplasms Male 0 124 0.00 0.00 0.00 0.00
NRAS Q61L cns cancer Female 1 1994 0.00 0.00 0.00 0.00
NRAS Q61L cns cancer Male 4 2569 0.00 0.00 0.00 0.00
NRAS Q61L prostate cancer Male 0 2436 0.00 0.00 0.00 0.00
NRAS Q61L anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS Q61L anal cancer Male 0 47 0.00 0.00 0.00 0.00
NRAS Q61L neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.00
NRAS Q61L neuroendocrine tumors Male 0 193 0.00 0.00 0.00 0.00
NRAS Q61L bladder cancer Female 0 393 0.00 0.00 0.00 0.00
NRAS Q61L bladder cancer Male 0 1187 0.00 0.00 0.00 0.00
NRAS Q61L b-lymphoblastic leukemia/lymphoma Female 0 106 0.00 0.00 0.00 0.00
NRAS Q61L b-lymphoblastic leukemia/lymphoma Male 0 142 0.00 0.00 0.00 0.00
NRAS Q61L small bowel cancer Female 0 78 0.00 0.00 0.00 0.00
NRAS Q61L small bowel cancer Male 0 132 0.00 0.00 0.00 0.00
NRAS Q61L sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
NRAS Q61L sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
NRAS Q61L bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS Q61L bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS Q61L vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
NRAS Q61L thymic tumor Female 0 70 0.00 0.00 0.00 0.00
NRAS Q61L thymic tumor Male 0 86 0.00 0.00 0.00 0.00
NRAS Q61L ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
NRAS Q61L ampullary cancer Male 0 65 0.00 0.00 0.00 0.00
NRAS Q61L small cell lung cancer Female 0 193 0.00 0.00 0.00 0.01
NRAS Q61L small cell lung cancer Male 1 205 0.00 0.00 0.00 0.02
NRAS Q61L mesothelioma Female 0 145 0.00 0.00 0.00 0.00
NRAS Q61L mesothelioma Male 0 352 0.00 0.00 0.00 0.00
NRAS Q61L germ cell tumor Female 1 175 0.00 0.00 0.00 0.02
NRAS Q61L germ cell tumor Male 0 711 0.00 0.00 0.00 0.00
NRAS Q61L nerve sheath tumor Female 0 80 0.00 0.00 0.00 0.00
NRAS Q61L nerve sheath tumor Male 0 74 0.00 0.00 0.00 0.00
NRAS Q61L penile cancer Male 0 25 0.00 0.00 0.00 0.03
NRAS Q61L pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
NRAS Q61L pineal tumor Male 0 12 0.00 0.00 0.00 0.05
NRAS Q61L b cell lymphoma Female 0 395 0.00 0.00 0.00 0.00
NRAS Q61L b cell lymphoma Male 1 567 0.00 0.00 0.00 0.00
NRAS Q61L non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.03
NRAS Q61L non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.03
NRAS Q61L t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.01
NRAS Q61L t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
NRAS Q61L retinoblastoma Female 0 23 0.00 0.00 0.00 0.01
NRAS Q61L retinoblastoma Male 0 28 0.00 0.00 0.00 0.01
NRAS Q61L hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.01
NRAS Q61L hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.01
NRAS Q61L lung cancer Male 0 16 0.00 0.00 0.00 0.04
NRAS Q61L blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
NRAS Q61L peritoneal cancer Female 0 17 0.00 0.00 0.00 0.04
NRAS Q61R appendiceal cancer Female 2 174 0.02 0.01 0.00 0.03
NRAS Q61R appendiceal cancer Male 3 167 0.02 0.02 0.00 0.04
NRAS Q61R colorectal cancer Female 25 3026 0.01 0.01 0.00 0.01
NRAS Q61R colorectal cancer Male 21 3694 0.01 0.01 0.00 0.01
NRAS Q61R cancer of unknown primary Female 3 1000 0.00 0.00 0.00 0.01
NRAS Q61R cancer of unknown primary Male 5 988 0.00 0.00 0.00 0.01
NRAS Q61R non-small cell lung cancer Female 6 5722 0.00 0.00 0.00 0.00
NRAS Q61R non-small cell lung cancer Male 9 4406 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer Female 0 9283 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer Male 0 48 0.00 0.00 0.00 0.00
NRAS Q61R soft tissue sarcoma Female 2 1413 0.00 0.00 0.00 0.00
NRAS Q61R soft tissue sarcoma Male 4 1360 0.00 0.00 0.00 0.00
NRAS Q61R pancreatic cancer Female 3 1153 0.00 0.00 0.00 0.01
NRAS Q61R pancreatic cancer Male 4 1340 0.00 0.00 0.00 0.01
NRAS Q61R leukemia Female 8 637 0.01 0.01 0.01 0.02
NRAS Q61R leukemia Male 9 930 0.01 0.01 0.01 0.02
NRAS Q61R melanoma Female 82 1104 0.08 0.08 0.06 0.09
NRAS Q61R melanoma Male 164 1742 0.09 0.09 0.08 0.11
NRAS Q61R head and neck cancer Female 0 564 0.00 0.00 0.00 0.00
NRAS Q61R head and neck cancer Male 0 1179 0.00 0.00 0.00 0.00
NRAS Q61R uterine cancer Female 9 2253 0.00 0.00 0.00 0.01
NRAS Q61R non-melanoma skin cancers Female 0 183 0.00 0.00 0.00 0.00
NRAS Q61R non-melanoma skin cancers Male 0 330 0.00 0.00 0.00 0.00
NRAS Q61R myelodysplastic/myeloproliferative syndromes Female 0 483 0.00 0.00 0.00 0.00
NRAS Q61R myelodysplastic/myeloproliferative syndromes Male 2 724 0.00 0.00 0.00 0.01
NRAS Q61R adrenocortical carcinoma Female 0 80 0.00 0.00 0.00 0.00
NRAS Q61R adrenocortical carcinoma Male 0 54 0.00 0.00 0.00 0.00
NRAS Q61R ovarian cancer Female 25 2336 0.01 0.01 0.01 0.02
NRAS Q61R esophagogastric cancer Female 0 504 0.00 0.00 0.00 0.00
NRAS Q61R esophagogastric cancer Male 3 1297 0.00 0.00 0.00 0.00
NRAS Q61R thyroid cancer Female 48 537 0.09 0.09 0.07 0.11
NRAS Q61R thyroid cancer Male 47 480 0.10 0.10 0.08 0.12
NRAS Q61R cervical cancer Female 1 365 0.00 0.00 0.00 0.01
NRAS Q61R hepatobiliary cancer Female 5 636 0.01 0.01 0.00 0.01
NRAS Q61R hepatobiliary cancer Male 4 738 0.01 0.01 0.00 0.01
NRAS Q61R kidney cancer Female 0 420 0.00 0.00 0.00 0.00
NRAS Q61R kidney cancer Male 0 1002 0.00 0.00 0.00 0.00
NRAS Q61R mature t and nk neoplasms Female 0 107 0.00 0.00 0.00 0.02
NRAS Q61R mature t and nk neoplasms Male 1 124 0.01 0.00 0.00 0.02
NRAS Q61R cns cancer Female 3 1994 0.00 0.00 0.00 0.00
NRAS Q61R cns cancer Male 4 2569 0.00 0.00 0.00 0.00
NRAS Q61R prostate cancer Male 1 2436 0.00 0.00 0.00 0.00
NRAS Q61R anal cancer Female 0 102 0.00 0.00 0.00 0.00
NRAS Q61R anal cancer Male 0 47 0.00 0.00 0.00 0.00
NRAS Q61R neuroendocrine tumors Female 0 166 0.00 0.00 0.00 0.01
NRAS Q61R neuroendocrine tumors Male 1 193 0.00 0.00 0.00 0.02
NRAS Q61R bladder cancer Female 2 393 0.00 0.00 0.00 0.01
NRAS Q61R bladder cancer Male 1 1187 0.00 0.00 0.00 0.00
NRAS Q61R b-lymphoblastic leukemia/lymphoma Female 1 106 0.01 0.01 0.00 0.03
NRAS Q61R b-lymphoblastic leukemia/lymphoma Male 1 142 0.01 0.01 0.00 0.02
NRAS Q61R small bowel cancer Female 1 78 0.01 0.01 0.00 0.04
NRAS Q61R small bowel cancer Male 1 132 0.01 0.01 0.00 0.03
NRAS Q61R sex cord stromal tumor Female 0 97 0.00 0.00 0.00 0.00
NRAS Q61R sex cord stromal tumor Male 0 10 0.00 0.00 0.00 0.01
NRAS Q61R bone cancer Female 0 242 0.00 0.00 0.00 0.00
NRAS Q61R bone cancer Male 0 328 0.00 0.00 0.00 0.00
NRAS Q61R vaginal cancer Female 0 78 0.00 0.00 0.00 0.01
NRAS Q61R thymic tumor Female 0 70 0.00 0.00 0.00 0.00
NRAS Q61R thymic tumor Male 0 86 0.00 0.00 0.00 0.00
NRAS Q61R ampullary cancer Female 0 41 0.00 0.00 0.00 0.01
NRAS Q61R ampullary cancer Male 0 65 0.00 0.00 0.00 0.01
NRAS Q61R small cell lung cancer Female 0 193 0.00 0.00 0.00 0.00
NRAS Q61R small cell lung cancer Male 0 205 0.00 0.00 0.00 0.00
NRAS Q61R mesothelioma Female 0 145 0.00 0.00 0.00 0.01
NRAS Q61R mesothelioma Male 1 352 0.00 0.00 0.00 0.01
NRAS Q61R germ cell tumor Female 0 175 0.00 0.00 0.00 0.01
NRAS Q61R germ cell tumor Male 3 711 0.00 0.00 0.00 0.01
NRAS Q61R nerve sheath tumor Female 1 80 0.01 0.01 0.00 0.04
NRAS Q61R nerve sheath tumor Male 1 74 0.02 0.01 0.00 0.04
NRAS Q61R penile cancer Male 0 25 0.00 0.00 0.00 0.02
NRAS Q61R pheochromocytoma Male 0 17 0.00 0.00 0.00 0.02
NRAS Q61R pineal tumor Male 0 12 0.00 0.00 0.00 0.03
NRAS Q61R b cell lymphoma Female 2 395 0.01 0.01 0.00 0.01
NRAS Q61R b cell lymphoma Male 4 567 0.01 0.01 0.00 0.01
NRAS Q61R non-hodgkin lymphoma Female 0 12 0.00 0.00 0.00 0.04
NRAS Q61R non-hodgkin lymphoma Male 0 11 0.00 0.00 0.00 0.04
NRAS Q61R t-lymphoblastic leukemia/lymphoma Female 0 12 0.00 0.00 0.00 0.02
NRAS Q61R t-lymphoblastic leukemia/lymphoma Male 0 28 0.00 0.00 0.00 0.01
NRAS Q61R retinoblastoma Female 0 23 0.00 0.00 0.00 0.02
NRAS Q61R retinoblastoma Male 0 28 0.00 0.00 0.00 0.02
NRAS Q61R hodgkin lymphoma Female 0 16 0.00 0.00 0.00 0.03
NRAS Q61R hodgkin lymphoma Male 0 24 0.00 0.00 0.00 0.02
NRAS Q61R lung cancer Male 0 16 0.00 0.00 0.00 0.04
NRAS Q61R blastic plasmacytoid dendritic cell neoplasm Male 0 11 0.01 0.00 0.00 0.07
NRAS Q61R peritoneal cancer Female 0 17 0.00 0.00 0.00 0.03
KRAS G12A appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.01
KRAS G12A appendiceal cancer Tumor Type:NA/Heme 0 10 0.01 0.00 0.00 0.04
KRAS G12A appendiceal cancer Primary 1 151 0.00 0.00 0.00 0.02
KRAS G12A colorectal cancer Metastasis 51 2354 0.02 0.02 0.02 0.03
KRAS G12A colorectal cancer Tumor Type:NA/Heme 6 224 0.02 0.02 0.02 0.03
KRAS G12A colorectal cancer Primary 88 4115 0.02 0.02 0.02 0.03
KRAS G12A colorectal cancer Tumor Type:Unspecified 0 31 0.02 0.02 0.01 0.03
KRAS G12A cancer of unknown primary Metastasis 13 1389 0.01 0.01 0.00 0.01
KRAS G12A cancer of unknown primary Tumor Type:NA/Heme 1 229 0.00 0.00 0.00 0.01
KRAS G12A cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.01
KRAS G12A cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.02
KRAS G12A non-small cell lung cancer Metastasis 70 3750 0.02 0.02 0.02 0.02
KRAS G12A non-small cell lung cancer Tumor Type:NA/Heme 2 223 0.02 0.02 0.01 0.03
KRAS G12A non-small cell lung cancer Primary 153 6059 0.02 0.02 0.02 0.03
KRAS G12A non-small cell lung cancer Tumor Type:Unspecified 1 99 0.02 0.02 0.01 0.03
KRAS G12A breast cancer Metastasis 2 3094 0.00 0.00 0.00 0.00
KRAS G12A breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
KRAS G12A breast cancer Primary 4 6125 0.00 0.00 0.00 0.00
KRAS G12A soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
KRAS G12A soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
KRAS G12A soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
KRAS G12A soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
KRAS G12A pancreatic cancer Metastasis 3 981 0.00 0.00 0.00 0.01
KRAS G12A pancreatic cancer Tumor Type:NA/Heme 1 75 0.01 0.01 0.00 0.02
KRAS G12A pancreatic cancer Primary 9 1429 0.01 0.01 0.00 0.01
KRAS G12A leukemia Metastasis 0 15 0.00 0.00 0.00 0.01
KRAS G12A leukemia Tumor Type:NA/Heme 3 923 0.00 0.00 0.00 0.01
KRAS G12A leukemia Primary 2 412 0.00 0.00 0.00 0.01
KRAS G12A leukemia Tumor Type:Unspecified 0 217 0.00 0.00 0.00 0.01
KRAS G12A melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
KRAS G12A melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
KRAS G12A melanoma Primary 1 898 0.00 0.00 0.00 0.00
KRAS G12A melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
KRAS G12A head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
KRAS G12A head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.01
KRAS G12A head and neck cancer Primary 1 938 0.00 0.00 0.00 0.00
KRAS G12A uterine cancer Metastasis 6 586 0.01 0.01 0.00 0.02
KRAS G12A uterine cancer Tumor Type:NA/Heme 0 76 0.01 0.01 0.00 0.03
KRAS G12A uterine cancer Primary 21 1541 0.01 0.01 0.01 0.02
KRAS G12A uterine cancer Tumor Type:Unspecified 4 51 0.04 0.03 0.01 0.13
KRAS G12A non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G12A non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
KRAS G12A non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
KRAS G12A myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.02
KRAS G12A myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
KRAS G12A myelodysplastic/myeloproliferative syndromes Primary 1 250 0.00 0.00 0.00 0.01
KRAS G12A myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
KRAS G12A adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.01
KRAS G12A adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
KRAS G12A ovarian cancer Metastasis 3 1088 0.00 0.00 0.00 0.01
KRAS G12A ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.01
KRAS G12A ovarian cancer Primary 10 1060 0.01 0.01 0.00 0.01
KRAS G12A ovarian cancer Tumor Type:Unspecified 1 28 0.01 0.01 0.00 0.07
KRAS G12A esophagogastric cancer Metastasis 1 462 0.00 0.00 0.00 0.01
KRAS G12A esophagogastric cancer Tumor Type:NA/Heme 1 43 0.01 0.00 0.00 0.03
KRAS G12A esophagogastric cancer Primary 4 1283 0.00 0.00 0.00 0.01
KRAS G12A esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.02
KRAS G12A thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
KRAS G12A thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
KRAS G12A thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
KRAS G12A cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.01
KRAS G12A cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.03
KRAS G12A cervical cancer Primary 1 211 0.00 0.00 0.00 0.01
KRAS G12A hepatobiliary cancer Metastasis 3 438 0.01 0.01 0.00 0.01
KRAS G12A hepatobiliary cancer Tumor Type:NA/Heme 1 34 0.01 0.01 0.00 0.05
KRAS G12A hepatobiliary cancer Primary 3 895 0.00 0.00 0.00 0.01
KRAS G12A kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
KRAS G12A kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
KRAS G12A kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
KRAS G12A mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
KRAS G12A mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
KRAS G12A mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
KRAS G12A cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
KRAS G12A cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
KRAS G12A cns cancer Primary 6 3522 0.00 0.00 0.00 0.00
KRAS G12A cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
KRAS G12A prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
KRAS G12A prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
KRAS G12A prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
KRAS G12A prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
KRAS G12A anal cancer Metastasis 1 59 0.01 0.01 0.00 0.05
KRAS G12A anal cancer Primary 0 84 0.01 0.00 0.00 0.02
KRAS G12A neuroendocrine tumors Metastasis 1 143 0.00 0.00 0.00 0.02
KRAS G12A neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.02
KRAS G12A neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.01
KRAS G12A bladder cancer Metastasis 0 390 0.00 0.00 0.00 0.00
KRAS G12A bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
KRAS G12A bladder cancer Primary 3 1164 0.00 0.00 0.00 0.01
KRAS G12A b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.01 0.00 0.00 0.03
KRAS G12A b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.02
KRAS G12A b-lymphoblastic leukemia/lymphoma Primary 1 101 0.01 0.00 0.00 0.02
KRAS G12A b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.02
KRAS G12A small bowel cancer Metastasis 3 78 0.03 0.02 0.01 0.07
KRAS G12A small bowel cancer Primary 1 128 0.02 0.01 0.00 0.04
KRAS G12A sex cord stromal tumor Metastasis 0 49 0.00 0.00 0.00 0.00
KRAS G12A sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
KRAS G12A bone cancer Metastasis 1 203 0.00 0.00 0.00 0.01
KRAS G12A bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
KRAS G12A bone cancer Primary 1 326 0.00 0.00 0.00 0.01
KRAS G12A bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.02
KRAS G12A vaginal cancer Metastasis 1 16 0.05 0.03 0.00 0.19
KRAS G12A vaginal cancer Primary 0 60 0.01 0.00 0.00 0.04
KRAS G12A thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS G12A thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS G12A ampullary cancer Metastasis 0 23 0.01 0.00 0.00 0.04
KRAS G12A ampullary cancer Primary 1 82 0.01 0.01 0.00 0.04
KRAS G12A small cell lung cancer Metastasis 1 207 0.00 0.00 0.00 0.02
KRAS G12A small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.01
KRAS G12A mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS G12A mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS G12A germ cell tumor Metastasis 2 274 0.01 0.01 0.00 0.02
KRAS G12A germ cell tumor Tumor Type:NA/Heme 0 81 0.01 0.01 0.00 0.02
KRAS G12A germ cell tumor Primary 5 517 0.01 0.01 0.00 0.02
KRAS G12A germ cell tumor Tumor Type:Unspecified 0 14 0.01 0.01 0.00 0.02
KRAS G12A nerve sheath tumor Metastasis 1 16 0.04 0.02 0.00 0.18
KRAS G12A nerve sheath tumor Tumor Type:NA/Heme 0 17 0.01 0.00 0.00 0.05
KRAS G12A nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.02
KRAS G12A penile cancer Metastasis 0 11 0.00 0.00 0.00 0.04
KRAS G12A penile cancer Primary 0 13 0.00 0.00 0.00 0.04
KRAS G12A pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.03
KRAS G12A pineal tumor Primary 0 14 0.00 0.00 0.00 0.03
KRAS G12A b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
KRAS G12A b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.01
KRAS G12A b cell lymphoma Primary 2 709 0.00 0.00 0.00 0.01
KRAS G12A b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
KRAS G12A non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
KRAS G12A t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
KRAS G12A t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
KRAS G12A retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
KRAS G12A retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
KRAS G12A hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
KRAS G12A lung cancer Primary 0 17 0.00 0.00 0.00 0.04
KRAS G12A parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
KRAS G12C appendiceal cancer Metastasis 6 174 0.03 0.03 0.01 0.06
KRAS G12C appendiceal cancer Tumor Type:NA/Heme 0 10 0.03 0.02 0.00 0.07
KRAS G12C appendiceal cancer Primary 3 151 0.02 0.02 0.01 0.05
KRAS G12C colorectal cancer Metastasis 108 2354 0.04 0.04 0.04 0.05
KRAS G12C colorectal cancer Tumor Type:NA/Heme 9 224 0.04 0.04 0.02 0.06
KRAS G12C colorectal cancer Primary 95 4115 0.02 0.02 0.02 0.03
KRAS G12C colorectal cancer Tumor Type:Unspecified 0 31 0.03 0.03 0.00 0.06
KRAS G12C cancer of unknown primary Metastasis 47 1389 0.03 0.03 0.02 0.04
KRAS G12C cancer of unknown primary Tumor Type:NA/Heme 5 229 0.03 0.03 0.01 0.04
KRAS G12C cancer of unknown primary Primary 6 311 0.03 0.03 0.01 0.04
KRAS G12C cancer of unknown primary Tumor Type:Unspecified 3 60 0.03 0.03 0.02 0.06
KRAS G12C non-small cell lung cancer Metastasis 407 3750 0.11 0.11 0.10 0.12
KRAS G12C non-small cell lung cancer Tumor Type:NA/Heme 19 223 0.10 0.10 0.07 0.13
KRAS G12C non-small cell lung cancer Primary 779 6059 0.13 0.13 0.12 0.14
KRAS G12C non-small cell lung cancer Tumor Type:Unspecified 8 99 0.10 0.10 0.06 0.14
KRAS G12C breast cancer Metastasis 6 3094 0.00 0.00 0.00 0.00
KRAS G12C breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.01
KRAS G12C breast cancer Primary 2 6125 0.00 0.00 0.00 0.00
KRAS G12C soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
KRAS G12C soft tissue sarcoma Tumor Type:NA/Heme 1 119 0.00 0.00 0.00 0.02
KRAS G12C soft tissue sarcoma Primary 4 1686 0.00 0.00 0.00 0.00
KRAS G12C soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.01
KRAS G12C pancreatic cancer Metastasis 7 981 0.01 0.01 0.00 0.01
KRAS G12C pancreatic cancer Tumor Type:NA/Heme 1 75 0.01 0.01 0.00 0.02
KRAS G12C pancreatic cancer Primary 14 1429 0.01 0.01 0.01 0.01
KRAS G12C leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
KRAS G12C leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
KRAS G12C leukemia Primary 0 412 0.00 0.00 0.00 0.00
KRAS G12C leukemia Tumor Type:Unspecified 0 217 0.00 0.00 0.00 0.00
KRAS G12C melanoma Metastasis 1 1738 0.00 0.00 0.00 0.00
KRAS G12C melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
KRAS G12C melanoma Primary 1 898 0.00 0.00 0.00 0.00
KRAS G12C melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
KRAS G12C head and neck cancer Metastasis 1 731 0.00 0.00 0.00 0.00
KRAS G12C head and neck cancer Tumor Type:NA/Heme 1 67 0.01 0.00 0.00 0.04
KRAS G12C head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
KRAS G12C uterine cancer Metastasis 5 586 0.01 0.01 0.00 0.02
KRAS G12C uterine cancer Tumor Type:NA/Heme 0 76 0.01 0.01 0.00 0.02
KRAS G12C uterine cancer Primary 21 1541 0.01 0.01 0.01 0.02
KRAS G12C uterine cancer Tumor Type:Unspecified 0 51 0.01 0.01 0.00 0.02
KRAS G12C non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G12C non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
KRAS G12C non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
KRAS G12C myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
KRAS G12C myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
KRAS G12C myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
KRAS G12C myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
KRAS G12C adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
KRAS G12C adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.01
KRAS G12C ovarian cancer Metastasis 5 1088 0.00 0.00 0.00 0.01
KRAS G12C ovarian cancer Tumor Type:NA/Heme 1 160 0.00 0.00 0.00 0.01
KRAS G12C ovarian cancer Primary 3 1060 0.00 0.00 0.00 0.01
KRAS G12C ovarian cancer Tumor Type:Unspecified 1 28 0.01 0.00 0.00 0.03
KRAS G12C esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
KRAS G12C esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.01
KRAS G12C esophagogastric cancer Primary 5 1283 0.00 0.00 0.00 0.01
KRAS G12C esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.02
KRAS G12C thyroid cancer Metastasis 1 402 0.00 0.00 0.00 0.01
KRAS G12C thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.01
KRAS G12C thyroid cancer Primary 1 582 0.00 0.00 0.00 0.01
KRAS G12C cervical cancer Metastasis 1 136 0.00 0.00 0.00 0.02
KRAS G12C cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.03
KRAS G12C cervical cancer Primary 0 211 0.00 0.00 0.00 0.01
KRAS G12C hepatobiliary cancer Metastasis 6 438 0.01 0.01 0.00 0.02
KRAS G12C hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.01 0.01 0.00 0.02
KRAS G12C hepatobiliary cancer Primary 4 895 0.01 0.01 0.00 0.01
KRAS G12C kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
KRAS G12C kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.01
KRAS G12C kidney cancer Primary 1 944 0.00 0.00 0.00 0.00
KRAS G12C mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
KRAS G12C mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
KRAS G12C mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
KRAS G12C cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
KRAS G12C cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
KRAS G12C cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
KRAS G12C cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
KRAS G12C prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
KRAS G12C prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
KRAS G12C prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
KRAS G12C prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
KRAS G12C anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
KRAS G12C anal cancer Primary 0 84 0.00 0.00 0.00 0.00
KRAS G12C neuroendocrine tumors Metastasis 1 143 0.01 0.00 0.00 0.02
KRAS G12C neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.01 0.00 0.00 0.02
KRAS G12C neuroendocrine tumors Primary 1 196 0.01 0.00 0.00 0.02
KRAS G12C bladder cancer Metastasis 4 390 0.01 0.01 0.00 0.02
KRAS G12C bladder cancer Tumor Type:NA/Heme 0 25 0.01 0.00 0.00 0.02
KRAS G12C bladder cancer Primary 4 1164 0.00 0.00 0.00 0.01
KRAS G12C b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
KRAS G12C b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
KRAS G12C b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
KRAS G12C b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
KRAS G12C small bowel cancer Metastasis 3 78 0.04 0.04 0.01 0.08
KRAS G12C small bowel cancer Primary 5 128 0.04 0.04 0.02 0.07
KRAS G12C sex cord stromal tumor Metastasis 0 49 0.00 0.00 0.00 0.01
KRAS G12C sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
KRAS G12C bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G12C bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS G12C bone cancer Primary 0 326 0.00 0.00 0.00 0.00
KRAS G12C bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
KRAS G12C vaginal cancer Metastasis 0 16 0.01 0.01 0.00 0.06
KRAS G12C vaginal cancer Primary 1 60 0.02 0.01 0.00 0.06
KRAS G12C thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS G12C thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS G12C ampullary cancer Metastasis 1 23 0.04 0.04 0.01 0.11
KRAS G12C ampullary cancer Primary 3 82 0.04 0.04 0.01 0.08
KRAS G12C small cell lung cancer Metastasis 2 207 0.01 0.01 0.00 0.02
KRAS G12C small cell lung cancer Primary 1 183 0.01 0.01 0.00 0.02
KRAS G12C mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS G12C mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS G12C germ cell tumor Metastasis 3 274 0.01 0.01 0.00 0.02
KRAS G12C germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.01
KRAS G12C germ cell tumor Primary 1 517 0.00 0.00 0.00 0.01
KRAS G12C germ cell tumor Tumor Type:Unspecified 0 14 0.01 0.00 0.00 0.02
KRAS G12C nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.01
KRAS G12C nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.01
KRAS G12C nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
KRAS G12C penile cancer Metastasis 0 11 0.00 0.00 0.00 0.02
KRAS G12C penile cancer Primary 0 13 0.00 0.00 0.00 0.02
KRAS G12C pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
KRAS G12C pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
KRAS G12C b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
KRAS G12C b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
KRAS G12C b cell lymphoma Primary 0 709 0.00 0.00 0.00 0.00
KRAS G12C b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
KRAS G12C non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.02
KRAS G12C t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
KRAS G12C t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
KRAS G12C retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
KRAS G12C retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
KRAS G12C hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
KRAS G12C lung cancer Primary 1 17 0.06 0.05 0.00 0.21
KRAS G12C parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.06
KRAS G12D appendiceal cancer Metastasis 42 174 0.25 0.25 0.19 0.31
KRAS G12D appendiceal cancer Tumor Type:NA/Heme 1 10 0.23 0.25 0.06 0.36
KRAS G12D appendiceal cancer Primary 48 151 0.30 0.29 0.23 0.37
KRAS G12D colorectal cancer Metastasis 307 2354 0.13 0.13 0.12 0.14
KRAS G12D colorectal cancer Tumor Type:NA/Heme 28 224 0.13 0.13 0.11 0.15
KRAS G12D colorectal cancer Primary 545 4115 0.13 0.13 0.12 0.14
KRAS G12D colorectal cancer Tumor Type:Unspecified 5 31 0.13 0.13 0.11 0.17
KRAS G12D cancer of unknown primary Metastasis 69 1389 0.05 0.05 0.04 0.06
KRAS G12D cancer of unknown primary Tumor Type:NA/Heme 23 229 0.09 0.09 0.05 0.13
KRAS G12D cancer of unknown primary Primary 15 311 0.05 0.05 0.03 0.07
KRAS G12D cancer of unknown primary Tumor Type:Unspecified 0 60 0.03 0.03 0.00 0.07
KRAS G12D non-small cell lung cancer Metastasis 130 3750 0.04 0.04 0.03 0.04
KRAS G12D non-small cell lung cancer Tumor Type:NA/Heme 8 223 0.04 0.04 0.02 0.06
KRAS G12D non-small cell lung cancer Primary 290 6059 0.05 0.05 0.04 0.05
KRAS G12D non-small cell lung cancer Tumor Type:Unspecified 4 99 0.04 0.04 0.02 0.06
KRAS G12D breast cancer Metastasis 4 3094 0.00 0.00 0.00 0.00
KRAS G12D breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
KRAS G12D breast cancer Primary 7 6125 0.00 0.00 0.00 0.00
KRAS G12D soft tissue sarcoma Metastasis 4 939 0.00 0.00 0.00 0.01
KRAS G12D soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.01
KRAS G12D soft tissue sarcoma Primary 7 1686 0.00 0.00 0.00 0.01
KRAS G12D soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.01
KRAS G12D pancreatic cancer Metastasis 311 981 0.32 0.32 0.29 0.34
KRAS G12D pancreatic cancer Tumor Type:NA/Heme 24 75 0.32 0.32 0.26 0.37
KRAS G12D pancreatic cancer Primary 445 1429 0.31 0.31 0.29 0.33
KRAS G12D leukemia Metastasis 0 15 0.01 0.01 0.00 0.03
KRAS G12D leukemia Tumor Type:NA/Heme 13 923 0.01 0.01 0.01 0.02
KRAS G12D leukemia Primary 6 412 0.01 0.01 0.01 0.02
KRAS G12D leukemia Tumor Type:Unspecified 2 217 0.01 0.01 0.00 0.02
KRAS G12D melanoma Metastasis 7 1738 0.00 0.00 0.00 0.01
KRAS G12D melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.01
KRAS G12D melanoma Primary 7 898 0.01 0.01 0.00 0.01
KRAS G12D melanoma Tumor Type:Unspecified 0 22 0.01 0.00 0.00 0.02
KRAS G12D head and neck cancer Metastasis 2 731 0.00 0.00 0.00 0.01
KRAS G12D head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.01
KRAS G12D head and neck cancer Primary 2 938 0.00 0.00 0.00 0.01
KRAS G12D uterine cancer Metastasis 25 586 0.04 0.04 0.03 0.06
KRAS G12D uterine cancer Tumor Type:NA/Heme 6 76 0.05 0.05 0.03 0.09
KRAS G12D uterine cancer Primary 69 1541 0.04 0.04 0.04 0.06
KRAS G12D uterine cancer Tumor Type:Unspecified 2 51 0.05 0.04 0.03 0.07
KRAS G12D non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.01
KRAS G12D non-melanoma skin cancers Tumor Type:NA/Heme 1 22 0.03 0.02 0.00 0.14
KRAS G12D non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.01
KRAS G12D myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.02
KRAS G12D myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 3 915 0.00 0.00 0.00 0.01
KRAS G12D myelodysplastic/myeloproliferative syndromes Primary 1 250 0.00 0.00 0.00 0.01
KRAS G12D myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
KRAS G12D adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
KRAS G12D adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
KRAS G12D ovarian cancer Metastasis 35 1088 0.03 0.03 0.02 0.04
KRAS G12D ovarian cancer Tumor Type:NA/Heme 4 160 0.03 0.03 0.02 0.05
KRAS G12D ovarian cancer Primary 42 1060 0.04 0.04 0.03 0.05
KRAS G12D ovarian cancer Tumor Type:Unspecified 1 28 0.04 0.04 0.02 0.06
KRAS G12D esophagogastric cancer Metastasis 9 462 0.02 0.02 0.01 0.03
KRAS G12D esophagogastric cancer Tumor Type:NA/Heme 1 43 0.02 0.02 0.01 0.04
KRAS G12D esophagogastric cancer Primary 22 1283 0.02 0.02 0.01 0.02
KRAS G12D esophagogastric cancer Tumor Type:Unspecified 1 14 0.02 0.02 0.01 0.06
KRAS G12D thyroid cancer Metastasis 2 402 0.00 0.00 0.00 0.01
KRAS G12D thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.02
KRAS G12D thyroid cancer Primary 1 582 0.00 0.00 0.00 0.01
KRAS G12D cervical cancer Metastasis 3 136 0.03 0.02 0.01 0.05
KRAS G12D cervical cancer Tumor Type:NA/Heme 0 12 0.03 0.03 0.00 0.06
KRAS G12D cervical cancer Primary 7 211 0.03 0.03 0.01 0.05
KRAS G12D hepatobiliary cancer Metastasis 17 438 0.04 0.04 0.03 0.06
KRAS G12D hepatobiliary cancer Tumor Type:NA/Heme 3 34 0.05 0.04 0.03 0.11
KRAS G12D hepatobiliary cancer Primary 35 895 0.04 0.04 0.03 0.05
KRAS G12D kidney cancer Metastasis 4 445 0.01 0.01 0.00 0.02
KRAS G12D kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.03
KRAS G12D kidney cancer Primary 1 944 0.00 0.00 0.00 0.01
KRAS G12D mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
KRAS G12D mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
KRAS G12D mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
KRAS G12D cns cancer Metastasis 1 409 0.00 0.00 0.00 0.00
KRAS G12D cns cancer Tumor Type:NA/Heme 1 526 0.00 0.00 0.00 0.00
KRAS G12D cns cancer Primary 5 3522 0.00 0.00 0.00 0.00
KRAS G12D cns cancer Tumor Type:Unspecified 1 108 0.00 0.00 0.00 0.01
KRAS G12D prostate cancer Metastasis 1 901 0.00 0.00 0.00 0.00
KRAS G12D prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
KRAS G12D prostate cancer Primary 1 1468 0.00 0.00 0.00 0.00
KRAS G12D prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.01
KRAS G12D anal cancer Metastasis 0 59 0.01 0.00 0.00 0.03
KRAS G12D anal cancer Primary 1 84 0.01 0.01 0.00 0.04
KRAS G12D neuroendocrine tumors Metastasis 4 143 0.04 0.04 0.02 0.06
KRAS G12D neuroendocrine tumors Tumor Type:NA/Heme 1 20 0.04 0.04 0.01 0.09
KRAS G12D neuroendocrine tumors Primary 9 196 0.04 0.04 0.02 0.07
KRAS G12D bladder cancer Metastasis 8 390 0.02 0.02 0.01 0.03
KRAS G12D bladder cancer Tumor Type:NA/Heme 0 25 0.02 0.02 0.00 0.04
KRAS G12D bladder cancer Primary 24 1164 0.02 0.02 0.01 0.03
KRAS G12D b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.03 0.03 0.00 0.07
KRAS G12D b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 5 109 0.04 0.03 0.02 0.07
KRAS G12D b-lymphoblastic leukemia/lymphoma Primary 2 101 0.03 0.03 0.01 0.06
KRAS G12D b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 1 25 0.03 0.03 0.01 0.08
KRAS G12D small bowel cancer Metastasis 8 78 0.12 0.11 0.06 0.18
KRAS G12D small bowel cancer Primary 17 128 0.13 0.12 0.08 0.18
KRAS G12D sex cord stromal tumor Metastasis 0 49 0.00 0.00 0.00 0.00
KRAS G12D sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
KRAS G12D bone cancer Metastasis 0 203 0.00 0.00 0.00 0.01
KRAS G12D bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
KRAS G12D bone cancer Primary 2 326 0.00 0.00 0.00 0.01
KRAS G12D bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.02
KRAS G12D vaginal cancer Metastasis 0 16 0.02 0.01 0.00 0.06
KRAS G12D vaginal cancer Primary 1 60 0.02 0.01 0.00 0.06
KRAS G12D thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS G12D thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS G12D ampullary cancer Metastasis 9 23 0.32 0.31 0.19 0.53
KRAS G12D ampullary cancer Primary 18 82 0.24 0.24 0.15 0.33
KRAS G12D small cell lung cancer Metastasis 2 207 0.01 0.01 0.00 0.02
KRAS G12D small cell lung cancer Primary 2 183 0.01 0.01 0.00 0.03
KRAS G12D mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS G12D mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS G12D germ cell tumor Metastasis 2 274 0.01 0.01 0.00 0.02
KRAS G12D germ cell tumor Tumor Type:NA/Heme 0 81 0.01 0.01 0.00 0.02
KRAS G12D germ cell tumor Primary 7 517 0.01 0.01 0.00 0.02
KRAS G12D germ cell tumor Tumor Type:Unspecified 0 14 0.01 0.01 0.00 0.03
KRAS G12D nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
KRAS G12D nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
KRAS G12D nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
KRAS G12D penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
KRAS G12D penile cancer Primary 0 13 0.00 0.00 0.00 0.03
KRAS G12D pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.03
KRAS G12D pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
KRAS G12D b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
KRAS G12D b cell lymphoma Tumor Type:NA/Heme 2 145 0.01 0.00 0.00 0.03
KRAS G12D b cell lymphoma Primary 1 709 0.00 0.00 0.00 0.01
KRAS G12D b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.02
KRAS G12D non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
KRAS G12D t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
KRAS G12D t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
KRAS G12D retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
KRAS G12D retinoblastoma Primary 0 41 0.00 0.00 0.00 0.02
KRAS G12D hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.02
KRAS G12D lung cancer Primary 0 17 0.00 0.00 0.00 0.03
KRAS G12D parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
KRAS G12F appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
KRAS G12F appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
KRAS G12F appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer Metastasis 0 2354 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer Primary 1 4115 0.00 0.00 0.00 0.00
KRAS G12F colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
KRAS G12F cancer of unknown primary Metastasis 2 1389 0.00 0.00 0.00 0.00
KRAS G12F cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
KRAS G12F cancer of unknown primary Primary 1 311 0.00 0.00 0.00 0.01
KRAS G12F cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.01
KRAS G12F non-small cell lung cancer Metastasis 8 3750 0.00 0.00 0.00 0.00
KRAS G12F non-small cell lung cancer Tumor Type:NA/Heme 1 223 0.00 0.00 0.00 0.01
KRAS G12F non-small cell lung cancer Primary 23 6059 0.00 0.00 0.00 0.00
KRAS G12F non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.01
KRAS G12F breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
KRAS G12F breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
KRAS G12F breast cancer Primary 0 6125 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
KRAS G12F soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
KRAS G12F pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
KRAS G12F pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
KRAS G12F pancreatic cancer Primary 1 1429 0.00 0.00 0.00 0.00
KRAS G12F leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
KRAS G12F leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
KRAS G12F leukemia Primary 0 412 0.00 0.00 0.00 0.00
KRAS G12F leukemia Tumor Type:Unspecified 0 217 0.00 0.00 0.00 0.00
KRAS G12F melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
KRAS G12F melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
KRAS G12F melanoma Primary 0 898 0.00 0.00 0.00 0.00
KRAS G12F melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
KRAS G12F head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
KRAS G12F head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
KRAS G12F head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
KRAS G12F uterine cancer Metastasis 0 586 0.00 0.00 0.00 0.00
KRAS G12F uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
KRAS G12F uterine cancer Primary 0 1541 0.00 0.00 0.00 0.00
KRAS G12F uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
KRAS G12F non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G12F non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
KRAS G12F non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
KRAS G12F myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
KRAS G12F myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
KRAS G12F myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
KRAS G12F myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
KRAS G12F adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
KRAS G12F adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
KRAS G12F ovarian cancer Metastasis 1 1088 0.00 0.00 0.00 0.00
KRAS G12F ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
KRAS G12F ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
KRAS G12F ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.01
KRAS G12F esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
KRAS G12F esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
KRAS G12F esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
KRAS G12F esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
KRAS G12F thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
KRAS G12F thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
KRAS G12F thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
KRAS G12F cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
KRAS G12F cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
KRAS G12F cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
KRAS G12F hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
KRAS G12F hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
KRAS G12F hepatobiliary cancer Primary 0 895 0.00 0.00 0.00 0.00
KRAS G12F kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
KRAS G12F kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
KRAS G12F kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
KRAS G12F mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
KRAS G12F mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
KRAS G12F mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
KRAS G12F cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
KRAS G12F cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
KRAS G12F cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
KRAS G12F cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
KRAS G12F prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
KRAS G12F prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
KRAS G12F prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
KRAS G12F prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
KRAS G12F anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
KRAS G12F anal cancer Primary 0 84 0.00 0.00 0.00 0.00
KRAS G12F neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
KRAS G12F neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
KRAS G12F neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
KRAS G12F bladder cancer Metastasis 0 390 0.00 0.00 0.00 0.00
KRAS G12F bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS G12F bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
KRAS G12F b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
KRAS G12F b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
KRAS G12F b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
KRAS G12F b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
KRAS G12F small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
KRAS G12F small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
KRAS G12F sex cord stromal tumor Metastasis 0 49 0.00 0.00 0.00 0.01
KRAS G12F sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
KRAS G12F bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G12F bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS G12F bone cancer Primary 0 326 0.00 0.00 0.00 0.00
KRAS G12F bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
KRAS G12F vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
KRAS G12F vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
KRAS G12F thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS G12F thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS G12F ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.00
KRAS G12F ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
KRAS G12F small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
KRAS G12F small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
KRAS G12F mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS G12F mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor Primary 0 517 0.00 0.00 0.00 0.00
KRAS G12F germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
KRAS G12F nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
KRAS G12F nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
KRAS G12F nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
KRAS G12F penile cancer Metastasis 0 11 0.00 0.00 0.00 0.05
KRAS G12F penile cancer Primary 0 13 0.00 0.00 0.00 0.05
KRAS G12F pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
KRAS G12F pineal tumor Primary 0 14 0.00 0.00 0.00 0.03
KRAS G12F b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
KRAS G12F b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
KRAS G12F b cell lymphoma Primary 0 709 0.00 0.00 0.00 0.00
KRAS G12F b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
KRAS G12F non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
KRAS G12F t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
KRAS G12F t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
KRAS G12F retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
KRAS G12F retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
KRAS G12F hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
KRAS G12F lung cancer Primary 0 17 0.00 0.00 0.00 0.04
KRAS G12F parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
KRAS G12R appendiceal cancer Metastasis 3 174 0.01 0.01 0.00 0.04
KRAS G12R appendiceal cancer Tumor Type:NA/Heme 0 10 0.01 0.00 0.00 0.06
KRAS G12R appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.02
KRAS G12R colorectal cancer Metastasis 12 2354 0.00 0.00 0.00 0.01
KRAS G12R colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.01
KRAS G12R colorectal cancer Primary 22 4115 0.00 0.00 0.00 0.01
KRAS G12R colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
KRAS G12R cancer of unknown primary Metastasis 13 1389 0.01 0.01 0.00 0.01
KRAS G12R cancer of unknown primary Tumor Type:NA/Heme 3 229 0.01 0.01 0.00 0.02
KRAS G12R cancer of unknown primary Primary 0 311 0.01 0.01 0.00 0.01
KRAS G12R cancer of unknown primary Tumor Type:Unspecified 1 60 0.01 0.01 0.00 0.03
KRAS G12R non-small cell lung cancer Metastasis 13 3750 0.00 0.00 0.00 0.00
KRAS G12R non-small cell lung cancer Tumor Type:NA/Heme 1 223 0.00 0.00 0.00 0.01
KRAS G12R non-small cell lung cancer Primary 22 6059 0.00 0.00 0.00 0.00
KRAS G12R non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.01
KRAS G12R breast cancer Metastasis 3 3094 0.00 0.00 0.00 0.00
KRAS G12R breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
KRAS G12R breast cancer Primary 1 6125 0.00 0.00 0.00 0.00
KRAS G12R soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
KRAS G12R soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
KRAS G12R soft tissue sarcoma Primary 3 1686 0.00 0.00 0.00 0.00
KRAS G12R soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.01
KRAS G12R pancreatic cancer Metastasis 105 981 0.11 0.11 0.09 0.13
KRAS G12R pancreatic cancer Tumor Type:NA/Heme 11 75 0.12 0.11 0.09 0.17
KRAS G12R pancreatic cancer Primary 160 1429 0.11 0.11 0.10 0.13
KRAS G12R leukemia Metastasis 0 15 0.00 0.00 0.00 0.02
KRAS G12R leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
KRAS G12R leukemia Primary 2 412 0.00 0.00 0.00 0.01
KRAS G12R leukemia Tumor Type:Unspecified 0 217 0.00 0.00 0.00 0.00
KRAS G12R melanoma Metastasis 2 1738 0.00 0.00 0.00 0.00
KRAS G12R melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
KRAS G12R melanoma Primary 1 898 0.00 0.00 0.00 0.00
KRAS G12R melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
KRAS G12R head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
KRAS G12R head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
KRAS G12R head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
KRAS G12R uterine cancer Metastasis 1 586 0.00 0.00 0.00 0.00
KRAS G12R uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
KRAS G12R uterine cancer Primary 1 1541 0.00 0.00 0.00 0.00
KRAS G12R uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
KRAS G12R non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G12R non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
KRAS G12R non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
KRAS G12R myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.02
KRAS G12R myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 1 915 0.00 0.00 0.00 0.00
KRAS G12R myelodysplastic/myeloproliferative syndromes Primary 1 250 0.00 0.00 0.00 0.01
KRAS G12R myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
KRAS G12R adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
KRAS G12R adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
KRAS G12R ovarian cancer Metastasis 4 1088 0.00 0.00 0.00 0.01
KRAS G12R ovarian cancer Tumor Type:NA/Heme 1 160 0.00 0.00 0.00 0.01
KRAS G12R ovarian cancer Primary 4 1060 0.00 0.00 0.00 0.01
KRAS G12R ovarian cancer Tumor Type:Unspecified 1 28 0.01 0.00 0.00 0.03
KRAS G12R esophagogastric cancer Metastasis 1 462 0.00 0.00 0.00 0.00
KRAS G12R esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.01
KRAS G12R esophagogastric cancer Primary 1 1283 0.00 0.00 0.00 0.00
KRAS G12R esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
KRAS G12R thyroid cancer Metastasis 1 402 0.00 0.00 0.00 0.01
KRAS G12R thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.01
KRAS G12R thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
KRAS G12R cervical cancer Metastasis 1 136 0.00 0.00 0.00 0.02
KRAS G12R cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.03
KRAS G12R cervical cancer Primary 0 211 0.00 0.00 0.00 0.01
KRAS G12R hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
KRAS G12R hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.01
KRAS G12R hepatobiliary cancer Primary 2 895 0.00 0.00 0.00 0.00
KRAS G12R kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
KRAS G12R kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
KRAS G12R kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
KRAS G12R mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
KRAS G12R mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
KRAS G12R mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
KRAS G12R cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
KRAS G12R cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
KRAS G12R cns cancer Primary 2 3522 0.00 0.00 0.00 0.00
KRAS G12R cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
KRAS G12R prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
KRAS G12R prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.01
KRAS G12R prostate cancer Primary 3 1468 0.00 0.00 0.00 0.00
KRAS G12R prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.02
KRAS G12R anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
KRAS G12R anal cancer Primary 0 84 0.00 0.00 0.00 0.00
KRAS G12R neuroendocrine tumors Metastasis 2 143 0.01 0.01 0.00 0.03
KRAS G12R neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.01 0.00 0.00 0.03
KRAS G12R neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.01
KRAS G12R bladder cancer Metastasis 0 390 0.00 0.00 0.00 0.00
KRAS G12R bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
KRAS G12R bladder cancer Primary 3 1164 0.00 0.00 0.00 0.01
KRAS G12R b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
KRAS G12R b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
KRAS G12R b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
KRAS G12R b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
KRAS G12R small bowel cancer Metastasis 1 78 0.02 0.01 0.00 0.04
KRAS G12R small bowel cancer Primary 2 128 0.02 0.01 0.00 0.04
KRAS G12R sex cord stromal tumor Metastasis 0 49 0.00 0.00 0.00 0.01
KRAS G12R sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
KRAS G12R bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G12R bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS G12R bone cancer Primary 0 326 0.00 0.00 0.00 0.00
KRAS G12R bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
KRAS G12R vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
KRAS G12R vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
KRAS G12R thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS G12R thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS G12R ampullary cancer Metastasis 1 23 0.04 0.03 0.00 0.11
KRAS G12R ampullary cancer Primary 2 82 0.03 0.03 0.01 0.07
KRAS G12R small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
KRAS G12R small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
KRAS G12R mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS G12R mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS G12R germ cell tumor Metastasis 3 274 0.01 0.01 0.00 0.02
KRAS G12R germ cell tumor Tumor Type:NA/Heme 0 81 0.01 0.01 0.00 0.02
KRAS G12R germ cell tumor Primary 5 517 0.01 0.01 0.00 0.02
KRAS G12R germ cell tumor Tumor Type:Unspecified 0 14 0.01 0.01 0.00 0.02
KRAS G12R nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
KRAS G12R nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
KRAS G12R nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
KRAS G12R penile cancer Metastasis 1 11 0.06 0.04 0.00 0.24
KRAS G12R penile cancer Primary 0 13 0.03 0.02 0.00 0.15
KRAS G12R pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
KRAS G12R pineal tumor Primary 0 14 0.00 0.00 0.00 0.03
KRAS G12R b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
KRAS G12R b cell lymphoma Tumor Type:NA/Heme 2 145 0.01 0.01 0.00 0.03
KRAS G12R b cell lymphoma Primary 0 709 0.00 0.00 0.00 0.00
KRAS G12R b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.02
KRAS G12R non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
KRAS G12R t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
KRAS G12R t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
KRAS G12R retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
KRAS G12R retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
KRAS G12R hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
KRAS G12R lung cancer Primary 0 17 0.00 0.00 0.00 0.04
KRAS G12R parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
KRAS G12S appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
KRAS G12S appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
KRAS G12S appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
KRAS G12S colorectal cancer Metastasis 46 2354 0.02 0.02 0.02 0.02
KRAS G12S colorectal cancer Tumor Type:NA/Heme 1 224 0.02 0.02 0.00 0.02
KRAS G12S colorectal cancer Primary 78 4115 0.02 0.02 0.02 0.02
KRAS G12S colorectal cancer Tumor Type:Unspecified 1 31 0.02 0.02 0.01 0.04
KRAS G12S cancer of unknown primary Metastasis 3 1389 0.00 0.00 0.00 0.00
KRAS G12S cancer of unknown primary Tumor Type:NA/Heme 1 229 0.00 0.00 0.00 0.01
KRAS G12S cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.01
KRAS G12S cancer of unknown primary Tumor Type:Unspecified 1 60 0.00 0.00 0.00 0.02
KRAS G12S non-small cell lung cancer Metastasis 21 3750 0.00 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer Primary 31 6059 0.00 0.00 0.00 0.01
KRAS G12S non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.01
KRAS G12S breast cancer Metastasis 3 3094 0.00 0.00 0.00 0.00
KRAS G12S breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
KRAS G12S breast cancer Primary 3 6125 0.00 0.00 0.00 0.00
KRAS G12S soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
KRAS G12S soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
KRAS G12S soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
KRAS G12S soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
KRAS G12S pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
KRAS G12S pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
KRAS G12S pancreatic cancer Primary 0 1429 0.00 0.00 0.00 0.00
KRAS G12S leukemia Metastasis 0 15 0.00 0.00 0.00 0.01
KRAS G12S leukemia Tumor Type:NA/Heme 1 923 0.00 0.00 0.00 0.00
KRAS G12S leukemia Primary 0 412 0.00 0.00 0.00 0.00
KRAS G12S leukemia Tumor Type:Unspecified 0 217 0.00 0.00 0.00 0.00
KRAS G12S melanoma Metastasis 1 1738 0.00 0.00 0.00 0.00
KRAS G12S melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
KRAS G12S melanoma Primary 0 898 0.00 0.00 0.00 0.00
KRAS G12S melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
KRAS G12S head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
KRAS G12S head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
KRAS G12S head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
KRAS G12S uterine cancer Metastasis 1 586 0.00 0.00 0.00 0.01
KRAS G12S uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.01
KRAS G12S uterine cancer Primary 5 1541 0.00 0.00 0.00 0.01
KRAS G12S uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
KRAS G12S non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G12S non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
KRAS G12S non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
KRAS G12S myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.01
KRAS G12S myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 2 915 0.00 0.00 0.00 0.00
KRAS G12S myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
KRAS G12S myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
KRAS G12S adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
KRAS G12S adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
KRAS G12S ovarian cancer Metastasis 1 1088 0.00 0.00 0.00 0.00
KRAS G12S ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
KRAS G12S ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
KRAS G12S ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
KRAS G12S esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
KRAS G12S esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.01
KRAS G12S esophagogastric cancer Primary 4 1283 0.00 0.00 0.00 0.01
KRAS G12S esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.02
KRAS G12S thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
KRAS G12S thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
KRAS G12S thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
KRAS G12S cervical cancer Metastasis 2 136 0.01 0.01 0.00 0.03
KRAS G12S cervical cancer Tumor Type:NA/Heme 0 12 0.01 0.01 0.00 0.04
KRAS G12S cervical cancer Primary 1 211 0.01 0.01 0.00 0.02
KRAS G12S hepatobiliary cancer Metastasis 1 438 0.00 0.00 0.00 0.01
KRAS G12S hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.01
KRAS G12S hepatobiliary cancer Primary 1 895 0.00 0.00 0.00 0.00
KRAS G12S kidney cancer Metastasis 1 445 0.00 0.00 0.00 0.01
KRAS G12S kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.02
KRAS G12S kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
KRAS G12S mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
KRAS G12S mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
KRAS G12S mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
KRAS G12S cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
KRAS G12S cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
KRAS G12S cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
KRAS G12S cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
KRAS G12S prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
KRAS G12S prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
KRAS G12S prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
KRAS G12S prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
KRAS G12S anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
KRAS G12S anal cancer Primary 0 84 0.00 0.00 0.00 0.00
KRAS G12S neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
KRAS G12S neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
KRAS G12S neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
KRAS G12S bladder cancer Metastasis 0 390 0.00 0.00 0.00 0.00
KRAS G12S bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
KRAS G12S bladder cancer Primary 2 1164 0.00 0.00 0.00 0.00
KRAS G12S b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
KRAS G12S b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
KRAS G12S b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
KRAS G12S b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
KRAS G12S small bowel cancer Metastasis 1 78 0.02 0.01 0.00 0.04
KRAS G12S small bowel cancer Primary 2 128 0.02 0.01 0.00 0.04
KRAS G12S sex cord stromal tumor Metastasis 0 49 0.00 0.00 0.00 0.00
KRAS G12S sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
KRAS G12S bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G12S bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS G12S bone cancer Primary 0 326 0.00 0.00 0.00 0.00
KRAS G12S bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
KRAS G12S vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.02
KRAS G12S vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
KRAS G12S thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS G12S thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS G12S ampullary cancer Metastasis 0 23 0.01 0.01 0.00 0.05
KRAS G12S ampullary cancer Primary 1 82 0.01 0.01 0.00 0.04
KRAS G12S small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
KRAS G12S small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
KRAS G12S mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS G12S mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS G12S germ cell tumor Metastasis 3 274 0.01 0.01 0.00 0.02
KRAS G12S germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.01
KRAS G12S germ cell tumor Primary 1 517 0.00 0.00 0.00 0.01
KRAS G12S germ cell tumor Tumor Type:Unspecified 0 14 0.01 0.00 0.00 0.03
KRAS G12S nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
KRAS G12S nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
KRAS G12S nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
KRAS G12S penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
KRAS G12S penile cancer Primary 0 13 0.00 0.00 0.00 0.03
KRAS G12S pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.03
KRAS G12S pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
KRAS G12S b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
KRAS G12S b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.01
KRAS G12S b cell lymphoma Primary 2 709 0.00 0.00 0.00 0.01
KRAS G12S b cell lymphoma Tumor Type:Unspecified 1 51 0.01 0.00 0.00 0.03
KRAS G12S non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
KRAS G12S t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
KRAS G12S t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
KRAS G12S retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
KRAS G12S retinoblastoma Primary 0 41 0.00 0.00 0.00 0.02
KRAS G12S hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.02
KRAS G12S lung cancer Primary 0 17 0.00 0.00 0.00 0.03
KRAS G12S parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
KRAS G12V appendiceal cancer Metastasis 16 174 0.11 0.11 0.06 0.15
KRAS G12V appendiceal cancer Tumor Type:NA/Heme 1 10 0.12 0.12 0.04 0.23
KRAS G12V appendiceal cancer Primary 23 151 0.14 0.13 0.09 0.19
KRAS G12V colorectal cancer Metastasis 202 2354 0.09 0.09 0.08 0.10
KRAS G12V colorectal cancer Tumor Type:NA/Heme 26 224 0.10 0.10 0.08 0.13
KRAS G12V colorectal cancer Primary 389 4115 0.09 0.09 0.09 0.10
KRAS G12V colorectal cancer Tumor Type:Unspecified 3 31 0.10 0.09 0.07 0.13
KRAS G12V cancer of unknown primary Metastasis 72 1389 0.05 0.05 0.04 0.06
KRAS G12V cancer of unknown primary Tumor Type:NA/Heme 20 229 0.07 0.07 0.05 0.11
KRAS G12V cancer of unknown primary Primary 10 311 0.04 0.04 0.02 0.06
KRAS G12V cancer of unknown primary Tumor Type:Unspecified 5 60 0.07 0.06 0.04 0.12
KRAS G12V non-small cell lung cancer Metastasis 166 3750 0.04 0.04 0.04 0.05
KRAS G12V non-small cell lung cancer Tumor Type:NA/Heme 12 223 0.05 0.05 0.03 0.08
KRAS G12V non-small cell lung cancer Primary 369 6059 0.06 0.06 0.05 0.07
KRAS G12V non-small cell lung cancer Tumor Type:Unspecified 1 99 0.04 0.04 0.01 0.06
KRAS G12V breast cancer Metastasis 16 3094 0.00 0.00 0.00 0.01
KRAS G12V breast cancer Tumor Type:NA/Heme 3 105 0.02 0.02 0.00 0.06
KRAS G12V breast cancer Primary 10 6125 0.00 0.00 0.00 0.00
KRAS G12V soft tissue sarcoma Metastasis 3 939 0.00 0.00 0.00 0.01
KRAS G12V soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.01
KRAS G12V soft tissue sarcoma Primary 1 1686 0.00 0.00 0.00 0.00
KRAS G12V soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.01
KRAS G12V pancreatic cancer Metastasis 216 981 0.22 0.22 0.20 0.25
KRAS G12V pancreatic cancer Tumor Type:NA/Heme 16 75 0.23 0.23 0.17 0.28
KRAS G12V pancreatic cancer Primary 350 1429 0.24 0.24 0.22 0.26
KRAS G12V leukemia Metastasis 2 15 0.04 0.02 0.01 0.19
KRAS G12V leukemia Tumor Type:NA/Heme 8 923 0.01 0.01 0.00 0.02
KRAS G12V leukemia Primary 5 412 0.01 0.01 0.00 0.02
KRAS G12V leukemia Tumor Type:Unspecified 1 217 0.01 0.01 0.00 0.02
KRAS G12V melanoma Metastasis 2 1738 0.00 0.00 0.00 0.00
KRAS G12V melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
KRAS G12V melanoma Primary 0 898 0.00 0.00 0.00 0.00
KRAS G12V melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
KRAS G12V head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
KRAS G12V head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.01
KRAS G12V head and neck cancer Primary 1 938 0.00 0.00 0.00 0.00
KRAS G12V uterine cancer Metastasis 26 586 0.05 0.05 0.04 0.06
KRAS G12V uterine cancer Tumor Type:NA/Heme 5 76 0.05 0.05 0.04 0.08
KRAS G12V uterine cancer Primary 77 1541 0.05 0.05 0.04 0.06
KRAS G12V uterine cancer Tumor Type:Unspecified 4 51 0.05 0.05 0.04 0.09
KRAS G12V non-melanoma skin cancers Metastasis 1 203 0.00 0.00 0.00 0.01
KRAS G12V non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.02
KRAS G12V non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.01
KRAS G12V myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.01
KRAS G12V myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 1 915 0.00 0.00 0.00 0.00
KRAS G12V myelodysplastic/myeloproliferative syndromes Primary 1 250 0.00 0.00 0.00 0.01
KRAS G12V myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
KRAS G12V adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
KRAS G12V adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
KRAS G12V ovarian cancer Metastasis 33 1088 0.03 0.03 0.02 0.04
KRAS G12V ovarian cancer Tumor Type:NA/Heme 3 160 0.03 0.03 0.01 0.05
KRAS G12V ovarian cancer Primary 47 1060 0.04 0.04 0.03 0.05
KRAS G12V ovarian cancer Tumor Type:Unspecified 0 28 0.03 0.03 0.00 0.06
KRAS G12V esophagogastric cancer Metastasis 5 462 0.01 0.01 0.00 0.02
KRAS G12V esophagogastric cancer Tumor Type:NA/Heme 0 43 0.01 0.01 0.00 0.02
KRAS G12V esophagogastric cancer Primary 10 1283 0.01 0.01 0.00 0.01
KRAS G12V esophagogastric cancer Tumor Type:Unspecified 0 14 0.01 0.01 0.00 0.02
KRAS G12V thyroid cancer Metastasis 3 402 0.01 0.01 0.00 0.01
KRAS G12V thyroid cancer Tumor Type:NA/Heme 0 28 0.01 0.01 0.00 0.02
KRAS G12V thyroid cancer Primary 3 582 0.01 0.01 0.00 0.01
KRAS G12V cervical cancer Metastasis 5 136 0.03 0.03 0.01 0.06
KRAS G12V cervical cancer Tumor Type:NA/Heme 1 12 0.04 0.03 0.01 0.14
KRAS G12V cervical cancer Primary 3 211 0.02 0.02 0.01 0.04
KRAS G12V hepatobiliary cancer Metastasis 17 438 0.03 0.03 0.02 0.05
KRAS G12V hepatobiliary cancer Tumor Type:NA/Heme 1 34 0.03 0.03 0.01 0.07
KRAS G12V hepatobiliary cancer Primary 20 895 0.02 0.02 0.02 0.04
KRAS G12V kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.01
KRAS G12V kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.02
KRAS G12V kidney cancer Primary 4 944 0.00 0.00 0.00 0.01
KRAS G12V mature t and nk neoplasms Metastasis 0 10 0.01 0.00 0.00 0.04
KRAS G12V mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.02
KRAS G12V mature t and nk neoplasms Primary 1 187 0.00 0.00 0.00 0.02
KRAS G12V cns cancer Metastasis 2 409 0.00 0.00 0.00 0.01
KRAS G12V cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
KRAS G12V cns cancer Primary 6 3522 0.00 0.00 0.00 0.00
KRAS G12V cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
KRAS G12V prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
KRAS G12V prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.01
KRAS G12V prostate cancer Primary 2 1468 0.00 0.00 0.00 0.00
KRAS G12V prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.01
KRAS G12V anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
KRAS G12V anal cancer Primary 0 84 0.00 0.00 0.00 0.00
KRAS G12V neuroendocrine tumors Metastasis 0 143 0.01 0.00 0.00 0.02
KRAS G12V neuroendocrine tumors Tumor Type:NA/Heme 2 20 0.07 0.05 0.01 0.23
KRAS G12V neuroendocrine tumors Primary 4 196 0.02 0.02 0.01 0.04
KRAS G12V bladder cancer Metastasis 3 390 0.01 0.01 0.00 0.02
KRAS G12V bladder cancer Tumor Type:NA/Heme 0 25 0.01 0.01 0.00 0.03
KRAS G12V bladder cancer Primary 16 1164 0.01 0.01 0.01 0.02
KRAS G12V b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.01 0.00 0.00 0.03
KRAS G12V b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 1 109 0.01 0.00 0.00 0.02
KRAS G12V b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.02
KRAS G12V b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.02
KRAS G12V small bowel cancer Metastasis 13 78 0.14 0.14 0.08 0.23
KRAS G12V small bowel cancer Primary 12 128 0.11 0.11 0.06 0.16
KRAS G12V sex cord stromal tumor Metastasis 1 49 0.02 0.02 0.00 0.06
KRAS G12V sex cord stromal tumor Primary 1 54 0.02 0.02 0.00 0.06
KRAS G12V bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G12V bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS G12V bone cancer Primary 0 326 0.00 0.00 0.00 0.00
KRAS G12V bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
KRAS G12V vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.00
KRAS G12V vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
KRAS G12V thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS G12V thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS G12V ampullary cancer Metastasis 3 23 0.12 0.12 0.05 0.23
KRAS G12V ampullary cancer Primary 9 82 0.11 0.11 0.06 0.18
KRAS G12V small cell lung cancer Metastasis 2 207 0.01 0.01 0.00 0.02
KRAS G12V small cell lung cancer Primary 1 183 0.01 0.01 0.00 0.02
KRAS G12V mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS G12V mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS G12V germ cell tumor Metastasis 5 274 0.02 0.02 0.01 0.03
KRAS G12V germ cell tumor Tumor Type:NA/Heme 0 81 0.02 0.02 0.00 0.03
KRAS G12V germ cell tumor Primary 13 517 0.02 0.02 0.01 0.04
KRAS G12V germ cell tumor Tumor Type:Unspecified 0 14 0.02 0.02 0.00 0.04
KRAS G12V nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
KRAS G12V nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
KRAS G12V nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
KRAS G12V penile cancer Metastasis 0 11 0.00 0.00 0.00 0.04
KRAS G12V penile cancer Primary 0 13 0.00 0.00 0.00 0.03
KRAS G12V pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.02
KRAS G12V pineal tumor Primary 0 14 0.00 0.00 0.00 0.05
KRAS G12V b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
KRAS G12V b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.01
KRAS G12V b cell lymphoma Primary 4 709 0.00 0.00 0.00 0.01
KRAS G12V b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
KRAS G12V non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.03
KRAS G12V t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
KRAS G12V t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.03
KRAS G12V retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.01
KRAS G12V retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
KRAS G12V hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.02
KRAS G12V lung cancer Primary 0 17 0.00 0.00 0.00 0.04
KRAS G12V parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
KRAS G13C appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
KRAS G13C appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
KRAS G13C appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
KRAS G13C colorectal cancer Metastasis 8 2354 0.00 0.00 0.00 0.01
KRAS G13C colorectal cancer Tumor Type:NA/Heme 1 224 0.00 0.00 0.00 0.01
KRAS G13C colorectal cancer Primary 15 4115 0.00 0.00 0.00 0.00
KRAS G13C colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
KRAS G13C cancer of unknown primary Metastasis 7 1389 0.00 0.00 0.00 0.01
KRAS G13C cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.01
KRAS G13C cancer of unknown primary Primary 1 311 0.00 0.00 0.00 0.01
KRAS G13C cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.01
KRAS G13C non-small cell lung cancer Metastasis 42 3750 0.01 0.01 0.01 0.01
KRAS G13C non-small cell lung cancer Tumor Type:NA/Heme 2 223 0.01 0.01 0.00 0.02
KRAS G13C non-small cell lung cancer Primary 65 6059 0.01 0.01 0.01 0.01
KRAS G13C non-small cell lung cancer Tumor Type:Unspecified 0 99 0.01 0.01 0.00 0.02
KRAS G13C breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
KRAS G13C breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
KRAS G13C breast cancer Primary 0 6125 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma Primary 1 1686 0.00 0.00 0.00 0.00
KRAS G13C soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
KRAS G13C pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
KRAS G13C pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
KRAS G13C pancreatic cancer Primary 0 1429 0.00 0.00 0.00 0.00
KRAS G13C leukemia Metastasis 0 15 0.00 0.00 0.00 0.01
KRAS G13C leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
KRAS G13C leukemia Primary 0 412 0.00 0.00 0.00 0.00
KRAS G13C leukemia Tumor Type:Unspecified 1 217 0.00 0.00 0.00 0.01
KRAS G13C melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
KRAS G13C melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
KRAS G13C melanoma Primary 0 898 0.00 0.00 0.00 0.00
KRAS G13C melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
KRAS G13C head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
KRAS G13C head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
KRAS G13C head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
KRAS G13C uterine cancer Metastasis 1 586 0.00 0.00 0.00 0.00
KRAS G13C uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.01
KRAS G13C uterine cancer Primary 4 1541 0.00 0.00 0.00 0.00
KRAS G13C uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
KRAS G13C non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G13C non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
KRAS G13C non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
KRAS G13C myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
KRAS G13C myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
KRAS G13C myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
KRAS G13C myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
KRAS G13C adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
KRAS G13C adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
KRAS G13C ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
KRAS G13C ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
KRAS G13C ovarian cancer Primary 1 1060 0.00 0.00 0.00 0.00
KRAS G13C ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
KRAS G13C esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
KRAS G13C thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
KRAS G13C thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
KRAS G13C thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
KRAS G13C cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
KRAS G13C cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
KRAS G13C cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
KRAS G13C hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
KRAS G13C hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
KRAS G13C hepatobiliary cancer Primary 0 895 0.00 0.00 0.00 0.00
KRAS G13C kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
KRAS G13C kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
KRAS G13C kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
KRAS G13C mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
KRAS G13C mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
KRAS G13C mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
KRAS G13C cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
KRAS G13C cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
KRAS G13C cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
KRAS G13C cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
KRAS G13C prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
KRAS G13C prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
KRAS G13C prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
KRAS G13C prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
KRAS G13C anal cancer Metastasis 0 59 0.01 0.00 0.00 0.03
KRAS G13C anal cancer Primary 1 84 0.01 0.01 0.00 0.04
KRAS G13C neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
KRAS G13C neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
KRAS G13C neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
KRAS G13C bladder cancer Metastasis 0 390 0.00 0.00 0.00 0.00
KRAS G13C bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS G13C bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
KRAS G13C b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
KRAS G13C b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
KRAS G13C b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
KRAS G13C b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
KRAS G13C small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
KRAS G13C small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
KRAS G13C sex cord stromal tumor Metastasis 0 49 0.00 0.00 0.00 0.01
KRAS G13C sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
KRAS G13C bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G13C bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS G13C bone cancer Primary 0 326 0.00 0.00 0.00 0.00
KRAS G13C bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
KRAS G13C vaginal cancer Metastasis 0 16 0.01 0.01 0.00 0.06
KRAS G13C vaginal cancer Primary 1 60 0.02 0.01 0.00 0.06
KRAS G13C thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS G13C thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS G13C ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
KRAS G13C ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
KRAS G13C small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
KRAS G13C small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
KRAS G13C mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS G13C mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor Primary 0 517 0.00 0.00 0.00 0.00
KRAS G13C germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
KRAS G13C nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.01
KRAS G13C nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.01
KRAS G13C nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
KRAS G13C penile cancer Metastasis 0 11 0.00 0.00 0.00 0.02
KRAS G13C penile cancer Primary 0 13 0.00 0.00 0.00 0.02
KRAS G13C pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
KRAS G13C pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
KRAS G13C b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
KRAS G13C b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
KRAS G13C b cell lymphoma Primary 1 709 0.00 0.00 0.00 0.00
KRAS G13C b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
KRAS G13C non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
KRAS G13C t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
KRAS G13C t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
KRAS G13C retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.01
KRAS G13C retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
KRAS G13C hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
KRAS G13C lung cancer Primary 0 17 0.00 0.00 0.00 0.03
KRAS G13C parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
KRAS G13D appendiceal cancer Metastasis 6 174 0.04 0.04 0.02 0.07
KRAS G13D appendiceal cancer Tumor Type:NA/Heme 1 10 0.05 0.04 0.02 0.15
KRAS G13D appendiceal cancer Primary 7 151 0.04 0.04 0.02 0.07
KRAS G13D colorectal cancer Metastasis 170 2354 0.07 0.07 0.06 0.08
KRAS G13D colorectal cancer Tumor Type:NA/Heme 18 224 0.08 0.08 0.06 0.10
KRAS G13D colorectal cancer Primary 311 4115 0.08 0.08 0.07 0.08
KRAS G13D colorectal cancer Tumor Type:Unspecified 2 31 0.08 0.07 0.05 0.10
KRAS G13D cancer of unknown primary Metastasis 18 1389 0.01 0.01 0.01 0.02
KRAS G13D cancer of unknown primary Tumor Type:NA/Heme 0 229 0.01 0.01 0.00 0.02
KRAS G13D cancer of unknown primary Primary 6 311 0.02 0.02 0.01 0.03
KRAS G13D cancer of unknown primary Tumor Type:Unspecified 2 60 0.02 0.02 0.01 0.06
KRAS G13D non-small cell lung cancer Metastasis 39 3750 0.01 0.01 0.01 0.01
KRAS G13D non-small cell lung cancer Tumor Type:NA/Heme 2 223 0.01 0.01 0.00 0.02
KRAS G13D non-small cell lung cancer Primary 46 6059 0.01 0.01 0.01 0.01
KRAS G13D non-small cell lung cancer Tumor Type:Unspecified 0 99 0.01 0.01 0.00 0.01
KRAS G13D breast cancer Metastasis 2 3094 0.00 0.00 0.00 0.00
KRAS G13D breast cancer Tumor Type:NA/Heme 1 105 0.00 0.00 0.00 0.02
KRAS G13D breast cancer Primary 2 6125 0.00 0.00 0.00 0.00
KRAS G13D soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
KRAS G13D soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
KRAS G13D soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
KRAS G13D soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
KRAS G13D pancreatic cancer Metastasis 4 981 0.00 0.00 0.00 0.01
KRAS G13D pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.01
KRAS G13D pancreatic cancer Primary 10 1429 0.01 0.01 0.00 0.01
KRAS G13D leukemia Metastasis 2 15 0.03 0.02 0.01 0.15
KRAS G13D leukemia Tumor Type:NA/Heme 14 923 0.02 0.02 0.01 0.02
KRAS G13D leukemia Primary 5 412 0.02 0.02 0.01 0.02
KRAS G13D leukemia Tumor Type:Unspecified 4 217 0.02 0.02 0.01 0.03
KRAS G13D melanoma Metastasis 5 1738 0.00 0.00 0.00 0.00
KRAS G13D melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.01
KRAS G13D melanoma Primary 2 898 0.00 0.00 0.00 0.00
KRAS G13D melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
KRAS G13D head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
KRAS G13D head and neck cancer Tumor Type:NA/Heme 1 67 0.01 0.00 0.00 0.04
KRAS G13D head and neck cancer Primary 2 938 0.00 0.00 0.00 0.00
KRAS G13D uterine cancer Metastasis 9 586 0.02 0.02 0.01 0.03
KRAS G13D uterine cancer Tumor Type:NA/Heme 2 76 0.02 0.02 0.01 0.04
KRAS G13D uterine cancer Primary 35 1541 0.02 0.02 0.02 0.03
KRAS G13D uterine cancer Tumor Type:Unspecified 0 51 0.02 0.02 0.00 0.03
KRAS G13D non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G13D non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
KRAS G13D non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
KRAS G13D myelodysplastic/myeloproliferative syndromes Metastasis 1 11 0.03 0.01 0.00 0.16
KRAS G13D myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 3 915 0.00 0.00 0.00 0.01
KRAS G13D myelodysplastic/myeloproliferative syndromes Primary 3 250 0.01 0.01 0.00 0.02
KRAS G13D myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.01 0.01 0.00 0.03
KRAS G13D adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
KRAS G13D adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
KRAS G13D ovarian cancer Metastasis 3 1088 0.00 0.00 0.00 0.01
KRAS G13D ovarian cancer Tumor Type:NA/Heme 3 160 0.01 0.01 0.00 0.03
KRAS G13D ovarian cancer Primary 4 1060 0.00 0.00 0.00 0.01
KRAS G13D ovarian cancer Tumor Type:Unspecified 0 28 0.01 0.00 0.00 0.02
KRAS G13D esophagogastric cancer Metastasis 5 462 0.01 0.01 0.00 0.02
KRAS G13D esophagogastric cancer Tumor Type:NA/Heme 0 43 0.01 0.01 0.00 0.02
KRAS G13D esophagogastric cancer Primary 17 1283 0.01 0.01 0.01 0.02
KRAS G13D esophagogastric cancer Tumor Type:Unspecified 0 14 0.01 0.01 0.00 0.03
KRAS G13D thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
KRAS G13D thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
KRAS G13D thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
KRAS G13D cervical cancer Metastasis 3 136 0.02 0.01 0.00 0.04
KRAS G13D cervical cancer Tumor Type:NA/Heme 0 12 0.01 0.01 0.00 0.05
KRAS G13D cervical cancer Primary 1 211 0.01 0.01 0.00 0.02
KRAS G13D hepatobiliary cancer Metastasis 3 438 0.01 0.01 0.00 0.01
KRAS G13D hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.01 0.01 0.00 0.02
KRAS G13D hepatobiliary cancer Primary 6 895 0.01 0.01 0.00 0.01
KRAS G13D kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
KRAS G13D kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
KRAS G13D kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
KRAS G13D mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
KRAS G13D mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
KRAS G13D mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
KRAS G13D cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
KRAS G13D cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
KRAS G13D cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
KRAS G13D cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
KRAS G13D prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
KRAS G13D prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
KRAS G13D prostate cancer Primary 1 1468 0.00 0.00 0.00 0.00
KRAS G13D prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.01
KRAS G13D anal cancer Metastasis 0 59 0.01 0.00 0.00 0.03
KRAS G13D anal cancer Primary 1 84 0.01 0.01 0.00 0.04
KRAS G13D neuroendocrine tumors Metastasis 1 143 0.01 0.01 0.00 0.03
KRAS G13D neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.02 0.01 0.00 0.05
KRAS G13D neuroendocrine tumors Primary 5 196 0.02 0.02 0.01 0.04
KRAS G13D bladder cancer Metastasis 0 390 0.00 0.00 0.00 0.01
KRAS G13D bladder cancer Tumor Type:NA/Heme 1 25 0.02 0.01 0.00 0.10
KRAS G13D bladder cancer Primary 3 1164 0.00 0.00 0.00 0.01
KRAS G13D b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.03 0.03 0.00 0.07
KRAS G13D b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 4 109 0.03 0.03 0.01 0.06
KRAS G13D b-lymphoblastic leukemia/lymphoma Primary 4 101 0.03 0.03 0.01 0.07
KRAS G13D b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.03 0.03 0.00 0.06
KRAS G13D small bowel cancer Metastasis 1 78 0.03 0.02 0.00 0.08
KRAS G13D small bowel cancer Primary 12 128 0.09 0.08 0.04 0.14
KRAS G13D sex cord stromal tumor Metastasis 0 49 0.00 0.00 0.00 0.01
KRAS G13D sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
KRAS G13D bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G13D bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS G13D bone cancer Primary 0 326 0.00 0.00 0.00 0.00
KRAS G13D bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
KRAS G13D vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
KRAS G13D vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
KRAS G13D thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS G13D thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS G13D ampullary cancer Metastasis 1 23 0.05 0.04 0.01 0.12
KRAS G13D ampullary cancer Primary 4 82 0.05 0.05 0.02 0.10
KRAS G13D small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
KRAS G13D small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
KRAS G13D mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS G13D mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS G13D germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
KRAS G13D germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.01
KRAS G13D germ cell tumor Primary 1 517 0.00 0.00 0.00 0.00
KRAS G13D germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
KRAS G13D nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.01
KRAS G13D nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.01
KRAS G13D nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
KRAS G13D penile cancer Metastasis 0 11 0.00 0.00 0.00 0.02
KRAS G13D penile cancer Primary 0 13 0.00 0.00 0.00 0.02
KRAS G13D pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
KRAS G13D pineal tumor Primary 1 14 0.08 0.06 0.00 0.26
KRAS G13D b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.02
KRAS G13D b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.01
KRAS G13D b cell lymphoma Primary 7 709 0.01 0.01 0.00 0.02
KRAS G13D b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.02
KRAS G13D non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
KRAS G13D t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
KRAS G13D t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
KRAS G13D retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.01
KRAS G13D retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
KRAS G13D hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
KRAS G13D lung cancer Primary 0 17 0.00 0.00 0.00 0.03
KRAS G13D parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
KRAS G13R appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
KRAS G13R appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
KRAS G13R appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer Metastasis 1 2354 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer Primary 1 4115 0.00 0.00 0.00 0.00
KRAS G13R colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary Metastasis 1 1389 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
KRAS G13R cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer Metastasis 4 3750 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer Primary 2 6059 0.00 0.00 0.00 0.00
KRAS G13R non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
KRAS G13R breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
KRAS G13R breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
KRAS G13R breast cancer Primary 0 6125 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
KRAS G13R soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
KRAS G13R pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
KRAS G13R pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
KRAS G13R pancreatic cancer Primary 0 1429 0.00 0.00 0.00 0.00
KRAS G13R leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
KRAS G13R leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
KRAS G13R leukemia Primary 0 412 0.00 0.00 0.00 0.00
KRAS G13R leukemia Tumor Type:Unspecified 0 217 0.00 0.00 0.00 0.00
KRAS G13R melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
KRAS G13R melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
KRAS G13R melanoma Primary 0 898 0.00 0.00 0.00 0.00
KRAS G13R melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
KRAS G13R head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
KRAS G13R head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
KRAS G13R head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
KRAS G13R uterine cancer Metastasis 0 586 0.00 0.00 0.00 0.00
KRAS G13R uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
KRAS G13R uterine cancer Primary 0 1541 0.00 0.00 0.00 0.00
KRAS G13R uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
KRAS G13R non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G13R non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
KRAS G13R non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
KRAS G13R myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
KRAS G13R myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
KRAS G13R myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
KRAS G13R myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
KRAS G13R adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
KRAS G13R adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
KRAS G13R ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
KRAS G13R ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
KRAS G13R ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
KRAS G13R ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
KRAS G13R esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
KRAS G13R thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
KRAS G13R thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
KRAS G13R thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
KRAS G13R cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
KRAS G13R cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
KRAS G13R cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
KRAS G13R hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
KRAS G13R hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
KRAS G13R hepatobiliary cancer Primary 0 895 0.00 0.00 0.00 0.00
KRAS G13R kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
KRAS G13R kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
KRAS G13R kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
KRAS G13R mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
KRAS G13R mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
KRAS G13R mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
KRAS G13R cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
KRAS G13R cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
KRAS G13R cns cancer Primary 1 3522 0.00 0.00 0.00 0.00
KRAS G13R cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
KRAS G13R prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
KRAS G13R prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
KRAS G13R prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
KRAS G13R prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
KRAS G13R anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
KRAS G13R anal cancer Primary 0 84 0.00 0.00 0.00 0.00
KRAS G13R neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
KRAS G13R neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
KRAS G13R neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
KRAS G13R bladder cancer Metastasis 0 390 0.00 0.00 0.00 0.00
KRAS G13R bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS G13R bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
KRAS G13R b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
KRAS G13R b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
KRAS G13R b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
KRAS G13R b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
KRAS G13R small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
KRAS G13R small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
KRAS G13R sex cord stromal tumor Metastasis 0 49 0.00 0.00 0.00 0.00
KRAS G13R sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
KRAS G13R bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G13R bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS G13R bone cancer Primary 0 326 0.00 0.00 0.00 0.00
KRAS G13R bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
KRAS G13R vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
KRAS G13R vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
KRAS G13R thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS G13R thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS G13R ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
KRAS G13R ampullary cancer Primary 0 82 0.00 0.00 0.00 0.01
KRAS G13R small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
KRAS G13R small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
KRAS G13R mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS G13R mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor Primary 0 517 0.00 0.00 0.00 0.00
KRAS G13R germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
KRAS G13R nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
KRAS G13R nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
KRAS G13R nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
KRAS G13R penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
KRAS G13R penile cancer Primary 0 13 0.00 0.00 0.00 0.03
KRAS G13R pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.02
KRAS G13R pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
KRAS G13R b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
KRAS G13R b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
KRAS G13R b cell lymphoma Primary 0 709 0.00 0.00 0.00 0.00
KRAS G13R b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
KRAS G13R non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
KRAS G13R t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
KRAS G13R t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.03
KRAS G13R retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
KRAS G13R retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
KRAS G13R hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
KRAS G13R lung cancer Primary 0 17 0.00 0.00 0.00 0.02
KRAS G13R parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
KRAS G13V appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
KRAS G13V appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
KRAS G13V appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer Metastasis 2 2354 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer Primary 0 4115 0.00 0.00 0.00 0.00
KRAS G13V colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
KRAS G13V cancer of unknown primary Metastasis 0 1389 0.00 0.00 0.00 0.00
KRAS G13V cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
KRAS G13V cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
KRAS G13V cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer Metastasis 2 3750 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer Primary 2 6059 0.00 0.00 0.00 0.00
KRAS G13V non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
KRAS G13V breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
KRAS G13V breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
KRAS G13V breast cancer Primary 0 6125 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
KRAS G13V soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
KRAS G13V pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
KRAS G13V pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.01
KRAS G13V pancreatic cancer Primary 2 1429 0.00 0.00 0.00 0.00
KRAS G13V leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
KRAS G13V leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
KRAS G13V leukemia Primary 0 412 0.00 0.00 0.00 0.00
KRAS G13V leukemia Tumor Type:Unspecified 0 217 0.00 0.00 0.00 0.00
KRAS G13V melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
KRAS G13V melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
KRAS G13V melanoma Primary 0 898 0.00 0.00 0.00 0.00
KRAS G13V melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
KRAS G13V head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
KRAS G13V head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
KRAS G13V head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
KRAS G13V uterine cancer Metastasis 0 586 0.00 0.00 0.00 0.00
KRAS G13V uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
KRAS G13V uterine cancer Primary 0 1541 0.00 0.00 0.00 0.00
KRAS G13V uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
KRAS G13V non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G13V non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
KRAS G13V non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
KRAS G13V myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
KRAS G13V myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
KRAS G13V myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
KRAS G13V myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
KRAS G13V adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
KRAS G13V adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
KRAS G13V ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
KRAS G13V ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
KRAS G13V ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
KRAS G13V ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
KRAS G13V esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
KRAS G13V thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
KRAS G13V thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
KRAS G13V thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
KRAS G13V cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
KRAS G13V cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
KRAS G13V cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
KRAS G13V hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
KRAS G13V hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
KRAS G13V hepatobiliary cancer Primary 0 895 0.00 0.00 0.00 0.00
KRAS G13V kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
KRAS G13V kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
KRAS G13V kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
KRAS G13V mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
KRAS G13V mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
KRAS G13V mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
KRAS G13V cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
KRAS G13V cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
KRAS G13V cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
KRAS G13V cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
KRAS G13V prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
KRAS G13V prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
KRAS G13V prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
KRAS G13V prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
KRAS G13V anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
KRAS G13V anal cancer Primary 0 84 0.00 0.00 0.00 0.00
KRAS G13V neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
KRAS G13V neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
KRAS G13V neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
KRAS G13V bladder cancer Metastasis 0 390 0.00 0.00 0.00 0.00
KRAS G13V bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS G13V bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
KRAS G13V b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
KRAS G13V b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
KRAS G13V b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
KRAS G13V b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
KRAS G13V small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
KRAS G13V small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
KRAS G13V sex cord stromal tumor Metastasis 0 49 0.00 0.00 0.00 0.01
KRAS G13V sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
KRAS G13V bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS G13V bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS G13V bone cancer Primary 0 326 0.00 0.00 0.00 0.00
KRAS G13V bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
KRAS G13V vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.00
KRAS G13V vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
KRAS G13V thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS G13V thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS G13V ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
KRAS G13V ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
KRAS G13V small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
KRAS G13V small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
KRAS G13V mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS G13V mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS G13V germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
KRAS G13V germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.01
KRAS G13V germ cell tumor Primary 1 517 0.00 0.00 0.00 0.00
KRAS G13V germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
KRAS G13V nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
KRAS G13V nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
KRAS G13V nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
KRAS G13V penile cancer Metastasis 0 11 0.00 0.00 0.00 0.04
KRAS G13V penile cancer Primary 0 13 0.00 0.00 0.00 0.03
KRAS G13V pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
KRAS G13V pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
KRAS G13V b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
KRAS G13V b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
KRAS G13V b cell lymphoma Primary 0 709 0.00 0.00 0.00 0.00
KRAS G13V b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
KRAS G13V non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.02
KRAS G13V t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
KRAS G13V t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
KRAS G13V retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
KRAS G13V retinoblastoma Primary 0 41 0.00 0.00 0.00 0.02
KRAS G13V hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
KRAS G13V lung cancer Primary 0 17 0.00 0.00 0.00 0.03
KRAS G13V parathyroid cancer Primary 1 13 0.09 0.07 0.00 0.28
KRAS Q61H appendiceal cancer Metastasis 3 174 0.01 0.01 0.00 0.04
KRAS Q61H appendiceal cancer Tumor Type:NA/Heme 0 10 0.01 0.00 0.00 0.05
KRAS Q61H appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.02
KRAS Q61H colorectal cancer Metastasis 30 2354 0.01 0.01 0.01 0.02
KRAS Q61H colorectal cancer Tumor Type:NA/Heme 1 224 0.01 0.01 0.00 0.02
KRAS Q61H colorectal cancer Primary 32 4115 0.01 0.01 0.01 0.01
KRAS Q61H colorectal cancer Tumor Type:Unspecified 1 31 0.01 0.01 0.00 0.04
KRAS Q61H cancer of unknown primary Metastasis 10 1389 0.01 0.01 0.00 0.01
KRAS Q61H cancer of unknown primary Tumor Type:NA/Heme 1 229 0.01 0.01 0.00 0.01
KRAS Q61H cancer of unknown primary Primary 4 311 0.01 0.01 0.00 0.02
KRAS Q61H cancer of unknown primary Tumor Type:Unspecified 0 60 0.01 0.01 0.00 0.02
KRAS Q61H non-small cell lung cancer Metastasis 53 3750 0.01 0.01 0.01 0.02
KRAS Q61H non-small cell lung cancer Tumor Type:NA/Heme 3 223 0.01 0.01 0.01 0.02
KRAS Q61H non-small cell lung cancer Primary 75 6059 0.01 0.01 0.01 0.02
KRAS Q61H non-small cell lung cancer Tumor Type:Unspecified 0 99 0.01 0.01 0.00 0.02
KRAS Q61H breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
KRAS Q61H breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
KRAS Q61H breast cancer Primary 0 6125 0.00 0.00 0.00 0.00
KRAS Q61H soft tissue sarcoma Metastasis 1 939 0.00 0.00 0.00 0.00
KRAS Q61H soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
KRAS Q61H soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
KRAS Q61H soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
KRAS Q61H pancreatic cancer Metastasis 27 981 0.03 0.03 0.02 0.04
KRAS Q61H pancreatic cancer Tumor Type:NA/Heme 0 75 0.02 0.02 0.00 0.04
KRAS Q61H pancreatic cancer Primary 58 1429 0.04 0.04 0.03 0.05
KRAS Q61H leukemia Metastasis 0 15 0.00 0.00 0.00 0.02
KRAS Q61H leukemia Tumor Type:NA/Heme 4 923 0.00 0.00 0.00 0.01
KRAS Q61H leukemia Primary 0 412 0.00 0.00 0.00 0.00
KRAS Q61H leukemia Tumor Type:Unspecified 0 217 0.00 0.00 0.00 0.01
KRAS Q61H melanoma Metastasis 1 1738 0.00 0.00 0.00 0.00
KRAS Q61H melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
KRAS Q61H melanoma Primary 1 898 0.00 0.00 0.00 0.00
KRAS Q61H melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
KRAS Q61H head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
KRAS Q61H head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
KRAS Q61H head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
KRAS Q61H uterine cancer Metastasis 2 586 0.00 0.00 0.00 0.01
KRAS Q61H uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.01
KRAS Q61H uterine cancer Primary 4 1541 0.00 0.00 0.00 0.00
KRAS Q61H uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
KRAS Q61H non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS Q61H non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
KRAS Q61H non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
KRAS Q61H myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
KRAS Q61H myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
KRAS Q61H myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
KRAS Q61H myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
KRAS Q61H adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
KRAS Q61H adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
KRAS Q61H ovarian cancer Metastasis 5 1088 0.00 0.00 0.00 0.01
KRAS Q61H ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.01
KRAS Q61H ovarian cancer Primary 3 1060 0.00 0.00 0.00 0.01
KRAS Q61H ovarian cancer Tumor Type:Unspecified 1 28 0.01 0.00 0.00 0.04
KRAS Q61H esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
KRAS Q61H esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.01
KRAS Q61H esophagogastric cancer Primary 2 1283 0.00 0.00 0.00 0.00
KRAS Q61H esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
KRAS Q61H thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
KRAS Q61H thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
KRAS Q61H thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
KRAS Q61H cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
KRAS Q61H cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
KRAS Q61H cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
KRAS Q61H hepatobiliary cancer Metastasis 4 438 0.01 0.01 0.00 0.02
KRAS Q61H hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.01 0.01 0.00 0.02
KRAS Q61H hepatobiliary cancer Primary 10 895 0.01 0.01 0.01 0.02
KRAS Q61H kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
KRAS Q61H kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.01
KRAS Q61H kidney cancer Primary 1 944 0.00 0.00 0.00 0.00
KRAS Q61H mature t and nk neoplasms Metastasis 0 10 0.01 0.01 0.00 0.05
KRAS Q61H mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.01 0.01 0.00 0.03
KRAS Q61H mature t and nk neoplasms Primary 2 187 0.01 0.01 0.00 0.03
KRAS Q61H cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
KRAS Q61H cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
KRAS Q61H cns cancer Primary 3 3522 0.00 0.00 0.00 0.00
KRAS Q61H cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
KRAS Q61H prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
KRAS Q61H prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
KRAS Q61H prostate cancer Primary 1 1468 0.00 0.00 0.00 0.00
KRAS Q61H prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.01
KRAS Q61H anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
KRAS Q61H anal cancer Primary 0 84 0.00 0.00 0.00 0.00
KRAS Q61H neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.01
KRAS Q61H neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.02
KRAS Q61H neuroendocrine tumors Primary 1 196 0.00 0.00 0.00 0.02
KRAS Q61H bladder cancer Metastasis 0 390 0.00 0.00 0.00 0.00
KRAS Q61H bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
KRAS Q61H bladder cancer Primary 3 1164 0.00 0.00 0.00 0.01
KRAS Q61H b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.01 0.01 0.00 0.06
KRAS Q61H b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 1 109 0.01 0.01 0.00 0.03
KRAS Q61H b-lymphoblastic leukemia/lymphoma Primary 0 101 0.01 0.00 0.00 0.03
KRAS Q61H b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 2 25 0.04 0.03 0.00 0.16
KRAS Q61H small bowel cancer Metastasis 3 78 0.03 0.03 0.01 0.07
KRAS Q61H small bowel cancer Primary 3 128 0.03 0.03 0.01 0.06
KRAS Q61H sex cord stromal tumor Metastasis 0 49 0.00 0.00 0.00 0.01
KRAS Q61H sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
KRAS Q61H bone cancer Metastasis 1 203 0.00 0.00 0.00 0.01
KRAS Q61H bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
KRAS Q61H bone cancer Primary 0 326 0.00 0.00 0.00 0.01
KRAS Q61H bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.02
KRAS Q61H vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.00
KRAS Q61H vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
KRAS Q61H thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS Q61H thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS Q61H ampullary cancer Metastasis 0 23 0.02 0.01 0.00 0.06
KRAS Q61H ampullary cancer Primary 2 82 0.02 0.02 0.00 0.06
KRAS Q61H small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
KRAS Q61H small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
KRAS Q61H mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS Q61H mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor Primary 0 517 0.00 0.00 0.00 0.00
KRAS Q61H germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
KRAS Q61H nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
KRAS Q61H nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
KRAS Q61H nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
KRAS Q61H penile cancer Metastasis 0 11 0.00 0.00 0.00 0.04
KRAS Q61H penile cancer Primary 0 13 0.00 0.00 0.00 0.03
KRAS Q61H pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
KRAS Q61H pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
KRAS Q61H b cell lymphoma Metastasis 2 57 0.02 0.01 0.00 0.05
KRAS Q61H b cell lymphoma Tumor Type:NA/Heme 1 145 0.01 0.01 0.00 0.02
KRAS Q61H b cell lymphoma Primary 6 709 0.01 0.01 0.00 0.02
KRAS Q61H b cell lymphoma Tumor Type:Unspecified 1 51 0.01 0.01 0.00 0.04
KRAS Q61H non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.02
KRAS Q61H t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
KRAS Q61H t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
KRAS Q61H retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
KRAS Q61H retinoblastoma Primary 0 41 0.00 0.00 0.00 0.02
KRAS Q61H hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
KRAS Q61H lung cancer Primary 0 17 0.00 0.00 0.00 0.03
KRAS Q61H parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
KRAS Q61K appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
KRAS Q61K appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
KRAS Q61K appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer Metastasis 3 2354 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer Primary 9 4115 0.00 0.00 0.00 0.00
KRAS Q61K colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
KRAS Q61K cancer of unknown primary Metastasis 1 1389 0.00 0.00 0.00 0.00
KRAS Q61K cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
KRAS Q61K cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
KRAS Q61K cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer Metastasis 1 3750 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer Primary 1 6059 0.00 0.00 0.00 0.00
KRAS Q61K non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
KRAS Q61K breast cancer Primary 0 6125 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
KRAS Q61K soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
KRAS Q61K pancreatic cancer Metastasis 2 981 0.00 0.00 0.00 0.00
KRAS Q61K pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.01
KRAS Q61K pancreatic cancer Primary 1 1429 0.00 0.00 0.00 0.00
KRAS Q61K leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
KRAS Q61K leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
KRAS Q61K leukemia Primary 0 412 0.00 0.00 0.00 0.00
KRAS Q61K leukemia Tumor Type:Unspecified 0 217 0.00 0.00 0.00 0.00
KRAS Q61K melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
KRAS Q61K melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
KRAS Q61K melanoma Primary 0 898 0.00 0.00 0.00 0.00
KRAS Q61K melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
KRAS Q61K head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
KRAS Q61K head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
KRAS Q61K head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
KRAS Q61K uterine cancer Metastasis 1 586 0.00 0.00 0.00 0.00
KRAS Q61K uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
KRAS Q61K uterine cancer Primary 0 1541 0.00 0.00 0.00 0.00
KRAS Q61K uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
KRAS Q61K non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS Q61K non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
KRAS Q61K non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
KRAS Q61K myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
KRAS Q61K myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
KRAS Q61K myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
KRAS Q61K myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
KRAS Q61K adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.01
KRAS Q61K adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
KRAS Q61K ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
KRAS Q61K ovarian cancer Tumor Type:NA/Heme 1 160 0.00 0.00 0.00 0.02
KRAS Q61K ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
KRAS Q61K ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.01
KRAS Q61K esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
KRAS Q61K esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
KRAS Q61K esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
KRAS Q61K esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
KRAS Q61K thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
KRAS Q61K thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.01
KRAS Q61K thyroid cancer Primary 1 582 0.00 0.00 0.00 0.00
KRAS Q61K cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
KRAS Q61K cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
KRAS Q61K cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
KRAS Q61K hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
KRAS Q61K hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
KRAS Q61K hepatobiliary cancer Primary 0 895 0.00 0.00 0.00 0.00
KRAS Q61K kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
KRAS Q61K kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
KRAS Q61K kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
KRAS Q61K mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
KRAS Q61K mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
KRAS Q61K mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer Primary 1 3522 0.00 0.00 0.00 0.00
KRAS Q61K cns cancer Tumor Type:Unspecified 1 108 0.00 0.00 0.00 0.02
KRAS Q61K prostate cancer Metastasis 1 901 0.00 0.00 0.00 0.00
KRAS Q61K prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
KRAS Q61K prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
KRAS Q61K prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.01
KRAS Q61K anal cancer Metastasis 1 59 0.01 0.01 0.00 0.05
KRAS Q61K anal cancer Primary 0 84 0.00 0.00 0.00 0.02
KRAS Q61K neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.01
KRAS Q61K neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.02
KRAS Q61K neuroendocrine tumors Primary 1 196 0.00 0.00 0.00 0.01
KRAS Q61K bladder cancer Metastasis 0 390 0.00 0.00 0.00 0.00
KRAS Q61K bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS Q61K bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
KRAS Q61K b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
KRAS Q61K b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
KRAS Q61K b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
KRAS Q61K b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
KRAS Q61K small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
KRAS Q61K small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
KRAS Q61K sex cord stromal tumor Metastasis 0 49 0.00 0.00 0.00 0.01
KRAS Q61K sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
KRAS Q61K bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS Q61K bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS Q61K bone cancer Primary 0 326 0.00 0.00 0.00 0.00
KRAS Q61K bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
KRAS Q61K vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
KRAS Q61K vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
KRAS Q61K thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS Q61K thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS Q61K ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
KRAS Q61K ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
KRAS Q61K small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
KRAS Q61K small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
KRAS Q61K mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS Q61K mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor Primary 0 517 0.00 0.00 0.00 0.00
KRAS Q61K germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
KRAS Q61K nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
KRAS Q61K nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
KRAS Q61K nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
KRAS Q61K penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
KRAS Q61K penile cancer Primary 0 13 0.00 0.00 0.00 0.03
KRAS Q61K pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.03
KRAS Q61K pineal tumor Primary 0 14 0.00 0.00 0.00 0.05
KRAS Q61K b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
KRAS Q61K b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
KRAS Q61K b cell lymphoma Primary 0 709 0.00 0.00 0.00 0.00
KRAS Q61K b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
KRAS Q61K non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
KRAS Q61K t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
KRAS Q61K t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
KRAS Q61K retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.01
KRAS Q61K retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
KRAS Q61K hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
KRAS Q61K lung cancer Primary 0 17 0.00 0.00 0.00 0.04
KRAS Q61K parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
KRAS Q61L appendiceal cancer Metastasis 1 174 0.00 0.00 0.00 0.02
KRAS Q61L appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.03
KRAS Q61L appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.01
KRAS Q61L colorectal cancer Metastasis 9 2354 0.00 0.00 0.00 0.01
KRAS Q61L colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.01
KRAS Q61L colorectal cancer Primary 15 4115 0.00 0.00 0.00 0.00
KRAS Q61L colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
KRAS Q61L cancer of unknown primary Metastasis 1 1389 0.00 0.00 0.00 0.00
KRAS Q61L cancer of unknown primary Tumor Type:NA/Heme 2 229 0.00 0.00 0.00 0.02
KRAS Q61L cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
KRAS Q61L cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.01
KRAS Q61L non-small cell lung cancer Metastasis 13 3750 0.00 0.00 0.00 0.00
KRAS Q61L non-small cell lung cancer Tumor Type:NA/Heme 2 223 0.00 0.00 0.00 0.01
KRAS Q61L non-small cell lung cancer Primary 22 6059 0.00 0.00 0.00 0.00
KRAS Q61L non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.01
KRAS Q61L breast cancer Metastasis 1 3094 0.00 0.00 0.00 0.00
KRAS Q61L breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
KRAS Q61L breast cancer Primary 0 6125 0.00 0.00 0.00 0.00
KRAS Q61L soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
KRAS Q61L soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
KRAS Q61L soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
KRAS Q61L soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
KRAS Q61L pancreatic cancer Metastasis 5 981 0.00 0.00 0.00 0.01
KRAS Q61L pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.01
KRAS Q61L pancreatic cancer Primary 1 1429 0.00 0.00 0.00 0.00
KRAS Q61L leukemia Metastasis 0 15 0.00 0.00 0.00 0.02
KRAS Q61L leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
KRAS Q61L leukemia Primary 0 412 0.00 0.00 0.00 0.00
KRAS Q61L leukemia Tumor Type:Unspecified 1 217 0.00 0.00 0.00 0.01
KRAS Q61L melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
KRAS Q61L melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
KRAS Q61L melanoma Primary 2 898 0.00 0.00 0.00 0.00
KRAS Q61L melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
KRAS Q61L head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
KRAS Q61L head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
KRAS Q61L head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
KRAS Q61L uterine cancer Metastasis 2 586 0.00 0.00 0.00 0.01
KRAS Q61L uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.01
KRAS Q61L uterine cancer Primary 0 1541 0.00 0.00 0.00 0.00
KRAS Q61L uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
KRAS Q61L non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS Q61L non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
KRAS Q61L non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
KRAS Q61L myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
KRAS Q61L myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
KRAS Q61L myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
KRAS Q61L myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
KRAS Q61L adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
KRAS Q61L adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
KRAS Q61L ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
KRAS Q61L ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
KRAS Q61L ovarian cancer Primary 1 1060 0.00 0.00 0.00 0.00
KRAS Q61L ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
KRAS Q61L esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
KRAS Q61L thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
KRAS Q61L thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
KRAS Q61L thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
KRAS Q61L cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
KRAS Q61L cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
KRAS Q61L cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
KRAS Q61L hepatobiliary cancer Metastasis 2 438 0.00 0.00 0.00 0.01
KRAS Q61L hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.02
KRAS Q61L hepatobiliary cancer Primary 0 895 0.00 0.00 0.00 0.00
KRAS Q61L kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
KRAS Q61L kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
KRAS Q61L kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
KRAS Q61L mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
KRAS Q61L mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
KRAS Q61L mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer Tumor Type:NA/Heme 1 526 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer Primary 1 3522 0.00 0.00 0.00 0.00
KRAS Q61L cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
KRAS Q61L prostate cancer Metastasis 1 901 0.00 0.00 0.00 0.00
KRAS Q61L prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
KRAS Q61L prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
KRAS Q61L prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.01
KRAS Q61L anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
KRAS Q61L anal cancer Primary 0 84 0.00 0.00 0.00 0.00
KRAS Q61L neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
KRAS Q61L neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
KRAS Q61L neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
KRAS Q61L bladder cancer Metastasis 0 390 0.00 0.00 0.00 0.00
KRAS Q61L bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
KRAS Q61L bladder cancer Primary 1 1164 0.00 0.00 0.00 0.00
KRAS Q61L b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
KRAS Q61L b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
KRAS Q61L b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
KRAS Q61L b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
KRAS Q61L small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
KRAS Q61L small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
KRAS Q61L sex cord stromal tumor Metastasis 0 49 0.00 0.00 0.00 0.01
KRAS Q61L sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
KRAS Q61L bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS Q61L bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS Q61L bone cancer Primary 0 326 0.00 0.00 0.00 0.00
KRAS Q61L bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
KRAS Q61L vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.00
KRAS Q61L vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
KRAS Q61L thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS Q61L thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS Q61L ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
KRAS Q61L ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
KRAS Q61L small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
KRAS Q61L small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
KRAS Q61L mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS Q61L mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor Primary 0 517 0.00 0.00 0.00 0.00
KRAS Q61L germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
KRAS Q61L nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
KRAS Q61L nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
KRAS Q61L nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
KRAS Q61L penile cancer Metastasis 0 11 0.03 0.02 0.00 0.15
KRAS Q61L penile cancer Primary 1 13 0.06 0.04 0.00 0.21
KRAS Q61L pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
KRAS Q61L pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
KRAS Q61L b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
KRAS Q61L b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
KRAS Q61L b cell lymphoma Primary 1 709 0.00 0.00 0.00 0.00
KRAS Q61L b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
KRAS Q61L non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.02
KRAS Q61L t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
KRAS Q61L t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
KRAS Q61L retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
KRAS Q61L retinoblastoma Primary 0 41 0.00 0.00 0.00 0.02
KRAS Q61L hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
KRAS Q61L lung cancer Primary 0 17 0.00 0.00 0.00 0.03
KRAS Q61L parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
KRAS Q61R appendiceal cancer Metastasis 1 174 0.00 0.00 0.00 0.02
KRAS Q61R appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.03
KRAS Q61R appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.01
KRAS Q61R colorectal cancer Metastasis 4 2354 0.00 0.00 0.00 0.00
KRAS Q61R colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.01
KRAS Q61R colorectal cancer Primary 16 4115 0.00 0.00 0.00 0.00
KRAS Q61R colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
KRAS Q61R cancer of unknown primary Metastasis 3 1389 0.00 0.00 0.00 0.00
KRAS Q61R cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
KRAS Q61R cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
KRAS Q61R cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.01
KRAS Q61R non-small cell lung cancer Metastasis 3 3750 0.00 0.00 0.00 0.00
KRAS Q61R non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
KRAS Q61R non-small cell lung cancer Primary 4 6059 0.00 0.00 0.00 0.00
KRAS Q61R non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
KRAS Q61R breast cancer Tumor Type:NA/Heme 1 105 0.01 0.00 0.00 0.03
KRAS Q61R breast cancer Primary 0 6125 0.00 0.00 0.00 0.00
KRAS Q61R soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
KRAS Q61R soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
KRAS Q61R soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
KRAS Q61R soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
KRAS Q61R pancreatic cancer Metastasis 22 981 0.02 0.02 0.01 0.03
KRAS Q61R pancreatic cancer Tumor Type:NA/Heme 0 75 0.01 0.01 0.00 0.03
KRAS Q61R pancreatic cancer Primary 16 1429 0.01 0.01 0.01 0.02
KRAS Q61R leukemia Metastasis 0 15 0.00 0.00 0.00 0.01
KRAS Q61R leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
KRAS Q61R leukemia Primary 1 412 0.00 0.00 0.00 0.01
KRAS Q61R leukemia Tumor Type:Unspecified 0 217 0.00 0.00 0.00 0.00
KRAS Q61R melanoma Metastasis 1 1738 0.00 0.00 0.00 0.00
KRAS Q61R melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
KRAS Q61R melanoma Primary 2 898 0.00 0.00 0.00 0.00
KRAS Q61R melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
KRAS Q61R head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
KRAS Q61R head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
KRAS Q61R head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
KRAS Q61R uterine cancer Metastasis 0 586 0.00 0.00 0.00 0.00
KRAS Q61R uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
KRAS Q61R uterine cancer Primary 0 1541 0.00 0.00 0.00 0.00
KRAS Q61R uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
KRAS Q61R non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS Q61R non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
KRAS Q61R non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
KRAS Q61R myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
KRAS Q61R myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
KRAS Q61R myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
KRAS Q61R myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
KRAS Q61R adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
KRAS Q61R adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
KRAS Q61R ovarian cancer Metastasis 1 1088 0.00 0.00 0.00 0.00
KRAS Q61R ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
KRAS Q61R ovarian cancer Primary 1 1060 0.00 0.00 0.00 0.00
KRAS Q61R ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.01
KRAS Q61R esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
KRAS Q61R esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
KRAS Q61R esophagogastric cancer Primary 1 1283 0.00 0.00 0.00 0.00
KRAS Q61R esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
KRAS Q61R thyroid cancer Metastasis 3 402 0.01 0.01 0.00 0.02
KRAS Q61R thyroid cancer Tumor Type:NA/Heme 3 28 0.06 0.04 0.01 0.19
KRAS Q61R thyroid cancer Primary 9 582 0.02 0.02 0.01 0.03
KRAS Q61R cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
KRAS Q61R cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
KRAS Q61R cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
KRAS Q61R hepatobiliary cancer Metastasis 1 438 0.00 0.00 0.00 0.01
KRAS Q61R hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.01
KRAS Q61R hepatobiliary cancer Primary 1 895 0.00 0.00 0.00 0.00
KRAS Q61R kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
KRAS Q61R kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
KRAS Q61R kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
KRAS Q61R mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
KRAS Q61R mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
KRAS Q61R mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer Metastasis 1 409 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer Primary 3 3522 0.00 0.00 0.00 0.00
KRAS Q61R cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
KRAS Q61R prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
KRAS Q61R prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.01
KRAS Q61R prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
KRAS Q61R prostate cancer Tumor Type:Unspecified 1 12 0.07 0.05 0.00 0.26
KRAS Q61R anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
KRAS Q61R anal cancer Primary 0 84 0.00 0.00 0.00 0.00
KRAS Q61R neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
KRAS Q61R neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
KRAS Q61R neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
KRAS Q61R bladder cancer Metastasis 0 390 0.00 0.00 0.00 0.00
KRAS Q61R bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
KRAS Q61R bladder cancer Primary 1 1164 0.00 0.00 0.00 0.00
KRAS Q61R b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
KRAS Q61R b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
KRAS Q61R b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
KRAS Q61R b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
KRAS Q61R small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
KRAS Q61R small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
KRAS Q61R sex cord stromal tumor Metastasis 0 49 0.00 0.00 0.00 0.00
KRAS Q61R sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
KRAS Q61R bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
KRAS Q61R bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
KRAS Q61R bone cancer Primary 0 326 0.00 0.00 0.00 0.00
KRAS Q61R bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
KRAS Q61R vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
KRAS Q61R vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
KRAS Q61R thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
KRAS Q61R thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
KRAS Q61R ampullary cancer Metastasis 0 23 0.02 0.01 0.00 0.06
KRAS Q61R ampullary cancer Primary 2 82 0.02 0.02 0.00 0.06
KRAS Q61R small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
KRAS Q61R small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
KRAS Q61R mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
KRAS Q61R mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor Primary 0 517 0.00 0.00 0.00 0.00
KRAS Q61R germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
KRAS Q61R nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.01
KRAS Q61R nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.01
KRAS Q61R nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
KRAS Q61R penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
KRAS Q61R penile cancer Primary 0 13 0.00 0.00 0.00 0.03
KRAS Q61R pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.02
KRAS Q61R pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
KRAS Q61R b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
KRAS Q61R b cell lymphoma Tumor Type:NA/Heme 2 145 0.01 0.00 0.00 0.03
KRAS Q61R b cell lymphoma Primary 1 709 0.00 0.00 0.00 0.01
KRAS Q61R b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
KRAS Q61R non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
KRAS Q61R t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
KRAS Q61R t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
KRAS Q61R retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.01
KRAS Q61R retinoblastoma Primary 0 41 0.00 0.00 0.00 0.00
KRAS Q61R hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
KRAS Q61R lung cancer Primary 0 17 0.00 0.00 0.00 0.04
KRAS Q61R parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
HRAS G12A appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS G12A appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS G12A appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
HRAS G12A colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
HRAS G12A cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
HRAS G12A non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS G12A breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
HRAS G12A breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS G12A breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
HRAS G12A pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
HRAS G12A pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS G12A pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
HRAS G12A leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS G12A leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS G12A leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS G12A leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS G12A melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
HRAS G12A melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
HRAS G12A melanoma Primary 0 898 0.00 0.00 0.00 0.00
HRAS G12A melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
HRAS G12A head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
HRAS G12A head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.01
HRAS G12A head and neck cancer Primary 1 938 0.00 0.00 0.00 0.00
HRAS G12A uterine cancer Metastasis 0 583 0.00 0.00 0.00 0.00
HRAS G12A uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS G12A uterine cancer Primary 0 1538 0.00 0.00 0.00 0.00
HRAS G12A uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G12A non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
HRAS G12A non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
HRAS G12A non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
HRAS G12A myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS G12A myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS G12A myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS G12A myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G12A adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.01
HRAS G12A adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma Metastasis 0 928 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma Primary 0 1668 0.00 0.00 0.00 0.00
HRAS G12A soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.00
HRAS G12A ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS G12A ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS G12A ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
HRAS G12A ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
HRAS G12A esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12A thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
HRAS G12A thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G12A thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
HRAS G12A cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
HRAS G12A cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
HRAS G12A cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
HRAS G12A hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS G12A hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
HRAS G12A hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
HRAS G12A kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS G12A kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS G12A kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS G12A cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS G12A cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
HRAS G12A cns cancer Primary 0 3521 0.00 0.00 0.00 0.00
HRAS G12A cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS G12A prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
HRAS G12A prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
HRAS G12A prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
HRAS G12A prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
HRAS G12A anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS G12A anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS G12A neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
HRAS G12A neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
HRAS G12A neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
HRAS G12A bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
HRAS G12A bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G12A bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
HRAS G12A b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS G12A b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS G12A b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS G12A b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS G12A small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS G12A small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS G12A sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
HRAS G12A sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
HRAS G12A bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS G12A bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G12A bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS G12A bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12A vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
HRAS G12A vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
HRAS G12A thymic tumor Metastasis 0 60 0.00 0.00 0.00 0.00
HRAS G12A thymic tumor Primary 0 83 0.00 0.00 0.00 0.00
HRAS G12A ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
HRAS G12A ampullary cancer Primary 0 82 0.00 0.00 0.00 0.01
HRAS G12A small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
HRAS G12A small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
HRAS G12A mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
HRAS G12A mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G12A mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS G12A mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS G12A mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS G12A germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12A nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS G12A nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
HRAS G12A nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS G12A penile cancer Metastasis 0 11 0.00 0.00 0.00 0.04
HRAS G12A penile cancer Primary 0 13 0.00 0.00 0.00 0.04
HRAS G12A pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.03
HRAS G12A pineal tumor Primary 0 14 0.00 0.00 0.00 0.03
HRAS G12A b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS G12A b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS G12A b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS G12A b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G12A non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
HRAS G12A t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
HRAS G12A t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
HRAS G12A retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
HRAS G12A retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
HRAS G12A hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
HRAS G12A lung cancer Primary 0 17 0.00 0.00 0.00 0.04
HRAS G12A parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
HRAS G12C appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS G12C appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS G12C appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
HRAS G12C colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
HRAS G12C cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
HRAS G12C non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS G12C breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
HRAS G12C breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS G12C breast cancer Primary 2 6124 0.00 0.00 0.00 0.00
HRAS G12C pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
HRAS G12C pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS G12C pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
HRAS G12C leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS G12C leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS G12C leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS G12C leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS G12C melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
HRAS G12C melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
HRAS G12C melanoma Primary 0 898 0.00 0.00 0.00 0.00
HRAS G12C melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
HRAS G12C head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
HRAS G12C head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
HRAS G12C head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
HRAS G12C uterine cancer Metastasis 0 583 0.00 0.00 0.00 0.00
HRAS G12C uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS G12C uterine cancer Primary 0 1538 0.00 0.00 0.00 0.00
HRAS G12C uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G12C non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.01
HRAS G12C non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.02
HRAS G12C non-melanoma skin cancers Primary 1 287 0.00 0.00 0.00 0.01
HRAS G12C myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS G12C myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS G12C myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS G12C myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G12C adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
HRAS G12C adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma Metastasis 0 928 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma Primary 0 1668 0.00 0.00 0.00 0.00
HRAS G12C soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.00
HRAS G12C ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS G12C ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS G12C ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
HRAS G12C ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
HRAS G12C esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12C thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
HRAS G12C thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G12C thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
HRAS G12C cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
HRAS G12C cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
HRAS G12C cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
HRAS G12C hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS G12C hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
HRAS G12C hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
HRAS G12C kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS G12C kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS G12C kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS G12C cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS G12C cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
HRAS G12C cns cancer Primary 0 3521 0.00 0.00 0.00 0.00
HRAS G12C cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS G12C prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
HRAS G12C prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
HRAS G12C prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
HRAS G12C prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
HRAS G12C anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS G12C anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS G12C neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
HRAS G12C neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
HRAS G12C neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
HRAS G12C bladder cancer Metastasis 1 389 0.00 0.00 0.00 0.01
HRAS G12C bladder cancer Tumor Type:NA/Heme 1 25 0.02 0.00 0.00 0.09
HRAS G12C bladder cancer Primary 1 1164 0.00 0.00 0.00 0.00
HRAS G12C b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS G12C b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS G12C b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS G12C b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS G12C small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS G12C small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS G12C sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
HRAS G12C sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
HRAS G12C bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS G12C bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G12C bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS G12C bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12C vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
HRAS G12C vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
HRAS G12C thymic tumor Metastasis 0 60 0.00 0.00 0.00 0.00
HRAS G12C thymic tumor Primary 0 83 0.00 0.00 0.00 0.00
HRAS G12C ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
HRAS G12C ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
HRAS G12C small cell lung cancer Metastasis 1 207 0.00 0.00 0.00 0.02
HRAS G12C small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.01
HRAS G12C mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
HRAS G12C mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G12C mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS G12C mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS G12C mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS G12C germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12C nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS G12C nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
HRAS G12C nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS G12C penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
HRAS G12C penile cancer Primary 0 13 0.00 0.00 0.00 0.03
HRAS G12C pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.02
HRAS G12C pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
HRAS G12C b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS G12C b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS G12C b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS G12C b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G12C non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
HRAS G12C t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
HRAS G12C t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.01
HRAS G12C retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
HRAS G12C retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
HRAS G12C hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.02
HRAS G12C lung cancer Primary 0 17 0.00 0.00 0.00 0.02
HRAS G12C parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
HRAS G12D appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS G12D appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS G12D appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS G12D colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS G12D colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS G12D colorectal cancer Primary 3 4113 0.00 0.00 0.00 0.00
HRAS G12D colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
HRAS G12D cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
HRAS G12D cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
HRAS G12D cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
HRAS G12D cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer Metastasis 1 3750 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
HRAS G12D non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS G12D breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
HRAS G12D breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS G12D breast cancer Primary 3 6124 0.00 0.00 0.00 0.00
HRAS G12D pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
HRAS G12D pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS G12D pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
HRAS G12D leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS G12D leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS G12D leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS G12D leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS G12D melanoma Metastasis 5 1738 0.00 0.00 0.00 0.00
HRAS G12D melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.01
HRAS G12D melanoma Primary 2 898 0.00 0.00 0.00 0.00
HRAS G12D melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
HRAS G12D head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
HRAS G12D head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.01
HRAS G12D head and neck cancer Primary 2 938 0.00 0.00 0.00 0.00
HRAS G12D uterine cancer Metastasis 1 583 0.00 0.00 0.00 0.00
HRAS G12D uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS G12D uterine cancer Primary 1 1538 0.00 0.00 0.00 0.00
HRAS G12D uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G12D non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.01
HRAS G12D non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.02
HRAS G12D non-melanoma skin cancers Primary 1 287 0.00 0.00 0.00 0.01
HRAS G12D myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS G12D myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS G12D myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS G12D myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G12D adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
HRAS G12D adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS G12D soft tissue sarcoma Metastasis 0 928 0.00 0.00 0.00 0.00
HRAS G12D soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
HRAS G12D soft tissue sarcoma Primary 1 1668 0.00 0.00 0.00 0.00
HRAS G12D soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.00
HRAS G12D ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS G12D ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS G12D ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
HRAS G12D ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
HRAS G12D esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12D thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
HRAS G12D thyroid cancer Tumor Type:NA/Heme 1 28 0.03 0.02 0.00 0.12
HRAS G12D thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
HRAS G12D cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
HRAS G12D cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
HRAS G12D cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
HRAS G12D hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS G12D hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
HRAS G12D hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
HRAS G12D kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS G12D kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS G12D kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS G12D cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS G12D cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
HRAS G12D cns cancer Primary 0 3521 0.00 0.00 0.00 0.00
HRAS G12D cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS G12D prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
HRAS G12D prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
HRAS G12D prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
HRAS G12D prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
HRAS G12D anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS G12D anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS G12D neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
HRAS G12D neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
HRAS G12D neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
HRAS G12D bladder cancer Metastasis 1 389 0.00 0.00 0.00 0.01
HRAS G12D bladder cancer Tumor Type:NA/Heme 1 25 0.01 0.01 0.00 0.07
HRAS G12D bladder cancer Primary 7 1164 0.01 0.01 0.00 0.01
HRAS G12D b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS G12D b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS G12D b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS G12D b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS G12D small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS G12D small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS G12D sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.01
HRAS G12D sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
HRAS G12D bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS G12D bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G12D bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS G12D bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12D vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
HRAS G12D vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
HRAS G12D thymic tumor Metastasis 0 60 0.00 0.00 0.00 0.00
HRAS G12D thymic tumor Primary 0 83 0.00 0.00 0.00 0.00
HRAS G12D ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.00
HRAS G12D ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
HRAS G12D small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
HRAS G12D small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
HRAS G12D mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
HRAS G12D mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G12D mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS G12D mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS G12D mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS G12D germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12D nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS G12D nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
HRAS G12D nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS G12D penile cancer Metastasis 0 11 0.00 0.00 0.00 0.05
HRAS G12D penile cancer Primary 0 13 0.00 0.00 0.00 0.05
HRAS G12D pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
HRAS G12D pineal tumor Primary 0 14 0.00 0.00 0.00 0.03
HRAS G12D b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS G12D b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS G12D b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS G12D b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G12D non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
HRAS G12D t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
HRAS G12D t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
HRAS G12D retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
HRAS G12D retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
HRAS G12D hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
HRAS G12D lung cancer Primary 0 17 0.00 0.00 0.00 0.04
HRAS G12D parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
HRAS G12F appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS G12F appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS G12F appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
HRAS G12F colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
HRAS G12F cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
HRAS G12F non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS G12F breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
HRAS G12F breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS G12F breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
HRAS G12F pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
HRAS G12F pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS G12F pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
HRAS G12F leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS G12F leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS G12F leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS G12F leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS G12F melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
HRAS G12F melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
HRAS G12F melanoma Primary 0 898 0.00 0.00 0.00 0.00
HRAS G12F melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
HRAS G12F head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
HRAS G12F head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
HRAS G12F head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
HRAS G12F uterine cancer Metastasis 0 583 0.00 0.00 0.00 0.00
HRAS G12F uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS G12F uterine cancer Primary 0 1538 0.00 0.00 0.00 0.00
HRAS G12F uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G12F non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
HRAS G12F non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
HRAS G12F non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
HRAS G12F myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS G12F myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS G12F myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS G12F myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G12F adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
HRAS G12F adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS G12F soft tissue sarcoma Metastasis 0 928 0.00 0.00 0.00 0.00
HRAS G12F soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
HRAS G12F soft tissue sarcoma Primary 0 1668 0.00 0.00 0.00 0.00
HRAS G12F soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.00
HRAS G12F ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS G12F ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS G12F ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
HRAS G12F ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
HRAS G12F esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12F thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
HRAS G12F thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G12F thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
HRAS G12F cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
HRAS G12F cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
HRAS G12F cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
HRAS G12F hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS G12F hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
HRAS G12F hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
HRAS G12F kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS G12F kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS G12F kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS G12F cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS G12F cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
HRAS G12F cns cancer Primary 0 3521 0.00 0.00 0.00 0.00
HRAS G12F cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS G12F prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
HRAS G12F prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
HRAS G12F prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
HRAS G12F prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
HRAS G12F anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS G12F anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS G12F neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
HRAS G12F neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
HRAS G12F neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
HRAS G12F bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
HRAS G12F bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
HRAS G12F bladder cancer Primary 1 1164 0.00 0.00 0.00 0.00
HRAS G12F b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS G12F b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS G12F b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS G12F b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS G12F small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS G12F small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS G12F sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.01
HRAS G12F sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
HRAS G12F bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS G12F bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G12F bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS G12F bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12F vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
HRAS G12F vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
HRAS G12F thymic tumor Metastasis 0 60 0.00 0.00 0.00 0.00
HRAS G12F thymic tumor Primary 0 83 0.00 0.00 0.00 0.00
HRAS G12F ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.00
HRAS G12F ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
HRAS G12F small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
HRAS G12F small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
HRAS G12F mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
HRAS G12F mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G12F mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS G12F mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS G12F mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS G12F germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12F nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS G12F nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
HRAS G12F nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS G12F penile cancer Metastasis 0 11 0.00 0.00 0.00 0.05
HRAS G12F penile cancer Primary 0 13 0.00 0.00 0.00 0.05
HRAS G12F pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
HRAS G12F pineal tumor Primary 0 14 0.00 0.00 0.00 0.03
HRAS G12F b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS G12F b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS G12F b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS G12F b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G12F non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
HRAS G12F t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
HRAS G12F t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
HRAS G12F retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
HRAS G12F retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
HRAS G12F hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
HRAS G12F lung cancer Primary 0 17 0.00 0.00 0.00 0.04
HRAS G12F parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
HRAS G12R appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS G12R appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS G12R appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
HRAS G12R colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
HRAS G12R cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
HRAS G12R non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS G12R breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
HRAS G12R breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS G12R breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
HRAS G12R pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
HRAS G12R pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS G12R pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
HRAS G12R leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS G12R leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS G12R leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS G12R leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS G12R melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
HRAS G12R melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
HRAS G12R melanoma Primary 0 898 0.00 0.00 0.00 0.00
HRAS G12R melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
HRAS G12R head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
HRAS G12R head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
HRAS G12R head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
HRAS G12R uterine cancer Metastasis 0 583 0.00 0.00 0.00 0.00
HRAS G12R uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS G12R uterine cancer Primary 0 1538 0.00 0.00 0.00 0.00
HRAS G12R uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G12R non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
HRAS G12R non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
HRAS G12R non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
HRAS G12R myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS G12R myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS G12R myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS G12R myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G12R adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
HRAS G12R adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma Metastasis 0 928 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma Primary 0 1668 0.00 0.00 0.00 0.00
HRAS G12R soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.00
HRAS G12R ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS G12R ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS G12R ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
HRAS G12R ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
HRAS G12R esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12R thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
HRAS G12R thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G12R thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
HRAS G12R cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
HRAS G12R cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
HRAS G12R cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
HRAS G12R hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS G12R hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
HRAS G12R hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
HRAS G12R kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS G12R kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS G12R kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS G12R cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS G12R cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
HRAS G12R cns cancer Primary 0 3521 0.00 0.00 0.00 0.00
HRAS G12R cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS G12R prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
HRAS G12R prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
HRAS G12R prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
HRAS G12R prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
HRAS G12R anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS G12R anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS G12R neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
HRAS G12R neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
HRAS G12R neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
HRAS G12R bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
HRAS G12R bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G12R bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
HRAS G12R b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS G12R b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS G12R b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS G12R b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS G12R small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS G12R small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS G12R sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
HRAS G12R sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
HRAS G12R bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS G12R bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G12R bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS G12R bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12R vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.02
HRAS G12R vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
HRAS G12R thymic tumor Metastasis 0 60 0.00 0.00 0.00 0.00
HRAS G12R thymic tumor Primary 0 83 0.00 0.00 0.00 0.00
HRAS G12R ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
HRAS G12R ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
HRAS G12R small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
HRAS G12R small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
HRAS G12R mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.01
HRAS G12R mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G12R mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS G12R mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS G12R mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS G12R germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12R nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS G12R nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
HRAS G12R nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS G12R penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
HRAS G12R penile cancer Primary 0 13 0.00 0.00 0.00 0.03
HRAS G12R pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.03
HRAS G12R pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
HRAS G12R b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS G12R b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS G12R b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS G12R b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G12R non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
HRAS G12R t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
HRAS G12R t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
HRAS G12R retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
HRAS G12R retinoblastoma Primary 0 41 0.00 0.00 0.00 0.02
HRAS G12R hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.02
HRAS G12R lung cancer Primary 0 17 0.00 0.00 0.00 0.03
HRAS G12R parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
HRAS G12S appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS G12S appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS G12S appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer Primary 1 4113 0.00 0.00 0.00 0.00
HRAS G12S colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G12S cancer of unknown primary Metastasis 1 1388 0.00 0.00 0.00 0.00
HRAS G12S cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
HRAS G12S cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
HRAS G12S cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
HRAS G12S non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS G12S breast cancer Metastasis 1 3094 0.00 0.00 0.00 0.00
HRAS G12S breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS G12S breast cancer Primary 2 6124 0.00 0.00 0.00 0.00
HRAS G12S pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
HRAS G12S pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS G12S pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
HRAS G12S leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS G12S leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS G12S leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS G12S leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS G12S melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
HRAS G12S melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
HRAS G12S melanoma Primary 0 898 0.00 0.00 0.00 0.00
HRAS G12S melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
HRAS G12S head and neck cancer Metastasis 2 731 0.00 0.00 0.00 0.01
HRAS G12S head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.02
HRAS G12S head and neck cancer Primary 9 938 0.01 0.01 0.00 0.02
HRAS G12S uterine cancer Metastasis 0 583 0.00 0.00 0.00 0.00
HRAS G12S uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS G12S uterine cancer Primary 2 1538 0.00 0.00 0.00 0.00
HRAS G12S uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G12S non-melanoma skin cancers Metastasis 1 203 0.00 0.00 0.00 0.01
HRAS G12S non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.02
HRAS G12S non-melanoma skin cancers Primary 1 287 0.00 0.00 0.00 0.01
HRAS G12S myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS G12S myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS G12S myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS G12S myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G12S adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
HRAS G12S adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma Metastasis 0 928 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma Primary 0 1668 0.00 0.00 0.00 0.00
HRAS G12S soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.00
HRAS G12S ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS G12S ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS G12S ovarian cancer Primary 1 1060 0.00 0.00 0.00 0.00
HRAS G12S ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS G12S esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS G12S esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.01
HRAS G12S esophagogastric cancer Primary 1 1283 0.00 0.00 0.00 0.00
HRAS G12S esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
HRAS G12S thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
HRAS G12S thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G12S thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
HRAS G12S cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
HRAS G12S cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
HRAS G12S cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
HRAS G12S hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS G12S hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
HRAS G12S hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
HRAS G12S kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS G12S kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS G12S kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS G12S cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS G12S cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
HRAS G12S cns cancer Primary 0 3521 0.00 0.00 0.00 0.00
HRAS G12S cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS G12S prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
HRAS G12S prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
HRAS G12S prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
HRAS G12S prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
HRAS G12S anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS G12S anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS G12S neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
HRAS G12S neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
HRAS G12S neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
HRAS G12S bladder cancer Metastasis 1 389 0.00 0.00 0.00 0.01
HRAS G12S bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
HRAS G12S bladder cancer Primary 2 1164 0.00 0.00 0.00 0.00
HRAS G12S b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS G12S b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS G12S b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS G12S b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS G12S small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS G12S small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS G12S sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
HRAS G12S sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
HRAS G12S bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS G12S bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G12S bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS G12S bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12S vaginal cancer Metastasis 0 16 0.02 0.01 0.00 0.06
HRAS G12S vaginal cancer Primary 1 60 0.02 0.01 0.00 0.06
HRAS G12S thymic tumor Metastasis 0 60 0.01 0.00 0.00 0.03
HRAS G12S thymic tumor Primary 1 83 0.01 0.01 0.00 0.04
HRAS G12S ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
HRAS G12S ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
HRAS G12S small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
HRAS G12S small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
HRAS G12S mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.01
HRAS G12S mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G12S mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS G12S mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS G12S mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS G12S germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12S nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS G12S nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
HRAS G12S nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS G12S penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
HRAS G12S penile cancer Primary 0 13 0.00 0.00 0.00 0.03
HRAS G12S pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.03
HRAS G12S pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
HRAS G12S b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS G12S b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS G12S b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS G12S b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G12S non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
HRAS G12S t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
HRAS G12S t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
HRAS G12S retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
HRAS G12S retinoblastoma Primary 0 41 0.00 0.00 0.00 0.02
HRAS G12S hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.02
HRAS G12S lung cancer Primary 0 17 0.00 0.00 0.00 0.03
HRAS G12S parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
HRAS G12V appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS G12V appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS G12V appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
HRAS G12V colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary Metastasis 1 1388 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
HRAS G12V cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
HRAS G12V non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS G12V breast cancer Metastasis 1 3094 0.00 0.00 0.00 0.00
HRAS G12V breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS G12V breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
HRAS G12V pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
HRAS G12V pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS G12V pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
HRAS G12V leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS G12V leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS G12V leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS G12V leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS G12V melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
HRAS G12V melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
HRAS G12V melanoma Primary 0 898 0.00 0.00 0.00 0.00
HRAS G12V melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
HRAS G12V head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
HRAS G12V head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
HRAS G12V head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
HRAS G12V uterine cancer Metastasis 0 583 0.00 0.00 0.00 0.00
HRAS G12V uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS G12V uterine cancer Primary 0 1538 0.00 0.00 0.00 0.00
HRAS G12V uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G12V non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
HRAS G12V non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
HRAS G12V non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
HRAS G12V myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS G12V myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS G12V myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS G12V myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G12V adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
HRAS G12V adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS G12V soft tissue sarcoma Metastasis 2 928 0.00 0.00 0.00 0.00
HRAS G12V soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
HRAS G12V soft tissue sarcoma Primary 0 1668 0.00 0.00 0.00 0.00
HRAS G12V soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.01
HRAS G12V ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS G12V ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS G12V ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
HRAS G12V ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
HRAS G12V esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12V thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
HRAS G12V thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G12V thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
HRAS G12V cervical cancer Metastasis 1 136 0.00 0.00 0.00 0.02
HRAS G12V cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.03
HRAS G12V cervical cancer Primary 0 211 0.00 0.00 0.00 0.01
HRAS G12V hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS G12V hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
HRAS G12V hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
HRAS G12V kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS G12V kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS G12V kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS G12V cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS G12V cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
HRAS G12V cns cancer Primary 0 3521 0.00 0.00 0.00 0.00
HRAS G12V cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS G12V prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
HRAS G12V prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
HRAS G12V prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
HRAS G12V prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
HRAS G12V anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS G12V anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS G12V neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
HRAS G12V neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
HRAS G12V neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
HRAS G12V bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
HRAS G12V bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G12V bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
HRAS G12V b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS G12V b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS G12V b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS G12V b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS G12V small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS G12V small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS G12V sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
HRAS G12V sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
HRAS G12V bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS G12V bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G12V bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS G12V bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12V vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
HRAS G12V vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
HRAS G12V thymic tumor Metastasis 0 60 0.00 0.00 0.00 0.00
HRAS G12V thymic tumor Primary 0 83 0.00 0.00 0.00 0.00
HRAS G12V ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
HRAS G12V ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
HRAS G12V small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
HRAS G12V small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
HRAS G12V mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
HRAS G12V mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G12V mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS G12V mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS G12V mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS G12V germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G12V nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS G12V nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
HRAS G12V nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS G12V penile cancer Metastasis 0 11 0.00 0.00 0.00 0.02
HRAS G12V penile cancer Primary 0 13 0.00 0.00 0.00 0.02
HRAS G12V pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
HRAS G12V pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
HRAS G12V b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS G12V b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS G12V b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS G12V b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G12V non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
HRAS G12V t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
HRAS G12V t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
HRAS G12V retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.01
HRAS G12V retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
HRAS G12V hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
HRAS G12V lung cancer Primary 0 17 0.00 0.00 0.00 0.03
HRAS G12V parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
HRAS G13C appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS G13C appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS G13C appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
HRAS G13C colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
HRAS G13C cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
HRAS G13C non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS G13C breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
HRAS G13C breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS G13C breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
HRAS G13C pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
HRAS G13C pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS G13C pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
HRAS G13C leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS G13C leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS G13C leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS G13C leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS G13C melanoma Metastasis 1 1738 0.00 0.00 0.00 0.00
HRAS G13C melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
HRAS G13C melanoma Primary 0 898 0.00 0.00 0.00 0.00
HRAS G13C melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
HRAS G13C head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
HRAS G13C head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
HRAS G13C head and neck cancer Primary 1 938 0.00 0.00 0.00 0.00
HRAS G13C uterine cancer Metastasis 0 583 0.00 0.00 0.00 0.00
HRAS G13C uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS G13C uterine cancer Primary 0 1538 0.00 0.00 0.00 0.00
HRAS G13C uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G13C non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
HRAS G13C non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
HRAS G13C non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
HRAS G13C myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS G13C myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS G13C myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS G13C myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G13C adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
HRAS G13C adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS G13C soft tissue sarcoma Metastasis 0 928 0.00 0.00 0.00 0.00
HRAS G13C soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
HRAS G13C soft tissue sarcoma Primary 0 1668 0.00 0.00 0.00 0.00
HRAS G13C soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.00
HRAS G13C ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS G13C ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS G13C ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
HRAS G13C ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
HRAS G13C esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G13C thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
HRAS G13C thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G13C thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
HRAS G13C cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
HRAS G13C cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
HRAS G13C cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
HRAS G13C hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS G13C hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
HRAS G13C hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
HRAS G13C kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS G13C kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS G13C kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS G13C cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS G13C cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
HRAS G13C cns cancer Primary 1 3521 0.00 0.00 0.00 0.00
HRAS G13C cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS G13C prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
HRAS G13C prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
HRAS G13C prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
HRAS G13C prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
HRAS G13C anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS G13C anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS G13C neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
HRAS G13C neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
HRAS G13C neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
HRAS G13C bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
HRAS G13C bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G13C bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
HRAS G13C b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS G13C b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS G13C b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS G13C b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS G13C small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS G13C small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS G13C sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
HRAS G13C sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
HRAS G13C bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS G13C bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G13C bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS G13C bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G13C vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
HRAS G13C vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
HRAS G13C thymic tumor Metastasis 0 60 0.00 0.00 0.00 0.00
HRAS G13C thymic tumor Primary 0 83 0.00 0.00 0.00 0.00
HRAS G13C ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
HRAS G13C ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
HRAS G13C small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
HRAS G13C small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
HRAS G13C mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
HRAS G13C mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G13C mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS G13C mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS G13C mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS G13C germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G13C nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS G13C nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
HRAS G13C nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS G13C penile cancer Metastasis 0 11 0.00 0.00 0.00 0.02
HRAS G13C penile cancer Primary 0 13 0.00 0.00 0.00 0.02
HRAS G13C pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
HRAS G13C pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
HRAS G13C b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS G13C b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS G13C b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS G13C b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G13C non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
HRAS G13C t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
HRAS G13C t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
HRAS G13C retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.01
HRAS G13C retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
HRAS G13C hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
HRAS G13C lung cancer Primary 0 17 0.00 0.00 0.00 0.03
HRAS G13C parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
HRAS G13D appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS G13D appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS G13D appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
HRAS G13D colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
HRAS G13D cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
HRAS G13D non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS G13D breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
HRAS G13D breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS G13D breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
HRAS G13D pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
HRAS G13D pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS G13D pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
HRAS G13D leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS G13D leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS G13D leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS G13D leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS G13D melanoma Metastasis 3 1738 0.00 0.00 0.00 0.00
HRAS G13D melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
HRAS G13D melanoma Primary 3 898 0.00 0.00 0.00 0.01
HRAS G13D melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
HRAS G13D head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
HRAS G13D head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
HRAS G13D head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
HRAS G13D uterine cancer Metastasis 0 583 0.00 0.00 0.00 0.00
HRAS G13D uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS G13D uterine cancer Primary 0 1538 0.00 0.00 0.00 0.00
HRAS G13D uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G13D non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
HRAS G13D non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
HRAS G13D non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
HRAS G13D myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS G13D myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS G13D myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS G13D myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G13D adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
HRAS G13D adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma Metastasis 0 928 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma Primary 0 1668 0.00 0.00 0.00 0.00
HRAS G13D soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.00
HRAS G13D ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS G13D ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS G13D ovarian cancer Primary 1 1060 0.00 0.00 0.00 0.00
HRAS G13D ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS G13D esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS G13D esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
HRAS G13D esophagogastric cancer Primary 1 1283 0.00 0.00 0.00 0.00
HRAS G13D esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
HRAS G13D thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
HRAS G13D thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G13D thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
HRAS G13D cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
HRAS G13D cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
HRAS G13D cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
HRAS G13D hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS G13D hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
HRAS G13D hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
HRAS G13D kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS G13D kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS G13D kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS G13D cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS G13D cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
HRAS G13D cns cancer Primary 0 3521 0.00 0.00 0.00 0.00
HRAS G13D cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS G13D prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
HRAS G13D prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.01
HRAS G13D prostate cancer Primary 2 1468 0.00 0.00 0.00 0.00
HRAS G13D prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.01
HRAS G13D anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS G13D anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS G13D neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
HRAS G13D neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
HRAS G13D neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
HRAS G13D bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
HRAS G13D bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
HRAS G13D bladder cancer Primary 2 1164 0.00 0.00 0.00 0.00
HRAS G13D b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS G13D b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS G13D b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS G13D b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS G13D small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS G13D small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS G13D sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
HRAS G13D sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
HRAS G13D bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS G13D bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G13D bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS G13D bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G13D vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
HRAS G13D vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
HRAS G13D thymic tumor Metastasis 0 60 0.01 0.00 0.00 0.03
HRAS G13D thymic tumor Primary 1 83 0.01 0.01 0.00 0.04
HRAS G13D ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
HRAS G13D ampullary cancer Primary 0 82 0.00 0.00 0.00 0.01
HRAS G13D small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
HRAS G13D small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
HRAS G13D mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
HRAS G13D mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G13D mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS G13D mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS G13D mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS G13D germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G13D nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS G13D nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
HRAS G13D nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS G13D penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
HRAS G13D penile cancer Primary 0 13 0.00 0.00 0.00 0.03
HRAS G13D pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.02
HRAS G13D pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
HRAS G13D b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS G13D b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS G13D b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS G13D b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G13D non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
HRAS G13D t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
HRAS G13D t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.03
HRAS G13D retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
HRAS G13D retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
HRAS G13D hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
HRAS G13D lung cancer Primary 0 17 0.00 0.00 0.00 0.02
HRAS G13D parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
HRAS G13R appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS G13R appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS G13R appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
HRAS G13R colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G13R cancer of unknown primary Metastasis 2 1388 0.00 0.00 0.00 0.00
HRAS G13R cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
HRAS G13R cancer of unknown primary Primary 1 311 0.00 0.00 0.00 0.01
HRAS G13R cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.01
HRAS G13R non-small cell lung cancer Metastasis 2 3750 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer Primary 2 6059 0.00 0.00 0.00 0.00
HRAS G13R non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS G13R breast cancer Metastasis 2 3094 0.00 0.00 0.00 0.00
HRAS G13R breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS G13R breast cancer Primary 3 6124 0.00 0.00 0.00 0.00
HRAS G13R pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
HRAS G13R pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS G13R pancreatic cancer Primary 1 1428 0.00 0.00 0.00 0.00
HRAS G13R leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS G13R leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS G13R leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS G13R leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS G13R melanoma Metastasis 2 1738 0.00 0.00 0.00 0.00
HRAS G13R melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
HRAS G13R melanoma Primary 0 898 0.00 0.00 0.00 0.00
HRAS G13R melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
HRAS G13R head and neck cancer Metastasis 2 731 0.00 0.00 0.00 0.01
HRAS G13R head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.02
HRAS G13R head and neck cancer Primary 8 938 0.01 0.01 0.00 0.01
HRAS G13R uterine cancer Metastasis 0 583 0.00 0.00 0.00 0.00
HRAS G13R uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS G13R uterine cancer Primary 0 1538 0.00 0.00 0.00 0.00
HRAS G13R uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G13R non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.01
HRAS G13R non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.01
HRAS G13R non-melanoma skin cancers Primary 1 287 0.00 0.00 0.00 0.01
HRAS G13R myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS G13R myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS G13R myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS G13R myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G13R adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
HRAS G13R adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS G13R soft tissue sarcoma Metastasis 1 928 0.00 0.00 0.00 0.00
HRAS G13R soft tissue sarcoma Tumor Type:NA/Heme 1 119 0.00 0.00 0.00 0.01
HRAS G13R soft tissue sarcoma Primary 2 1668 0.00 0.00 0.00 0.00
HRAS G13R soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.01
HRAS G13R ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS G13R ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS G13R ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
HRAS G13R ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
HRAS G13R esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G13R thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
HRAS G13R thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.02
HRAS G13R thyroid cancer Primary 2 582 0.00 0.00 0.00 0.01
HRAS G13R cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
HRAS G13R cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
HRAS G13R cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
HRAS G13R hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS G13R hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
HRAS G13R hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
HRAS G13R kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS G13R kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS G13R kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS G13R cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS G13R cns cancer Tumor Type:NA/Heme 1 526 0.00 0.00 0.00 0.00
HRAS G13R cns cancer Primary 0 3521 0.00 0.00 0.00 0.00
HRAS G13R cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS G13R prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
HRAS G13R prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
HRAS G13R prostate cancer Primary 1 1468 0.00 0.00 0.00 0.00
HRAS G13R prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.01
HRAS G13R anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS G13R anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS G13R neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
HRAS G13R neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
HRAS G13R neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
HRAS G13R bladder cancer Metastasis 2 389 0.00 0.00 0.00 0.01
HRAS G13R bladder cancer Tumor Type:NA/Heme 0 25 0.01 0.00 0.00 0.02
HRAS G13R bladder cancer Primary 6 1164 0.00 0.00 0.00 0.01
HRAS G13R b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS G13R b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS G13R b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS G13R b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS G13R small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS G13R small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS G13R sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
HRAS G13R sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
HRAS G13R bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS G13R bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G13R bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS G13R bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G13R vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
HRAS G13R vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
HRAS G13R thymic tumor Metastasis 0 60 0.00 0.00 0.00 0.00
HRAS G13R thymic tumor Primary 0 83 0.00 0.00 0.00 0.00
HRAS G13R ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
HRAS G13R ampullary cancer Primary 0 82 0.00 0.00 0.00 0.01
HRAS G13R small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
HRAS G13R small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
HRAS G13R mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
HRAS G13R mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G13R mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS G13R mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS G13R mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS G13R germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS G13R germ cell tumor Tumor Type:NA/Heme 1 81 0.01 0.00 0.00 0.03
HRAS G13R germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS G13R germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.02
HRAS G13R nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS G13R nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
HRAS G13R nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS G13R penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
HRAS G13R penile cancer Primary 0 13 0.00 0.00 0.00 0.03
HRAS G13R pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.02
HRAS G13R pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
HRAS G13R b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS G13R b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS G13R b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS G13R b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G13R non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
HRAS G13R t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
HRAS G13R t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.03
HRAS G13R retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
HRAS G13R retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
HRAS G13R hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
HRAS G13R lung cancer Primary 0 17 0.00 0.00 0.00 0.02
HRAS G13R parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
HRAS G13V appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS G13V appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS G13V appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
HRAS G13V colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G13V cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
HRAS G13V cancer of unknown primary Tumor Type:NA/Heme 1 229 0.00 0.00 0.00 0.01
HRAS G13V cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
HRAS G13V cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.01
HRAS G13V non-small cell lung cancer Metastasis 4 3750 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer Primary 2 6059 0.00 0.00 0.00 0.00
HRAS G13V non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS G13V breast cancer Metastasis 1 3094 0.00 0.00 0.00 0.00
HRAS G13V breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS G13V breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
HRAS G13V pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
HRAS G13V pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS G13V pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
HRAS G13V leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS G13V leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS G13V leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS G13V leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS G13V melanoma Metastasis 2 1738 0.00 0.00 0.00 0.00
HRAS G13V melanoma Tumor Type:NA/Heme 1 188 0.00 0.00 0.00 0.01
HRAS G13V melanoma Primary 0 898 0.00 0.00 0.00 0.00
HRAS G13V melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
HRAS G13V head and neck cancer Metastasis 2 731 0.00 0.00 0.00 0.01
HRAS G13V head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.01
HRAS G13V head and neck cancer Primary 1 938 0.00 0.00 0.00 0.00
HRAS G13V uterine cancer Metastasis 1 583 0.00 0.00 0.00 0.00
HRAS G13V uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS G13V uterine cancer Primary 0 1538 0.00 0.00 0.00 0.00
HRAS G13V uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
HRAS G13V non-melanoma skin cancers Metastasis 1 203 0.00 0.00 0.00 0.01
HRAS G13V non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.02
HRAS G13V non-melanoma skin cancers Primary 1 287 0.00 0.00 0.00 0.01
HRAS G13V myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS G13V myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS G13V myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS G13V myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS G13V adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
HRAS G13V adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma Metastasis 0 928 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma Primary 0 1668 0.00 0.00 0.00 0.00
HRAS G13V soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.00
HRAS G13V ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS G13V ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS G13V ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
HRAS G13V ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
HRAS G13V esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G13V thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
HRAS G13V thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G13V thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
HRAS G13V cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
HRAS G13V cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
HRAS G13V cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
HRAS G13V hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS G13V hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
HRAS G13V hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
HRAS G13V kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS G13V kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS G13V kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS G13V cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS G13V cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
HRAS G13V cns cancer Primary 0 3521 0.00 0.00 0.00 0.00
HRAS G13V cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS G13V prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
HRAS G13V prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
HRAS G13V prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
HRAS G13V prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
HRAS G13V anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS G13V anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS G13V neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
HRAS G13V neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
HRAS G13V neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
HRAS G13V bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
HRAS G13V bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
HRAS G13V bladder cancer Primary 3 1164 0.00 0.00 0.00 0.01
HRAS G13V b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS G13V b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS G13V b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS G13V b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS G13V small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS G13V small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS G13V sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.01
HRAS G13V sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
HRAS G13V bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS G13V bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS G13V bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS G13V bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G13V vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS G13V vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
HRAS G13V thymic tumor Metastasis 0 60 0.00 0.00 0.00 0.00
HRAS G13V thymic tumor Primary 0 83 0.00 0.00 0.00 0.00
HRAS G13V ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
HRAS G13V ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
HRAS G13V small cell lung cancer Metastasis 1 207 0.00 0.00 0.00 0.02
HRAS G13V small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.01
HRAS G13V mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
HRAS G13V mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS G13V mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS G13V mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS G13V mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS G13V germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS G13V nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.01
HRAS G13V nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.01
HRAS G13V nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS G13V penile cancer Metastasis 0 11 0.00 0.00 0.00 0.04
HRAS G13V penile cancer Primary 0 13 0.00 0.00 0.00 0.03
HRAS G13V pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
HRAS G13V pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
HRAS G13V b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS G13V b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS G13V b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS G13V b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS G13V non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.02
HRAS G13V t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
HRAS G13V t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
HRAS G13V retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
HRAS G13V retinoblastoma Primary 0 41 0.00 0.00 0.00 0.02
HRAS G13V hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
HRAS G13V lung cancer Primary 0 17 0.00 0.00 0.00 0.03
HRAS G13V parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
HRAS Q61H appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS Q61H appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS Q61H appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
HRAS Q61H colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
HRAS Q61H cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer Metastasis 1 3750 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer Primary 1 6059 0.00 0.00 0.00 0.00
HRAS Q61H non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS Q61H breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
HRAS Q61H pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
HRAS Q61H pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS Q61H pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
HRAS Q61H leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS Q61H leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS Q61H leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS Q61H leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS Q61H melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
HRAS Q61H melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
HRAS Q61H melanoma Primary 0 898 0.00 0.00 0.00 0.00
HRAS Q61H melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
HRAS Q61H head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
HRAS Q61H head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
HRAS Q61H head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
HRAS Q61H uterine cancer Metastasis 0 583 0.00 0.00 0.00 0.00
HRAS Q61H uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS Q61H uterine cancer Primary 1 1538 0.00 0.00 0.00 0.00
HRAS Q61H uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS Q61H non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
HRAS Q61H non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
HRAS Q61H non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
HRAS Q61H myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS Q61H myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS Q61H myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS Q61H myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS Q61H adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
HRAS Q61H adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma Metastasis 0 928 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma Primary 0 1668 0.00 0.00 0.00 0.00
HRAS Q61H soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.00
HRAS Q61H ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS Q61H ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS Q61H ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
HRAS Q61H ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
HRAS Q61H esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS Q61H thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
HRAS Q61H thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS Q61H thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
HRAS Q61H cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
HRAS Q61H cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
HRAS Q61H cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
HRAS Q61H hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS Q61H hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
HRAS Q61H hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
HRAS Q61H kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS Q61H kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS Q61H kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer Primary 0 3521 0.00 0.00 0.00 0.00
HRAS Q61H cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS Q61H prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
HRAS Q61H prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
HRAS Q61H prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
HRAS Q61H prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
HRAS Q61H anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS Q61H anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS Q61H neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
HRAS Q61H neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
HRAS Q61H neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
HRAS Q61H bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
HRAS Q61H bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS Q61H bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
HRAS Q61H b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS Q61H b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS Q61H b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS Q61H b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS Q61H small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS Q61H small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS Q61H sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.01
HRAS Q61H sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
HRAS Q61H bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS Q61H bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS Q61H bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS Q61H bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS Q61H vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
HRAS Q61H vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
HRAS Q61H thymic tumor Metastasis 0 60 0.00 0.00 0.00 0.00
HRAS Q61H thymic tumor Primary 0 83 0.00 0.00 0.00 0.00
HRAS Q61H ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.00
HRAS Q61H ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
HRAS Q61H small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
HRAS Q61H small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
HRAS Q61H mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
HRAS Q61H mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS Q61H mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS Q61H mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS Q61H mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS Q61H germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS Q61H nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS Q61H nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
HRAS Q61H nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS Q61H penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
HRAS Q61H penile cancer Primary 0 13 0.00 0.00 0.00 0.03
HRAS Q61H pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.02
HRAS Q61H pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
HRAS Q61H b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS Q61H b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS Q61H b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS Q61H b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS Q61H non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
HRAS Q61H t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
HRAS Q61H t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
HRAS Q61H retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.01
HRAS Q61H retinoblastoma Primary 0 41 0.00 0.00 0.00 0.00
HRAS Q61H hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
HRAS Q61H lung cancer Primary 0 17 0.00 0.00 0.00 0.04
HRAS Q61H parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
HRAS Q61K appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS Q61K appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS Q61K appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
HRAS Q61K colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS Q61K cancer of unknown primary Metastasis 1 1388 0.00 0.00 0.00 0.00
HRAS Q61K cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
HRAS Q61K cancer of unknown primary Primary 2 311 0.00 0.00 0.00 0.01
HRAS Q61K cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.01
HRAS Q61K non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
HRAS Q61K non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer Metastasis 1 3094 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS Q61K breast cancer Primary 1 6124 0.00 0.00 0.00 0.00
HRAS Q61K pancreatic cancer Metastasis 1 981 0.00 0.00 0.00 0.00
HRAS Q61K pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS Q61K pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
HRAS Q61K leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS Q61K leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS Q61K leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS Q61K leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS Q61K melanoma Metastasis 5 1738 0.00 0.00 0.00 0.00
HRAS Q61K melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.01
HRAS Q61K melanoma Primary 3 898 0.00 0.00 0.00 0.01
HRAS Q61K melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
HRAS Q61K head and neck cancer Metastasis 2 731 0.00 0.00 0.00 0.01
HRAS Q61K head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.01
HRAS Q61K head and neck cancer Primary 3 938 0.00 0.00 0.00 0.01
HRAS Q61K uterine cancer Metastasis 0 583 0.00 0.00 0.00 0.00
HRAS Q61K uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS Q61K uterine cancer Primary 0 1538 0.00 0.00 0.00 0.00
HRAS Q61K uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS Q61K non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.01
HRAS Q61K non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.02
HRAS Q61K non-melanoma skin cancers Primary 2 287 0.00 0.00 0.00 0.02
HRAS Q61K myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS Q61K myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS Q61K myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS Q61K myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS Q61K adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.01
HRAS Q61K adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma Metastasis 0 928 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma Primary 1 1668 0.00 0.00 0.00 0.00
HRAS Q61K soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.00
HRAS Q61K ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS Q61K ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS Q61K ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
HRAS Q61K ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
HRAS Q61K esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS Q61K thyroid cancer Metastasis 2 402 0.01 0.01 0.00 0.02
HRAS Q61K thyroid cancer Tumor Type:NA/Heme 1 28 0.02 0.01 0.00 0.07
HRAS Q61K thyroid cancer Primary 9 582 0.01 0.01 0.01 0.02
HRAS Q61K cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
HRAS Q61K cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
HRAS Q61K cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
HRAS Q61K hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS Q61K hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.01
HRAS Q61K hepatobiliary cancer Primary 1 894 0.00 0.00 0.00 0.00
HRAS Q61K kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS Q61K kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS Q61K kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer Primary 0 3521 0.00 0.00 0.00 0.00
HRAS Q61K cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS Q61K prostate cancer Metastasis 2 901 0.00 0.00 0.00 0.00
HRAS Q61K prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.01
HRAS Q61K prostate cancer Primary 4 1468 0.00 0.00 0.00 0.00
HRAS Q61K prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.01
HRAS Q61K anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS Q61K anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS Q61K neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
HRAS Q61K neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
HRAS Q61K neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
HRAS Q61K bladder cancer Metastasis 1 389 0.00 0.00 0.00 0.01
HRAS Q61K bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
HRAS Q61K bladder cancer Primary 4 1164 0.00 0.00 0.00 0.01
HRAS Q61K b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS Q61K b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS Q61K b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS Q61K b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS Q61K small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS Q61K small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS Q61K sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
HRAS Q61K sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
HRAS Q61K bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS Q61K bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS Q61K bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS Q61K bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS Q61K vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
HRAS Q61K vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
HRAS Q61K thymic tumor Metastasis 0 60 0.00 0.00 0.00 0.00
HRAS Q61K thymic tumor Primary 0 83 0.00 0.00 0.00 0.00
HRAS Q61K ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
HRAS Q61K ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
HRAS Q61K small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
HRAS Q61K small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
HRAS Q61K mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
HRAS Q61K mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS Q61K mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS Q61K mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS Q61K mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS Q61K germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS Q61K nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS Q61K nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
HRAS Q61K nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS Q61K penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
HRAS Q61K penile cancer Primary 0 13 0.00 0.00 0.00 0.03
HRAS Q61K pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.03
HRAS Q61K pineal tumor Primary 0 14 0.00 0.00 0.00 0.05
HRAS Q61K b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS Q61K b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS Q61K b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS Q61K b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS Q61K non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
HRAS Q61K t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
HRAS Q61K t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
HRAS Q61K retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.01
HRAS Q61K retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
HRAS Q61K hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
HRAS Q61K lung cancer Primary 0 17 0.00 0.00 0.00 0.04
HRAS Q61K parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
HRAS Q61L appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS Q61L appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS Q61L appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
HRAS Q61L colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
HRAS Q61L cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
HRAS Q61L non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS Q61L breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
HRAS Q61L pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
HRAS Q61L pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS Q61L pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
HRAS Q61L leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS Q61L leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS Q61L leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS Q61L leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS Q61L melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
HRAS Q61L melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
HRAS Q61L melanoma Primary 0 898 0.00 0.00 0.00 0.00
HRAS Q61L melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
HRAS Q61L head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
HRAS Q61L head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
HRAS Q61L head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
HRAS Q61L uterine cancer Metastasis 0 583 0.00 0.00 0.00 0.00
HRAS Q61L uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS Q61L uterine cancer Primary 0 1538 0.00 0.00 0.00 0.00
HRAS Q61L uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS Q61L non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
HRAS Q61L non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
HRAS Q61L non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
HRAS Q61L myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS Q61L myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS Q61L myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS Q61L myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS Q61L adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
HRAS Q61L adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS Q61L soft tissue sarcoma Metastasis 1 928 0.00 0.00 0.00 0.00
HRAS Q61L soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
HRAS Q61L soft tissue sarcoma Primary 0 1668 0.00 0.00 0.00 0.00
HRAS Q61L soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.01
HRAS Q61L ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS Q61L ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS Q61L ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
HRAS Q61L ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
HRAS Q61L esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS Q61L thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
HRAS Q61L thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS Q61L thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
HRAS Q61L cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
HRAS Q61L cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
HRAS Q61L cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
HRAS Q61L hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS Q61L hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
HRAS Q61L hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
HRAS Q61L kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS Q61L kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS Q61L kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer Primary 0 3521 0.00 0.00 0.00 0.00
HRAS Q61L cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS Q61L prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
HRAS Q61L prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
HRAS Q61L prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
HRAS Q61L prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
HRAS Q61L anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS Q61L anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS Q61L neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
HRAS Q61L neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
HRAS Q61L neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
HRAS Q61L bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
HRAS Q61L bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS Q61L bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
HRAS Q61L b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS Q61L b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS Q61L b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS Q61L b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS Q61L small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS Q61L small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS Q61L sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.01
HRAS Q61L sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
HRAS Q61L bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS Q61L bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS Q61L bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS Q61L bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS Q61L vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS Q61L vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
HRAS Q61L thymic tumor Metastasis 0 60 0.00 0.00 0.00 0.00
HRAS Q61L thymic tumor Primary 0 83 0.00 0.00 0.00 0.00
HRAS Q61L ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
HRAS Q61L ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
HRAS Q61L small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
HRAS Q61L small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
HRAS Q61L mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
HRAS Q61L mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS Q61L mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS Q61L mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS Q61L mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS Q61L germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS Q61L nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.01
HRAS Q61L nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.01
HRAS Q61L nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS Q61L penile cancer Metastasis 0 11 0.00 0.00 0.00 0.04
HRAS Q61L penile cancer Primary 0 13 0.00 0.00 0.00 0.03
HRAS Q61L pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
HRAS Q61L pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
HRAS Q61L b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS Q61L b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS Q61L b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS Q61L b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS Q61L non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.02
HRAS Q61L t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
HRAS Q61L t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
HRAS Q61L retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
HRAS Q61L retinoblastoma Primary 0 41 0.00 0.00 0.00 0.02
HRAS Q61L hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
HRAS Q61L lung cancer Primary 0 17 0.00 0.00 0.00 0.03
HRAS Q61L parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
HRAS Q61R appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
HRAS Q61R appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
HRAS Q61R appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
HRAS Q61R colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
HRAS Q61R cancer of unknown primary Tumor Type:Unspecified 0 57 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer Metastasis 2 3750 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer Primary 1 6059 0.00 0.00 0.00 0.00
HRAS Q61R non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer Metastasis 1 3094 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
HRAS Q61R breast cancer Primary 3 6124 0.00 0.00 0.00 0.00
HRAS Q61R pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
HRAS Q61R pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
HRAS Q61R pancreatic cancer Primary 1 1428 0.00 0.00 0.00 0.00
HRAS Q61R leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
HRAS Q61R leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
HRAS Q61R leukemia Primary 0 407 0.00 0.00 0.00 0.00
HRAS Q61R leukemia Tumor Type:Unspecified 0 215 0.00 0.00 0.00 0.00
HRAS Q61R melanoma Metastasis 2 1738 0.00 0.00 0.00 0.00
HRAS Q61R melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
HRAS Q61R melanoma Primary 3 898 0.00 0.00 0.00 0.01
HRAS Q61R melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
HRAS Q61R head and neck cancer Metastasis 3 731 0.00 0.00 0.00 0.01
HRAS Q61R head and neck cancer Tumor Type:NA/Heme 1 67 0.01 0.01 0.00 0.02
HRAS Q61R head and neck cancer Primary 5 938 0.00 0.00 0.00 0.01
HRAS Q61R uterine cancer Metastasis 0 583 0.00 0.00 0.00 0.00
HRAS Q61R uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
HRAS Q61R uterine cancer Primary 0 1538 0.00 0.00 0.00 0.00
HRAS Q61R uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS Q61R non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.01
HRAS Q61R non-melanoma skin cancers Tumor Type:NA/Heme 1 22 0.03 0.02 0.00 0.14
HRAS Q61R non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.01
HRAS Q61R myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
HRAS Q61R myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 914 0.00 0.00 0.00 0.00
HRAS Q61R myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
HRAS Q61R myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
HRAS Q61R adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.01
HRAS Q61R adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
HRAS Q61R soft tissue sarcoma Metastasis 0 928 0.00 0.00 0.00 0.00
HRAS Q61R soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
HRAS Q61R soft tissue sarcoma Primary 1 1668 0.00 0.00 0.00 0.00
HRAS Q61R soft tissue sarcoma Tumor Type:Unspecified 0 23 0.00 0.00 0.00 0.00
HRAS Q61R ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
HRAS Q61R ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
HRAS Q61R ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
HRAS Q61R ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer Primary 1 1283 0.00 0.00 0.00 0.00
HRAS Q61R esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
HRAS Q61R thyroid cancer Metastasis 8 402 0.03 0.02 0.01 0.04
HRAS Q61R thyroid cancer Tumor Type:NA/Heme 1 28 0.03 0.03 0.01 0.07
HRAS Q61R thyroid cancer Primary 21 582 0.03 0.03 0.02 0.05
HRAS Q61R cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
HRAS Q61R cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
HRAS Q61R cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
HRAS Q61R hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
HRAS Q61R hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
HRAS Q61R hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
HRAS Q61R kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
HRAS Q61R kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
HRAS Q61R kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer Primary 0 3521 0.00 0.00 0.00 0.00
HRAS Q61R cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
HRAS Q61R prostate cancer Metastasis 4 901 0.00 0.00 0.00 0.01
HRAS Q61R prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.01
HRAS Q61R prostate cancer Primary 2 1468 0.00 0.00 0.00 0.00
HRAS Q61R prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.02
HRAS Q61R anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
HRAS Q61R anal cancer Primary 0 84 0.00 0.00 0.00 0.00
HRAS Q61R neuroendocrine tumors Metastasis 1 143 0.00 0.00 0.00 0.02
HRAS Q61R neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.02
HRAS Q61R neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.01
HRAS Q61R bladder cancer Metastasis 4 389 0.01 0.01 0.00 0.02
HRAS Q61R bladder cancer Tumor Type:NA/Heme 0 25 0.01 0.01 0.00 0.02
HRAS Q61R bladder cancer Primary 12 1164 0.01 0.01 0.01 0.02
HRAS Q61R b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
HRAS Q61R b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
HRAS Q61R b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
HRAS Q61R b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
HRAS Q61R small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
HRAS Q61R small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
HRAS Q61R sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
HRAS Q61R sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
HRAS Q61R bone cancer Metastasis 0 197 0.00 0.00 0.00 0.00
HRAS Q61R bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
HRAS Q61R bone cancer Primary 0 319 0.00 0.00 0.00 0.00
HRAS Q61R bone cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS Q61R vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
HRAS Q61R vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
HRAS Q61R thymic tumor Metastasis 1 60 0.01 0.01 0.00 0.05
HRAS Q61R thymic tumor Primary 0 83 0.01 0.00 0.00 0.02
HRAS Q61R ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
HRAS Q61R ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
HRAS Q61R small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
HRAS Q61R small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
HRAS Q61R mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
HRAS Q61R mature t and nk neoplasms Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
HRAS Q61R mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
HRAS Q61R mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
HRAS Q61R mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor Primary 0 516 0.00 0.00 0.00 0.00
HRAS Q61R germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
HRAS Q61R nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
HRAS Q61R nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
HRAS Q61R nerve sheath tumor Primary 0 115 0.00 0.00 0.00 0.00
HRAS Q61R penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
HRAS Q61R penile cancer Primary 0 13 0.00 0.00 0.00 0.03
HRAS Q61R pheochromocytoma Primary 1 18 0.06 0.05 0.00 0.20
HRAS Q61R pineal tumor Primary 0 14 0.00 0.00 0.00 0.05
HRAS Q61R b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
HRAS Q61R b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
HRAS Q61R b cell lymphoma Primary 0 708 0.00 0.00 0.00 0.00
HRAS Q61R b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
HRAS Q61R non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
HRAS Q61R t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
HRAS Q61R t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
HRAS Q61R retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.01
HRAS Q61R retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
HRAS Q61R hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
HRAS Q61R lung cancer Primary 0 17 0.00 0.00 0.00 0.04
HRAS Q61R parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
NRAS G12A appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
NRAS G12A appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
NRAS G12A appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer Metastasis 4 2352 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer Primary 1 4113 0.00 0.00 0.00 0.00
NRAS G12A colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
NRAS G12A cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
NRAS G12A cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
NRAS G12A cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
NRAS G12A cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer Metastasis 1 3750 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer Primary 1 6059 0.00 0.00 0.00 0.00
NRAS G12A non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
NRAS G12A breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
NRAS G12A breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS G12A breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
NRAS G12A soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
NRAS G12A pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
NRAS G12A pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
NRAS G12A pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
NRAS G12A leukemia Metastasis 0 15 0.01 0.01 0.00 0.02
NRAS G12A leukemia Tumor Type:NA/Heme 9 923 0.01 0.01 0.00 0.02
NRAS G12A leukemia Primary 3 412 0.01 0.01 0.00 0.02
NRAS G12A leukemia Tumor Type:Unspecified 2 217 0.01 0.01 0.00 0.02
NRAS G12A melanoma Metastasis 2 1738 0.00 0.00 0.00 0.00
NRAS G12A melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
NRAS G12A melanoma Primary 3 898 0.00 0.00 0.00 0.01
NRAS G12A melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
NRAS G12A head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
NRAS G12A head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
NRAS G12A head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
NRAS G12A uterine cancer Metastasis 0 585 0.00 0.00 0.00 0.00
NRAS G12A uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
NRAS G12A uterine cancer Primary 0 1541 0.00 0.00 0.00 0.00
NRAS G12A uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
NRAS G12A non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G12A non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
NRAS G12A non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
NRAS G12A myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.02
NRAS G12A myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 4 915 0.00 0.00 0.00 0.01
NRAS G12A myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.01
NRAS G12A myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
NRAS G12A adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.01
NRAS G12A adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
NRAS G12A ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
NRAS G12A ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
NRAS G12A ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
NRAS G12A ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
NRAS G12A esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
NRAS G12A esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
NRAS G12A esophagogastric cancer Primary 1 1283 0.00 0.00 0.00 0.00
NRAS G12A esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
NRAS G12A thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
NRAS G12A thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
NRAS G12A thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
NRAS G12A cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
NRAS G12A cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
NRAS G12A cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
NRAS G12A hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
NRAS G12A hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
NRAS G12A hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
NRAS G12A kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS G12A kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS G12A kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS G12A mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
NRAS G12A mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
NRAS G12A mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
NRAS G12A cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
NRAS G12A cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
NRAS G12A cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
NRAS G12A cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
NRAS G12A prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
NRAS G12A prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
NRAS G12A prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
NRAS G12A prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
NRAS G12A anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS G12A anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS G12A neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
NRAS G12A neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
NRAS G12A neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
NRAS G12A bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
NRAS G12A bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G12A bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
NRAS G12A b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.01 0.00 0.00 0.04
NRAS G12A b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 2 109 0.01 0.01 0.00 0.04
NRAS G12A b-lymphoblastic leukemia/lymphoma Primary 0 101 0.01 0.00 0.00 0.02
NRAS G12A b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.01 0.00 0.00 0.03
NRAS G12A small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
NRAS G12A small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
NRAS G12A sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
NRAS G12A sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
NRAS G12A bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G12A bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G12A bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS G12A bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS G12A vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS G12A vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
NRAS G12A thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
NRAS G12A thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
NRAS G12A ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
NRAS G12A ampullary cancer Primary 0 82 0.00 0.00 0.00 0.01
NRAS G12A small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
NRAS G12A small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
NRAS G12A mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
NRAS G12A mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
NRAS G12A germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
NRAS G12A germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.01
NRAS G12A germ cell tumor Primary 1 517 0.00 0.00 0.00 0.00
NRAS G12A germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
NRAS G12A nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS G12A nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.01
NRAS G12A nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
NRAS G12A penile cancer Metastasis 0 11 0.00 0.00 0.00 0.04
NRAS G12A penile cancer Primary 0 13 0.00 0.00 0.00 0.04
NRAS G12A pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.03
NRAS G12A pineal tumor Primary 0 14 0.00 0.00 0.00 0.03
NRAS G12A b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
NRAS G12A b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
NRAS G12A b cell lymphoma Primary 0 709 0.00 0.00 0.00 0.00
NRAS G12A b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
NRAS G12A non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
NRAS G12A t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
NRAS G12A t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
NRAS G12A retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
NRAS G12A retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
NRAS G12A hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
NRAS G12A lung cancer Primary 0 17 0.00 0.00 0.00 0.04
NRAS G12A parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
NRAS G12C appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.01
NRAS G12C appendiceal cancer Tumor Type:NA/Heme 0 10 0.01 0.00 0.00 0.03
NRAS G12C appendiceal cancer Primary 1 151 0.00 0.00 0.00 0.02
NRAS G12C colorectal cancer Metastasis 4 2352 0.00 0.00 0.00 0.00
NRAS G12C colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
NRAS G12C colorectal cancer Primary 12 4113 0.00 0.00 0.00 0.00
NRAS G12C colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
NRAS G12C cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
NRAS G12C cancer of unknown primary Tumor Type:NA/Heme 1 229 0.00 0.00 0.00 0.01
NRAS G12C cancer of unknown primary Primary 1 311 0.00 0.00 0.00 0.01
NRAS G12C cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.01
NRAS G12C non-small cell lung cancer Metastasis 1 3750 0.00 0.00 0.00 0.00
NRAS G12C non-small cell lung cancer Tumor Type:NA/Heme 1 223 0.00 0.00 0.00 0.01
NRAS G12C non-small cell lung cancer Primary 1 6059 0.00 0.00 0.00 0.00
NRAS G12C non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
NRAS G12C breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
NRAS G12C breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS G12C breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
NRAS G12C soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
NRAS G12C pancreatic cancer Metastasis 1 981 0.00 0.00 0.00 0.00
NRAS G12C pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
NRAS G12C pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
NRAS G12C leukemia Metastasis 0 15 0.01 0.00 0.00 0.01
NRAS G12C leukemia Tumor Type:NA/Heme 5 923 0.00 0.00 0.00 0.01
NRAS G12C leukemia Primary 2 412 0.00 0.00 0.00 0.01
NRAS G12C leukemia Tumor Type:Unspecified 1 217 0.00 0.00 0.00 0.01
NRAS G12C melanoma Metastasis 5 1738 0.00 0.00 0.00 0.01
NRAS G12C melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.01
NRAS G12C melanoma Primary 7 898 0.01 0.00 0.00 0.01
NRAS G12C melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.02
NRAS G12C head and neck cancer Metastasis 1 731 0.00 0.00 0.00 0.00
NRAS G12C head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
NRAS G12C head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
NRAS G12C uterine cancer Metastasis 1 585 0.00 0.00 0.00 0.00
NRAS G12C uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.01
NRAS G12C uterine cancer Primary 4 1541 0.00 0.00 0.00 0.00
NRAS G12C uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS G12C non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G12C non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
NRAS G12C non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
NRAS G12C myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.02
NRAS G12C myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
NRAS G12C myelodysplastic/myeloproliferative syndromes Primary 1 250 0.00 0.00 0.00 0.01
NRAS G12C myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
NRAS G12C adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
NRAS G12C adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
NRAS G12C ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
NRAS G12C ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
NRAS G12C ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
NRAS G12C ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
NRAS G12C esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
NRAS G12C thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
NRAS G12C thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
NRAS G12C thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
NRAS G12C cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
NRAS G12C cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
NRAS G12C cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
NRAS G12C hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
NRAS G12C hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.01
NRAS G12C hepatobiliary cancer Primary 2 894 0.00 0.00 0.00 0.00
NRAS G12C kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS G12C kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS G12C kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS G12C mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
NRAS G12C mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
NRAS G12C mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
NRAS G12C cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
NRAS G12C cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
NRAS G12C cns cancer Primary 2 3522 0.00 0.00 0.00 0.00
NRAS G12C cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
NRAS G12C prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
NRAS G12C prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
NRAS G12C prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
NRAS G12C prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
NRAS G12C anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS G12C anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS G12C neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
NRAS G12C neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
NRAS G12C neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
NRAS G12C bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
NRAS G12C bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
NRAS G12C bladder cancer Primary 1 1164 0.00 0.00 0.00 0.00
NRAS G12C b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.01 0.00 0.00 0.03
NRAS G12C b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 1 109 0.01 0.00 0.00 0.02
NRAS G12C b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.02
NRAS G12C b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.02
NRAS G12C small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
NRAS G12C small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
NRAS G12C sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
NRAS G12C sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
NRAS G12C bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G12C bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G12C bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS G12C bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS G12C vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS G12C vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
NRAS G12C thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
NRAS G12C thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
NRAS G12C ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.00
NRAS G12C ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
NRAS G12C small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
NRAS G12C small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
NRAS G12C mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
NRAS G12C mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
NRAS G12C germ cell tumor Metastasis 1 274 0.00 0.00 0.00 0.01
NRAS G12C germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.01
NRAS G12C germ cell tumor Primary 0 517 0.00 0.00 0.00 0.00
NRAS G12C germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.02
NRAS G12C nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS G12C nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.01
NRAS G12C nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
NRAS G12C penile cancer Metastasis 0 11 0.00 0.00 0.00 0.02
NRAS G12C penile cancer Primary 0 13 0.00 0.00 0.00 0.02
NRAS G12C pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.03
NRAS G12C pineal tumor Primary 0 14 0.00 0.00 0.00 0.05
NRAS G12C b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
NRAS G12C b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
NRAS G12C b cell lymphoma Primary 0 709 0.00 0.00 0.00 0.00
NRAS G12C b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
NRAS G12C non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
NRAS G12C t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
NRAS G12C t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.03
NRAS G12C retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
NRAS G12C retinoblastoma Primary 0 41 0.00 0.00 0.00 0.02
NRAS G12C hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
NRAS G12C lung cancer Primary 0 17 0.00 0.00 0.00 0.02
NRAS G12C parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
NRAS G12D appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
NRAS G12D appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
NRAS G12D appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
NRAS G12D colorectal cancer Metastasis 20 2352 0.01 0.01 0.01 0.01
NRAS G12D colorectal cancer Tumor Type:NA/Heme 2 224 0.01 0.01 0.00 0.01
NRAS G12D colorectal cancer Primary 31 4113 0.01 0.01 0.01 0.01
NRAS G12D colorectal cancer Tumor Type:Unspecified 0 31 0.01 0.01 0.00 0.02
NRAS G12D cancer of unknown primary Metastasis 1 1388 0.00 0.00 0.00 0.00
NRAS G12D cancer of unknown primary Tumor Type:NA/Heme 1 229 0.00 0.00 0.00 0.01
NRAS G12D cancer of unknown primary Primary 1 311 0.00 0.00 0.00 0.01
NRAS G12D cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.01
NRAS G12D non-small cell lung cancer Metastasis 1 3750 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer Tumor Type:NA/Heme 2 223 0.00 0.00 0.00 0.02
NRAS G12D non-small cell lung cancer Primary 5 6059 0.00 0.00 0.00 0.00
NRAS G12D non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.01
NRAS G12D breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
NRAS G12D breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS G12D breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma Primary 2 1686 0.00 0.00 0.00 0.00
NRAS G12D soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.01
NRAS G12D pancreatic cancer Metastasis 1 981 0.00 0.00 0.00 0.00
NRAS G12D pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
NRAS G12D pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
NRAS G12D leukemia Metastasis 0 15 0.04 0.04 0.02 0.07
NRAS G12D leukemia Tumor Type:NA/Heme 43 923 0.05 0.04 0.04 0.06
NRAS G12D leukemia Primary 17 412 0.04 0.04 0.03 0.06
NRAS G12D leukemia Tumor Type:Unspecified 11 217 0.05 0.05 0.03 0.07
NRAS G12D melanoma Metastasis 8 1738 0.00 0.00 0.00 0.01
NRAS G12D melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.01
NRAS G12D melanoma Primary 9 898 0.01 0.01 0.00 0.02
NRAS G12D melanoma Tumor Type:Unspecified 0 22 0.01 0.00 0.00 0.02
NRAS G12D head and neck cancer Metastasis 3 731 0.00 0.00 0.00 0.01
NRAS G12D head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.01
NRAS G12D head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
NRAS G12D uterine cancer Metastasis 2 585 0.00 0.00 0.00 0.01
NRAS G12D uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.01
NRAS G12D uterine cancer Primary 6 1541 0.00 0.00 0.00 0.01
NRAS G12D uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS G12D non-melanoma skin cancers Metastasis 1 203 0.00 0.00 0.00 0.01
NRAS G12D non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.02
NRAS G12D non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.01
NRAS G12D myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.02 0.02 0.00 0.06
NRAS G12D myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 12 915 0.02 0.02 0.01 0.02
NRAS G12D myelodysplastic/myeloproliferative syndromes Primary 8 250 0.02 0.02 0.01 0.05
NRAS G12D myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.02 0.02 0.00 0.04
NRAS G12D adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
NRAS G12D adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
NRAS G12D ovarian cancer Metastasis 1 1088 0.00 0.00 0.00 0.00
NRAS G12D ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
NRAS G12D ovarian cancer Primary 1 1060 0.00 0.00 0.00 0.00
NRAS G12D ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
NRAS G12D esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
NRAS G12D thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
NRAS G12D thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
NRAS G12D thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
NRAS G12D cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
NRAS G12D cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
NRAS G12D cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
NRAS G12D hepatobiliary cancer Metastasis 1 438 0.00 0.00 0.00 0.01
NRAS G12D hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.01
NRAS G12D hepatobiliary cancer Primary 3 894 0.00 0.00 0.00 0.01
NRAS G12D kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS G12D kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS G12D kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS G12D mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
NRAS G12D mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
NRAS G12D mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
NRAS G12D cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
NRAS G12D cns cancer Tumor Type:NA/Heme 1 526 0.00 0.00 0.00 0.00
NRAS G12D cns cancer Primary 1 3522 0.00 0.00 0.00 0.00
NRAS G12D cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
NRAS G12D prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
NRAS G12D prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
NRAS G12D prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
NRAS G12D prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
NRAS G12D anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS G12D anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS G12D neuroendocrine tumors Metastasis 1 143 0.00 0.00 0.00 0.02
NRAS G12D neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.02
NRAS G12D neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.01
NRAS G12D bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
NRAS G12D bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
NRAS G12D bladder cancer Primary 1 1164 0.00 0.00 0.00 0.00
NRAS G12D b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.03 0.03 0.00 0.10
NRAS G12D b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 8 109 0.06 0.06 0.02 0.11
NRAS G12D b-lymphoblastic leukemia/lymphoma Primary 1 101 0.02 0.02 0.00 0.06
NRAS G12D b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 1 25 0.04 0.04 0.00 0.11
NRAS G12D small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
NRAS G12D small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
NRAS G12D sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.01
NRAS G12D sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
NRAS G12D bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G12D bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G12D bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS G12D bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS G12D vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS G12D vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
NRAS G12D thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
NRAS G12D thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
NRAS G12D ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.00
NRAS G12D ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
NRAS G12D small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
NRAS G12D small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
NRAS G12D mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
NRAS G12D mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
NRAS G12D germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.01
NRAS G12D germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.01
NRAS G12D germ cell tumor Primary 2 517 0.00 0.00 0.00 0.01
NRAS G12D germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.02
NRAS G12D nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
NRAS G12D nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
NRAS G12D nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
NRAS G12D penile cancer Metastasis 0 11 0.00 0.00 0.00 0.05
NRAS G12D penile cancer Primary 0 13 0.00 0.00 0.00 0.05
NRAS G12D pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
NRAS G12D pineal tumor Primary 0 14 0.00 0.00 0.00 0.03
NRAS G12D b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
NRAS G12D b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
NRAS G12D b cell lymphoma Primary 1 709 0.00 0.00 0.00 0.00
NRAS G12D b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS G12D non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
NRAS G12D t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 1 25 0.04 0.03 0.00 0.12
NRAS G12D t-lymphoblastic leukemia/lymphoma Primary 0 11 0.03 0.01 0.00 0.12
NRAS G12D retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
NRAS G12D retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
NRAS G12D hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
NRAS G12D lung cancer Primary 0 17 0.00 0.00 0.00 0.04
NRAS G12D parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
NRAS G12F appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
NRAS G12F appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
NRAS G12F appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
NRAS G12F colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
NRAS G12F cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
NRAS G12F non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
NRAS G12F breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
NRAS G12F breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS G12F breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
NRAS G12F soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
NRAS G12F pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
NRAS G12F pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
NRAS G12F pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
NRAS G12F leukemia Metastasis 0 15 0.00 0.00 0.00 0.00
NRAS G12F leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
NRAS G12F leukemia Primary 0 412 0.00 0.00 0.00 0.00
NRAS G12F leukemia Tumor Type:Unspecified 0 217 0.00 0.00 0.00 0.00
NRAS G12F melanoma Metastasis 0 1738 0.00 0.00 0.00 0.00
NRAS G12F melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
NRAS G12F melanoma Primary 0 898 0.00 0.00 0.00 0.00
NRAS G12F melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.00
NRAS G12F head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
NRAS G12F head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
NRAS G12F head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
NRAS G12F uterine cancer Metastasis 0 585 0.00 0.00 0.00 0.00
NRAS G12F uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
NRAS G12F uterine cancer Primary 0 1541 0.00 0.00 0.00 0.00
NRAS G12F uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
NRAS G12F non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G12F non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
NRAS G12F non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
NRAS G12F myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
NRAS G12F myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
NRAS G12F myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
NRAS G12F myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
NRAS G12F adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
NRAS G12F adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
NRAS G12F ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
NRAS G12F ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
NRAS G12F ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
NRAS G12F ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
NRAS G12F esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
NRAS G12F thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
NRAS G12F thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
NRAS G12F thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
NRAS G12F cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
NRAS G12F cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
NRAS G12F cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
NRAS G12F hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
NRAS G12F hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
NRAS G12F hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
NRAS G12F kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS G12F kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS G12F kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS G12F mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
NRAS G12F mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
NRAS G12F mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
NRAS G12F cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
NRAS G12F cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
NRAS G12F cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
NRAS G12F cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
NRAS G12F prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
NRAS G12F prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
NRAS G12F prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
NRAS G12F prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
NRAS G12F anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS G12F anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS G12F neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
NRAS G12F neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
NRAS G12F neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
NRAS G12F bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
NRAS G12F bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G12F bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
NRAS G12F b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
NRAS G12F b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
NRAS G12F b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
NRAS G12F b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
NRAS G12F small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
NRAS G12F small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
NRAS G12F sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.01
NRAS G12F sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
NRAS G12F bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G12F bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G12F bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS G12F bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS G12F vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS G12F vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
NRAS G12F thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
NRAS G12F thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
NRAS G12F ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.00
NRAS G12F ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
NRAS G12F small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
NRAS G12F small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
NRAS G12F mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
NRAS G12F mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor Primary 0 517 0.00 0.00 0.00 0.00
NRAS G12F germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
NRAS G12F nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
NRAS G12F nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
NRAS G12F nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
NRAS G12F penile cancer Metastasis 0 11 0.00 0.00 0.00 0.05
NRAS G12F penile cancer Primary 0 13 0.00 0.00 0.00 0.05
NRAS G12F pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
NRAS G12F pineal tumor Primary 0 14 0.00 0.00 0.00 0.03
NRAS G12F b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
NRAS G12F b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
NRAS G12F b cell lymphoma Primary 0 709 0.00 0.00 0.00 0.00
NRAS G12F b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
NRAS G12F non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
NRAS G12F t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
NRAS G12F t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
NRAS G12F retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
NRAS G12F retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
NRAS G12F hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
NRAS G12F lung cancer Primary 0 17 0.00 0.00 0.00 0.04
NRAS G12F parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
NRAS G12R appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
NRAS G12R appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
NRAS G12R appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
NRAS G12R colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
NRAS G12R cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
NRAS G12R non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
NRAS G12R breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
NRAS G12R breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS G12R breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
NRAS G12R soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
NRAS G12R pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
NRAS G12R pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
NRAS G12R pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
NRAS G12R leukemia Metastasis 0 15 0.00 0.00 0.00 0.01
NRAS G12R leukemia Tumor Type:NA/Heme 2 923 0.00 0.00 0.00 0.00
NRAS G12R leukemia Primary 0 412 0.00 0.00 0.00 0.00
NRAS G12R leukemia Tumor Type:Unspecified 1 217 0.00 0.00 0.00 0.01
NRAS G12R melanoma Metastasis 2 1738 0.00 0.00 0.00 0.00
NRAS G12R melanoma Tumor Type:NA/Heme 1 188 0.00 0.00 0.00 0.01
NRAS G12R melanoma Primary 0 898 0.00 0.00 0.00 0.00
NRAS G12R melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
NRAS G12R head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
NRAS G12R head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
NRAS G12R head and neck cancer Primary 1 938 0.00 0.00 0.00 0.00
NRAS G12R uterine cancer Metastasis 1 585 0.00 0.00 0.00 0.00
NRAS G12R uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
NRAS G12R uterine cancer Primary 0 1541 0.00 0.00 0.00 0.00
NRAS G12R uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
NRAS G12R non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G12R non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
NRAS G12R non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
NRAS G12R myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.02
NRAS G12R myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 4 915 0.00 0.00 0.00 0.01
NRAS G12R myelodysplastic/myeloproliferative syndromes Primary 1 250 0.00 0.00 0.00 0.01
NRAS G12R myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.02
NRAS G12R adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
NRAS G12R adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
NRAS G12R ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
NRAS G12R ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
NRAS G12R ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
NRAS G12R ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
NRAS G12R esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
NRAS G12R thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
NRAS G12R thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
NRAS G12R thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
NRAS G12R cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
NRAS G12R cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
NRAS G12R cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
NRAS G12R hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
NRAS G12R hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
NRAS G12R hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
NRAS G12R kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS G12R kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS G12R kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS G12R mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
NRAS G12R mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
NRAS G12R mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
NRAS G12R cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
NRAS G12R cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
NRAS G12R cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
NRAS G12R cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
NRAS G12R prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
NRAS G12R prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
NRAS G12R prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
NRAS G12R prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
NRAS G12R anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS G12R anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS G12R neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
NRAS G12R neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
NRAS G12R neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
NRAS G12R bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
NRAS G12R bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G12R bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
NRAS G12R b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
NRAS G12R b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
NRAS G12R b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
NRAS G12R b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
NRAS G12R small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
NRAS G12R small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
NRAS G12R sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.01
NRAS G12R sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
NRAS G12R bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G12R bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G12R bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS G12R bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS G12R vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS G12R vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
NRAS G12R thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
NRAS G12R thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
NRAS G12R ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.00
NRAS G12R ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
NRAS G12R small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
NRAS G12R small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
NRAS G12R mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
NRAS G12R mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor Primary 0 517 0.00 0.00 0.00 0.00
NRAS G12R germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
NRAS G12R nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
NRAS G12R nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
NRAS G12R nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
NRAS G12R penile cancer Metastasis 0 11 0.00 0.00 0.00 0.05
NRAS G12R penile cancer Primary 0 13 0.00 0.00 0.00 0.05
NRAS G12R pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
NRAS G12R pineal tumor Primary 0 14 0.00 0.00 0.00 0.03
NRAS G12R b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
NRAS G12R b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
NRAS G12R b cell lymphoma Primary 1 709 0.00 0.00 0.00 0.00
NRAS G12R b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS G12R non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
NRAS G12R t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
NRAS G12R t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
NRAS G12R retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
NRAS G12R retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
NRAS G12R hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
NRAS G12R lung cancer Primary 0 17 0.00 0.00 0.00 0.04
NRAS G12R parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
NRAS G12S appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
NRAS G12S appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
NRAS G12S appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer Metastasis 1 2352 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
NRAS G12S colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary Metastasis 1 1388 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
NRAS G12S cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer Primary 2 6059 0.00 0.00 0.00 0.00
NRAS G12S non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
NRAS G12S breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
NRAS G12S breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS G12S breast cancer Primary 1 6124 0.00 0.00 0.00 0.00
NRAS G12S soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
NRAS G12S soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
NRAS G12S soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
NRAS G12S soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
NRAS G12S pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
NRAS G12S pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
NRAS G12S pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
NRAS G12S leukemia Metastasis 0 15 0.00 0.00 0.00 0.02
NRAS G12S leukemia Tumor Type:NA/Heme 5 923 0.00 0.00 0.00 0.01
NRAS G12S leukemia Primary 1 412 0.00 0.00 0.00 0.01
NRAS G12S leukemia Tumor Type:Unspecified 0 217 0.00 0.00 0.00 0.01
NRAS G12S melanoma Metastasis 3 1738 0.00 0.00 0.00 0.00
NRAS G12S melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
NRAS G12S melanoma Primary 3 898 0.00 0.00 0.00 0.01
NRAS G12S melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
NRAS G12S head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
NRAS G12S head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
NRAS G12S head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
NRAS G12S uterine cancer Metastasis 0 585 0.00 0.00 0.00 0.00
NRAS G12S uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
NRAS G12S uterine cancer Primary 2 1541 0.00 0.00 0.00 0.00
NRAS G12S uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS G12S non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G12S non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
NRAS G12S non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
NRAS G12S myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.01 0.01 0.00 0.02
NRAS G12S myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 6 915 0.01 0.01 0.00 0.01
NRAS G12S myelodysplastic/myeloproliferative syndromes Primary 2 250 0.01 0.01 0.00 0.02
NRAS G12S myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.01 0.01 0.00 0.02
NRAS G12S adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
NRAS G12S adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
NRAS G12S ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
NRAS G12S ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
NRAS G12S ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
NRAS G12S ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer Primary 1 1283 0.00 0.00 0.00 0.00
NRAS G12S esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
NRAS G12S thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
NRAS G12S thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
NRAS G12S thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
NRAS G12S cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
NRAS G12S cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
NRAS G12S cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
NRAS G12S hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
NRAS G12S hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.01
NRAS G12S hepatobiliary cancer Primary 2 894 0.00 0.00 0.00 0.00
NRAS G12S kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS G12S kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS G12S kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS G12S mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
NRAS G12S mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
NRAS G12S mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
NRAS G12S cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
NRAS G12S cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
NRAS G12S cns cancer Primary 1 3522 0.00 0.00 0.00 0.00
NRAS G12S cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
NRAS G12S prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
NRAS G12S prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
NRAS G12S prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
NRAS G12S prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
NRAS G12S anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS G12S anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS G12S neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
NRAS G12S neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
NRAS G12S neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
NRAS G12S bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
NRAS G12S bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G12S bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
NRAS G12S b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.02 0.01 0.00 0.05
NRAS G12S b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 3 109 0.02 0.02 0.00 0.05
NRAS G12S b-lymphoblastic leukemia/lymphoma Primary 1 101 0.02 0.01 0.00 0.04
NRAS G12S b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.02 0.01 0.00 0.04
NRAS G12S small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
NRAS G12S small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
NRAS G12S sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
NRAS G12S sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
NRAS G12S bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G12S bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G12S bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS G12S bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS G12S vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.00
NRAS G12S vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
NRAS G12S thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
NRAS G12S thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
NRAS G12S ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
NRAS G12S ampullary cancer Primary 0 82 0.00 0.00 0.00 0.01
NRAS G12S small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
NRAS G12S small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
NRAS G12S mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
NRAS G12S mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
NRAS G12S germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
NRAS G12S germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.01
NRAS G12S germ cell tumor Primary 1 517 0.00 0.00 0.00 0.01
NRAS G12S germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.02
NRAS G12S nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
NRAS G12S nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
NRAS G12S nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
NRAS G12S penile cancer Metastasis 0 11 0.00 0.00 0.00 0.04
NRAS G12S penile cancer Primary 0 13 0.00 0.00 0.00 0.03
NRAS G12S pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.02
NRAS G12S pineal tumor Primary 0 14 0.00 0.00 0.00 0.05
NRAS G12S b cell lymphoma Metastasis 1 57 0.01 0.00 0.00 0.03
NRAS G12S b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.01
NRAS G12S b cell lymphoma Primary 1 709 0.00 0.00 0.00 0.01
NRAS G12S b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS G12S non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.03
NRAS G12S t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 1 25 0.04 0.03 0.00 0.12
NRAS G12S t-lymphoblastic leukemia/lymphoma Primary 0 11 0.02 0.01 0.00 0.11
NRAS G12S retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.01
NRAS G12S retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
NRAS G12S hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.02
NRAS G12S lung cancer Primary 0 17 0.00 0.00 0.00 0.04
NRAS G12S parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
NRAS G12V appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
NRAS G12V appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
NRAS G12V appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer Metastasis 2 2352 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer Primary 5 4113 0.00 0.00 0.00 0.00
NRAS G12V colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
NRAS G12V cancer of unknown primary Metastasis 1 1388 0.00 0.00 0.00 0.00
NRAS G12V cancer of unknown primary Tumor Type:NA/Heme 1 229 0.00 0.00 0.00 0.01
NRAS G12V cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
NRAS G12V cancer of unknown primary Tumor Type:Unspecified 1 60 0.00 0.00 0.00 0.03
NRAS G12V non-small cell lung cancer Metastasis 1 3750 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer Primary 2 6059 0.00 0.00 0.00 0.00
NRAS G12V non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
NRAS G12V breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
NRAS G12V breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS G12V breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma Primary 1 1686 0.00 0.00 0.00 0.00
NRAS G12V soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
NRAS G12V pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
NRAS G12V pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
NRAS G12V pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
NRAS G12V leukemia Metastasis 0 15 0.01 0.00 0.00 0.02
NRAS G12V leukemia Tumor Type:NA/Heme 5 923 0.00 0.00 0.00 0.01
NRAS G12V leukemia Primary 1 412 0.00 0.00 0.00 0.01
NRAS G12V leukemia Tumor Type:Unspecified 2 217 0.01 0.00 0.00 0.02
NRAS G12V melanoma Metastasis 1 1738 0.00 0.00 0.00 0.00
NRAS G12V melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
NRAS G12V melanoma Primary 2 898 0.00 0.00 0.00 0.00
NRAS G12V melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
NRAS G12V head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
NRAS G12V head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
NRAS G12V head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
NRAS G12V uterine cancer Metastasis 0 585 0.00 0.00 0.00 0.00
NRAS G12V uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
NRAS G12V uterine cancer Primary 1 1541 0.00 0.00 0.00 0.00
NRAS G12V uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
NRAS G12V non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G12V non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
NRAS G12V non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
NRAS G12V myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.02
NRAS G12V myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 2 915 0.00 0.00 0.00 0.01
NRAS G12V myelodysplastic/myeloproliferative syndromes Primary 1 250 0.00 0.00 0.00 0.01
NRAS G12V myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
NRAS G12V adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
NRAS G12V adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
NRAS G12V ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
NRAS G12V ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
NRAS G12V ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
NRAS G12V ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
NRAS G12V esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
NRAS G12V thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
NRAS G12V thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
NRAS G12V thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
NRAS G12V cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
NRAS G12V cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
NRAS G12V cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
NRAS G12V hepatobiliary cancer Metastasis 1 438 0.00 0.00 0.00 0.01
NRAS G12V hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.01
NRAS G12V hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
NRAS G12V kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS G12V kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS G12V kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS G12V mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
NRAS G12V mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
NRAS G12V mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
NRAS G12V cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
NRAS G12V cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
NRAS G12V cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
NRAS G12V cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
NRAS G12V prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
NRAS G12V prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
NRAS G12V prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
NRAS G12V prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
NRAS G12V anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS G12V anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS G12V neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
NRAS G12V neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
NRAS G12V neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
NRAS G12V bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
NRAS G12V bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G12V bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
NRAS G12V b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
NRAS G12V b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
NRAS G12V b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
NRAS G12V b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
NRAS G12V small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
NRAS G12V small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
NRAS G12V sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
NRAS G12V sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
NRAS G12V bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G12V bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G12V bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS G12V bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS G12V vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS G12V vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
NRAS G12V thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
NRAS G12V thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
NRAS G12V ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
NRAS G12V ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
NRAS G12V small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
NRAS G12V small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
NRAS G12V mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
NRAS G12V mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
NRAS G12V germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.01
NRAS G12V germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.01
NRAS G12V germ cell tumor Primary 2 517 0.00 0.00 0.00 0.01
NRAS G12V germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.02
NRAS G12V nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS G12V nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.01
NRAS G12V nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
NRAS G12V penile cancer Metastasis 0 11 0.00 0.00 0.00 0.02
NRAS G12V penile cancer Primary 0 13 0.00 0.00 0.00 0.02
NRAS G12V pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
NRAS G12V pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
NRAS G12V b cell lymphoma Metastasis 1 57 0.01 0.00 0.00 0.05
NRAS G12V b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.01
NRAS G12V b cell lymphoma Primary 0 709 0.00 0.00 0.00 0.00
NRAS G12V b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS G12V non-hodgkin lymphoma Primary 1 14 0.08 0.06 0.00 0.26
NRAS G12V t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
NRAS G12V t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
NRAS G12V retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.01
NRAS G12V retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
NRAS G12V hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
NRAS G12V lung cancer Primary 0 17 0.00 0.00 0.00 0.03
NRAS G12V parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
NRAS G13C appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
NRAS G13C appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
NRAS G13C appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer Metastasis 1 2352 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer Primary 2 4113 0.00 0.00 0.00 0.00
NRAS G13C colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
NRAS G13C cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
NRAS G13C non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
NRAS G13C breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
NRAS G13C breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS G13C breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
NRAS G13C soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
NRAS G13C pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
NRAS G13C pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
NRAS G13C pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
NRAS G13C leukemia Metastasis 0 15 0.00 0.00 0.00 0.01
NRAS G13C leukemia Tumor Type:NA/Heme 0 923 0.00 0.00 0.00 0.00
NRAS G13C leukemia Primary 1 412 0.00 0.00 0.00 0.01
NRAS G13C leukemia Tumor Type:Unspecified 0 217 0.00 0.00 0.00 0.00
NRAS G13C melanoma Metastasis 2 1738 0.00 0.00 0.00 0.00
NRAS G13C melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
NRAS G13C melanoma Primary 2 898 0.00 0.00 0.00 0.00
NRAS G13C melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
NRAS G13C head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
NRAS G13C head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
NRAS G13C head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
NRAS G13C uterine cancer Metastasis 0 585 0.00 0.00 0.00 0.00
NRAS G13C uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
NRAS G13C uterine cancer Primary 0 1541 0.00 0.00 0.00 0.00
NRAS G13C uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
NRAS G13C non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G13C non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
NRAS G13C non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
NRAS G13C myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.01 0.00 0.00 0.02
NRAS G13C myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 3 915 0.00 0.00 0.00 0.01
NRAS G13C myelodysplastic/myeloproliferative syndromes Primary 2 250 0.00 0.00 0.00 0.01
NRAS G13C myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.02
NRAS G13C adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
NRAS G13C adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
NRAS G13C ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
NRAS G13C ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
NRAS G13C ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
NRAS G13C ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
NRAS G13C esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
NRAS G13C thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
NRAS G13C thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
NRAS G13C thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
NRAS G13C cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
NRAS G13C cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
NRAS G13C cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
NRAS G13C hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
NRAS G13C hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
NRAS G13C hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
NRAS G13C kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS G13C kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS G13C kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS G13C mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
NRAS G13C mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
NRAS G13C mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
NRAS G13C cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
NRAS G13C cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
NRAS G13C cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
NRAS G13C cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
NRAS G13C prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
NRAS G13C prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
NRAS G13C prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
NRAS G13C prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
NRAS G13C anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS G13C anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS G13C neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
NRAS G13C neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
NRAS G13C neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
NRAS G13C bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
NRAS G13C bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G13C bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
NRAS G13C b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
NRAS G13C b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
NRAS G13C b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
NRAS G13C b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
NRAS G13C small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
NRAS G13C small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
NRAS G13C sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
NRAS G13C sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
NRAS G13C bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G13C bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G13C bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS G13C bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS G13C vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS G13C vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
NRAS G13C thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
NRAS G13C thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
NRAS G13C ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
NRAS G13C ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
NRAS G13C small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
NRAS G13C small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
NRAS G13C mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
NRAS G13C mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor Primary 0 517 0.00 0.00 0.00 0.00
NRAS G13C germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
NRAS G13C nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS G13C nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.01
NRAS G13C nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
NRAS G13C penile cancer Metastasis 0 11 0.00 0.00 0.00 0.02
NRAS G13C penile cancer Primary 0 13 0.00 0.00 0.00 0.02
NRAS G13C pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
NRAS G13C pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
NRAS G13C b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
NRAS G13C b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
NRAS G13C b cell lymphoma Primary 1 709 0.00 0.00 0.00 0.00
NRAS G13C b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS G13C non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.05
NRAS G13C t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
NRAS G13C t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
NRAS G13C retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.01
NRAS G13C retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
NRAS G13C hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
NRAS G13C lung cancer Primary 0 17 0.00 0.00 0.00 0.03
NRAS G13C parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
NRAS G13D appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
NRAS G13D appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
NRAS G13D appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer Metastasis 8 2352 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer Primary 4 4113 0.00 0.00 0.00 0.00
NRAS G13D colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
NRAS G13D cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
NRAS G13D cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
NRAS G13D cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
NRAS G13D cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer Primary 0 6059 0.00 0.00 0.00 0.00
NRAS G13D non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
NRAS G13D breast cancer Metastasis 1 3094 0.00 0.00 0.00 0.00
NRAS G13D breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS G13D breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
NRAS G13D soft tissue sarcoma Metastasis 1 939 0.00 0.00 0.00 0.00
NRAS G13D soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
NRAS G13D soft tissue sarcoma Primary 2 1686 0.00 0.00 0.00 0.00
NRAS G13D soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.01
NRAS G13D pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
NRAS G13D pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
NRAS G13D pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
NRAS G13D leukemia Metastasis 1 15 0.02 0.02 0.01 0.05
NRAS G13D leukemia Tumor Type:NA/Heme 19 923 0.02 0.02 0.01 0.03
NRAS G13D leukemia Primary 7 412 0.02 0.02 0.01 0.03
NRAS G13D leukemia Tumor Type:Unspecified 5 217 0.02 0.02 0.01 0.04
NRAS G13D melanoma Metastasis 5 1738 0.00 0.00 0.00 0.00
NRAS G13D melanoma Tumor Type:NA/Heme 1 188 0.00 0.00 0.00 0.01
NRAS G13D melanoma Primary 2 898 0.00 0.00 0.00 0.01
NRAS G13D melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
NRAS G13D head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
NRAS G13D head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
NRAS G13D head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
NRAS G13D uterine cancer Metastasis 0 585 0.00 0.00 0.00 0.00
NRAS G13D uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
NRAS G13D uterine cancer Primary 1 1541 0.00 0.00 0.00 0.00
NRAS G13D uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
NRAS G13D non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G13D non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
NRAS G13D non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
NRAS G13D myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.01 0.01 0.00 0.03
NRAS G13D myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 6 915 0.01 0.01 0.00 0.01
NRAS G13D myelodysplastic/myeloproliferative syndromes Primary 3 250 0.01 0.01 0.00 0.02
NRAS G13D myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.01 0.01 0.00 0.02
NRAS G13D adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
NRAS G13D adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
NRAS G13D ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
NRAS G13D ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
NRAS G13D ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
NRAS G13D ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
NRAS G13D esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
NRAS G13D esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
NRAS G13D esophagogastric cancer Primary 1 1283 0.00 0.00 0.00 0.00
NRAS G13D esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
NRAS G13D thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
NRAS G13D thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
NRAS G13D thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
NRAS G13D cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
NRAS G13D cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
NRAS G13D cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
NRAS G13D hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
NRAS G13D hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
NRAS G13D hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
NRAS G13D kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS G13D kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS G13D kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS G13D mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
NRAS G13D mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
NRAS G13D mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
NRAS G13D cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
NRAS G13D cns cancer Tumor Type:NA/Heme 1 526 0.00 0.00 0.00 0.00
NRAS G13D cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
NRAS G13D cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
NRAS G13D prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
NRAS G13D prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
NRAS G13D prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
NRAS G13D prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
NRAS G13D anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS G13D anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS G13D neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.01
NRAS G13D neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.02
NRAS G13D neuroendocrine tumors Primary 1 196 0.00 0.00 0.00 0.01
NRAS G13D bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
NRAS G13D bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G13D bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
NRAS G13D b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.02 0.02 0.00 0.07
NRAS G13D b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 3 109 0.03 0.02 0.01 0.05
NRAS G13D b-lymphoblastic leukemia/lymphoma Primary 1 101 0.02 0.02 0.00 0.05
NRAS G13D b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 2 25 0.04 0.03 0.01 0.12
NRAS G13D small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
NRAS G13D small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
NRAS G13D sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
NRAS G13D sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
NRAS G13D bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G13D bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G13D bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS G13D bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS G13D vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS G13D vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
NRAS G13D thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
NRAS G13D thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
NRAS G13D ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
NRAS G13D ampullary cancer Primary 0 82 0.00 0.00 0.00 0.01
NRAS G13D small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
NRAS G13D small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
NRAS G13D mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
NRAS G13D mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
NRAS G13D germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
NRAS G13D germ cell tumor Tumor Type:NA/Heme 1 81 0.01 0.00 0.00 0.04
NRAS G13D germ cell tumor Primary 0 517 0.00 0.00 0.00 0.00
NRAS G13D germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.02
NRAS G13D nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
NRAS G13D nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
NRAS G13D nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
NRAS G13D penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
NRAS G13D penile cancer Primary 0 13 0.00 0.00 0.00 0.03
NRAS G13D pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.02
NRAS G13D pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
NRAS G13D b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
NRAS G13D b cell lymphoma Tumor Type:NA/Heme 1 145 0.00 0.00 0.00 0.01
NRAS G13D b cell lymphoma Primary 1 709 0.00 0.00 0.00 0.01
NRAS G13D b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS G13D non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
NRAS G13D t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
NRAS G13D t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.03
NRAS G13D retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
NRAS G13D retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
NRAS G13D hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
NRAS G13D lung cancer Primary 0 17 0.00 0.00 0.00 0.02
NRAS G13D parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
NRAS G13R appendiceal cancer Metastasis 1 174 0.00 0.00 0.00 0.02
NRAS G13R appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.03
NRAS G13R appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.01
NRAS G13R colorectal cancer Metastasis 7 2352 0.00 0.00 0.00 0.00
NRAS G13R colorectal cancer Tumor Type:NA/Heme 1 224 0.00 0.00 0.00 0.01
NRAS G13R colorectal cancer Primary 11 4113 0.00 0.00 0.00 0.00
NRAS G13R colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
NRAS G13R cancer of unknown primary Metastasis 4 1388 0.00 0.00 0.00 0.01
NRAS G13R cancer of unknown primary Tumor Type:NA/Heme 1 229 0.00 0.00 0.00 0.01
NRAS G13R cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.01
NRAS G13R cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.01
NRAS G13R non-small cell lung cancer Metastasis 1 3750 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer Primary 1 6059 0.00 0.00 0.00 0.00
NRAS G13R non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
NRAS G13R breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
NRAS G13R breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS G13R breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
NRAS G13R soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
NRAS G13R pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
NRAS G13R pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
NRAS G13R pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
NRAS G13R leukemia Metastasis 1 15 0.01 0.00 0.00 0.07
NRAS G13R leukemia Tumor Type:NA/Heme 4 923 0.00 0.00 0.00 0.01
NRAS G13R leukemia Primary 1 412 0.00 0.00 0.00 0.01
NRAS G13R leukemia Tumor Type:Unspecified 1 217 0.00 0.00 0.00 0.01
NRAS G13R melanoma Metastasis 14 1738 0.01 0.01 0.00 0.01
NRAS G13R melanoma Tumor Type:NA/Heme 1 188 0.01 0.01 0.00 0.01
NRAS G13R melanoma Primary 5 898 0.01 0.01 0.00 0.01
NRAS G13R melanoma Tumor Type:Unspecified 0 22 0.01 0.01 0.00 0.02
NRAS G13R head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
NRAS G13R head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.01
NRAS G13R head and neck cancer Primary 2 938 0.00 0.00 0.00 0.00
NRAS G13R uterine cancer Metastasis 0 585 0.00 0.00 0.00 0.00
NRAS G13R uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
NRAS G13R uterine cancer Primary 0 1541 0.00 0.00 0.00 0.00
NRAS G13R uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
NRAS G13R non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G13R non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
NRAS G13R non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
NRAS G13R myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.02
NRAS G13R myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
NRAS G13R myelodysplastic/myeloproliferative syndromes Primary 1 250 0.00 0.00 0.00 0.01
NRAS G13R myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
NRAS G13R adrenocortical carcinoma Metastasis 1 55 0.01 0.01 0.00 0.05
NRAS G13R adrenocortical carcinoma Primary 0 72 0.01 0.00 0.00 0.03
NRAS G13R ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
NRAS G13R ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
NRAS G13R ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
NRAS G13R ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
NRAS G13R esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
NRAS G13R thyroid cancer Metastasis 2 402 0.00 0.00 0.00 0.01
NRAS G13R thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.02
NRAS G13R thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
NRAS G13R cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
NRAS G13R cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
NRAS G13R cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
NRAS G13R hepatobiliary cancer Metastasis 2 438 0.00 0.00 0.00 0.01
NRAS G13R hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.01
NRAS G13R hepatobiliary cancer Primary 1 894 0.00 0.00 0.00 0.00
NRAS G13R kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS G13R kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS G13R kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS G13R mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
NRAS G13R mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
NRAS G13R mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
NRAS G13R cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
NRAS G13R cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
NRAS G13R cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
NRAS G13R cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
NRAS G13R prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
NRAS G13R prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
NRAS G13R prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
NRAS G13R prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
NRAS G13R anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS G13R anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS G13R neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
NRAS G13R neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
NRAS G13R neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
NRAS G13R bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
NRAS G13R bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
NRAS G13R bladder cancer Primary 2 1164 0.00 0.00 0.00 0.00
NRAS G13R b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.01 0.00 0.00 0.02
NRAS G13R b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 1 109 0.01 0.00 0.00 0.02
NRAS G13R b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.02
NRAS G13R b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.02
NRAS G13R small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
NRAS G13R small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
NRAS G13R sex cord stromal tumor Metastasis 0 48 0.01 0.00 0.00 0.04
NRAS G13R sex cord stromal tumor Primary 1 54 0.02 0.01 0.00 0.05
NRAS G13R bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G13R bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G13R bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS G13R bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS G13R vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS G13R vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
NRAS G13R thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
NRAS G13R thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
NRAS G13R ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
NRAS G13R ampullary cancer Primary 0 82 0.00 0.00 0.00 0.01
NRAS G13R small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
NRAS G13R small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
NRAS G13R mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
NRAS G13R mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
NRAS G13R germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.01
NRAS G13R germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.01
NRAS G13R germ cell tumor Primary 2 517 0.00 0.00 0.00 0.01
NRAS G13R germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.02
NRAS G13R nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
NRAS G13R nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
NRAS G13R nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
NRAS G13R penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
NRAS G13R penile cancer Primary 0 13 0.00 0.00 0.00 0.03
NRAS G13R pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.02
NRAS G13R pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
NRAS G13R b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
NRAS G13R b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
NRAS G13R b cell lymphoma Primary 1 709 0.00 0.00 0.00 0.00
NRAS G13R b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS G13R non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
NRAS G13R t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 1 25 0.04 0.03 0.00 0.12
NRAS G13R t-lymphoblastic leukemia/lymphoma Primary 0 11 0.03 0.02 0.00 0.11
NRAS G13R retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
NRAS G13R retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
NRAS G13R hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
NRAS G13R lung cancer Primary 0 17 0.00 0.00 0.00 0.02
NRAS G13R parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
NRAS G13V appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
NRAS G13V appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
NRAS G13V appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer Metastasis 0 2352 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer Primary 0 4113 0.00 0.00 0.00 0.00
NRAS G13V colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary Metastasis 0 1388 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
NRAS G13V cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer Primary 1 6059 0.00 0.00 0.00 0.00
NRAS G13V non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
NRAS G13V breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
NRAS G13V breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS G13V breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma Metastasis 0 939 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma Primary 0 1686 0.00 0.00 0.00 0.00
NRAS G13V soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
NRAS G13V pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
NRAS G13V pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
NRAS G13V pancreatic cancer Primary 1 1428 0.00 0.00 0.00 0.00
NRAS G13V leukemia Metastasis 0 15 0.00 0.00 0.00 0.02
NRAS G13V leukemia Tumor Type:NA/Heme 2 923 0.00 0.00 0.00 0.01
NRAS G13V leukemia Primary 1 412 0.00 0.00 0.00 0.01
NRAS G13V leukemia Tumor Type:Unspecified 2 217 0.00 0.00 0.00 0.02
NRAS G13V melanoma Metastasis 1 1738 0.00 0.00 0.00 0.00
NRAS G13V melanoma Tumor Type:NA/Heme 0 188 0.00 0.00 0.00 0.00
NRAS G13V melanoma Primary 3 898 0.00 0.00 0.00 0.01
NRAS G13V melanoma Tumor Type:Unspecified 0 22 0.00 0.00 0.00 0.01
NRAS G13V head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
NRAS G13V head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
NRAS G13V head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
NRAS G13V uterine cancer Metastasis 0 585 0.00 0.00 0.00 0.00
NRAS G13V uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.00
NRAS G13V uterine cancer Primary 0 1541 0.00 0.00 0.00 0.00
NRAS G13V uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
NRAS G13V non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G13V non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
NRAS G13V non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
NRAS G13V myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.01 0.00 0.00 0.02
NRAS G13V myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 3 915 0.00 0.00 0.00 0.01
NRAS G13V myelodysplastic/myeloproliferative syndromes Primary 2 250 0.00 0.00 0.00 0.02
NRAS G13V myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.02
NRAS G13V adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
NRAS G13V adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
NRAS G13V ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
NRAS G13V ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
NRAS G13V ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
NRAS G13V ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
NRAS G13V esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
NRAS G13V thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
NRAS G13V thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
NRAS G13V thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
NRAS G13V cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
NRAS G13V cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
NRAS G13V cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
NRAS G13V hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
NRAS G13V hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
NRAS G13V hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
NRAS G13V kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS G13V kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS G13V kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS G13V mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
NRAS G13V mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
NRAS G13V mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
NRAS G13V cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
NRAS G13V cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
NRAS G13V cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
NRAS G13V cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
NRAS G13V prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
NRAS G13V prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
NRAS G13V prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
NRAS G13V prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
NRAS G13V anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS G13V anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS G13V neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
NRAS G13V neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
NRAS G13V neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
NRAS G13V bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
NRAS G13V bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G13V bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
NRAS G13V b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.02
NRAS G13V b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.02
NRAS G13V b-lymphoblastic leukemia/lymphoma Primary 1 101 0.01 0.00 0.00 0.02
NRAS G13V b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.02
NRAS G13V small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
NRAS G13V small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
NRAS G13V sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.01
NRAS G13V sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
NRAS G13V bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS G13V bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS G13V bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS G13V bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS G13V vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.00
NRAS G13V vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
NRAS G13V thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
NRAS G13V thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
NRAS G13V ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
NRAS G13V ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
NRAS G13V small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
NRAS G13V small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
NRAS G13V mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
NRAS G13V mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor Metastasis 0 274 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor Primary 0 517 0.00 0.00 0.00 0.00
NRAS G13V germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
NRAS G13V nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
NRAS G13V nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
NRAS G13V nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
NRAS G13V penile cancer Metastasis 0 11 0.00 0.00 0.00 0.04
NRAS G13V penile cancer Primary 0 13 0.00 0.00 0.00 0.03
NRAS G13V pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
NRAS G13V pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
NRAS G13V b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.00
NRAS G13V b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
NRAS G13V b cell lymphoma Primary 0 709 0.00 0.00 0.00 0.00
NRAS G13V b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.00
NRAS G13V non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.02
NRAS G13V t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
NRAS G13V t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
NRAS G13V retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
NRAS G13V retinoblastoma Primary 0 41 0.00 0.00 0.00 0.02
NRAS G13V hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
NRAS G13V lung cancer Primary 0 17 0.00 0.00 0.00 0.03
NRAS G13V parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
NRAS Q61H appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
NRAS Q61H appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
NRAS Q61H appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
NRAS Q61H colorectal cancer Metastasis 4 2352 0.00 0.00 0.00 0.00
NRAS Q61H colorectal cancer Tumor Type:NA/Heme 0 224 0.00 0.00 0.00 0.00
NRAS Q61H colorectal cancer Primary 13 4113 0.00 0.00 0.00 0.00
NRAS Q61H colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
NRAS Q61H cancer of unknown primary Metastasis 1 1388 0.00 0.00 0.00 0.00
NRAS Q61H cancer of unknown primary Tumor Type:NA/Heme 1 229 0.00 0.00 0.00 0.01
NRAS Q61H cancer of unknown primary Primary 1 311 0.00 0.00 0.00 0.01
NRAS Q61H cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.01
NRAS Q61H non-small cell lung cancer Metastasis 0 3750 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer Primary 4 6059 0.00 0.00 0.00 0.00
NRAS Q61H non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS Q61H breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma Metastasis 1 939 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma Primary 2 1686 0.00 0.00 0.00 0.00
NRAS Q61H soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.01
NRAS Q61H pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
NRAS Q61H pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
NRAS Q61H pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
NRAS Q61H leukemia Metastasis 0 15 0.01 0.00 0.00 0.02
NRAS Q61H leukemia Tumor Type:NA/Heme 3 923 0.00 0.00 0.00 0.01
NRAS Q61H leukemia Primary 1 412 0.00 0.00 0.00 0.01
NRAS Q61H leukemia Tumor Type:Unspecified 3 217 0.01 0.01 0.00 0.02
NRAS Q61H melanoma Metastasis 14 1738 0.01 0.01 0.00 0.01
NRAS Q61H melanoma Tumor Type:NA/Heme 2 188 0.01 0.01 0.00 0.02
NRAS Q61H melanoma Primary 11 898 0.01 0.01 0.01 0.02
NRAS Q61H melanoma Tumor Type:Unspecified 0 22 0.01 0.01 0.00 0.02
NRAS Q61H head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
NRAS Q61H head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.01
NRAS Q61H head and neck cancer Primary 1 938 0.00 0.00 0.00 0.00
NRAS Q61H uterine cancer Metastasis 1 585 0.00 0.00 0.00 0.00
NRAS Q61H uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.01
NRAS Q61H uterine cancer Primary 3 1541 0.00 0.00 0.00 0.00
NRAS Q61H uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS Q61H non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS Q61H non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
NRAS Q61H non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
NRAS Q61H myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.03
NRAS Q61H myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
NRAS Q61H myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
NRAS Q61H myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 1 31 0.02 0.01 0.00 0.10
NRAS Q61H adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
NRAS Q61H adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
NRAS Q61H ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
NRAS Q61H ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
NRAS Q61H ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
NRAS Q61H ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer Primary 0 1283 0.00 0.00 0.00 0.00
NRAS Q61H esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.00
NRAS Q61H thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
NRAS Q61H thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
NRAS Q61H thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
NRAS Q61H cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.01
NRAS Q61H cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.02
NRAS Q61H cervical cancer Primary 1 211 0.00 0.00 0.00 0.01
NRAS Q61H hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
NRAS Q61H hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
NRAS Q61H hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
NRAS Q61H kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS Q61H kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS Q61H kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS Q61H mature t and nk neoplasms Metastasis 0 10 0.01 0.00 0.00 0.04
NRAS Q61H mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.01 0.00 0.00 0.03
NRAS Q61H mature t and nk neoplasms Primary 1 187 0.00 0.00 0.00 0.02
NRAS Q61H cns cancer Metastasis 0 409 0.00 0.00 0.00 0.00
NRAS Q61H cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
NRAS Q61H cns cancer Primary 0 3522 0.00 0.00 0.00 0.00
NRAS Q61H cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
NRAS Q61H prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
NRAS Q61H prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.01
NRAS Q61H prostate cancer Primary 2 1468 0.00 0.00 0.00 0.00
NRAS Q61H prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.01
NRAS Q61H anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS Q61H anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS Q61H neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
NRAS Q61H neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
NRAS Q61H neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
NRAS Q61H bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
NRAS Q61H bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS Q61H bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
NRAS Q61H b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.01 0.01 0.00 0.03
NRAS Q61H b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 1 109 0.01 0.01 0.00 0.03
NRAS Q61H b-lymphoblastic leukemia/lymphoma Primary 1 101 0.01 0.01 0.00 0.03
NRAS Q61H b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.01 0.01 0.00 0.03
NRAS Q61H small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
NRAS Q61H small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
NRAS Q61H sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
NRAS Q61H sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
NRAS Q61H bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS Q61H bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS Q61H bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS Q61H bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS Q61H vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS Q61H vaginal cancer Primary 0 60 0.00 0.00 0.00 0.01
NRAS Q61H thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
NRAS Q61H thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
NRAS Q61H ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
NRAS Q61H ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
NRAS Q61H small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
NRAS Q61H small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
NRAS Q61H mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
NRAS Q61H mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
NRAS Q61H germ cell tumor Metastasis 2 274 0.00 0.00 0.00 0.01
NRAS Q61H germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.01
NRAS Q61H germ cell tumor Primary 1 517 0.00 0.00 0.00 0.01
NRAS Q61H germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.02
NRAS Q61H nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS Q61H nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.01
NRAS Q61H nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
NRAS Q61H penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
NRAS Q61H penile cancer Primary 0 13 0.00 0.00 0.00 0.03
NRAS Q61H pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.02
NRAS Q61H pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
NRAS Q61H b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
NRAS Q61H b cell lymphoma Tumor Type:NA/Heme 1 145 0.00 0.00 0.00 0.01
NRAS Q61H b cell lymphoma Primary 1 709 0.00 0.00 0.00 0.01
NRAS Q61H b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS Q61H non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
NRAS Q61H t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
NRAS Q61H t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
NRAS Q61H retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
NRAS Q61H retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
NRAS Q61H hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.02
NRAS Q61H lung cancer Primary 1 17 0.07 0.05 0.00 0.22
NRAS Q61H parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.04
NRAS Q61K appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
NRAS Q61K appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
NRAS Q61K appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
NRAS Q61K colorectal cancer Metastasis 28 2352 0.01 0.01 0.01 0.02
NRAS Q61K colorectal cancer Tumor Type:NA/Heme 3 224 0.01 0.01 0.01 0.02
NRAS Q61K colorectal cancer Primary 34 4113 0.01 0.01 0.01 0.01
NRAS Q61K colorectal cancer Tumor Type:Unspecified 0 31 0.01 0.01 0.00 0.02
NRAS Q61K cancer of unknown primary Metastasis 4 1388 0.00 0.00 0.00 0.01
NRAS Q61K cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.01
NRAS Q61K cancer of unknown primary Primary 2 311 0.00 0.00 0.00 0.01
NRAS Q61K cancer of unknown primary Tumor Type:Unspecified 1 60 0.01 0.00 0.00 0.02
NRAS Q61K non-small cell lung cancer Metastasis 2 3750 0.00 0.00 0.00 0.00
NRAS Q61K non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
NRAS Q61K non-small cell lung cancer Primary 5 6059 0.00 0.00 0.00 0.00
NRAS Q61K non-small cell lung cancer Tumor Type:Unspecified 1 99 0.00 0.00 0.00 0.01
NRAS Q61K breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS Q61K breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
NRAS Q61K soft tissue sarcoma Metastasis 2 939 0.00 0.00 0.00 0.01
NRAS Q61K soft tissue sarcoma Tumor Type:NA/Heme 1 119 0.01 0.00 0.00 0.02
NRAS Q61K soft tissue sarcoma Primary 12 1686 0.01 0.01 0.00 0.01
NRAS Q61K soft tissue sarcoma Tumor Type:Unspecified 0 29 0.01 0.00 0.00 0.02
NRAS Q61K pancreatic cancer Metastasis 1 981 0.00 0.00 0.00 0.00
NRAS Q61K pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
NRAS Q61K pancreatic cancer Primary 1 1428 0.00 0.00 0.00 0.00
NRAS Q61K leukemia Metastasis 1 15 0.01 0.01 0.00 0.05
NRAS Q61K leukemia Tumor Type:NA/Heme 8 923 0.01 0.01 0.00 0.02
NRAS Q61K leukemia Primary 3 412 0.01 0.01 0.00 0.02
NRAS Q61K leukemia Tumor Type:Unspecified 2 217 0.01 0.01 0.00 0.02
NRAS Q61K melanoma Metastasis 128 1738 0.07 0.07 0.06 0.08
NRAS Q61K melanoma Tumor Type:NA/Heme 16 188 0.07 0.07 0.05 0.10
NRAS Q61K melanoma Primary 55 898 0.07 0.07 0.05 0.08
NRAS Q61K melanoma Tumor Type:Unspecified 0 22 0.07 0.07 0.02 0.10
NRAS Q61K head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
NRAS Q61K head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.01
NRAS Q61K head and neck cancer Primary 3 938 0.00 0.00 0.00 0.01
NRAS Q61K uterine cancer Metastasis 1 585 0.00 0.00 0.00 0.01
NRAS Q61K uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.01
NRAS Q61K uterine cancer Primary 4 1541 0.00 0.00 0.00 0.00
NRAS Q61K uterine cancer Tumor Type:Unspecified 1 51 0.00 0.00 0.00 0.03
NRAS Q61K non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS Q61K non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
NRAS Q61K non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
NRAS Q61K myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
NRAS Q61K myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
NRAS Q61K myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
NRAS Q61K myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
NRAS Q61K adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
NRAS Q61K adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
NRAS Q61K ovarian cancer Metastasis 0 1088 0.00 0.00 0.00 0.00
NRAS Q61K ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.01
NRAS Q61K ovarian cancer Primary 5 1060 0.00 0.00 0.00 0.01
NRAS Q61K ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.02
NRAS Q61K esophagogastric cancer Metastasis 1 462 0.00 0.00 0.00 0.00
NRAS Q61K esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.01
NRAS Q61K esophagogastric cancer Primary 1 1283 0.00 0.00 0.00 0.00
NRAS Q61K esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
NRAS Q61K thyroid cancer Metastasis 5 402 0.02 0.02 0.00 0.03
NRAS Q61K thyroid cancer Tumor Type:NA/Heme 0 28 0.02 0.02 0.00 0.06
NRAS Q61K thyroid cancer Primary 24 582 0.04 0.04 0.02 0.06
NRAS Q61K cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
NRAS Q61K cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
NRAS Q61K cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
NRAS Q61K hepatobiliary cancer Metastasis 3 438 0.01 0.00 0.00 0.01
NRAS Q61K hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.01 0.00 0.00 0.02
NRAS Q61K hepatobiliary cancer Primary 4 894 0.00 0.00 0.00 0.01
NRAS Q61K kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS Q61K kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS Q61K kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS Q61K mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
NRAS Q61K mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
NRAS Q61K mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
NRAS Q61K cns cancer Metastasis 2 409 0.00 0.00 0.00 0.01
NRAS Q61K cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
NRAS Q61K cns cancer Primary 6 3522 0.00 0.00 0.00 0.00
NRAS Q61K cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.01
NRAS Q61K prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
NRAS Q61K prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
NRAS Q61K prostate cancer Primary 1 1468 0.00 0.00 0.00 0.00
NRAS Q61K prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.01
NRAS Q61K anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS Q61K anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS Q61K neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
NRAS Q61K neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
NRAS Q61K neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
NRAS Q61K bladder cancer Metastasis 1 389 0.00 0.00 0.00 0.01
NRAS Q61K bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
NRAS Q61K bladder cancer Primary 2 1164 0.00 0.00 0.00 0.00
NRAS Q61K b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.01 0.01 0.00 0.05
NRAS Q61K b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 2 109 0.02 0.01 0.00 0.04
NRAS Q61K b-lymphoblastic leukemia/lymphoma Primary 0 101 0.01 0.01 0.00 0.03
NRAS Q61K b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 1 25 0.02 0.01 0.00 0.08
NRAS Q61K small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
NRAS Q61K small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
NRAS Q61K sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.01
NRAS Q61K sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
NRAS Q61K bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS Q61K bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS Q61K bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS Q61K bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS Q61K vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.00
NRAS Q61K vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
NRAS Q61K thymic tumor Metastasis 0 61 0.01 0.00 0.00 0.03
NRAS Q61K thymic tumor Primary 1 84 0.01 0.01 0.00 0.04
NRAS Q61K ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
NRAS Q61K ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
NRAS Q61K small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.01
NRAS Q61K small cell lung cancer Primary 1 183 0.00 0.00 0.00 0.02
NRAS Q61K mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
NRAS Q61K mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
NRAS Q61K germ cell tumor Metastasis 2 274 0.00 0.00 0.00 0.01
NRAS Q61K germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.01
NRAS Q61K germ cell tumor Primary 1 517 0.00 0.00 0.00 0.01
NRAS Q61K germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.02
NRAS Q61K nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
NRAS Q61K nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
NRAS Q61K nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
NRAS Q61K penile cancer Metastasis 0 11 0.00 0.00 0.00 0.04
NRAS Q61K penile cancer Primary 0 13 0.00 0.00 0.00 0.03
NRAS Q61K pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
NRAS Q61K pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
NRAS Q61K b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
NRAS Q61K b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.01
NRAS Q61K b cell lymphoma Primary 3 709 0.00 0.00 0.00 0.01
NRAS Q61K b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS Q61K non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.02
NRAS Q61K t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
NRAS Q61K t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
NRAS Q61K retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
NRAS Q61K retinoblastoma Primary 0 41 0.00 0.00 0.00 0.02
NRAS Q61K hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
NRAS Q61K lung cancer Primary 0 17 0.00 0.00 0.00 0.03
NRAS Q61K parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
NRAS Q61L appendiceal cancer Metastasis 0 174 0.00 0.00 0.00 0.00
NRAS Q61L appendiceal cancer Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.00
NRAS Q61L appendiceal cancer Primary 0 151 0.00 0.00 0.00 0.00
NRAS Q61L colorectal cancer Metastasis 8 2352 0.00 0.00 0.00 0.01
NRAS Q61L colorectal cancer Tumor Type:NA/Heme 2 224 0.00 0.00 0.00 0.01
NRAS Q61L colorectal cancer Primary 12 4113 0.00 0.00 0.00 0.00
NRAS Q61L colorectal cancer Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.01
NRAS Q61L cancer of unknown primary Metastasis 1 1388 0.00 0.00 0.00 0.00
NRAS Q61L cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.00
NRAS Q61L cancer of unknown primary Primary 0 311 0.00 0.00 0.00 0.00
NRAS Q61L cancer of unknown primary Tumor Type:Unspecified 0 60 0.00 0.00 0.00 0.00
NRAS Q61L non-small cell lung cancer Metastasis 14 3750 0.00 0.00 0.00 0.00
NRAS Q61L non-small cell lung cancer Tumor Type:NA/Heme 1 223 0.00 0.00 0.00 0.01
NRAS Q61L non-small cell lung cancer Primary 17 6059 0.00 0.00 0.00 0.00
NRAS Q61L non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.01
NRAS Q61L breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
NRAS Q61L breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS Q61L breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
NRAS Q61L soft tissue sarcoma Metastasis 1 939 0.00 0.00 0.00 0.00
NRAS Q61L soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.00
NRAS Q61L soft tissue sarcoma Primary 3 1686 0.00 0.00 0.00 0.00
NRAS Q61L soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.00
NRAS Q61L pancreatic cancer Metastasis 0 981 0.00 0.00 0.00 0.00
NRAS Q61L pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.00
NRAS Q61L pancreatic cancer Primary 0 1428 0.00 0.00 0.00 0.00
NRAS Q61L leukemia Metastasis 0 15 0.00 0.00 0.00 0.02
NRAS Q61L leukemia Tumor Type:NA/Heme 5 923 0.00 0.00 0.00 0.01
NRAS Q61L leukemia Primary 0 412 0.00 0.00 0.00 0.01
NRAS Q61L leukemia Tumor Type:Unspecified 1 217 0.00 0.00 0.00 0.01
NRAS Q61L melanoma Metastasis 56 1738 0.03 0.03 0.02 0.04
NRAS Q61L melanoma Tumor Type:NA/Heme 4 188 0.03 0.03 0.02 0.04
NRAS Q61L melanoma Primary 28 898 0.03 0.03 0.02 0.04
NRAS Q61L melanoma Tumor Type:Unspecified 0 22 0.03 0.03 0.01 0.05
NRAS Q61L head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
NRAS Q61L head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
NRAS Q61L head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
NRAS Q61L uterine cancer Metastasis 1 585 0.00 0.00 0.00 0.01
NRAS Q61L uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.01
NRAS Q61L uterine cancer Primary 5 1541 0.00 0.00 0.00 0.01
NRAS Q61L uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS Q61L non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS Q61L non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
NRAS Q61L non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
NRAS Q61L myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.00
NRAS Q61L myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 0 915 0.00 0.00 0.00 0.00
NRAS Q61L myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.00
NRAS Q61L myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 0 31 0.00 0.00 0.00 0.00
NRAS Q61L adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.00
NRAS Q61L adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
NRAS Q61L ovarian cancer Metastasis 1 1088 0.00 0.00 0.00 0.00
NRAS Q61L ovarian cancer Tumor Type:NA/Heme 0 160 0.00 0.00 0.00 0.00
NRAS Q61L ovarian cancer Primary 0 1060 0.00 0.00 0.00 0.00
NRAS Q61L ovarian cancer Tumor Type:Unspecified 0 28 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer Metastasis 0 462 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer Primary 1 1283 0.00 0.00 0.00 0.00
NRAS Q61L esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
NRAS Q61L thyroid cancer Metastasis 0 402 0.00 0.00 0.00 0.00
NRAS Q61L thyroid cancer Tumor Type:NA/Heme 0 28 0.00 0.00 0.00 0.00
NRAS Q61L thyroid cancer Primary 0 582 0.00 0.00 0.00 0.00
NRAS Q61L cervical cancer Metastasis 0 136 0.00 0.00 0.00 0.00
NRAS Q61L cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.00
NRAS Q61L cervical cancer Primary 0 211 0.00 0.00 0.00 0.00
NRAS Q61L hepatobiliary cancer Metastasis 0 438 0.00 0.00 0.00 0.00
NRAS Q61L hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.00 0.00 0.00 0.00
NRAS Q61L hepatobiliary cancer Primary 0 894 0.00 0.00 0.00 0.00
NRAS Q61L kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS Q61L kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS Q61L kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS Q61L mature t and nk neoplasms Metastasis 0 10 0.00 0.00 0.00 0.00
NRAS Q61L mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.00 0.00 0.00 0.00
NRAS Q61L mature t and nk neoplasms Primary 0 187 0.00 0.00 0.00 0.00
NRAS Q61L cns cancer Metastasis 1 409 0.00 0.00 0.00 0.01
NRAS Q61L cns cancer Tumor Type:NA/Heme 0 526 0.00 0.00 0.00 0.00
NRAS Q61L cns cancer Primary 3 3522 0.00 0.00 0.00 0.00
NRAS Q61L cns cancer Tumor Type:Unspecified 1 108 0.00 0.00 0.00 0.02
NRAS Q61L prostate cancer Metastasis 0 901 0.00 0.00 0.00 0.00
NRAS Q61L prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
NRAS Q61L prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
NRAS Q61L prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.00
NRAS Q61L anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS Q61L anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS Q61L neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.00
NRAS Q61L neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.00
NRAS Q61L neuroendocrine tumors Primary 0 196 0.00 0.00 0.00 0.00
NRAS Q61L bladder cancer Metastasis 0 389 0.00 0.00 0.00 0.00
NRAS Q61L bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS Q61L bladder cancer Primary 0 1164 0.00 0.00 0.00 0.00
NRAS Q61L b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.00 0.00 0.00 0.00
NRAS Q61L b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.00
NRAS Q61L b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.00
NRAS Q61L b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 0 25 0.00 0.00 0.00 0.00
NRAS Q61L small bowel cancer Metastasis 0 78 0.00 0.00 0.00 0.00
NRAS Q61L small bowel cancer Primary 0 128 0.00 0.00 0.00 0.00
NRAS Q61L sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.01
NRAS Q61L sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.01
NRAS Q61L bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS Q61L bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS Q61L bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS Q61L bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS Q61L vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.00
NRAS Q61L vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
NRAS Q61L thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
NRAS Q61L thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
NRAS Q61L ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
NRAS Q61L ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
NRAS Q61L small cell lung cancer Metastasis 1 207 0.00 0.00 0.00 0.02
NRAS Q61L small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.01
NRAS Q61L mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.00
NRAS Q61L mesothelioma Primary 0 408 0.00 0.00 0.00 0.00
NRAS Q61L germ cell tumor Metastasis 1 274 0.00 0.00 0.00 0.01
NRAS Q61L germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.01
NRAS Q61L germ cell tumor Primary 0 517 0.00 0.00 0.00 0.00
NRAS Q61L germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.02
NRAS Q61L nerve sheath tumor Metastasis 0 16 0.00 0.00 0.00 0.00
NRAS Q61L nerve sheath tumor Tumor Type:NA/Heme 0 17 0.00 0.00 0.00 0.00
NRAS Q61L nerve sheath tumor Primary 0 117 0.00 0.00 0.00 0.00
NRAS Q61L penile cancer Metastasis 0 11 0.00 0.00 0.00 0.04
NRAS Q61L penile cancer Primary 0 13 0.00 0.00 0.00 0.03
NRAS Q61L pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.04
NRAS Q61L pineal tumor Primary 0 14 0.00 0.00 0.00 0.04
NRAS Q61L b cell lymphoma Metastasis 0 57 0.00 0.00 0.00 0.01
NRAS Q61L b cell lymphoma Tumor Type:NA/Heme 0 145 0.00 0.00 0.00 0.00
NRAS Q61L b cell lymphoma Primary 1 709 0.00 0.00 0.00 0.00
NRAS Q61L b cell lymphoma Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS Q61L non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.02
NRAS Q61L t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.02
NRAS Q61L t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
NRAS Q61L retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.02
NRAS Q61L retinoblastoma Primary 0 41 0.00 0.00 0.00 0.02
NRAS Q61L hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
NRAS Q61L lung cancer Primary 0 17 0.00 0.00 0.00 0.03
NRAS Q61L parathyroid cancer Primary 0 13 0.00 0.00 0.00 0.05
NRAS Q61R appendiceal cancer Metastasis 3 174 0.02 0.02 0.00 0.03
NRAS Q61R appendiceal cancer Tumor Type:NA/Heme 0 10 0.02 0.01 0.00 0.05
NRAS Q61R appendiceal cancer Primary 2 151 0.02 0.01 0.00 0.03
NRAS Q61R colorectal cancer Metastasis 13 2352 0.01 0.01 0.00 0.01
NRAS Q61R colorectal cancer Tumor Type:NA/Heme 1 224 0.01 0.01 0.00 0.01
NRAS Q61R colorectal cancer Primary 30 4113 0.01 0.01 0.00 0.01
NRAS Q61R colorectal cancer Tumor Type:Unspecified 2 31 0.02 0.01 0.00 0.08
NRAS Q61R cancer of unknown primary Metastasis 6 1388 0.00 0.00 0.00 0.01
NRAS Q61R cancer of unknown primary Tumor Type:NA/Heme 0 229 0.00 0.00 0.00 0.01
NRAS Q61R cancer of unknown primary Primary 1 311 0.00 0.00 0.00 0.01
NRAS Q61R cancer of unknown primary Tumor Type:Unspecified 1 60 0.01 0.00 0.00 0.02
NRAS Q61R non-small cell lung cancer Metastasis 5 3750 0.00 0.00 0.00 0.00
NRAS Q61R non-small cell lung cancer Tumor Type:NA/Heme 0 223 0.00 0.00 0.00 0.00
NRAS Q61R non-small cell lung cancer Primary 10 6059 0.00 0.00 0.00 0.00
NRAS Q61R non-small cell lung cancer Tumor Type:Unspecified 0 99 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer Metastasis 0 3094 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer Tumor Type:NA/Heme 0 105 0.00 0.00 0.00 0.00
NRAS Q61R breast cancer Primary 0 6124 0.00 0.00 0.00 0.00
NRAS Q61R soft tissue sarcoma Metastasis 3 939 0.00 0.00 0.00 0.00
NRAS Q61R soft tissue sarcoma Tumor Type:NA/Heme 0 119 0.00 0.00 0.00 0.01
NRAS Q61R soft tissue sarcoma Primary 3 1686 0.00 0.00 0.00 0.00
NRAS Q61R soft tissue sarcoma Tumor Type:Unspecified 0 29 0.00 0.00 0.00 0.01
NRAS Q61R pancreatic cancer Metastasis 2 981 0.00 0.00 0.00 0.00
NRAS Q61R pancreatic cancer Tumor Type:NA/Heme 0 75 0.00 0.00 0.00 0.01
NRAS Q61R pancreatic cancer Primary 5 1428 0.00 0.00 0.00 0.01
NRAS Q61R leukemia Metastasis 0 15 0.01 0.01 0.00 0.05
NRAS Q61R leukemia Tumor Type:NA/Heme 5 923 0.01 0.01 0.00 0.02
NRAS Q61R leukemia Primary 9 412 0.02 0.02 0.01 0.03
NRAS Q61R leukemia Tumor Type:Unspecified 3 217 0.01 0.01 0.00 0.03
NRAS Q61R melanoma Metastasis 174 1738 0.10 0.10 0.08 0.11
NRAS Q61R melanoma Tumor Type:NA/Heme 13 188 0.07 0.07 0.04 0.10
NRAS Q61R melanoma Primary 59 898 0.07 0.07 0.05 0.09
NRAS Q61R melanoma Tumor Type:Unspecified 0 22 0.06 0.07 0.01 0.11
NRAS Q61R head and neck cancer Metastasis 0 731 0.00 0.00 0.00 0.00
NRAS Q61R head and neck cancer Tumor Type:NA/Heme 0 67 0.00 0.00 0.00 0.00
NRAS Q61R head and neck cancer Primary 0 938 0.00 0.00 0.00 0.00
NRAS Q61R uterine cancer Metastasis 3 585 0.00 0.00 0.00 0.01
NRAS Q61R uterine cancer Tumor Type:NA/Heme 0 76 0.00 0.00 0.00 0.01
NRAS Q61R uterine cancer Primary 6 1541 0.00 0.00 0.00 0.01
NRAS Q61R uterine cancer Tumor Type:Unspecified 0 51 0.00 0.00 0.00 0.01
NRAS Q61R non-melanoma skin cancers Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS Q61R non-melanoma skin cancers Tumor Type:NA/Heme 0 22 0.00 0.00 0.00 0.00
NRAS Q61R non-melanoma skin cancers Primary 0 287 0.00 0.00 0.00 0.00
NRAS Q61R myelodysplastic/myeloproliferative syndromes Metastasis 0 11 0.00 0.00 0.00 0.03
NRAS Q61R myelodysplastic/myeloproliferative syndromes Tumor Type:NA/Heme 1 915 0.00 0.00 0.00 0.00
NRAS Q61R myelodysplastic/myeloproliferative syndromes Primary 0 250 0.00 0.00 0.00 0.01
NRAS Q61R myelodysplastic/myeloproliferative syndromes Tumor Type:Unspecified 1 31 0.01 0.00 0.00 0.07
NRAS Q61R adrenocortical carcinoma Metastasis 0 55 0.00 0.00 0.00 0.01
NRAS Q61R adrenocortical carcinoma Primary 0 72 0.00 0.00 0.00 0.00
NRAS Q61R ovarian cancer Metastasis 13 1088 0.01 0.01 0.01 0.02
NRAS Q61R ovarian cancer Tumor Type:NA/Heme 3 160 0.01 0.01 0.01 0.03
NRAS Q61R ovarian cancer Primary 9 1060 0.01 0.01 0.01 0.02
NRAS Q61R ovarian cancer Tumor Type:Unspecified 0 28 0.01 0.01 0.00 0.02
NRAS Q61R esophagogastric cancer Metastasis 1 462 0.00 0.00 0.00 0.00
NRAS Q61R esophagogastric cancer Tumor Type:NA/Heme 0 43 0.00 0.00 0.00 0.01
NRAS Q61R esophagogastric cancer Primary 2 1283 0.00 0.00 0.00 0.00
NRAS Q61R esophagogastric cancer Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.01
NRAS Q61R thyroid cancer Metastasis 36 402 0.09 0.09 0.07 0.11
NRAS Q61R thyroid cancer Tumor Type:NA/Heme 1 28 0.08 0.09 0.03 0.12
NRAS Q61R thyroid cancer Primary 56 582 0.09 0.09 0.07 0.12
NRAS Q61R cervical cancer Metastasis 1 136 0.00 0.00 0.00 0.02
NRAS Q61R cervical cancer Tumor Type:NA/Heme 0 12 0.00 0.00 0.00 0.03
NRAS Q61R cervical cancer Primary 0 211 0.00 0.00 0.00 0.01
NRAS Q61R hepatobiliary cancer Metastasis 2 438 0.01 0.01 0.00 0.01
NRAS Q61R hepatobiliary cancer Tumor Type:NA/Heme 0 34 0.01 0.01 0.00 0.02
NRAS Q61R hepatobiliary cancer Primary 7 894 0.01 0.01 0.00 0.01
NRAS Q61R kidney cancer Metastasis 0 445 0.00 0.00 0.00 0.00
NRAS Q61R kidney cancer Tumor Type:NA/Heme 0 24 0.00 0.00 0.00 0.00
NRAS Q61R kidney cancer Primary 0 944 0.00 0.00 0.00 0.00
NRAS Q61R mature t and nk neoplasms Metastasis 0 10 0.01 0.00 0.00 0.03
NRAS Q61R mature t and nk neoplasms Tumor Type:NA/Heme 0 29 0.01 0.00 0.00 0.02
NRAS Q61R mature t and nk neoplasms Primary 1 187 0.00 0.00 0.00 0.02
NRAS Q61R cns cancer Metastasis 1 409 0.00 0.00 0.00 0.00
NRAS Q61R cns cancer Tumor Type:NA/Heme 1 526 0.00 0.00 0.00 0.00
NRAS Q61R cns cancer Primary 5 3522 0.00 0.00 0.00 0.00
NRAS Q61R cns cancer Tumor Type:Unspecified 0 108 0.00 0.00 0.00 0.00
NRAS Q61R prostate cancer Metastasis 1 901 0.00 0.00 0.00 0.00
NRAS Q61R prostate cancer Tumor Type:NA/Heme 0 57 0.00 0.00 0.00 0.00
NRAS Q61R prostate cancer Primary 0 1468 0.00 0.00 0.00 0.00
NRAS Q61R prostate cancer Tumor Type:Unspecified 0 12 0.00 0.00 0.00 0.01
NRAS Q61R anal cancer Metastasis 0 59 0.00 0.00 0.00 0.00
NRAS Q61R anal cancer Primary 0 84 0.00 0.00 0.00 0.00
NRAS Q61R neuroendocrine tumors Metastasis 0 143 0.00 0.00 0.00 0.01
NRAS Q61R neuroendocrine tumors Tumor Type:NA/Heme 0 20 0.00 0.00 0.00 0.02
NRAS Q61R neuroendocrine tumors Primary 1 196 0.00 0.00 0.00 0.01
NRAS Q61R bladder cancer Metastasis 1 389 0.00 0.00 0.00 0.01
NRAS Q61R bladder cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
NRAS Q61R bladder cancer Primary 2 1164 0.00 0.00 0.00 0.00
NRAS Q61R b-lymphoblastic leukemia/lymphoma Metastasis 0 13 0.01 0.00 0.00 0.05
NRAS Q61R b-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 109 0.00 0.00 0.00 0.02
NRAS Q61R b-lymphoblastic leukemia/lymphoma Primary 0 101 0.00 0.00 0.00 0.02
NRAS Q61R b-lymphoblastic leukemia/lymphoma Tumor Type:Unspecified 2 25 0.06 0.05 0.00 0.19
NRAS Q61R small bowel cancer Metastasis 1 78 0.01 0.01 0.00 0.04
NRAS Q61R small bowel cancer Primary 0 128 0.00 0.00 0.00 0.02
NRAS Q61R sex cord stromal tumor Metastasis 0 48 0.00 0.00 0.00 0.00
NRAS Q61R sex cord stromal tumor Primary 0 54 0.00 0.00 0.00 0.00
NRAS Q61R bone cancer Metastasis 0 203 0.00 0.00 0.00 0.00
NRAS Q61R bone cancer Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.00
NRAS Q61R bone cancer Primary 0 326 0.00 0.00 0.00 0.00
NRAS Q61R bone cancer Tumor Type:Unspecified 0 16 0.00 0.00 0.00 0.00
NRAS Q61R vaginal cancer Metastasis 0 16 0.00 0.00 0.00 0.01
NRAS Q61R vaginal cancer Primary 0 60 0.00 0.00 0.00 0.00
NRAS Q61R thymic tumor Metastasis 0 61 0.00 0.00 0.00 0.00
NRAS Q61R thymic tumor Primary 0 84 0.00 0.00 0.00 0.00
NRAS Q61R ampullary cancer Metastasis 0 23 0.00 0.00 0.00 0.01
NRAS Q61R ampullary cancer Primary 0 82 0.00 0.00 0.00 0.00
NRAS Q61R small cell lung cancer Metastasis 0 207 0.00 0.00 0.00 0.00
NRAS Q61R small cell lung cancer Primary 0 183 0.00 0.00 0.00 0.00
NRAS Q61R mesothelioma Metastasis 0 82 0.00 0.00 0.00 0.01
NRAS Q61R mesothelioma Primary 1 408 0.00 0.00 0.00 0.01
NRAS Q61R germ cell tumor Metastasis 1 274 0.00 0.00 0.00 0.01
NRAS Q61R germ cell tumor Tumor Type:NA/Heme 0 81 0.00 0.00 0.00 0.01
NRAS Q61R germ cell tumor Primary 2 517 0.00 0.00 0.00 0.01
NRAS Q61R germ cell tumor Tumor Type:Unspecified 0 14 0.00 0.00 0.00 0.02
NRAS Q61R nerve sheath tumor Metastasis 0 16 0.02 0.01 0.00 0.06
NRAS Q61R nerve sheath tumor Tumor Type:NA/Heme 1 17 0.03 0.02 0.00 0.12
NRAS Q61R nerve sheath tumor Primary 1 117 0.01 0.01 0.00 0.04
NRAS Q61R penile cancer Metastasis 0 11 0.00 0.00 0.00 0.03
NRAS Q61R penile cancer Primary 0 13 0.00 0.00 0.00 0.03
NRAS Q61R pheochromocytoma Primary 0 18 0.00 0.00 0.00 0.03
NRAS Q61R pineal tumor Primary 0 14 0.00 0.00 0.00 0.05
NRAS Q61R b cell lymphoma Metastasis 0 57 0.01 0.00 0.00 0.02
NRAS Q61R b cell lymphoma Tumor Type:NA/Heme 1 145 0.01 0.01 0.00 0.02
NRAS Q61R b cell lymphoma Primary 5 709 0.01 0.01 0.00 0.01
NRAS Q61R b cell lymphoma Tumor Type:Unspecified 0 51 0.01 0.00 0.00 0.02
NRAS Q61R non-hodgkin lymphoma Primary 0 14 0.00 0.00 0.00 0.04
NRAS Q61R t-lymphoblastic leukemia/lymphoma Tumor Type:NA/Heme 0 25 0.00 0.00 0.00 0.01
NRAS Q61R t-lymphoblastic leukemia/lymphoma Primary 0 11 0.00 0.00 0.00 0.02
NRAS Q61R retinoblastoma Tumor Type:NA/Heme 0 10 0.00 0.00 0.00 0.01
NRAS Q61R retinoblastoma Primary 0 41 0.00 0.00 0.00 0.01
NRAS Q61R hodgkin lymphoma Primary 0 35 0.00 0.00 0.00 0.01
NRAS Q61R lung cancer Primary 0 17 0.00 0.00 0.00 0.04
NRAS Q61R parathyroid cancer Primary 1 13 0.08 0.06 0.00 0.28

R version 3.6.1 (2019-07-05)
Platform: x86_64-apple-darwin15.6.0 (64-bit)
Running under: macOS High Sierra 10.13.4

Matrix products: default
BLAS:   /Library/Frameworks/R.framework/Versions/3.6/Resources/lib/libRblas.0.dylib
LAPACK: /Library/Frameworks/R.framework/Versions/3.6/Resources/lib/libRlapack.dylib

locale:
[1] en_US.UTF-8/en_US.UTF-8/en_US.UTF-8/C/en_US.UTF-8/en_US.UTF-8

attached base packages:
[1] stats     graphics  grDevices utils     datasets  methods   base     

other attached packages:
 [1] here_1.0.1      gt_0.6.0        forcats_0.5.1   stringr_1.4.0  
 [5] dplyr_1.0.9     purrr_0.3.4     readr_2.1.2     tidyr_1.2.0    
 [9] tibble_3.1.7    ggplot2_3.3.6   tidyverse_1.3.1 magrittr_2.0.3 
[13] workflowr_1.7.0

loaded via a namespace (and not attached):
 [1] Rcpp_1.0.8.3     lubridate_1.8.0  getPass_0.2-2    ps_1.7.0        
 [5] assertthat_0.2.1 rprojroot_2.0.3  digest_0.6.29    utf8_1.2.2      
 [9] R6_2.5.1         cellranger_1.1.0 backports_1.4.1  reprex_2.0.1    
[13] evaluate_0.15    httr_1.4.3       pillar_1.7.0     rlang_1.0.2     
[17] readxl_1.4.0     rstudioapi_0.13  whisker_0.4      callr_3.7.0     
[21] jquerylib_0.1.4  checkmate_2.1.0  rmarkdown_2.14   bit_4.0.4       
[25] munsell_0.5.0    broom_0.8.0      compiler_3.6.1   httpuv_1.6.5    
[29] modelr_0.1.8     xfun_0.31        pkgconfig_2.0.3  htmltools_0.5.2 
[33] tidyselect_1.1.2 fansi_1.0.3      withr_2.5.0      crayon_1.5.1    
[37] tzdb_0.3.0       dbplyr_2.2.0     later_1.3.0      rappdirs_0.3.3  
[41] grid_3.6.1       jsonlite_1.8.0   gtable_0.3.0     lifecycle_1.0.1 
[45] DBI_1.1.2        git2r_0.30.1     scales_1.2.0     vroom_1.5.7     
[49] cli_3.3.0        stringi_1.7.6    fs_1.5.2         promises_1.2.0.1
[53] xml2_1.3.3       bslib_0.3.1      ellipsis_0.3.2   generics_0.1.2  
[57] vctrs_0.4.1      tools_3.6.1      bit64_4.0.5      glue_1.6.2      
[61] hms_1.1.1        parallel_3.6.1   processx_3.5.3   fastmap_1.1.0   
[65] yaml_2.3.5       colorspace_2.0-3 rvest_1.0.2      knitr_1.39      
[69] haven_2.5.0      sass_0.4.1